{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "9e0e84dc",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Use a pipeline as a high-level helper\n",
    "from transformers import pipeline\n",
    "\n",
    "pipe = pipeline(\"token-classification\", model=\"d4data/biomedical-ner-all\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 971,
   "id": "0512ed9f",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import json\n",
    "split = \"train.json\"\n",
    "data = json.load(open(f\"data/{split}\"))\n",
    "files = os.listdir(\"data/CT json/\")\n",
    "#files.remove(\".DS_Store\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 972,
   "id": "268b8925",
   "metadata": {},
   "outputs": [],
   "source": [
    "files_data = {file[:-5]:json.load(open(f\"data/CT json/{file}\")) for file in files}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1070,
   "id": "c5711d79",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Type</th>\n",
       "      <th>Section_id</th>\n",
       "      <th>Primary_id</th>\n",
       "      <th>Secondary_id</th>\n",
       "      <th>Statement</th>\n",
       "      <th>Label</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5bc844fc-e852-4270-bfaf-36ea9eface3d</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT01928186</td>\n",
       "      <td>NCT00684983</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>Contradiction</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86b7cb3d-6186-4a04-9aa6-b174ab764eed</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00662129</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Patients with Platelet count over 100,000/mm¬¨...</td>\n",
       "      <td>Contradiction</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dbed5471-c2fc-45b5-b26f-430c9fa37a37</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Adverse Events</td>\n",
       "      <td>NCT00093145</td>\n",
       "      <td>NCT00703326</td>\n",
       "      <td>Heart-related adverse events were recorded in ...</td>\n",
       "      <td>Entailment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20c35c89-8d23-4be3-b603-ac0ee0f3b4de</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT01097642</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Adult Patients with histologic confirmation of...</td>\n",
       "      <td>Contradiction</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>f17cb242-419d-4f5d-bfa4-41494ed5ac0e</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT00852930</td>\n",
       "      <td>NCT02308020</td>\n",
       "      <td>Laser Therapy is in each cohort of the primary...</td>\n",
       "      <td>Contradiction</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>f37774f4-db96-4aa6-b3a1-626953faeecf</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00213980</td>\n",
       "      <td>NCT02536339</td>\n",
       "      <td>Adequate blood, kidney, and hepatic function a...</td>\n",
       "      <td>Entailment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4fef4cdf-53bf-4239-9d31-4710fd3edc6f</th>\n",
       "      <td>Single</td>\n",
       "      <td>Results</td>\n",
       "      <td>NCT01605396</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The Ridaforolimus + Dalotuzumab + Exemestane g...</td>\n",
       "      <td>Contradiction</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>331affb2-f8e9-4a55-ac4c-62d2ecc4f80b</th>\n",
       "      <td>Single</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT00181363</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The only difference between the interventions ...</td>\n",
       "      <td>Entailment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>a577e819-c928-4217-8743-f4809e852919</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00834678</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Patients must have a white blood cell count ab...</td>\n",
       "      <td>Entailment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>bd073d05-3ba2-4898-9d86-a51951a7ad1f</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Results</td>\n",
       "      <td>NCT01004172</td>\n",
       "      <td>NCT00802945</td>\n",
       "      <td>the primary trial and the secondary trial both...</td>\n",
       "      <td>Contradiction</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1700 rows × 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            Type      Section_id   Primary_id  \\\n",
       "5bc844fc-e852-4270-bfaf-36ea9eface3d  Comparison    Intervention  NCT01928186   \n",
       "86b7cb3d-6186-4a04-9aa6-b174ab764eed      Single     Eligibility  NCT00662129   \n",
       "dbed5471-c2fc-45b5-b26f-430c9fa37a37  Comparison  Adverse Events  NCT00093145   \n",
       "20c35c89-8d23-4be3-b603-ac0ee0f3b4de      Single     Eligibility  NCT01097642   \n",
       "f17cb242-419d-4f5d-bfa4-41494ed5ac0e  Comparison    Intervention  NCT00852930   \n",
       "...                                          ...             ...          ...   \n",
       "f37774f4-db96-4aa6-b3a1-626953faeecf  Comparison     Eligibility  NCT00213980   \n",
       "4fef4cdf-53bf-4239-9d31-4710fd3edc6f      Single         Results  NCT01605396   \n",
       "331affb2-f8e9-4a55-ac4c-62d2ecc4f80b      Single    Intervention  NCT00181363   \n",
       "a577e819-c928-4217-8743-f4809e852919      Single     Eligibility  NCT00834678   \n",
       "bd073d05-3ba2-4898-9d86-a51951a7ad1f  Comparison         Results  NCT01004172   \n",
       "\n",
       "                                     Secondary_id  \\\n",
       "5bc844fc-e852-4270-bfaf-36ea9eface3d  NCT00684983   \n",
       "86b7cb3d-6186-4a04-9aa6-b174ab764eed          NaN   \n",
       "dbed5471-c2fc-45b5-b26f-430c9fa37a37  NCT00703326   \n",
       "20c35c89-8d23-4be3-b603-ac0ee0f3b4de          NaN   \n",
       "f17cb242-419d-4f5d-bfa4-41494ed5ac0e  NCT02308020   \n",
       "...                                           ...   \n",
       "f37774f4-db96-4aa6-b3a1-626953faeecf  NCT02536339   \n",
       "4fef4cdf-53bf-4239-9d31-4710fd3edc6f          NaN   \n",
       "331affb2-f8e9-4a55-ac4c-62d2ecc4f80b          NaN   \n",
       "a577e819-c928-4217-8743-f4809e852919          NaN   \n",
       "bd073d05-3ba2-4898-9d86-a51951a7ad1f  NCT00802945   \n",
       "\n",
       "                                                                              Statement  \\\n",
       "5bc844fc-e852-4270-bfaf-36ea9eface3d  All the primary trial participants do not rece...   \n",
       "86b7cb3d-6186-4a04-9aa6-b174ab764eed  Patients with Platelet count over 100,000/mm¬¨...   \n",
       "dbed5471-c2fc-45b5-b26f-430c9fa37a37  Heart-related adverse events were recorded in ...   \n",
       "20c35c89-8d23-4be3-b603-ac0ee0f3b4de  Adult Patients with histologic confirmation of...   \n",
       "f17cb242-419d-4f5d-bfa4-41494ed5ac0e  Laser Therapy is in each cohort of the primary...   \n",
       "...                                                                                 ...   \n",
       "f37774f4-db96-4aa6-b3a1-626953faeecf  Adequate blood, kidney, and hepatic function a...   \n",
       "4fef4cdf-53bf-4239-9d31-4710fd3edc6f  The Ridaforolimus + Dalotuzumab + Exemestane g...   \n",
       "331affb2-f8e9-4a55-ac4c-62d2ecc4f80b  The only difference between the interventions ...   \n",
       "a577e819-c928-4217-8743-f4809e852919  Patients must have a white blood cell count ab...   \n",
       "bd073d05-3ba2-4898-9d86-a51951a7ad1f  the primary trial and the secondary trial both...   \n",
       "\n",
       "                                              Label  \n",
       "5bc844fc-e852-4270-bfaf-36ea9eface3d  Contradiction  \n",
       "86b7cb3d-6186-4a04-9aa6-b174ab764eed  Contradiction  \n",
       "dbed5471-c2fc-45b5-b26f-430c9fa37a37     Entailment  \n",
       "20c35c89-8d23-4be3-b603-ac0ee0f3b4de  Contradiction  \n",
       "f17cb242-419d-4f5d-bfa4-41494ed5ac0e  Contradiction  \n",
       "...                                             ...  \n",
       "f37774f4-db96-4aa6-b3a1-626953faeecf     Entailment  \n",
       "4fef4cdf-53bf-4239-9d31-4710fd3edc6f  Contradiction  \n",
       "331affb2-f8e9-4a55-ac4c-62d2ecc4f80b     Entailment  \n",
       "a577e819-c928-4217-8743-f4809e852919     Entailment  \n",
       "bd073d05-3ba2-4898-9d86-a51951a7ad1f  Contradiction  \n",
       "\n",
       "[1700 rows x 6 columns]"
      ]
     },
     "execution_count": 1070,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "df = pd.DataFrame(data).T\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1071,
   "id": "da031d4a",
   "metadata": {},
   "outputs": [],
   "source": [
    "data_dict = {}\n",
    "\n",
    "for index, row in df.iterrows():\n",
    "    key = row['Statement']\n",
    "    value = row.drop('Statement').to_dict()\n",
    "    data_dict[f\"{key}_____{row['Label']}\"] = value\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1072,
   "id": "61266ae7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1700"
      ]
     },
     "execution_count": 1072,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(data_dict)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1073,
   "id": "1458a1dc",
   "metadata": {},
   "outputs": [],
   "source": [
    "hypotheses = list(df['Statement'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1074,
   "id": "21e29301",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1700"
      ]
     },
     "execution_count": 1074,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(hypotheses)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "521926d3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">When \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sebastian Thrun\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " started working on self-driving cars at \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Google\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " in \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    2007\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       ", few people outside of the company took him seriously.</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import spacy\n",
    "from spacy import displacy\n",
    "\n",
    "text = \"When Sebastian Thrun started working on self-driving cars at Google in 2007, few people outside of the company took him seriously.\"\n",
    "\n",
    "nlp = spacy.load(\"en_core_web_sm\")\n",
    "doc = nlp(text)\n",
    "displacy.render(doc, style=\"ent\", jupyter=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "3f22d799",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'entity': 'B-Sign_symptom',\n",
       "  'score': 0.9999311,\n",
       "  'index': 9,\n",
       "  'word': 'pal',\n",
       "  'start': 38,\n",
       "  'end': 41},\n",
       " {'entity': 'B-Sign_symptom',\n",
       "  'score': 0.86968315,\n",
       "  'index': 10,\n",
       "  'word': '##pit',\n",
       "  'start': 41,\n",
       "  'end': 44},\n",
       " {'entity': 'I-Sign_symptom',\n",
       "  'score': 0.94298196,\n",
       "  'index': 11,\n",
       "  'word': '##ations',\n",
       "  'start': 44,\n",
       "  'end': 50},\n",
       " {'entity': 'B-Clinical_event',\n",
       "  'score': 0.99975544,\n",
       "  'index': 13,\n",
       "  'word': 'follow',\n",
       "  'start': 54,\n",
       "  'end': 60},\n",
       " {'entity': 'B-Date',\n",
       "  'score': 0.999851,\n",
       "  'index': 16,\n",
       "  'word': '6',\n",
       "  'start': 64,\n",
       "  'end': 65},\n",
       " {'entity': 'I-Date',\n",
       "  'score': 0.9999045,\n",
       "  'index': 17,\n",
       "  'word': 'months',\n",
       "  'start': 66,\n",
       "  'end': 72},\n",
       " {'entity': 'I-Date',\n",
       "  'score': 0.9998456,\n",
       "  'index': 18,\n",
       "  'word': 'after',\n",
       "  'start': 73,\n",
       "  'end': 78}]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pipe(\"\"\"The patient reported no recurrence of palpitations at follow-up 6 months after the ablation.\"\"\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1051,
   "id": "803c91e7",
   "metadata": {},
   "outputs": [],
   "source": [
    "from types import SimpleNamespace\n",
    "\n",
    "def convert_to_desired_format(entity_list, text):\n",
    "    # Extracting text from the provided entities\n",
    "    #text = \" \".join([entity['word'] for entity in entity_list])\n",
    "\n",
    "    # Combining consecutive entities with the same type\n",
    "    combined_entities = []\n",
    "    current_entity = None\n",
    "\n",
    "    for entity in entity_list:\n",
    "        if entity['score'] < 0.7:\n",
    "            continue\n",
    "        if current_entity is None:\n",
    "            current_entity = {\"start\": entity['start'], \"end\": entity['end'], \"label\": entity['entity'].split('-')[-1]}\n",
    "        elif entity['entity'].split('-')[-1] == current_entity['label'] and entity['start'] in [current_entity['end'],current_entity['end']+1]:\n",
    "            current_entity['end'] = entity['end']\n",
    "        else:\n",
    "            combined_entities.append(current_entity)\n",
    "            current_entity = {\"start\": entity['start'], \"end\": entity['end'], \n",
    "                              \"label\": entity['entity'].split('-')[-1],\n",
    "                            }\n",
    "\n",
    "    if current_entity is not None:\n",
    "        combined_entities.append(current_entity)\n",
    "\n",
    "    # Creating the final output in the desired format\n",
    "    output = {\"text\": text, \"ents\": combined_entities, \"title\": None}\n",
    "    return output\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1052,
   "id": "6f173ca2",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|███████████████████████████████████████████████████████████████████████████████████████| 1700/1700 [00:35<00:00, 47.72it/s]\n"
     ]
    }
   ],
   "source": [
    "from tqdm import tqdm\n",
    "res = []\n",
    "outs = []\n",
    "for text in tqdm(hypotheses):\n",
    "    ents = pipe(text)\n",
    "    \n",
    "    res.append(convert_to_desired_format(ents, text))\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "fbf4c283",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial.</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "displacy.render(res[19], manual=True, style='ent', jupyter=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1053,
   "id": "33c322ca",
   "metadata": {},
   "outputs": [],
   "source": [
    "outs=[]\n",
    "for out in res:\n",
    "    ents = out['ents']\n",
    "    for ent in ents:\n",
    "        ent['text'] = out['text'] \n",
    "        ent['entity'] = out['text'][ent['start']:ent['end']]\n",
    "    outs.extend(ents)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8c2803a6",
   "metadata": {},
   "source": [
    "## Entities in Hypotheses"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1054,
   "id": "d475c233",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "entities = pd.DataFrame(outs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1055,
   "id": "7b7fad99",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>start</th>\n",
       "      <th>end</th>\n",
       "      <th>label</th>\n",
       "      <th>text</th>\n",
       "      <th>entity</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>54</td>\n",
       "      <td>58</td>\n",
       "      <td>Administration</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>oral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>59</td>\n",
       "      <td>69</td>\n",
       "      <td>Medication</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>capecitabi</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>73</td>\n",
       "      <td>77</td>\n",
       "      <td>Administration</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>oral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>78</td>\n",
       "      <td>98</td>\n",
       "      <td>Medication</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>lapatinib ditosylate</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>102</td>\n",
       "      <td>113</td>\n",
       "      <td>Medication</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>cixutumumab</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4836</th>\n",
       "      <td>85</td>\n",
       "      <td>88</td>\n",
       "      <td>Diagnostic_procedure</td>\n",
       "      <td>The Ridaforolimus + Dalotuzumab + Exemestane g...</td>\n",
       "      <td>PFS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4837</th>\n",
       "      <td>21</td>\n",
       "      <td>43</td>\n",
       "      <td>Diagnostic_procedure</td>\n",
       "      <td>Patients must have a white blood cell count ab...</td>\n",
       "      <td>white blood cell count</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4838</th>\n",
       "      <td>44</td>\n",
       "      <td>61</td>\n",
       "      <td>Lab_value</td>\n",
       "      <td>Patients must have a white blood cell count ab...</td>\n",
       "      <td>above 1,500/mm¬¨‚</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4839</th>\n",
       "      <td>26</td>\n",
       "      <td>35</td>\n",
       "      <td>Detailed_description</td>\n",
       "      <td>the primary trial and the secondary trial both...</td>\n",
       "      <td>secondary</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4840</th>\n",
       "      <td>51</td>\n",
       "      <td>56</td>\n",
       "      <td>Coreference</td>\n",
       "      <td>the primary trial and the secondary trial both...</td>\n",
       "      <td>tumor</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>4841 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      start  end                 label  \\\n",
       "0        54   58        Administration   \n",
       "1        59   69            Medication   \n",
       "2        73   77        Administration   \n",
       "3        78   98            Medication   \n",
       "4       102  113            Medication   \n",
       "...     ...  ...                   ...   \n",
       "4836     85   88  Diagnostic_procedure   \n",
       "4837     21   43  Diagnostic_procedure   \n",
       "4838     44   61             Lab_value   \n",
       "4839     26   35  Detailed_description   \n",
       "4840     51   56           Coreference   \n",
       "\n",
       "                                                   text  \\\n",
       "0     All the primary trial participants do not rece...   \n",
       "1     All the primary trial participants do not rece...   \n",
       "2     All the primary trial participants do not rece...   \n",
       "3     All the primary trial participants do not rece...   \n",
       "4     All the primary trial participants do not rece...   \n",
       "...                                                 ...   \n",
       "4836  The Ridaforolimus + Dalotuzumab + Exemestane g...   \n",
       "4837  Patients must have a white blood cell count ab...   \n",
       "4838  Patients must have a white blood cell count ab...   \n",
       "4839  the primary trial and the secondary trial both...   \n",
       "4840  the primary trial and the secondary trial both...   \n",
       "\n",
       "                      entity  \n",
       "0                       oral  \n",
       "1                 capecitabi  \n",
       "2                       oral  \n",
       "3       lapatinib ditosylate  \n",
       "4                cixutumumab  \n",
       "...                      ...  \n",
       "4836                     PFS  \n",
       "4837  white blood cell count  \n",
       "4838       above 1,500/mm¬¨‚  \n",
       "4839               secondary  \n",
       "4840                   tumor  \n",
       "\n",
       "[4841 rows x 5 columns]"
      ]
     },
     "execution_count": 1055,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "entities"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 382,
   "id": "0468e0fb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'capecitabi'"
      ]
     },
     "execution_count": 382,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "entities.loc[0]['text'][59:69]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1056,
   "id": "2d19c6d9",
   "metadata": {},
   "outputs": [],
   "source": [
    "entities_no_duplicate = entities.drop_duplicates()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1057,
   "id": "c76e50cd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>start</th>\n",
       "      <th>end</th>\n",
       "      <th>label</th>\n",
       "      <th>text</th>\n",
       "      <th>entity</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>54</td>\n",
       "      <td>58</td>\n",
       "      <td>Administration</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>oral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>59</td>\n",
       "      <td>69</td>\n",
       "      <td>Medication</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>capecitabi</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>73</td>\n",
       "      <td>77</td>\n",
       "      <td>Administration</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>oral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>78</td>\n",
       "      <td>98</td>\n",
       "      <td>Medication</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>lapatinib ditosylate</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>102</td>\n",
       "      <td>113</td>\n",
       "      <td>Medication</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>cixutumumab</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4836</th>\n",
       "      <td>85</td>\n",
       "      <td>88</td>\n",
       "      <td>Diagnostic_procedure</td>\n",
       "      <td>The Ridaforolimus + Dalotuzumab + Exemestane g...</td>\n",
       "      <td>PFS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4837</th>\n",
       "      <td>21</td>\n",
       "      <td>43</td>\n",
       "      <td>Diagnostic_procedure</td>\n",
       "      <td>Patients must have a white blood cell count ab...</td>\n",
       "      <td>white blood cell count</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4838</th>\n",
       "      <td>44</td>\n",
       "      <td>61</td>\n",
       "      <td>Lab_value</td>\n",
       "      <td>Patients must have a white blood cell count ab...</td>\n",
       "      <td>above 1,500/mm¬¨‚</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4839</th>\n",
       "      <td>26</td>\n",
       "      <td>35</td>\n",
       "      <td>Detailed_description</td>\n",
       "      <td>the primary trial and the secondary trial both...</td>\n",
       "      <td>secondary</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4840</th>\n",
       "      <td>51</td>\n",
       "      <td>56</td>\n",
       "      <td>Coreference</td>\n",
       "      <td>the primary trial and the secondary trial both...</td>\n",
       "      <td>tumor</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>4818 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      start  end                 label  \\\n",
       "0        54   58        Administration   \n",
       "1        59   69            Medication   \n",
       "2        73   77        Administration   \n",
       "3        78   98            Medication   \n",
       "4       102  113            Medication   \n",
       "...     ...  ...                   ...   \n",
       "4836     85   88  Diagnostic_procedure   \n",
       "4837     21   43  Diagnostic_procedure   \n",
       "4838     44   61             Lab_value   \n",
       "4839     26   35  Detailed_description   \n",
       "4840     51   56           Coreference   \n",
       "\n",
       "                                                   text  \\\n",
       "0     All the primary trial participants do not rece...   \n",
       "1     All the primary trial participants do not rece...   \n",
       "2     All the primary trial participants do not rece...   \n",
       "3     All the primary trial participants do not rece...   \n",
       "4     All the primary trial participants do not rece...   \n",
       "...                                                 ...   \n",
       "4836  The Ridaforolimus + Dalotuzumab + Exemestane g...   \n",
       "4837  Patients must have a white blood cell count ab...   \n",
       "4838  Patients must have a white blood cell count ab...   \n",
       "4839  the primary trial and the secondary trial both...   \n",
       "4840  the primary trial and the secondary trial both...   \n",
       "\n",
       "                      entity  \n",
       "0                       oral  \n",
       "1                 capecitabi  \n",
       "2                       oral  \n",
       "3       lapatinib ditosylate  \n",
       "4                cixutumumab  \n",
       "...                      ...  \n",
       "4836                     PFS  \n",
       "4837  white blood cell count  \n",
       "4838       above 1,500/mm¬¨‚  \n",
       "4839               secondary  \n",
       "4840                   tumor  \n",
       "\n",
       "[4818 rows x 5 columns]"
      ]
     },
     "execution_count": 1057,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "entities_no_duplicate"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1058,
   "id": "2b833661",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['Administration', 'Medication', 'Diagnostic_procedure',\n",
       "       'Lab_value', 'Detailed_description', 'Sign_symptom',\n",
       "       'Biological_structure', 'Disease_disorder',\n",
       "       'Therapeutic_procedure', 'Age', 'Sex', 'Dosage', 'Duration',\n",
       "       'Coreference', 'Severity', 'History', 'Personal_background',\n",
       "       'Date', 'Subject', 'Distance', 'Frequency', 'Clinical_event',\n",
       "       'Outcome', 'Quantitative_concept', 'Activity', 'Family_history',\n",
       "       'Nonbiological_location', 'Volume'], dtype=object)"
      ]
     },
     "execution_count": 1058,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "entities_no_duplicate['label'].unique()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ee22d1fe",
   "metadata": {},
   "source": [
    "## Handling Acronyms"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 391,
   "id": "bbd3cd6c",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/5c/l985x1v12kxb69md6b3p67dm0000gn/T/ipykernel_38853/1432079811.py:1: DtypeWarning: Columns (9) have mixed types. Specify dtype option on import or set low_memory=False.\n",
      "  inventory = pd.read_csv('/Users/bhuvanesh/Downloads/Metainventory_Version1.0.0.csv', sep= '|')\n"
     ]
    }
   ],
   "source": [
    "inventory = pd.read_csv('data/Metainventory_Version1.0.0.csv', sep= '|')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 392,
   "id": "efa3ea36",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>GroupID</th>\n",
       "      <th>RecordID</th>\n",
       "      <th>SF</th>\n",
       "      <th>SFUI</th>\n",
       "      <th>NormSF</th>\n",
       "      <th>LF</th>\n",
       "      <th>LFUI</th>\n",
       "      <th>NormLF</th>\n",
       "      <th>Source</th>\n",
       "      <th>Modified</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>G002754</td>\n",
       "      <td>R000001</td>\n",
       "      <td>AA</td>\n",
       "      <td>S003081</td>\n",
       "      <td>aa</td>\n",
       "      <td>achievement age</td>\n",
       "      <td>L037913</td>\n",
       "      <td>achievement age</td>\n",
       "      <td>UMLS</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>G159189</td>\n",
       "      <td>R000002</td>\n",
       "      <td>AA</td>\n",
       "      <td>S003081</td>\n",
       "      <td>aa</td>\n",
       "      <td>Alcoholics Anonymous</td>\n",
       "      <td>L004250</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UMLS</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>G178751</td>\n",
       "      <td>R000003</td>\n",
       "      <td>AA</td>\n",
       "      <td>S003081</td>\n",
       "      <td>aa</td>\n",
       "      <td>alcohol abuse</td>\n",
       "      <td>L040702</td>\n",
       "      <td>alcohol abuse</td>\n",
       "      <td>UMLS</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>G178751</td>\n",
       "      <td>R000004</td>\n",
       "      <td>AA</td>\n",
       "      <td>S003081</td>\n",
       "      <td>aa</td>\n",
       "      <td>alcohol-abuse</td>\n",
       "      <td>L040752</td>\n",
       "      <td>alcohol abuse</td>\n",
       "      <td>UMLS</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>G159190</td>\n",
       "      <td>R000005</td>\n",
       "      <td>AA</td>\n",
       "      <td>S003081</td>\n",
       "      <td>aa</td>\n",
       "      <td>aortic aneurysm</td>\n",
       "      <td>L045559</td>\n",
       "      <td>aortic aneurysm</td>\n",
       "      <td>UMLS</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>405538</th>\n",
       "      <td>G079548</td>\n",
       "      <td>R409664</td>\n",
       "      <td>VAVD</td>\n",
       "      <td>S074754</td>\n",
       "      <td>vavd</td>\n",
       "      <td>Vacuum-assisted vaginal delivery</td>\n",
       "      <td>L035392</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Columbia</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>405539</th>\n",
       "      <td>G157433</td>\n",
       "      <td>R409665</td>\n",
       "      <td>VBAC</td>\n",
       "      <td>S074768</td>\n",
       "      <td>vbac</td>\n",
       "      <td>Vaginal birth after caesarean section</td>\n",
       "      <td>L035393</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Columbia</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>405540</th>\n",
       "      <td>G157471</td>\n",
       "      <td>R409666</td>\n",
       "      <td>VSD</td>\n",
       "      <td>S075523</td>\n",
       "      <td>vsd</td>\n",
       "      <td>Ventricular septal defect</td>\n",
       "      <td>L035516</td>\n",
       "      <td>ventricular septal defect</td>\n",
       "      <td>Columbia</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>405541</th>\n",
       "      <td>G080510</td>\n",
       "      <td>R409667</td>\n",
       "      <td>VTOP</td>\n",
       "      <td>S075577</td>\n",
       "      <td>vtop</td>\n",
       "      <td>Voluntary termination of pregnancy</td>\n",
       "      <td>L035817</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Columbia</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>405542</th>\n",
       "      <td>G080513</td>\n",
       "      <td>R409668</td>\n",
       "      <td>VTX</td>\n",
       "      <td>S075579</td>\n",
       "      <td>vtx</td>\n",
       "      <td>Vertex</td>\n",
       "      <td>L035562</td>\n",
       "      <td>vertex</td>\n",
       "      <td>Columbia</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>405543 rows × 10 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        GroupID RecordID    SF     SFUI NormSF  \\\n",
       "0       G002754  R000001    AA  S003081     aa   \n",
       "1       G159189  R000002    AA  S003081     aa   \n",
       "2       G178751  R000003    AA  S003081     aa   \n",
       "3       G178751  R000004    AA  S003081     aa   \n",
       "4       G159190  R000005    AA  S003081     aa   \n",
       "...         ...      ...   ...      ...    ...   \n",
       "405538  G079548  R409664  VAVD  S074754   vavd   \n",
       "405539  G157433  R409665  VBAC  S074768   vbac   \n",
       "405540  G157471  R409666   VSD  S075523    vsd   \n",
       "405541  G080510  R409667  VTOP  S075577   vtop   \n",
       "405542  G080513  R409668   VTX  S075579    vtx   \n",
       "\n",
       "                                           LF     LFUI  \\\n",
       "0                             achievement age  L037913   \n",
       "1                        Alcoholics Anonymous  L004250   \n",
       "2                               alcohol abuse  L040702   \n",
       "3                               alcohol-abuse  L040752   \n",
       "4                             aortic aneurysm  L045559   \n",
       "...                                       ...      ...   \n",
       "405538       Vacuum-assisted vaginal delivery  L035392   \n",
       "405539  Vaginal birth after caesarean section  L035393   \n",
       "405540              Ventricular septal defect  L035516   \n",
       "405541     Voluntary termination of pregnancy  L035817   \n",
       "405542                                 Vertex  L035562   \n",
       "\n",
       "                           NormLF    Source Modified  \n",
       "0                 achievement age      UMLS      NaN  \n",
       "1                             NaN      UMLS      NaN  \n",
       "2                   alcohol abuse      UMLS      NaN  \n",
       "3                   alcohol abuse      UMLS      NaN  \n",
       "4                 aortic aneurysm      UMLS      NaN  \n",
       "...                           ...       ...      ...  \n",
       "405538                        NaN  Columbia      NaN  \n",
       "405539                        NaN  Columbia      NaN  \n",
       "405540  ventricular septal defect  Columbia      NaN  \n",
       "405541                        NaN  Columbia      NaN  \n",
       "405542                     vertex  Columbia      NaN  \n",
       "\n",
       "[405543 rows x 10 columns]"
      ]
     },
     "execution_count": 392,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "inventory"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1145,
   "id": "1280853c",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "\n",
    "sf2lf = dd(set)\n",
    "lf2sf = dd(set)\n",
    "\n",
    "for index, row in inventory.iterrows():\n",
    "    if not isinstance(row['SF'], str):\n",
    "        continue\n",
    "    if row['SF'][0].lower() != row['LF'][0].lower() or len(row['SF']) < len(row['LF'].split()):\n",
    "        continue\n",
    "    \n",
    "    sf2lf[row['SF']].add(row['LF'])\n",
    "    lf2sf[row['LF']].add(row['SF'].upper())\n",
    "    \n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1110,
   "id": "64d48135",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "defaultdict(set,\n",
       "            {'achievement age': {'AA'},\n",
       "             'Alcoholics Anonymous': {'A.A.', 'AA'},\n",
       "             'alcohol abuse': {'AA'},\n",
       "             'alcohol-abuse': {'AA'},\n",
       "             'aortic aneurysm': {'AA'},\n",
       "             'aortic arch': {'AA'},\n",
       "             'ascending aorta': {'AA', 'AO', 'ASCAO'},\n",
       "             'attendance allowance': {'AA'},\n",
       "             'aminoacid': {'AA'},\n",
       "             'amino acid': {'A.A.', 'AA'},\n",
       "             'amino-acid': {'AA'},\n",
       "             'arachidonic acid': {'AA', 'ARA'},\n",
       "             'ascorbic acid': {'AA', 'ASA', 'ASC'},\n",
       "             'aplastic anemia': {'AA'},\n",
       "             'aplastic anaemia': {'AA'},\n",
       "             'adjuvant arthritis': {'AA'},\n",
       "             'anaplastic astrocytoma': {'AA'},\n",
       "             'alopecia areata': {'AA'},\n",
       "             'African American': {'A-A', 'AA'},\n",
       "             'African-American': {'A-A', 'AA'},\n",
       "             'acrylic acid': {'AA', 'AAC'},\n",
       "             'aristolochic acid': {'AA'},\n",
       "             'allylalcohol': {'AA'},\n",
       "             'allyl alcohol': {'AA'},\n",
       "             'acute appendicitis': {'AA', 'AAP'},\n",
       "             'abdominal aorta': {'AA', 'AO'},\n",
       "             'aromatase activity': {'AA'},\n",
       "             'acupuncture analgesia': {'AA'},\n",
       "             'afferent arteriole': {'AA', 'AF-ART'},\n",
       "             'adrenal androgen': {'AA'},\n",
       "             'atomic absorption': {'AA'},\n",
       "             'amyloid angiopathy': {'AA'},\n",
       "             'atopic asthmatic': {'AA'},\n",
       "             'aromatic amine': {'AA'},\n",
       "             'atrial arrhythmia': {'AA'},\n",
       "             'atrial activity': {'AA'},\n",
       "             'acetaminophen': {'AA', 'AAP', 'ACM', 'AP', 'APAP'},\n",
       "             'acrylamide': {'AA', 'AAM', 'AC', 'ACR', 'AM'},\n",
       "             'acetaldehyde': {'AA', 'ACA', 'ACE', 'ACH'},\n",
       "             'amyloid A': {'AA'},\n",
       "             'amyloid-A': {'AA'},\n",
       "             'abdominal aortic aneurysmectomy': {'AAA'},\n",
       "             'acne associated arthritis': {'AAA'},\n",
       "             'acne-associated arthritis': {'AAA'},\n",
       "             'acquired aplastic anemia': {'AAA'},\n",
       "             'acquired aplastic anaemia': {'AAA'},\n",
       "             'acute anxiety attack': {'AAA'},\n",
       "             'androgenic anabolic agent': {'AAA'},\n",
       "             'aromatic amino acid': {'AAA'},\n",
       "             'acute apical abscess': {'AAA'},\n",
       "             'abdominal aortic aneurism': {'AAA'},\n",
       "             'abdominal aortic aneurysm': {'AAA'},\n",
       "             'alpha-aminoadipic acid': {'AAA'},\n",
       "             'antialbumin antibody': {'AAA'},\n",
       "             'anti-albumin antibody': {'AAA'},\n",
       "             'acetylaminoantipyrine': {'AAA'},\n",
       "             'acetyl-amino-antipyrine': {'AAA'},\n",
       "             'antiactin antibody': {'AAA'},\n",
       "             'anti-actin antibody': {'AAA'},\n",
       "             'Aleuria aurantia agglutinin': {'AAA'},\n",
       "             'Anguilla anguilla agglutinin': {'AAA'},\n",
       "             'amino acid analysis': {'AAA'},\n",
       "             'arylacylamidase': {'AAA'},\n",
       "             'aryl acylamidase': {'AAA'},\n",
       "             'aryl acyl amidase': {'AAA'},\n",
       "             'American Association on Mental Deficiency': {'A.A.M.D.'},\n",
       "             'automatic atrial tachycardia': {'AAT'},\n",
       "             'Aachen aphasia test': {'AAT'},\n",
       "             'alanine aminotransferase': {'AAT',\n",
       "              'ALA-AT',\n",
       "              'ALA-T',\n",
       "              'ALAAT',\n",
       "              'ALAT',\n",
       "              'ALT'},\n",
       "             'alanine amino transferase': {'AAT', 'ALA-T', 'ALAT', 'ALT'},\n",
       "             'alanine-aminotransferase': {'AAT', 'ALA-T', 'ALAT', 'ALT'},\n",
       "             'alanine amino-transferase': {'AAT', 'ALA-T', 'ALAT', 'ALT'},\n",
       "             'alanine-amino-transferase': {'AAT', 'ALA-T', 'ALAT', 'ALT'},\n",
       "             'alkylating agent therapy': {'AAT'},\n",
       "             'alkylating-agent therapy': {'AAT'},\n",
       "             'Academic Aptitude test': {'AAT'},\n",
       "             'academic aptitude test': {'AAT'},\n",
       "             'aspartate aminotransferase': {'AAT',\n",
       "              'AATASE',\n",
       "              'ASAT',\n",
       "              'ASP-AT',\n",
       "              'ASPAT',\n",
       "              'AST'},\n",
       "             'aspartate amino transferase': {'AAT',\n",
       "              'AATASE',\n",
       "              'ASAT',\n",
       "              'ASPAT',\n",
       "              'AST'},\n",
       "             'aspartate-aminotransferase': {'AAT', 'AATASE', 'ASPAT', 'AST'},\n",
       "             'aspartate amino-transferase': {'AAT', 'AATASE', 'ASPAT', 'AST'},\n",
       "             'aspartate-amino-transferase': {'AAT', 'AATASE', 'ASPAT', 'AST'},\n",
       "             'acute acoustic trauma': {'AAT'},\n",
       "             'animal assisted therapy': {'AAT'},\n",
       "             'animal-assisted therapy': {'AAT'},\n",
       "             'African animal trypanosomosis': {'AAT'},\n",
       "             'acetic acid test': {'AAT'},\n",
       "             'artium baccalaureus': {'AB'},\n",
       "             'Ace bandage': {'AB'},\n",
       "             'antibody': {'AB', 'ABO', 'ARA'},\n",
       "             'anti-body': {'AB', 'ABO'},\n",
       "             'Alcian blue': {'AB'},\n",
       "             'alcian blue': {'AB'},\n",
       "             'asbestos body': {'AB'},\n",
       "             'amphotericin B': {'AB',\n",
       "              'AM-B',\n",
       "              'AMB',\n",
       "              'AMP B',\n",
       "              'AMP-B',\n",
       "              'AMPB',\n",
       "              'AMPH',\n",
       "              'AMPH B',\n",
       "              'AMPH-B',\n",
       "              'AMPHB',\n",
       "              'AMPHO B',\n",
       "              'AMPHO-B'},\n",
       "             'amphotericin-B': {'AB',\n",
       "              'AMB',\n",
       "              'AMP B',\n",
       "              'AMP-B',\n",
       "              'AMPB',\n",
       "              'AMPH B',\n",
       "              'AMPH-B',\n",
       "              'AMPHB',\n",
       "              'AMPHO B',\n",
       "              'AMPHO-B'},\n",
       "             'antibiotic': {'AB', 'ATB'},\n",
       "             'anti-biotic': {'AB', 'ATB'},\n",
       "             'autologous blood': {'AB'},\n",
       "             'attentional blink': {'AB'},\n",
       "             'autonomic blockade': {'AB'},\n",
       "             'asthmatic bronchitis': {'AB'},\n",
       "             'autogenous bone': {'AB'},\n",
       "             'arsenobetaine': {'AB', 'ASB'},\n",
       "             'alamarBlue': {'AB'},\n",
       "             'Alamar blue': {'AB'},\n",
       "             'alamar blue': {'AB'},\n",
       "             'aortic banding': {'AB'},\n",
       "             'ammonia borane': {'AB'},\n",
       "             'ammonia-borane': {'AB'},\n",
       "             'ameloblastoma': {'AB'},\n",
       "             'absolute bioavailability': {'AB'},\n",
       "             'absolute bio-availability': {'AB'},\n",
       "             'abortion': {'A', 'AB', 'ABO'},\n",
       "             'abdomen': {'AB', 'ABD', 'ABDOM'},\n",
       "             'aspiration biopsy cytology': {'ABC'},\n",
       "             'alternative birth center': {'ABC'},\n",
       "             'adenosine triphosphate-binding cassette': {'ABC',\n",
       "              'ATP BINDING CASSETTE',\n",
       "              'ATP-BINDING CASSETTE'},\n",
       "             'ATP binding cassette': {'ABC'},\n",
       "             'ATP-binding cassette': {'ABC'},\n",
       "             'avidinbiotin peroxidase complex': {'ABC'},\n",
       "             'avidinbiotin-peroxidase complex': {'ABC'},\n",
       "             'avidin-biotin peroxidase complex': {'ABC'},\n",
       "             'avidin-biotin-peroxidase complex': {'ABC'},\n",
       "             'avidin biotin complex': {'ABC'},\n",
       "             'avidin-biotin complex': {'ABC'},\n",
       "             'aneurismal bone cyst': {'ABC'},\n",
       "             'aneurysmal bone cyst': {'ABC'},\n",
       "             'advanced breast cancer': {'ABC'},\n",
       "             'antibody binding capacity': {'ABC'},\n",
       "             'antibody-binding capacity': {'ABC'},\n",
       "             'activity based costing': {'ABC'},\n",
       "             'activity-based costing': {'ABC'},\n",
       "             'antigen binding cell': {'ABC'},\n",
       "             'antigen-binding cell': {'ABC'},\n",
       "             'argon beam coagulator': {'ABC'},\n",
       "             'argon-beam coagulator': {'ABC'},\n",
       "             'Autism Behavior Checklist': {'ABC'},\n",
       "             'Aberrant Behavior Checklist': {'ABC'},\n",
       "             'antigen binding capacity': {'ABC'},\n",
       "             'antigen-binding capacity': {'ABC'},\n",
       "             'adenoid basal carcinoma': {'ABC'},\n",
       "             'antibothropic complex': {'ABC'},\n",
       "             'anti-bothropic complex': {'ABC'},\n",
       "             'activity-based cost': {'ABC'},\n",
       "             'active breathing control': {'ABC'},\n",
       "             'absolute basophil count': {'ABC'},\n",
       "             'acalculous biliary colic': {'ABC'},\n",
       "             'accelerated blood clearance': {'ABC'},\n",
       "             'approximate Bayesian computation': {'ABC'},\n",
       "             'abacavir': {'ABC'},\n",
       "             'abnormal coronary artery': {'ACA'},\n",
       "             'acrodermatitis chronica atrophicans': {'ACA'},\n",
       "             'acute cerebellar ataxia': {'ACA'},\n",
       "             'adenocarcinoma': {'AC', 'ACA', 'AD', 'ADC', 'ADCA', 'ADENOCA'},\n",
       "             'adeno carcinoma': {'AC', 'ACA', 'AD', 'ADC', 'ADCA', 'ADENOCA'},\n",
       "             'adeno-carcinoma': {'AC', 'ACA', 'AD', 'ADC', 'ADCA', 'ADENOCA'},\n",
       "             'American Chiropractic Association': {'ACA'},\n",
       "             'American Counseling Association': {'ACA'},\n",
       "             'aminocephalosporanic acid': {'ACA'},\n",
       "             'amyotrophic choreoacanthocytosis': {'ACA'},\n",
       "             'amyotrophic choreo-acanthocytosis': {'ACA'},\n",
       "             'anterior cerebral artery': {'A-1', 'ACA'},\n",
       "             'anticapsular antibody': {'ACA'},\n",
       "             'anti-capsular antibody': {'ACA'},\n",
       "             'anticardiolipin antibody': {'A-CL',\n",
       "              'ACA',\n",
       "              'ACL',\n",
       "              'ACL-A',\n",
       "              'ACLA'},\n",
       "             'anti-cardiolipin antibody': {'ACA', 'ACL', 'ACLA'},\n",
       "             'anticentromere antibody': {'ACA'},\n",
       "             'anti-centromere antibody': {'ACA'},\n",
       "             'anticollagen antibody': {'ACA'},\n",
       "             'anti-collagen antibody': {'ACA'},\n",
       "             'anticomplement activity': {'ACA'},\n",
       "             'anti-complement activity': {'ACA'},\n",
       "             'anticytoplasmic antibody': {'ACA'},\n",
       "             'anti-cytoplasmic antibody': {'ACA'},\n",
       "             'arrhythmic cardiac arrest': {'ACA'},\n",
       "             'Affordable Care Act': {'ACA'},\n",
       "             'anterior chamber angle': {'ACA'},\n",
       "             'angiotensinconverting enzyme': {'ACE'},\n",
       "             'angiotensin converting enzyme': {'ACE', 'ACE-I', 'ACEI'},\n",
       "             'angiotensin-converting enzyme': {'ACE'},\n",
       "             'adrenocortical extract': {'ACE'},\n",
       "             'angiotensin I-converting enzyme': {'ACE', 'AICE'},\n",
       "             'angiotensin-I converting enzyme': {'ACE', 'AICE'},\n",
       "             'angiotensin-I-converting enzyme': {'ACE', 'AICE'},\n",
       "             'affinity capillary electrophoresis': {'ACE'},\n",
       "             'acetylcholinesterase': {'ACCHE',\n",
       "              'ACE',\n",
       "              'ACH ESTERASE',\n",
       "              'ACH-E',\n",
       "              'ACH-ESTERASE',\n",
       "              'ACHASE',\n",
       "              'ACHE'},\n",
       "             'acetyl cholinesterase': {'ACE', 'ACH-E', 'ACH-ESTERASE', 'ACHE'},\n",
       "             'acetylcholine esterase': {'ACE',\n",
       "              'ACH-E',\n",
       "              'ACH-ESTERASE',\n",
       "              'ACHE'},\n",
       "             'acetyl choline esterase': {'ACE',\n",
       "              'ACH-E',\n",
       "              'ACH-ESTERASE',\n",
       "              'ACHE'},\n",
       "             'acetyl-cholinesterase': {'ACE', 'ACH-E', 'ACH-ESTERASE', 'ACHE'},\n",
       "             'acetyl-choline esterase': {'ACE',\n",
       "              'ACH-E',\n",
       "              'ACH-ESTERASE',\n",
       "              'ACHE'},\n",
       "             'antegrade continence enema': {'ACE'},\n",
       "             'antegrade colonic enema': {'ACE'},\n",
       "             'amygdaloid central nucleus': {'ACE'},\n",
       "             'accessory cholera enterotoxin': {'ACE'},\n",
       "             \"Addenbrooke's Cognitive Examination\": {'ACE'},\n",
       "             \"Addenbrooke's cognitive examination\": {'ACE'},\n",
       "             'adverse childhood experience': {'ACE'},\n",
       "             'acute cerebral encephalopathy': {'ACE'},\n",
       "             'acute coronary event': {'ACE'},\n",
       "             'acetate': {'AC', 'AC-', 'ACE'},\n",
       "             'acetone': {'A', 'AC', 'ACE', 'ACON'},\n",
       "             'access control system': {'ACS'},\n",
       "             'access-control system': {'ACS'},\n",
       "             'acrocallosal syndrome': {'ACLS', 'ACS'},\n",
       "             'acrocephalosyndactyly': {'ACS'},\n",
       "             'acrocephalo-syndactyly': {'ACS'},\n",
       "             'acute chest syndrome': {'ACS'},\n",
       "             'acute confusional state': {'ACS'},\n",
       "             'acute coronary syndrome': {'ACS'},\n",
       "             'American Chemical Society': {'A.C.S.', 'ACS'},\n",
       "             'antireticular cytotoxic serum': {'A.C.S.', 'ACS'},\n",
       "             'American Cancer Society': {'ACS'},\n",
       "             'acute compartment syndrome': {'ACS'},\n",
       "             'abdominal compartment syndrome': {'ACS'},\n",
       "             'acute care surgery': {'ACS'},\n",
       "             'acute-care surgery': {'ACS'},\n",
       "             'adrenocorticotropic hormone': {'ACTH'},\n",
       "             'adrenocorticotrophic hormone': {'ACTH'},\n",
       "             'adreno-corticotropic hormone': {'ACTH'},\n",
       "             'adreno-corticotrophic hormone': {'ACTH'},\n",
       "             'adrenocorticotropin hormone': {'ACTH'},\n",
       "             'adrenocorticotrophin hormone': {'ACTH'},\n",
       "             'adreno-corticotropin hormone': {'ACTH'},\n",
       "             'adreno-corticotrophin hormone': {'ACTH'},\n",
       "             'acetylcholine': {'AC', 'ACCH', 'ACCHO', 'ACH'},\n",
       "             'acetyl choline': {'AC', 'ACCH', 'ACCHO', 'ACH'},\n",
       "             'acetyl-choline': {'AC', 'ACCH', 'ACCHO', 'ACH'},\n",
       "             'acetylcholine chloride': {'ACH'},\n",
       "             'ACh-esterase': {'ACH-E', 'ACHE'},\n",
       "             'arousal disorder': {'AD'},\n",
       "             'acetate dialysis': {'AD'},\n",
       "             'active disease': {'AD'},\n",
       "             'Alzheimers disease': {'AD'},\n",
       "             \"Alzheimer's disease\": {'AD'},\n",
       "             \"Alzheimers' disease\": {'AD'},\n",
       "             \"Alzheimer's dementia\": {'AD'},\n",
       "             'atopic dermatitis': {'AD'},\n",
       "             'alveolar duct': {'AD', 'AV'},\n",
       "             'affective disorder': {'AD'},\n",
       "             'anodal duration': {'AD'},\n",
       "             'Alzheimer disease': {'AD'},\n",
       "             'Alzheimer dementia': {'AD'},\n",
       "             'alcohol dependence': {'AD'},\n",
       "             'alcohol-dependence': {'AD'},\n",
       "             'aortic dissection': {'AD'},\n",
       "             'axillary dissection': {'AD'},\n",
       "             'androgen deprivation': {'AD'},\n",
       "             'anxiety disorder': {'AD'},\n",
       "             'adjustment disorder': {'AD'},\n",
       "             'autonomic dysreflexia': {'AD'},\n",
       "             'activation domain': {'AD', 'AF-1', 'AF-2', 'AF1', 'AF2'},\n",
       "             'antidepressant': {'AD'},\n",
       "             'anti-depressant': {'AD'},\n",
       "             'autoimmune disease': {'AD', 'AID'},\n",
       "             'auto-immune disease': {'AD'},\n",
       "             'atypical depression': {'AD'},\n",
       "             'androstenedione': {'A',\n",
       "              'A-DIONE',\n",
       "              'A4',\n",
       "              'AD',\n",
       "              'ADIONE',\n",
       "              'AE',\n",
       "              'ASD'},\n",
       "             'androstene dione': {'A-DIONE', 'AD', 'ADIONE', 'ASD'},\n",
       "             'androstene-dione': {'A', 'A-DIONE', 'AD', 'ADIONE', 'ASD'},\n",
       "             'Addisons disease': {'AD'},\n",
       "             \"Addison's disease\": {'AD'},\n",
       "             'actinomycin D': {'ACD',\n",
       "              'ACT',\n",
       "              'ACT D',\n",
       "              'ACT-D',\n",
       "              'ACTD',\n",
       "              'AD',\n",
       "              'AMD'},\n",
       "             'actinomycin-D': {'ACD', 'ACT D', 'ACT-D', 'ACTD', 'AD', 'AMD'},\n",
       "             'actino-mycin D': {'ACD', 'ACT D', 'ACT-D', 'ACTD', 'AD', 'AMD'},\n",
       "             'autonomic dysfunction': {'AD'},\n",
       "             'aortic distensibility': {'AD'},\n",
       "             'accidental death': {'AD'},\n",
       "             'advance directive': {'AD'},\n",
       "             'advanced directive': {'AD'},\n",
       "             'anaerobic digestion': {'AD'},\n",
       "             'anoxic depolarisation': {'AD'},\n",
       "             'anoxic depolarization': {'AD'},\n",
       "             'axial diffusivity': {'AD'},\n",
       "             'adenosine deaminase': {'AD', 'ADA', 'ADAR1', 'ADASE', 'ADD'},\n",
       "             'adenosine-deaminase': {'ADA', 'ADASE', 'ADD'},\n",
       "             'American Diabetes Association': {'ADA'},\n",
       "             'American Dental Association': {'A.D.A.', 'ADA'},\n",
       "             'American Dietetic Association': {'A.D.A.', 'ADA'},\n",
       "             'American Diabetic Association': {'A.D.A.', 'ADA'},\n",
       "             'antidrug antibody': {'ADA'},\n",
       "             'anti-drug antibody': {'ADA'},\n",
       "             'adalimumab': {'ADA'},\n",
       "             'antibody dependent cell-mediated cytotoxicity': {'ADCC'},\n",
       "             'antibody-dependent cell-mediated cytotoxicity': {'ADCC',\n",
       "              'ADCMC'},\n",
       "             'antibody dependent cellular cytotoxicity': {'ADCC'},\n",
       "             'antibody-dependent cellular cytotoxicity': {'ADCC'},\n",
       "             'adverse drug reaction': {'ADR'},\n",
       "             'adrenergic receptor': {'ADR', 'AR'},\n",
       "             'adrenodoxin reductase': {'ADR', 'AR'},\n",
       "             'adenoma detection rate': {'ADR'},\n",
       "             'Adriamycin': {'AD', 'ADM', 'ADR', 'ADRIA'},\n",
       "             'adriamycin': {'A', 'AA', 'ADR', 'ADRIA', 'AM'},\n",
       "             'adrenalin': {'A', 'ADR'},\n",
       "             'antidiuretic substance': {'ADS'},\n",
       "             'acute death syndrome': {'ADS'},\n",
       "             'acute diarrheal syndrome': {'ADS'},\n",
       "             'Alcohol Dependence Scale': {'ADS'},\n",
       "             'alternative delivery system': {'ADS'},\n",
       "             'anatomical dead space': {'ADS'},\n",
       "             'alcohol dependence syndrome': {'ADS'},\n",
       "             'alcohol-dependence syndrome': {'ADS'},\n",
       "             'apocrine epithelial antigen': {'AEA'},\n",
       "             'anandamide': {'AEA', 'ANA'},\n",
       "             'aflatoxin B1': {'AB1', 'AF B1', 'AF-B1', 'AFB', 'AFB1'},\n",
       "             'aflatoxin b1': {'AB1', 'AF B1', 'AF-B1', 'AFB1'},\n",
       "             'Army General Classification Test': {'AGCT'},\n",
       "             'African green monkey kidney': {'AGMK'},\n",
       "             'artificial insemination': {'A.I.', 'AI'},\n",
       "             'accidental injury': {'AI'},\n",
       "             'adiposity index': {'AI'},\n",
       "             'aggregation index': {'AI'},\n",
       "             'anaphylatoxin inactivator': {'AI'},\n",
       "             'angiogenesis inhibitor': {'AI'},\n",
       "             'angiotensin 1': {'AI',\n",
       "              'ANG I',\n",
       "              'ANGI',\n",
       "              'ANGIO I',\n",
       "              'AT I',\n",
       "              'AT-I',\n",
       "              'AT1'},\n",
       "             'angiotensin I': {'A-I',\n",
       "              'AI',\n",
       "              'ANG I',\n",
       "              'ANG-I',\n",
       "              'ANGI',\n",
       "              'ANGIO I',\n",
       "              'AT I',\n",
       "              'AT-I',\n",
       "              'AT1'},\n",
       "             'angiotensine 1': {'AI',\n",
       "              'ANG I',\n",
       "              'ANGI',\n",
       "              'ANGIO I',\n",
       "              'AT I',\n",
       "              'AT-I',\n",
       "              'AT1'},\n",
       "             'angiotensine I': {'AI',\n",
       "              'ANG I',\n",
       "              'ANGI',\n",
       "              'ANGIO I',\n",
       "              'AT I',\n",
       "              'AT-I',\n",
       "              'AT1'},\n",
       "             'angiotensin-1': {'AI',\n",
       "              'ANG I',\n",
       "              'ANGI',\n",
       "              'ANGIO I',\n",
       "              'AT I',\n",
       "              'AT-I',\n",
       "              'AT1'},\n",
       "             'angiotensin-I': {'A-I',\n",
       "              'AI',\n",
       "              'ANG I',\n",
       "              'ANGI',\n",
       "              'ANGIO I',\n",
       "              'AT I',\n",
       "              'AT-I',\n",
       "              'AT1'},\n",
       "             'angiotensine-1': {'AI',\n",
       "              'ANG I',\n",
       "              'ANGI',\n",
       "              'ANGIO I',\n",
       "              'AT I',\n",
       "              'AT-I',\n",
       "              'AT1'},\n",
       "             'angiotensine-I': {'AI',\n",
       "              'ANG I',\n",
       "              'ANGI',\n",
       "              'ANGIO I',\n",
       "              'AT I',\n",
       "              'AT-I',\n",
       "              'AT1'},\n",
       "             'anxiety index': {'AI'},\n",
       "             'articulation index': {'AI'},\n",
       "             'atherogenic index': {'AI'},\n",
       "             'atrial insufficiency': {'AI'},\n",
       "             'autoimmunity': {'AI'},\n",
       "             'auto-immunity': {'AI'},\n",
       "             'active ingredient': {'A.I.', 'AI'},\n",
       "             'activity index': {'AI'},\n",
       "             'adequate intake': {'AI'},\n",
       "             'allelic imbalance': {'AI'},\n",
       "             'Apnea Index': {'AI'},\n",
       "             'apnea index': {'AI'},\n",
       "             'Apnoea Index': {'AI'},\n",
       "             'apnoea index': {'AI'},\n",
       "             'apoptosis index': {'AI'},\n",
       "             'apoptotic index': {'AI'},\n",
       "             'asymmetry index': {'AI'},\n",
       "             'avidity index': {'AI'},\n",
       "             'acetabular index': {'AI'},\n",
       "             'anal incontinence': {'AI'},\n",
       "             'anterior insula': {'AI'},\n",
       "             'acquired immunodeficiency syndrome': {'AIDS'},\n",
       "             'acquired immuno deficiency syndrome': {'AIDS'},\n",
       "             'acquired immuno-deficiency syndrome': {'AIDS'},\n",
       "             'acquired immune deficiency syndrome': {'AIDS'},\n",
       "             'acquired immune-deficiency syndrome': {'AIDS'},\n",
       "             'acquired immunodeficiency disease syndrome': {'AIDS'},\n",
       "             'AIDS associated Kaposi sarcoma': {'AIDS-KS'},\n",
       "             'AIDS-associated Kaposi sarcoma': {'AIDS-KS'},\n",
       "             \"AIDS associated Kaposi's sarcoma\": {'AIDS-KS'},\n",
       "             \"AIDS-associated Kaposi's sarcoma\": {'AIDS-KS'},\n",
       "             'aminolevulinic acid': {'ALA'},\n",
       "             'aminolaevulinic acid': {'ALA'},\n",
       "             'American Laryngological Association': {'A.L.A.', 'ALA'},\n",
       "             'amebic liver abscess': {'ALA'},\n",
       "             'amoebic liver abscess': {'ALA'},\n",
       "             'American Lung Association': {'ALA'},\n",
       "             'aminolevulinate': {'ALA'},\n",
       "             'aminolaevulinate': {'ALA'},\n",
       "             'antilymphocyte globulin': {'ALG'},\n",
       "             'anti-lymphocyte globulin': {'ALG'},\n",
       "             'antilymphocytic globulin': {'ALG'},\n",
       "             'antihuman lymphocyte globulin': {'ALG'},\n",
       "             'anti-human lymphocyte globulin': {'AHLG', 'ALG'},\n",
       "             'acute lymphoblastic leucemia': {'ALL'},\n",
       "             'acute lymphoblastic leukemia': {'ALL'},\n",
       "             'acute lymphoblastic leucaemia': {'ALL'},\n",
       "             'acute lymphoblastic leukaemia': {'A.L.L.', 'ALL'},\n",
       "             'acute lymphocytic leucemia': {'ALL'},\n",
       "             'acute lymphocytic leukemia': {'ALL'},\n",
       "             'acute lymphocytic leucaemia': {'ALL'},\n",
       "             'acute lymphocytic leukaemia': {'ALL'},\n",
       "             'acute lymphatic leukemia': {'ALL'},\n",
       "             'acute lymphatic leukaemia': {'ALL'},\n",
       "             'acute lymphoid leukemia': {'ALL'},\n",
       "             'acute lymphoid leukaemia': {'ALL'},\n",
       "             'alveolar lining material': {'ALM'},\n",
       "             'alkalinephosphatase': {'AKP',\n",
       "              'ALK',\n",
       "              \"ALK P'TASE\",\n",
       "              \"ALK. P'TASE\",\n",
       "              'ALK. PHOS.',\n",
       "              'ALKPH',\n",
       "              'ALP',\n",
       "              'ALP-ASE',\n",
       "              'ALPASE',\n",
       "              'AP',\n",
       "              'APASE',\n",
       "              'APH'},\n",
       "             'alkaline phosphatase': {'A-P',\n",
       "              'AKP',\n",
       "              'AL-P',\n",
       "              'AL-PASE',\n",
       "              'ALK',\n",
       "              \"ALK P'TASE\",\n",
       "              'ALK PHOS',\n",
       "              'ALK-P',\n",
       "              'ALK-PASE',\n",
       "              \"ALK. P'TASE\",\n",
       "              'ALK. PHOS.',\n",
       "              'ALKP',\n",
       "              'ALKPASE',\n",
       "              'ALKPH',\n",
       "              'ALP',\n",
       "              'ALP-ASE',\n",
       "              'ALPASE',\n",
       "              'ALPL',\n",
       "              'AP',\n",
       "              'AP-ASE',\n",
       "              'APASE',\n",
       "              'APH'},\n",
       "             'alkaline-phosphatase': {'AKP',\n",
       "              'AL-P',\n",
       "              'ALK',\n",
       "              \"ALK P'TASE\",\n",
       "              \"ALK. P'TASE\",\n",
       "              'ALK. PHOS.',\n",
       "              'ALKPH',\n",
       "              'ALP',\n",
       "              'ALP-ASE',\n",
       "              'ALPASE',\n",
       "              'AP',\n",
       "              'APASE',\n",
       "              'APH'},\n",
       "             'acute leucemia protocol': {'ALP'},\n",
       "             'acute leukemia protocol': {'ALP'},\n",
       "             'acute leucaemia protocol': {'ALP'},\n",
       "             'acute leukaemia protocol': {'ALP'},\n",
       "             'acute lupus pericarditis': {'ALP'},\n",
       "             'alveolar proteinosis': {'ALP'},\n",
       "             'antileucoproteinase': {'ALP'},\n",
       "             'antileukoproteinase': {'ALP'},\n",
       "             'anti-leucoproteinase': {'ALP'},\n",
       "             'anti-leukoproteinase': {'ALP'},\n",
       "             'antilymphocytic plasma': {'ALP'},\n",
       "             'argon laser photocoagulation': {'ALP', 'ALPC'},\n",
       "             'acute lateral sclerosis': {'ALS'},\n",
       "             'advanced life support': {'ALS'},\n",
       "             'afferent loop syndrome': {'ALS'},\n",
       "             'amyotropic lateral sclerosis': {'ALS'},\n",
       "             'angiotensin-like substance': {'ALS'},\n",
       "             'anterolateral sclerosis': {'ALS'},\n",
       "             'anticipated life span': {'ALS'},\n",
       "             'antilymphocyte serum': {'ALS'},\n",
       "             'anti-lymphocyte serum': {'ALS'},\n",
       "             'acetolactate synthase': {'ALS'},\n",
       "             'acid labile subunit': {'ALS'},\n",
       "             'acid-labile subunit': {'ALS'},\n",
       "             'amplitude modulation': {'AM'},\n",
       "             'ante meridien': {'AM'},\n",
       "             'alveolar macrophage': {'A-MPHI', 'AM', 'AM PHI', 'AMPHI'},\n",
       "             'artium magister': {'AM'},\n",
       "             'actomyosin': {'AM'},\n",
       "             'acto-myosin': {'AM'},\n",
       "             'acute myelofibrosis': {'AM'},\n",
       "             'adult male': {'AM'},\n",
       "             'adult monocyte': {'AM'},\n",
       "             'aerospace medicine': {'AM'},\n",
       "             'affected male': {'AM'},\n",
       "             'akinetic mutism': {'AM'},\n",
       "             'alcoholic male': {'AM'},\n",
       "             'alveolar mucosa': {'AM'},\n",
       "             'anovular menstruation': {'AM'},\n",
       "             'arousal mechanism': {'AM'},\n",
       "             'aviation medicine': {'AM', 'AVM'},\n",
       "             'adhesion molecule': {'AM'},\n",
       "             'arbuscular mycorrhiza': {'AM'},\n",
       "             'autobiographical memory': {'AM'},\n",
       "             'ampicillin': {'A', 'AB-PC', 'ABPC', 'AM', 'AMP', 'AP'},\n",
       "             'ampicilline': {'A', 'AM', 'AMP'},\n",
       "             'Aero-Medical Acceleration Laboratory': {'AMAL'},\n",
       "             'Aero-Medical Equipment Laboratory': {'AMEL'},\n",
       "             'amelogenin': {'AMEL'},\n",
       "             'acute myocardial infarction': {'AIM', 'AMI'},\n",
       "             'acute mesenteric ischemia': {'AMI'},\n",
       "             'acute mesenteric ischaemia': {'AMI'},\n",
       "             'acute myocardial ischemia': {'AMI'},\n",
       "             'acute myocardial ischaemia': {'AMI'},\n",
       "             'acute myocardial infarct': {'AMI'},\n",
       "             'auditory midbrain implant': {'AMI'},\n",
       "             'age-related memory impairment': {'AMI'},\n",
       "             'arthrogenic muscle inhibition': {'AMI'},\n",
       "             'amitriptyline': {'AMI', 'AMIT', 'AMT', 'AT'},\n",
       "             'amitryptiline': {'AMI', 'AMIT', 'AMT', 'AT'},\n",
       "             'amitryptyline': {'AMI', 'AMIT', 'AMT', 'AT'},\n",
       "             'amifostine': {'AMI'},\n",
       "             'amiloride': {'AMI'},\n",
       "             'amiodarone': {'AD', 'AM', 'AMD', 'AMI', 'AMIO'},\n",
       "             'acute myelogenous leukemia': {'AML'},\n",
       "             'acute myelogenous leukaemia': {'AML'},\n",
       "             'acute myeloid leukemia': {'AML', 'AML-M2'},\n",
       "             'acute myeloid leukaemia': {'AML'},\n",
       "             'acute myeloblastic leukemia': {'AML'},\n",
       "             'acute myeloblastic leukaemia': {'AML'},\n",
       "             'acute myelocytic leukemia': {'AML'},\n",
       "             'acute myelocytic leukaemia': {'AML'},\n",
       "             'angiomyolipoma': {'AML'},\n",
       "             'angio-myolipoma': {'AML'},\n",
       "             'anterior mitral leaflet': {'AML'},\n",
       "             'acute mucosal lesion': {'AML'},\n",
       "             'amlodipine': {'AML'},\n",
       "             'angiotensin': {'A-II', 'AGT', 'AII', 'ANG', 'AT'},\n",
       "             'angiotensine': {'AGT', 'ANG', 'AT'},\n",
       "             'angiography': {'ANG', 'ANGIO'},\n",
       "             'angiogram': {'ANG', 'ANGIO'},\n",
       "             'angiogenin': {'ANG'},\n",
       "             'acute nonlymphocytic leucemia': {'ANL', 'ANLL'},\n",
       "             'acute nonlymphocytic leucaemia': {'ANL', 'ANLL'},\n",
       "             'acute non-lymphocytic leucemia': {'ANL', 'ANLL'},\n",
       "             'acute non-lymphocytic leucaemia': {'ANL', 'ANLL'},\n",
       "             'acute nonlymphoblastic leucemia': {'ANL', 'ANLL'},\n",
       "             'acute nonlymphoblastic leukemia': {'ANL', 'ANLL'},\n",
       "             'acute nonlymphoblastic leucaemia': {'ANL', 'ANLL'},\n",
       "             'acute nonlymphoblastic leukaemia': {'ANL', 'ANLL'},\n",
       "             'acute non-lymphoblastic leucemia': {'ANL', 'ANLL'},\n",
       "             'acute non-lymphoblastic leukemia': {'ANL', 'ANLL'},\n",
       "             'acute non-lymphoblastic leucaemia': {'ANL', 'ANLL'},\n",
       "             'acute non-lymphoblastic leukaemia': {'ANL', 'ANLL'},\n",
       "             'acceptable noise level': {'ANL'},\n",
       "             'alpha-naphthylthiourea': {'ANTU'},\n",
       "             'ankle orthosis': {'AO'},\n",
       "             'acridin orange': {'AO'},\n",
       "             'acridine orange': {'AO'},\n",
       "             'acridin-orange': {'AO'},\n",
       "             'acridine-orange': {'AO'},\n",
       "             'anodal opening': {'AO'},\n",
       "             'anterior oblique': {'AO'},\n",
       "             'antisense oligonucleotide': {'AO',\n",
       "              'AS',\n",
       "              'AS-ODN',\n",
       "              'AS-ON',\n",
       "              'ASO',\n",
       "              'ASODN',\n",
       "              'ASON'},\n",
       "             'anti-sense oligonucleotide': {'AO', 'AS-ON', 'ASO', 'ASON'},\n",
       "             'aortic opening': {'AO'},\n",
       "             'arthroophthalmopathy': {'AO'},\n",
       "             'arthro ophthalmopathy': {'AO'},\n",
       "             'arthro-ophthalmopathy': {'AO'},\n",
       "             'atelosteogenesis': {'AO'},\n",
       "             'abdominal obesity': {'AO'},\n",
       "             'adaptive optics': {'AO'},\n",
       "             'anaplastic oligodendroglioma': {'AO'},\n",
       "             'American Occupational Therapy Association': {'A.O.T.A.', 'AOTA'},\n",
       "             'action potential': {'AP', 'APD'},\n",
       "             'action-potential': {'AP'},\n",
       "             'anterior pituitary': {'AP'},\n",
       "             'aortic pressure': {'AOP', 'AP'},\n",
       "             'angina pectoris': {'AP'},\n",
       "             'arterial pressure': {'AP'},\n",
       "             'abdominal pain': {'AP'},\n",
       "             'accessory pathway': {'AP'},\n",
       "             'accounts payable': {'AP'},\n",
       "             'acid phosphatase': {'AC-P',\n",
       "              'AC-PASE',\n",
       "              'ACP',\n",
       "              'ACP-ASE',\n",
       "              'ACP1',\n",
       "              'ACPASE',\n",
       "              'ACPH',\n",
       "              'AP',\n",
       "              'AP-ASE',\n",
       "              'APASE',\n",
       "              'APH'},\n",
       "             'acid-phosphatase': {'ACP', 'ACPASE', 'ACPH', 'AP'},\n",
       "             'acinar parenchyma': {'AP'},\n",
       "             'action plan': {'AP'},\n",
       "             'activator protein': {'AP', 'AP-1', 'AP1'},\n",
       "             'active pepsin': {'AP'},\n",
       "             'active pressure': {'AP'},\n",
       "             'acute pancreatitis': {'AP'},\n",
       "             'acute phase': {'AP'},\n",
       "             'acute pneumonia': {'AP'},\n",
       "             'adenomatous polyposis': {'AP', 'APC'},\n",
       "             'aminopeptidase': {'AP'},\n",
       "             'amino-peptidase': {'AP'},\n",
       "             'aminopurine': {'AP'},\n",
       "             'amyloid peptide': {'AP'},\n",
       "             'anatomic profile': {'AP'},\n",
       "             'antidromic potential': {'AP'},\n",
       "             'antipyrin': {'AP'},\n",
       "             'antipyrine': {'AP'},\n",
       "             'antral peristalsis': {'AP'},\n",
       "             'apical pulse': {'AP'},\n",
       "             'apothecary': {'AP'},\n",
       "             'appendectomy': {'AP', 'APPY'},\n",
       "             'appendicitis': {'AP'},\n",
       "             'appendix': {'AP', 'APP'},\n",
       "             'apurinic acid': {'AP'},\n",
       "             'area postrema': {'AP'},\n",
       "             'arithmetic progression': {'AP'},\n",
       "             'artificial pneumothorax': {'AP'},\n",
       "             'aspiration pneumonia': {'AP'},\n",
       "             'atherosclerotic plaque': {'AP'},\n",
       "             'atrial pacing': {'AP'},\n",
       "             'atrioventricular pathway': {'AP'},\n",
       "             'absolute pitch': {'AP'},\n",
       "             'accelerated phase': {'AP'},\n",
       "             'adapter protein': {'AP'},\n",
       "             'adaptor protein': {'AP'},\n",
       "             'alternative pathway': {'AP'},\n",
       "             'ammonium perchlorate': {'AP'},\n",
       "             'activated protein C': {'APC'},\n",
       "             'adenomatous polyposis coli': {'APC'},\n",
       "             'antigen presenting cell': {'APC'},\n",
       "             'antigen-presenting cell': {'APC'},\n",
       "             'antiphlogistic corticoid': {'AC', 'APC'},\n",
       "             'aortopulmonary collateral artery': {'APC'},\n",
       "             'aorto-pulmonary collateral artery': {'APC'},\n",
       "             'apneustic center': {'APC'},\n",
       "             'apneustic centre': {'APC'},\n",
       "             'argon plasma coagulation': {'APC'},\n",
       "             'atrial premature contraction': {'APC'},\n",
       "             'autologous platelet concentrate': {'APC'},\n",
       "             'advanced pancreatic cancer': {'APC'},\n",
       "             'aerobic plate count': {'APC'},\n",
       "             'air pollution control': {'APC'},\n",
       "             'air-pollution control': {'APC'},\n",
       "             'anaphase promoting complex': {'APC'},\n",
       "             'anaphase-promoting complex': {'APC', 'APC/C'},\n",
       "             'annual percent change': {'APC'},\n",
       "             'annual-percent-change': {'APC'},\n",
       "             'anterior piriform cortex': {'APC', 'APCX'},\n",
       "             'annual percentage change': {'APC'},\n",
       "             'aphidicholin': {'APC'},\n",
       "             'allophyocyanin': {'APC'},\n",
       "             'adenylylimidodiphosphate': {'AMP--PNP',\n",
       "              'AMP-PNP',\n",
       "              'AMPPNP',\n",
       "              'APPNHP'},\n",
       "             'adenylyl imidodiphosphate': {'AMP-PNP', 'AMPPNP', 'APPNHP'},\n",
       "             'adenylylimido diphosphate': {'AMP-PNP', 'AMPPNP', 'APPNHP'},\n",
       "             'adenylyl-imidodiphosphate': {'AMP-PNP', 'AMPPNP', 'APPNHP'},\n",
       "             'adenylylimido-diphosphate': {'AMP-PNP', 'AMPPNP', 'APPNHP'},\n",
       "             'adenylyl-imido diphosphate': {'AMP-PNP', 'AMPPNP', 'APPNHP'},\n",
       "             'adenylyl-imido-diphosphate': {'AMP-PNP', 'AMPPNP', 'APPNHP'},\n",
       "             'adenine phosphoribosyltransferase': {'A-PRT', 'APRT', 'APRTASE'},\n",
       "             'adenine phosphoribosyl transferase': {'APRT', 'APRTASE'},\n",
       "             'aminopropylisothiuronium': {'APT'},\n",
       "             'antiplatelet trial': {'APT'},\n",
       "             'anti-platelet trial': {'APT'},\n",
       "             'atopy patch test': {'APT'},\n",
       "             'atom probe tomography': {'APT'},\n",
       "             'atom-probe tomography': {'APT'},\n",
       "             'anterior pelvic tilt': {'APT'},\n",
       "             'amide proton transfer': {'APT'},\n",
       "             'amide-proton transfer': {'APT'},\n",
       "             'amine precursor uptake decarboxylase cell': {'APUD CELL'},\n",
       "             'autoimmune rheumatic disease': {'ARD'},\n",
       "             'ankyrin repeat domain': {'ARD'},\n",
       "             'ankyrin-repeat domain': {'ARD'},\n",
       "             'acireductone dioxygenase': {'ARD'},\n",
       "             'aci-reductone dioxygenase': {'ARD'},\n",
       "             'acute renal dysfunction': {'ARD'},\n",
       "             'absolute risk difference': {'ARD'},\n",
       "             'automatic relevance determination': {'ARD'},\n",
       "             'acid rock drainage': {'ARD'},\n",
       "             'acid-rock drainage': {'ARD'},\n",
       "             'alcohol related dementia': {'ARD'},\n",
       "             'alcohol-related dementia': {'ARD'},\n",
       "             'antimicrobial removal device': {'ARD'},\n",
       "             'acute respiratory disease': {'ARD'},\n",
       "             'acute respiratory failure': {'ARDS', 'ARF'},\n",
       "             'adenosine diphosphate-ribosylation factor': {'ADP RIBOSYLATION FACTOR',\n",
       "              'ADP-RIBOSYLATION FACTOR',\n",
       "              'ARF'},\n",
       "             'ADP ribosylation factor': {'ARF'},\n",
       "             'ADP-ribosylation factor': {'ARF'},\n",
       "             'auxin response factor': {'ARF'},\n",
       "             'acute rheumatic fever': {'ARF'},\n",
       "             'alternative reading frame': {'ARF'},\n",
       "             'alternate reading frame': {'ARF'},\n",
       "             'Area Resource File': {'ARF'},\n",
       "             'acute renal failure': {'ARF'},\n",
       "             'Australian Radiation Laboratory': {'ARL'},\n",
       "             'adult rat liver': {'ARL'},\n",
       "             'AIDS-related lymphoma': {'ARL'},\n",
       "             'acetylsalicylic acid': {'AAS', 'ASA', 'ASA.', 'ASPIRIN', 'ASS'},\n",
       "             'acetyl salicylic acid': {'ASA', 'ASS'},\n",
       "             'argininosuccinic acid': {'ASA'},\n",
       "             'atrial septal aneurysm': {'ASA'},\n",
       "             'accessible surface area': {'ASA'},\n",
       "             'antisperm antibody': {'ASA'},\n",
       "             'anti-sperm antibody': {'ASA'},\n",
       "             'arylsulfatase A': {'ARS A', 'ARS-A', 'ARSA', 'ASA'},\n",
       "             'aryl sulfatase A': {'ARS A', 'ARS-A', 'ARSA', 'ASA'},\n",
       "             'arylsulphatase A': {'ARS A', 'ARS-A', 'ARSA', 'ASA'},\n",
       "             'aryl sulphatase A': {'ARS A', 'ARS-A', 'ARSA', 'ASA'},\n",
       "             'arylsulfatase-A': {'ARS A', 'ARS-A', 'ARSA', 'ASA'},\n",
       "             'aryl sulfatase-A': {'ARS A', 'ARS-A', 'ARSA', 'ASA'},\n",
       "             'arylsulphatase-A': {'ARS A', 'ARS-A', 'ARSA', 'ASA'},\n",
       "             'aryl sulphatase-A': {'ARS A', 'ARS-A', 'ARSA', 'ASA'},\n",
       "             'alcohol septal ablation': {'ASA'},\n",
       "             'anterior spinal artery': {'ASA'},\n",
       "             'allele specific amplification': {'ASA'},\n",
       "             'allele-specific amplification': {'ASA'},\n",
       "             'American Stroke Association': {'ASA'},\n",
       "             'aspirin sensitive asthma': {'ASA'},\n",
       "             'aspirin-sensitive asthma': {'ASA'},\n",
       "             'acute severe asthma': {'ASA'},\n",
       "             'active systemic anaphylaxis': {'ASA'},\n",
       "             'anterior septal artery': {'ASA'},\n",
       "             'ascorbate': {'AA', 'ASA', 'ASC', 'ASCH'},\n",
       "             'arteriosclerotic cardiovascular disease': {'ACVD', 'ASCVD'},\n",
       "             'atherosclerotic cardiovascular disease': {'ACVD', 'ASCVD'},\n",
       "             'alpha subunit glycoprotein hormone': {'ASGPH'},\n",
       "             'arteriosclerosis obliterans': {'ASO'},\n",
       "             'AIDS service organization': {'ASO'},\n",
       "             'arterial switch operation': {'ASO'},\n",
       "             'Amplatzer septal occluder': {'ASO'},\n",
       "             'atrial septal occluder': {'ASO'},\n",
       "             'allele specific oligonucleotide': {'ASO'},\n",
       "             'allele-specific oligonucleotide': {'ASO'},\n",
       "             'antistreptolysin O': {'ASLO', 'ASO', 'ASTO'},\n",
       "             'antistreptolysin-O': {'ASLO', 'ASO', 'ASTO'},\n",
       "             'anti-streptolysin O': {'ASLO', 'ASO', 'ASTO'},\n",
       "             'anti-streptolysin-O': {'ASLO', 'ASO', 'ASTO'},\n",
       "             'atherosclerosis obliterans': {'ASO'},\n",
       "             'androgen sterilized rat': {'ASR'},\n",
       "             'androgen-sterilized rat': {'ASR'},\n",
       "             'acoustic startle response': {'ASR'},\n",
       "             'auditory startle response': {'ASR'},\n",
       "             'age-standardised incidence rate': {'ASIR', 'ASR'},\n",
       "             'age-standardized incidence rate': {'ASIR', 'ASR'},\n",
       "             'age standardised rate': {'ASR'},\n",
       "             'age standardized rate': {'ASR'},\n",
       "             'age-standardised rate': {'ASR'},\n",
       "             'age-standardized rate': {'ASR'},\n",
       "             'absolute synthesis rate': {'ASR'},\n",
       "             'acoustic startle reflex': {'ASR'},\n",
       "             'auditory startle reflex': {'ASR'},\n",
       "             'automobile shredder residue': {'ASR'},\n",
       "             'automotive shredder residue': {'ASR'},\n",
       "             'automatic speech recognition': {'ASR'},\n",
       "             'acute stress reaction': {'ASR'},\n",
       "             'analyte specific reagent': {'ASR'},\n",
       "             'analyte-specific reagent': {'ASR'},\n",
       "             'Anabaena sensory rhodopsin': {'ASR'},\n",
       "             'aquatic surface respiration': {'ASR'},\n",
       "             'Asian soybean rust': {'ASR'},\n",
       "             'aldosterone secretion rate': {'ASR'},\n",
       "             'absolute secretion rate': {'ASR'},\n",
       "             'angiotensin sensitivity test': {'AST'},\n",
       "             'anterior spinothalamic tract': {'AST'},\n",
       "             'antistreptolysin test': {'AST'},\n",
       "             'anti-streptolysin test': {'AST'},\n",
       "             'antimicrobial susceptibility testing': {'AST'},\n",
       "             'anti-microbial susceptibility testing': {'AST'},\n",
       "             'antifungal susceptibility testing': {'AST'},\n",
       "             'anti-fungal susceptibility testing': {'AST'},\n",
       "             'antibiotic susceptibility testing': {'AST'},\n",
       "             'androgen suppression therapy': {'AST'},\n",
       "             'androgen-suppression therapy': {'AST'},\n",
       "             'acid suppressive therapy': {'AST'},\n",
       "             'acid-suppressive therapy': {'AST'},\n",
       "             'arginine stimulation test': {'AST'},\n",
       "             'arginine-stimulation test': {'AST'},\n",
       "             'average survival time': {'AST'},\n",
       "             'acute suppurative thyroiditis': {'AST'},\n",
       "             'arterial spin tagging': {'AST'},\n",
       "             'arterial spin-tagging': {'AST'},\n",
       "             'astigmatism': {'AS', 'AST'},\n",
       "             'allatostatin': {'AST'},\n",
       "             'astaxanthin': {'AST', 'ASTA', 'ASX', 'AX'},\n",
       "             'astaxanthine': {'AST', 'ASTA', 'ASX', 'AX'},\n",
       "             'astrocyte': {'AS', 'AST'},\n",
       "             'alimentary toxic aleukia': {'ATA'},\n",
       "             'atmosphere absolute': {'ATA'},\n",
       "             'aurintricarboxylic acid': {'ATA'},\n",
       "             'aurin tricarboxylic acid': {'ATA'},\n",
       "             'aurinetricarboxylic acid': {'ATA'},\n",
       "             'aurine tricarboxylic acid': {'ATA'},\n",
       "             'aurin tri-carboxylic acid': {'ATA'},\n",
       "             'aurine tri-carboxylic acid': {'ATA'},\n",
       "             'aspirin tolerant asthma': {'ATA'},\n",
       "             'aspirin-tolerant asthma': {'ATA'},\n",
       "             'antithyroid antibody': {'ATA'},\n",
       "             'anti-thyroid antibody': {'ATA'},\n",
       "             'American Thyroid Association': {'ATA'},\n",
       "             'American Telemedicine Association': {'ATA'},\n",
       "             'American Type Culture Collection': {'ATCC'},\n",
       "             'American type culture collection': {'ATCC'},\n",
       "             'American-type culture collection': {'ATCC'},\n",
       "             'antithymocyte globulin': {'ATG'},\n",
       "             'anti thymocyte globulin': {'ATG'},\n",
       "             'anti-thymocyte globulin': {'ATG'},\n",
       "             'antithymoglobulin': {'ATG'},\n",
       "             'anti-thymoglobulin': {'ATG'},\n",
       "             'anti-thymoglobuline': {'ATG'},\n",
       "             'aurothioglucose': {'ATG', 'AUTG'},\n",
       "             'angiotensinogen': {'AGT', 'AO', 'ATG'},\n",
       "             'autophagy': {'ATG'},\n",
       "             'autophagy-related gene': {'ATG'},\n",
       "             'Autogel': {'ATG'},\n",
       "             'adult T-cell leucemia': {'ATL'},\n",
       "             'adult T-cell leukemia': {'ATL'},\n",
       "             'adult T-cell leucaemia': {'ATL'},\n",
       "             'adult T-cell leukaemia': {'ATL'},\n",
       "             'adult T-cell lymphoma': {'ATL'},\n",
       "             'Achilles tendon lengthening': {'ATL'},\n",
       "             \"Achilles' tendon lengthening\": {'ATL'},\n",
       "             'anterior tricuspid leaflet': {'ATL'},\n",
       "             'antitension line': {'ATL'},\n",
       "             'anti-tension line': {'ATL'},\n",
       "             'atypical lymphocyte': {'ATL'},\n",
       "             'anterior temporal lobectomy': {'ATL'},\n",
       "             'American tegumentary leishmaniasis': {'ATL'},\n",
       "             'anterior temporal lobe': {'ATL'},\n",
       "             'aspirin-triggered lipoxin': {'ATL'},\n",
       "             'ascending thin limb': {'ATL'},\n",
       "             'adult T-cell leukemia-lymphoma': {'ATL', 'ATLL'},\n",
       "             'adult T-cell leukemia/lymphoma': {'ATL', 'ATL/L', 'ATLL'},\n",
       "             'adult T-cell leukaemia-lymphoma': {'ATL', 'ATLL'},\n",
       "             'adult T-cell leukaemia/lymphoma': {'ATL', 'ATLL'},\n",
       "             'adult T cell leukemia-lymphoma': {'ATLL'},\n",
       "             'adult T cell leukemia/lymphoma': {'ATLL'},\n",
       "             'adult T-cell leukemia lymphoma': {'ATLL'},\n",
       "             'adult T cell leukaemia-lymphoma': {'ATLL'},\n",
       "             'adult T cell leukaemia/lymphoma': {'ATLL'},\n",
       "             'adult T-cell leukaemia lymphoma': {'ATLL'},\n",
       "             'adult T cell lymphoma-leukemia': {'ATLL'},\n",
       "             'adult T cell lymphoma/leukemia': {'ATLL'},\n",
       "             'adult T-cell lymphoma leukemia': {'ATLL'},\n",
       "             'adult T-cell lymphoma-leukemia': {'ATLL'},\n",
       "             'adult T-cell lymphoma/leukemia': {'ATLL'},\n",
       "             'adult T cell lymphoma-leukaemia': {'ATLL'},\n",
       "             'adult T cell lymphoma/leukaemia': {'ATLL'},\n",
       "             'adult T-cell lymphoma leukaemia': {'ATLL'},\n",
       "             'adult T-cell lymphoma-leukaemia': {'ATLL'},\n",
       "             'adult T-cell lymphoma/leukaemia': {'ATLL'},\n",
       "             'adenosinetriphosphate': {'ADT', 'ATP'},\n",
       "             'adenosine triphosphate': {'ADT', 'ATP', 'ATPASE'},\n",
       "             'adenosine-triphosphate': {'ADT', 'ATP'},\n",
       "             \"adenosine 5'-triphosphate\": {'ATP'},\n",
       "             'antitachycardia pacing': {'ATP'},\n",
       "             'anti-tachycardia pacing': {'ATP'},\n",
       "             'adenosinetriphosphatase': {'AT-PASE', 'ATP-ASE', 'ATPASE'},\n",
       "             'adenosine triphosphatase': {'AT-PASE',\n",
       "              'ATP',\n",
       "              'ATP-ASE',\n",
       "              'ATPASE'},\n",
       "             'adenosine-triphosphatase': {'AT-PASE', 'ATP-ASE', 'ATPASE'},\n",
       "             'anterior uveitis': {'AU'},\n",
       "             'Angstrom unit': {'A. U.', 'A.U.', 'AU'},\n",
       "             'angstrom unit': {'A. U.', 'A.U.', 'AU'},\n",
       "             'Australia antigen': {'AU', 'AU-AG', 'AUAG'},\n",
       "             'antitoxin unit': {'AU'},\n",
       "             'arbitrary unit': {'AU'},\n",
       "             'azauridine': {'AU'},\n",
       "             'allergenic unit': {'AU'},\n",
       "             'action unit': {'AU'},\n",
       "             'alopecia universalis': {'AU'},\n",
       "             'Agatston unit': {'AU'},\n",
       "             'area under curve': {'AUC'},\n",
       "             'active vertical corrector': {'AVC'},\n",
       "             'aortic valve calcification': {'AVC'},\n",
       "             'atrioventricular canal': {'AVC'},\n",
       "             'atrio-ventricular canal': {'AVC'},\n",
       "             'aortic valve calcium': {'AVC'},\n",
       "             'aortic valve closure': {'AVC'},\n",
       "             'atrioventricular conduction': {'AVC'},\n",
       "             'atrio-ventricular conduction': {'AVC'},\n",
       "             'associative visual cortex': {'AVC'},\n",
       "             'arginin vasopressin': {'AVP'},\n",
       "             'arginine vasopressin': {'A-VP', 'AVP'},\n",
       "             'arginin-vasopressin': {'AVP'},\n",
       "             'arginine-vasopressin': {'A-VP', 'AVP'},\n",
       "             'Amplatzer Vascular Plug': {'AVP'},\n",
       "             'Amplatzer vascular plug': {'AVP'},\n",
       "             'ambulatory venous pressure': {'AVP'},\n",
       "             'adenovirus proteinase': {'AVP'},\n",
       "             'aortic valve prolapse': {'AVP'},\n",
       "             'aziridinylbenzoquinone': {'AZQ'},\n",
       "             'aziridinyl benzoquinone': {'AZQ'},\n",
       "             'aziridinyl-benzoquinone': {'AZQ'},\n",
       "             'azidothymidine': {'AZT'},\n",
       "             'aztreonam': {'AZ', 'AZT'},\n",
       "             'azathioprine': {'ATP', 'AZ', 'AZA', 'AZP', 'AZT'},\n",
       "             'azithromycin': {'AZ', 'AZI', 'AZITHRO', 'AZT'},\n",
       "             'azythromycin': {'AZ', 'AZITHRO', 'AZT'},\n",
       "             'accelerator globulin': {'ACG'},\n",
       "             'aluminum': {'A1', 'AI', 'AL', 'AL3+'},\n",
       "             'albumen': {'A', 'AL', 'ALB'},\n",
       "             'albumin': {'A', 'AL', 'ALB'},\n",
       "             'albumine': {'A', 'AL', 'ALB'},\n",
       "             'alanine': {'A', 'ALA'},\n",
       "             'americium': {'AM'},\n",
       "             'argon': {'A', 'AR'},\n",
       "             'aromatase': {'AR', 'ARO', 'AROM'},\n",
       "             'azophenylarsonate': {'AR'},\n",
       "             'arcuate nucleus': {'AN', 'AR', 'ARC', 'ARCN', 'ARH', 'ARN'},\n",
       "             'adenine arabinoside': {'ARA A', 'ARA-A', 'ARAA'},\n",
       "             'araboascorbic acid': {'ARA A', 'ARA-A', 'ARAA'},\n",
       "             'adenine 9-beta-D-arabinofuranoside': {'ARA A', 'ARA-A', 'ARAA'},\n",
       "             'arabinofuranosylcytosine triphosphate': {'ARA CTP',\n",
       "              'ARA-CTP',\n",
       "              'ARACTP'},\n",
       "             'arabinofuranosyluracil': {'ARA U', 'ARA-U', 'ARAU'},\n",
       "             'arabinosyluracil': {'ARA U', 'ARA-U', 'ARAU'},\n",
       "             'Armenian Soviet Socialist Republic': {'ARMENIAN S.S.R.'},\n",
       "             'astatine': {'AT'},\n",
       "             'August': {'AUG.'},\n",
       "             'azacitidine': {'AZA', 'AZA C', 'AZA-C', 'AZAC', 'AZC'},\n",
       "             'azacytidine': {'AZA', 'AZA C', 'AZA-C', 'AZAC', 'AZC'},\n",
       "             'azadirachtin': {'AZA'},\n",
       "             'Azerbaijan Soviet Socialist Republic': {'AZERBAIJAN S.S.R.'},\n",
       "             'American Academy of Allergy': {'A.A.A.'},\n",
       "             'American Association of Anatomists': {'A.A.A.'},\n",
       "             'Area Agency on Aging': {'A.A.A.'},\n",
       "             'American Association for the Advancement of Science': {'A.A.A.S.'},\n",
       "             'American Association of Blood Banks': {'A.A.B.B.'},\n",
       "             'American Academy of Cerebral Palsy': {'A.A.C.P.'},\n",
       "             'American Academy of Denture Prosthetics': {'A.A.D.P.'},\n",
       "             'American Association of Dental Schools': {'A.A.D.S.'},\n",
       "             'American Association of Endodontists': {'A.A.E.'},\n",
       "             'American Academy of Family Physicians': {'A.A.F.P.'},\n",
       "             'American Academy of General Practice': {'A.A.G.P.'},\n",
       "             'American Association of Immunologists': {'A.A.I.'},\n",
       "             'American Academy of Implant Dentures': {'A.A.I.D.'},\n",
       "             'American Association of Industrial Nurses': {'A.A.I.N.'},\n",
       "             'American Association of Medical Assistants': {'A.A.M.A.'},\n",
       "             'American Association of Medical Colleges': {'A.A.M.C.'},\n",
       "             'American Association of Medical Record Librarians': {'A.A.M.R.L.'},\n",
       "             'American Association of Orthodontists': {'A.A.O.'},\n",
       "             'American Academy of Otolaryngology': {'A.A.O.'},\n",
       "             'American Academy of Oral Pathology': {'A.A.O.P.'},\n",
       "             'American Academy of Pediatrics': {'A.A.P.'},\n",
       "             'American Academy of Pedodontics': {'A.A.P.'},\n",
       "             'American Academy of Periodontology': {'A.A.P.'},\n",
       "             'American Association of Pathologists': {'A.A.P.'},\n",
       "             'American Academy of Physician Assistants': {'A.A.P.A.'},\n",
       "             'American Association of Pathologists and Bacteriologists': {'A.A.P.B.'},\n",
       "             'American Academy of Physical Medicine and Rehabilitation': {'A.A.P.M.R.'},\n",
       "             'American Association of Plastic Surgeons': {'A.A.P.S.'},\n",
       "             'American Board of Examiners in Professional Psychology': {'A.B.E.P.P.'},\n",
       "             'air conduction': {'A.C.', 'AC'},\n",
       "             'air-conduction': {'A.C.', 'AC'},\n",
       "             'alternating current': {'A.C.', 'AC'},\n",
       "             'aortic closure': {'A.C.', 'AC'},\n",
       "             'anodal closure': {'A.C.', 'AC'},\n",
       "             'air conditioner': {'A.C.'},\n",
       "             'air-conditioner': {'A.C.'},\n",
       "             'airconditioning': {'A.C.', 'AC'},\n",
       "             'air conditioning': {'A.C.', 'AC'},\n",
       "             'air-conditioning': {'A.C.', 'AC'},\n",
       "             'American College of Angiology': {'A.C.A.'},\n",
       "             'American College of Apothecaries': {'A.C.A.'},\n",
       "             'American College of Gastroenterology': {'A.C.G.'},\n",
       "             'American College of Nurse-Midwives': {'A.C.N.M.', 'ACNM'},\n",
       "             'American College of Obstetricians and Gynecologists': {'A.C.O.G.'},\n",
       "             'American College of Osteopathic Hospital Administrators': {'A.C.O.H.A.'},\n",
       "             'American College of Osteopathic Obstetricians and Gynecologists': {'A.C.O.O.G.'},\n",
       "             'American College of Osteopathic Surgeons': {'A.C.O.S.'},\n",
       "             'American College of Pathologists': {'A.C.P.'},\n",
       "             'American College of Radiology': {'A.C.R.'},\n",
       "             'American College of Sports Medicine': {'A.C.S.M.'},\n",
       "             'auris dextra': {'A.D.', 'AD'},\n",
       "             'antitoxineinheit': {'A.E.'},\n",
       "             'American Epidermological Society': {'A.E.S.'},\n",
       "             'American Geriatrics Society': {'A.G.S.', 'AGS'},\n",
       "             'Assistant House Physician': {'A.H.P.', 'AHP'},\n",
       "             'assistant house surgeon': {'A.H.S.', 'AHS'},\n",
       "             'anaphylatoxin inhibitor': {'A.I.', 'AI'},\n",
       "             'aortic incompetence': {'A.I.', 'AI'},\n",
       "             'aortic insufficiency': {'A.I.', 'AI'},\n",
       "             'apical impulse': {'A.I.', 'AI'},\n",
       "             'artificial intelligence': {'A.I.', 'AI'},\n",
       "             'American Institute of Homeopathy': {'A.I.H.'},\n",
       "             'American Industrial Hygiene Association': {'A.I.H.A.', 'AIHA'},\n",
       "             'American Laryngological, Rhinological, and Otological Society': {'A.L.R.O.S.'},\n",
       "             'American Medical Association': {'A.M.A.', 'AMA'},\n",
       "             'Aerospace Medical Association': {'A.M.A.', 'AMA'},\n",
       "             'Australian Medical Association': {'A.M.A.', 'AMA'},\n",
       "             'Aerospace Medical Research Laboratories': {'A.M.R.L.'},\n",
       "             'American Meteorological Society': {'A.M.S.'},\n",
       "             \"American Medical Women's Association\": {'A.M.W.A.'},\n",
       "             \"American Medical Writers' Association\": {'A.M.W.A.'},\n",
       "             'American Neurological Association': {'A.N.A.'},\n",
       "             'American Nurses Association': {'A.N.A.', 'ANA'},\n",
       "             \"American Nurses' Association\": {'A.N.A.', 'ANA'},\n",
       "             'American Optometric Association': {'A.O.A.', 'AOA'},\n",
       "             'American Orthopedic Association': {'A.O.A.', 'AOA'},\n",
       "             'American Orthopaedic Association': {'A.O.A.', 'AOA'},\n",
       "             'American Orthopsychiatric Association': {'A.O.A.', 'AOA'},\n",
       "             'American Osteopathic Association': {'A.O.A.', 'AOA'},\n",
       "             'American Orthotics and Prosthetics Association': {'A.O.P.A.'},\n",
       "             'American Otological Society': {'A.O.S.', 'AOS'},\n",
       "             'American Pharmaceutical Association': {'A.P.A.',\n",
       "              'A.PH.A.',\n",
       "              'APA',\n",
       "              'APHA'},\n",
       "             'American Public Health Association': {'A.P.H.A.', 'APHA'},\n",
       "             'American Protestant Hospital Association': {'A.P.H.A.'},\n",
       "             'Academy of Physical Medicine': {'A.P.M.'},\n",
       "             'Academy of Psychosomatic Medicine': {'A.P.M.'},\n",
       "             'American Pediatric Society': {'A.P.S.', 'APS'},\n",
       "             'American Physiological Society': {'A.P.S.', 'APS'},\n",
       "             'American Proctologic Society': {'A.P.S.', 'APS'},\n",
       "             'American Psychological Society': {'A.P.S.', 'APS'},\n",
       "             'American Psychosomatic Society': {'A.P.S.', 'APS'},\n",
       "             'American Red Cross': {'A.R.C.', 'ARC'},\n",
       "             'anomalous retinal correspondence': {'A.R.C.', 'ARC'},\n",
       "             'Academy of Religion and Mental Health': {'A.R.M.H.'},\n",
       "             'Association for Research in Nervous and Mental Disease': {'A.R.N.M.D.'},\n",
       "             'Association for Research in Ophthalmology': {'A.R.O.'},\n",
       "             'American Roentgen Ray Society': {'A.R.R.S.', 'ARRS'},\n",
       "             'American Radium Society': {'A.R.S.'},\n",
       "             'Accredited Record Technician': {'A.R.T.'},\n",
       "             'American Society for Artificial Internal Organs': {'A.S.A.I.O.'},\n",
       "             'American Society of Bacteriologists': {'A.S.B.'},\n",
       "             'American Society of Clinical Hypnosis': {'A.S.C.H.'},\n",
       "             'American Society for Clinical Investigation': {'A.S.C.I.'},\n",
       "             'American Society of Clinical Laboratory Technicians': {'A.S.C.L.T.'},\n",
       "             'American Society of Clinical Pathologists': {'A.S.C.P.'},\n",
       "             'American Society for Genetics': {'A.S.G.'},\n",
       "             'American Society for Hematology': {'A.S.H.'},\n",
       "             'American School Health Association': {'A.S.H.A.'},\n",
       "             'American Speech and Hearing Association': {'A.S.H.A.'},\n",
       "             'Association for the Study of Human Infertility': {'A.S.H.I.'},\n",
       "             'American Society of Hospital Pharmacists': {'A.S.H.P.'},\n",
       "             'American Science Information Institute': {'A.S.I.I.'},\n",
       "             'American Society of Internal Medicine': {'A.S.I.M.'},\n",
       "             'American Society of Parasitologists': {'A.S.P.'},\n",
       "             'American Society of Radiologic Technologists': {'A.S.R.T.'},\n",
       "             'American Society of Tropical Medicine and Hygiene': {'A.S.T.M.H.'},\n",
       "             'aures unitas': {'A. U.', 'A.U.', 'AU'},\n",
       "             'auris uterque': {'A. U.', 'A.U.'},\n",
       "             'albumin/coagulin ratio': {'A/C'},\n",
       "             'account': {'A/C', 'ACCT'},\n",
       "             'bronchial asthma': {'BA'},\n",
       "             'backache': {'BA'},\n",
       "             'bacterial agglutination': {'BA'},\n",
       "             'basilar artery': {'BA'},\n",
       "             'benzyladenine': {'BA'},\n",
       "             'best amplitude': {'BA'},\n",
       "             'betamethasone acetate': {'BA'},\n",
       "             'bile acid': {'BA'},\n",
       "             'biliary atresia': {'BA'},\n",
       "             'biological activity': {'BA'},\n",
       "             'blocking antibody': {'BA'},\n",
       "             'blood agar': {'BA'},\n",
       "             'blood-agar': {'BA'},\n",
       "             'blood alcohol': {'BA'},\n",
       "             'blood-alcohol': {'BA'},\n",
       "             'bone age': {'BA'},\n",
       "             'boric acid': {'BA'},\n",
       "             'bovine albumin': {'BA'},\n",
       "             'brachial artery': {'BA'},\n",
       "             'breathing apparatus': {'BA'},\n",
       "             'benzylaminopurine': {'BA', 'BAP'},\n",
       "             \"Brodman's area\": {'BA'},\n",
       "             \"Brodmann's area\": {'BA'},\n",
       "             'Brodman area': {'BA'},\n",
       "             'Brodmann area': {'BA'},\n",
       "             'benzoic acid': {'BA'},\n",
       "             'betulinic acid': {'BA'},\n",
       "             'bryonolic acid': {'BA'},\n",
       "             'butyric acid': {'BA'},\n",
       "             'barbituric acid': {'BA'},\n",
       "             'behenic acid': {'BA'},\n",
       "             'bone area': {'BA'},\n",
       "             'boronic acid': {'BA'},\n",
       "             'basion': {'BA'},\n",
       "             'bronchoalveolar lavage': {'BAL', 'BALF'},\n",
       "             'broncho-alveolar lavage': {'BAL'},\n",
       "             'British antilewisite': {'BAL'},\n",
       "             'British anti-Lewisite': {'BAL'},\n",
       "             'British anti-lewisite': {'BAL'},\n",
       "             'blood alcohol level': {'BAL'},\n",
       "             'blood-alcohol level': {'BAL'},\n",
       "             ...})"
      ]
     },
     "execution_count": 1110,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lf2sf"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "27d00afc",
   "metadata": {},
   "source": [
    "1. Convert Acronyms in Hypotheses to Longform using inventory.\n",
    "    1.1 Create three instance out of one: Shortform, Softform (LongForm), Longform , all having same label\n",
    "    1.2 Find a LF for SF in inventory with different meaning and create three instance similar to above, having label flipped.\n",
    "2. Convert Longform to shortform in similar fashion as above."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "15aeba7d",
   "metadata": {},
   "source": [
    "### SF to LF"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1059,
   "id": "5003bec8",
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "from collections import defaultdict as dd\n",
    "acronym_pattern = re.compile(r'\\b(?:[^\\w\\s\\d]*[A-Z\\d]{2,}|[A-Z\\d]{2,}[^\\w\\s\\d]*)\\b')\n",
    "\n",
    "available_sfs = list(inventory['SF'])\n",
    "hypothesis2sf = dd(list)\n",
    "for h in hypotheses:\n",
    "    matches = acronym_pattern.findall(h)\n",
    "    for match in matches:\n",
    "        if match in available_sfs :\n",
    "            hypothesis2sf[h].append(match)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1060,
   "id": "a4ef6878",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "358"
      ]
     },
     "execution_count": 1060,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(hypothesis2sf)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0d59463a",
   "metadata": {},
   "source": [
    "### Positive hypotheses"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 424,
   "id": "e8109222",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████████████████████████████████████████████████| 358/358 [09:08<00:00,  1.53s/it]\n"
     ]
    }
   ],
   "source": [
    "from sentence_transformers import SentenceTransformer\n",
    "from numpy import dot\n",
    "from numpy.linalg import norm\n",
    "from tqdm import tqdm\n",
    "\n",
    "model = SentenceTransformer('sentence-transformers/all-mpnet-base-v2')\n",
    "model.to(\"mps\")\n",
    "\n",
    "hyp2sf2lf = dd(lambda: dd(lambda:dd(float)))\n",
    "for h, sfs in tqdm(hypothesis2sf.items()):\n",
    "    h_v = model.encode(h)\n",
    "    for sf in sfs:\n",
    "        for lf in list(sf2lf[sf]):\n",
    "            lf_v = model.encode(lf)\n",
    "            cos_sim = dot(h_v, lf_v)/(norm(h_v)*norm(lf_v))\n",
    "            hyp2sf2lf[h][sf][lf] = cos_sim"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 425,
   "id": "a161f487",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "defaultdict(<function __main__.<lambda>()>,\n",
       "            {'All the primary trial participants do not receive any oral capecitabine, oral lapatinib ditosylate or cixutumumab IV, in conrast all the secondary trial subjects receive these.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.12956472,\n",
       "                                       'intravenous injection': 0.2964559,\n",
       "                                       'iridovirus': 0.16016147,\n",
       "                                       'intra-venous': 0.22123541,\n",
       "                                       'invitro': 0.109973565,\n",
       "                                       'intra ventricular': 0.12872648,\n",
       "                                       'intra vascular': 0.19378778,\n",
       "                                       'in vivo': 0.22476748,\n",
       "                                       'intravascular': 0.20327389,\n",
       "                                       'in-vivo': 0.2727964,\n",
       "                                       'inter-vertebral': 0.17497125,\n",
       "                                       'ichthyosis vulgaris': 0.087048635,\n",
       "                                       'intravenous': 0.30835202,\n",
       "                                       'intravaginal': 0.1483379,\n",
       "                                       'invasive': 0.062812045,\n",
       "                                       'iridescent virus': 0.10506473,\n",
       "                                       'isometric virus': 0.114859685,\n",
       "                                       'intravenous feeding device': 0.18931304,\n",
       "                                       'invivo': 0.08840467,\n",
       "                                       'instrumental variable': 0.094880655,\n",
       "                                       'intraventricular': 0.12614986,\n",
       "                                       'intra-vaginal': 0.162617,\n",
       "                                       'intravertebral': 0.16444999,\n",
       "                                       'in vitro': 0.13455527,\n",
       "                                       'interventricular': 0.14308159,\n",
       "                                       'in-vitro': 0.19550146,\n",
       "                                       'intra venous': 0.19901422,\n",
       "                                       'iodine value': 0.08090642,\n",
       "                                       'ichnovirus': 0.08561762,\n",
       "                                       'inter-ventricular': 0.1399625,\n",
       "                                       'intra-vertebral': 0.1727398,\n",
       "                                       'intravenous injection device': 0.23699589,\n",
       "                                       'intervertebral': 0.18449873,\n",
       "                                       'initial visit': 0.11966417,\n",
       "                                       'intravenous feeding': 0.22555159,\n",
       "                                       'intra-vascular': 0.21943861,\n",
       "                                       'intra-ventricular': 0.1384871})}),\n",
       "             'Patients with Platelet count over 100,000/mm¬¨‚â•, ANC <  1,700/mm¬¨‚â• and Hemoglobin between 4 to 5 grams per deciliter are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ANC': defaultdict(float,\n",
       "                                      {'acid neutralising capacity': 0.18113714,\n",
       "                                       'antigen-neutralising capacity': 0.267808,\n",
       "                                       'antenatal care': 0.17860995,\n",
       "                                       'acid neutralization capacity': 0.1754619,\n",
       "                                       'ante-natal clinic': 0.29178104,\n",
       "                                       'antenatal clinics': 0.233106,\n",
       "                                       'acid-neutralising capacity': 0.16808744,\n",
       "                                       'absolute neutrophil count': 0.40826538,\n",
       "                                       'Active noise control': 0.01483946,\n",
       "                                       'acid neutralizing capacity': 0.18925211,\n",
       "                                       'antigen-neutralizing capacity': 0.2715419,\n",
       "                                       'acid neutralisation capacity': 0.18848436,\n",
       "                                       'absolute neutrophil counts': 0.41875023,\n",
       "                                       'Army Nurse Corps': 0.18077075,\n",
       "                                       'antenatal clinic': 0.27841118,\n",
       "                                       'acid-neutralizing capacity': 0.17731999})}),\n",
       "             'Adult Patients with histologic confirmation of invasive bilateral breast carcinoma (T1 N1 M1) are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'T1': defaultdict(float,\n",
       "                                      {'thoracic 1': 0.1959786,\n",
       "                                       'term births': 0.019129789,\n",
       "                                       'tricuspid first sound': 0.033794954,\n",
       "                                       'type 1': 0.15423419,\n",
       "                                       'twitch height': -0.022884542,\n",
       "                                       'Time 1': 0.09505166,\n",
       "                                       'thoracic vertebra 1': 0.0981848,\n",
       "                                       't1 (size, tumor staging)': 0.45337507,\n",
       "                                       'time 1': 0.09505166,\n",
       "                                       'therapy': 0.03202416,\n",
       "                                       't1 (first thoracic vertebra)': 0.1803361,\n",
       "                                       'treatment 1': 0.19855718}),\n",
       "                          'N1': defaultdict(float,\n",
       "                                      {'negativity': -0.044060487,\n",
       "                                       'negative wave': -0.03547165,\n",
       "                                       'negative peak': 0.057340812,\n",
       "                                       'negative': 0.042267334,\n",
       "                                       'negative component': -0.03541779}),\n",
       "                          'M1': defaultdict(float,\n",
       "                                      {'matrix protein': -1.665205e-06,\n",
       "                                       'mouse myeloid leukemia': 0.11567623,\n",
       "                                       'mouse myeloid leukemia cells': 0.07335358,\n",
       "                                       'muscarinic': 0.006891705,\n",
       "                                       'middle cerebral artery': 0.09032317,\n",
       "                                       'matrix': -0.03302012,\n",
       "                                       'metastatic disease': 0.3034521,\n",
       "                                       'metabolite': 0.017821413,\n",
       "                                       'metastatic': 0.21792121})}),\n",
       "             'Patients with Clinical stage II (T2 N1) invasive mammary carcinoma are not eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'II': defaultdict(float,\n",
       "                                      {'image intensifier': -0.0006772746,\n",
       "                                       'icterus index': 0.08195094}),\n",
       "                          'T2': defaultdict(float,\n",
       "                                      {'time 2': 0.055000264,\n",
       "                                       'type 2': 0.21753454,\n",
       "                                       't2 (thoracic vertebra 2)': 0.10278468,\n",
       "                                       't2dm': 0.11847511,\n",
       "                                       'transverse relaxation': -0.021769274,\n",
       "                                       'twins two': 0.012220752,\n",
       "                                       'therapy': 0.040514585,\n",
       "                                       'Time 2': 0.055000264,\n",
       "                                       'thoracic vertebra 2': -0.009564254,\n",
       "                                       'T-2 toxin': 0.18938057}),\n",
       "                          'N1': defaultdict(float,\n",
       "                                      {'negativity': -0.07331892,\n",
       "                                       'negative wave': -0.06915174,\n",
       "                                       'negative peak': -0.0023324827,\n",
       "                                       'negative': 0.009831561,\n",
       "                                       'negative component': -0.083798476})}),\n",
       "             'Adele is an 85 year old woman with Stage II histologically confirmed ER+ breast cancer with an ECOG of 0, she is eligible for the primary trial': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'II': defaultdict(float,\n",
       "                                      {'image intensifier': 0.028233957,\n",
       "                                       'icterus index': 0.2000895}),\n",
       "                          'ER': defaultdict(float,\n",
       "                                      {'extinction-ratio': 0.05800755,\n",
       "                                       'equivalent rontgen': 0.04672324,\n",
       "                                       'endo-plasmic reticulum': 0.09586153,\n",
       "                                       'emergency room': 0.21253587,\n",
       "                                       'estrogen receptor-alpha': 0.26055998,\n",
       "                                       'environmental resistance': 0.005859861,\n",
       "                                       'erythrocyte receptor': 0.16602041,\n",
       "                                       'estradiol receptor': 0.20174791,\n",
       "                                       'extended-release': 0.14585714,\n",
       "                                       'energy restriction': 0.11297959,\n",
       "                                       'energy-restricted': 0.12994741,\n",
       "                                       'estrogen-receptor': 0.23736687,\n",
       "                                       'energy retention': 0.02600601,\n",
       "                                       'electrorheological': 0.07990457,\n",
       "                                       'ejection rate': 0.07184925,\n",
       "                                       'external resistance': 0.0026329383,\n",
       "                                       'Estrogen receptor alpha': 0.2402109,\n",
       "                                       'estrogen receptor': 0.23431721,\n",
       "                                       'early': 0.10394165,\n",
       "                                       'endoplasmatic reticulum': 0.10482303,\n",
       "                                       'Estradiol': 0.20662282,\n",
       "                                       'expiratory reserve': 0.14285354,\n",
       "                                       'endovascular repair': 0.14848255,\n",
       "                                       'Emergency Room': 0.21253587,\n",
       "                                       'early reticulocyte': 0.0941,\n",
       "                                       'esophageal rupture': 0.13514015,\n",
       "                                       'Estrogen receptors': 0.17389454,\n",
       "                                       'evoked responses': 0.09852586,\n",
       "                                       'estrogen receptor protein': 0.21706824,\n",
       "                                       'erythromycin': 0.18585235,\n",
       "                                       'enhancement ratios': 0.12893291,\n",
       "                                       'equine rhinopneumonia': 0.07700894,\n",
       "                                       'eye research': 0.15481813,\n",
       "                                       'extinction ratio': 0.057919722,\n",
       "                                       'equivalent roentgen': 0.112655416,\n",
       "                                       'emotion regulation': 0.05538506,\n",
       "                                       'enhancement ratio': 0.14927712,\n",
       "                                       'estrogen receptor status': 0.2749286,\n",
       "                                       'early repolarization': 0.11615126,\n",
       "                                       'early repolarisation': 0.119976364,\n",
       "                                       'electrical resistance': 0.056983408,\n",
       "                                       'evoked response': 0.1258418,\n",
       "                                       'efficacy ratio': 0.22153111,\n",
       "                                       'estrogen': 0.17478482,\n",
       "                                       'endoplasmic reticular': 0.09615237,\n",
       "                                       'extraction ratio': 0.11455983,\n",
       "                                       'extended release': 0.14765935,\n",
       "                                       'external rotation': -0.03856991,\n",
       "                                       'epigastric region': 0.21436392,\n",
       "                                       'endoscopic resection': 0.13928215,\n",
       "                                       'ethoxyresorufin': 0.18060224,\n",
       "                                       'electro-resection': 0.18184817,\n",
       "                                       'early response': 0.22158118,\n",
       "                                       'endoplasmic reticulum': 0.10376761,\n",
       "                                       'enhanced reactivation': 0.13658993,\n",
       "                                       'electroresection': 0.12170883}),\n",
       "                          'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.10061904,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.5123696,\n",
       "                                       'eastern cooperative oncology group': 0.5123696,\n",
       "                                       'Electrocochleography': 0.12637524,\n",
       "                                       'electrocochleogram': 0.12495847,\n",
       "                                       'electrocortical activity': 0.07678878,\n",
       "                                       'electrocorticograms': 0.10160803,\n",
       "                                       'electrocortical': 0.084229186})}),\n",
       "             'Most of the cases of CHF in the primary trial, were in cohort 1.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CHF': defaultdict(float,\n",
       "                                      {'congestive heart failure': 0.34586832,\n",
       "                                       'Crimean hemorrhagic fever': 0.23151864,\n",
       "                                       'chick embryo fibroblast': 0.15059356,\n",
       "                                       'Congenital hepatic fibrosis': 0.33199444,\n",
       "                                       'Crimean haemorrhagic fever': 0.24327761,\n",
       "                                       'continuous hemofiltration': 0.20617503,\n",
       "                                       'Crimean Haemorrhagic Fever': 0.24327761,\n",
       "                                       'congenital hepatic fibrosis': 0.33199444,\n",
       "                                       'chick-embryo fibroblast': 0.16842246})}),\n",
       "             'Patients eligible for the primary trial must live in the USA.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'USA': defaultdict(float,\n",
       "                                      {'United States Army': 0.18117325,\n",
       "                                       'United States of America': 0.309504,\n",
       "                                       'United States': 0.38988686})}),\n",
       "             'both the primary trial and the secondary trial administer Bevacizumab to every single HER2+ patient.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.24821606,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.25850764,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.2491865,\n",
       "                                       'human epidermal growth factor receptor 2': 0.25844842,\n",
       "                                       'human epidermal growth factor receptor-2': 0.25850764})}),\n",
       "             'CO2 is utilised as part of the intervention in a single one of the study groups in the primary trial, and not used in either of the study groups in the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CO2': defaultdict(float,\n",
       "                                      {'carbon dioxide': 0.4440335,\n",
       "                                       'carbon-dioxide': 0.43384096})}),\n",
       "             'At least 4 patients in both cohorts of the primary trial achieved either complete response (CR) or partial response (PR). ': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.12396784,\n",
       "                                       'clot retraction': 0.18078141,\n",
       "                                       'conditioned response': 0.21305549,\n",
       "                                       'conditioned reflex': 0.1287589,\n",
       "                                       'charge recombination': 0.060320575,\n",
       "                                       'Czech Republic': 0.044212833,\n",
       "                                       'control region': 0.09671893,\n",
       "                                       'colonization rate': 0.10466365,\n",
       "                                       'complete remission rate': 0.59334075,\n",
       "                                       'Charles River': 0.074056864,\n",
       "                                       'Caloric restriction': 0.118184,\n",
       "                                       'colonisation resistance': 0.083476946,\n",
       "                                       'complete regression': 0.16417594,\n",
       "                                       'conversion rate': 0.15809159,\n",
       "                                       'chest roentgenography': 0.20638883,\n",
       "                                       'chest radiograph': 0.20800228,\n",
       "                                       'colony reared': 0.015278394,\n",
       "                                       'cardiorespiratory': 0.14946315,\n",
       "                                       'circadian rhythm': 0.10462875,\n",
       "                                       'cardiac rupture': 0.16058618,\n",
       "                                       'carbonyl reductase': 0.10627286,\n",
       "                                       'calorie restriction': 0.095366836,\n",
       "                                       'cortical reaction': 0.18707922,\n",
       "                                       'complete remissions': 0.5324828,\n",
       "                                       'chest radiography': 0.19712907,\n",
       "                                       'computerised record': 0.07466071,\n",
       "                                       'charge-recombination': 0.065678194,\n",
       "                                       'Cardiac Rehabilitation': 0.24997798,\n",
       "                                       'calcium-binding protein calretinin': 0.1586375,\n",
       "                                       'chronic rejection': 0.16309416,\n",
       "                                       'colony-reared': 0.0365993,\n",
       "                                       'cognitive reserve': 0.11075872,\n",
       "                                       'critical ratio': 0.19796725,\n",
       "                                       'cortico-resistant': 0.30754623,\n",
       "                                       'caloric restriction': 0.118184,\n",
       "                                       'corticoresistant': 0.19735593,\n",
       "                                       'corticosteroid-resistant': 0.28777874,\n",
       "                                       'Congo red': 0.082411624,\n",
       "                                       'complete responses': 0.34042063,\n",
       "                                       'chest and right arm': 0.16914716,\n",
       "                                       'conditioned reinforcement': 0.10685192,\n",
       "                                       'constant routine': 0.07774041,\n",
       "                                       'cardio-respiratory': 0.21977918,\n",
       "                                       'complete response rate': 0.47015476,\n",
       "                                       'cockroach': -0.027590675,\n",
       "                                       'chief resident': 0.055476733,\n",
       "                                       'calorie-restricted': 0.12566614,\n",
       "                                       'complete responders': 0.3917331,\n",
       "                                       'cysteine-rich': 0.13610104,\n",
       "                                       'controlled-release': 0.18517624,\n",
       "                                       'chemoradiation': 0.15427779,\n",
       "                                       'crown-rump': 0.028639797,\n",
       "                                       'crown-rump length': 0.06498288,\n",
       "                                       'creatinine': 0.2066404,\n",
       "                                       'capture-recapture': 0.11972023,\n",
       "                                       'Congo-red': 0.09666452,\n",
       "                                       'coefficient of repeatability': 0.2528544,\n",
       "                                       'computed radiography': 0.19351378,\n",
       "                                       'controlled respiration': 0.15582368,\n",
       "                                       'conditioned reward': 0.14158037,\n",
       "                                       'complement receptors': 0.31330127,\n",
       "                                       'concentration-response': 0.19184914,\n",
       "                                       'complete': 0.18030128,\n",
       "                                       'chest roentgenogram': 0.21662603,\n",
       "                                       'complement receptor': 0.33064014,\n",
       "                                       'Cajal-Retzius': 0.09757666,\n",
       "                                       'cremasteric reflex': 0.2555516,\n",
       "                                       'clot-retraction': 0.16890621,\n",
       "                                       'conserved regions': 0.04492065,\n",
       "                                       'child-resistant': 0.034763712,\n",
       "                                       'control rats': 0.03713035,\n",
       "                                       'caries-resistant': 0.1244158,\n",
       "                                       'coronary revascularization': 0.2964671,\n",
       "                                       'colon resection': 0.15795197,\n",
       "                                       'contrast ratio': 0.12250422,\n",
       "                                       'concentration ratio': 0.16902658,\n",
       "                                       'Calreticulin': 0.17053531,\n",
       "                                       'composite resin': 0.055938594,\n",
       "                                       'completely': 0.16860893,\n",
       "                                       'colorectal': 0.17252114,\n",
       "                                       'complete response': 0.3158602,\n",
       "                                       'coronary risk': 0.19317406,\n",
       "                                       'conventional radiology': 0.22927886,\n",
       "                                       'Complete response': 0.3158602,\n",
       "                                       'cathode ray': 0.03993525,\n",
       "                                       'complete responder': 0.36258537,\n",
       "                                       'controlled release': 0.13686731,\n",
       "                                       'conditioned reflexes': 0.13580173,\n",
       "                                       'chemo-radiation': 0.36490524,\n",
       "                                       'complete remission': 0.478899,\n",
       "                                       'conserved region': 0.026682828,\n",
       "                                       'coronary resistance': 0.276175,\n",
       "                                       'cardiac resuscitation': 0.20879927,\n",
       "                                       'computed radiographic': 0.21090895,\n",
       "                                       'cooling rate': 0.033070937,\n",
       "                                       'clinical research': 0.4360963,\n",
       "                                       'colonization resistance': 0.060547303,\n",
       "                                       'compression ratio': 0.055095002,\n",
       "                                       'computerized record': 0.07093873,\n",
       "                                       'chromium': 0.13322836,\n",
       "                                       'colo-rectal': 0.20240684,\n",
       "                                       'contractile reserve': 0.12943837,\n",
       "                                       'clinical record': 0.37730178,\n",
       "                                       'concentration ratios': 0.17461067,\n",
       "                                       'clinical remission': 0.5361781,\n",
       "                                       'centric relation': 0.054276254,\n",
       "                                       'cardiac rhythm': 0.12419847,\n",
       "                                       'capillary refill': 0.12994665,\n",
       "                                       'colonisation rate': 0.09532289,\n",
       "                                       'conventional radiography': 0.15646398,\n",
       "                                       'cellular receptor': 0.17905945}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.28200293,\n",
       "                                       'plaque reduction': 0.16142216,\n",
       "                                       'partial response': 0.45602334,\n",
       "                                       'photoreactivation': 0.09266222,\n",
       "                                       'pentoxyresorufin': 0.19119988,\n",
       "                                       'panoramic radiography': 0.14919017,\n",
       "                                       'proliferative retinopathy': 0.2124784,\n",
       "                                       'partial responses': 0.4492219,\n",
       "                                       'protein': 0.059996415,\n",
       "                                       'prorennin': 0.20777468,\n",
       "                                       'prevalence rate': 0.24116316,\n",
       "                                       'prealbumin': 0.15053001,\n",
       "                                       'pregnancy rates': 0.09535338,\n",
       "                                       'pain relief': 0.18667412,\n",
       "                                       'partial remissions': 0.6413439,\n",
       "                                       'pattern recognition': 0.030957708,\n",
       "                                       'photo-reactivation': 0.13389,\n",
       "                                       'protein restriction': 0.124646954,\n",
       "                                       'progesterone receptor': 0.18548283,\n",
       "                                       'placental restriction': 0.17534712,\n",
       "                                       'pneumatic retinopexy': 0.2738492,\n",
       "                                       'prorenin': 0.2608673,\n",
       "                                       'perirhinal cortex': 0.1521968,\n",
       "                                       'prothrombin ratio': 0.22987661,\n",
       "                                       'pars recta': 0.13168798,\n",
       "                                       'pattern reversal': 0.05963349,\n",
       "                                       'pr interval (ekg)': 0.27827263,\n",
       "                                       'pityriasis rosea': 0.12232928,\n",
       "                                       'prevalence ratio': 0.2774702,\n",
       "                                       'Projection reconstruction': 0.04059992,\n",
       "                                       'pregnancy rate': 0.098804265,\n",
       "                                       'phenol red': 0.175903,\n",
       "                                       'photoreceptor': 0.046811882,\n",
       "                                       'prednisolon': 0.28196386,\n",
       "                                       'partial responders': 0.46300843,\n",
       "                                       'proline-rich': 0.093055226,\n",
       "                                       'pseudorabies': 0.15065607,\n",
       "                                       'pulmonary regurgitation': 0.19585025,\n",
       "                                       'projection reconstruction': 0.04059992,\n",
       "                                       'photo-receptor': 0.10872454,\n",
       "                                       'protease': 0.15460879,\n",
       "                                       'progestine': 0.1382456,\n",
       "                                       'pentoxy-resorufin': 0.223833,\n",
       "                                       'partial remission': 0.5946186,\n",
       "                                       'progestin receptor': 0.1734084,\n",
       "                                       'per rectum': 0.18051384,\n",
       "                                       'Plain radiography': 0.14749871,\n",
       "                                       'production rate': 0.100157015,\n",
       "                                       'pulmonary rehabilitation': 0.25337577,\n",
       "                                       'pentoxy resorufin': 0.23481901,\n",
       "                                       'proteinase': 0.10537464,\n",
       "                                       'Paeoniae radix': 0.20876229,\n",
       "                                       'Puerto Rico': 0.1083103,\n",
       "                                       'Prevalence ratios': 0.26800245,\n",
       "                                       'perirenal': 0.1074933,\n",
       "                                       'passive recovery': 0.18216865,\n",
       "                                       'propranolol': 0.23702097,\n",
       "                                       'primary response': 0.43856743,\n",
       "                                       'pregnant': 0.06770686,\n",
       "                                       'partial regression': 0.21236555,\n",
       "                                       'Photoreactivation': 0.09266222,\n",
       "                                       'peripheral resistance': 0.20966338,\n",
       "                                       'polymorphic reticulosis': 0.221865,\n",
       "                                       'progressive ratio': 0.25928208,\n",
       "                                       'partial responder': 0.40883124,\n",
       "                                       'projection-reconstruction': 0.08347337,\n",
       "                                       'pro-renin': 0.2760703,\n",
       "                                       'phenol-red': 0.18418351,\n",
       "                                       'progestin': 0.13257223,\n",
       "                                       'pro-rennin': 0.19057274})}),\n",
       "             'More than 5% of the primary trial participants achieved partial response (PR).': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.17212164,\n",
       "                                       'plaque reduction': 0.079683974,\n",
       "                                       'partial response': 0.52472174,\n",
       "                                       'photoreactivation': 0.08200843,\n",
       "                                       'pentoxyresorufin': 0.11864404,\n",
       "                                       'panoramic radiography': 0.08707223,\n",
       "                                       'proliferative retinopathy': 0.12471397,\n",
       "                                       'partial responses': 0.5241361,\n",
       "                                       'protein': 0.0748935,\n",
       "                                       'prorennin': 0.15937392,\n",
       "                                       'prevalence rate': 0.23910938,\n",
       "                                       'prealbumin': 0.10617286,\n",
       "                                       'pregnancy rates': 0.12664959,\n",
       "                                       'pain relief': 0.16376388,\n",
       "                                       'partial remissions': 0.53061223,\n",
       "                                       'pattern recognition': -0.001140047,\n",
       "                                       'photo-reactivation': 0.11620367,\n",
       "                                       'protein restriction': 0.12759128,\n",
       "                                       'progesterone receptor': 0.18480265,\n",
       "                                       'placental restriction': 0.14428852,\n",
       "                                       'pneumatic retinopexy': 0.21245396,\n",
       "                                       'prorenin': 0.22354767,\n",
       "                                       'perirhinal cortex': 0.19174644,\n",
       "                                       'prothrombin ratio': 0.20831048,\n",
       "                                       'pars recta': 0.12044837,\n",
       "                                       'pattern reversal': 0.04440487,\n",
       "                                       'pr interval (ekg)': 0.27225336,\n",
       "                                       'pityriasis rosea': 0.06124589,\n",
       "                                       'prevalence ratio': 0.26543963,\n",
       "                                       'Projection reconstruction': 0.05428247,\n",
       "                                       'pregnancy rate': 0.12788141,\n",
       "                                       'phenol red': 0.12853664,\n",
       "                                       'photoreceptor': 0.045407902,\n",
       "                                       'prednisolon': 0.1719312,\n",
       "                                       'partial responders': 0.54300255,\n",
       "                                       'proline-rich': 0.04516419,\n",
       "                                       'pseudorabies': 0.14046718,\n",
       "                                       'pulmonary regurgitation': 0.122782245,\n",
       "                                       'projection reconstruction': 0.05428247,\n",
       "                                       'photo-receptor': 0.08550148,\n",
       "                                       'protease': 0.116618,\n",
       "                                       'progestine': 0.1362243,\n",
       "                                       'pentoxy-resorufin': 0.1730184,\n",
       "                                       'partial remission': 0.4993064,\n",
       "                                       'progestin receptor': 0.16409735,\n",
       "                                       'per rectum': 0.14180112,\n",
       "                                       'Plain radiography': 0.067458265,\n",
       "                                       'production rate': 0.11017832,\n",
       "                                       'pulmonary rehabilitation': 0.24472961,\n",
       "                                       'pentoxy resorufin': 0.18222447,\n",
       "                                       'proteinase': 0.086788855,\n",
       "                                       'Paeoniae radix': 0.14327985,\n",
       "                                       'Puerto Rico': 0.12160942,\n",
       "                                       'Prevalence ratios': 0.25630212,\n",
       "                                       'perirenal': 0.08509251,\n",
       "                                       'passive recovery': 0.2531204,\n",
       "                                       'propranolol': 0.17148753,\n",
       "                                       'primary response': 0.46142536,\n",
       "                                       'pregnant': 0.03318741,\n",
       "                                       'partial regression': 0.30388737,\n",
       "                                       'Photoreactivation': 0.08200843,\n",
       "                                       'peripheral resistance': 0.24449946,\n",
       "                                       'polymorphic reticulosis': 0.16758355,\n",
       "                                       'progressive ratio': 0.23849986,\n",
       "                                       'partial responder': 0.48651996,\n",
       "                                       'projection-reconstruction': 0.08648368,\n",
       "                                       'pro-renin': 0.20008785,\n",
       "                                       'phenol-red': 0.13540734,\n",
       "                                       'progestin': 0.11265124,\n",
       "                                       'pro-rennin': 0.16116463})}),\n",
       "             'the primary trial is testing a novel radiotracer called 89Zr-trastuzumab to evaluate its use for visualization of HER2+ lesions.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.32514814,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.32903042,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.32207263,\n",
       "                                       'human epidermal growth factor receptor 2': 0.3182399,\n",
       "                                       'human epidermal growth factor receptor-2': 0.32903042})}),\n",
       "             'The shortest PFS in the Talazoparib group of the primary trial was over a month shorter than the Median PFS for that group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.098421544,\n",
       "                                       'pyrogen-free saline': 0.1640704,\n",
       "                                       'pressure-flow study': -0.054521203,\n",
       "                                       'posterior fossa syndrome': 0.14116018,\n",
       "                                       'pressure flow study': -0.04049279,\n",
       "                                       'primary fibromyalgia syndrome': 0.22972682,\n",
       "                                       'Piper Fatigue Scale': 0.15884939,\n",
       "                                       'patellofemoral syndrome': 0.1379171,\n",
       "                                       'Progression-free': 0.14329694,\n",
       "                                       'pulmonary function score': 0.1786106,\n",
       "                                       'pressure flow studies': -0.04328643,\n",
       "                                       'protein-free supernatant': 0.052643616,\n",
       "                                       'progression free survival': 0.27167222,\n",
       "                                       'protein free supernatant': 0.064877234,\n",
       "                                       'progression-free survival': 0.3197397,\n",
       "                                       'pressure/flow study': -0.038057152})}),\n",
       "             'the secondary trial is testing for the DLT of its interventions, whereas the primary trial is evaluating the efficacy of lymph node detection through the use of SentiMag and SiennaXP. ': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DLT': defaultdict(float,\n",
       "                                      {'double-lung transplantation': 0.17249644,\n",
       "                                       'direct linear transformation': 0.039829917,\n",
       "                                       'double lumen tube': 0.23689261,\n",
       "                                       'double-lumen tube': 0.2362345,\n",
       "                                       'dose limiting toxicity': 0.23683004,\n",
       "                                       'dose-limiting toxicity': 0.25453943,\n",
       "                                       'donor leukocyte transfusion': 0.21992657,\n",
       "                                       'double-lumen endobronchial tube': 0.30917475,\n",
       "                                       'double lumen endotracheal tube': 0.30169556,\n",
       "                                       'double lung transplantation': 0.1723408,\n",
       "                                       'double-lumen endotracheal tube': 0.29409218})}),\n",
       "             'Participants of the primary trial must be older than 18, have histologically confirmed stage 4 breast cancer, ECOG<2 and a life expectancy exceeding 6 months.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.058354396,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.50858873,\n",
       "                                       'eastern cooperative oncology group': 0.50858873,\n",
       "                                       'Electrocochleography': 0.061423726,\n",
       "                                       'electrocochleogram': 0.05136241,\n",
       "                                       'electrocortical activity': 0.04234816,\n",
       "                                       'electrocorticograms': 0.07802097,\n",
       "                                       'electrocortical': 0.028611112})}),\n",
       "             'Participants in cohort 1 of the primary trial weighing less than 45 kg receive 5 million units/m^2 less of IL-2, than participants over 45 kg, but all participants will be administered Methylprednisolone 3 times per week for 6 doses.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IL': defaultdict(float,\n",
       "                                      {'internal loop': 0.070733584,\n",
       "                                       'insertion loss': 0.043930102,\n",
       "                                       'Illinois': 0.04196467,\n",
       "                                       'interleukins': 0.33113676,\n",
       "                                       'interleukine': 0.36238444,\n",
       "                                       'intralipid': 0.17764543,\n",
       "                                       'intra-cellular loop': 0.1072119,\n",
       "                                       'ileum': 0.04842001,\n",
       "                                       'intra-ocular lens': 0.044172645,\n",
       "                                       'independent laboratory': 0.12836707,\n",
       "                                       'Intralipid': 0.17764543,\n",
       "                                       'Intravascular lymphomatosis': 0.17534457,\n",
       "                                       'ionic liquid': -0.016637206,\n",
       "                                       'infralimbic': 0.03728175,\n",
       "                                       'Independent Living': 0.013506795,\n",
       "                                       'immature lung': 0.09088168,\n",
       "                                       'Interleukin': 0.35037,\n",
       "                                       'inguinal ligament': 0.11527865,\n",
       "                                       'interleukin': 0.35037,\n",
       "                                       'immunoblastic lymphoma': 0.24338977,\n",
       "                                       'introgression line': 0.039283674,\n",
       "                                       'intraluminal': 0.09017979,\n",
       "                                       'intraocular lens': 0.05161713,\n",
       "                                       'intracellular loop': 0.09822998,\n",
       "                                       'intestinal lymphocyte': 0.16170196,\n",
       "                                       'Ionic liquid': -0.016637206,\n",
       "                                       'intermediate lobe': 0.0010752041})}),\n",
       "             'There was 38% more patients with DLT in cohort 2 of the primary trial than in cohort 1.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DLT': defaultdict(float,\n",
       "                                      {'double-lung transplantation': 0.24315397,\n",
       "                                       'direct linear transformation': 0.0035876145,\n",
       "                                       'double lumen tube': 0.1812871,\n",
       "                                       'double-lumen tube': 0.17989056,\n",
       "                                       'dose limiting toxicity': 0.18104224,\n",
       "                                       'dose-limiting toxicity': 0.16907951,\n",
       "                                       'donor leukocyte transfusion': 0.16255532,\n",
       "                                       'double-lumen endobronchial tube': 0.2110477,\n",
       "                                       'double lumen endotracheal tube': 0.22565487,\n",
       "                                       'double lung transplantation': 0.25309476,\n",
       "                                       'double-lumen endotracheal tube': 0.21466485})}),\n",
       "             'the primary trial and the secondary trial are not studying PFS, PBR or DLTs.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.098383635,\n",
       "                                       'pyrogen-free saline': 0.18054488,\n",
       "                                       'pressure-flow study': 0.0013194568,\n",
       "                                       'posterior fossa syndrome': 0.13974951,\n",
       "                                       'pressure flow study': -0.0069025904,\n",
       "                                       'primary fibromyalgia syndrome': 0.18374173,\n",
       "                                       'Piper Fatigue Scale': 0.10649294,\n",
       "                                       'patellofemoral syndrome': 0.111403376,\n",
       "                                       'Progression-free': 0.07024816,\n",
       "                                       'pulmonary function score': 0.13770008,\n",
       "                                       'pressure flow studies': 0.01740563,\n",
       "                                       'protein-free supernatant': 0.19253403,\n",
       "                                       'progression free survival': 0.14893727,\n",
       "                                       'protein free supernatant': 0.18064295,\n",
       "                                       'progression-free survival': 0.17850137,\n",
       "                                       'pressure/flow study': 0.02611308}),\n",
       "                          'PBR': defaultdict(float,\n",
       "                                      {'parabrachial region': 0.12842205,\n",
       "                                       'packed-bed reactor': 0.024993472,\n",
       "                                       'polybasic region': -0.02018665,\n",
       "                                       'peripheral benzodiazepine receptor': 0.18326397,\n",
       "                                       'packed bed reactor': 0.03217485,\n",
       "                                       'peptide-binding region': 0.08277507,\n",
       "                                       'peptide binding region': 0.08395112,\n",
       "                                       'positive biopsy rate': 0.18175101,\n",
       "                                       'peripheral-type benzodiazepine receptor': 0.15532309})}),\n",
       "             'the primary trial requires participants to have undergone PTR.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PTR': defaultdict(float,\n",
       "                                      {'prothrombin time ratio': 0.25817007,\n",
       "                                       'Pan troglodytes': 0.058049247,\n",
       "                                       'phagocytic cells of the thymic reticulum': 0.13520417,\n",
       "                                       'pressure transmission ratio': 0.13457006,\n",
       "                                       'peptide transporter': 0.14035015,\n",
       "                                       'patellar tendon reflex': 0.12454535,\n",
       "                                       'platelet transfusion refractoriness': 0.33220378,\n",
       "                                       'Pap Test Register': 0.44626045,\n",
       "                                       'pars triangularis': 0.118815325,\n",
       "                                       'platelet-transfusion refractoriness': 0.31286573})}),\n",
       "             'participants of cohort 1 in the primary trial and all participants of the secondary trial take 1 milligram of anastrozole and 40 milligrams of simvastatin PO QD.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.23994265,\n",
       "                                       'parietal operculum': 0.13451439,\n",
       "                                       'post office': 0.022162974,\n",
       "                                       'percentage of observed value': 0.20598459,\n",
       "                                       'Phenol oxidase': 0.21472171,\n",
       "                                       'parapineal organ': 0.15337986,\n",
       "                                       'power output': 0.013358753,\n",
       "                                       'predominant organism': 0.1399745,\n",
       "                                       'pulse-oximetry': 0.23907058,\n",
       "                                       'perceptual organisation': -0.048410006,\n",
       "                                       'power outputs': -0.015477007,\n",
       "                                       'Personality Organization': -0.031459853,\n",
       "                                       'postoperative': 0.17554738,\n",
       "                                       'parieto occipital': 0.12282714,\n",
       "                                       'polyolefin': 0.10334005,\n",
       "                                       'parietooccipital': 0.111443706,\n",
       "                                       'poly-olefin': 0.07920953,\n",
       "                                       'peroral': 0.14963023,\n",
       "                                       'prostate only': 0.081616566,\n",
       "                                       'pressure overload': 0.042178344,\n",
       "                                       'peroxidase': 0.16327201,\n",
       "                                       'principal olive': 0.06134575,\n",
       "                                       'peri-operative': 0.12867469,\n",
       "                                       'posterior': 0.15478118,\n",
       "                                       'Perceptual Organization': -0.04253789,\n",
       "                                       'period of onset': 0.1858363,\n",
       "                                       'posterior nuclear group': 0.11912453,\n",
       "                                       'phenol oxidase': 0.21472171,\n",
       "                                       'pressure': 0.015252886,\n",
       "                                       'per os (by mouth)': 0.18338601,\n",
       "                                       'parieto-occipital': 0.107920155,\n",
       "                                       'preoptic area': 0.06645576,\n",
       "                                       'perceptual organization': -0.04253789,\n",
       "                                       'prophylactic oophorectomy': 0.14560762,\n",
       "                                       'phosphodiester': 0.23060843,\n",
       "                                       'pre-ovulatory': 0.1818746,\n",
       "                                       'palm oil': 0.06558731,\n",
       "                                       'preovulatory': 0.25169802,\n",
       "                                       'perioperative': 0.19563417,\n",
       "                                       'post operative': 0.15986693,\n",
       "                                       'post-operative': 0.18332924,\n",
       "                                       'phospho-diester': 0.11047186,\n",
       "                                       'protein oxidation': 0.086334944,\n",
       "                                       'palm-oil': 0.05368605,\n",
       "                                       'per os': 0.15855907,\n",
       "                                       'pericardial organ': 0.16314638,\n",
       "                                       'Pulse oximetry': 0.23994265,\n",
       "                                       'paraoxon': 0.33593124,\n",
       "                                       'propylene oxide': 0.12245781,\n",
       "                                       'phenoloxidase': 0.18829736,\n",
       "                                       'peanut oil': 0.044068325}),\n",
       "                          'QD': defaultdict(float,\n",
       "                                      {'quinidine': 0.33506486,\n",
       "                                       'quaque die (every day)': 0.14561242,\n",
       "                                       'quaque die': 0.15567827,\n",
       "                                       'quinupristin-dalfopristin': 0.40106732,\n",
       "                                       'quater die': 0.19493258,\n",
       "                                       'quantum dot': 0.0005678981,\n",
       "                                       'questionable dementia': 0.099145256})}),\n",
       "             \"the primary trial and the secondary trial use ECOG to evaluate potential candidates' performance status.\": defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.2726551,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.2221912,\n",
       "                                       'eastern cooperative oncology group': 0.2221912,\n",
       "                                       'Electrocochleography': 0.2234054,\n",
       "                                       'electrocochleogram': 0.24291322,\n",
       "                                       'electrocortical activity': 0.28409225,\n",
       "                                       'electrocorticograms': 0.2997099,\n",
       "                                       'electrocortical': 0.17526765})}),\n",
       "             'More than 5% of the primary trial participants achieved Objective Response (OR).': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'OR': defaultdict(float,\n",
       "                                      {'overall response': 0.41444123,\n",
       "                                       'objective response': 0.4800611,\n",
       "                                       'odds ratio': 0.30138022,\n",
       "                                       'open repair': 0.15849192,\n",
       "                                       'ovulation rate': 0.20186265,\n",
       "                                       'odds ration': 0.25431263,\n",
       "                                       'operating room': 0.13621546,\n",
       "                                       'oxido-reductase': 0.1691275,\n",
       "                                       'obesity-resistant': 0.15640448,\n",
       "                                       'ouabain-resistant': 0.16472545,\n",
       "                                       'objective responses': 0.4098402,\n",
       "                                       'orienting reflex': 0.17289245,\n",
       "                                       'operations research': 0.23702553,\n",
       "                                       'opioid receptor': 0.18022618,\n",
       "                                       'odds-ratio': 0.30618146,\n",
       "                                       'orienting response': 0.26079825,\n",
       "                                       'odorant receptor': 0.09262068,\n",
       "                                       'operating rooms': 0.12763315,\n",
       "                                       'oxidoreductase': 0.16671862,\n",
       "                                       'oestrogen receptor': 0.18477693,\n",
       "                                       'optic radiation': 0.08660945,\n",
       "                                       'oxido reductase': 0.18950678,\n",
       "                                       'optical rotation': 0.05468302,\n",
       "                                       'orthopedic research': 0.24208164,\n",
       "                                       'odds ratios': 0.28784212,\n",
       "                                       'oral rehydration': 0.15539198,\n",
       "                                       'operating-room': 0.15670428,\n",
       "                                       'olfactory receptor': 0.11792875,\n",
       "                                       'outflow resistance': 0.11696962,\n",
       "                                       'Oregon': 0.12745985,\n",
       "                                       'oestrogen-receptor': 0.16761236})}),\n",
       "             'Every patient in the primary trial is given tipifarnib PO, along with paclitaxel, doxorubicin hydrochloride and acyclophosphamide IV, but only a subset of participants undergo axillary lymph node dissection.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.085183464,\n",
       "                                       'parietal operculum': 0.21796465,\n",
       "                                       'post office': -0.005928505,\n",
       "                                       'percentage of observed value': 0.059824925,\n",
       "                                       'Phenol oxidase': 0.07230612,\n",
       "                                       'parapineal organ': 0.25375885,\n",
       "                                       'power output': 0.00095181155,\n",
       "                                       'predominant organism': 0.070716485,\n",
       "                                       'pulse-oximetry': 0.08066867,\n",
       "                                       'perceptual organisation': 0.013225018,\n",
       "                                       'power outputs': 0.010141031,\n",
       "                                       'Personality Organization': -0.084407754,\n",
       "                                       'postoperative': 0.25701413,\n",
       "                                       'parieto occipital': 0.22410464,\n",
       "                                       'polyolefin': 0.11372132,\n",
       "                                       'parietooccipital': 0.19820327,\n",
       "                                       'poly-olefin': 0.06872097,\n",
       "                                       'peroral': 0.1143175,\n",
       "                                       'prostate only': 0.13031293,\n",
       "                                       'pressure overload': -0.003500055,\n",
       "                                       'peroxidase': 0.048499554,\n",
       "                                       'principal olive': 0.099157885,\n",
       "                                       'peri-operative': 0.17156424,\n",
       "                                       'posterior': 0.0787885,\n",
       "                                       'Perceptual Organization': 0.015993437,\n",
       "                                       'period of onset': 0.03978253,\n",
       "                                       'posterior nuclear group': 0.08162192,\n",
       "                                       'phenol oxidase': 0.07230612,\n",
       "                                       'pressure': -0.03931315,\n",
       "                                       'per os (by mouth)': 0.04962627,\n",
       "                                       'parieto-occipital': 0.19935934,\n",
       "                                       'preoptic area': 0.097568125,\n",
       "                                       'perceptual organization': 0.015993437,\n",
       "                                       'prophylactic oophorectomy': 0.20062381,\n",
       "                                       'phosphodiester': 0.16855119,\n",
       "                                       'pre-ovulatory': 0.090472974,\n",
       "                                       'palm oil': 0.030494498,\n",
       "                                       'preovulatory': 0.23411451,\n",
       "                                       'perioperative': 0.20866957,\n",
       "                                       'post operative': 0.23571023,\n",
       "                                       'post-operative': 0.2660262,\n",
       "                                       'phospho-diester': 0.120142125,\n",
       "                                       'protein oxidation': 0.003111336,\n",
       "                                       'palm-oil': 0.013671378,\n",
       "                                       'per os': 0.06617496,\n",
       "                                       'pericardial organ': 0.15487659,\n",
       "                                       'Pulse oximetry': 0.085183464,\n",
       "                                       'paraoxon': 0.23433802,\n",
       "                                       'propylene oxide': 0.10377115,\n",
       "                                       'phenoloxidase': 0.17531903,\n",
       "                                       'peanut oil': 0.08557992}),\n",
       "                          'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.12879507,\n",
       "                                       'intravenous injection': 0.29165706,\n",
       "                                       'iridovirus': 0.09470259,\n",
       "                                       'intra-venous': 0.24047787,\n",
       "                                       'invitro': 0.049198397,\n",
       "                                       'intra ventricular': 0.065825805,\n",
       "                                       'intra vascular': 0.24289738,\n",
       "                                       'in vivo': 0.244983,\n",
       "                                       'intravascular': 0.25614804,\n",
       "                                       'in-vivo': 0.27873546,\n",
       "                                       'inter-vertebral': 0.17688358,\n",
       "                                       'ichthyosis vulgaris': 0.14851905,\n",
       "                                       'intravenous': 0.28503087,\n",
       "                                       'intravaginal': 0.15014143,\n",
       "                                       'invasive': 0.13747327,\n",
       "                                       'iridescent virus': 0.040882092,\n",
       "                                       'isometric virus': 0.037364908,\n",
       "                                       'intravenous feeding device': 0.16244595,\n",
       "                                       'invivo': 0.052921843,\n",
       "                                       'instrumental variable': 0.03766288,\n",
       "                                       'intraventricular': 0.09622604,\n",
       "                                       'intra-vaginal': 0.16448642,\n",
       "                                       'intravertebral': 0.16862603,\n",
       "                                       'in vitro': 0.13213162,\n",
       "                                       'interventricular': 0.067496955,\n",
       "                                       'in-vitro': 0.16944979,\n",
       "                                       'intra venous': 0.20748727,\n",
       "                                       'iodine value': 0.011851204,\n",
       "                                       'ichnovirus': 0.09247181,\n",
       "                                       'inter-ventricular': 0.049478024,\n",
       "                                       'intra-vertebral': 0.22674593,\n",
       "                                       'intravenous injection device': 0.22076167,\n",
       "                                       'intervertebral': 0.12053524,\n",
       "                                       'initial visit': 0.070556074,\n",
       "                                       'intravenous feeding': 0.18258458,\n",
       "                                       'intra-vascular': 0.2783904,\n",
       "                                       'intra-ventricular': 0.08478663})}),\n",
       "             'Patients with ERBB2 positive tumors are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ERBB2': defaultdict(float,\n",
       "                                      {'erythroblastic leukemia viral oncogene homologue 2': 0.37099966,\n",
       "                                       'erythroblastic leukemia viral oncogene homolog 2': 0.36436164,\n",
       "                                       'erythroblastic leukaemia viral oncogene homolog 2': 0.35981128,\n",
       "                                       'erythroblastic leukaemia viral oncogene homologue 2': 0.36884624})}),\n",
       "             'Most patients in the primary trial treated with Eribulin Mesylate did not achieve complete response (CR) or partial response (PR).': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.06391794,\n",
       "                                       'clot retraction': 0.11056288,\n",
       "                                       'conditioned response': 0.14249618,\n",
       "                                       'conditioned reflex': 0.07472671,\n",
       "                                       'charge recombination': 0.046348397,\n",
       "                                       'Czech Republic': -0.010154612,\n",
       "                                       'control region': 0.031062443,\n",
       "                                       'colonization rate': -0.008665027,\n",
       "                                       'complete remission rate': 0.41464865,\n",
       "                                       'Charles River': -0.032411862,\n",
       "                                       'Caloric restriction': 0.07046419,\n",
       "                                       'colonisation resistance': 0.080809884,\n",
       "                                       'complete regression': 0.11472979,\n",
       "                                       'conversion rate': 0.061627757,\n",
       "                                       'chest roentgenography': 0.15456986,\n",
       "                                       'chest radiograph': 0.13922007,\n",
       "                                       'colony reared': -0.04796291,\n",
       "                                       'cardiorespiratory': 0.1093406,\n",
       "                                       'circadian rhythm': 0.0902426,\n",
       "                                       'cardiac rupture': 0.17309275,\n",
       "                                       'carbonyl reductase': 0.15259561,\n",
       "                                       'calorie restriction': 0.041734517,\n",
       "                                       'cortical reaction': 0.16229938,\n",
       "                                       'complete remissions': 0.37893397,\n",
       "                                       'chest radiography': 0.12631387,\n",
       "                                       'computerised record': 0.0010441652,\n",
       "                                       'charge-recombination': 0.06304966,\n",
       "                                       'Cardiac Rehabilitation': 0.16521408,\n",
       "                                       'calcium-binding protein calretinin': 0.19166583,\n",
       "                                       'chronic rejection': 0.19308013,\n",
       "                                       'colony-reared': -0.028715894,\n",
       "                                       'cognitive reserve': 0.060181376,\n",
       "                                       'critical ratio': 0.092969164,\n",
       "                                       'cortico-resistant': 0.3584482,\n",
       "                                       'caloric restriction': 0.07046419,\n",
       "                                       'corticoresistant': 0.19544059,\n",
       "                                       'corticosteroid-resistant': 0.36195093,\n",
       "                                       'Congo red': 0.027605604,\n",
       "                                       'complete responses': 0.19419713,\n",
       "                                       'chest and right arm': 0.058888905,\n",
       "                                       'conditioned reinforcement': 0.037220202,\n",
       "                                       'constant routine': 0.045097575,\n",
       "                                       'cardio-respiratory': 0.16277215,\n",
       "                                       'complete response rate': 0.30138272,\n",
       "                                       'cockroach': 0.0018877555,\n",
       "                                       'chief resident': -0.06746205,\n",
       "                                       'calorie-restricted': 0.07506631,\n",
       "                                       'complete responders': 0.2128241,\n",
       "                                       'cysteine-rich': 0.16340002,\n",
       "                                       'controlled-release': 0.13137928,\n",
       "                                       'chemoradiation': 0.11659717,\n",
       "                                       'crown-rump': -0.036704943,\n",
       "                                       'crown-rump length': -0.018768413,\n",
       "                                       'creatinine': 0.3145531,\n",
       "                                       'capture-recapture': 0.049225997,\n",
       "                                       'Congo-red': 0.046038866,\n",
       "                                       'coefficient of repeatability': 0.09792994,\n",
       "                                       'computed radiography': 0.09153355,\n",
       "                                       'controlled respiration': 0.15757373,\n",
       "                                       'conditioned reward': 0.066179745,\n",
       "                                       'complement receptors': 0.29132953,\n",
       "                                       'concentration-response': 0.13827732,\n",
       "                                       'complete': 0.06084126,\n",
       "                                       'chest roentgenogram': 0.17616518,\n",
       "                                       'complement receptor': 0.3097063,\n",
       "                                       'Cajal-Retzius': 0.014981274,\n",
       "                                       'cremasteric reflex': 0.19939467,\n",
       "                                       'clot-retraction': 0.087923236,\n",
       "                                       'conserved regions': -0.050831486,\n",
       "                                       'child-resistant': -0.007758007,\n",
       "                                       'control rats': 0.08089826,\n",
       "                                       'caries-resistant': 0.030670742,\n",
       "                                       'coronary revascularization': 0.20232967,\n",
       "                                       'colon resection': 0.09459178,\n",
       "                                       'contrast ratio': 0.019416835,\n",
       "                                       'concentration ratio': 0.103981026,\n",
       "                                       'Calreticulin': 0.29466236,\n",
       "                                       'composite resin': 0.011220708,\n",
       "                                       'completely': 0.07626389,\n",
       "                                       'colorectal': 0.15264127,\n",
       "                                       'complete response': 0.19997633,\n",
       "                                       'coronary risk': 0.13577335,\n",
       "                                       'conventional radiology': 0.20241712,\n",
       "                                       'Complete response': 0.19997633,\n",
       "                                       'cathode ray': -0.0007873401,\n",
       "                                       'complete responder': 0.22267348,\n",
       "                                       'controlled release': 0.080061726,\n",
       "                                       'conditioned reflexes': 0.075812526,\n",
       "                                       'chemo-radiation': 0.34874982,\n",
       "                                       'complete remission': 0.3208174,\n",
       "                                       'conserved region': -0.04563699,\n",
       "                                       'coronary resistance': 0.21574074,\n",
       "                                       'cardiac resuscitation': 0.104323626,\n",
       "                                       'computed radiographic': 0.12047409,\n",
       "                                       'cooling rate': -0.014754545,\n",
       "                                       'clinical research': 0.25312516,\n",
       "                                       'colonization resistance': 0.034530558,\n",
       "                                       'compression ratio': -0.02814145,\n",
       "                                       'computerized record': 0.0016609138,\n",
       "                                       'chromium': 0.0866335,\n",
       "                                       'colo-rectal': 0.127278,\n",
       "                                       'contractile reserve': 0.116517514,\n",
       "                                       'clinical record': 0.23774073,\n",
       "                                       'concentration ratios': 0.105798595,\n",
       "                                       'clinical remission': 0.3938786,\n",
       "                                       'centric relation': -0.014871323,\n",
       "                                       'cardiac rhythm': 0.104180366,\n",
       "                                       'capillary refill': 0.07591549,\n",
       "                                       'colonisation rate': 0.0038531972,\n",
       "                                       'conventional radiography': 0.1220364,\n",
       "                                       'cellular receptor': 0.17248356}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.31194913,\n",
       "                                       'plaque reduction': 0.034762055,\n",
       "                                       'partial response': 0.2867763,\n",
       "                                       'photoreactivation': 0.079923466,\n",
       "                                       'pentoxyresorufin': 0.13509795,\n",
       "                                       'panoramic radiography': 0.026923781,\n",
       "                                       'proliferative retinopathy': 0.20994517,\n",
       "                                       'partial responses': 0.2677459,\n",
       "                                       'protein': 0.06277952,\n",
       "                                       'prorennin': 0.22256614,\n",
       "                                       'prevalence rate': 0.13452163,\n",
       "                                       'prealbumin': 0.22572552,\n",
       "                                       'pregnancy rates': 0.028700687,\n",
       "                                       'pain relief': 0.045506828,\n",
       "                                       'partial remissions': 0.4731098,\n",
       "                                       'pattern recognition': -0.11298955,\n",
       "                                       'photo-reactivation': 0.08701499,\n",
       "                                       'protein restriction': 0.16086371,\n",
       "                                       'progesterone receptor': 0.18177941,\n",
       "                                       'placental restriction': 0.1898163,\n",
       "                                       'pneumatic retinopexy': 0.25936806,\n",
       "                                       'prorenin': 0.27843124,\n",
       "                                       'perirhinal cortex': 0.09410423,\n",
       "                                       'prothrombin ratio': 0.24143669,\n",
       "                                       'pars recta': 0.071108565,\n",
       "                                       'pattern reversal': -0.0036744897,\n",
       "                                       'pr interval (ekg)': 0.17364967,\n",
       "                                       'pityriasis rosea': 0.048628576,\n",
       "                                       'prevalence ratio': 0.15461795,\n",
       "                                       'Projection reconstruction': -0.056937084,\n",
       "                                       'pregnancy rate': 0.05124664,\n",
       "                                       'phenol red': 0.10706971,\n",
       "                                       'photoreceptor': 0.007919122,\n",
       "                                       'prednisolon': 0.28717878,\n",
       "                                       'partial responders': 0.2839575,\n",
       "                                       'proline-rich': 0.11420247,\n",
       "                                       'pseudorabies': 0.14902724,\n",
       "                                       'pulmonary regurgitation': 0.18708271,\n",
       "                                       'projection reconstruction': -0.056937084,\n",
       "                                       'photo-receptor': 0.09286332,\n",
       "                                       'protease': 0.17512576,\n",
       "                                       'progestine': 0.1947675,\n",
       "                                       'pentoxy-resorufin': 0.1411025,\n",
       "                                       'partial remission': 0.41384283,\n",
       "                                       'progestin receptor': 0.1973219,\n",
       "                                       'per rectum': 0.17169443,\n",
       "                                       'Plain radiography': 0.09371402,\n",
       "                                       'production rate': 0.04807783,\n",
       "                                       'pulmonary rehabilitation': 0.16401094,\n",
       "                                       'pentoxy resorufin': 0.14668272,\n",
       "                                       'proteinase': 0.09164959,\n",
       "                                       'Paeoniae radix': 0.11711964,\n",
       "                                       'Puerto Rico': 0.045049973,\n",
       "                                       'Prevalence ratios': 0.1418993,\n",
       "                                       'perirenal': 0.108515784,\n",
       "                                       'passive recovery': 0.09062196,\n",
       "                                       'propranolol': 0.25186342,\n",
       "                                       'primary response': 0.25853977,\n",
       "                                       'pregnant': 0.05088492,\n",
       "                                       'partial regression': 0.11953437,\n",
       "                                       'Photoreactivation': 0.079923466,\n",
       "                                       'peripheral resistance': 0.15578762,\n",
       "                                       'polymorphic reticulosis': 0.17631473,\n",
       "                                       'progressive ratio': 0.106429674,\n",
       "                                       'partial responder': 0.26094377,\n",
       "                                       'projection-reconstruction': -0.03350532,\n",
       "                                       'pro-renin': 0.25397718,\n",
       "                                       'phenol-red': 0.10898398,\n",
       "                                       'progestin': 0.19907537,\n",
       "                                       'pro-rennin': 0.2007217})}),\n",
       "             'Patients with HER2 positive breast tumors are eligible for the primary trial, but excluded from the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.29516432,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.2966663,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.29671764,\n",
       "                                       'human epidermal growth factor receptor 2': 0.2907368,\n",
       "                                       'human epidermal growth factor receptor-2': 0.2966663})}),\n",
       "             'Patients with pure ductal carcinoma in situ (DCIS) or Melanoma are eligible for both the secondary trial and the primary trial, and are able to participate in these trials alongside other drug trials, up to a maximum of 3.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DCIS': defaultdict(float,\n",
       "                                      {'ductal carcinoma in-situ': 0.44963375,\n",
       "                                       'ductal carcinoma in situ': 0.42473733,\n",
       "                                       'ductal carcinoma-in-situ': 0.45000967,\n",
       "                                       'ductal carcinoma of breast': 0.3290225,\n",
       "                                       'ductal carcinoma in situ of the breast': 0.34935758})}),\n",
       "             ' Patients must have histologically or cytologically confirmed PR+ invasive breast cancer, with Primary tumor > 2 cm in diameter TO PARTICIPATE in the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.101484336,\n",
       "                                       'plaque reduction': 0.091822505,\n",
       "                                       'partial response': 0.18202737,\n",
       "                                       'photoreactivation': 0.08090539,\n",
       "                                       'pentoxyresorufin': 0.08660635,\n",
       "                                       'panoramic radiography': 0.13525026,\n",
       "                                       'proliferative retinopathy': 0.19838697,\n",
       "                                       'partial responses': 0.1539131,\n",
       "                                       'protein': -0.065967575,\n",
       "                                       'prorennin': 0.11834324,\n",
       "                                       'prevalence rate': 0.20969458,\n",
       "                                       'prealbumin': 0.103327766,\n",
       "                                       'pregnancy rates': 0.032562148,\n",
       "                                       'pain relief': 0.04806555,\n",
       "                                       'partial remissions': 0.38440567,\n",
       "                                       'pattern recognition': 0.006992304,\n",
       "                                       'photo-reactivation': 0.10986517,\n",
       "                                       'protein restriction': 0.0884127,\n",
       "                                       'progesterone receptor': 0.19465227,\n",
       "                                       'placental restriction': 0.16056193,\n",
       "                                       'pneumatic retinopexy': 0.20042858,\n",
       "                                       'prorenin': 0.09238029,\n",
       "                                       'perirhinal cortex': 0.03145601,\n",
       "                                       'prothrombin ratio': 0.13940412,\n",
       "                                       'pars recta': 0.081372246,\n",
       "                                       'pattern reversal': 0.031026969,\n",
       "                                       'pr interval (ekg)': 0.25736463,\n",
       "                                       'pityriasis rosea': 0.09720867,\n",
       "                                       'prevalence ratio': 0.22306311,\n",
       "                                       'Projection reconstruction': 0.01822695,\n",
       "                                       'pregnancy rate': 0.03855423,\n",
       "                                       'phenol red': 0.17345424,\n",
       "                                       'photoreceptor': 0.07754198,\n",
       "                                       'prednisolon': 0.10178489,\n",
       "                                       'partial responders': 0.20454206,\n",
       "                                       'proline-rich': 0.036710143,\n",
       "                                       'pseudorabies': 0.11815514,\n",
       "                                       'pulmonary regurgitation': 0.10596631,\n",
       "                                       'projection reconstruction': 0.01822695,\n",
       "                                       'photo-receptor': 0.08010874,\n",
       "                                       'protease': 0.03395684,\n",
       "                                       'progestine': 0.069141895,\n",
       "                                       'pentoxy-resorufin': 0.101141244,\n",
       "                                       'partial remission': 0.33640707,\n",
       "                                       'progestin receptor': 0.1832439,\n",
       "                                       'per rectum': 0.06354367,\n",
       "                                       'Plain radiography': 0.17612909,\n",
       "                                       'production rate': 0.04229572,\n",
       "                                       'pulmonary rehabilitation': 0.06357308,\n",
       "                                       'pentoxy resorufin': 0.10406104,\n",
       "                                       'proteinase': 0.018192964,\n",
       "                                       'Paeoniae radix': 0.19600649,\n",
       "                                       'Puerto Rico': 0.08552503,\n",
       "                                       'Prevalence ratios': 0.20361356,\n",
       "                                       'perirenal': 0.072506495,\n",
       "                                       'passive recovery': 0.08811404,\n",
       "                                       'propranolol': 0.1037719,\n",
       "                                       'primary response': 0.2793677,\n",
       "                                       'pregnant': -0.010555745,\n",
       "                                       'partial regression': 0.09004435,\n",
       "                                       'Photoreactivation': 0.08090539,\n",
       "                                       'peripheral resistance': 0.13455121,\n",
       "                                       'polymorphic reticulosis': 0.16291437,\n",
       "                                       'progressive ratio': 0.18512323,\n",
       "                                       'partial responder': 0.19383162,\n",
       "                                       'projection-reconstruction': 0.03800862,\n",
       "                                       'pro-renin': 0.13096148,\n",
       "                                       'phenol-red': 0.17938986,\n",
       "                                       'progestin': 0.10007824,\n",
       "                                       'pro-rennin': 0.11495024}),\n",
       "                          'TO': defaultdict(float,\n",
       "                                      {'turbulence onset': 0.0031306455,\n",
       "                                       'tracheobronchopathia-osteochondroplastica': 0.10216466,\n",
       "                                       'Tryptophan oxygenase': -0.039527882,\n",
       "                                       'tryptophan oxygenase': -0.039527882,\n",
       "                                       'tracheal obstruction': 0.050415184,\n",
       "                                       'tectum opticum': 0.0708329,\n",
       "                                       'turpentine oil': 0.061764505,\n",
       "                                       'triolein': -3.1119216e-05,\n",
       "                                       'time-out': -0.033340875,\n",
       "                                       'tracheobronchopathia osteochondroplastica': 0.116574064,\n",
       "                                       'tuna oil': -0.0051953956,\n",
       "                                       'timeout': -0.04194766,\n",
       "                                       'tri-olein': 0.0012215527,\n",
       "                                       'turn-over': 0.015063894,\n",
       "                                       'thiazole orange': 0.090729706,\n",
       "                                       'tracheo-bronchopathia osteochondroplastica': 0.0961469,\n",
       "                                       'temperature': -0.08708701,\n",
       "                                       'turnover': 0.00089004094,\n",
       "                                       'toremifene': 0.082174264,\n",
       "                                       'tracheo-bronchopathia osteo-chondroplastica': 0.08038251,\n",
       "                                       'tracheal occlusion': 0.06526194})}),\n",
       "             'In the primary trial, Dasatinib, 70 mg, Twice Daily results in a better median PFS than Dasatinib, 100 mg, Daily. The opposite was true in the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.012424724,\n",
       "                                       'pyrogen-free saline': 0.11197032,\n",
       "                                       'pressure-flow study': 0.007851041,\n",
       "                                       'posterior fossa syndrome': 0.09975547,\n",
       "                                       'pressure flow study': 0.0077892584,\n",
       "                                       'primary fibromyalgia syndrome': 0.20186052,\n",
       "                                       'Piper Fatigue Scale': 0.14194079,\n",
       "                                       'patellofemoral syndrome': 0.0259385,\n",
       "                                       'Progression-free': 0.064412445,\n",
       "                                       'pulmonary function score': 0.15116686,\n",
       "                                       'pressure flow studies': 0.010797103,\n",
       "                                       'protein-free supernatant': 0.07184278,\n",
       "                                       'progression free survival': 0.20092517,\n",
       "                                       'protein free supernatant': 0.0823242,\n",
       "                                       'progression-free survival': 0.21639311,\n",
       "                                       'pressure/flow study': 0.0142036155})}),\n",
       "             'At least one participant in the primary trial receiving an oral treatment of film-coated Afatinib tablet at a starting dose of 40 milligram (mg) once daily and weekly 10 minutes intravenous infusions of Vinorelbine 25 mg/meter^2 (meter=m) had a PFS over 9 months.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.12919684,\n",
       "                                       'pyrogen-free saline': 0.20099206,\n",
       "                                       'pressure-flow study': 0.04114684,\n",
       "                                       'posterior fossa syndrome': 0.21392679,\n",
       "                                       'pressure flow study': 0.05386993,\n",
       "                                       'primary fibromyalgia syndrome': 0.23731552,\n",
       "                                       'Piper Fatigue Scale': 0.10281526,\n",
       "                                       'patellofemoral syndrome': 0.14961135,\n",
       "                                       'Progression-free': 0.09549308,\n",
       "                                       'pulmonary function score': 0.14029469,\n",
       "                                       'pressure flow studies': 0.04838451,\n",
       "                                       'protein-free supernatant': 0.060444456,\n",
       "                                       'progression free survival': 0.18650852,\n",
       "                                       'protein free supernatant': 0.07317356,\n",
       "                                       'progression-free survival': 0.22975878,\n",
       "                                       'pressure/flow study': 0.043308344})}),\n",
       "             'Patients will have to undergo an MRI scan for before entry for both the secondary trial and the primary trial, for the primary trial patients will also need to have a brain MR and PET imaging, after study entry.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MRI': defaultdict(float,\n",
       "                                      {'magnetic-resonance imaging': 0.3585268,\n",
       "                                       'MR-imaging': 0.45386636,\n",
       "                                       'magnetic resonance imaging': 0.4003026,\n",
       "                                       'magnetic resonance images': 0.38428137,\n",
       "                                       'magnetic resonance': 0.24506937,\n",
       "                                       'Magnetic resonance imagings': 0.43578705,\n",
       "                                       'magnet resonance imaging': 0.41065577,\n",
       "                                       'MR imaging': 0.46812797,\n",
       "                                       'magnetic-resonance-imaging': 0.3412472,\n",
       "                                       'magnetic resonance imagery': 0.35050258,\n",
       "                                       'Magnetic resonance imaging scan': 0.47352117,\n",
       "                                       'magnetic resonance tomography': 0.37484053,\n",
       "                                       'magnetic resonance image': 0.3513087,\n",
       "                                       'Magnetic resonance image': 0.3513087}),\n",
       "                          'MR': defaultdict(float,\n",
       "                                      {'molecular remission': 0.15090169,\n",
       "                                       'measles and rubella': 0.1309842,\n",
       "                                       'muscle relaxant': 0.04869221,\n",
       "                                       'Maillard reaction': -0.052156527,\n",
       "                                       'mitochondria-rich': 0.024820356,\n",
       "                                       'mitotic rate': 0.023948338,\n",
       "                                       'Maudsley reactive': -0.0278095,\n",
       "                                       'mitral regurgitation': 0.15019628,\n",
       "                                       'methyl-red': 0.056848403,\n",
       "                                       'mentally-retarded': 0.025667638,\n",
       "                                       'multiresistant': 0.048493274,\n",
       "                                       'mannose receptor': 0.09071309,\n",
       "                                       'magnetoresistance': 0.054634597,\n",
       "                                       'median raphe nucleus': 0.14656012,\n",
       "                                       'mister': -0.032869734,\n",
       "                                       'methemoglobin reductase': 0.092229635,\n",
       "                                       'mannose-resistant': 0.014819917,\n",
       "                                       'muscle-relaxant': 0.078115776,\n",
       "                                       'macrophage mannose receptor': 0.074151345,\n",
       "                                       'mandelate racemase': -0.051959816,\n",
       "                                       'medical record': 0.30228338,\n",
       "                                       'mandibular reflex': 0.029243637,\n",
       "                                       'mentally retarded': 0.052503385,\n",
       "                                       'milk replacer': -0.056793313,\n",
       "                                       'medial raphe': 0.15902407,\n",
       "                                       'magnetic resistance': 0.07613503,\n",
       "                                       'molecular replacement': 0.015024779,\n",
       "                                       'modulation rate': 0.06743274,\n",
       "                                       'magnetic resonance': 0.24506937,\n",
       "                                       'mitral reflux': 0.1719622,\n",
       "                                       'mortality ratio': 0.028686218,\n",
       "                                       'minor response': 0.0516944,\n",
       "                                       'metabolic rate': 0.047048822,\n",
       "                                       'methyl red': 0.0367542,\n",
       "                                       'medical representative': 0.23181397,\n",
       "                                       'mortality-rate': 0.019602414,\n",
       "                                       'metabolic rates': 0.041385952,\n",
       "                                       'mineralocorticoid receptor': 0.068976805,\n",
       "                                       'mannose resistant': 0.011393668,\n",
       "                                       'metabolic ratio': 0.06733245,\n",
       "                                       'methicillin-resistant': 0.057900734,\n",
       "                                       'morbid risk': 0.18611164,\n",
       "                                       'multicentric reticulohistiocytosis': 0.07189149,\n",
       "                                       'muscle receptor': 0.05483712,\n",
       "                                       'modified release': 0.13984187,\n",
       "                                       'megaroentgen': 0.02218609,\n",
       "                                       'metabolic ratios': 0.07158596,\n",
       "                                       'mortality rate': -0.00051413476,\n",
       "                                       'multi-receptive': 0.108103506,\n",
       "                                       'magnetic-resonance': 0.21413293,\n",
       "                                       'Maddox rod': 0.014413789,\n",
       "                                       'modified-release': 0.11459094,\n",
       "                                       'myocardial revascularization': 0.177754,\n",
       "                                       'mother reared': -0.05453357,\n",
       "                                       'minor responses': 0.06912772,\n",
       "                                       'mitral valve regurgitation': 0.104031645,\n",
       "                                       'Multicentric reticulohistiocytosis': 0.07189149,\n",
       "                                       'medication reconciliation': 0.26170978,\n",
       "                                       'mental retardation': 0.093417905,\n",
       "                                       'morphinone reductase': 0.09962473,\n",
       "                                       'mineralocorticoid receptors': 0.037351582,\n",
       "                                       'Maudsley Reactive': -0.0278095,\n",
       "                                       'mannose-receptor': 0.07433494,\n",
       "                                       'Menstrual regulation': 0.03145082,\n",
       "                                       'medial rectus': 0.19424954,\n",
       "                                       'multireceptive': 0.09034918,\n",
       "                                       'mother-reared': -0.044916853,\n",
       "                                       'multi-resistant': 0.030394394,\n",
       "                                       'Mental Rotation': 0.13149486,\n",
       "                                       'median raphe': 0.028958956}),\n",
       "                          'PET': defaultdict(float,\n",
       "                                      {'paraffin-embedded tissue': 0.09878962,\n",
       "                                       'polyethylene terephtalate': -0.023661107,\n",
       "                                       'peritoneal equilibration test': 0.20529848,\n",
       "                                       'polyester': -0.108945616,\n",
       "                                       'poly (ethylene terephthalate)': -0.057519764,\n",
       "                                       'peritoneal equilibration tests': 0.17479956,\n",
       "                                       'pancreatic endocrine tumors': -0.025810614,\n",
       "                                       'Positron emission tomography': 0.25165528,\n",
       "                                       'positron emission computed tomography': 0.28348735,\n",
       "                                       'polyethylene terephthalate': -0.048469465,\n",
       "                                       'patulous eustachian tube': 0.095830515,\n",
       "                                       'pre-eclamptic toxemia': 0.030253336,\n",
       "                                       'poly(ethylene terephthalate)': -0.057519764,\n",
       "                                       'poly-(ethylene terephthalate)': -0.044868268,\n",
       "                                       'pre-eclamptic toxaemia': 0.02298574,\n",
       "                                       'peritonaeal equilibration test': 0.215336,\n",
       "                                       'positron-emission tomography': 0.24349332,\n",
       "                                       'positron-emission-tomography': 0.23804829,\n",
       "                                       'positron emission tomography': 0.25165528,\n",
       "                                       'photoinduced electron transfer': 0.037849024,\n",
       "                                       'positron emission tomograph': 0.232671,\n",
       "                                       'preeclamptic toxaemia': 0.017733483,\n",
       "                                       'partial exchange transfusion': 0.1927745,\n",
       "                                       'pressure equalization tubes': 0.09931651,\n",
       "                                       'polyethylene-terephthalate': -0.042209342,\n",
       "                                       'pancreatic endocrine tumour': -0.033799224,\n",
       "                                       'positron emission-computed tomography': 0.274153,\n",
       "                                       'polyethyleneterephthalate': -0.053190365,\n",
       "                                       'poly-ethylene terephthalate': -0.033343315,\n",
       "                                       'preeclamptic toxemia': 0.026407622,\n",
       "                                       'Polyethyleneterephthalate': -0.053190365,\n",
       "                                       'poly(ethyleneterephthalate)': -0.053415384,\n",
       "                                       'pancreatic endocrine tumor': -0.031243328,\n",
       "                                       'Peritoneal Equilibration Test': 0.20529848,\n",
       "                                       'positron emission tomographic': 0.24105333,\n",
       "                                       'phosphatidylethanol': -0.020886593,\n",
       "                                       'paraffin embedded tissue': 0.10007997})}),\n",
       "             'the primary trial uses a 3 week cycle for SB-715992 administration.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'SB': defaultdict(float,\n",
       "                                      {'Specific binding': 0.05534516,\n",
       "                                       'single breath': 0.06689658,\n",
       "                                       'spontaneous breathing': -0.01290281,\n",
       "                                       'sympathetic blockade': 0.18443303,\n",
       "                                       'Southern blotting': 0.20004736,\n",
       "                                       'sinus bradycardia': 0.14736378,\n",
       "                                       'Southern blot': 0.17214857,\n",
       "                                       'stereotyped behavior': 0.0030879176,\n",
       "                                       'Saccharomyces boulardii': 0.1391115,\n",
       "                                       'scleral buckling': 0.0949761,\n",
       "                                       'serum bilirubin': 0.15530236,\n",
       "                                       'secobarbital': 0.15163706,\n",
       "                                       'sodium bicarbonate': 0.13741124,\n",
       "                                       'sodium butyrate': 0.16769284,\n",
       "                                       'spina bifida': 0.063501306,\n",
       "                                       'spina-bifida': 0.053220984,\n",
       "                                       'single-breath': 0.059864722,\n",
       "                                       'small bowel': 0.059017066,\n",
       "                                       'sulforhodamine B': 0.24358518,\n",
       "                                       'Single Bond': 0.077133454,\n",
       "                                       'strand breaks': -0.027346991,\n",
       "                                       'spontaneous blastogenesis': 0.041423056,\n",
       "                                       'small-bowel': 0.07709328,\n",
       "                                       'sulphorhodamine B': 0.25442493,\n",
       "                                       'stereotyped behaviour': -0.0021922705,\n",
       "                                       'sulforhodamine-B': 0.26990297,\n",
       "                                       'side branch': 0.03629915,\n",
       "                                       'specific binding': 0.05534516,\n",
       "                                       'sulphorhodamine-B': 0.2693996,\n",
       "                                       'salbutamol': 0.20507573,\n",
       "                                       'Sleeping Beauty': -0.018610964,\n",
       "                                       'Schiff base': 0.17886095,\n",
       "                                       'sleep bruxism': 0.12560296})}),\n",
       "             'the primary trial is a phase II trial in which all participants will recieve topical fluocinonide 0.05% cream to apply to their genitalia twice daily for two weeks.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'II': defaultdict(float,\n",
       "                                      {'image intensifier': 0.101608075,\n",
       "                                       'icterus index': 0.20282896})}),\n",
       "             'There was over 14 weeks difference in Progression-free Survival between the minimum and maximum PFS in the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.1064351,\n",
       "                                       'pyrogen-free saline': 0.14219204,\n",
       "                                       'pressure-flow study': 0.043283686,\n",
       "                                       'posterior fossa syndrome': 0.111058034,\n",
       "                                       'pressure flow study': 0.05104397,\n",
       "                                       'primary fibromyalgia syndrome': 0.24271274,\n",
       "                                       'Piper Fatigue Scale': 0.19060943,\n",
       "                                       'patellofemoral syndrome': 0.13043572,\n",
       "                                       'Progression-free': 0.26196775,\n",
       "                                       'pulmonary function score': 0.26215443,\n",
       "                                       'pressure flow studies': 0.035524197,\n",
       "                                       'protein-free supernatant': 0.07250974,\n",
       "                                       'progression free survival': 0.528779,\n",
       "                                       'protein free supernatant': 0.09883214,\n",
       "                                       'progression-free survival': 0.55856496,\n",
       "                                       'pressure/flow study': 0.07419378})}),\n",
       "             'The Median length of time that a patient in Arm A of the primary trial survived after receiving a TNBC diagnosis was 6 months.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'TNBC': defaultdict(float,\n",
       "                                      {'triple negative breast carcinoma': 0.32219544,\n",
       "                                       'triple-negative breast cancer': 0.3456993,\n",
       "                                       'triple negative breast cancer': 0.34086052})}),\n",
       "             'Patients with HER2 negative tumours are eligible for the primary trial but not for the secondary trial': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.293257,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.30019844,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.2954012,\n",
       "                                       'human epidermal growth factor receptor 2': 0.29598022,\n",
       "                                       'human epidermal growth factor receptor-2': 0.30019844})}),\n",
       "             'At least 400 participants in the primary trial receiving an oral treatment of film-coated Afatinib tablet at a starting dose of 40 milligram (mg) once daily and weekly 10 minutes intravenous infusions of Vinorelbine 25 mg/meter^2 (meter=m) had a PFS over 9 months.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.12028709,\n",
       "                                       'pyrogen-free saline': 0.1906425,\n",
       "                                       'pressure-flow study': 0.044494245,\n",
       "                                       'posterior fossa syndrome': 0.201711,\n",
       "                                       'pressure flow study': 0.058883436,\n",
       "                                       'primary fibromyalgia syndrome': 0.24841212,\n",
       "                                       'Piper Fatigue Scale': 0.11416109,\n",
       "                                       'patellofemoral syndrome': 0.14310388,\n",
       "                                       'Progression-free': 0.096387774,\n",
       "                                       'pulmonary function score': 0.15422335,\n",
       "                                       'pressure flow studies': 0.053849056,\n",
       "                                       'protein-free supernatant': 0.055443358,\n",
       "                                       'progression free survival': 0.20015952,\n",
       "                                       'protein free supernatant': 0.06913405,\n",
       "                                       'progression-free survival': 0.24239394,\n",
       "                                       'pressure/flow study': 0.048906483})}),\n",
       "             'the secondary trial and the primary trial both used MRI and Letrozole for their interventions.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MRI': defaultdict(float,\n",
       "                                      {'magnetic-resonance imaging': 0.37275985,\n",
       "                                       'MR-imaging': 0.40975124,\n",
       "                                       'magnetic resonance imaging': 0.37743735,\n",
       "                                       'magnetic resonance images': 0.35985544,\n",
       "                                       'magnetic resonance': 0.29309255,\n",
       "                                       'Magnetic resonance imagings': 0.43448338,\n",
       "                                       'magnet resonance imaging': 0.35389864,\n",
       "                                       'MR imaging': 0.39766273,\n",
       "                                       'magnetic-resonance-imaging': 0.36255923,\n",
       "                                       'magnetic resonance imagery': 0.30776498,\n",
       "                                       'Magnetic resonance imaging scan': 0.42330202,\n",
       "                                       'magnetic resonance tomography': 0.33708233,\n",
       "                                       'magnetic resonance image': 0.31689957,\n",
       "                                       'Magnetic resonance image': 0.31689957})}),\n",
       "             'The difference in Percentage of Participants With At Least 1 Adverse Event (AE) During the Treatment Period in both cohorts of the primary trial is less than 1%.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'AE': defaultdict(float,\n",
       "                                      {'adverse events': 0.45522726,\n",
       "                                       'acute exacerbation': 0.27162346,\n",
       "                                       'atherosclerotic encephalopathy': 0.124121726,\n",
       "                                       'assimilation efficiency': 0.07261661,\n",
       "                                       'adverse-event': 0.44904667,\n",
       "                                       'atopic eczema': 0.14515637,\n",
       "                                       'apoenzyme': 0.10526709,\n",
       "                                       'apo-enzyme': 0.1363619,\n",
       "                                       'allylestrenol': 0.15733746,\n",
       "                                       'acrodermatitis enteropathica': 0.0869088,\n",
       "                                       'air entry': 0.01738883,\n",
       "                                       'anion exchange': 0.11135704,\n",
       "                                       'acoustic emission': -0.06937461,\n",
       "                                       'attaching and effacing': 0.08457465,\n",
       "                                       'aerobic exercise': 0.06645691,\n",
       "                                       'activation energy': 0.046616226,\n",
       "                                       'adverse effects': 0.28235137,\n",
       "                                       'air-entry': 0.024897926,\n",
       "                                       'adverse experience': 0.36237136,\n",
       "                                       'avian encephalomyelitis': 0.06823078,\n",
       "                                       'anion exchanger': 0.07567759,\n",
       "                                       'aqueous extract': 0.107570365,\n",
       "                                       'adverse event': 0.41762546,\n",
       "                                       'alcoholic embryopathy': 0.100325376,\n",
       "                                       'Absolute Error': 0.16164473,\n",
       "                                       'androstenedione': 0.07443693,\n",
       "                                       'anoxic encephalopathy': 0.059293684,\n",
       "                                       'alveolar echinococcosis': 0.07995119,\n",
       "                                       'agarose electrophoresis': 0.08552433,\n",
       "                                       'agricultural engineer': -0.026118401,\n",
       "                                       'Acoustic emission': -0.06937461,\n",
       "                                       'air embolism': 0.12241141,\n",
       "                                       'aeronautical engineer': 0.005699888,\n",
       "                                       'aldrin epoxidase': 0.15336984,\n",
       "                                       'absence epilepsy': 0.21398659,\n",
       "                                       'acridinium ester': 0.18125048})}),\n",
       "             \"Cohort 1 of the primary trial recieves less than 60% of cohort 2's dose of LA-EP2006.\": defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'LA': defaultdict(float,\n",
       "                                      {'Latin American': 0.059059486,\n",
       "                                       'latex agglutination': -0.009217083,\n",
       "                                       'low achievement': 0.1325821,\n",
       "                                       'local anaesthetics': 0.18819086,\n",
       "                                       'learning automaton': -0.03784654,\n",
       "                                       'locally advanced': 0.043307763,\n",
       "                                       'Lactobacillus acidophilus': 0.05038733,\n",
       "                                       'lactate': 0.089014865,\n",
       "                                       'Latin America': 0.0752368,\n",
       "                                       'Lyme arthritis': 0.12932116,\n",
       "                                       'leucine aminopeptidase': 0.11485849,\n",
       "                                       'large amount': 0.036065355,\n",
       "                                       'laevulinic acid': 0.20360613,\n",
       "                                       'levulinic acid': 0.17896947,\n",
       "                                       'lateral nucleus': 0.07996499,\n",
       "                                       'L-arginine': 0.23957783,\n",
       "                                       'large aggregates': 0.0015746669,\n",
       "                                       'local anesthetic': 0.15827683,\n",
       "                                       'linear array': 0.028618755,\n",
       "                                       'lymphoid aggregates': 0.12877569,\n",
       "                                       'leuco-araiosis': 0.09826765,\n",
       "                                       'local anaesthetic': 0.16749477,\n",
       "                                       'low altitude': 0.063675895,\n",
       "                                       'laser angioplasty': 0.11964885,\n",
       "                                       'low affinity': 0.07829229,\n",
       "                                       'lauric acid': 0.067438364,\n",
       "                                       'latex agglutination test': 0.037610088,\n",
       "                                       'localised adherence': 0.127178,\n",
       "                                       'leaf area': -0.0026506095,\n",
       "                                       'lichen amyloidosus': 0.14791717,\n",
       "                                       'light adapted': 0.008246773,\n",
       "                                       'left atria': 0.103244744,\n",
       "                                       'leukoaraiosis': 0.16583411,\n",
       "                                       'locomotor activity': 0.01164916,\n",
       "                                       'levator ani': 0.10533188,\n",
       "                                       'lard': 0.074220926,\n",
       "                                       'long acting': 0.027301678,\n",
       "                                       'leucoagglutination': 0.19186197,\n",
       "                                       'laser ablation': 0.1253604,\n",
       "                                       'leukoagglutinin': 0.14334227,\n",
       "                                       'local anaesthesia': 0.17504852,\n",
       "                                       'lumen area': 0.10061103,\n",
       "                                       'lacticacidaemia': 0.13156989,\n",
       "                                       'large aspiny': -0.037494887,\n",
       "                                       'lateral': 0.019412616,\n",
       "                                       'loss of attachment': 0.028387107,\n",
       "                                       'laminin': 0.180462,\n",
       "                                       'luminal area': 0.11051381,\n",
       "                                       'laparoscopic appendicectomy': 0.08357837,\n",
       "                                       'leucine amino-peptidase': 0.14348567,\n",
       "                                       'lactalbumen': 0.19711784,\n",
       "                                       'leuko-agglutination': 0.107442565,\n",
       "                                       'lymphadenopathy': 0.2096166,\n",
       "                                       'lateral nucleus of the amygdala': 0.06678052,\n",
       "                                       'longacting': 0.0006988682,\n",
       "                                       'localized adherence': 0.056202065,\n",
       "                                       'lactalbumin': 0.28335753,\n",
       "                                       'Los Angeles': 0.08116903,\n",
       "                                       'large surfactant aggregates': -0.035971314,\n",
       "                                       'leuprolide acetate': 0.3273256,\n",
       "                                       'lymph-adenectomy': 0.19059768,\n",
       "                                       'left atrial': 0.14289062,\n",
       "                                       'lactic acidosis': 0.16220163,\n",
       "                                       'lactide': 0.144026,\n",
       "                                       'Louisiana': 0.074135385,\n",
       "                                       'lipoatrophy': 0.15896942,\n",
       "                                       'leucine amino peptidase': 0.11821188,\n",
       "                                       'laparoscopic appendectomy': 0.11341065,\n",
       "                                       'leuko-araiosis': 0.09059911,\n",
       "                                       'lacticacidemia': 0.11463309,\n",
       "                                       'long-acting': 0.0563721,\n",
       "                                       'lithocholic acid': 0.1810969,\n",
       "                                       'late antigen': 0.28457287,\n",
       "                                       'leukoagglutination': 0.13016562,\n",
       "                                       'light-adapted': 0.00088789326,\n",
       "                                       'lactic acid': 0.09041201,\n",
       "                                       'leuko-agglutinin': 0.16141573,\n",
       "                                       'local anesthesia': 0.13694443,\n",
       "                                       'left auricle': 0.091017164,\n",
       "                                       'lymphadenectomy': 0.17579941,\n",
       "                                       'Ludwig angina': 0.12823871,\n",
       "                                       'leucoaraiosis': 0.19327867,\n",
       "                                       'Laparoscopic adrenalectomy': 0.17544855,\n",
       "                                       'Latinamerican': 0.06991814,\n",
       "                                       'laparoscopic adrenalectomy': 0.17544855,\n",
       "                                       'lactic acidemia': 0.1769646,\n",
       "                                       'linoleate': 0.02912638,\n",
       "                                       'lateral amygdala': 0.09024057,\n",
       "                                       'left atrial diameter': 0.14296305,\n",
       "                                       'lactalbumine': 0.2831795,\n",
       "                                       'leucoagglutinin': 0.2027429,\n",
       "                                       'leuco-agglutination': 0.12872447,\n",
       "                                       'Lupus anticoagulants': 0.33368072,\n",
       "                                       'lipid A': 0.18308102,\n",
       "                                       'left arm': 0.05798646,\n",
       "                                       'long axis': 0.04146078,\n",
       "                                       'low-average': 0.19300778,\n",
       "                                       'late abortion': 0.20008203,\n",
       "                                       'lactic acidaemia': 0.1628525,\n",
       "                                       'leuco-agglutinin': 0.17940576,\n",
       "                                       'linoleic acid': 0.08473443,\n",
       "                                       'lupus anticoagulant': 0.3580406,\n",
       "                                       'laminine': 0.16153862,\n",
       "                                       'large aggregate': 0.03798287,\n",
       "                                       'Latin-American': 0.06674925,\n",
       "                                       'limit of agreement': 0.098061725,\n",
       "                                       'left atrium': 0.10080951,\n",
       "                                       'l-arginine': 0.23957783,\n",
       "                                       'linoleic': 0.008031058,\n",
       "                                       'low-affinity': 0.07320819,\n",
       "                                       'lymphoadenectomy': 0.1814227,\n",
       "                                       'lead acetate': 0.14788912,\n",
       "                                       'local anesthetics': 0.18198211,\n",
       "                                       'laparoscopic': 0.09269679,\n",
       "                                       'los angeles': 0.08116903})}),\n",
       "             'In order to be eligible for the primary trial, patients must not have prior radiation, anthracycline or systemic anticancer therapy , and must have T1-4, N1 and M1 bilateral breast cancer.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'T1': defaultdict(float,\n",
       "                                      {'thoracic 1': 0.19188134,\n",
       "                                       'term births': 0.007443829,\n",
       "                                       'tricuspid first sound': 0.0682509,\n",
       "                                       'type 1': 0.20164505,\n",
       "                                       'twitch height': -0.02009565,\n",
       "                                       'Time 1': 0.11920567,\n",
       "                                       'thoracic vertebra 1': 0.08662774,\n",
       "                                       't1 (size, tumor staging)': 0.43153632,\n",
       "                                       'time 1': 0.11920567,\n",
       "                                       'therapy': 0.10776876,\n",
       "                                       't1 (first thoracic vertebra)': 0.18702537,\n",
       "                                       'treatment 1': 0.3198347}),\n",
       "                          'N1': defaultdict(float,\n",
       "                                      {'negativity': -0.025719602,\n",
       "                                       'negative wave': -0.03147461,\n",
       "                                       'negative peak': 0.01511542,\n",
       "                                       'negative': 0.06291796,\n",
       "                                       'negative component': -0.027684426}),\n",
       "                          'M1': defaultdict(float,\n",
       "                                      {'matrix protein': -0.017130777,\n",
       "                                       'mouse myeloid leukemia': 0.1630666,\n",
       "                                       'mouse myeloid leukemia cells': 0.14835924,\n",
       "                                       'muscarinic': 0.092405535,\n",
       "                                       'middle cerebral artery': 0.1001097,\n",
       "                                       'matrix': -0.058111157,\n",
       "                                       'metastatic disease': 0.31443676,\n",
       "                                       'metabolite': 0.08435438,\n",
       "                                       'metastatic': 0.24798493})}),\n",
       "             'INR of 1.35 is enough for participation in the primary trial and the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'INR': defaultdict(float,\n",
       "                                      {'international normalised ratio': 0.30048966,\n",
       "                                       'insulin receptor': 0.15120804,\n",
       "                                       'initiator': 0.22744873,\n",
       "                                       'international normalized ratio': 0.28644028,\n",
       "                                       'international normalized ratios': 0.28150794,\n",
       "                                       'initiator element': 0.19619113,\n",
       "                                       'International Normalised Ratios': 0.29862428})}),\n",
       "             'the primary trial studies the effects of CTX/IMQ/RT and Epothilone on Central Nervous System (CNS) Progression-free Survival(PFS), 9 weeks after the start of treatment.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CTX': defaultdict(float,\n",
       "                                      {'cefotaxime': 0.18438822,\n",
       "                                       'Cytoxan': 0.30404237,\n",
       "                                       'Crosslaps': -0.09460768,\n",
       "                                       'chemotaxis': 0.10895444,\n",
       "                                       'chemotherapy': 0.32229513,\n",
       "                                       'ceftriaxon': 0.21658733,\n",
       "                                       'cerebrotendinous xanthomatosis': 0.18971449,\n",
       "                                       'Charybdotoxin': 0.13226306,\n",
       "                                       'canthaxanthin': 0.12420588,\n",
       "                                       'cholera toxin': 0.02604755,\n",
       "                                       'cortical': 0.10980361,\n",
       "                                       'cerebral cortex': 0.1741161,\n",
       "                                       'costotendinous xanthomatosis': 0.12352249,\n",
       "                                       'C-telopeptides': 0.08199007,\n",
       "                                       'C-telopeptide': 0.1517933,\n",
       "                                       'cytotoxicity': 0.20223558,\n",
       "                                       'contractions': 0.020816574,\n",
       "                                       'ciguatoxin': 0.13408014,\n",
       "                                       'Contractions': 0.020816574,\n",
       "                                       'ceftriaxone': 0.322491,\n",
       "                                       'Cefotaxime': 0.18438822,\n",
       "                                       'cyclophosphamide': 0.27476636,\n",
       "                                       'cardiotoxin': 0.23339011}),\n",
       "                          'CNS': defaultdict(float,\n",
       "                                      {'central nerve system': 0.28315982,\n",
       "                                       'Congenital nephrotic syndrome': 0.06303869,\n",
       "                                       'Coagulase negative staphylococci': -0.06361228,\n",
       "                                       'Clinical nurse specialist': 0.074712895,\n",
       "                                       'coagulase negative staphylococcus': -0.060642716,\n",
       "                                       'coagulase-negative Staphylococcus': -0.04746541,\n",
       "                                       'central nerves system': 0.25925136,\n",
       "                                       'central-nervous-system': 0.22955431,\n",
       "                                       'congenital nephrotic syndrome': 0.06303869,\n",
       "                                       'central nervous system': 0.25708532,\n",
       "                                       'central nervous systems': 0.24783936,\n",
       "                                       'Crigler Najjar syndrome': 0.052361358,\n",
       "                                       'coagulase negative staph': -0.03677977,\n",
       "                                       'clinical nurse specialists': 0.09149864,\n",
       "                                       'Crigler-Najjar syndrome': 0.070106044,\n",
       "                                       'coagulase-negative staphylococci': -0.054836523,\n",
       "                                       'coagulase-negative staphylococcus': -0.04746541,\n",
       "                                       'central nervous': 0.24464054,\n",
       "                                       'clinical nurse specialist': 0.074712895,\n",
       "                                       'Canadian Neurological Scale': 0.32326728,\n",
       "                                       'coagulase-negative staphylococcal': -0.013696357,\n",
       "                                       'coagulase negative Staphylococcus': -0.060642716})}),\n",
       "             'the primary trial participants will receive either Lapatinib, WBRT or Herceptin.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'WBRT': defaultdict(float,\n",
       "                                      {'whole brain radiotherapy': 0.15811007,\n",
       "                                       'whole-breast radiotherapy': 0.16200806,\n",
       "                                       'whole-brain radiation therapy': 0.19069323,\n",
       "                                       'whole brain radiation therapy': 0.2011324,\n",
       "                                       'whole brain irradiation': 0.1872976,\n",
       "                                       'whole-brain radiotherapy treatment': 0.18345274,\n",
       "                                       'whole-brain radiotherapy': 0.16155937,\n",
       "                                       'whole breast radiotherapy': 0.16396432})}),\n",
       "             'the primary trial has a topical intervention, whereas the secondary trial has both oral and IV interventions.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.13378891,\n",
       "                                       'intravenous injection': 0.30254894,\n",
       "                                       'iridovirus': 0.1360196,\n",
       "                                       'intra-venous': 0.29582876,\n",
       "                                       'invitro': 0.062027708,\n",
       "                                       'intra ventricular': 0.102012806,\n",
       "                                       'intra vascular': 0.23982905,\n",
       "                                       'in vivo': 0.24717472,\n",
       "                                       'intravascular': 0.2709264,\n",
       "                                       'in-vivo': 0.30681226,\n",
       "                                       'inter-vertebral': 0.20170562,\n",
       "                                       'ichthyosis vulgaris': 0.16263331,\n",
       "                                       'intravenous': 0.3250866,\n",
       "                                       'intravaginal': 0.25812498,\n",
       "                                       'invasive': 0.14978027,\n",
       "                                       'iridescent virus': 0.08995146,\n",
       "                                       'isometric virus': 0.058686536,\n",
       "                                       'intravenous feeding device': 0.20283481,\n",
       "                                       'invivo': 0.08568321,\n",
       "                                       'instrumental variable': 0.12621953,\n",
       "                                       'intraventricular': 0.09666028,\n",
       "                                       'intra-vaginal': 0.28801537,\n",
       "                                       'intravertebral': 0.21662387,\n",
       "                                       'in vitro': 0.17219506,\n",
       "                                       'interventricular': 0.13309686,\n",
       "                                       'in-vitro': 0.2364132,\n",
       "                                       'intra venous': 0.25174204,\n",
       "                                       'iodine value': 0.070907496,\n",
       "                                       'ichnovirus': 0.08598511,\n",
       "                                       'inter-ventricular': 0.14609276,\n",
       "                                       'intra-vertebral': 0.18907233,\n",
       "                                       'intravenous injection device': 0.26728147,\n",
       "                                       'intervertebral': 0.22811945,\n",
       "                                       'initial visit': 0.21845093,\n",
       "                                       'intravenous feeding': 0.20543726,\n",
       "                                       'intra-vascular': 0.28038663,\n",
       "                                       'intra-ventricular': 0.12411424})}),\n",
       "             'the percentage of participants achieving complete response (CR) or partial response (PR) was 6x higher in the HER2-positive group in the primary trial, than in the ER+ and/or PR+ group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.0889061,\n",
       "                                       'clot retraction': 0.10142748,\n",
       "                                       'conditioned response': 0.22647053,\n",
       "                                       'conditioned reflex': 0.14030291,\n",
       "                                       'charge recombination': 0.05476906,\n",
       "                                       'Czech Republic': -0.016507413,\n",
       "                                       'control region': 0.061345164,\n",
       "                                       'colonization rate': 0.08354009,\n",
       "                                       'complete remission rate': 0.49048716,\n",
       "                                       'Charles River': -0.0504291,\n",
       "                                       'Caloric restriction': 0.015332045,\n",
       "                                       'colonisation resistance': 0.07535735,\n",
       "                                       'complete regression': 0.11304577,\n",
       "                                       'conversion rate': 0.15500344,\n",
       "                                       'chest roentgenography': 0.13776162,\n",
       "                                       'chest radiograph': 0.11817985,\n",
       "                                       'colony reared': -0.012854695,\n",
       "                                       'cardiorespiratory': 0.11256063,\n",
       "                                       'circadian rhythm': 0.08206375,\n",
       "                                       'cardiac rupture': 0.10222353,\n",
       "                                       'carbonyl reductase': 0.10371347,\n",
       "                                       'calorie restriction': -0.027487373,\n",
       "                                       'cortical reaction': 0.1881035,\n",
       "                                       'complete remissions': 0.39163846,\n",
       "                                       'chest radiography': 0.09118505,\n",
       "                                       'computerised record': 0.020588705,\n",
       "                                       'charge-recombination': 0.06323353,\n",
       "                                       'Cardiac Rehabilitation': 0.17031193,\n",
       "                                       'calcium-binding protein calretinin': 0.14750455,\n",
       "                                       'chronic rejection': 0.13813446,\n",
       "                                       'colony-reared': -0.004119601,\n",
       "                                       'cognitive reserve': 0.1827804,\n",
       "                                       'critical ratio': 0.1757335,\n",
       "                                       'cortico-resistant': 0.27190742,\n",
       "                                       'caloric restriction': 0.015332045,\n",
       "                                       'corticoresistant': 0.08939469,\n",
       "                                       'corticosteroid-resistant': 0.22234364,\n",
       "                                       'Congo red': 7.844716e-05,\n",
       "                                       'complete responses': 0.29977685,\n",
       "                                       'chest and right arm': 0.10643801,\n",
       "                                       'conditioned reinforcement': 0.07448048,\n",
       "                                       'constant routine': -0.00095133483,\n",
       "                                       'cardio-respiratory': 0.17447254,\n",
       "                                       'complete response rate': 0.44931155,\n",
       "                                       'cockroach': -0.07553862,\n",
       "                                       'chief resident': -0.038918857,\n",
       "                                       'calorie-restricted': -0.020284427,\n",
       "                                       'complete responders': 0.32600135,\n",
       "                                       'cysteine-rich': 0.094911166,\n",
       "                                       'controlled-release': 0.054503683,\n",
       "                                       'chemoradiation': 0.03318521,\n",
       "                                       'crown-rump': -0.064624906,\n",
       "                                       'crown-rump length': 0.020265939,\n",
       "                                       'creatinine': 0.16457227,\n",
       "                                       'capture-recapture': 0.06878001,\n",
       "                                       'Congo-red': 0.018456269,\n",
       "                                       'coefficient of repeatability': 0.22690433,\n",
       "                                       'computed radiography': 0.06951899,\n",
       "                                       'controlled respiration': 0.10551612,\n",
       "                                       'conditioned reward': 0.10970457,\n",
       "                                       'complement receptors': 0.33891597,\n",
       "                                       'concentration-response': 0.21100047,\n",
       "                                       'complete': 0.096043676,\n",
       "                                       'chest roentgenogram': 0.1505735,\n",
       "                                       'complement receptor': 0.33515218,\n",
       "                                       'Cajal-Retzius': 0.022815775,\n",
       "                                       'cremasteric reflex': 0.25304967,\n",
       "                                       'clot-retraction': 0.08320216,\n",
       "                                       'conserved regions': 0.018744094,\n",
       "                                       'child-resistant': -0.027529767,\n",
       "                                       'control rats': 0.02557158,\n",
       "                                       'caries-resistant': 0.03422845,\n",
       "                                       'coronary revascularization': 0.21195665,\n",
       "                                       'colon resection': 0.061834387,\n",
       "                                       'contrast ratio': 0.14566474,\n",
       "                                       'concentration ratio': 0.16002654,\n",
       "                                       'Calreticulin': 0.08270121,\n",
       "                                       'composite resin': -0.023348257,\n",
       "                                       'completely': 0.13609669,\n",
       "                                       'colorectal': 0.07950367,\n",
       "                                       'complete response': 0.2822385,\n",
       "                                       'coronary risk': 0.18660067,\n",
       "                                       'conventional radiology': 0.13780914,\n",
       "                                       'Complete response': 0.2822385,\n",
       "                                       'cathode ray': -0.024618568,\n",
       "                                       'complete responder': 0.30689,\n",
       "                                       'controlled release': 0.016687173,\n",
       "                                       'conditioned reflexes': 0.1761356,\n",
       "                                       'chemo-radiation': 0.27595064,\n",
       "                                       'complete remission': 0.33345854,\n",
       "                                       'conserved region': 0.007913802,\n",
       "                                       'coronary resistance': 0.24298081,\n",
       "                                       'cardiac resuscitation': 0.09616573,\n",
       "                                       'computed radiographic': 0.09783291,\n",
       "                                       'cooling rate': -0.020088421,\n",
       "                                       'clinical research': 0.33132464,\n",
       "                                       'colonization resistance': 0.049735527,\n",
       "                                       'compression ratio': 0.050832637,\n",
       "                                       'computerized record': 0.017773962,\n",
       "                                       'chromium': 0.026178673,\n",
       "                                       'colo-rectal': 0.06415648,\n",
       "                                       'contractile reserve': 0.053976778,\n",
       "                                       'clinical record': 0.20751043,\n",
       "                                       'concentration ratios': 0.16242012,\n",
       "                                       'clinical remission': 0.40784124,\n",
       "                                       'centric relation': 0.0038503397,\n",
       "                                       'cardiac rhythm': 0.09613261,\n",
       "                                       'capillary refill': 0.029295087,\n",
       "                                       'colonisation rate': 0.08679198,\n",
       "                                       'conventional radiography': 0.0746268,\n",
       "                                       'cellular receptor': 0.19330347}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.15261663,\n",
       "                                       'plaque reduction': 0.02171389,\n",
       "                                       'partial response': 0.39359486,\n",
       "                                       'photoreactivation': 0.060005993,\n",
       "                                       'pentoxyresorufin': 0.041718457,\n",
       "                                       'panoramic radiography': 0.04030028,\n",
       "                                       'proliferative retinopathy': 0.17287722,\n",
       "                                       'partial responses': 0.39462548,\n",
       "                                       'protein': 0.059014734,\n",
       "                                       'prorennin': 0.11229044,\n",
       "                                       'prevalence rate': 0.24289745,\n",
       "                                       'prealbumin': 0.021051662,\n",
       "                                       'pregnancy rates': 0.099157415,\n",
       "                                       'pain relief': 0.06387295,\n",
       "                                       'partial remissions': 0.48035705,\n",
       "                                       'pattern recognition': -0.058433097,\n",
       "                                       'photo-reactivation': 0.08470953,\n",
       "                                       'protein restriction': 0.113346644,\n",
       "                                       'progesterone receptor': 0.22914189,\n",
       "                                       'placental restriction': 0.13697001,\n",
       "                                       'pneumatic retinopexy': 0.14417934,\n",
       "                                       'prorenin': 0.17925748,\n",
       "                                       'perirhinal cortex': 0.1514534,\n",
       "                                       'prothrombin ratio': 0.2794516,\n",
       "                                       'pars recta': 0.06695555,\n",
       "                                       'pattern reversal': 0.038541976,\n",
       "                                       'pr interval (ekg)': 0.24226126,\n",
       "                                       'pityriasis rosea': 0.011710492,\n",
       "                                       'prevalence ratio': 0.2854361,\n",
       "                                       'Projection reconstruction': -0.062416334,\n",
       "                                       'pregnancy rate': 0.11638232,\n",
       "                                       'phenol red': 0.06882362,\n",
       "                                       'photoreceptor': 0.038421776,\n",
       "                                       'prednisolon': 0.15195215,\n",
       "                                       'partial responders': 0.38197353,\n",
       "                                       'proline-rich': 0.020272115,\n",
       "                                       'pseudorabies': 0.082670875,\n",
       "                                       'pulmonary regurgitation': 0.12405519,\n",
       "                                       'projection reconstruction': -0.062416334,\n",
       "                                       'photo-receptor': 0.1306594,\n",
       "                                       'protease': 0.15715188,\n",
       "                                       'progestine': 0.09521507,\n",
       "                                       'pentoxy-resorufin': 0.07158074,\n",
       "                                       'partial remission': 0.42613146,\n",
       "                                       'progestin receptor': 0.19592202,\n",
       "                                       'per rectum': 0.07652665,\n",
       "                                       'Plain radiography': 0.04821082,\n",
       "                                       'production rate': 0.10570233,\n",
       "                                       'pulmonary rehabilitation': 0.17599994,\n",
       "                                       'pentoxy resorufin': 0.0847282,\n",
       "                                       'proteinase': 0.114586756,\n",
       "                                       'Paeoniae radix': 0.13862239,\n",
       "                                       'Puerto Rico': 0.04242627,\n",
       "                                       'Prevalence ratios': 0.2902919,\n",
       "                                       'perirenal': 0.003211813,\n",
       "                                       'passive recovery': 0.122807704,\n",
       "                                       'propranolol': 0.06086162,\n",
       "                                       'primary response': 0.3585092,\n",
       "                                       'pregnant': 0.005593434,\n",
       "                                       'partial regression': 0.16364725,\n",
       "                                       'Photoreactivation': 0.060005993,\n",
       "                                       'peripheral resistance': 0.21817762,\n",
       "                                       'polymorphic reticulosis': 0.1555498,\n",
       "                                       'progressive ratio': 0.16606124,\n",
       "                                       'partial responder': 0.3413464,\n",
       "                                       'projection-reconstruction': -0.005466249,\n",
       "                                       'pro-renin': 0.15776132,\n",
       "                                       'phenol-red': 0.0903576,\n",
       "                                       'progestin': 0.1010485,\n",
       "                                       'pro-rennin': 0.116735}),\n",
       "                          'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.34017438,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.35184205,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.34499705,\n",
       "                                       'human epidermal growth factor receptor 2': 0.3428532,\n",
       "                                       'human epidermal growth factor receptor-2': 0.35184205}),\n",
       "                          'ER': defaultdict(float,\n",
       "                                      {'extinction-ratio': 0.16556181,\n",
       "                                       'equivalent rontgen': 0.14439347,\n",
       "                                       'endo-plasmic reticulum': 0.11964996,\n",
       "                                       'emergency room': 0.030021083,\n",
       "                                       'estrogen receptor-alpha': 0.32258743,\n",
       "                                       'environmental resistance': 0.04902157,\n",
       "                                       'erythrocyte receptor': 0.35512406,\n",
       "                                       'estradiol receptor': 0.24840334,\n",
       "                                       'extended-release': 0.12614225,\n",
       "                                       'energy restriction': 0.02072407,\n",
       "                                       'energy-restricted': 0.010466662,\n",
       "                                       'estrogen-receptor': 0.27084246,\n",
       "                                       'energy retention': 0.0867265,\n",
       "                                       'electrorheological': 0.08731676,\n",
       "                                       'ejection rate': 0.17473221,\n",
       "                                       'external resistance': 0.0677235,\n",
       "                                       'Estrogen receptor alpha': 0.27267736,\n",
       "                                       'estrogen receptor': 0.25584087,\n",
       "                                       'early': 0.011102056,\n",
       "                                       'endoplasmatic reticulum': 0.1916812,\n",
       "                                       'Estradiol': 0.10314975,\n",
       "                                       'expiratory reserve': 0.14551672,\n",
       "                                       'endovascular repair': 0.08112187,\n",
       "                                       'Emergency Room': 0.030021083,\n",
       "                                       'early reticulocyte': 0.20727126,\n",
       "                                       'esophageal rupture': 0.064601175,\n",
       "                                       'Estrogen receptors': 0.23649034,\n",
       "                                       'evoked responses': 0.312327,\n",
       "                                       'estrogen receptor protein': 0.27728248,\n",
       "                                       'erythromycin': 0.18548235,\n",
       "                                       'enhancement ratios': 0.22917031,\n",
       "                                       'equine rhinopneumonia': 0.028624164,\n",
       "                                       'eye research': 0.11648397,\n",
       "                                       'extinction ratio': 0.17181566,\n",
       "                                       'equivalent roentgen': 0.14976211,\n",
       "                                       'emotion regulation': 0.11754134,\n",
       "                                       'enhancement ratio': 0.22188935,\n",
       "                                       'estrogen receptor status': 0.3514816,\n",
       "                                       'early repolarization': 0.17598401,\n",
       "                                       'early repolarisation': 0.17050022,\n",
       "                                       'electrical resistance': 0.062341698,\n",
       "                                       'evoked response': 0.31935942,\n",
       "                                       'efficacy ratio': 0.32647726,\n",
       "                                       'estrogen': 0.09937039,\n",
       "                                       'endoplasmic reticular': 0.15670428,\n",
       "                                       'extraction ratio': 0.18681857,\n",
       "                                       'extended release': 0.11959384,\n",
       "                                       'external rotation': 0.066063344,\n",
       "                                       'epigastric region': 0.15244326,\n",
       "                                       'endoscopic resection': 0.044313,\n",
       "                                       'ethoxyresorufin': 0.06734056,\n",
       "                                       'electro-resection': 0.12683627,\n",
       "                                       'early response': 0.31493714,\n",
       "                                       'endoplasmic reticulum': 0.20646162,\n",
       "                                       'enhanced reactivation': 0.22759774,\n",
       "                                       'electroresection': 0.092789546})}),\n",
       "             'The median TTP for patients in cohort one of the primary trial is NA.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'TTP': defaultdict(float,\n",
       "                                      {'tocopherol transfer protein': 0.13267781,\n",
       "                                       'time to positivity': 0.10804079,\n",
       "                                       'time to peak tension': 0.099656396,\n",
       "                                       'time to progression': 0.16938284,\n",
       "                                       'thrombotic thrombocytopenic purpura': 0.32854223,\n",
       "                                       'tristetraprolin': 0.27453256,\n",
       "                                       'time to pregnancy': 0.060772873,\n",
       "                                       'time to disease progression': 0.23029877,\n",
       "                                       'thiamine triphosphate': 0.22877939,\n",
       "                                       'thymidine triphosphate': 0.2511671,\n",
       "                                       'Time to progression': 0.16938284,\n",
       "                                       'time to peak contraction': 0.145214,\n",
       "                                       'time to peak': 0.19321097,\n",
       "                                       'thiamin triphosphate': 0.21061867,\n",
       "                                       'tender to palpation': 0.09987237,\n",
       "                                       'time to tumor progression': 0.22833973,\n",
       "                                       'Tolpa Torf Preparation': 0.18113713,\n",
       "                                       'thrombotic-thrombocytopenic purpura': 0.31287435,\n",
       "                                       'time-to-peak': 0.25530785})}),\n",
       "             'A female with Hemoglobin > 10.0 g/dl, Absolute neutrophil count 1,733/mm3, platelet count = 100,000/¬¨¬µl and total bilirubin < 1.2 x ULN are eligilbe for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ULN': defaultdict(float,\n",
       "                                      {'upper limit of normal': 0.15736592})}),\n",
       "             'Women in cohort A and B of the primary trial with serum 25 (OH)D greater than or equal to 30 ng/ml did not receive weekly supplementation of cholecalciferol.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'OH': defaultdict(float,\n",
       "                                      {'on hand': 0.052447904,\n",
       "                                       'on-hand': 0.054848116,\n",
       "                                       'ocular hypertension': 0.17472583,\n",
       "                                       'open heart': 0.026842713,\n",
       "                                       'omni hora': 0.043989584,\n",
       "                                       'outpatient hospital': 0.0652869,\n",
       "                                       'occupational history': 0.03538826,\n",
       "                                       'Ohio': 0.07665391,\n",
       "                                       'ocular hypertensive': 0.1965161,\n",
       "                                       'Orthostatic hypotension': 0.16818202,\n",
       "                                       'orthostatic hypotension': 0.16818202,\n",
       "                                       'out of hospital': 0.027202312,\n",
       "                                       'ovarian hyperstimulation': 0.26824486,\n",
       "                                       'occipital horn': 0.052548967,\n",
       "                                       'obstructive hypopnea': 0.12908618,\n",
       "                                       'occupational health': 0.16218309})}),\n",
       "             'The patient group with the highest percent of PFS at 5 months in the primary trial was Stage IIIB patients, and the worst was Stage IV Disease patients.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.16810988,\n",
       "                                       'pyrogen-free saline': 0.1180292,\n",
       "                                       'pressure-flow study': 0.00091740105,\n",
       "                                       'posterior fossa syndrome': 0.24068075,\n",
       "                                       'pressure flow study': 0.009471483,\n",
       "                                       'primary fibromyalgia syndrome': 0.3239342,\n",
       "                                       'Piper Fatigue Scale': 0.24928124,\n",
       "                                       'patellofemoral syndrome': 0.20196004,\n",
       "                                       'Progression-free': 0.17042238,\n",
       "                                       'pulmonary function score': 0.33130535,\n",
       "                                       'pressure flow studies': 0.010544675,\n",
       "                                       'protein-free supernatant': 0.11439208,\n",
       "                                       'progression free survival': 0.34572536,\n",
       "                                       'protein free supernatant': 0.14566022,\n",
       "                                       'progression-free survival': 0.37764788,\n",
       "                                       'pressure/flow study': 0.037021957}),\n",
       "                          'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.07150318,\n",
       "                                       'intravenous injection': 0.22445649,\n",
       "                                       'iridovirus': 0.12773158,\n",
       "                                       'intra-venous': 0.25064868,\n",
       "                                       'invitro': 0.03680751,\n",
       "                                       'intra ventricular': 0.13806398,\n",
       "                                       'intra vascular': 0.18453349,\n",
       "                                       'in vivo': 0.21211158,\n",
       "                                       'intravascular': 0.21325645,\n",
       "                                       'in-vivo': 0.25786862,\n",
       "                                       'inter-vertebral': 0.18199797,\n",
       "                                       'ichthyosis vulgaris': 0.09942302,\n",
       "                                       'intravenous': 0.25673902,\n",
       "                                       'intravaginal': 0.13607685,\n",
       "                                       'invasive': 0.06095271,\n",
       "                                       'iridescent virus': 0.057331093,\n",
       "                                       'isometric virus': 0.025505288,\n",
       "                                       'intravenous feeding device': 0.1456817,\n",
       "                                       'invivo': 0.07502126,\n",
       "                                       'instrumental variable': 0.05825018,\n",
       "                                       'intraventricular': 0.10744267,\n",
       "                                       'intra-vaginal': 0.1735684,\n",
       "                                       'intravertebral': 0.14952545,\n",
       "                                       'in vitro': 0.1639381,\n",
       "                                       'interventricular': 0.13093176,\n",
       "                                       'in-vitro': 0.19738293,\n",
       "                                       'intra venous': 0.20035252,\n",
       "                                       'iodine value': 0.06641697,\n",
       "                                       'ichnovirus': 0.047843672,\n",
       "                                       'inter-ventricular': 0.16824925,\n",
       "                                       'intra-vertebral': 0.2169108,\n",
       "                                       'intravenous injection device': 0.16207574,\n",
       "                                       'intervertebral': 0.119353116,\n",
       "                                       'initial visit': 0.08290544,\n",
       "                                       'intravenous feeding': 0.18596219,\n",
       "                                       'intra-vascular': 0.26130518,\n",
       "                                       'intra-ventricular': 0.17051199})}),\n",
       "             'Black men with and ECOG <=2, with ANC >1.5 x 10^9/L, PLT >100 x 10^9/L and no prior history of blood clots are eligible for the primary trial but excluded from the secondary trial': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.13031575,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.30143762,\n",
       "                                       'eastern cooperative oncology group': 0.30143762,\n",
       "                                       'Electrocochleography': 0.13327593,\n",
       "                                       'electrocochleogram': 0.12399004,\n",
       "                                       'electrocortical activity': 0.06357778,\n",
       "                                       'electrocorticograms': 0.14427686,\n",
       "                                       'electrocortical': 0.059174743}),\n",
       "                          'ANC': defaultdict(float,\n",
       "                                      {'acid neutralising capacity': 0.12616971,\n",
       "                                       'antigen-neutralising capacity': 0.20449202,\n",
       "                                       'antenatal care': 0.16814752,\n",
       "                                       'acid neutralization capacity': 0.116770804,\n",
       "                                       'ante-natal clinic': 0.29826063,\n",
       "                                       'antenatal clinics': 0.21070251,\n",
       "                                       'acid-neutralising capacity': 0.11713093,\n",
       "                                       'absolute neutrophil count': 0.26396427,\n",
       "                                       'Active noise control': -0.016135983,\n",
       "                                       'acid neutralizing capacity': 0.13408351,\n",
       "                                       'antigen-neutralizing capacity': 0.2068442,\n",
       "                                       'acid neutralisation capacity': 0.122604415,\n",
       "                                       'absolute neutrophil counts': 0.26940197,\n",
       "                                       'Army Nurse Corps': 0.17901272,\n",
       "                                       'antenatal clinic': 0.25449958,\n",
       "                                       'acid-neutralizing capacity': 0.12679966}),\n",
       "                          'PLT': defaultdict(float,\n",
       "                                      {'platelet': 0.39875716,\n",
       "                                       'platelet count': 0.41371423,\n",
       "                                       'Pancreolauryl Test': 0.3003251,\n",
       "                                       'preferential looking test': 0.31946108,\n",
       "                                       'preferential-looking test': 0.3000182,\n",
       "                                       'platelet counts': 0.41142267,\n",
       "                                       'primed lymphocyte test': 0.40103522,\n",
       "                                       'posterolateral thoracotomy': 0.13648695,\n",
       "                                       'postero-lateral thoracotomy': 0.14030968,\n",
       "                                       'pancreolauryl test': 0.3003251,\n",
       "                                       'primed lymphocyte testing': 0.38253552,\n",
       "                                       'plantaris': 0.02979836,\n",
       "                                       'platelets': 0.4020859,\n",
       "                                       'primed lymphocyte typing': 0.3369577,\n",
       "                                       'pyoluteorin': 0.12993445,\n",
       "                                       'primed-lymphocyte test': 0.40880448})}),\n",
       "             'the primary trial and the secondary trial both evaluate response rates, however the primary trial studies CNS response, whereas the secondary trial studies tumor response, additionally, they test different treatments.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CNS': defaultdict(float,\n",
       "                                      {'central nerve system': 0.18877572,\n",
       "                                       'Congenital nephrotic syndrome': 0.046004754,\n",
       "                                       'Coagulase negative staphylococci': 0.014396158,\n",
       "                                       'Clinical nurse specialist': 0.09054356,\n",
       "                                       'coagulase negative staphylococcus': 0.020292161,\n",
       "                                       'coagulase-negative Staphylococcus': 0.028815195,\n",
       "                                       'central nerves system': 0.18230255,\n",
       "                                       'central-nervous-system': 0.1933659,\n",
       "                                       'congenital nephrotic syndrome': 0.046004754,\n",
       "                                       'central nervous system': 0.173711,\n",
       "                                       'central nervous systems': 0.18440194,\n",
       "                                       'Crigler Najjar syndrome': 0.06580478,\n",
       "                                       'coagulase negative staph': 0.04198277,\n",
       "                                       'clinical nurse specialists': 0.10324253,\n",
       "                                       'Crigler-Najjar syndrome': 0.07986664,\n",
       "                                       'coagulase-negative staphylococci': 0.021156324,\n",
       "                                       'coagulase-negative staphylococcus': 0.028815195,\n",
       "                                       'central nervous': 0.1826485,\n",
       "                                       'clinical nurse specialist': 0.09054356,\n",
       "                                       'Canadian Neurological Scale': 0.29511726,\n",
       "                                       'coagulase-negative staphylococcal': 0.06436232,\n",
       "                                       'coagulase negative Staphylococcus': 0.020292161})}),\n",
       "             'Fluorouracil, epirubicin, and cyclophosphamide (FEC) are used in both cohorts of the secondary trial, but not in cohort 1 of the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'FEC': defaultdict(float,\n",
       "                                      {'faecal egg counts': 0.086298935,\n",
       "                                       'Friend erythroleukaemia cell': 0.25247547,\n",
       "                                       'free erythrocyte coproporphyrin': 0.258316,\n",
       "                                       'faecal egg count': 0.09092725,\n",
       "                                       'Friend erythroleukemia cell': 0.26110283,\n",
       "                                       'Friend erythroleukæmia cell': 0.23505782,\n",
       "                                       'fecal egg count': 0.08992744,\n",
       "                                       'fæcal egg count': 0.17488907})}),\n",
       "             'Patients in the primary trial receive at most 200mg of IMGN853 by IV every 3 weeks.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.16214272,\n",
       "                                       'intravenous injection': 0.46217772,\n",
       "                                       'iridovirus': 0.21190368,\n",
       "                                       'intra-venous': 0.2828802,\n",
       "                                       'invitro': 0.19987676,\n",
       "                                       'intra ventricular': 0.19867793,\n",
       "                                       'intra vascular': 0.3089459,\n",
       "                                       'in vivo': 0.29994383,\n",
       "                                       'intravascular': 0.3333144,\n",
       "                                       'in-vivo': 0.36035633,\n",
       "                                       'inter-vertebral': 0.20299885,\n",
       "                                       'ichthyosis vulgaris': 0.1259811,\n",
       "                                       'intravenous': 0.4220169,\n",
       "                                       'intravaginal': 0.22966179,\n",
       "                                       'invasive': 0.082062796,\n",
       "                                       'iridescent virus': 0.11841178,\n",
       "                                       'isometric virus': 0.13208544,\n",
       "                                       'intravenous feeding device': 0.2908272,\n",
       "                                       'invivo': 0.1658851,\n",
       "                                       'instrumental variable': 0.08124383,\n",
       "                                       'intraventricular': 0.1651907,\n",
       "                                       'intra-vaginal': 0.25108993,\n",
       "                                       'intravertebral': 0.19684507,\n",
       "                                       'in vitro': 0.1994709,\n",
       "                                       'interventricular': 0.16644613,\n",
       "                                       'in-vitro': 0.2810908,\n",
       "                                       'intra venous': 0.27061233,\n",
       "                                       'iodine value': 0.28122094,\n",
       "                                       'ichnovirus': 0.17481838,\n",
       "                                       'inter-ventricular': 0.18619624,\n",
       "                                       'intra-vertebral': 0.25550902,\n",
       "                                       'intravenous injection device': 0.39453462,\n",
       "                                       'intervertebral': 0.14782262,\n",
       "                                       'initial visit': 0.17320214,\n",
       "                                       'intravenous feeding': 0.37518483,\n",
       "                                       'intra-vascular': 0.32466632,\n",
       "                                       'intra-ventricular': 0.21654603})}),\n",
       "             'Patients with an FEV1 of 80% to 120% are ineligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'FEV1': defaultdict(float,\n",
       "                                      {'forced expiratory volume in 1s': 0.12626183,\n",
       "                                       'forced expiratory volume during first second of expiration': 0.09926344,\n",
       "                                       'forced expiratory volume at one second': 0.06291454,\n",
       "                                       'forced expiratory volume in 1 sec': 0.066927,\n",
       "                                       'forced expiratory volume after 1 second': 0.09659137,\n",
       "                                       'forced expiratory volume in 1 second': 0.051475424})}),\n",
       "             'T2 N1 M0 adenocarcinoma of the breast are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'T2': defaultdict(float,\n",
       "                                      {'time 2': 0.09047723,\n",
       "                                       'type 2': 0.14523046,\n",
       "                                       't2 (thoracic vertebra 2)': 0.2542288,\n",
       "                                       't2dm': 0.10639203,\n",
       "                                       'transverse relaxation': 0.07944264,\n",
       "                                       'twins two': 0.06529738,\n",
       "                                       'therapy': 0.036164563,\n",
       "                                       'Time 2': 0.09047723,\n",
       "                                       'thoracic vertebra 2': 0.15080988,\n",
       "                                       'T-2 toxin': 0.2074752}),\n",
       "                          'N1': defaultdict(float,\n",
       "                                      {'negativity': -0.012893245,\n",
       "                                       'negative wave': -0.0028902749,\n",
       "                                       'negative peak': 0.07047476,\n",
       "                                       'negative': 0.017001126,\n",
       "                                       'negative component': 0.013025386}),\n",
       "                          'M0': defaultdict(float,\n",
       "                                      {'metastasis': 0.3131483})}),\n",
       "             'Patients with tumors overexpressing HER-2 are eligible for the secondary trial, but not for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER': defaultdict(float,\n",
       "                                      {'heroin': 0.013878409,\n",
       "                                       'human epidermal receptor': 0.14352235,\n",
       "                                       'hydrogen evolution reaction': 0.0929119,\n",
       "                                       'human epidermal growth factor receptor': 0.22739826,\n",
       "                                       'human EGF receptor': 0.2630443,\n",
       "                                       'human estrogen receptor': 0.254473})}),\n",
       "             'The the primary trial placebo group had a better mean retention than the donepezil hydrochloride PO QD group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.14561817,\n",
       "                                       'parietal operculum': 0.0944611,\n",
       "                                       'post office': -0.03065704,\n",
       "                                       'percentage of observed value': 0.19779246,\n",
       "                                       'Phenol oxidase': 0.16341084,\n",
       "                                       'parapineal organ': 0.09604405,\n",
       "                                       'power output': -0.02272033,\n",
       "                                       'predominant organism': 0.024944218,\n",
       "                                       'pulse-oximetry': 0.14429097,\n",
       "                                       'perceptual organisation': 0.011013714,\n",
       "                                       'power outputs': -0.057906706,\n",
       "                                       'Personality Organization': 0.031373013,\n",
       "                                       'postoperative': 0.20472817,\n",
       "                                       'parieto occipital': 0.08953126,\n",
       "                                       'polyolefin': 0.07325834,\n",
       "                                       'parietooccipital': 0.07180708,\n",
       "                                       'poly-olefin': 0.114541955,\n",
       "                                       'peroral': 0.110961564,\n",
       "                                       'prostate only': 0.11316642,\n",
       "                                       'pressure overload': 0.0519856,\n",
       "                                       'peroxidase': 0.08009683,\n",
       "                                       'principal olive': 0.040180728,\n",
       "                                       'peri-operative': 0.08689203,\n",
       "                                       'posterior': 0.074752904,\n",
       "                                       'Perceptual Organization': 0.019864634,\n",
       "                                       'period of onset': 0.08316288,\n",
       "                                       'posterior nuclear group': 0.08161367,\n",
       "                                       'phenol oxidase': 0.16341084,\n",
       "                                       'pressure': 0.035805903,\n",
       "                                       'per os (by mouth)': 0.097448304,\n",
       "                                       'parieto-occipital': 0.081163675,\n",
       "                                       'preoptic area': 0.004585332,\n",
       "                                       'perceptual organization': 0.019864634,\n",
       "                                       'prophylactic oophorectomy': 0.12129812,\n",
       "                                       'phosphodiester': 0.104668275,\n",
       "                                       'pre-ovulatory': 0.16168506,\n",
       "                                       'palm oil': 0.072846904,\n",
       "                                       'preovulatory': 0.17361945,\n",
       "                                       'perioperative': 0.16012648,\n",
       "                                       'post operative': 0.15880762,\n",
       "                                       'post-operative': 0.18901443,\n",
       "                                       'phospho-diester': 0.066153556,\n",
       "                                       'protein oxidation': 0.061469056,\n",
       "                                       'palm-oil': 0.060778957,\n",
       "                                       'per os': 0.06933534,\n",
       "                                       'pericardial organ': 0.058395475,\n",
       "                                       'Pulse oximetry': 0.14561817,\n",
       "                                       'paraoxon': 0.20186712,\n",
       "                                       'propylene oxide': 0.15262365,\n",
       "                                       'phenoloxidase': 0.108572915,\n",
       "                                       'peanut oil': 0.0917234}),\n",
       "                          'QD': defaultdict(float,\n",
       "                                      {'quinidine': 0.25712058,\n",
       "                                       'quaque die (every day)': 0.09864582,\n",
       "                                       'quaque die': 0.089443855,\n",
       "                                       'quinupristin-dalfopristin': 0.31093845,\n",
       "                                       'quater die': 0.0872066,\n",
       "                                       'quantum dot': -0.07190822,\n",
       "                                       'questionable dementia': 0.15450655})}),\n",
       "             'Participants in the primary trial are assigned an intervention depending on their HIV diagnosis, whereas in the secondary trial the interventions are randomly assigned.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HIV': defaultdict(float,\n",
       "                                      {'human immunodeficiency virus type-1': 0.41461062,\n",
       "                                       'human immunodeficiency virus type I': 0.41852313,\n",
       "                                       'human immunodeficiency': 0.2821069,\n",
       "                                       'human immune-deficiency virus': 0.2595055,\n",
       "                                       'human immunodeficiency viral': 0.3130055,\n",
       "                                       'human immunodeficiency virus infection': 0.35488552,\n",
       "                                       'human immune deficiency virus': 0.28586736,\n",
       "                                       'human immunodeficiency virus-1': 0.4044792,\n",
       "                                       'human immunodeficiency viruses': 0.3546154,\n",
       "                                       'human immunodeficiency virus': 0.3694773,\n",
       "                                       'human Immunodeficiency virus': 0.3694773,\n",
       "                                       'human-immunodeficiency-virus': 0.3688409,\n",
       "                                       'Human immunodeficiency syndrome': 0.2823915,\n",
       "                                       'Human Immunodeficiency Virus type 1': 0.40634233,\n",
       "                                       'human immuno-deficiency virus': 0.19322482,\n",
       "                                       'human immuno deficiency virus': 0.19587669})}),\n",
       "             'HIV+ Patients are excluded from both the secondary trial and the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HIV': defaultdict(float,\n",
       "                                      {'human immunodeficiency virus type-1': 0.40567297,\n",
       "                                       'human immunodeficiency virus type I': 0.39318317,\n",
       "                                       'human immunodeficiency': 0.35956243,\n",
       "                                       'human immune-deficiency virus': 0.34514955,\n",
       "                                       'human immunodeficiency viral': 0.36303797,\n",
       "                                       'human immunodeficiency virus infection': 0.32771376,\n",
       "                                       'human immune deficiency virus': 0.34985358,\n",
       "                                       'human immunodeficiency virus-1': 0.39768952,\n",
       "                                       'human immunodeficiency viruses': 0.38667876,\n",
       "                                       'human immunodeficiency virus': 0.37597147,\n",
       "                                       'human Immunodeficiency virus': 0.37597147,\n",
       "                                       'human-immunodeficiency-virus': 0.38872832,\n",
       "                                       'Human immunodeficiency syndrome': 0.35204062,\n",
       "                                       'Human Immunodeficiency Virus type 1': 0.39358032,\n",
       "                                       'human immuno-deficiency virus': 0.30898303,\n",
       "                                       'human immuno deficiency virus': 0.31003407})}),\n",
       "             ' To be eligible for both the secondary trial and the primary trial patients must satisfy all the following conditions; alkaline phosphatase  < 2 x ULN, aspartate aminotransferase  <= 1.5 x ULN and Hemoglobin > 10 g/dL.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ULN': defaultdict(float,\n",
       "                                      {'upper limit of normal': 0.036212437})}),\n",
       "             'Patients in cohort 1 of the primary trial may receive gradually increasing doses of Afatinib monotherapy from 40mg PO to 50mg PO.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.09658073,\n",
       "                                       'parietal operculum': 0.06989339,\n",
       "                                       'post office': 0.017878,\n",
       "                                       'percentage of observed value': 0.14028078,\n",
       "                                       'Phenol oxidase': -0.014073198,\n",
       "                                       'parapineal organ': 0.014813528,\n",
       "                                       'power output': 0.023865707,\n",
       "                                       'predominant organism': 0.02597968,\n",
       "                                       'pulse-oximetry': 0.07888095,\n",
       "                                       'perceptual organisation': -0.06780766,\n",
       "                                       'power outputs': -0.010528761,\n",
       "                                       'Personality Organization': -0.032844592,\n",
       "                                       'postoperative': 0.035276156,\n",
       "                                       'parieto occipital': 0.06503171,\n",
       "                                       'polyolefin': 0.020675955,\n",
       "                                       'parietooccipital': 0.016128836,\n",
       "                                       'poly-olefin': 0.030981328,\n",
       "                                       'peroral': 0.016142087,\n",
       "                                       'prostate only': 0.027861431,\n",
       "                                       'pressure overload': 0.013277374,\n",
       "                                       'peroxidase': -0.048718058,\n",
       "                                       'principal olive': 0.05323356,\n",
       "                                       'peri-operative': -0.0032170976,\n",
       "                                       'posterior': 0.027494254,\n",
       "                                       'Perceptual Organization': -0.0649327,\n",
       "                                       'period of onset': 0.1119532,\n",
       "                                       'posterior nuclear group': 0.027974576,\n",
       "                                       'phenol oxidase': -0.014073198,\n",
       "                                       'pressure': -0.032932274,\n",
       "                                       'per os (by mouth)': 0.10422169,\n",
       "                                       'parieto-occipital': 0.07121443,\n",
       "                                       'preoptic area': 0.06057281,\n",
       "                                       'perceptual organization': -0.0649327,\n",
       "                                       'prophylactic oophorectomy': 0.060623538,\n",
       "                                       'phosphodiester': 0.056199696,\n",
       "                                       'pre-ovulatory': 0.040309347,\n",
       "                                       'palm oil': -0.04175886,\n",
       "                                       'preovulatory': 0.1292373,\n",
       "                                       'perioperative': 0.017774474,\n",
       "                                       'post operative': 0.02460486,\n",
       "                                       'post-operative': 0.027146295,\n",
       "                                       'phospho-diester': -0.029876081,\n",
       "                                       'protein oxidation': 0.019955292,\n",
       "                                       'palm-oil': -0.04989062,\n",
       "                                       'per os': 0.10309638,\n",
       "                                       'pericardial organ': -0.029647188,\n",
       "                                       'Pulse oximetry': 0.09658073,\n",
       "                                       'paraoxon': 0.11156071,\n",
       "                                       'propylene oxide': 0.045578644,\n",
       "                                       'phenoloxidase': -0.008912613,\n",
       "                                       'peanut oil': 0.01506641})}),\n",
       "             'There was 1 MRSA infection in cohort 1 of the secondary trial and 4 in cohort 2 of the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MRSA': defaultdict(float,\n",
       "                                      {'meticillin resistant Staphylococcus aureus': 0.50338894,\n",
       "                                       'Methicillin-resistant Staphylococcus aureus': 0.53486526,\n",
       "                                       'methicillin resistant Staphylococcus aureus': 0.5064593,\n",
       "                                       'Methicillin-resistant Staphylococcus aureus strains': 0.4783281,\n",
       "                                       'methicillin-resistant strains': 0.318977,\n",
       "                                       'methicillin resistant staphylococcus aureus': 0.5064593,\n",
       "                                       'Methicillin-resistant S aureus': 0.49285048,\n",
       "                                       'meticillin-resistant Staphylococcus aureus': 0.5376954,\n",
       "                                       'methicillin-resistant Staphylococcus aureus': 0.53486526,\n",
       "                                       'methicillin resistant': 0.2763206,\n",
       "                                       'methicillin-resistant': 0.304407})}),\n",
       "             'The Ridaforolimus + Dalotuzumab + Exemestane group of the primary trial had a median PFS of over 5 months.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.1320514,\n",
       "                                       'pyrogen-free saline': 0.18901128,\n",
       "                                       'pressure-flow study': -0.053960763,\n",
       "                                       'posterior fossa syndrome': 0.24579762,\n",
       "                                       'pressure flow study': -0.04674358,\n",
       "                                       'primary fibromyalgia syndrome': 0.3003079,\n",
       "                                       'Piper Fatigue Scale': 0.15965323,\n",
       "                                       'patellofemoral syndrome': 0.15686207,\n",
       "                                       'Progression-free': 0.1508409,\n",
       "                                       'pulmonary function score': 0.26854244,\n",
       "                                       'pressure flow studies': -0.05538622,\n",
       "                                       'protein-free supernatant': 0.047003064,\n",
       "                                       'progression free survival': 0.32823905,\n",
       "                                       'protein free supernatant': 0.07310922,\n",
       "                                       'progression-free survival': 0.35760987,\n",
       "                                       'pressure/flow study': -0.029926287})}),\n",
       "             '1 patient in the primary trial died in an event not associated with a specifc CTCAE term.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CTCAE': defaultdict(float,\n",
       "                                      {'Common Terminology Criteria for Adverse Events': 0.44156048,\n",
       "                                       'Common Toxicity Criteria for Adverse Effects': 0.28322414})}),\n",
       "             'Lower doses of MM-121 and Paclitaxel are utilised in cohort1 of the primary trial than in cohort 2.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MM': defaultdict(float,\n",
       "                                      {'mixed micelles': 0.1208706,\n",
       "                                       'mathematical morphology': -0.081927165,\n",
       "                                       'Michaelis-Menten': 0.08677941,\n",
       "                                       'Mycoplasma meleagridis': 0.13102023,\n",
       "                                       'malignant melanomas': 0.2015563,\n",
       "                                       'mismatch': 0.10670573,\n",
       "                                       'Malignant mesothelioma': 0.22759095,\n",
       "                                       'myelomeningocoele': 0.16486865,\n",
       "                                       'malignant mesothelioma': 0.22759095,\n",
       "                                       'megamitochondria': 0.04505879,\n",
       "                                       'meningococcal meningitis': 0.11819111,\n",
       "                                       'Miyoshi myopathy': 0.116871774,\n",
       "                                       'middle meningeal': 0.124227695,\n",
       "                                       'Michaelis Menten': 0.10135306,\n",
       "                                       'myelo-meningocoele': 0.20925319,\n",
       "                                       'muscularis mucosae': 0.017147943,\n",
       "                                       'mycophenolate mofetil': 0.21591918,\n",
       "                                       'methylmercury': 0.109988555,\n",
       "                                       'Menstrual Migraine': 0.062444143,\n",
       "                                       'macro-molecule': -0.01644732,\n",
       "                                       'molecular mechanics': -0.072765015,\n",
       "                                       'methadone maintenance': 0.1511372,\n",
       "                                       'multiple myelomas': 0.30936244,\n",
       "                                       'myelomeningocele': 0.1519157,\n",
       "                                       'Mirror movements': -0.085302405,\n",
       "                                       'mucous membranes': 0.010683681,\n",
       "                                       'middle molecule': 0.09653581,\n",
       "                                       'myelo-meningocele': 0.20402229,\n",
       "                                       'molecular mass': 0.08303739,\n",
       "                                       'myeloid metaplasia': 0.246937,\n",
       "                                       'malignant melanoma': 0.21111675,\n",
       "                                       'minimal medium': 0.12540272,\n",
       "                                       'metanephric mesenchyme': 0.108210236,\n",
       "                                       'malignant mesotheliomas': 0.23492083,\n",
       "                                       'middle molecules': 0.07836371,\n",
       "                                       'medial malleolus': 0.122137316,\n",
       "                                       'mucous membrane': 0.0182774,\n",
       "                                       'macromolecule': 0.02845987,\n",
       "                                       'multiple myeloma': 0.3225475,\n",
       "                                       'maternal mortality': 0.13383408,\n",
       "                                       'Muscle mass': -0.021073025,\n",
       "                                       'masseter muscle': 0.04417791,\n",
       "                                       'Mitochondrial myopathy': 0.0983884,\n",
       "                                       'mismatches': 0.075118095,\n",
       "                                       'model': 0.005309268,\n",
       "                                       'Molecular mechanics': -0.072765015,\n",
       "                                       'mesangial matrix': -0.04118299,\n",
       "                                       'metastatic melanoma': 0.23922044})}),\n",
       "             'A female with Hemoglobin > 10.0 g/dl, Absolute neutrophil count 1,733/mm3, platelet count = 100,000/¬¨¬µl and total bilirubin > 1.6 x ULN are eligilbe for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ULN': defaultdict(float,\n",
       "                                      {'upper limit of normal': 0.16167644})}),\n",
       "             'Patients must have either AST or ALT < 1.5 ULN to participate in the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'AST': defaultdict(float,\n",
       "                                      {'anti-streptolysin test': 0.31432882,\n",
       "                                       'atrial systolic tachycardia': 0.16518064,\n",
       "                                       'astrocyte': 0.13123628,\n",
       "                                       'arginine stimulation test': 0.34852144,\n",
       "                                       'astaxanthine': 0.28553778,\n",
       "                                       'aspartate amino-transferase': 0.2062377,\n",
       "                                       'anti-microbial susceptibility testing': 0.2330726,\n",
       "                                       'anterior spinothalamic tract': 0.20825121,\n",
       "                                       'arterial spin tagging': 0.18779925,\n",
       "                                       'Antimicrobial susceptibility testing': 0.21453469,\n",
       "                                       'aspartate-aminotransferase': 0.22482154,\n",
       "                                       'arginine-stimulation test': 0.34292305,\n",
       "                                       'antimicrobial susceptibility testing': 0.21453469,\n",
       "                                       'aspartate amino transferase': 0.20123355,\n",
       "                                       'average survival time': 0.10055089,\n",
       "                                       'aspartate transaminase': 0.2342834,\n",
       "                                       'acid suppressive therapy': 0.2785987,\n",
       "                                       'aspartate': 0.17382848,\n",
       "                                       'atrial overdrive stimulation rate': 0.22714947,\n",
       "                                       'arterial spin-tagging': 0.18438117,\n",
       "                                       'aspartate transferase': 0.19352396,\n",
       "                                       'aspartate aminotransferase': 0.23283406,\n",
       "                                       'antistreptolysin test': 0.32996807,\n",
       "                                       'androgen suppression therapy': 0.30151054,\n",
       "                                       'acute suppurative thyroiditis': 0.24164246,\n",
       "                                       'allatostatin': 0.2667506,\n",
       "                                       'anti-fungal susceptibility testing': 0.19462691,\n",
       "                                       'angiotensin sensitivity test': 0.34780732,\n",
       "                                       'acid-suppressive therapy': 0.2659856,\n",
       "                                       'antibiotic susceptibility testing': 0.2470437,\n",
       "                                       'Aryl sulfotransferase': 0.15972187,\n",
       "                                       'astigmatism': 0.19849126,\n",
       "                                       'androgen-suppression therapy': 0.28529346,\n",
       "                                       'aspartate-amino-transferase': 0.21094903,\n",
       "                                       'astaxanthin': 0.23854393,\n",
       "                                       'antifungal susceptibility testing': 0.21270913}),\n",
       "                          'ALT': defaultdict(float,\n",
       "                                      {'altitude': 0.10796852,\n",
       "                                       'alanine amino transferase': 0.19661772,\n",
       "                                       'avian laryngotracheitis': 0.03212751,\n",
       "                                       'alanine-aminotransferase': 0.20859703,\n",
       "                                       'alanine aminotransaminase': 0.22367306,\n",
       "                                       'alanine aminotransferase': 0.22644046,\n",
       "                                       'alanine transferase': 0.21483275,\n",
       "                                       'anterolateral thigh': 0.19785546,\n",
       "                                       'auxiliary liver transplantation': 0.33244532,\n",
       "                                       'alanine amino-transferase': 0.19848421,\n",
       "                                       'antero-lateral thigh': 0.1799138,\n",
       "                                       'alanine aminotransferases': 0.19093004,\n",
       "                                       'alanine-amino-transferase': 0.1962087,\n",
       "                                       'alternative lengthening of telomeres': 0.12596416,\n",
       "                                       'alanine aminotransferase activity': 0.21921197,\n",
       "                                       'autolymphocyte therapy': 0.28657195,\n",
       "                                       'alanine transaminase': 0.22697727,\n",
       "                                       'argon laser trabeculoplasty': 0.21312653}),\n",
       "                          'ULN': defaultdict(float,\n",
       "                                      {'upper limit of normal': 0.104091816})}),\n",
       "             'the primary trial and the secondary trial interventions involve a variety of scans, such as CT, PET, MRI and dosimetry ': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CT': defaultdict(float,\n",
       "                                      {'condensed tannin': 0.037431285,\n",
       "                                       'crista terminalis': 0.12706804,\n",
       "                                       'chlamydia': 0.030880447,\n",
       "                                       'chronic tonsillitis': 0.114501074,\n",
       "                                       'computed-tomographic': 0.3389257,\n",
       "                                       'computed tomogram': 0.29701582,\n",
       "                                       'coal-tar': -0.007463487,\n",
       "                                       'calf thymus': 0.18196863,\n",
       "                                       'curly tail': -0.047118906,\n",
       "                                       'condensed tannins': 0.053749386,\n",
       "                                       'computerised tomograph': 0.24316607,\n",
       "                                       'counter-transference': 0.060068145,\n",
       "                                       'cardiothoracic': 0.1824422,\n",
       "                                       'choroidal thickness': 0.17102815,\n",
       "                                       'core temperature': 0.0004957058,\n",
       "                                       'collecting tubule': 0.10829745,\n",
       "                                       'C-terminal': 0.099619046,\n",
       "                                       'cytotrophoblast': 0.06571894,\n",
       "                                       'cytoplasmic domain': 0.020186288,\n",
       "                                       'chest tube': 0.17979383,\n",
       "                                       'computerised tomographic': 0.28685233,\n",
       "                                       'clotting time': 0.15395537,\n",
       "                                       'carbon tetra-chloride': 0.027369764,\n",
       "                                       'charge transport': -0.049263187,\n",
       "                                       'chemo-therapy': 0.34100172,\n",
       "                                       'circadian times': 0.069572866,\n",
       "                                       'cytidylyl-transferase': 0.08782093,\n",
       "                                       'charge transfer': 0.0025782885,\n",
       "                                       'cognitive therapy': 0.28193533,\n",
       "                                       'computertomography': 0.24109954,\n",
       "                                       'celiac trunc': 0.046432167,\n",
       "                                       'computerised tomography': 0.33314708,\n",
       "                                       'chronic thyroiditis': 0.188321,\n",
       "                                       'crico-thyroid': 0.17585985,\n",
       "                                       'carbon tetra chloride': 0.022627719,\n",
       "                                       'contraction time': 0.07194887,\n",
       "                                       'Cardiac transplantation': 0.17308058,\n",
       "                                       'clinical trial': 0.54323786,\n",
       "                                       'central tendon': 0.15974574,\n",
       "                                       'cortical thickness': 0.22281992,\n",
       "                                       'conventional tillage': 0.056125443,\n",
       "                                       'carboxylterminus': 0.024035055,\n",
       "                                       'catalase': -0.03705313,\n",
       "                                       'circadian time': 0.06242451,\n",
       "                                       'concentration': 0.15092632,\n",
       "                                       'conservative treatment': 0.28709227,\n",
       "                                       'CTP': 0.14358886,\n",
       "                                       'corneal thickness': 0.05989377,\n",
       "                                       'critical thinking': 0.112203985,\n",
       "                                       'celiac trunk': 0.042178802,\n",
       "                                       'charge-transfer': 0.016260741,\n",
       "                                       'cytoplasmic tail': -0.022058498,\n",
       "                                       'countertransference': 0.06434556,\n",
       "                                       'computed tomographies': 0.3889858,\n",
       "                                       'code treatment time': 0.22502996,\n",
       "                                       'cellulose-triacetate': -0.004856483,\n",
       "                                       'conventional treatment': 0.36212206,\n",
       "                                       'corticothalamic': 0.13527423,\n",
       "                                       'carcinoid tumor': 0.2085123,\n",
       "                                       'coeliac trunk': 0.15380208,\n",
       "                                       'chloramine-T': 0.17365399,\n",
       "                                       'carbontetrachloride': 0.06978513,\n",
       "                                       'cricothyroid muscle': 0.14666241,\n",
       "                                       'cerebral toxoplasmosis': 0.10288286,\n",
       "                                       'computerized tomography': 0.31231537,\n",
       "                                       'cervicothoracic': 0.14776339,\n",
       "                                       'computed tomography scan': 0.44705117,\n",
       "                                       'carboxyl-terminus': 0.049309038,\n",
       "                                       'Computer-Tomography': 0.26816964,\n",
       "                                       'corticotectal': 0.11672479,\n",
       "                                       'computerised tomogram': 0.18385328,\n",
       "                                       'computerized tomographic': 0.27625725,\n",
       "                                       'chemotherapy': 0.29375714,\n",
       "                                       'Cholera enterotoxin': -0.011530164,\n",
       "                                       'Catalase': -0.03705313,\n",
       "                                       'carbon tetrachloride': 0.10311825,\n",
       "                                       'choleratoxin': 0.008444954,\n",
       "                                       'computed tomography': 0.3984479,\n",
       "                                       'cholera toxin': 0.06783382,\n",
       "                                       'chorda tympani': 0.02289159,\n",
       "                                       'carcinoid tumour': 0.17837441,\n",
       "                                       'conventional therapy': 0.33444735,\n",
       "                                       'cold test': 0.18046789,\n",
       "                                       'cortico-thalamic': 0.18572073,\n",
       "                                       'conditioning-test': 0.12216781,\n",
       "                                       'chorda tympani nerve': 0.117253885,\n",
       "                                       'computed tomographic scans': 0.4615712,\n",
       "                                       'cyto-toxic': 0.08861923,\n",
       "                                       'cardio-thoracic': 0.28219634,\n",
       "                                       'calcitonin': 0.19907595,\n",
       "                                       'chloramine T': 0.12796515,\n",
       "                                       'cycle threshold': 0.12184628,\n",
       "                                       'cytotoxic': 0.12159792,\n",
       "                                       'carboxyl terminal': 0.04964613,\n",
       "                                       'coeliac trunc': 0.11874423,\n",
       "                                       'closure time': 0.0011445285,\n",
       "                                       'cancer/testis': 0.15397796,\n",
       "                                       'connective tissue': 0.19648525,\n",
       "                                       'cellulose triacetate': -0.02119525,\n",
       "                                       'Computed-tomography': 0.4003761,\n",
       "                                       'control': 0.051658288,\n",
       "                                       'computerized tomogram': 0.16968611,\n",
       "                                       'counseling and testing': 0.31930035,\n",
       "                                       'carboxyl-terminal': 0.07715894,\n",
       "                                       'cricothyroid': 0.14822643,\n",
       "                                       'Cerebral toxoplasmosis': 0.10288286,\n",
       "                                       'computed-tomography': 0.4003761,\n",
       "                                       'chest-tube': 0.20979385,\n",
       "                                       'carboxyl terminus': 0.030046878,\n",
       "                                       'counter-transport': 0.06615466,\n",
       "                                       'cancer-testis': 0.15507783,\n",
       "                                       'countertransport': 0.030124597,\n",
       "                                       'corticosterone': 0.1911371,\n",
       "                                       'compliance': 0.077047355,\n",
       "                                       'Computed tomographic scanning': 0.38044614,\n",
       "                                       'Connecticut': 0.024848731,\n",
       "                                       'computed tomography scans': 0.48192024,\n",
       "                                       'cardiac transplantation': 0.17308058,\n",
       "                                       'computed tomography scanning': 0.42007738,\n",
       "                                       'computed tomograpy': 0.41853052,\n",
       "                                       'computed tomograph': 0.308415,\n",
       "                                       'coal tar': 0.0060186246,\n",
       "                                       'chloramin-T': 0.1896581,\n",
       "                                       'Computed tomographic scan': 0.42000756,\n",
       "                                       'computerized tomograms': 0.17447698,\n",
       "                                       'control group': 0.2046925,\n",
       "                                       'chymotrypsin': 0.04255163,\n",
       "                                       'carboxylterminal': 0.10827591,\n",
       "                                       'congenital Toxoplasmosis': -0.009559223,\n",
       "                                       'cellulose-tri-acetate': 0.010472664,\n",
       "                                       'Computed tomograms': 0.34353018,\n",
       "                                       'conduction time': -0.0019580408,\n",
       "                                       'computerized tomograph': 0.23250842,\n",
       "                                       'Chlamydia trachomatis': 0.055264283,\n",
       "                                       'congenital toxoplasmosis': -0.009559223,\n",
       "                                       'cytidylyltransferase': 0.072637625,\n",
       "                                       'cardiac tamponade': 0.067464225,\n",
       "                                       'Category Test': 0.12128264,\n",
       "                                       'chloramin T': 0.13169187,\n",
       "                                       'cortico-tectal': 0.17844447,\n",
       "                                       'cancer testis': 0.114960216,\n",
       "                                       'connective-tissue': 0.19222492,\n",
       "                                       'computed tomographic': 0.3429608,\n",
       "                                       'carbon-tetrachloride': 0.103956565}),\n",
       "                          'PET': defaultdict(float,\n",
       "                                      {'paraffin-embedded tissue': 0.18080236,\n",
       "                                       'polyethylene terephtalate': 0.09104843,\n",
       "                                       'peritoneal equilibration test': 0.317319,\n",
       "                                       'polyester': -0.040362794,\n",
       "                                       'poly (ethylene terephthalate)': 0.027855335,\n",
       "                                       'peritoneal equilibration tests': 0.30870137,\n",
       "                                       'pancreatic endocrine tumors': 0.083365686,\n",
       "                                       'Positron emission tomography': 0.32212535,\n",
       "                                       'positron emission computed tomography': 0.39622772,\n",
       "                                       'polyethylene terephthalate': 0.061690997,\n",
       "                                       'patulous eustachian tube': 0.18507446,\n",
       "                                       'pre-eclamptic toxemia': 0.014418099,\n",
       "                                       'poly(ethylene terephthalate)': 0.027855335,\n",
       "                                       'poly-(ethylene terephthalate)': 0.050016902,\n",
       "                                       'pre-eclamptic toxaemia': 0.0045381472,\n",
       "                                       'peritonaeal equilibration test': 0.31133434,\n",
       "                                       'positron-emission tomography': 0.3306978,\n",
       "                                       'positron-emission-tomography': 0.3279421,\n",
       "                                       'positron emission tomography': 0.32212535,\n",
       "                                       'photoinduced electron transfer': 0.08460518,\n",
       "                                       'positron emission tomograph': 0.28243113,\n",
       "                                       'preeclamptic toxaemia': -0.013970168,\n",
       "                                       'partial exchange transfusion': 0.2529506,\n",
       "                                       'pressure equalization tubes': 0.13604227,\n",
       "                                       'polyethylene-terephthalate': 0.06514091,\n",
       "                                       'pancreatic endocrine tumour': 0.064110935,\n",
       "                                       'positron emission-computed tomography': 0.39879328,\n",
       "                                       'polyethyleneterephthalate': 0.03822093,\n",
       "                                       'poly-ethylene terephthalate': 0.067682825,\n",
       "                                       'preeclamptic toxemia': -0.0039287847,\n",
       "                                       'Polyethyleneterephthalate': 0.03822093,\n",
       "                                       'poly(ethyleneterephthalate)': 0.026128188,\n",
       "                                       'pancreatic endocrine tumor': 0.073074624,\n",
       "                                       'Peritoneal Equilibration Test': 0.317319,\n",
       "                                       'positron emission tomographic': 0.2933933,\n",
       "                                       'phosphatidylethanol': 0.01883055,\n",
       "                                       'paraffin embedded tissue': 0.17530008}),\n",
       "                          'MRI': defaultdict(float,\n",
       "                                      {'magnetic-resonance imaging': 0.3963961,\n",
       "                                       'MR-imaging': 0.4374575,\n",
       "                                       'magnetic resonance imaging': 0.4083212,\n",
       "                                       'magnetic resonance images': 0.35305697,\n",
       "                                       'magnetic resonance': 0.18798375,\n",
       "                                       'Magnetic resonance imagings': 0.48540658,\n",
       "                                       'magnet resonance imaging': 0.32567546,\n",
       "                                       'MR imaging': 0.42182273,\n",
       "                                       'magnetic-resonance-imaging': 0.36827317,\n",
       "                                       'magnetic resonance imagery': 0.2775291,\n",
       "                                       'Magnetic resonance imaging scan': 0.45786414,\n",
       "                                       'magnetic resonance tomography': 0.3622159,\n",
       "                                       'magnetic resonance image': 0.2677752,\n",
       "                                       'Magnetic resonance image': 0.2677752})}),\n",
       "             'All the primary trial participants and cohort 1 participants in the secondary trial do not receive any oral capecitabine, oral lapatinib ditosylate or cixutumumab IV, however cohort 2 of the secondary trial receive all of these.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.051405556,\n",
       "                                       'intravenous injection': 0.2164455,\n",
       "                                       'iridovirus': 0.10810347,\n",
       "                                       'intra-venous': 0.16518538,\n",
       "                                       'invitro': 0.061162338,\n",
       "                                       'intra ventricular': 0.08922859,\n",
       "                                       'intra vascular': 0.14148049,\n",
       "                                       'in vivo': 0.13451603,\n",
       "                                       'intravascular': 0.12637845,\n",
       "                                       'in-vivo': 0.19179693,\n",
       "                                       'inter-vertebral': 0.1346489,\n",
       "                                       'ichthyosis vulgaris': 0.033423442,\n",
       "                                       'intravenous': 0.21962085,\n",
       "                                       'intravaginal': 0.09697869,\n",
       "                                       'invasive': 0.029919889,\n",
       "                                       'iridescent virus': 0.05779497,\n",
       "                                       'isometric virus': 0.070874564,\n",
       "                                       'intravenous feeding device': 0.12956566,\n",
       "                                       'invivo': 0.06638899,\n",
       "                                       'instrumental variable': 0.10068999,\n",
       "                                       'intraventricular': 0.07272977,\n",
       "                                       'intra-vaginal': 0.114218384,\n",
       "                                       'intravertebral': 0.09906458,\n",
       "                                       'in vitro': 0.06457357,\n",
       "                                       'interventricular': 0.09329536,\n",
       "                                       'in-vitro': 0.12658277,\n",
       "                                       'intra venous': 0.14827542,\n",
       "                                       'iodine value': 0.055457205,\n",
       "                                       'ichnovirus': 0.025053818,\n",
       "                                       'inter-ventricular': 0.10605282,\n",
       "                                       'intra-vertebral': 0.12113333,\n",
       "                                       'intravenous injection device': 0.16703524,\n",
       "                                       'intervertebral': 0.1310068,\n",
       "                                       'initial visit': 0.12345003,\n",
       "                                       'intravenous feeding': 0.16568823,\n",
       "                                       'intra-vascular': 0.16003358,\n",
       "                                       'intra-ventricular': 0.09649712})}),\n",
       "             'A patient with stage 2B , pathologically confirmed PR positive breast cancer is elgible for both the primary trial and the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.09338588,\n",
       "                                       'plaque reduction': 0.026773585,\n",
       "                                       'partial response': 0.19748682,\n",
       "                                       'photoreactivation': 0.049754865,\n",
       "                                       'pentoxyresorufin': 0.08822129,\n",
       "                                       'panoramic radiography': 0.0577654,\n",
       "                                       'proliferative retinopathy': 0.231458,\n",
       "                                       'partial responses': 0.18023802,\n",
       "                                       'protein': -0.010934745,\n",
       "                                       'prorennin': 0.12979777,\n",
       "                                       'prevalence rate': 0.14378366,\n",
       "                                       'prealbumin': 0.12029063,\n",
       "                                       'pregnancy rates': 0.059136633,\n",
       "                                       'pain relief': -0.0023769683,\n",
       "                                       'partial remissions': 0.43472427,\n",
       "                                       'pattern recognition': -0.00045399374,\n",
       "                                       'photo-reactivation': 0.085305505,\n",
       "                                       'protein restriction': 0.10600138,\n",
       "                                       'progesterone receptor': 0.1918402,\n",
       "                                       'placental restriction': 0.17765203,\n",
       "                                       'pneumatic retinopexy': 0.18810906,\n",
       "                                       'prorenin': 0.120754294,\n",
       "                                       'perirhinal cortex': 0.018934006,\n",
       "                                       'prothrombin ratio': 0.19391139,\n",
       "                                       'pars recta': 0.14694704,\n",
       "                                       'pattern reversal': 0.06568275,\n",
       "                                       'pr interval (ekg)': 0.2570316,\n",
       "                                       'pityriasis rosea': 0.10659575,\n",
       "                                       'prevalence ratio': 0.15960564,\n",
       "                                       'Projection reconstruction': -0.02526321,\n",
       "                                       'pregnancy rate': 0.0741962,\n",
       "                                       'phenol red': 0.18098785,\n",
       "                                       'photoreceptor': 0.047735263,\n",
       "                                       'prednisolon': 0.09339662,\n",
       "                                       'partial responders': 0.20674628,\n",
       "                                       'proline-rich': 0.09546865,\n",
       "                                       'pseudorabies': 0.12949745,\n",
       "                                       'pulmonary regurgitation': 0.12656416,\n",
       "                                       'projection reconstruction': -0.02526321,\n",
       "                                       'photo-receptor': 0.05484948,\n",
       "                                       'protease': 0.11616149,\n",
       "                                       'progestine': 0.094317295,\n",
       "                                       'pentoxy-resorufin': 0.104350105,\n",
       "                                       'partial remission': 0.3845812,\n",
       "                                       'progestin receptor': 0.18477316,\n",
       "                                       'per rectum': 0.09141787,\n",
       "                                       'Plain radiography': 0.106451154,\n",
       "                                       'production rate': 0.076934986,\n",
       "                                       'pulmonary rehabilitation': 0.09598745,\n",
       "                                       'pentoxy resorufin': 0.12036866,\n",
       "                                       'proteinase': 0.08211097,\n",
       "                                       'Paeoniae radix': 0.18555029,\n",
       "                                       'Puerto Rico': 0.09051302,\n",
       "                                       'Prevalence ratios': 0.15563403,\n",
       "                                       'perirenal': 0.105401956,\n",
       "                                       'passive recovery': 0.111410074,\n",
       "                                       'propranolol': 0.09419099,\n",
       "                                       'primary response': 0.23167257,\n",
       "                                       'pregnant': 0.088631496,\n",
       "                                       'partial regression': 0.073021986,\n",
       "                                       'Photoreactivation': 0.049754865,\n",
       "                                       'peripheral resistance': 0.13379101,\n",
       "                                       'polymorphic reticulosis': 0.17434765,\n",
       "                                       'progressive ratio': 0.16750237,\n",
       "                                       'partial responder': 0.19503465,\n",
       "                                       'projection-reconstruction': 0.0008981792,\n",
       "                                       'pro-renin': 0.14940201,\n",
       "                                       'phenol-red': 0.18803495,\n",
       "                                       'progestin': 0.11276398,\n",
       "                                       'pro-rennin': 0.14837308})}),\n",
       "             'Group 1 of the secondary trial has a higher ORR than both the Everolimus + Letrozole cohort of the primary trial and the trastuzumab cohort.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ORR': defaultdict(float,\n",
       "                                      {'oxygen-reduction reaction': 0.16498291,\n",
       "                                       'overall response rate': 0.2837608,\n",
       "                                       'objective response rate': 0.2218692,\n",
       "                                       'oxygen reduction reaction': 0.16090298})}),\n",
       "             'the primary trial participants are given saracatinib PO every single day of the study duration.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.20967701,\n",
       "                                       'parietal operculum': 0.13413148,\n",
       "                                       'post office': 0.042488087,\n",
       "                                       'percentage of observed value': 0.15376417,\n",
       "                                       'Phenol oxidase': 0.17365177,\n",
       "                                       'parapineal organ': 0.21707964,\n",
       "                                       'power output': 0.037694626,\n",
       "                                       'predominant organism': 0.10925223,\n",
       "                                       'pulse-oximetry': 0.20734279,\n",
       "                                       'perceptual organisation': -0.028538538,\n",
       "                                       'power outputs': -0.023045525,\n",
       "                                       'Personality Organization': 0.013807568,\n",
       "                                       'postoperative': 0.16278343,\n",
       "                                       'parieto occipital': 0.14995317,\n",
       "                                       'polyolefin': 0.14812395,\n",
       "                                       'parietooccipital': 0.1265138,\n",
       "                                       'poly-olefin': 0.16455126,\n",
       "                                       'peroral': 0.16372861,\n",
       "                                       'prostate only': 0.137019,\n",
       "                                       'pressure overload': 0.031371277,\n",
       "                                       'peroxidase': 0.17229359,\n",
       "                                       'principal olive': 0.13014606,\n",
       "                                       'peri-operative': 0.14740472,\n",
       "                                       'posterior': 0.13589658,\n",
       "                                       'Perceptual Organization': -0.01808338,\n",
       "                                       'period of onset': 0.23224157,\n",
       "                                       'posterior nuclear group': 0.09733548,\n",
       "                                       'phenol oxidase': 0.17365177,\n",
       "                                       'pressure': 0.018013319,\n",
       "                                       'per os (by mouth)': 0.20230879,\n",
       "                                       'parieto-occipital': 0.13784717,\n",
       "                                       'preoptic area': 0.10658216,\n",
       "                                       'perceptual organization': -0.01808338,\n",
       "                                       'prophylactic oophorectomy': 0.1218197,\n",
       "                                       'phosphodiester': 0.22703998,\n",
       "                                       'pre-ovulatory': 0.2648064,\n",
       "                                       'palm oil': 0.14960736,\n",
       "                                       'preovulatory': 0.29806167,\n",
       "                                       'perioperative': 0.18928708,\n",
       "                                       'post operative': 0.1360518,\n",
       "                                       'post-operative': 0.17211717,\n",
       "                                       'phospho-diester': 0.07156763,\n",
       "                                       'protein oxidation': 0.11600996,\n",
       "                                       'palm-oil': 0.1281477,\n",
       "                                       'per os': 0.13038467,\n",
       "                                       'pericardial organ': 0.12646845,\n",
       "                                       'Pulse oximetry': 0.20967701,\n",
       "                                       'paraoxon': 0.33324096,\n",
       "                                       'propylene oxide': 0.14754888,\n",
       "                                       'phenoloxidase': 0.20177004,\n",
       "                                       'peanut oil': 0.15997916})}),\n",
       "             'No participants of the primary trial had a Progression Free Survival over 1 year, but several patients had a PFS of less than 1 month.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.1310392,\n",
       "                                       'pyrogen-free saline': 0.19852126,\n",
       "                                       'pressure-flow study': 0.0025321078,\n",
       "                                       'posterior fossa syndrome': 0.12302635,\n",
       "                                       'pressure flow study': -3.8295984e-06,\n",
       "                                       'primary fibromyalgia syndrome': 0.24550296,\n",
       "                                       'Piper Fatigue Scale': 0.12526166,\n",
       "                                       'patellofemoral syndrome': 0.13944787,\n",
       "                                       'Progression-free': 0.2928876,\n",
       "                                       'pulmonary function score': 0.17414421,\n",
       "                                       'pressure flow studies': -0.004866522,\n",
       "                                       'protein-free supernatant': 0.17619993,\n",
       "                                       'progression free survival': 0.46375707,\n",
       "                                       'protein free supernatant': 0.17697464,\n",
       "                                       'progression-free survival': 0.5017891,\n",
       "                                       'pressure/flow study': 0.018459009})}),\n",
       "             'Abraxane + Capecitabine group of the primary trial has 61 more patients with either Complete Response (CR) disappearance of all target lesions; Partial Response (PR) at least a 30% decrease in the sum of the longest diameter of target lesions than the Abraxane Alone group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.108527645,\n",
       "                                       'clot retraction': 0.21299973,\n",
       "                                       'conditioned response': 0.09041434,\n",
       "                                       'conditioned reflex': 0.0046123057,\n",
       "                                       'charge recombination': 0.09718853,\n",
       "                                       'Czech Republic': -0.007136017,\n",
       "                                       'control region': 0.11407582,\n",
       "                                       'colonization rate': 0.07740231,\n",
       "                                       'complete remission rate': 0.5000965,\n",
       "                                       'Charles River': -0.0042450633,\n",
       "                                       'Caloric restriction': -0.0037443694,\n",
       "                                       'colonisation resistance': 0.07779392,\n",
       "                                       'complete regression': 0.02424566,\n",
       "                                       'conversion rate': 0.0941156,\n",
       "                                       'chest roentgenography': 0.20811057,\n",
       "                                       'chest radiograph': 0.14691417,\n",
       "                                       'colony reared': -0.055412818,\n",
       "                                       'cardiorespiratory': 0.03920269,\n",
       "                                       'circadian rhythm': 0.022064695,\n",
       "                                       'cardiac rupture': 0.08617788,\n",
       "                                       'carbonyl reductase': 0.10232708,\n",
       "                                       'calorie restriction': -0.011805978,\n",
       "                                       'cortical reaction': 0.12245689,\n",
       "                                       'complete remissions': 0.46797925,\n",
       "                                       'chest radiography': 0.18426815,\n",
       "                                       'computerised record': -0.019192634,\n",
       "                                       'charge-recombination': 0.09108396,\n",
       "                                       'Cardiac Rehabilitation': 0.13404883,\n",
       "                                       'calcium-binding protein calretinin': 0.08831233,\n",
       "                                       'chronic rejection': 0.09794214,\n",
       "                                       'colony-reared': -0.044661652,\n",
       "                                       'cognitive reserve': -0.0037096208,\n",
       "                                       'critical ratio': 0.14963908,\n",
       "                                       'cortico-resistant': 0.20103039,\n",
       "                                       'caloric restriction': -0.0037443694,\n",
       "                                       'corticoresistant': 0.13624828,\n",
       "                                       'corticosteroid-resistant': 0.25050223,\n",
       "                                       'Congo red': 0.03528527,\n",
       "                                       'complete responses': 0.18606673,\n",
       "                                       'chest and right arm': 0.13749391,\n",
       "                                       'conditioned reinforcement': 0.021902272,\n",
       "                                       'constant routine': 0.033007674,\n",
       "                                       'cardio-respiratory': 0.103793,\n",
       "                                       'complete response rate': 0.307047,\n",
       "                                       'cockroach': 0.002302546,\n",
       "                                       'chief resident': -0.0085322205,\n",
       "                                       'calorie-restricted': -0.0016489197,\n",
       "                                       'complete responders': 0.22117777,\n",
       "                                       'cysteine-rich': 0.08899251,\n",
       "                                       'controlled-release': 0.12652008,\n",
       "                                       'chemoradiation': 0.1901484,\n",
       "                                       'crown-rump': 0.010150396,\n",
       "                                       'crown-rump length': 0.06588522,\n",
       "                                       'creatinine': 0.04800092,\n",
       "                                       'capture-recapture': 0.12390883,\n",
       "                                       'Congo-red': 0.034741934,\n",
       "                                       'coefficient of repeatability': 0.10133824,\n",
       "                                       'computed radiography': 0.15295023,\n",
       "                                       'controlled respiration': 0.088505924,\n",
       "                                       'conditioned reward': 0.056200057,\n",
       "                                       'complement receptors': 0.21699825,\n",
       "                                       'concentration-response': 0.11865507,\n",
       "                                       'complete': 0.09657696,\n",
       "                                       'chest roentgenogram': 0.1806767,\n",
       "                                       'complement receptor': 0.22391286,\n",
       "                                       'Cajal-Retzius': 0.064327024,\n",
       "                                       'cremasteric reflex': 0.10329286,\n",
       "                                       'clot-retraction': 0.18868795,\n",
       "                                       'conserved regions': 0.07458245,\n",
       "                                       'child-resistant': -0.04607271,\n",
       "                                       'control rats': 0.06537034,\n",
       "                                       'caries-resistant': 0.103956595,\n",
       "                                       'coronary revascularization': 0.26009175,\n",
       "                                       'colon resection': 0.22098163,\n",
       "                                       'contrast ratio': 0.15736838,\n",
       "                                       'concentration ratio': 0.09716781,\n",
       "                                       'Calreticulin': 0.10735251,\n",
       "                                       'composite resin': 0.035898585,\n",
       "                                       'completely': 0.12430216,\n",
       "                                       'colorectal': 0.14979956,\n",
       "                                       'complete response': 0.1984941,\n",
       "                                       'coronary risk': 0.07103232,\n",
       "                                       'conventional radiology': 0.2672161,\n",
       "                                       'Complete response': 0.1984941,\n",
       "                                       'cathode ray': 0.06262848,\n",
       "                                       'complete responder': 0.20357686,\n",
       "                                       'controlled release': 0.09066662,\n",
       "                                       'conditioned reflexes': 0.01597598,\n",
       "                                       'chemo-radiation': 0.4552741,\n",
       "                                       'complete remission': 0.41159424,\n",
       "                                       'conserved region': 0.063514434,\n",
       "                                       'coronary resistance': 0.17189936,\n",
       "                                       'cardiac resuscitation': 0.11573155,\n",
       "                                       'computed radiographic': 0.14566253,\n",
       "                                       'cooling rate': 0.020472426,\n",
       "                                       'clinical research': 0.26003838,\n",
       "                                       'colonization resistance': 0.050952177,\n",
       "                                       'compression ratio': 0.0068174284,\n",
       "                                       'computerized record': -0.019162407,\n",
       "                                       'chromium': 0.080056176,\n",
       "                                       'colo-rectal': 0.14977048,\n",
       "                                       'contractile reserve': 0.10485518,\n",
       "                                       'clinical record': 0.18239045,\n",
       "                                       'concentration ratios': 0.1162911,\n",
       "                                       'clinical remission': 0.45230478,\n",
       "                                       'centric relation': 0.032786332,\n",
       "                                       'cardiac rhythm': 0.06354247,\n",
       "                                       'capillary refill': 0.11606115,\n",
       "                                       'colonisation rate': 0.084249154,\n",
       "                                       'conventional radiography': 0.16631588,\n",
       "                                       'cellular receptor': 0.1817136}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.286352,\n",
       "                                       'plaque reduction': 0.20502344,\n",
       "                                       'partial response': 0.26151806,\n",
       "                                       'photoreactivation': 0.09835891,\n",
       "                                       'pentoxyresorufin': 0.14706899,\n",
       "                                       'panoramic radiography': 0.13275,\n",
       "                                       'proliferative retinopathy': 0.2592438,\n",
       "                                       'partial responses': 0.23470825,\n",
       "                                       'protein': -0.036515288,\n",
       "                                       'prorennin': 0.12041083,\n",
       "                                       'prevalence rate': 0.17610416,\n",
       "                                       'prealbumin': 0.12479272,\n",
       "                                       'pregnancy rates': 0.01896812,\n",
       "                                       'pain relief': 0.17585458,\n",
       "                                       'partial remissions': 0.5352736,\n",
       "                                       'pattern recognition': 0.0090272715,\n",
       "                                       'photo-reactivation': 0.13103326,\n",
       "                                       'protein restriction': 0.013854344,\n",
       "                                       'progesterone receptor': 0.13621533,\n",
       "                                       'placental restriction': 0.076361254,\n",
       "                                       'pneumatic retinopexy': 0.25824785,\n",
       "                                       'prorenin': 0.17617393,\n",
       "                                       'perirhinal cortex': 0.11644228,\n",
       "                                       'prothrombin ratio': 0.11555643,\n",
       "                                       'pars recta': 0.068472795,\n",
       "                                       'pattern reversal': 0.09326411,\n",
       "                                       'pr interval (ekg)': 0.09485107,\n",
       "                                       'pityriasis rosea': 0.050432626,\n",
       "                                       'prevalence ratio': 0.19664016,\n",
       "                                       'Projection reconstruction': -0.016172463,\n",
       "                                       'pregnancy rate': 0.023327194,\n",
       "                                       'phenol red': 0.118003026,\n",
       "                                       'photoreceptor': 0.0089831175,\n",
       "                                       'prednisolon': 0.25824893,\n",
       "                                       'partial responders': 0.2683359,\n",
       "                                       'proline-rich': 0.020083833,\n",
       "                                       'pseudorabies': 0.12518997,\n",
       "                                       'pulmonary regurgitation': 0.12097951,\n",
       "                                       'projection reconstruction': -0.016172463,\n",
       "                                       'photo-receptor': 0.10639291,\n",
       "                                       'protease': 0.13953213,\n",
       "                                       'progestine': 0.10008182,\n",
       "                                       'pentoxy-resorufin': 0.19065312,\n",
       "                                       'partial remission': 0.4736186,\n",
       "                                       'progestin receptor': 0.112847745,\n",
       "                                       'per rectum': 0.13769922,\n",
       "                                       'Plain radiography': 0.10921983,\n",
       "                                       'production rate': 0.058283612,\n",
       "                                       'pulmonary rehabilitation': 0.094474345,\n",
       "                                       'pentoxy resorufin': 0.19422205,\n",
       "                                       'proteinase': 0.085639104,\n",
       "                                       'Paeoniae radix': 0.13416083,\n",
       "                                       'Puerto Rico': 0.04394213,\n",
       "                                       'Prevalence ratios': 0.19267948,\n",
       "                                       'perirenal': 0.06803501,\n",
       "                                       'passive recovery': 0.18542537,\n",
       "                                       'propranolol': 0.2569331,\n",
       "                                       'primary response': 0.2578072,\n",
       "                                       'pregnant': -0.02068566,\n",
       "                                       'partial regression': 0.029319987,\n",
       "                                       'Photoreactivation': 0.09835891,\n",
       "                                       'peripheral resistance': 0.19436687,\n",
       "                                       'polymorphic reticulosis': 0.1475869,\n",
       "                                       'progressive ratio': 0.17784384,\n",
       "                                       'partial responder': 0.24710749,\n",
       "                                       'projection-reconstruction': 0.027444158,\n",
       "                                       'pro-renin': 0.19687048,\n",
       "                                       'phenol-red': 0.13460991,\n",
       "                                       'progestin': 0.084853835,\n",
       "                                       'pro-rennin': 0.12736818})}),\n",
       "             'Participants with T4 N1 M0 breast carcinoma are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'T4': defaultdict(float,\n",
       "                                      {'tetraiodothyronine': 0.10467884,\n",
       "                                       'thyroxin': 0.101426825,\n",
       "                                       'thyroxine': 0.11750231,\n",
       "                                       'thyroid hormone': 0.07707287,\n",
       "                                       't4 (fourth thoracic vertebra)': 0.30114764,\n",
       "                                       'T helper cells': 0.1935557,\n",
       "                                       'thyroxine level': 0.16354713,\n",
       "                                       'tripchlorolide': 0.0352043,\n",
       "                                       'tumor': 0.27352473,\n",
       "                                       'thoracic vertebra 4': 0.15734993,\n",
       "                                       'time 4': 0.17296414,\n",
       "                                       'T helper': 0.13532726}),\n",
       "                          'N1': defaultdict(float,\n",
       "                                      {'negativity': 0.009327024,\n",
       "                                       'negative wave': -0.025580468,\n",
       "                                       'negative peak': 0.03421978,\n",
       "                                       'negative': 0.07668697,\n",
       "                                       'negative component': -0.020103097}),\n",
       "                          'M0': defaultdict(float,\n",
       "                                      {'metastasis': 0.26474136})}),\n",
       "             'Female Patients with LVEF > 50%,  who have previously undergone treatment with any of the following drugs; trastuzumab emtansine, paclitaxel, abraxane or lapatinib are still eligible for the primary trial but are excluded from the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'LVEF': defaultdict(float,\n",
       "                                      {'left-ventricular ejection fraction': 0.20281906,\n",
       "                                       'Left ventricular ejection fractions': 0.21199223,\n",
       "                                       'left ventricular function': 0.18682635,\n",
       "                                       'left ventricular ejection fraction': 0.21451676,\n",
       "                                       'left ventricle ejection fraction': 0.22033331,\n",
       "                                       'left-ventricle ejection fraction': 0.20241797,\n",
       "                                       'LV ejection fraction': 0.22735026})}),\n",
       "             'According to the results of the primary trial the MTD of paclitaxel is approximately is 120 mg.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MTD': defaultdict(float,\n",
       "                                      {'maximum tolerated dose': 0.47176927,\n",
       "                                       'Monroe tidal drainage': 0.0008102609,\n",
       "                                       \"Midwife Teacher's Diploma\": 0.06668789,\n",
       "                                       'mean total dose': 0.4528022,\n",
       "                                       'maximally-tolerated dose': 0.48800465,\n",
       "                                       'metastatic trophoblastic disease': 0.21136527,\n",
       "                                       'maximal tolerated dose': 0.49422604,\n",
       "                                       'maximal-tolerated dose': 0.5011323,\n",
       "                                       'maximum tolerable dose': 0.43446022,\n",
       "                                       'muscle tension dysphonia': 0.08411273,\n",
       "                                       'muscle-tension dysphonia': 0.06187469,\n",
       "                                       'maximum tolerated dosage': 0.46096277,\n",
       "                                       'maximum tolerated doses': 0.44334716,\n",
       "                                       'maximum-tolerated dose': 0.48063752,\n",
       "                                       'multiple tic disorder': 0.121134944,\n",
       "                                       'mannitol dehydrogenase': 0.22681956,\n",
       "                                       'methadone': 0.14111385,\n",
       "                                       'maximally tolerated dose': 0.48739177})}),\n",
       "             'Less than 5% of the primary trial participants achieved CR or PR.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.004379627,\n",
       "                                       'clot retraction': 0.10487433,\n",
       "                                       'conditioned response': 0.09478683,\n",
       "                                       'conditioned reflex': 0.06407126,\n",
       "                                       'charge recombination': 0.023305152,\n",
       "                                       'Czech Republic': 0.057552386,\n",
       "                                       'control region': 0.07649616,\n",
       "                                       'colonization rate': 0.13146684,\n",
       "                                       'complete remission rate': 0.40429515,\n",
       "                                       'Charles River': 0.053606607,\n",
       "                                       'Caloric restriction': 0.22424917,\n",
       "                                       'colonisation resistance': 0.09429218,\n",
       "                                       'complete regression': 0.09582821,\n",
       "                                       'conversion rate': 0.2242366,\n",
       "                                       'chest roentgenography': 0.15204476,\n",
       "                                       'chest radiograph': 0.164266,\n",
       "                                       'colony reared': 0.0044830535,\n",
       "                                       'cardiorespiratory': 0.08427853,\n",
       "                                       'circadian rhythm': 0.09502838,\n",
       "                                       'cardiac rupture': 0.13496888,\n",
       "                                       'carbonyl reductase': 0.089418605,\n",
       "                                       'calorie restriction': 0.19187063,\n",
       "                                       'cortical reaction': 0.1059712,\n",
       "                                       'complete remissions': 0.2534674,\n",
       "                                       'chest radiography': 0.14920157,\n",
       "                                       'computerised record': 0.031022161,\n",
       "                                       'charge-recombination': 0.018113825,\n",
       "                                       'Cardiac Rehabilitation': 0.2502385,\n",
       "                                       'calcium-binding protein calretinin': 0.10495423,\n",
       "                                       'chronic rejection': 0.18686867,\n",
       "                                       'colony-reared': 0.022571657,\n",
       "                                       'cognitive reserve': 0.1447973,\n",
       "                                       'critical ratio': 0.23305145,\n",
       "                                       'cortico-resistant': 0.25631207,\n",
       "                                       'caloric restriction': 0.22424917,\n",
       "                                       'corticoresistant': 0.11207168,\n",
       "                                       'corticosteroid-resistant': 0.20441595,\n",
       "                                       'Congo red': 0.055669073,\n",
       "                                       'complete responses': 0.13838194,\n",
       "                                       'chest and right arm': 0.09013136,\n",
       "                                       'conditioned reinforcement': 0.05947538,\n",
       "                                       'constant routine': 0.057904713,\n",
       "                                       'cardio-respiratory': 0.162062,\n",
       "                                       'complete response rate': 0.3551985,\n",
       "                                       'cockroach': -0.04104778,\n",
       "                                       'chief resident': 0.0344629,\n",
       "                                       'calorie-restricted': 0.16927077,\n",
       "                                       'complete responders': 0.2115928,\n",
       "                                       'cysteine-rich': 0.06067964,\n",
       "                                       'controlled-release': 0.08682708,\n",
       "                                       'chemoradiation': 0.038361523,\n",
       "                                       'crown-rump': -0.022027131,\n",
       "                                       'crown-rump length': 0.04640912,\n",
       "                                       'creatinine': 0.22019227,\n",
       "                                       'capture-recapture': 0.022605922,\n",
       "                                       'Congo-red': 0.064853884,\n",
       "                                       'coefficient of repeatability': 0.24273118,\n",
       "                                       'computed radiography': 0.15953645,\n",
       "                                       'controlled respiration': 0.09546372,\n",
       "                                       'conditioned reward': 0.056471854,\n",
       "                                       'complement receptors': 0.20017268,\n",
       "                                       'concentration-response': 0.16136613,\n",
       "                                       'complete': -0.00869976,\n",
       "                                       'chest roentgenogram': 0.14943792,\n",
       "                                       'complement receptor': 0.19718707,\n",
       "                                       'Cajal-Retzius': 0.045134798,\n",
       "                                       'cremasteric reflex': 0.22706199,\n",
       "                                       'clot-retraction': 0.090745434,\n",
       "                                       'conserved regions': -0.027317965,\n",
       "                                       'child-resistant': 0.020015985,\n",
       "                                       'control rats': 0.06576224,\n",
       "                                       'caries-resistant': 0.049581803,\n",
       "                                       'coronary revascularization': 0.21571532,\n",
       "                                       'colon resection': 0.06898928,\n",
       "                                       'contrast ratio': 0.18929219,\n",
       "                                       'concentration ratio': 0.23741516,\n",
       "                                       'Calreticulin': 0.08878745,\n",
       "                                       'composite resin': -0.036965,\n",
       "                                       'completely': 0.037453532,\n",
       "                                       'colorectal': 0.08438589,\n",
       "                                       'complete response': 0.10873845,\n",
       "                                       'coronary risk': 0.22988221,\n",
       "                                       'conventional radiology': 0.19765303,\n",
       "                                       'Complete response': 0.10873845,\n",
       "                                       'cathode ray': 0.0020872112,\n",
       "                                       'complete responder': 0.16630141,\n",
       "                                       'controlled release': 0.05636932,\n",
       "                                       'conditioned reflexes': 0.081758946,\n",
       "                                       'chemo-radiation': 0.16960087,\n",
       "                                       'complete remission': 0.21828015,\n",
       "                                       'conserved region': -0.021459838,\n",
       "                                       'coronary resistance': 0.2759049,\n",
       "                                       'cardiac resuscitation': 0.1402477,\n",
       "                                       'computed radiographic': 0.17024004,\n",
       "                                       'cooling rate': 0.020103836,\n",
       "                                       'clinical research': 0.39787483,\n",
       "                                       'colonization resistance': 0.059569903,\n",
       "                                       'compression ratio': 0.1344498,\n",
       "                                       'computerized record': 0.031447638,\n",
       "                                       'chromium': 0.08391552,\n",
       "                                       'colo-rectal': 0.13934334,\n",
       "                                       'contractile reserve': 0.13595277,\n",
       "                                       'clinical record': 0.26678512,\n",
       "                                       'concentration ratios': 0.2188414,\n",
       "                                       'clinical remission': 0.32222345,\n",
       "                                       'centric relation': -7.108227e-05,\n",
       "                                       'cardiac rhythm': 0.07687953,\n",
       "                                       'capillary refill': 0.07448195,\n",
       "                                       'colonisation rate': 0.13609116,\n",
       "                                       'conventional radiography': 0.15831193,\n",
       "                                       'cellular receptor': 0.06442339}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.1248172,\n",
       "                                       'plaque reduction': 0.09699434,\n",
       "                                       'partial response': 0.22614902,\n",
       "                                       'photoreactivation': 0.032410342,\n",
       "                                       'pentoxyresorufin': 0.11585321,\n",
       "                                       'panoramic radiography': 0.12115577,\n",
       "                                       'proliferative retinopathy': 0.13142097,\n",
       "                                       'partial responses': 0.23751615,\n",
       "                                       'protein': 0.012941309,\n",
       "                                       'prorennin': 0.1207443,\n",
       "                                       'prevalence rate': 0.28695154,\n",
       "                                       'prealbumin': 0.06145272,\n",
       "                                       'pregnancy rates': 0.16456465,\n",
       "                                       'pain relief': 0.07725897,\n",
       "                                       'partial remissions': 0.3586494,\n",
       "                                       'pattern recognition': -0.03696785,\n",
       "                                       'photo-reactivation': 0.048118893,\n",
       "                                       'protein restriction': 0.2186927,\n",
       "                                       'progesterone receptor': 0.10467266,\n",
       "                                       'placental restriction': 0.2159915,\n",
       "                                       'pneumatic retinopexy': 0.18911156,\n",
       "                                       'prorenin': 0.155004,\n",
       "                                       'perirhinal cortex': 0.14227289,\n",
       "                                       'prothrombin ratio': 0.26834643,\n",
       "                                       'pars recta': 0.07933053,\n",
       "                                       'pattern reversal': 0.02409029,\n",
       "                                       'pr interval (ekg)': 0.29519665,\n",
       "                                       'pityriasis rosea': 0.09156222,\n",
       "                                       'prevalence ratio': 0.32778573,\n",
       "                                       'Projection reconstruction': 0.015871529,\n",
       "                                       'pregnancy rate': 0.16903014,\n",
       "                                       'phenol red': 0.11492728,\n",
       "                                       'photoreceptor': -0.0034292073,\n",
       "                                       'prednisolon': 0.12189184,\n",
       "                                       'partial responders': 0.30471158,\n",
       "                                       'proline-rich': 0.0661592,\n",
       "                                       'pseudorabies': 0.1525361,\n",
       "                                       'pulmonary regurgitation': 0.14702098,\n",
       "                                       'projection reconstruction': 0.015871529,\n",
       "                                       'photo-receptor': 0.012636604,\n",
       "                                       'protease': 0.035096962,\n",
       "                                       'progestine': 0.095404945,\n",
       "                                       'pentoxy-resorufin': 0.12388538,\n",
       "                                       'partial remission': 0.33159366,\n",
       "                                       'progestin receptor': 0.091152065,\n",
       "                                       'per rectum': 0.09273473,\n",
       "                                       'Plain radiography': 0.13927542,\n",
       "                                       'production rate': 0.15827376,\n",
       "                                       'pulmonary rehabilitation': 0.22469008,\n",
       "                                       'pentoxy resorufin': 0.14011236,\n",
       "                                       'proteinase': 0.008013308,\n",
       "                                       'Paeoniae radix': 0.14779992,\n",
       "                                       'Puerto Rico': 0.09847429,\n",
       "                                       'Prevalence ratios': 0.312111,\n",
       "                                       'perirenal': 0.045708276,\n",
       "                                       'passive recovery': 0.09794465,\n",
       "                                       'propranolol': 0.12101102,\n",
       "                                       'primary response': 0.29152918,\n",
       "                                       'pregnant': -0.008542184,\n",
       "                                       'partial regression': 0.14261058,\n",
       "                                       'Photoreactivation': 0.032410342,\n",
       "                                       'peripheral resistance': 0.23273794,\n",
       "                                       'polymorphic reticulosis': 0.17238402,\n",
       "                                       'progressive ratio': 0.18523282,\n",
       "                                       'partial responder': 0.2202301,\n",
       "                                       'projection-reconstruction': 0.047590755,\n",
       "                                       'pro-renin': 0.1792703,\n",
       "                                       'phenol-red': 0.11482923,\n",
       "                                       'progestin': 0.07622278,\n",
       "                                       'pro-rennin': 0.14221802})}),\n",
       "             ' To be eligible for both the secondary trial and the primary trial patients must satisfy all the following conditions; alkaline phosphatase  < 2.5 x ULN, aspartate aminotransferase  <= 1.5 x ULN and Hemoglobin > 10 g/dL.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ULN': defaultdict(float,\n",
       "                                      {'upper limit of normal': 0.0390083})}),\n",
       "             'The Herceptin group in the primary trial had a higher percentage of Patients Achieving partial Pathological Response than the CT-P6 and ZA group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CT': defaultdict(float,\n",
       "                                      {'condensed tannin': 0.0126491245,\n",
       "                                       'crista terminalis': 0.117918,\n",
       "                                       'chlamydia': 0.09186741,\n",
       "                                       'chronic tonsillitis': 0.06602657,\n",
       "                                       'computed-tomographic': 0.11019348,\n",
       "                                       'computed tomogram': 0.094231665,\n",
       "                                       'coal-tar': -0.013214393,\n",
       "                                       'calf thymus': 0.10263682,\n",
       "                                       'curly tail': -0.023107195,\n",
       "                                       'condensed tannins': 0.024546899,\n",
       "                                       'computerised tomograph': 0.03213365,\n",
       "                                       'counter-transference': 0.06594697,\n",
       "                                       'cardiothoracic': 0.1430925,\n",
       "                                       'choroidal thickness': 0.06968502,\n",
       "                                       'core temperature': -0.0714757,\n",
       "                                       'collecting tubule': 0.09532058,\n",
       "                                       'C-terminal': -0.017942298,\n",
       "                                       'cytotrophoblast': 0.13327931,\n",
       "                                       'cytoplasmic domain': 0.025924943,\n",
       "                                       'chest tube': 0.077948585,\n",
       "                                       'computerised tomographic': 0.05280704,\n",
       "                                       'clotting time': 0.12797655,\n",
       "                                       'carbon tetra-chloride': 0.041344307,\n",
       "                                       'charge transport': -0.009930284,\n",
       "                                       'chemo-therapy': 0.3700278,\n",
       "                                       'circadian times': 0.038771052,\n",
       "                                       'cytidylyl-transferase': 0.12901072,\n",
       "                                       'charge transfer': 0.00935715,\n",
       "                                       'cognitive therapy': 0.1690995,\n",
       "                                       'computertomography': 0.03319887,\n",
       "                                       'celiac trunc': 0.1074204,\n",
       "                                       'computerised tomography': 0.0819398,\n",
       "                                       'chronic thyroiditis': 0.20916806,\n",
       "                                       'crico-thyroid': 0.2022398,\n",
       "                                       'carbon tetra chloride': 0.041279662,\n",
       "                                       'contraction time': 0.033881504,\n",
       "                                       'Cardiac transplantation': 0.15039438,\n",
       "                                       'clinical trial': 0.40396526,\n",
       "                                       'central tendon': 0.08608281,\n",
       "                                       'cortical thickness': 0.09012415,\n",
       "                                       'conventional tillage': -0.018187886,\n",
       "                                       'carboxylterminus': 0.048644792,\n",
       "                                       'catalase': 0.047212765,\n",
       "                                       'circadian time': 0.04013608,\n",
       "                                       'concentration': 0.051317252,\n",
       "                                       'conservative treatment': 0.20945041,\n",
       "                                       'CTP': 0.21961066,\n",
       "                                       'corneal thickness': 0.0035240285,\n",
       "                                       'critical thinking': 0.031732872,\n",
       "                                       'celiac trunk': -0.016676832,\n",
       "                                       'charge-transfer': 0.015436928,\n",
       "                                       'cytoplasmic tail': 0.026397903,\n",
       "                                       'countertransference': 0.0212353,\n",
       "                                       'computed tomographies': 0.13664857,\n",
       "                                       'code treatment time': 0.19537856,\n",
       "                                       'cellulose-triacetate': 0.008932399,\n",
       "                                       'conventional treatment': 0.28586057,\n",
       "                                       'corticothalamic': 0.15944074,\n",
       "                                       'carcinoid tumor': 0.24799176,\n",
       "                                       'coeliac trunk': 0.026306074,\n",
       "                                       'chloramine-T': 0.1384652,\n",
       "                                       'carbontetrachloride': 0.06226266,\n",
       "                                       'cricothyroid muscle': 0.10698319,\n",
       "                                       'cerebral toxoplasmosis': 0.12751272,\n",
       "                                       'computerized tomography': 0.07422385,\n",
       "                                       'cervicothoracic': 0.110409744,\n",
       "                                       'computed tomography scan': 0.22993398,\n",
       "                                       'carboxyl-terminus': 0.08140965,\n",
       "                                       'Computer-Tomography': 0.031739306,\n",
       "                                       'corticotectal': 0.096019566,\n",
       "                                       'computerised tomogram': 0.0019096306,\n",
       "                                       'computerized tomographic': 0.053580415,\n",
       "                                       'chemotherapy': 0.33264166,\n",
       "                                       'Cholera enterotoxin': 0.082128905,\n",
       "                                       'Catalase': 0.047212765,\n",
       "                                       'carbon tetrachloride': 0.08238622,\n",
       "                                       'choleratoxin': 0.072179,\n",
       "                                       'computed tomography': 0.15769397,\n",
       "                                       'cholera toxin': 0.119056776,\n",
       "                                       'chorda tympani': 0.008867889,\n",
       "                                       'carcinoid tumour': 0.23397306,\n",
       "                                       'conventional therapy': 0.24751905,\n",
       "                                       'cold test': 0.12079741,\n",
       "                                       'cortico-thalamic': 0.13105254,\n",
       "                                       'conditioning-test': 0.15208928,\n",
       "                                       'chorda tympani nerve': 0.15367374,\n",
       "                                       'computed tomographic scans': 0.18541776,\n",
       "                                       'cyto-toxic': 0.10965357,\n",
       "                                       'cardio-thoracic': 0.11667231,\n",
       "                                       'calcitonin': 0.24907328,\n",
       "                                       'chloramine T': 0.09207971,\n",
       "                                       'cycle threshold': 0.0792702,\n",
       "                                       'cytotoxic': 0.20334655,\n",
       "                                       'carboxyl terminal': 0.07741773,\n",
       "                                       'coeliac trunc': 0.13318774,\n",
       "                                       'closure time': -0.012515673,\n",
       "                                       'cancer/testis': 0.19962072,\n",
       "                                       'connective tissue': 0.0837537,\n",
       "                                       'cellulose triacetate': 0.012739729,\n",
       "                                       'Computed-tomography': 0.16016805,\n",
       "                                       'control': 0.02864573,\n",
       "                                       'computerized tomogram': -0.0012000429,\n",
       "                                       'counseling and testing': 0.2174782,\n",
       "                                       'carboxyl-terminal': 0.07834271,\n",
       "                                       'cricothyroid': 0.1655377,\n",
       "                                       'Cerebral toxoplasmosis': 0.12751272,\n",
       "                                       'computed-tomography': 0.16016805,\n",
       "                                       'chest-tube': 0.09713708,\n",
       "                                       'carboxyl terminus': 0.09060243,\n",
       "                                       'counter-transport': 0.027207982,\n",
       "                                       'cancer-testis': 0.211177,\n",
       "                                       'countertransport': 0.039715182,\n",
       "                                       'corticosterone': 0.17993297,\n",
       "                                       'compliance': 0.021322222,\n",
       "                                       'Computed tomographic scanning': 0.14003026,\n",
       "                                       'Connecticut': 0.016446603,\n",
       "                                       'computed tomography scans': 0.21083869,\n",
       "                                       'cardiac transplantation': 0.15039438,\n",
       "                                       'computed tomography scanning': 0.1682065,\n",
       "                                       'computed tomograpy': 0.19391972,\n",
       "                                       'computed tomograph': 0.09620883,\n",
       "                                       'coal tar': -0.007151914,\n",
       "                                       'chloramin-T': 0.16378191,\n",
       "                                       'Computed tomographic scan': 0.1974756,\n",
       "                                       'computerized tomograms': -0.009277794,\n",
       "                                       'control group': 0.18654086,\n",
       "                                       'chymotrypsin': 0.25499088,\n",
       "                                       'carboxylterminal': 0.099413365,\n",
       "                                       'congenital Toxoplasmosis': 0.030868016,\n",
       "                                       'cellulose-tri-acetate': -0.013410138,\n",
       "                                       'Computed tomograms': 0.10486546,\n",
       "                                       'conduction time': -0.02831626,\n",
       "                                       'computerized tomograph': 0.030018505,\n",
       "                                       'Chlamydia trachomatis': 0.10320283,\n",
       "                                       'congenital toxoplasmosis': 0.030868016,\n",
       "                                       'cytidylyltransferase': 0.09239001,\n",
       "                                       'cardiac tamponade': 0.0805807,\n",
       "                                       'Category Test': 0.11931781,\n",
       "                                       'chloramin T': 0.0942836,\n",
       "                                       'cortico-tectal': 0.12727125,\n",
       "                                       'cancer testis': 0.1872874,\n",
       "                                       'connective-tissue': 0.073016964,\n",
       "                                       'computed tomographic': 0.11048706,\n",
       "                                       'carbon-tetrachloride': 0.08335116}),\n",
       "                          'ZA': defaultdict(float,\n",
       "                                      {'zeolite A': 0.007254605,\n",
       "                                       'zonula adhaerens': 0.011723217,\n",
       "                                       'zygapophyseal': -0.0036606886,\n",
       "                                       'zonula adherens': 0.10176857,\n",
       "                                       'zinc adequate': 0.05685872,\n",
       "                                       'zinc acetate': 0.093782336,\n",
       "                                       'zinc-adequate': 0.06318538,\n",
       "                                       'zoledronic acid': 0.14534399,\n",
       "                                       'zygapophysial': 0.023155816})}),\n",
       "             'The the primary trial placebo group performed much better than the test group, as a lower PFS is ideal.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.09456514,\n",
       "                                       'pyrogen-free saline': 0.18325943,\n",
       "                                       'pressure-flow study': 0.061064072,\n",
       "                                       'posterior fossa syndrome': 0.14522591,\n",
       "                                       'pressure flow study': 0.07671494,\n",
       "                                       'primary fibromyalgia syndrome': 0.24195302,\n",
       "                                       'Piper Fatigue Scale': 0.20843291,\n",
       "                                       'patellofemoral syndrome': 0.13984276,\n",
       "                                       'Progression-free': 0.08402654,\n",
       "                                       'pulmonary function score': 0.27581578,\n",
       "                                       'pressure flow studies': 0.06871073,\n",
       "                                       'protein-free supernatant': 0.1631047,\n",
       "                                       'progression free survival': 0.25334093,\n",
       "                                       'protein free supernatant': 0.19480307,\n",
       "                                       'progression-free survival': 0.28793743,\n",
       "                                       'pressure/flow study': 0.09484837})}),\n",
       "             'Patients in the primary trial receive a lower dose of Zometa by IV than the secondary trial patients receive of ado-trastuzumab emtansine.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.08697903,\n",
       "                                       'intravenous injection': 0.25943092,\n",
       "                                       'iridovirus': 0.13125421,\n",
       "                                       'intra-venous': 0.17960417,\n",
       "                                       'invitro': 0.107974924,\n",
       "                                       'intra ventricular': 0.07776235,\n",
       "                                       'intra vascular': 0.16169158,\n",
       "                                       'in vivo': 0.14639312,\n",
       "                                       'intravascular': 0.175206,\n",
       "                                       'in-vivo': 0.19338465,\n",
       "                                       'inter-vertebral': 0.10684225,\n",
       "                                       'ichthyosis vulgaris': 0.11586146,\n",
       "                                       'intravenous': 0.22342661,\n",
       "                                       'intravaginal': 0.154564,\n",
       "                                       'invasive': 0.04632593,\n",
       "                                       'iridescent virus': 0.066126615,\n",
       "                                       'isometric virus': 0.03915505,\n",
       "                                       'intravenous feeding device': 0.12918994,\n",
       "                                       'invivo': 0.09448062,\n",
       "                                       'instrumental variable': 0.12620683,\n",
       "                                       'intraventricular': 0.055173203,\n",
       "                                       'intra-vaginal': 0.17838709,\n",
       "                                       'intravertebral': 0.08797878,\n",
       "                                       'in vitro': 0.08439487,\n",
       "                                       'interventricular': 0.0568314,\n",
       "                                       'in-vitro': 0.14244078,\n",
       "                                       'intra venous': 0.15228249,\n",
       "                                       'iodine value': 0.10176015,\n",
       "                                       'ichnovirus': 0.07896279,\n",
       "                                       'inter-ventricular': 0.080616705,\n",
       "                                       'intra-vertebral': 0.11438805,\n",
       "                                       'intravenous injection device': 0.19260491,\n",
       "                                       'intervertebral': 0.09760089,\n",
       "                                       'initial visit': 0.13590576,\n",
       "                                       'intravenous feeding': 0.150004,\n",
       "                                       'intra-vascular': 0.19073537,\n",
       "                                       'intra-ventricular': 0.09170319})}),\n",
       "             '0/49 the primary trial Participants With HER2-expressing Metastatic and/or Unresectable Breast Cancer had a Maximum change from baseline in QTcF of <60ms.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.2798389,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.27820882,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.2843631,\n",
       "                                       'human epidermal growth factor receptor 2': 0.2779122,\n",
       "                                       'human epidermal growth factor receptor-2': 0.27820882})}),\n",
       "             'According to the results of the primary trial the MTD of dasatinib in combination with weekly paclitaxel is approximately is 120 mg.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MTD': defaultdict(float,\n",
       "                                      {'maximum tolerated dose': 0.45684782,\n",
       "                                       'Monroe tidal drainage': -0.027182337,\n",
       "                                       \"Midwife Teacher's Diploma\": 0.075893104,\n",
       "                                       'mean total dose': 0.4866439,\n",
       "                                       'maximally-tolerated dose': 0.4623521,\n",
       "                                       'metastatic trophoblastic disease': 0.24202016,\n",
       "                                       'maximal tolerated dose': 0.4769499,\n",
       "                                       'maximal-tolerated dose': 0.47411624,\n",
       "                                       'maximum tolerable dose': 0.4090328,\n",
       "                                       'muscle tension dysphonia': 0.12963638,\n",
       "                                       'muscle-tension dysphonia': 0.111058496,\n",
       "                                       'maximum tolerated dosage': 0.4391914,\n",
       "                                       'maximum tolerated doses': 0.42870334,\n",
       "                                       'maximum-tolerated dose': 0.45373464,\n",
       "                                       'multiple tic disorder': 0.13805524,\n",
       "                                       'mannitol dehydrogenase': 0.20145667,\n",
       "                                       'methadone': 0.1660512,\n",
       "                                       'maximally tolerated dose': 0.4646629})}),\n",
       "             'All 4 of the CHF cases in the primary trial, were in cohort 1.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CHF': defaultdict(float,\n",
       "                                      {'congestive heart failure': 0.29577965,\n",
       "                                       'Crimean hemorrhagic fever': 0.19550705,\n",
       "                                       'chick embryo fibroblast': 0.1476097,\n",
       "                                       'Congenital hepatic fibrosis': 0.28586027,\n",
       "                                       'Crimean haemorrhagic fever': 0.20733708,\n",
       "                                       'continuous hemofiltration': 0.14665473,\n",
       "                                       'Crimean Haemorrhagic Fever': 0.20733708,\n",
       "                                       'congenital hepatic fibrosis': 0.28586027,\n",
       "                                       'chick-embryo fibroblast': 0.17542858})}),\n",
       "             'the secondary trial and the primary trial both accept patients with HER-2/neu-overexpressing adenocarcinoma of the breast.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER': defaultdict(float,\n",
       "                                      {'heroin': 0.0054398486,\n",
       "                                       'human epidermal receptor': 0.109388515,\n",
       "                                       'hydrogen evolution reaction': 0.06490175,\n",
       "                                       'human epidermal growth factor receptor': 0.1471582,\n",
       "                                       'human EGF receptor': 0.17685632,\n",
       "                                       'human estrogen receptor': 0.24861231})}),\n",
       "             'Patients with T1N2M0, T2N1M0, T3N1M1 and TxN1M0 tumors are eliglbe for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'T1N2M0': defaultdict(float,\n",
       "                                      {'tumor-1, node-2, metastasis-0': 0.4715505}),\n",
       "                          'T2N1M0': defaultdict(float,\n",
       "                                      {'tumor-2, node-1, metastasis-0': 0.48542914}),\n",
       "                          'T3N1M1': defaultdict(float,\n",
       "                                      {'tumor stage 3, lymph node stage 1, distant metastasis': 0.46266565})}),\n",
       "             'the primary trial measured the Number of Participants With Disease Progression (PD) or Death, to evaluate the performance of its interventions.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PD': defaultdict(float,\n",
       "                                      {'personality disorders': 0.16983405,\n",
       "                                       'pyridostigmine': 0.15378638,\n",
       "                                       'protein': 0.07745161,\n",
       "                                       'protein deposition': 0.040353846,\n",
       "                                       \"Parkinsons's disease\": 0.3288635,\n",
       "                                       \"Parkinson's disease with dementia\": 0.39004704,\n",
       "                                       'posterior descending': 0.06074785,\n",
       "                                       'pancreatoduodenectomy': 0.19022855,\n",
       "                                       'percutaneous drainage': 0.101649284,\n",
       "                                       'proximal-distal': 0.12357732,\n",
       "                                       'postural drainage': 0.09670753,\n",
       "                                       'periodontal disease': 0.157548,\n",
       "                                       'peritoneal dialysate': 0.19564876,\n",
       "                                       'psychological distress': 0.18413757,\n",
       "                                       'pyloric dilator': 0.045662355,\n",
       "                                       'plasmodesma': 0.16063479,\n",
       "                                       'pharmacokinetic (PK)-pharmacodynamic': 0.30559945,\n",
       "                                       'provocation dose': 0.14639352,\n",
       "                                       'Perfusion defect': 0.12664017,\n",
       "                                       'prism diopter': 0.009323383,\n",
       "                                       'pharmacodynamic': 0.2537085,\n",
       "                                       'Preterm Delivery': 0.108702675,\n",
       "                                       'protein D': 0.16968127,\n",
       "                                       'Peyronies disease': 0.14211199,\n",
       "                                       'Pagets disease': 0.1880303,\n",
       "                                       'probing pocket depth': -0.01085882,\n",
       "                                       'pupillary diameter': 0.09584957,\n",
       "                                       'pancreatic duct': 0.07914165,\n",
       "                                       'pneumatic dilation': 0.09763749,\n",
       "                                       'Postnatal Day': 0.07979712,\n",
       "                                       'pupil diameter': 0.04962672,\n",
       "                                       'prednisolone': 0.25368956,\n",
       "                                       'pharmaco-dynamic': 0.29839337,\n",
       "                                       'parkinsonism-dementia': 0.3226235,\n",
       "                                       'persistent diarrhea': 0.06429234,\n",
       "                                       'persistent diarrhoea': 0.06943793,\n",
       "                                       'Phosducin': 0.14722414,\n",
       "                                       'parkinsonian': 0.18404278,\n",
       "                                       \"prisoner's dilemma\": 0.12605676,\n",
       "                                       'pharmaco-dynamics': 0.23385012,\n",
       "                                       'progressed': 0.18933746,\n",
       "                                       'Parkinsonism-dementia': 0.3226235,\n",
       "                                       'pancreatico-duodenectomy': 0.12933718,\n",
       "                                       'prism diopters': -0.009680814,\n",
       "                                       'postnatal days': 0.08276109,\n",
       "                                       'potential difference across the cell membrane': -0.056869462,\n",
       "                                       'peritoneal drainage': 0.083633624,\n",
       "                                       'Pancreas divisum': 0.21737002,\n",
       "                                       'pancreas disease': 0.20814458,\n",
       "                                       'personality disorder': 0.17752801,\n",
       "                                       'pulse duration': 0.18077259,\n",
       "                                       'paired domain': -0.02352636,\n",
       "                                       'population doubling': 0.07078082,\n",
       "                                       'Picks disease': 0.17968205,\n",
       "                                       'peripheral dose': 0.30291477,\n",
       "                                       \"Peyronie's disease\": 0.189502,\n",
       "                                       'pancreato-duodenectomy': 0.140138,\n",
       "                                       'plasmodesmata': 0.032049898,\n",
       "                                       'platelet deposition': 0.13191949,\n",
       "                                       \"Parkinson's disease\": 0.33949816,\n",
       "                                       'power density': -0.017148832,\n",
       "                                       'potential differences': 0.019418137,\n",
       "                                       \"Pierce's disease\": 0.17129317,\n",
       "                                       'progestin-dependent': 0.08630987,\n",
       "                                       'protein degradation': 0.12645109,\n",
       "                                       'parkinsonism dementia': 0.3025318,\n",
       "                                       'plasma desorption': 0.00504885,\n",
       "                                       'purging disorder': 0.19262686,\n",
       "                                       'Parkinsonism dementia': 0.3025318,\n",
       "                                       \"Parkinson's diseases\": 0.35517833,\n",
       "                                       'power Doppler': 0.04183509,\n",
       "                                       'prism dioptres': -0.018906452,\n",
       "                                       'pneumatic dilatation': 0.095734,\n",
       "                                       'platycodin D': 0.118602216,\n",
       "                                       'pharmacodynamics': 0.19461365,\n",
       "                                       'phosphate depletion': 0.14023636,\n",
       "                                       'probing depth': 0.017700005,\n",
       "                                       'program director': 0.14139192,\n",
       "                                       'progressive disease': 0.4172359,\n",
       "                                       \"Paget's disease\": 0.21350212,\n",
       "                                       'poorly differentiated': 0.095926344,\n",
       "                                       'prenatal diagnosis': 0.10513651,\n",
       "                                       'Prenatal diagnosis': 0.10513651,\n",
       "                                       \"parkinson's disease\": 0.33949816,\n",
       "                                       'pressure-diameter': 0.008544812,\n",
       "                                       'pars distalis': 0.08193832,\n",
       "                                       'pancreaticoduodenectomy': 0.15851223,\n",
       "                                       \"Prisoner's Dilemma\": 0.12605676,\n",
       "                                       'panic disorder': 0.1055155,\n",
       "                                       'Parkinsons disease': 0.31296924,\n",
       "                                       \"Parkinsons' disease\": 0.32844678,\n",
       "                                       'P-wave dispersion': 0.009562345,\n",
       "                                       'P wave dispersion': 0.023596857,\n",
       "                                       'parkinsons disease': 0.31296924,\n",
       "                                       'pulsed Doppler': 0.029421922,\n",
       "                                       'Psychopathic deviate': 0.055132456,\n",
       "                                       'pancreas divisum': 0.21737002,\n",
       "                                       'postnatal day': 0.07979712,\n",
       "                                       'Prolidase deficiency': 0.14727376,\n",
       "                                       'pocket depth': -0.019348064,\n",
       "                                       'proton density': -0.018995,\n",
       "                                       'pirfenidone': 0.0956328,\n",
       "                                       'probing depths': -0.0017020216,\n",
       "                                       'Parkinson disease': 0.317541,\n",
       "                                       'potential difference': -0.0522542,\n",
       "                                       \"Pick's disease\": 0.12037908,\n",
       "                                       'peritoneal dialysis': 0.23653208,\n",
       "                                       'power of discrimination': 0.13938081,\n",
       "                                       'pseudo-deficiency': 0.16059957,\n",
       "                                       'patients': 0.36072382,\n",
       "                                       'population doublings': 0.059325386,\n",
       "                                       'psychiatric disorder': 0.18818235,\n",
       "                                       \"prisoners' dilemma\": 0.106074944,\n",
       "                                       'preferred direction': 0.041882817,\n",
       "                                       'Parkinsonism': 0.25241265,\n",
       "                                       'pseudodeficiency': 0.20608282})}),\n",
       "             'The the primary trial placebo group had a over 10% higher mean retention than the donepezil hydrochloride PO QD group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.11667791,\n",
       "                                       'parietal operculum': 0.10701801,\n",
       "                                       'post office': -0.037206206,\n",
       "                                       'percentage of observed value': 0.24168658,\n",
       "                                       'Phenol oxidase': 0.16725953,\n",
       "                                       'parapineal organ': 0.114859045,\n",
       "                                       'power output': 0.012287619,\n",
       "                                       'predominant organism': 0.04009173,\n",
       "                                       'pulse-oximetry': 0.11717882,\n",
       "                                       'perceptual organisation': 0.023564605,\n",
       "                                       'power outputs': -0.038665373,\n",
       "                                       'Personality Organization': 0.026027944,\n",
       "                                       'postoperative': 0.1918472,\n",
       "                                       'parieto occipital': 0.0920623,\n",
       "                                       'polyolefin': 0.079069585,\n",
       "                                       'parietooccipital': 0.086020485,\n",
       "                                       'poly-olefin': 0.12591335,\n",
       "                                       'peroral': 0.1324209,\n",
       "                                       'prostate only': 0.09021252,\n",
       "                                       'pressure overload': 0.04436689,\n",
       "                                       'peroxidase': 0.10781203,\n",
       "                                       'principal olive': 0.05049554,\n",
       "                                       'peri-operative': 0.09085455,\n",
       "                                       'posterior': 0.09600182,\n",
       "                                       'Perceptual Organization': 0.028208673,\n",
       "                                       'period of onset': 0.068004906,\n",
       "                                       'posterior nuclear group': 0.096662365,\n",
       "                                       'phenol oxidase': 0.16725953,\n",
       "                                       'pressure': 0.021540077,\n",
       "                                       'per os (by mouth)': 0.116944365,\n",
       "                                       'parieto-occipital': 0.09211505,\n",
       "                                       'preoptic area': 0.01127129,\n",
       "                                       'perceptual organization': 0.028208673,\n",
       "                                       'prophylactic oophorectomy': 0.11390905,\n",
       "                                       'phosphodiester': 0.10055147,\n",
       "                                       'pre-ovulatory': 0.16354074,\n",
       "                                       'palm oil': 0.08500146,\n",
       "                                       'preovulatory': 0.16709585,\n",
       "                                       'perioperative': 0.15993479,\n",
       "                                       'post operative': 0.15166056,\n",
       "                                       'post-operative': 0.1776189,\n",
       "                                       'phospho-diester': 0.05554657,\n",
       "                                       'protein oxidation': 0.060076714,\n",
       "                                       'palm-oil': 0.07646863,\n",
       "                                       'per os': 0.09270137,\n",
       "                                       'pericardial organ': 0.08063501,\n",
       "                                       'Pulse oximetry': 0.11667791,\n",
       "                                       'paraoxon': 0.21641749,\n",
       "                                       'propylene oxide': 0.14641218,\n",
       "                                       'phenoloxidase': 0.10360134,\n",
       "                                       'peanut oil': 0.09064597}),\n",
       "                          'QD': defaultdict(float,\n",
       "                                      {'quinidine': 0.2569443,\n",
       "                                       'quaque die (every day)': 0.08321718,\n",
       "                                       'quaque die': 0.080524415,\n",
       "                                       'quinupristin-dalfopristin': 0.31909835,\n",
       "                                       'quater die': 0.07120978,\n",
       "                                       'quantum dot': -0.07058303,\n",
       "                                       'questionable dementia': 0.1618226})}),\n",
       "             'the primary trial and the secondary trial both investigate Pharmacokinetics Itraconazole 500mg QD.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'QD': defaultdict(float,\n",
       "                                      {'quinidine': 0.32429084,\n",
       "                                       'quaque die (every day)': 0.059690256,\n",
       "                                       'quaque die': 0.047115307,\n",
       "                                       'quinupristin-dalfopristin': 0.2789912,\n",
       "                                       'quater die': 0.05695097,\n",
       "                                       'quantum dot': -0.070686325,\n",
       "                                       'questionable dementia': -0.012881682})}),\n",
       "             'Participants with HER2- primary breast tumors, confirmed by fluorescence in-situ hybridization are eligible for the secondary trial and the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.26457334,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.26912022,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.27078465,\n",
       "                                       'human epidermal growth factor receptor 2': 0.27039105,\n",
       "                                       'human epidermal growth factor receptor-2': 0.26912022})}),\n",
       "             'Both cohorts of the primary trial receive identical interventions; Pegylated Irinotecan Administered intravenously (IV) at 145 mg/m¬¨‚â§ as monotherapy once every 21 days , the differences between the cohorts is the type of cancers that patients are diagnosed with, cohort 1 is NSCLC, whereas cohort 2 is mBC and the number of cycles for each cohort, 1 for cohort 1 and 4 for cohort 2.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.06282732,\n",
       "                                       'intravenous injection': 0.3344507,\n",
       "                                       'iridovirus': 0.18187039,\n",
       "                                       'intra-venous': 0.2113874,\n",
       "                                       'invitro': 0.16450143,\n",
       "                                       'intra ventricular': 0.18359779,\n",
       "                                       'intra vascular': 0.25443122,\n",
       "                                       'in vivo': 0.19402844,\n",
       "                                       'intravascular': 0.24325053,\n",
       "                                       'in-vivo': 0.25513315,\n",
       "                                       'inter-vertebral': 0.1559857,\n",
       "                                       'ichthyosis vulgaris': 0.0015746355,\n",
       "                                       'intravenous': 0.33186865,\n",
       "                                       'intravaginal': 0.18098493,\n",
       "                                       'invasive': 0.041657753,\n",
       "                                       'iridescent virus': 0.11556207,\n",
       "                                       'isometric virus': 0.10555541,\n",
       "                                       'intravenous feeding device': 0.22695501,\n",
       "                                       'invivo': 0.108968504,\n",
       "                                       'instrumental variable': 0.13434294,\n",
       "                                       'intraventricular': 0.17470893,\n",
       "                                       'intra-vaginal': 0.18826038,\n",
       "                                       'intravertebral': 0.13227633,\n",
       "                                       'in vitro': 0.09963663,\n",
       "                                       'interventricular': 0.17539419,\n",
       "                                       'in-vitro': 0.16579005,\n",
       "                                       'intra venous': 0.18602799,\n",
       "                                       'iodine value': 0.22911644,\n",
       "                                       'ichnovirus': 0.10177398,\n",
       "                                       'inter-ventricular': 0.19475947,\n",
       "                                       'intra-vertebral': 0.16648135,\n",
       "                                       'intravenous injection device': 0.3002865,\n",
       "                                       'intervertebral': 0.105923936,\n",
       "                                       'initial visit': 0.13406475,\n",
       "                                       'intravenous feeding': 0.2692228,\n",
       "                                       'intra-vascular': 0.27873924,\n",
       "                                       'intra-ventricular': 0.19670032}),\n",
       "                          'NSCLC': defaultdict(float,\n",
       "                                      {'nonsmall-cell lung cancer': 0.23185012,\n",
       "                                       'non–small cell lung carcinoma': 0.23215652,\n",
       "                                       'non small cell lung carcinoma': 0.24769206,\n",
       "                                       'non-small-cell lung cancer': 0.24344368,\n",
       "                                       'non small-cell lung cancer': 0.2588235,\n",
       "                                       'non small cell lung cancer': 0.26774073,\n",
       "                                       'non-small cell carcinoma of the lung': 0.19240543,\n",
       "                                       'non-small cell lung cancers': 0.23524953,\n",
       "                                       'nonsmall cell lung carcinoma': 0.22296253,\n",
       "                                       'non-small-cell lung carcinoma': 0.23479663,\n",
       "                                       'non-small cell lung carcinoma': 0.23563457,\n",
       "                                       'Non-small cell lung cancer': 0.24702504,\n",
       "                                       'nonsmall cell lung cancer': 0.24492642,\n",
       "                                       'non-small cell lung carcinomas': 0.20970446,\n",
       "                                       'non-small cell lung cancer': 0.24702504})}),\n",
       "             'Median (95% Confidence Interval) Progression-Free Survival (PFS) was over a year higher for patients in the Trastuzumab + Sunitinib group of the primary trial than for the Docetaxel group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.099934176,\n",
       "                                       'pyrogen-free saline': 0.011564694,\n",
       "                                       'pressure-flow study': -0.050715685,\n",
       "                                       'posterior fossa syndrome': 0.033146016,\n",
       "                                       'pressure flow study': -0.040232204,\n",
       "                                       'primary fibromyalgia syndrome': 0.20613301,\n",
       "                                       'Piper Fatigue Scale': 0.06908363,\n",
       "                                       'patellofemoral syndrome': 0.090415575,\n",
       "                                       'Progression-free': 0.12221129,\n",
       "                                       'pulmonary function score': 0.21684092,\n",
       "                                       'pressure flow studies': -0.053248536,\n",
       "                                       'protein-free supernatant': -0.02731166,\n",
       "                                       'progression free survival': 0.39938915,\n",
       "                                       'protein free supernatant': -0.011248431,\n",
       "                                       'progression-free survival': 0.43472588,\n",
       "                                       'pressure/flow study': -0.03513354})}),\n",
       "             'Patients with left-sided breast cancer and an ECOG between 1-2 are excluded from the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.11524021,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.40057606,\n",
       "                                       'eastern cooperative oncology group': 0.40057606,\n",
       "                                       'Electrocochleography': 0.15909849,\n",
       "                                       'electrocochleogram': 0.1528719,\n",
       "                                       'electrocortical activity': 0.06749288,\n",
       "                                       'electrocorticograms': 0.12793845,\n",
       "                                       'electrocortical': 0.09427054})}),\n",
       "             'Patients with HER2 positive tumors are excluded from the primary trial, but may be included in the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.30942604,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.3138765,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.30369142,\n",
       "                                       'human epidermal growth factor receptor 2': 0.2977851,\n",
       "                                       'human epidermal growth factor receptor-2': 0.3138765})}),\n",
       "             'Every patient in the primary trial is given tipifarnib PO, along with paclitaxel, doxorubicin hydrochloride and acyclophosphamide IV.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.15164632,\n",
       "                                       'parietal operculum': 0.19637474,\n",
       "                                       'post office': 0.030916784,\n",
       "                                       'percentage of observed value': 0.0868157,\n",
       "                                       'Phenol oxidase': 0.14360973,\n",
       "                                       'parapineal organ': 0.21218367,\n",
       "                                       'power output': -0.015621936,\n",
       "                                       'predominant organism': 0.14152057,\n",
       "                                       'pulse-oximetry': 0.1425477,\n",
       "                                       'perceptual organisation': -0.01413444,\n",
       "                                       'power outputs': 0.0022413332,\n",
       "                                       'Personality Organization': -0.06296969,\n",
       "                                       'postoperative': 0.20129427,\n",
       "                                       'parieto occipital': 0.19038343,\n",
       "                                       'polyolefin': 0.13011207,\n",
       "                                       'parietooccipital': 0.15914133,\n",
       "                                       'poly-olefin': 0.11733701,\n",
       "                                       'peroral': 0.17337038,\n",
       "                                       'prostate only': 0.17817542,\n",
       "                                       'pressure overload': 0.024589004,\n",
       "                                       'peroxidase': 0.112603426,\n",
       "                                       'principal olive': 0.16617,\n",
       "                                       'peri-operative': 0.18553554,\n",
       "                                       'posterior': 0.12774777,\n",
       "                                       'Perceptual Organization': -0.016188622,\n",
       "                                       'period of onset': 0.105159976,\n",
       "                                       'posterior nuclear group': 0.118826516,\n",
       "                                       'phenol oxidase': 0.14360973,\n",
       "                                       'pressure': -0.025662173,\n",
       "                                       'per os (by mouth)': 0.16458623,\n",
       "                                       'parieto-occipital': 0.16392662,\n",
       "                                       'preoptic area': 0.091641024,\n",
       "                                       'perceptual organization': -0.016188622,\n",
       "                                       'prophylactic oophorectomy': 0.22670953,\n",
       "                                       'phosphodiester': 0.1956794,\n",
       "                                       'pre-ovulatory': 0.1857874,\n",
       "                                       'palm oil': 0.10506973,\n",
       "                                       'preovulatory': 0.2923261,\n",
       "                                       'perioperative': 0.23383516,\n",
       "                                       'post operative': 0.17843895,\n",
       "                                       'post-operative': 0.19248734,\n",
       "                                       'phospho-diester': 0.11947876,\n",
       "                                       'protein oxidation': 0.05234137,\n",
       "                                       'palm-oil': 0.08510313,\n",
       "                                       'per os': 0.16055311,\n",
       "                                       'pericardial organ': 0.10664733,\n",
       "                                       'Pulse oximetry': 0.15164632,\n",
       "                                       'paraoxon': 0.32676828,\n",
       "                                       'propylene oxide': 0.1958358,\n",
       "                                       'phenoloxidase': 0.21305458,\n",
       "                                       'peanut oil': 0.14308031}),\n",
       "                          'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.13606012,\n",
       "                                       'intravenous injection': 0.33856636,\n",
       "                                       'iridovirus': 0.16464329,\n",
       "                                       'intra-venous': 0.21472715,\n",
       "                                       'invitro': 0.13452242,\n",
       "                                       'intra ventricular': 0.1074684,\n",
       "                                       'intra vascular': 0.19220285,\n",
       "                                       'in vivo': 0.2609009,\n",
       "                                       'intravascular': 0.21473372,\n",
       "                                       'in-vivo': 0.31081975,\n",
       "                                       'inter-vertebral': 0.14889431,\n",
       "                                       'ichthyosis vulgaris': 0.06571767,\n",
       "                                       'intravenous': 0.3305719,\n",
       "                                       'intravaginal': 0.16979004,\n",
       "                                       'invasive': 0.1015246,\n",
       "                                       'iridescent virus': 0.10694345,\n",
       "                                       'isometric virus': 0.09289074,\n",
       "                                       'intravenous feeding device': 0.21399185,\n",
       "                                       'invivo': 0.121980906,\n",
       "                                       'instrumental variable': 0.065006584,\n",
       "                                       'intraventricular': 0.104431026,\n",
       "                                       'intra-vaginal': 0.19483171,\n",
       "                                       'intravertebral': 0.14671597,\n",
       "                                       'in vitro': 0.16870919,\n",
       "                                       'interventricular': 0.093459375,\n",
       "                                       'in-vitro': 0.2379608,\n",
       "                                       'intra venous': 0.1844192,\n",
       "                                       'iodine value': 0.09155976,\n",
       "                                       'ichnovirus': 0.14136992,\n",
       "                                       'inter-ventricular': 0.0980769,\n",
       "                                       'intra-vertebral': 0.18986095,\n",
       "                                       'intravenous injection device': 0.2636011,\n",
       "                                       'intervertebral': 0.12259064,\n",
       "                                       'initial visit': 0.15780447,\n",
       "                                       'intravenous feeding': 0.24828517,\n",
       "                                       'intra-vascular': 0.22779617,\n",
       "                                       'intra-ventricular': 0.12305267})}),\n",
       "             'There was just under 8 weeks difference in Progression-free Survival between the minimum and maximum PFS in the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.08713689,\n",
       "                                       'pyrogen-free saline': 0.14136285,\n",
       "                                       'pressure-flow study': 0.048043586,\n",
       "                                       'posterior fossa syndrome': 0.087872304,\n",
       "                                       'pressure flow study': 0.05625686,\n",
       "                                       'primary fibromyalgia syndrome': 0.23031598,\n",
       "                                       'Piper Fatigue Scale': 0.18868095,\n",
       "                                       'patellofemoral syndrome': 0.10793812,\n",
       "                                       'Progression-free': 0.26897988,\n",
       "                                       'pulmonary function score': 0.2549756,\n",
       "                                       'pressure flow studies': 0.03858143,\n",
       "                                       'protein-free supernatant': 0.08382569,\n",
       "                                       'progression free survival': 0.52981716,\n",
       "                                       'protein free supernatant': 0.10754543,\n",
       "                                       'progression-free survival': 0.55856824,\n",
       "                                       'pressure/flow study': 0.07524782})}),\n",
       "             'Patients with Platelet count over 100,000/mm¬¨‚â•, ANC <  1,700/mm¬¨‚â• and Hemoglobin between 11 to 18 grams per deciliter are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ANC': defaultdict(float,\n",
       "                                      {'acid neutralising capacity': 0.18042767,\n",
       "                                       'antigen-neutralising capacity': 0.26643756,\n",
       "                                       'antenatal care': 0.17922425,\n",
       "                                       'acid neutralization capacity': 0.17528273,\n",
       "                                       'ante-natal clinic': 0.29168844,\n",
       "                                       'antenatal clinics': 0.23359168,\n",
       "                                       'acid-neutralising capacity': 0.16704117,\n",
       "                                       'absolute neutrophil count': 0.40596652,\n",
       "                                       'Active noise control': 0.013998711,\n",
       "                                       'acid neutralizing capacity': 0.18846188,\n",
       "                                       'antigen-neutralizing capacity': 0.270458,\n",
       "                                       'acid neutralisation capacity': 0.18826851,\n",
       "                                       'absolute neutrophil counts': 0.41616416,\n",
       "                                       'Army Nurse Corps': 0.1813575,\n",
       "                                       'antenatal clinic': 0.27956116,\n",
       "                                       'acid-neutralizing capacity': 0.17623131})}),\n",
       "             'Both cohorts of the primary trial receive identical interventions; Pegylated Irinotecan Administered intravenously (IV) at 145 mg/m¬¨‚â§ as monotherapy once every 21 days (1 cycle), the difference between the cohorts is the type of cancers that patients are diagnosed with, cohort 1 is NSCLC, whereas cohort 2 is mBC.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.059894785,\n",
       "                                       'intravenous injection': 0.342016,\n",
       "                                       'iridovirus': 0.17921294,\n",
       "                                       'intra-venous': 0.21523935,\n",
       "                                       'invitro': 0.17437984,\n",
       "                                       'intra ventricular': 0.1953081,\n",
       "                                       'intra vascular': 0.263468,\n",
       "                                       'in vivo': 0.19689167,\n",
       "                                       'intravascular': 0.2525432,\n",
       "                                       'in-vivo': 0.2572064,\n",
       "                                       'inter-vertebral': 0.15818153,\n",
       "                                       'ichthyosis vulgaris': -0.0036298516,\n",
       "                                       'intravenous': 0.34316048,\n",
       "                                       'intravaginal': 0.17588128,\n",
       "                                       'invasive': 0.033811074,\n",
       "                                       'iridescent virus': 0.12232661,\n",
       "                                       'isometric virus': 0.117832504,\n",
       "                                       'intravenous feeding device': 0.23309503,\n",
       "                                       'invivo': 0.11445141,\n",
       "                                       'instrumental variable': 0.1239136,\n",
       "                                       'intraventricular': 0.18652764,\n",
       "                                       'intra-vaginal': 0.1809063,\n",
       "                                       'intravertebral': 0.13529395,\n",
       "                                       'in vitro': 0.097552925,\n",
       "                                       'interventricular': 0.1830273,\n",
       "                                       'in-vitro': 0.16738674,\n",
       "                                       'intra venous': 0.19228308,\n",
       "                                       'iodine value': 0.22459194,\n",
       "                                       'ichnovirus': 0.1037404,\n",
       "                                       'inter-ventricular': 0.20426326,\n",
       "                                       'intra-vertebral': 0.16526379,\n",
       "                                       'intravenous injection device': 0.30683604,\n",
       "                                       'intervertebral': 0.114359334,\n",
       "                                       'initial visit': 0.12905021,\n",
       "                                       'intravenous feeding': 0.2792366,\n",
       "                                       'intra-vascular': 0.28147262,\n",
       "                                       'intra-ventricular': 0.20577307}),\n",
       "                          'NSCLC': defaultdict(float,\n",
       "                                      {'nonsmall-cell lung cancer': 0.21908236,\n",
       "                                       'non–small cell lung carcinoma': 0.21979782,\n",
       "                                       'non small cell lung carcinoma': 0.23661788,\n",
       "                                       'non-small-cell lung cancer': 0.22394875,\n",
       "                                       'non small-cell lung cancer': 0.23934051,\n",
       "                                       'non small cell lung cancer': 0.25167444,\n",
       "                                       'non-small cell carcinoma of the lung': 0.17914282,\n",
       "                                       'non-small cell lung cancers': 0.21446276,\n",
       "                                       'nonsmall cell lung carcinoma': 0.21488203,\n",
       "                                       'non-small-cell lung carcinoma': 0.22010729,\n",
       "                                       'non-small cell lung carcinoma': 0.22198018,\n",
       "                                       'Non-small cell lung cancer': 0.22868297,\n",
       "                                       'nonsmall cell lung cancer': 0.23310843,\n",
       "                                       'non-small cell lung carcinomas': 0.19483875,\n",
       "                                       'non-small cell lung cancer': 0.22868297})}),\n",
       "             'Patients with HER2 + breast cancer are eligible for both the primary trial and the secondary trial. However, only patients with stage 1-2 breast cancer are eligible for the primary trial, and patients with stage 3-4 are eligilbe for the secondary trial. ': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.2662307,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.2746722,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.27511635,\n",
       "                                       'human epidermal growth factor receptor 2': 0.27902985,\n",
       "                                       'human epidermal growth factor receptor-2': 0.2746722})}),\n",
       "             '27.6% of Patients Who Have Fatty Acid Synthase (FASN) Expression in the primary trial treated with Minocycline Hydrochloride did not have Pathological Complete Response.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'FASN': defaultdict(float,\n",
       "                                      {'fatty-acid synthase': 0.56310904,\n",
       "                                       'fatty acid synthase': 0.5555148})}),\n",
       "             'participants of cohort 1 in the primary trial and all participants of the secondary trial take 1 milligram of anastrozole PO QD.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.20592311,\n",
       "                                       'parietal operculum': 0.16908698,\n",
       "                                       'post office': 0.06448679,\n",
       "                                       'percentage of observed value': 0.1936943,\n",
       "                                       'Phenol oxidase': 0.2232486,\n",
       "                                       'parapineal organ': 0.16148447,\n",
       "                                       'power output': 0.0019206144,\n",
       "                                       'predominant organism': 0.14773712,\n",
       "                                       'pulse-oximetry': 0.21129233,\n",
       "                                       'perceptual organisation': -0.032843232,\n",
       "                                       'power outputs': -0.033637382,\n",
       "                                       'Personality Organization': -0.021534203,\n",
       "                                       'postoperative': 0.15116242,\n",
       "                                       'parieto occipital': 0.15597555,\n",
       "                                       'polyolefin': 0.13848737,\n",
       "                                       'parietooccipital': 0.121968664,\n",
       "                                       'poly-olefin': 0.10947078,\n",
       "                                       'peroral': 0.18448876,\n",
       "                                       'prostate only': 0.11883536,\n",
       "                                       'pressure overload': 0.044551753,\n",
       "                                       'peroxidase': 0.14116302,\n",
       "                                       'principal olive': 0.11939047,\n",
       "                                       'peri-operative': 0.12288418,\n",
       "                                       'posterior': 0.23557338,\n",
       "                                       'Perceptual Organization': -0.035248064,\n",
       "                                       'period of onset': 0.21081868,\n",
       "                                       'posterior nuclear group': 0.16994351,\n",
       "                                       'phenol oxidase': 0.2232486,\n",
       "                                       'pressure': 0.012797216,\n",
       "                                       'per os (by mouth)': 0.22137925,\n",
       "                                       'parieto-occipital': 0.1471591,\n",
       "                                       'preoptic area': 0.06953569,\n",
       "                                       'perceptual organization': -0.035248064,\n",
       "                                       'prophylactic oophorectomy': 0.13092235,\n",
       "                                       'phosphodiester': 0.2257201,\n",
       "                                       'pre-ovulatory': 0.19877285,\n",
       "                                       'palm oil': 0.076828755,\n",
       "                                       'preovulatory': 0.23446134,\n",
       "                                       'perioperative': 0.18460555,\n",
       "                                       'post operative': 0.14729065,\n",
       "                                       'post-operative': 0.15078577,\n",
       "                                       'phospho-diester': 0.14588585,\n",
       "                                       'protein oxidation': 0.04321152,\n",
       "                                       'palm-oil': 0.06144246,\n",
       "                                       'per os': 0.17579098,\n",
       "                                       'pericardial organ': 0.114620715,\n",
       "                                       'Pulse oximetry': 0.20592311,\n",
       "                                       'paraoxon': 0.32680717,\n",
       "                                       'propylene oxide': 0.17917524,\n",
       "                                       'phenoloxidase': 0.18646158,\n",
       "                                       'peanut oil': 0.10104156}),\n",
       "                          'QD': defaultdict(float,\n",
       "                                      {'quinidine': 0.38724464,\n",
       "                                       'quaque die (every day)': 0.18521833,\n",
       "                                       'quaque die': 0.20492226,\n",
       "                                       'quinupristin-dalfopristin': 0.3770193,\n",
       "                                       'quater die': 0.22099885,\n",
       "                                       'quantum dot': 0.06497499,\n",
       "                                       'questionable dementia': 0.09701483})}),\n",
       "             'the primary trial and the secondary trial measure the DLT of their respective interventions, using the same time frame.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DLT': defaultdict(float,\n",
       "                                      {'double-lung transplantation': 0.18861623,\n",
       "                                       'direct linear transformation': 0.093712956,\n",
       "                                       'double lumen tube': 0.15569827,\n",
       "                                       'double-lumen tube': 0.14340341,\n",
       "                                       'dose limiting toxicity': 0.16013125,\n",
       "                                       'dose-limiting toxicity': 0.16787341,\n",
       "                                       'donor leukocyte transfusion': 0.08100471,\n",
       "                                       'double-lumen endobronchial tube': 0.16998857,\n",
       "                                       'double lumen endotracheal tube': 0.20099887,\n",
       "                                       'double lung transplantation': 0.19273907,\n",
       "                                       'double-lumen endotracheal tube': 0.1939631})}),\n",
       "             'Cohort 1 of the primary trial had a longer PFS than cohort 2. However the patient with the longest PFS was in cohort 2.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.17630705,\n",
       "                                       'pyrogen-free saline': 0.098987445,\n",
       "                                       'pressure-flow study': 0.029699389,\n",
       "                                       'posterior fossa syndrome': 0.21574737,\n",
       "                                       'pressure flow study': 0.033891417,\n",
       "                                       'primary fibromyalgia syndrome': 0.29089642,\n",
       "                                       'Piper Fatigue Scale': 0.15144151,\n",
       "                                       'patellofemoral syndrome': 0.20372707,\n",
       "                                       'Progression-free': 0.19969933,\n",
       "                                       'pulmonary function score': 0.2629196,\n",
       "                                       'pressure flow studies': 0.017430542,\n",
       "                                       'protein-free supernatant': 0.041959975,\n",
       "                                       'progression free survival': 0.37187544,\n",
       "                                       'protein free supernatant': 0.06599141,\n",
       "                                       'progression-free survival': 0.423459,\n",
       "                                       'pressure/flow study': 0.058681954})}),\n",
       "             'Adele is an 85 year old woman with Stage IV histologically confirmed ER+ breast cancer with an ECOG of 0, she has a life expectancy below 6 months and a history of thrombotic events. She is eligible for the primary trial': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.07609998,\n",
       "                                       'intravenous injection': 0.29005107,\n",
       "                                       'iridovirus': 0.11267311,\n",
       "                                       'intra-venous': 0.29754892,\n",
       "                                       'invitro': 0.07892492,\n",
       "                                       'intra ventricular': 0.25779876,\n",
       "                                       'intra vascular': 0.2740576,\n",
       "                                       'in vivo': 0.20903543,\n",
       "                                       'intravascular': 0.2796324,\n",
       "                                       'in-vivo': 0.24291193,\n",
       "                                       'inter-vertebral': 0.13615914,\n",
       "                                       'ichthyosis vulgaris': 0.08800872,\n",
       "                                       'intravenous': 0.29401472,\n",
       "                                       'intravaginal': 0.20399305,\n",
       "                                       'invasive': 0.110157005,\n",
       "                                       'iridescent virus': 0.08042345,\n",
       "                                       'isometric virus': 0.07597829,\n",
       "                                       'intravenous feeding device': 0.20405452,\n",
       "                                       'invivo': 0.099451445,\n",
       "                                       'instrumental variable': 0.15087445,\n",
       "                                       'intraventricular': 0.22671054,\n",
       "                                       'intra-vaginal': 0.20989703,\n",
       "                                       'intravertebral': 0.16905273,\n",
       "                                       'in vitro': 0.13412927,\n",
       "                                       'interventricular': 0.21597193,\n",
       "                                       'in-vitro': 0.16624916,\n",
       "                                       'intra venous': 0.26166013,\n",
       "                                       'iodine value': 0.060741577,\n",
       "                                       'ichnovirus': 0.09278053,\n",
       "                                       'inter-ventricular': 0.24943376,\n",
       "                                       'intra-vertebral': 0.17509045,\n",
       "                                       'intravenous injection device': 0.23484513,\n",
       "                                       'intervertebral': 0.1326258,\n",
       "                                       'initial visit': 0.19822638,\n",
       "                                       'intravenous feeding': 0.24546283,\n",
       "                                       'intra-vascular': 0.32495028,\n",
       "                                       'intra-ventricular': 0.2774057}),\n",
       "                          'ER': defaultdict(float,\n",
       "                                      {'extinction-ratio': 0.04274597,\n",
       "                                       'equivalent rontgen': 0.06712344,\n",
       "                                       'endo-plasmic reticulum': 0.10192106,\n",
       "                                       'emergency room': 0.2510878,\n",
       "                                       'estrogen receptor-alpha': 0.22351724,\n",
       "                                       'environmental resistance': -0.012363767,\n",
       "                                       'erythrocyte receptor': 0.19106318,\n",
       "                                       'estradiol receptor': 0.16241418,\n",
       "                                       'extended-release': 0.15761158,\n",
       "                                       'energy restriction': 0.089281894,\n",
       "                                       'energy-restricted': 0.116081506,\n",
       "                                       'estrogen-receptor': 0.20092897,\n",
       "                                       'energy retention': -0.0014885666,\n",
       "                                       'electrorheological': 0.078097396,\n",
       "                                       'ejection rate': 0.108859956,\n",
       "                                       'external resistance': 0.0022864463,\n",
       "                                       'Estrogen receptor alpha': 0.203462,\n",
       "                                       'estrogen receptor': 0.19643268,\n",
       "                                       'early': 0.11704801,\n",
       "                                       'endoplasmatic reticulum': 0.0908348,\n",
       "                                       'Estradiol': 0.18677467,\n",
       "                                       'expiratory reserve': 0.1559427,\n",
       "                                       'endovascular repair': 0.22038679,\n",
       "                                       'Emergency Room': 0.2510878,\n",
       "                                       'early reticulocyte': 0.11152324,\n",
       "                                       'esophageal rupture': 0.1642214,\n",
       "                                       'Estrogen receptors': 0.13493674,\n",
       "                                       'evoked responses': 0.10253111,\n",
       "                                       'estrogen receptor protein': 0.17955495,\n",
       "                                       'erythromycin': 0.22130662,\n",
       "                                       'enhancement ratios': 0.09788706,\n",
       "                                       'equine rhinopneumonia': 0.06601685,\n",
       "                                       'eye research': 0.13727538,\n",
       "                                       'extinction ratio': 0.046369288,\n",
       "                                       'equivalent roentgen': 0.13216609,\n",
       "                                       'emotion regulation': 0.040645547,\n",
       "                                       'enhancement ratio': 0.11751549,\n",
       "                                       'estrogen receptor status': 0.23137142,\n",
       "                                       'early repolarization': 0.07320975,\n",
       "                                       'early repolarisation': 0.07685622,\n",
       "                                       'electrical resistance': 0.044806655,\n",
       "                                       'evoked response': 0.13312729,\n",
       "                                       'efficacy ratio': 0.21139513,\n",
       "                                       'estrogen': 0.14594255,\n",
       "                                       'endoplasmic reticular': 0.090333365,\n",
       "                                       'extraction ratio': 0.09957164,\n",
       "                                       'extended release': 0.15985796,\n",
       "                                       'external rotation': -0.027742416,\n",
       "                                       'epigastric region': 0.20281677,\n",
       "                                       'endoscopic resection': 0.17362544,\n",
       "                                       'ethoxyresorufin': 0.19098374,\n",
       "                                       'electro-resection': 0.20101689,\n",
       "                                       'early response': 0.2344545,\n",
       "                                       'endoplasmic reticulum': 0.08555299,\n",
       "                                       'enhanced reactivation': 0.11580027,\n",
       "                                       'electroresection': 0.12141822}),\n",
       "                          'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.07156069,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.515731,\n",
       "                                       'eastern cooperative oncology group': 0.515731,\n",
       "                                       'Electrocochleography': 0.10401536,\n",
       "                                       'electrocochleogram': 0.1001011,\n",
       "                                       'electrocortical activity': 0.032332305,\n",
       "                                       'electrocorticograms': 0.07296195,\n",
       "                                       'electrocortical': 0.05635026})}),\n",
       "             'the primary trial results show that Zoledronic Acid Upfront is a better treatment than Zoledronic Acid Delayed-start for preventing any change in Lumbar Spine (L1-L4) Bone Mineral Density (BMD).': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'L1': defaultdict(float,\n",
       "                                      {'l1 (first lumbar vertebra)': 0.39650553,\n",
       "                                       'long interspersed nucleotide element 1': 0.080148585,\n",
       "                                       'long interspersed nucleotide element-1': 0.08450565,\n",
       "                                       'LINE-1': 0.045887984,\n",
       "                                       'Long Interspersed Sequence One': 0.053102124,\n",
       "                                       'lipoxygenase-1': 0.15306708,\n",
       "                                       'long interspersed nuclear element 1': 0.021757303,\n",
       "                                       'long interspersed element 1': 0.0147023555,\n",
       "                                       'lipoxygenase 1': 0.13288756,\n",
       "                                       'lumbar 1': 0.39749733,\n",
       "                                       'long interspersed nuclear element-1': 0.03381084,\n",
       "                                       'lymphatic vessel invasion stage 1': 0.13143925,\n",
       "                                       'long interspersed element-1': 0.01661459,\n",
       "                                       'lumbar vertebra 1': 0.3941036}),\n",
       "                          'BMD': defaultdict(float,\n",
       "                                      {'Becker muscular dystrophy': 0.091429204,\n",
       "                                       'bacitracin methylenedisalicylate': 0.15616663,\n",
       "                                       'Best macular dystrophy': 0.22834703,\n",
       "                                       'bone-mineral density': 0.390831,\n",
       "                                       'bone mineral densities': 0.31579944,\n",
       "                                       \"Best's macular dystrophy\": 0.19359425,\n",
       "                                       'benchmark dose': 0.2753519,\n",
       "                                       'broth microdilution': 0.11051181,\n",
       "                                       'bacitracin methylene disalicylate': 0.16434488,\n",
       "                                       'Bone mineral density': 0.393555,\n",
       "                                       \"Becker's muscular dystrophy\": 0.11001378,\n",
       "                                       'bone mass density': 0.30037937,\n",
       "                                       'bone mineral density': 0.393555,\n",
       "                                       'bone mineral densitometry': 0.3459011})}),\n",
       "             'The difference in median Overall Survival (OS) of Patients between the two cohort of the primary trial was less than one month, the patient with the longest OS was in cohort 1.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'OS': defaultdict(float,\n",
       "                                      {'oculus sinister': -0.00015971903,\n",
       "                                       'opposite-sex': 0.03511428,\n",
       "                                       'open surgery': 0.15601006,\n",
       "                                       'over-shoot': 0.039620306,\n",
       "                                       'oxi-dative stress': 0.044866417,\n",
       "                                       'oligosaccharides': 0.08413942,\n",
       "                                       'orthopedic surgery': 0.17271824,\n",
       "                                       'overshoot': 0.08145265,\n",
       "                                       'open splenectomy': 0.14645007,\n",
       "                                       'ovarian stimulation': 0.1444051,\n",
       "                                       'over shoot': 0.06906885,\n",
       "                                       'obese strain': 0.08858888,\n",
       "                                       'Opitz syndrome': 0.15347227,\n",
       "                                       'outer segments': 0.063910514,\n",
       "                                       'ouabain-sensitive': 0.11535537,\n",
       "                                       'osteosarcoma': 0.27729458,\n",
       "                                       'oxidative stress': 0.11652315,\n",
       "                                       'overall survival time': 0.49801502,\n",
       "                                       'osteosarcomas': 0.25860804,\n",
       "                                       'oculus sinister (left eye)': 0.044044014,\n",
       "                                       'overlap syndrome': 0.10985059,\n",
       "                                       'outer segment': 0.08623627,\n",
       "                                       'oligomycin-sensitive': 0.12570316,\n",
       "                                       'oxidative-stress': 0.14590491,\n",
       "                                       'oral secretion': -0.009519147,\n",
       "                                       'oligosaccharide': 0.096478656,\n",
       "                                       'overall survival rate': 0.57301563,\n",
       "                                       'Omenn syndrome': 0.09984711,\n",
       "                                       'osteogenic sarcoma': 0.22354412,\n",
       "                                       \"Omenn's syndrome\": 0.11383626,\n",
       "                                       'one-step': 0.03738443,\n",
       "                                       'oligo-saccharide': 0.11032329,\n",
       "                                       'Ocimum sanctum': 0.09684062,\n",
       "                                       'overall survival': 0.41665468,\n",
       "                                       'One-Step': 0.03738443,\n",
       "                                       'oxydative stress': 0.11239037})}),\n",
       "             'The majority of the primary trial subjects either had Progressive disease or undetermined CNS objective response rate.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CNS': defaultdict(float,\n",
       "                                      {'central nerve system': 0.38308188,\n",
       "                                       'Congenital nephrotic syndrome': 0.13164838,\n",
       "                                       'Coagulase negative staphylococci': 0.046635997,\n",
       "                                       'Clinical nurse specialist': 0.16826925,\n",
       "                                       'coagulase negative staphylococcus': 0.05240214,\n",
       "                                       'coagulase-negative Staphylococcus': 0.068478316,\n",
       "                                       'central nerves system': 0.34287173,\n",
       "                                       'central-nervous-system': 0.32694462,\n",
       "                                       'congenital nephrotic syndrome': 0.13164838,\n",
       "                                       'central nervous system': 0.36328477,\n",
       "                                       'central nervous systems': 0.37188083,\n",
       "                                       'Crigler Najjar syndrome': 0.17050445,\n",
       "                                       'coagulase negative staph': 0.050253145,\n",
       "                                       'clinical nurse specialists': 0.16602336,\n",
       "                                       'Crigler-Najjar syndrome': 0.18221828,\n",
       "                                       'coagulase-negative staphylococci': 0.05962191,\n",
       "                                       'coagulase-negative staphylococcus': 0.068478316,\n",
       "                                       'central nervous': 0.3347768,\n",
       "                                       'clinical nurse specialist': 0.16826925,\n",
       "                                       'Canadian Neurological Scale': 0.51276386,\n",
       "                                       'coagulase-negative staphylococcal': 0.114189945,\n",
       "                                       'coagulase negative Staphylococcus': 0.05240214})}),\n",
       "             'the primary trial and the secondary trial both administer treatments to their patients through IV.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.1260666,\n",
       "                                       'intravenous injection': 0.5177678,\n",
       "                                       'iridovirus': 0.21543038,\n",
       "                                       'intra-venous': 0.43963072,\n",
       "                                       'invitro': 0.14671622,\n",
       "                                       'intra ventricular': 0.29181522,\n",
       "                                       'intra vascular': 0.39668986,\n",
       "                                       'in vivo': 0.34686518,\n",
       "                                       'intravascular': 0.41105023,\n",
       "                                       'in-vivo': 0.40251827,\n",
       "                                       'inter-vertebral': 0.23744926,\n",
       "                                       'ichthyosis vulgaris': 0.09406148,\n",
       "                                       'intravenous': 0.494792,\n",
       "                                       'intravaginal': 0.34991205,\n",
       "                                       'invasive': 0.09435769,\n",
       "                                       'iridescent virus': 0.15316744,\n",
       "                                       'isometric virus': 0.16640726,\n",
       "                                       'intravenous feeding device': 0.39945602,\n",
       "                                       'invivo': 0.18632083,\n",
       "                                       'instrumental variable': 0.21310276,\n",
       "                                       'intraventricular': 0.24258937,\n",
       "                                       'intra-vaginal': 0.37256458,\n",
       "                                       'intravertebral': 0.23302954,\n",
       "                                       'in vitro': 0.2822158,\n",
       "                                       'interventricular': 0.2512989,\n",
       "                                       'in-vitro': 0.3330242,\n",
       "                                       'intra venous': 0.4219865,\n",
       "                                       'iodine value': 0.10993867,\n",
       "                                       'ichnovirus': 0.13668251,\n",
       "                                       'inter-ventricular': 0.30516854,\n",
       "                                       'intra-vertebral': 0.23905966,\n",
       "                                       'intravenous injection device': 0.49426988,\n",
       "                                       'intervertebral': 0.23952764,\n",
       "                                       'initial visit': 0.23713656,\n",
       "                                       'intravenous feeding': 0.4098789,\n",
       "                                       'intra-vascular': 0.41047543,\n",
       "                                       'intra-ventricular': 0.30287135})}),\n",
       "             'Patients with severe malabsorption disorders are ineligible for the primary trial, unless they are able to receive intravenous (IV) alimentation.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.2130722,\n",
       "                                       'intravenous injection': 0.47769246,\n",
       "                                       'iridovirus': 0.101322114,\n",
       "                                       'intra-venous': 0.35802728,\n",
       "                                       'invitro': 0.12383055,\n",
       "                                       'intra ventricular': 0.24098195,\n",
       "                                       'intra vascular': 0.25493667,\n",
       "                                       'in vivo': 0.20054464,\n",
       "                                       'intravascular': 0.3317855,\n",
       "                                       'in-vivo': 0.24369104,\n",
       "                                       'inter-vertebral': 0.1840255,\n",
       "                                       'ichthyosis vulgaris': 0.17539687,\n",
       "                                       'intravenous': 0.44564378,\n",
       "                                       'intravaginal': 0.24593718,\n",
       "                                       'invasive': 0.092365265,\n",
       "                                       'iridescent virus': 0.08369871,\n",
       "                                       'isometric virus': 0.08320446,\n",
       "                                       'intravenous feeding device': 0.39739624,\n",
       "                                       'invivo': 0.06805852,\n",
       "                                       'instrumental variable': 0.059634816,\n",
       "                                       'intraventricular': 0.23113762,\n",
       "                                       'intra-vaginal': 0.2682561,\n",
       "                                       'intravertebral': 0.20042968,\n",
       "                                       'in vitro': 0.12423362,\n",
       "                                       'interventricular': 0.2230384,\n",
       "                                       'in-vitro': 0.18771334,\n",
       "                                       'intra venous': 0.3211642,\n",
       "                                       'iodine value': 0.14498943,\n",
       "                                       'ichnovirus': 0.13786261,\n",
       "                                       'inter-ventricular': 0.24712966,\n",
       "                                       'intra-vertebral': 0.22056827,\n",
       "                                       'intravenous injection device': 0.40647048,\n",
       "                                       'intervertebral': 0.16407934,\n",
       "                                       'initial visit': 0.121323556,\n",
       "                                       'intravenous feeding': 0.48463824,\n",
       "                                       'intra-vascular': 0.30131626,\n",
       "                                       'intra-ventricular': 0.27503523})}),\n",
       "             'There were no patients in either cohort of the primary trial with a PFS exceeding one year.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.13937844,\n",
       "                                       'pyrogen-free saline': 0.17718561,\n",
       "                                       'pressure-flow study': 0.06575645,\n",
       "                                       'posterior fossa syndrome': 0.1658156,\n",
       "                                       'pressure flow study': 0.058445692,\n",
       "                                       'primary fibromyalgia syndrome': 0.18447654,\n",
       "                                       'Piper Fatigue Scale': 0.064011656,\n",
       "                                       'patellofemoral syndrome': 0.14623205,\n",
       "                                       'Progression-free': 0.16106924,\n",
       "                                       'pulmonary function score': 0.15645291,\n",
       "                                       'pressure flow studies': 0.050942224,\n",
       "                                       'protein-free supernatant': 0.17422631,\n",
       "                                       'progression free survival': 0.2183155,\n",
       "                                       'protein free supernatant': 0.16348305,\n",
       "                                       'progression-free survival': 0.24951878,\n",
       "                                       'pressure/flow study': 0.056139678})}),\n",
       "             'the primary trial and the secondary trial both administer Zometa to their patients through IV, although in different doses.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.13028196,\n",
       "                                       'intravenous injection': 0.44381198,\n",
       "                                       'iridovirus': 0.15687746,\n",
       "                                       'intra-venous': 0.3366023,\n",
       "                                       'invitro': 0.16051911,\n",
       "                                       'intra ventricular': 0.19702435,\n",
       "                                       'intra vascular': 0.2802733,\n",
       "                                       'in vivo': 0.27703145,\n",
       "                                       'intravascular': 0.30463406,\n",
       "                                       'in-vivo': 0.34476748,\n",
       "                                       'inter-vertebral': 0.17013781,\n",
       "                                       'ichthyosis vulgaris': 0.08716015,\n",
       "                                       'intravenous': 0.4030843,\n",
       "                                       'intravaginal': 0.32639602,\n",
       "                                       'invasive': 0.055624377,\n",
       "                                       'iridescent virus': 0.09157054,\n",
       "                                       'isometric virus': 0.080611,\n",
       "                                       'intravenous feeding device': 0.32204202,\n",
       "                                       'invivo': 0.14451143,\n",
       "                                       'instrumental variable': 0.13403763,\n",
       "                                       'intraventricular': 0.16545312,\n",
       "                                       'intra-vaginal': 0.3483456,\n",
       "                                       'intravertebral': 0.14360423,\n",
       "                                       'in vitro': 0.2655202,\n",
       "                                       'interventricular': 0.16738601,\n",
       "                                       'in-vitro': 0.33677068,\n",
       "                                       'intra venous': 0.32440305,\n",
       "                                       'iodine value': 0.15994133,\n",
       "                                       'ichnovirus': 0.10434723,\n",
       "                                       'inter-ventricular': 0.20542583,\n",
       "                                       'intra-vertebral': 0.18292975,\n",
       "                                       'intravenous injection device': 0.41879848,\n",
       "                                       'intervertebral': 0.15526195,\n",
       "                                       'initial visit': 0.13698198,\n",
       "                                       'intravenous feeding': 0.33096537,\n",
       "                                       'intra-vascular': 0.28358775,\n",
       "                                       'intra-ventricular': 0.21484728})}),\n",
       "             'One patient in the primary trial had a 2.87 cm3 decrease in Total MRI Functional Tumor Volume (FTV) over 3 months.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MRI': defaultdict(float,\n",
       "                                      {'magnetic-resonance imaging': 0.35637546,\n",
       "                                       'MR-imaging': 0.47957712,\n",
       "                                       'magnetic resonance imaging': 0.3758427,\n",
       "                                       'magnetic resonance images': 0.3334622,\n",
       "                                       'magnetic resonance': 0.21989359,\n",
       "                                       'Magnetic resonance imagings': 0.40133965,\n",
       "                                       'magnet resonance imaging': 0.36398405,\n",
       "                                       'MR imaging': 0.5014144,\n",
       "                                       'magnetic-resonance-imaging': 0.3392915,\n",
       "                                       'magnetic resonance imagery': 0.28450543,\n",
       "                                       'Magnetic resonance imaging scan': 0.4413102,\n",
       "                                       'magnetic resonance tomography': 0.3891075,\n",
       "                                       'magnetic resonance image': 0.31045914,\n",
       "                                       'Magnetic resonance image': 0.31045914})}),\n",
       "             'Cohort 1 of the primary trial reported one case of AML.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'AML': defaultdict(float,\n",
       "                                      {'acute myelogenous leukemias': 0.55688876,\n",
       "                                       'acute myelogenous': 0.41739506,\n",
       "                                       'acute myeloblastic leukaemia': 0.49000823,\n",
       "                                       'amlodipine': 0.34346732,\n",
       "                                       'acute myeloid leukaemic': 0.44511163,\n",
       "                                       'acute myelogenous leukaemia': 0.48557845,\n",
       "                                       'Amlodipine': 0.34346732,\n",
       "                                       'acute myelogenous leukemia': 0.54647344,\n",
       "                                       'acute myeloid leukemia': 0.5615047,\n",
       "                                       'acute myeloid leukemic': 0.43105945,\n",
       "                                       'acute mucosal lesion': 0.32654285,\n",
       "                                       'acute myeloid leukaemias': 0.5063485,\n",
       "                                       'acute myelocytic leukemia': 0.53932,\n",
       "                                       'anterior mitral leaflet': 0.26411468,\n",
       "                                       'acute myeloid': 0.41990647,\n",
       "                                       'acute myelocytic leukaemia': 0.4848304,\n",
       "                                       'acute myeloid leukemias': 0.5735124,\n",
       "                                       'acute myeloid leukaemia': 0.49298525,\n",
       "                                       'acute myeloblastic leukemia': 0.5421677,\n",
       "                                       'anatomic medullary locking': 0.1421535,\n",
       "                                       'angiomyolipoma': 0.23071869,\n",
       "                                       'angio-myolipoma': 0.34240314,\n",
       "                                       'acute myeloblastic': 0.4066944})}),\n",
       "             'Patients with tumors underexpressing HER2 are excluded from the primary trial, but may be included in the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.3221266,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.3252983,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.32188937,\n",
       "                                       'human epidermal growth factor receptor 2': 0.31476244,\n",
       "                                       'human epidermal growth factor receptor-2': 0.3252983})}),\n",
       "             'the primary trial patients receive Trametinib, Akt Inhibitor GSK2141795 PO QD on days 1-28, up to a maximum of 8 cycles.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.15342206,\n",
       "                                       'parietal operculum': 0.0076484703,\n",
       "                                       'post office': 0.023810668,\n",
       "                                       'percentage of observed value': 0.05923855,\n",
       "                                       'Phenol oxidase': 0.08429005,\n",
       "                                       'parapineal organ': 0.060326587,\n",
       "                                       'power output': 0.023011291,\n",
       "                                       'predominant organism': -0.012255908,\n",
       "                                       'pulse-oximetry': 0.15044628,\n",
       "                                       'perceptual organisation': -0.050522204,\n",
       "                                       'power outputs': -0.009634967,\n",
       "                                       'Personality Organization': -0.056334645,\n",
       "                                       'postoperative': 0.10071094,\n",
       "                                       'parieto occipital': 0.024693586,\n",
       "                                       'polyolefin': 0.017668167,\n",
       "                                       'parietooccipital': -0.0037689884,\n",
       "                                       'poly-olefin': 0.010342751,\n",
       "                                       'peroral': 0.09345145,\n",
       "                                       'prostate only': 0.083747394,\n",
       "                                       'pressure overload': -0.001343025,\n",
       "                                       'peroxidase': 0.083765365,\n",
       "                                       'principal olive': -0.010724514,\n",
       "                                       'peri-operative': 0.065214284,\n",
       "                                       'posterior': 0.03782778,\n",
       "                                       'Perceptual Organization': -0.041497175,\n",
       "                                       'period of onset': 0.29094523,\n",
       "                                       'posterior nuclear group': 0.06758661,\n",
       "                                       'phenol oxidase': 0.08429005,\n",
       "                                       'pressure': -0.036717042,\n",
       "                                       'per os (by mouth)': 0.13747782,\n",
       "                                       'parieto-occipital': 0.0018381738,\n",
       "                                       'preoptic area': 0.03126883,\n",
       "                                       'perceptual organization': -0.041497175,\n",
       "                                       'prophylactic oophorectomy': 0.14695905,\n",
       "                                       'phosphodiester': 0.20377006,\n",
       "                                       'pre-ovulatory': 0.2512733,\n",
       "                                       'palm oil': -0.013372394,\n",
       "                                       'preovulatory': 0.1919991,\n",
       "                                       'perioperative': 0.11157262,\n",
       "                                       'post operative': 0.10091959,\n",
       "                                       'post-operative': 0.093698725,\n",
       "                                       'phospho-diester': 0.08064034,\n",
       "                                       'protein oxidation': 0.07904565,\n",
       "                                       'palm-oil': -0.035556126,\n",
       "                                       'per os': 0.14788003,\n",
       "                                       'pericardial organ': 0.088615365,\n",
       "                                       'Pulse oximetry': 0.15342206,\n",
       "                                       'paraoxon': 0.15336771,\n",
       "                                       'propylene oxide': 0.052943897,\n",
       "                                       'phenoloxidase': 0.11718788,\n",
       "                                       'peanut oil': 0.020342294}),\n",
       "                          'QD': defaultdict(float,\n",
       "                                      {'quinidine': 0.2855081,\n",
       "                                       'quaque die (every day)': 0.19975126,\n",
       "                                       'quaque die': 0.13315143,\n",
       "                                       'quinupristin-dalfopristin': 0.34154952,\n",
       "                                       'quater die': 0.1504773,\n",
       "                                       'quantum dot': 0.04324221,\n",
       "                                       'questionable dementia': 0.05303168})}),\n",
       "             'Abnormal LVEF, Pregnancy or lactating automatically eliminates patients from participating in the primary trial, unless treated with herbal medicines.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'LVEF': defaultdict(float,\n",
       "                                      {'left-ventricular ejection fraction': 0.21922813,\n",
       "                                       'Left ventricular ejection fractions': 0.23061308,\n",
       "                                       'left ventricular function': 0.20552059,\n",
       "                                       'left ventricular ejection fraction': 0.21787745,\n",
       "                                       'left ventricle ejection fraction': 0.22234783,\n",
       "                                       'left-ventricle ejection fraction': 0.21707183,\n",
       "                                       'LV ejection fraction': 0.23300405})}),\n",
       "             'None of the adverse events which occurred in the primary trial were not GI related.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'GI': defaultdict(float,\n",
       "                                      {'gyrification index': 0.09531802,\n",
       "                                       'Glucagon immunoreactivity': 0.2071304,\n",
       "                                       'Gingival inflammation': 0.11529893,\n",
       "                                       'growth index': -0.037143316,\n",
       "                                       'growth inhibition': 0.11356436,\n",
       "                                       'guided imagery': -0.026146527,\n",
       "                                       'gastrointestinal tract': 0.18948467,\n",
       "                                       'genomic island': 0.06259977,\n",
       "                                       'gastrointestinal': 0.21745175,\n",
       "                                       'glass ionomer cement': 0.022521457,\n",
       "                                       'gastrointestinal illness': 0.19394617,\n",
       "                                       'germination index': 0.024678744,\n",
       "                                       'global ischaemia': 0.18608737,\n",
       "                                       'global ischemia': 0.1430689,\n",
       "                                       'galvanic isolation': 0.050242882,\n",
       "                                       'gait-initiation': 0.057870768,\n",
       "                                       'gastro-intestinal illness': 0.21680422,\n",
       "                                       'gastroenterology': 0.20949563,\n",
       "                                       'gastro-intestinal': 0.2169963,\n",
       "                                       'glycaemic indices': 0.18392114,\n",
       "                                       'glossopharyngeal insufflation': 0.12710655,\n",
       "                                       'gingival indices': 0.09931457,\n",
       "                                       'gingival index': 0.083673395,\n",
       "                                       'gastro intestinal': 0.20505887,\n",
       "                                       'glucose intolerance': 0.20075274,\n",
       "                                       'gastroenterologist': 0.17203738,\n",
       "                                       'glucose-inhibited': 0.26123378,\n",
       "                                       'GIGANTEA': 0.059634104,\n",
       "                                       'gigantocellular reticular nucleus': 0.074105196,\n",
       "                                       'gait initiation': 0.050578184,\n",
       "                                       'glycemic index': 0.15442207,\n",
       "                                       'glass ionomer': 0.027354434,\n",
       "                                       'genogroup I': 0.087713376,\n",
       "                                       'genogroup 1': 0.10221598,\n",
       "                                       'gingival inflammation': 0.11529893,\n",
       "                                       'Great Island': 0.020526687,\n",
       "                                       'gastro-enterology': 0.18473555,\n",
       "                                       'Group I': -0.025031457,\n",
       "                                       'Glass ionomer': 0.027354434,\n",
       "                                       'glycaemic index': 0.1739619,\n",
       "                                       'giant interneuron': 0.004703118,\n",
       "                                       'glass-ionomer': 0.014801892,\n",
       "                                       'genomic instability': 0.078167565})}),\n",
       "             'The Triple-Negative Breast Cancer cohort of the primary trial had a much lower ORR than the HR+/HER2- cohort.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ORR': defaultdict(float,\n",
       "                                      {'oxygen-reduction reaction': 0.17066152,\n",
       "                                       'overall response rate': 0.26460442,\n",
       "                                       'objective response rate': 0.23907349,\n",
       "                                       'oxygen reduction reaction': 0.17493813}),\n",
       "                          'HR': defaultdict(float,\n",
       "                                      {'homing receptors': 0.020053525,\n",
       "                                       'hypersensitive response': 0.07336218,\n",
       "                                       'hyperpolarizing response': -0.016905354,\n",
       "                                       'high-resolution': -0.048018355,\n",
       "                                       'Hoffmann reflex': 0.06069222,\n",
       "                                       'hypersensitive reaction': 0.060755566,\n",
       "                                       'high-resistance': 0.05996669,\n",
       "                                       'homing receptor': 0.04240129,\n",
       "                                       'Hazard ratios': 0.19817387,\n",
       "                                       'heart-rate': 0.08556952,\n",
       "                                       'high risk': 0.06250241,\n",
       "                                       'heptad repeat': 0.018969376,\n",
       "                                       'hydroxyethylrutoside': 0.031067643,\n",
       "                                       'histamine release': 0.025731709,\n",
       "                                       'hepatic resection': 0.069016084,\n",
       "                                       'heart': 0.03867519,\n",
       "                                       'high responders to novelty': 0.121764235,\n",
       "                                       'homologous region': -0.011835887,\n",
       "                                       'High Resolution': -0.05793659,\n",
       "                                       'heavy rough': -0.026765857,\n",
       "                                       'high responders': 0.14181404,\n",
       "                                       'heat-resistant': 0.0034186945,\n",
       "                                       'Hybrid resistance': 0.104911365,\n",
       "                                       'hazards ratio': 0.19055724,\n",
       "                                       'homologous recombination': 0.039901964,\n",
       "                                       'hazard rate': 0.16785087,\n",
       "                                       'heparin releasable': 0.10939152,\n",
       "                                       'host range': 0.0073250313,\n",
       "                                       'hyperpolarising response': 0.019371033,\n",
       "                                       'high responder': 0.11164647,\n",
       "                                       'high resolution': -0.05793659,\n",
       "                                       'high-risk': 0.08296,\n",
       "                                       'hazard ratio': 0.1751099,\n",
       "                                       'highrisk': 0.008372807,\n",
       "                                       'heparin-releasable': 0.111535855,\n",
       "                                       'heart rates': 0.06993614,\n",
       "                                       'heartrate': 0.062593386,\n",
       "                                       'hairless gene': 0.11319218,\n",
       "                                       'halorhodopsin': 0.042402167,\n",
       "                                       'heart rate': 0.059824504,\n",
       "                                       'hybrid resistance': 0.104911365,\n",
       "                                       'hairless': 0.07205889,\n",
       "                                       'hormone receptor': 0.18158601,\n",
       "                                       'human resource': 0.040520635,\n",
       "                                       'high-responder': 0.100768164})}),\n",
       "             'Patients must have eceptorsestrogen receptor (ER) -, progesterone receptor (PR) - and human epidermal growth factor receptor 2 (HER2) - non metastatic breast cancer, aswell as not having Dysphagia.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ER': defaultdict(float,\n",
       "                                      {'extinction-ratio': 0.00657324,\n",
       "                                       'equivalent rontgen': 0.05486884,\n",
       "                                       'endo-plasmic reticulum': 0.07087569,\n",
       "                                       'emergency room': 0.10174262,\n",
       "                                       'estrogen receptor-alpha': 0.4854908,\n",
       "                                       'environmental resistance': -0.05560829,\n",
       "                                       'erythrocyte receptor': 0.25776538,\n",
       "                                       'estradiol receptor': 0.448459,\n",
       "                                       'extended-release': 0.11456968,\n",
       "                                       'energy restriction': 0.09553337,\n",
       "                                       'energy-restricted': 0.12627709,\n",
       "                                       'estrogen-receptor': 0.48250818,\n",
       "                                       'energy retention': -0.038062613,\n",
       "                                       'electrorheological': 0.08764326,\n",
       "                                       'ejection rate': 0.096209526,\n",
       "                                       'external resistance': 0.011921497,\n",
       "                                       'Estrogen receptor alpha': 0.45389366,\n",
       "                                       'estrogen receptor': 0.47301444,\n",
       "                                       'early': -0.028138788,\n",
       "                                       'endoplasmatic reticulum': 0.09490097,\n",
       "                                       'Estradiol': 0.33065972,\n",
       "                                       'expiratory reserve': 0.19873127,\n",
       "                                       'endovascular repair': 0.14151236,\n",
       "                                       'Emergency Room': 0.10174262,\n",
       "                                       'early reticulocyte': 0.094269514,\n",
       "                                       'esophageal rupture': 0.13170539,\n",
       "                                       'Estrogen receptors': 0.44401515,\n",
       "                                       'evoked responses': 0.15554471,\n",
       "                                       'estrogen receptor protein': 0.42891952,\n",
       "                                       'erythromycin': 0.22257501,\n",
       "                                       'enhancement ratios': 0.10061262,\n",
       "                                       'equine rhinopneumonia': 0.094666034,\n",
       "                                       'eye research': 0.11238448,\n",
       "                                       'extinction ratio': 0.010448615,\n",
       "                                       'equivalent roentgen': 0.09912961,\n",
       "                                       'emotion regulation': 0.05638805,\n",
       "                                       'enhancement ratio': 0.102862924,\n",
       "                                       'estrogen receptor status': 0.52342063,\n",
       "                                       'early repolarization': 0.16655327,\n",
       "                                       'early repolarisation': 0.15772751,\n",
       "                                       'electrical resistance': -0.009178565,\n",
       "                                       'evoked response': 0.15701698,\n",
       "                                       'efficacy ratio': 0.15969631,\n",
       "                                       'estrogen': 0.29024604,\n",
       "                                       'endoplasmic reticular': 0.12862399,\n",
       "                                       'extraction ratio': 0.10861362,\n",
       "                                       'extended release': 0.09259806,\n",
       "                                       'external rotation': -0.0034177764,\n",
       "                                       'epigastric region': 0.24840865,\n",
       "                                       'endoscopic resection': 0.20231743,\n",
       "                                       'ethoxyresorufin': 0.19649394,\n",
       "                                       'electro-resection': 0.21039125,\n",
       "                                       'early response': 0.14581569,\n",
       "                                       'endoplasmic reticulum': 0.08748718,\n",
       "                                       'enhanced reactivation': 0.10160322,\n",
       "                                       'electroresection': 0.1503797}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.2549656,\n",
       "                                       'plaque reduction': 0.06575359,\n",
       "                                       'partial response': 0.15027267,\n",
       "                                       'photoreactivation': -0.025979422,\n",
       "                                       'pentoxyresorufin': 0.123028055,\n",
       "                                       'panoramic radiography': 0.121477164,\n",
       "                                       'proliferative retinopathy': 0.111629166,\n",
       "                                       'partial responses': 0.15722348,\n",
       "                                       'protein': 0.005309419,\n",
       "                                       'prorennin': 0.11356177,\n",
       "                                       'prevalence rate': 0.20551,\n",
       "                                       'prealbumin': 0.1287866,\n",
       "                                       'pregnancy rates': 0.007128008,\n",
       "                                       'pain relief': 0.16928937,\n",
       "                                       'partial remissions': 0.40532884,\n",
       "                                       'pattern recognition': -0.0873199,\n",
       "                                       'photo-reactivation': -0.016149385,\n",
       "                                       'protein restriction': 0.14046441,\n",
       "                                       'progesterone receptor': 0.40838358,\n",
       "                                       'placental restriction': 0.23533086,\n",
       "                                       'pneumatic retinopexy': 0.21955065,\n",
       "                                       'prorenin': 0.19341587,\n",
       "                                       'perirhinal cortex': 0.07501897,\n",
       "                                       'prothrombin ratio': 0.12588334,\n",
       "                                       'pars recta': 0.059835583,\n",
       "                                       'pattern reversal': -0.024511272,\n",
       "                                       'pr interval (ekg)': 0.16550161,\n",
       "                                       'pityriasis rosea': 0.06904543,\n",
       "                                       'prevalence ratio': 0.23079276,\n",
       "                                       'Projection reconstruction': -0.03443679,\n",
       "                                       'pregnancy rate': 0.011536101,\n",
       "                                       'phenol red': 0.15264724,\n",
       "                                       'photoreceptor': 0.00660934,\n",
       "                                       'prednisolon': 0.24510135,\n",
       "                                       'partial responders': 0.18850352,\n",
       "                                       'proline-rich': 0.098193,\n",
       "                                       'pseudorabies': 0.10581106,\n",
       "                                       'pulmonary regurgitation': 0.2145188,\n",
       "                                       'projection reconstruction': -0.03443679,\n",
       "                                       'photo-receptor': 0.12039412,\n",
       "                                       'protease': 0.0684384,\n",
       "                                       'progestine': 0.2596292,\n",
       "                                       'pentoxy-resorufin': 0.12972014,\n",
       "                                       'partial remission': 0.35689005,\n",
       "                                       'progestin receptor': 0.37105706,\n",
       "                                       'per rectum': 0.10113826,\n",
       "                                       'Plain radiography': 0.1610705,\n",
       "                                       'production rate': -0.04798643,\n",
       "                                       'pulmonary rehabilitation': 0.15980054,\n",
       "                                       'pentoxy resorufin': 0.13739769,\n",
       "                                       'proteinase': 0.033752795,\n",
       "                                       'Paeoniae radix': 0.122133836,\n",
       "                                       'Puerto Rico': -0.013193316,\n",
       "                                       'Prevalence ratios': 0.21575095,\n",
       "                                       'perirenal': 0.060013134,\n",
       "                                       'passive recovery': 0.024742575,\n",
       "                                       'propranolol': 0.22464405,\n",
       "                                       'primary response': 0.12657088,\n",
       "                                       'pregnant': 0.012831696,\n",
       "                                       'partial regression': 0.027565977,\n",
       "                                       'Photoreactivation': -0.025979422,\n",
       "                                       'peripheral resistance': 0.11290991,\n",
       "                                       'polymorphic reticulosis': 0.122806326,\n",
       "                                       'progressive ratio': 0.05815126,\n",
       "                                       'partial responder': 0.16315325,\n",
       "                                       'projection-reconstruction': -0.026791347,\n",
       "                                       'pro-renin': 0.12869832,\n",
       "                                       'phenol-red': 0.16759597,\n",
       "                                       'progestin': 0.2536712,\n",
       "                                       'pro-rennin': 0.0604989}),\n",
       "                          'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.3570221,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.35802075,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.3556946,\n",
       "                                       'human epidermal growth factor receptor 2': 0.3520108,\n",
       "                                       'human epidermal growth factor receptor-2': 0.35802075})}),\n",
       "             'the primary trial results show that Participants receiving lapatinib 1500 milligrams (mg) orally were twice as likely to achieve DFS at 5 years than placebo patients.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DFS': defaultdict(float,\n",
       "                                      {'Defensive Functioning Scale': 0.19100404,\n",
       "                                       'Disease free survival': 0.33524904,\n",
       "                                       'decayed and filled tooth surfaces': 0.04269244,\n",
       "                                       'dysplasia of the fibrous sheath': 0.21508378,\n",
       "                                       'diclofenac-sodium': 0.18336077,\n",
       "                                       'disease-free survivals': 0.32145992,\n",
       "                                       'diclofenac sodium': 0.17549802,\n",
       "                                       'deoxyfructoserotonin': 0.1637965,\n",
       "                                       'Disease-free': 0.2149552,\n",
       "                                       'dental fear survey': 0.06360929,\n",
       "                                       'disease-free survival': 0.3677446,\n",
       "                                       'deoxyfructo-serotonin': 0.2465941,\n",
       "                                       'Dental Fear Survey': 0.06360929,\n",
       "                                       'disease free survival': 0.33524904,\n",
       "                                       'dental fear scale': 0.1028822,\n",
       "                                       'decayed or filled surfaces': -0.008369515,\n",
       "                                       'diabetic foot syndrome': 0.20203154,\n",
       "                                       'desoxyfructosylserotonin': 0.14774004,\n",
       "                                       'desoxyfructo-serotonin': 0.24443644})}),\n",
       "             'There were twice as many patients with DLT in cohort 2 of the primary trial than in cohort 1.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DLT': defaultdict(float,\n",
       "                                      {'double-lung transplantation': 0.3166137,\n",
       "                                       'direct linear transformation': 0.040606484,\n",
       "                                       'double lumen tube': 0.22826217,\n",
       "                                       'double-lumen tube': 0.22403958,\n",
       "                                       'dose limiting toxicity': 0.19492015,\n",
       "                                       'dose-limiting toxicity': 0.19206005,\n",
       "                                       'donor leukocyte transfusion': 0.16142896,\n",
       "                                       'double-lumen endobronchial tube': 0.24813783,\n",
       "                                       'double lumen endotracheal tube': 0.26351914,\n",
       "                                       'double lung transplantation': 0.32628077,\n",
       "                                       'double-lumen endotracheal tube': 0.24773443})}),\n",
       "             'The difference in median, maximum and minimum Overall Survival (OS) of Patients between the two cohort of the primary trial was less than one month.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'OS': defaultdict(float,\n",
       "                                      {'oculus sinister': -0.019230258,\n",
       "                                       'opposite-sex': 0.041220877,\n",
       "                                       'open surgery': 0.17808956,\n",
       "                                       'over-shoot': 0.035933465,\n",
       "                                       'oxi-dative stress': 0.041560218,\n",
       "                                       'oligosaccharides': 0.09861724,\n",
       "                                       'orthopedic surgery': 0.16930419,\n",
       "                                       'overshoot': 0.058018245,\n",
       "                                       'open splenectomy': 0.17812641,\n",
       "                                       'ovarian stimulation': 0.17929676,\n",
       "                                       'over shoot': 0.06962462,\n",
       "                                       'obese strain': 0.038971666,\n",
       "                                       'Opitz syndrome': 0.14405216,\n",
       "                                       'outer segments': 0.06336229,\n",
       "                                       'ouabain-sensitive': 0.1230312,\n",
       "                                       'osteosarcoma': 0.2535137,\n",
       "                                       'oxidative stress': 0.102323174,\n",
       "                                       'overall survival time': 0.465609,\n",
       "                                       'osteosarcomas': 0.23581117,\n",
       "                                       'oculus sinister (left eye)': 0.03789144,\n",
       "                                       'overlap syndrome': 0.10458337,\n",
       "                                       'outer segment': 0.090448156,\n",
       "                                       'oligomycin-sensitive': 0.13287674,\n",
       "                                       'oxidative-stress': 0.13654053,\n",
       "                                       'oral secretion': -0.016786292,\n",
       "                                       'oligosaccharide': 0.10998378,\n",
       "                                       'overall survival rate': 0.51957893,\n",
       "                                       'Omenn syndrome': 0.06914523,\n",
       "                                       'osteogenic sarcoma': 0.19232038,\n",
       "                                       \"Omenn's syndrome\": 0.08510243,\n",
       "                                       'one-step': 0.102451734,\n",
       "                                       'oligo-saccharide': 0.112556964,\n",
       "                                       'Ocimum sanctum': 0.09911146,\n",
       "                                       'overall survival': 0.374715,\n",
       "                                       'One-Step': 0.102451734,\n",
       "                                       'oxydative stress': 0.09339415})}),\n",
       "             'the primary trial results indicate that CoQ10 reduces the PFS of breast cancer patients compared to a placebo by about 8%': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.0629366,\n",
       "                                       'pyrogen-free saline': 0.20820765,\n",
       "                                       'pressure-flow study': -0.049625207,\n",
       "                                       'posterior fossa syndrome': 0.08992412,\n",
       "                                       'pressure flow study': -0.036336403,\n",
       "                                       'primary fibromyalgia syndrome': 0.13363937,\n",
       "                                       'Piper Fatigue Scale': 0.16338073,\n",
       "                                       'patellofemoral syndrome': 0.05562579,\n",
       "                                       'Progression-free': 0.06700251,\n",
       "                                       'pulmonary function score': 0.21508811,\n",
       "                                       'pressure flow studies': -0.03232547,\n",
       "                                       'protein-free supernatant': 0.16391958,\n",
       "                                       'progression free survival': 0.25941265,\n",
       "                                       'protein free supernatant': 0.1743765,\n",
       "                                       'progression-free survival': 0.27992362,\n",
       "                                       'pressure/flow study': -0.024273183})}),\n",
       "             '2 patients in the primary trial suffer from DVT, 0 in the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DVT': defaultdict(float,\n",
       "                                      {'deep venous thromboses': 0.40707815,\n",
       "                                       'deep venous thrombophlebitis': 0.4448573,\n",
       "                                       'deep vein thrombophlebitis': 0.46637148,\n",
       "                                       'deep venous thrombosis': 0.4241365,\n",
       "                                       'deep vein thromboses': 0.46927527,\n",
       "                                       'deep-vein thrombosis': 0.47045287,\n",
       "                                       'deep vein thrombosis': 0.47734645,\n",
       "                                       'deep-venous thrombosis': 0.43363586})}),\n",
       "             'All participants in the primary trial had a Central Nervous System (CNS) Progression Free Survival (PFS) >= 16 weeks.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CNS': defaultdict(float,\n",
       "                                      {'central nerve system': 0.35280967,\n",
       "                                       'Congenital nephrotic syndrome': 0.10743593,\n",
       "                                       'Coagulase negative staphylococci': 0.040057875,\n",
       "                                       'Clinical nurse specialist': 0.18970567,\n",
       "                                       'coagulase negative staphylococcus': 0.048350636,\n",
       "                                       'coagulase-negative Staphylococcus': 0.06539256,\n",
       "                                       'central nerves system': 0.32377568,\n",
       "                                       'central-nervous-system': 0.32812443,\n",
       "                                       'congenital nephrotic syndrome': 0.10743593,\n",
       "                                       'central nervous system': 0.3453113,\n",
       "                                       'central nervous systems': 0.33424988,\n",
       "                                       'Crigler Najjar syndrome': 0.14340699,\n",
       "                                       'coagulase negative staph': 0.05339247,\n",
       "                                       'clinical nurse specialists': 0.2052162,\n",
       "                                       'Crigler-Najjar syndrome': 0.14577848,\n",
       "                                       'coagulase-negative staphylococci': 0.05001111,\n",
       "                                       'coagulase-negative staphylococcus': 0.06539256,\n",
       "                                       'central nervous': 0.3304823,\n",
       "                                       'clinical nurse specialist': 0.18970567,\n",
       "                                       'Canadian Neurological Scale': 0.39585358,\n",
       "                                       'coagulase-negative staphylococcal': 0.10578717,\n",
       "                                       'coagulase negative Staphylococcus': 0.048350636}),\n",
       "                          'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.06176267,\n",
       "                                       'pyrogen-free saline': 0.12543689,\n",
       "                                       'pressure-flow study': -0.04113639,\n",
       "                                       'posterior fossa syndrome': 0.16021201,\n",
       "                                       'pressure flow study': -0.020055521,\n",
       "                                       'primary fibromyalgia syndrome': 0.23488773,\n",
       "                                       'Piper Fatigue Scale': 0.18338196,\n",
       "                                       'patellofemoral syndrome': 0.08300931,\n",
       "                                       'Progression-free': 0.25706464,\n",
       "                                       'pulmonary function score': 0.23884837,\n",
       "                                       'pressure flow studies': -0.043659918,\n",
       "                                       'protein-free supernatant': 0.114403754,\n",
       "                                       'progression free survival': 0.53772485,\n",
       "                                       'protein free supernatant': 0.12675656,\n",
       "                                       'progression-free survival': 0.56433046,\n",
       "                                       'pressure/flow study': -0.004291143})}),\n",
       "             'Cohort 2 subjects of the primary trial receive 3.25 mg of vaginal DHEA gel QD more than cohort 1 subjects, of the two cohorts in the secondary trial only the cohort without pain recieves Duloxetine 30 mg daily.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DHEA': defaultdict(float,\n",
       "                                      {'dehydroepiandrosterone': 0.32052395,\n",
       "                                       'dehydroepi-androsterone': 0.27628556,\n",
       "                                       'dihydroepiandrosterone': 0.32142863,\n",
       "                                       'dehydro-epiandrosterone': 0.33050203}),\n",
       "                          'QD': defaultdict(float,\n",
       "                                      {'quinidine': 0.37114015,\n",
       "                                       'quaque die (every day)': 0.16242824,\n",
       "                                       'quaque die': 0.1801066,\n",
       "                                       'quinupristin-dalfopristin': 0.36961246,\n",
       "                                       'quater die': 0.20360126,\n",
       "                                       'quantum dot': 0.11154322,\n",
       "                                       'questionable dementia': 0.13117911})}),\n",
       "             'There were no MRSA infections in either the secondary trial or the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MRSA': defaultdict(float,\n",
       "                                      {'meticillin resistant Staphylococcus aureus': 0.3627542,\n",
       "                                       'Methicillin-resistant Staphylococcus aureus': 0.39785263,\n",
       "                                       'methicillin resistant Staphylococcus aureus': 0.37325177,\n",
       "                                       'Methicillin-resistant Staphylococcus aureus strains': 0.36011252,\n",
       "                                       'methicillin-resistant strains': 0.28972983,\n",
       "                                       'methicillin resistant staphylococcus aureus': 0.37325177,\n",
       "                                       'Methicillin-resistant S aureus': 0.38928765,\n",
       "                                       'meticillin-resistant Staphylococcus aureus': 0.3912776,\n",
       "                                       'methicillin-resistant Staphylococcus aureus': 0.39785263,\n",
       "                                       'methicillin resistant': 0.24332228,\n",
       "                                       'methicillin-resistant': 0.29464298})}),\n",
       "             'In the primary trial The Percentage of Participants With Objective Response (OR) for the Afatinib Monotherapy was 18% lower than the Afatinib and Paclitaxel or Vinorelbine Combination Therapy group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'OR': defaultdict(float,\n",
       "                                      {'overall response': 0.31487876,\n",
       "                                       'objective response': 0.35345608,\n",
       "                                       'odds ratio': 0.3093451,\n",
       "                                       'open repair': 0.08938237,\n",
       "                                       'ovulation rate': 0.18000096,\n",
       "                                       'odds ration': 0.23983736,\n",
       "                                       'operating room': 0.064899825,\n",
       "                                       'oxido-reductase': 0.16684805,\n",
       "                                       'obesity-resistant': 0.07688936,\n",
       "                                       'ouabain-resistant': 0.22378781,\n",
       "                                       'objective responses': 0.29897892,\n",
       "                                       'orienting reflex': 0.07813462,\n",
       "                                       'operations research': 0.11910597,\n",
       "                                       'opioid receptor': 0.13788457,\n",
       "                                       'odds-ratio': 0.311873,\n",
       "                                       'orienting response': 0.19263305,\n",
       "                                       'odorant receptor': 0.059437703,\n",
       "                                       'operating rooms': 0.060539935,\n",
       "                                       'oxidoreductase': 0.13326472,\n",
       "                                       'oestrogen receptor': 0.16577554,\n",
       "                                       'optic radiation': 0.057692394,\n",
       "                                       'oxido reductase': 0.16652627,\n",
       "                                       'optical rotation': 0.04842732,\n",
       "                                       'orthopedic research': 0.11549866,\n",
       "                                       'odds ratios': 0.30404648,\n",
       "                                       'oral rehydration': 0.06205142,\n",
       "                                       'operating-room': 0.088045456,\n",
       "                                       'olfactory receptor': 0.06728299,\n",
       "                                       'outflow resistance': 0.09007605,\n",
       "                                       'Oregon': 0.071166866,\n",
       "                                       'oestrogen-receptor': 0.15341395})}),\n",
       "             'Adult Patients with Histologically proven HER2- infiltrating breast cancer that have had a Previous lumpectomy or same side mammary reduction are excluded from both the secondary trial and the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.23198947,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.22922324,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.23313567,\n",
       "                                       'human epidermal growth factor receptor 2': 0.2277042,\n",
       "                                       'human epidermal growth factor receptor-2': 0.22922324})}),\n",
       "             'the primary trial do not receive any intervention by IV, orally or by surgery during the study.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.14635791,\n",
       "                                       'intravenous injection': 0.31686223,\n",
       "                                       'iridovirus': 0.13052079,\n",
       "                                       'intra-venous': 0.3063209,\n",
       "                                       'invitro': 0.06573793,\n",
       "                                       'intra ventricular': 0.1646232,\n",
       "                                       'intra vascular': 0.27856255,\n",
       "                                       'in vivo': 0.27272114,\n",
       "                                       'intravascular': 0.29236653,\n",
       "                                       'in-vivo': 0.3146793,\n",
       "                                       'inter-vertebral': 0.21527348,\n",
       "                                       'ichthyosis vulgaris': 0.12845042,\n",
       "                                       'intravenous': 0.3722124,\n",
       "                                       'intravaginal': 0.2278223,\n",
       "                                       'invasive': 0.05660455,\n",
       "                                       'iridescent virus': 0.07957129,\n",
       "                                       'isometric virus': 0.12782435,\n",
       "                                       'intravenous feeding device': 0.2639898,\n",
       "                                       'invivo': 0.049645577,\n",
       "                                       'instrumental variable': 0.044478863,\n",
       "                                       'intraventricular': 0.17068169,\n",
       "                                       'intra-vaginal': 0.25524908,\n",
       "                                       'intravertebral': 0.22271657,\n",
       "                                       'in vitro': 0.21743402,\n",
       "                                       'interventricular': 0.163883,\n",
       "                                       'in-vitro': 0.26982448,\n",
       "                                       'intra venous': 0.2713354,\n",
       "                                       'iodine value': 0.03715476,\n",
       "                                       'ichnovirus': 0.08561804,\n",
       "                                       'inter-ventricular': 0.18296053,\n",
       "                                       'intra-vertebral': 0.24036504,\n",
       "                                       'intravenous injection device': 0.27064037,\n",
       "                                       'intervertebral': 0.21932454,\n",
       "                                       'initial visit': 0.036263358,\n",
       "                                       'intravenous feeding': 0.29675287,\n",
       "                                       'intra-vascular': 0.30107468,\n",
       "                                       'intra-ventricular': 0.19562843})}),\n",
       "             'the primary trial and the secondary trial interventions involve a variety of scans, such as CT, PET and dosimetry ': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CT': defaultdict(float,\n",
       "                                      {'condensed tannin': 0.036826294,\n",
       "                                       'crista terminalis': 0.11666289,\n",
       "                                       'chlamydia': 0.028605748,\n",
       "                                       'chronic tonsillitis': 0.11155599,\n",
       "                                       'computed-tomographic': 0.33204728,\n",
       "                                       'computed tomogram': 0.2930062,\n",
       "                                       'coal-tar': -0.008185746,\n",
       "                                       'calf thymus': 0.18314469,\n",
       "                                       'curly tail': -0.04595151,\n",
       "                                       'condensed tannins': 0.049713008,\n",
       "                                       'computerised tomograph': 0.23736404,\n",
       "                                       'counter-transference': 0.0526782,\n",
       "                                       'cardiothoracic': 0.1837628,\n",
       "                                       'choroidal thickness': 0.15138137,\n",
       "                                       'core temperature': -0.003150601,\n",
       "                                       'collecting tubule': 0.093781985,\n",
       "                                       'C-terminal': 0.09813691,\n",
       "                                       'cytotrophoblast': 0.062350735,\n",
       "                                       'cytoplasmic domain': 0.005020175,\n",
       "                                       'chest tube': 0.17732139,\n",
       "                                       'computerised tomographic': 0.2807222,\n",
       "                                       'clotting time': 0.1381361,\n",
       "                                       'carbon tetra-chloride': 0.027302291,\n",
       "                                       'charge transport': -0.055640496,\n",
       "                                       'chemo-therapy': 0.3280828,\n",
       "                                       'circadian times': 0.07392369,\n",
       "                                       'cytidylyl-transferase': 0.07822744,\n",
       "                                       'charge transfer': -0.00057674106,\n",
       "                                       'cognitive therapy': 0.28389558,\n",
       "                                       'computertomography': 0.23197705,\n",
       "                                       'celiac trunc': 0.040674485,\n",
       "                                       'computerised tomography': 0.33037397,\n",
       "                                       'chronic thyroiditis': 0.19145006,\n",
       "                                       'crico-thyroid': 0.17477077,\n",
       "                                       'carbon tetra chloride': 0.023934474,\n",
       "                                       'contraction time': 0.05707437,\n",
       "                                       'Cardiac transplantation': 0.16693383,\n",
       "                                       'clinical trial': 0.5316804,\n",
       "                                       'central tendon': 0.14900874,\n",
       "                                       'cortical thickness': 0.20337129,\n",
       "                                       'conventional tillage': 0.051379096,\n",
       "                                       'carboxylterminus': 0.0120695485,\n",
       "                                       'catalase': -0.039462257,\n",
       "                                       'circadian time': 0.06715541,\n",
       "                                       'concentration': 0.13524131,\n",
       "                                       'conservative treatment': 0.2874584,\n",
       "                                       'CTP': 0.16692507,\n",
       "                                       'corneal thickness': 0.05002128,\n",
       "                                       'critical thinking': 0.11362754,\n",
       "                                       'celiac trunk': 0.03303553,\n",
       "                                       'charge-transfer': 0.011150061,\n",
       "                                       'cytoplasmic tail': -0.032696106,\n",
       "                                       'countertransference': 0.058155715,\n",
       "                                       'computed tomographies': 0.38219768,\n",
       "                                       'code treatment time': 0.2296187,\n",
       "                                       'cellulose-triacetate': -0.019597802,\n",
       "                                       'conventional treatment': 0.35008943,\n",
       "                                       'corticothalamic': 0.123679936,\n",
       "                                       'carcinoid tumor': 0.1995109,\n",
       "                                       'coeliac trunk': 0.14268011,\n",
       "                                       'chloramine-T': 0.16454177,\n",
       "                                       'carbontetrachloride': 0.069567025,\n",
       "                                       'cricothyroid muscle': 0.12756519,\n",
       "                                       'cerebral toxoplasmosis': 0.09733274,\n",
       "                                       'computerized tomography': 0.3106415,\n",
       "                                       'cervicothoracic': 0.13338047,\n",
       "                                       'computed tomography scan': 0.45186687,\n",
       "                                       'carboxyl-terminus': 0.04527883,\n",
       "                                       'Computer-Tomography': 0.2605915,\n",
       "                                       'corticotectal': 0.09619965,\n",
       "                                       'computerised tomogram': 0.17763488,\n",
       "                                       'computerized tomographic': 0.27077368,\n",
       "                                       'chemotherapy': 0.2752383,\n",
       "                                       'Cholera enterotoxin': -0.015473081,\n",
       "                                       'Catalase': -0.039462257,\n",
       "                                       'carbon tetrachloride': 0.104699545,\n",
       "                                       'choleratoxin': 0.0007713028,\n",
       "                                       'computed tomography': 0.39806333,\n",
       "                                       'cholera toxin': 0.05867018,\n",
       "                                       'chorda tympani': 0.022104343,\n",
       "                                       'carcinoid tumour': 0.1728182,\n",
       "                                       'conventional therapy': 0.32980895,\n",
       "                                       'cold test': 0.1742223,\n",
       "                                       'cortico-thalamic': 0.17044266,\n",
       "                                       'conditioning-test': 0.12006217,\n",
       "                                       'chorda tympani nerve': 0.105346695,\n",
       "                                       'computed tomographic scans': 0.46196872,\n",
       "                                       'cyto-toxic': 0.08854882,\n",
       "                                       'cardio-thoracic': 0.27222344,\n",
       "                                       'calcitonin': 0.18940622,\n",
       "                                       'chloramine T': 0.12305763,\n",
       "                                       'cycle threshold': 0.117879465,\n",
       "                                       'cytotoxic': 0.11192485,\n",
       "                                       'carboxyl terminal': 0.05190159,\n",
       "                                       'coeliac trunc': 0.11134925,\n",
       "                                       'closure time': -8.265488e-05,\n",
       "                                       'cancer/testis': 0.14763089,\n",
       "                                       'connective tissue': 0.17439255,\n",
       "                                       'cellulose triacetate': -0.03499899,\n",
       "                                       'Computed-tomography': 0.3971741,\n",
       "                                       'control': 0.047474515,\n",
       "                                       'computerized tomogram': 0.16372687,\n",
       "                                       'counseling and testing': 0.32066372,\n",
       "                                       'carboxyl-terminal': 0.07623935,\n",
       "                                       'cricothyroid': 0.14084074,\n",
       "                                       'Cerebral toxoplasmosis': 0.09733274,\n",
       "                                       'computed-tomography': 0.3971741,\n",
       "                                       'chest-tube': 0.2037154,\n",
       "                                       'carboxyl terminus': 0.027317902,\n",
       "                                       'counter-transport': 0.0580998,\n",
       "                                       'cancer-testis': 0.15087992,\n",
       "                                       'countertransport': 0.03162365,\n",
       "                                       'corticosterone': 0.17677794,\n",
       "                                       'compliance': 0.084810294,\n",
       "                                       'Computed tomographic scanning': 0.3864581,\n",
       "                                       'Connecticut': 0.02457909,\n",
       "                                       'computed tomography scans': 0.4848212,\n",
       "                                       'cardiac transplantation': 0.16693383,\n",
       "                                       'computed tomography scanning': 0.4279518,\n",
       "                                       'computed tomograpy': 0.41500214,\n",
       "                                       'computed tomograph': 0.30723464,\n",
       "                                       'coal tar': 0.0014748834,\n",
       "                                       'chloramin-T': 0.1819344,\n",
       "                                       'Computed tomographic scan': 0.42366135,\n",
       "                                       'computerized tomograms': 0.16669062,\n",
       "                                       'control group': 0.20462924,\n",
       "                                       'chymotrypsin': 0.040349614,\n",
       "                                       'carboxylterminal': 0.09745857,\n",
       "                                       'congenital Toxoplasmosis': -0.012556693,\n",
       "                                       'cellulose-tri-acetate': -0.001997903,\n",
       "                                       'Computed tomograms': 0.33556724,\n",
       "                                       'conduction time': -0.008517923,\n",
       "                                       'computerized tomograph': 0.22801101,\n",
       "                                       'Chlamydia trachomatis': 0.0518821,\n",
       "                                       'congenital toxoplasmosis': -0.012556693,\n",
       "                                       'cytidylyltransferase': 0.059690714,\n",
       "                                       'cardiac tamponade': 0.054830667,\n",
       "                                       'Category Test': 0.12855998,\n",
       "                                       'chloramin T': 0.12907432,\n",
       "                                       'cortico-tectal': 0.15834725,\n",
       "                                       'cancer testis': 0.112907015,\n",
       "                                       'connective-tissue': 0.17292073,\n",
       "                                       'computed tomographic': 0.33965537,\n",
       "                                       'carbon-tetrachloride': 0.106572896}),\n",
       "                          'PET': defaultdict(float,\n",
       "                                      {'paraffin-embedded tissue': 0.16603309,\n",
       "                                       'polyethylene terephtalate': 0.092681706,\n",
       "                                       'peritoneal equilibration test': 0.31481713,\n",
       "                                       'polyester': -0.0460621,\n",
       "                                       'poly (ethylene terephthalate)': 0.033273276,\n",
       "                                       'peritoneal equilibration tests': 0.30392924,\n",
       "                                       'pancreatic endocrine tumors': 0.08216212,\n",
       "                                       'Positron emission tomography': 0.33200753,\n",
       "                                       'positron emission computed tomography': 0.40851286,\n",
       "                                       'polyethylene terephthalate': 0.06817729,\n",
       "                                       'patulous eustachian tube': 0.17648102,\n",
       "                                       'pre-eclamptic toxemia': 0.0064588543,\n",
       "                                       'poly(ethylene terephthalate)': 0.033273276,\n",
       "                                       'poly-(ethylene terephthalate)': 0.05701348,\n",
       "                                       'pre-eclamptic toxaemia': -0.0048440183,\n",
       "                                       'peritonaeal equilibration test': 0.30530545,\n",
       "                                       'positron-emission tomography': 0.33882794,\n",
       "                                       'positron-emission-tomography': 0.33479407,\n",
       "                                       'positron emission tomography': 0.33200753,\n",
       "                                       'photoinduced electron transfer': 0.084666915,\n",
       "                                       'positron emission tomograph': 0.29328793,\n",
       "                                       'preeclamptic toxaemia': -0.021266682,\n",
       "                                       'partial exchange transfusion': 0.25250372,\n",
       "                                       'pressure equalization tubes': 0.13765457,\n",
       "                                       'polyethylene-terephthalate': 0.07201249,\n",
       "                                       'pancreatic endocrine tumour': 0.0631536,\n",
       "                                       'positron emission-computed tomography': 0.4097712,\n",
       "                                       'polyethyleneterephthalate': 0.047914814,\n",
       "                                       'poly-ethylene terephthalate': 0.075516164,\n",
       "                                       'preeclamptic toxemia': -0.009492056,\n",
       "                                       'Polyethyleneterephthalate': 0.047914814,\n",
       "                                       'poly(ethyleneterephthalate)': 0.029235112,\n",
       "                                       'pancreatic endocrine tumor': 0.07168147,\n",
       "                                       'Peritoneal Equilibration Test': 0.31481713,\n",
       "                                       'positron emission tomographic': 0.3053825,\n",
       "                                       'phosphatidylethanol': 0.018549455,\n",
       "                                       'paraffin embedded tissue': 0.16145143})}),\n",
       "             'Both cohorts in the primary trial outperformed cohort 1 of the secondary trial in median PFS.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.08079005,\n",
       "                                       'pyrogen-free saline': 0.10017435,\n",
       "                                       'pressure-flow study': 0.017206006,\n",
       "                                       'posterior fossa syndrome': 0.17901266,\n",
       "                                       'pressure flow study': 0.026999036,\n",
       "                                       'primary fibromyalgia syndrome': 0.25548768,\n",
       "                                       'Piper Fatigue Scale': 0.14126979,\n",
       "                                       'patellofemoral syndrome': 0.11413794,\n",
       "                                       'Progression-free': 0.14110881,\n",
       "                                       'pulmonary function score': 0.27349737,\n",
       "                                       'pressure flow studies': 0.025151595,\n",
       "                                       'protein-free supernatant': 0.064457,\n",
       "                                       'progression free survival': 0.30498004,\n",
       "                                       'protein free supernatant': 0.09953292,\n",
       "                                       'progression-free survival': 0.34696373,\n",
       "                                       'pressure/flow study': 0.049807243})}),\n",
       "             'Patients with ER positive, PR positive or HER2 positive stage 4 tumors may be eligible for the secondary trial or the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ER': defaultdict(float,\n",
       "                                      {'extinction-ratio': 0.065505095,\n",
       "                                       'equivalent rontgen': 0.10740146,\n",
       "                                       'endo-plasmic reticulum': 0.12587155,\n",
       "                                       'emergency room': 0.1172542,\n",
       "                                       'estrogen receptor-alpha': 0.28686953,\n",
       "                                       'environmental resistance': 0.0029655444,\n",
       "                                       'erythrocyte receptor': 0.23505872,\n",
       "                                       'estradiol receptor': 0.17849652,\n",
       "                                       'extended-release': 0.19153231,\n",
       "                                       'energy restriction': 0.09428677,\n",
       "                                       'energy-restricted': 0.114018485,\n",
       "                                       'estrogen-receptor': 0.20923285,\n",
       "                                       'energy retention': -0.025620451,\n",
       "                                       'electrorheological': 0.07069186,\n",
       "                                       'ejection rate': 0.0765377,\n",
       "                                       'external resistance': 0.050886754,\n",
       "                                       'Estrogen receptor alpha': 0.24310304,\n",
       "                                       'estrogen receptor': 0.19011964,\n",
       "                                       'early': 0.06358296,\n",
       "                                       'endoplasmatic reticulum': 0.11498932,\n",
       "                                       'Estradiol': 0.03947855,\n",
       "                                       'expiratory reserve': 0.13324785,\n",
       "                                       'endovascular repair': 0.1419564,\n",
       "                                       'Emergency Room': 0.1172542,\n",
       "                                       'early reticulocyte': 0.21146688,\n",
       "                                       'esophageal rupture': 0.10970002,\n",
       "                                       'Estrogen receptors': 0.14821829,\n",
       "                                       'evoked responses': 0.15074082,\n",
       "                                       'estrogen receptor protein': 0.21604426,\n",
       "                                       'erythromycin': 0.17004196,\n",
       "                                       'enhancement ratios': 0.17127998,\n",
       "                                       'equine rhinopneumonia': 0.01429219,\n",
       "                                       'eye research': 0.12335887,\n",
       "                                       'extinction ratio': 0.06889224,\n",
       "                                       'equivalent roentgen': 0.14269777,\n",
       "                                       'emotion regulation': 0.031388145,\n",
       "                                       'enhancement ratio': 0.17296004,\n",
       "                                       'estrogen receptor status': 0.27813396,\n",
       "                                       'early repolarization': 0.17250097,\n",
       "                                       'early repolarisation': 0.17565411,\n",
       "                                       'electrical resistance': 0.038032185,\n",
       "                                       'evoked response': 0.16826831,\n",
       "                                       'efficacy ratio': 0.21024185,\n",
       "                                       'estrogen': 0.04210609,\n",
       "                                       'endoplasmic reticular': 0.14533131,\n",
       "                                       'extraction ratio': 0.114096805,\n",
       "                                       'extended release': 0.17585205,\n",
       "                                       'external rotation': 0.045903534,\n",
       "                                       'epigastric region': 0.24825275,\n",
       "                                       'endoscopic resection': 0.14037646,\n",
       "                                       'ethoxyresorufin': 0.1005278,\n",
       "                                       'electro-resection': 0.2052794,\n",
       "                                       'early response': 0.20863456,\n",
       "                                       'endoplasmic reticulum': 0.098907046,\n",
       "                                       'enhanced reactivation': 0.18119384,\n",
       "                                       'electroresection': 0.1433111}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.13907166,\n",
       "                                       'plaque reduction': 0.035967056,\n",
       "                                       'partial response': 0.17203464,\n",
       "                                       'photoreactivation': 0.033703286,\n",
       "                                       'pentoxyresorufin': 0.06808906,\n",
       "                                       'panoramic radiography': 0.09496013,\n",
       "                                       'proliferative retinopathy': 0.2118183,\n",
       "                                       'partial responses': 0.16159211,\n",
       "                                       'protein': -0.025494656,\n",
       "                                       'prorennin': 0.12186201,\n",
       "                                       'prevalence rate': 0.11428742,\n",
       "                                       'prealbumin': 0.08988121,\n",
       "                                       'pregnancy rates': -0.030470874,\n",
       "                                       'pain relief': 0.015023833,\n",
       "                                       'partial remissions': 0.48223376,\n",
       "                                       'pattern recognition': -0.0073114745,\n",
       "                                       'photo-reactivation': 0.064747825,\n",
       "                                       'protein restriction': 0.118015885,\n",
       "                                       'progesterone receptor': 0.16703777,\n",
       "                                       'placental restriction': 0.16735251,\n",
       "                                       'pneumatic retinopexy': 0.15268086,\n",
       "                                       'prorenin': 0.11246753,\n",
       "                                       'perirhinal cortex': 0.092850514,\n",
       "                                       'prothrombin ratio': 0.1674939,\n",
       "                                       'pars recta': 0.07018957,\n",
       "                                       'pattern reversal': 0.020401338,\n",
       "                                       'pr interval (ekg)': 0.23778854,\n",
       "                                       'pityriasis rosea': 0.053895768,\n",
       "                                       'prevalence ratio': 0.15118627,\n",
       "                                       'Projection reconstruction': -0.048982702,\n",
       "                                       'pregnancy rate': -0.012082167,\n",
       "                                       'phenol red': 0.12913294,\n",
       "                                       'photoreceptor': 0.08050951,\n",
       "                                       'prednisolon': 0.12863338,\n",
       "                                       'partial responders': 0.20666955,\n",
       "                                       'proline-rich': 0.04610877,\n",
       "                                       'pseudorabies': 0.1192366,\n",
       "                                       'pulmonary regurgitation': 0.11303065,\n",
       "                                       'projection reconstruction': -0.048982702,\n",
       "                                       'photo-receptor': 0.10978174,\n",
       "                                       'protease': 0.07845616,\n",
       "                                       'progestine': 0.010077983,\n",
       "                                       'pentoxy-resorufin': 0.09673857,\n",
       "                                       'partial remission': 0.42310318,\n",
       "                                       'progestin receptor': 0.13793941,\n",
       "                                       'per rectum': 0.08863864,\n",
       "                                       'Plain radiography': 0.13439256,\n",
       "                                       'production rate': 0.04927851,\n",
       "                                       'pulmonary rehabilitation': 0.12300732,\n",
       "                                       'pentoxy resorufin': 0.0976093,\n",
       "                                       'proteinase': 0.06516193,\n",
       "                                       'Paeoniae radix': 0.16743657,\n",
       "                                       'Puerto Rico': 0.06725926,\n",
       "                                       'Prevalence ratios': 0.13607252,\n",
       "                                       'perirenal': 0.08765745,\n",
       "                                       'passive recovery': 0.11376167,\n",
       "                                       'propranolol': 0.06945745,\n",
       "                                       'primary response': 0.30086577,\n",
       "                                       'pregnant': -0.022778144,\n",
       "                                       'partial regression': 0.06964366,\n",
       "                                       'Photoreactivation': 0.033703286,\n",
       "                                       'peripheral resistance': 0.1625795,\n",
       "                                       'polymorphic reticulosis': 0.16267757,\n",
       "                                       'progressive ratio': 0.16104278,\n",
       "                                       'partial responder': 0.19659762,\n",
       "                                       'projection-reconstruction': -0.02498841,\n",
       "                                       'pro-renin': 0.14096008,\n",
       "                                       'phenol-red': 0.13530211,\n",
       "                                       'progestin': 0.022789594,\n",
       "                                       'pro-rennin': 0.12566483}),\n",
       "                          'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.32083637,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.33365086,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.3225122,\n",
       "                                       'human epidermal growth factor receptor 2': 0.32828224,\n",
       "                                       'human epidermal growth factor receptor-2': 0.33365086})}),\n",
       "             'Cohort 1 of the primary trial included over 200 patients being treated with Sunitinib and Paclitaxel for a duration of 18 months or until death, and the median PFS for this group was just under 7 and a half months.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.10059425,\n",
       "                                       'pyrogen-free saline': 0.12396791,\n",
       "                                       'pressure-flow study': -0.024266442,\n",
       "                                       'posterior fossa syndrome': 0.095754735,\n",
       "                                       'pressure flow study': -0.009887549,\n",
       "                                       'primary fibromyalgia syndrome': 0.13597116,\n",
       "                                       'Piper Fatigue Scale': 0.07936561,\n",
       "                                       'patellofemoral syndrome': 0.09820647,\n",
       "                                       'Progression-free': 0.10689644,\n",
       "                                       'pulmonary function score': 0.15866621,\n",
       "                                       'pressure flow studies': -0.031073118,\n",
       "                                       'protein-free supernatant': 0.010638856,\n",
       "                                       'progression free survival': 0.33721122,\n",
       "                                       'protein free supernatant': 0.01877903,\n",
       "                                       'progression-free survival': 0.36054945,\n",
       "                                       'pressure/flow study': -0.012637315})}),\n",
       "             'Patients eligible for the primary trial and the secondary trial must live in the USA.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'USA': defaultdict(float,\n",
       "                                      {'United States Army': 0.18879116,\n",
       "                                       'United States of America': 0.3262937,\n",
       "                                       'United States': 0.4105682})}),\n",
       "             \"Female patients over the age of 60, with Histologically confirmed breast cancer and advanced Alzheimer's disease are ineligible for both the secondary trial and the primary trial, unless they have an ECOG>2.\": defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.09243271,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.33926883,\n",
       "                                       'eastern cooperative oncology group': 0.33926883,\n",
       "                                       'Electrocochleography': 0.06391704,\n",
       "                                       'electrocochleogram': 0.057058446,\n",
       "                                       'electrocortical activity': 0.12345492,\n",
       "                                       'electrocorticograms': 0.10604202,\n",
       "                                       'electrocortical': 0.06531536})}),\n",
       "             'Patients with BCC are excluded from the primary trial and the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'BCC': defaultdict(float,\n",
       "                                      {'bacterial community composition': -0.004375323,\n",
       "                                       'Basal cell carcinoma': 0.201544,\n",
       "                                       'body-centered cubic': 0.028171174,\n",
       "                                       'blind carbon copy': 0.19991313,\n",
       "                                       'basal cell cancer': 0.22810666,\n",
       "                                       'breast cancer cell': 0.15231626,\n",
       "                                       'basal cell': 0.2532321,\n",
       "                                       'basal cell carcinoma': 0.201544,\n",
       "                                       'basal cell carcinomas': 0.21154366,\n",
       "                                       'biliary cholesterol concentration': 0.12832426,\n",
       "                                       'breast cancer case': 0.19837226,\n",
       "                                       'Burkholderia cepacia complex': 0.14941022,\n",
       "                                       'basal-cell carcinoma': 0.21792232,\n",
       "                                       'B. cepacia complex': 0.15973149})}),\n",
       "             'Patients with metastatic HER-2-negative adenocarcinoma of the breast may be eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER': defaultdict(float,\n",
       "                                      {'heroin': 0.018076757,\n",
       "                                       'human epidermal receptor': 0.12515101,\n",
       "                                       'hydrogen evolution reaction': 0.031232681,\n",
       "                                       'human epidermal growth factor receptor': 0.16861354,\n",
       "                                       'human EGF receptor': 0.19126855,\n",
       "                                       'human estrogen receptor': 0.2205797})}),\n",
       "             'Participants of the primary trial must undergo at least one MRI during the intervention, in the secondary trial patients must use a fitbit.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MRI': defaultdict(float,\n",
       "                                      {'magnetic-resonance imaging': 0.37120953,\n",
       "                                       'MR-imaging': 0.4211395,\n",
       "                                       'magnetic resonance imaging': 0.4048783,\n",
       "                                       'magnetic resonance images': 0.35231242,\n",
       "                                       'magnetic resonance': 0.28149283,\n",
       "                                       'Magnetic resonance imagings': 0.41284633,\n",
       "                                       'magnet resonance imaging': 0.39178276,\n",
       "                                       'MR imaging': 0.40842873,\n",
       "                                       'magnetic-resonance-imaging': 0.3588481,\n",
       "                                       'magnetic resonance imagery': 0.32409883,\n",
       "                                       'Magnetic resonance imaging scan': 0.43760836,\n",
       "                                       'magnetic resonance tomography': 0.3622264,\n",
       "                                       'magnetic resonance image': 0.3119231,\n",
       "                                       'Magnetic resonance image': 0.3119231})}),\n",
       "             'There 55 more Participants With Best Tumor Response of Partial Response (PR) or Complete Response (CR) in cohort 2 of the primary trial than in cohort 1.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.15893084,\n",
       "                                       'plaque reduction': 0.012172924,\n",
       "                                       'partial response': 0.40617704,\n",
       "                                       'photoreactivation': -0.018624457,\n",
       "                                       'pentoxyresorufin': 0.044101764,\n",
       "                                       'panoramic radiography': 0.07835233,\n",
       "                                       'proliferative retinopathy': 0.16106066,\n",
       "                                       'partial responses': 0.40380183,\n",
       "                                       'protein': -0.028173633,\n",
       "                                       'prorennin': 0.08746964,\n",
       "                                       'prevalence rate': 0.23280677,\n",
       "                                       'prealbumin': 0.046558995,\n",
       "                                       'pregnancy rates': 0.07656653,\n",
       "                                       'pain relief': 0.08069797,\n",
       "                                       'partial remissions': 0.53964335,\n",
       "                                       'pattern recognition': -0.013005724,\n",
       "                                       'photo-reactivation': 0.03777991,\n",
       "                                       'protein restriction': 0.049504276,\n",
       "                                       'progesterone receptor': 0.11713725,\n",
       "                                       'placental restriction': 0.049913093,\n",
       "                                       'pneumatic retinopexy': 0.093630545,\n",
       "                                       'prorenin': 0.108795814,\n",
       "                                       'perirhinal cortex': 0.056421366,\n",
       "                                       'prothrombin ratio': 0.1794863,\n",
       "                                       'pars recta': 0.07066108,\n",
       "                                       'pattern reversal': 0.03235176,\n",
       "                                       'pr interval (ekg)': 0.17930855,\n",
       "                                       'pityriasis rosea': 0.029436031,\n",
       "                                       'prevalence ratio': 0.27512562,\n",
       "                                       'Projection reconstruction': -0.018255433,\n",
       "                                       'pregnancy rate': 0.08294974,\n",
       "                                       'phenol red': 0.07468262,\n",
       "                                       'photoreceptor': -0.006871154,\n",
       "                                       'prednisolon': 0.16580561,\n",
       "                                       'partial responders': 0.4229849,\n",
       "                                       'proline-rich': -0.012695244,\n",
       "                                       'pseudorabies': 0.0490255,\n",
       "                                       'pulmonary regurgitation': 0.07310605,\n",
       "                                       'projection reconstruction': -0.018255433,\n",
       "                                       'photo-receptor': 0.07264967,\n",
       "                                       'protease': 0.06800895,\n",
       "                                       'progestine': -0.01488965,\n",
       "                                       'pentoxy-resorufin': 0.06488722,\n",
       "                                       'partial remission': 0.47856912,\n",
       "                                       'progestin receptor': 0.08732435,\n",
       "                                       'per rectum': 0.077750295,\n",
       "                                       'Plain radiography': 0.08133719,\n",
       "                                       'production rate': 0.11890686,\n",
       "                                       'pulmonary rehabilitation': 0.10807963,\n",
       "                                       'pentoxy resorufin': 0.06318799,\n",
       "                                       'proteinase': 0.021343738,\n",
       "                                       'Paeoniae radix': 0.103077866,\n",
       "                                       'Puerto Rico': 0.0847064,\n",
       "                                       'Prevalence ratios': 0.2771539,\n",
       "                                       'perirenal': -0.012020301,\n",
       "                                       'passive recovery': 0.08407797,\n",
       "                                       'propranolol': 0.10356147,\n",
       "                                       'primary response': 0.38436785,\n",
       "                                       'pregnant': -0.001920063,\n",
       "                                       'partial regression': 0.19124056,\n",
       "                                       'Photoreactivation': -0.018624457,\n",
       "                                       'peripheral resistance': 0.12414587,\n",
       "                                       'polymorphic reticulosis': 0.094357885,\n",
       "                                       'progressive ratio': 0.21867834,\n",
       "                                       'partial responder': 0.37891164,\n",
       "                                       'projection-reconstruction': 0.00939713,\n",
       "                                       'pro-renin': 0.120907,\n",
       "                                       'phenol-red': 0.08105008,\n",
       "                                       'progestin': 0.011445133,\n",
       "                                       'pro-rennin': 0.10698048}),\n",
       "                          'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.021547534,\n",
       "                                       'clot retraction': 0.09143684,\n",
       "                                       'conditioned response': 0.13030459,\n",
       "                                       'conditioned reflex': 0.017353153,\n",
       "                                       'charge recombination': 0.004968386,\n",
       "                                       'Czech Republic': 0.035564464,\n",
       "                                       'control region': 0.0647394,\n",
       "                                       'colonization rate': 0.14096686,\n",
       "                                       'complete remission rate': 0.5637381,\n",
       "                                       'Charles River': -0.0053689033,\n",
       "                                       'Caloric restriction': 0.055102408,\n",
       "                                       'colonisation resistance': 0.09005848,\n",
       "                                       'complete regression': 0.12564462,\n",
       "                                       'conversion rate': 0.15682817,\n",
       "                                       'chest roentgenography': 0.17465508,\n",
       "                                       'chest radiograph': 0.13781036,\n",
       "                                       'colony reared': -0.009659441,\n",
       "                                       'cardiorespiratory': 0.034873534,\n",
       "                                       'circadian rhythm': 0.013751129,\n",
       "                                       'cardiac rupture': 0.078575835,\n",
       "                                       'carbonyl reductase': 0.06970287,\n",
       "                                       'calorie restriction': 0.03396882,\n",
       "                                       'cortical reaction': 0.08203784,\n",
       "                                       'complete remissions': 0.4272114,\n",
       "                                       'chest radiography': 0.15954201,\n",
       "                                       'computerised record': 0.0077017923,\n",
       "                                       'charge-recombination': 0.0075487476,\n",
       "                                       'Cardiac Rehabilitation': 0.10686733,\n",
       "                                       'calcium-binding protein calretinin': 0.11778368,\n",
       "                                       'chronic rejection': 0.06633891,\n",
       "                                       'colony-reared': -0.005271524,\n",
       "                                       'cognitive reserve': 0.0962693,\n",
       "                                       'critical ratio': 0.19111557,\n",
       "                                       'cortico-resistant': 0.2247882,\n",
       "                                       'caloric restriction': 0.055102408,\n",
       "                                       'corticoresistant': 0.09189342,\n",
       "                                       'corticosteroid-resistant': 0.21260864,\n",
       "                                       'Congo red': 0.031858236,\n",
       "                                       'complete responses': 0.3000377,\n",
       "                                       'chest and right arm': 0.0638593,\n",
       "                                       'conditioned reinforcement': 0.016124811,\n",
       "                                       'constant routine': -0.0364816,\n",
       "                                       'cardio-respiratory': 0.099149905,\n",
       "                                       'complete response rate': 0.41849732,\n",
       "                                       'cockroach': -0.04012584,\n",
       "                                       'chief resident': 0.04205112,\n",
       "                                       'calorie-restricted': 0.028148303,\n",
       "                                       'complete responders': 0.3504194,\n",
       "                                       'cysteine-rich': 0.08523671,\n",
       "                                       'controlled-release': 0.031029884,\n",
       "                                       'chemoradiation': 0.09181713,\n",
       "                                       'crown-rump': -0.0031519048,\n",
       "                                       'crown-rump length': 0.046060123,\n",
       "                                       'creatinine': 0.06834998,\n",
       "                                       'capture-recapture': 0.038738005,\n",
       "                                       'Congo-red': 0.04486748,\n",
       "                                       'coefficient of repeatability': 0.1709542,\n",
       "                                       'computed radiography': 0.12427677,\n",
       "                                       'controlled respiration': 0.04317539,\n",
       "                                       'conditioned reward': 0.061541516,\n",
       "                                       'complement receptors': 0.21058549,\n",
       "                                       'concentration-response': 0.17313418,\n",
       "                                       'complete': 0.09762822,\n",
       "                                       'chest roentgenogram': 0.15735896,\n",
       "                                       'complement receptor': 0.21934941,\n",
       "                                       'Cajal-Retzius': -0.010365756,\n",
       "                                       'cremasteric reflex': 0.14330481,\n",
       "                                       'clot-retraction': 0.060164735,\n",
       "                                       'conserved regions': 0.030515065,\n",
       "                                       'child-resistant': -0.02816555,\n",
       "                                       'control rats': 0.02165454,\n",
       "                                       'caries-resistant': 0.02128673,\n",
       "                                       'coronary revascularization': 0.20486885,\n",
       "                                       'colon resection': 0.16843165,\n",
       "                                       'contrast ratio': 0.11930137,\n",
       "                                       'concentration ratio': 0.12588543,\n",
       "                                       'Calreticulin': 0.08015748,\n",
       "                                       'composite resin': -0.010232926,\n",
       "                                       'completely': 0.11138344,\n",
       "                                       'colorectal': 0.112741746,\n",
       "                                       'complete response': 0.28445622,\n",
       "                                       'coronary risk': 0.18967026,\n",
       "                                       'conventional radiology': 0.17403209,\n",
       "                                       'Complete response': 0.28445622,\n",
       "                                       'cathode ray': 0.0022004861,\n",
       "                                       'complete responder': 0.3247133,\n",
       "                                       'controlled release': 0.00717436,\n",
       "                                       'conditioned reflexes': 0.024736166,\n",
       "                                       'chemo-radiation': 0.46341932,\n",
       "                                       'complete remission': 0.37371007,\n",
       "                                       'conserved region': 0.011285897,\n",
       "                                       'coronary resistance': 0.22453423,\n",
       "                                       'cardiac resuscitation': 0.08651996,\n",
       "                                       'computed radiographic': 0.15425187,\n",
       "                                       'cooling rate': -0.002474498,\n",
       "                                       'clinical research': 0.3171562,\n",
       "                                       'colonization resistance': 0.069527686,\n",
       "                                       'compression ratio': 0.050596237,\n",
       "                                       'computerized record': 0.008472927,\n",
       "                                       'chromium': 0.08192845,\n",
       "                                       'colo-rectal': 0.07575955,\n",
       "                                       'contractile reserve': 0.040320933,\n",
       "                                       'clinical record': 0.25983888,\n",
       "                                       'concentration ratios': 0.13376902,\n",
       "                                       'clinical remission': 0.42111588,\n",
       "                                       'centric relation': 0.006213606,\n",
       "                                       'cardiac rhythm': 0.011264874,\n",
       "                                       'capillary refill': 0.03321867,\n",
       "                                       'colonisation rate': 0.14383298,\n",
       "                                       'conventional radiography': 0.09171222,\n",
       "                                       'cellular receptor': 0.15971968})}),\n",
       "             'In the primary trial There was less than 3 days difference between the maximum recorded TTP of the Exemestane group and the Anastrozole group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'TTP': defaultdict(float,\n",
       "                                      {'tocopherol transfer protein': 0.10507438,\n",
       "                                       'time to positivity': 0.16215229,\n",
       "                                       'time to peak tension': 0.17166966,\n",
       "                                       'time to progression': 0.2436452,\n",
       "                                       'thrombotic thrombocytopenic purpura': 0.21713871,\n",
       "                                       'tristetraprolin': 0.38212872,\n",
       "                                       'time to pregnancy': 0.13304473,\n",
       "                                       'time to disease progression': 0.27771422,\n",
       "                                       'thiamine triphosphate': 0.2393869,\n",
       "                                       'thymidine triphosphate': 0.33568093,\n",
       "                                       'Time to progression': 0.2436452,\n",
       "                                       'time to peak contraction': 0.312801,\n",
       "                                       'time to peak': 0.23724656,\n",
       "                                       'thiamin triphosphate': 0.21571967,\n",
       "                                       'tender to palpation': 0.020674566,\n",
       "                                       'time to tumor progression': 0.27765125,\n",
       "                                       'Tolpa Torf Preparation': 0.16625752,\n",
       "                                       'thrombotic-thrombocytopenic purpura': 0.23014475,\n",
       "                                       'time-to-peak': 0.34614107})}),\n",
       "             'Group 1 of the secondary trial has a higher ORR than both the NKTR-102 14 Day cohort of the primary trial and the NKTR-102 21 Days cohort.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ORR': defaultdict(float,\n",
       "                                      {'oxygen-reduction reaction': 0.1787022,\n",
       "                                       'overall response rate': 0.29281205,\n",
       "                                       'objective response rate': 0.251084,\n",
       "                                       'oxygen reduction reaction': 0.18075678}),\n",
       "                          'NKTR': defaultdict(float,\n",
       "                                      {'NK-triggering receptor': 0.3307245,\n",
       "                                       'natural killer triggering receptor': 0.27904266})}),\n",
       "             'Patients with AIDS are eligible for both the secondary trial and the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'AIDS': defaultdict(float,\n",
       "                                      {'acquired immune-deficiency syndrome': 0.30722815,\n",
       "                                       'acquired immune deficiency syndrome': 0.30800843,\n",
       "                                       'acquired immune deficiency': 0.2995206,\n",
       "                                       'acquired immuno deficiency syndrome': 0.24382372,\n",
       "                                       'acquired immunodeficiency': 0.3565325,\n",
       "                                       'acquired immunodeficiency virus': 0.3660821,\n",
       "                                       'acquired immunodeficiency disease': 0.36049825,\n",
       "                                       'acquired immunodeficiency syndrome': 0.36629683,\n",
       "                                       'acquired immuno-deficiency syndrome': 0.23899345,\n",
       "                                       'acquired immunodeficiency disease syndrome': 0.35857213,\n",
       "                                       'acquired immunodeficiency syndromes': 0.3792975})}),\n",
       "             'the secondary trial and the primary trial both measure PFS of their patient cohorts and use the same time frame.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.07495025,\n",
       "                                       'pyrogen-free saline': 0.08411959,\n",
       "                                       'pressure-flow study': 0.039948594,\n",
       "                                       'posterior fossa syndrome': 0.12531985,\n",
       "                                       'pressure flow study': 0.04089909,\n",
       "                                       'primary fibromyalgia syndrome': 0.26741996,\n",
       "                                       'Piper Fatigue Scale': 0.13171786,\n",
       "                                       'patellofemoral syndrome': 0.09730248,\n",
       "                                       'Progression-free': 0.068691514,\n",
       "                                       'pulmonary function score': 0.26008916,\n",
       "                                       'pressure flow studies': 0.036760166,\n",
       "                                       'protein-free supernatant': 0.019722646,\n",
       "                                       'progression free survival': 0.2907845,\n",
       "                                       'protein free supernatant': 0.045372687,\n",
       "                                       'progression-free survival': 0.31670833,\n",
       "                                       'pressure/flow study': 0.05847303})}),\n",
       "             'Patients prescribed with bisoprolol or labetalol to treat CHF are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CHF': defaultdict(float,\n",
       "                                      {'congestive heart failure': 0.32152113,\n",
       "                                       'Crimean hemorrhagic fever': 0.15382572,\n",
       "                                       'chick embryo fibroblast': 0.08144518,\n",
       "                                       'Congenital hepatic fibrosis': 0.19716258,\n",
       "                                       'Crimean haemorrhagic fever': 0.14435463,\n",
       "                                       'continuous hemofiltration': 0.28514853,\n",
       "                                       'Crimean Haemorrhagic Fever': 0.14435463,\n",
       "                                       'congenital hepatic fibrosis': 0.19716258,\n",
       "                                       'chick-embryo fibroblast': 0.08677625})}),\n",
       "             'Patients with Cancer that has spread from a breast tumor to their CNS are able to take part in the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CNS': defaultdict(float,\n",
       "                                      {'central nerve system': 0.23484363,\n",
       "                                       'Congenital nephrotic syndrome': 0.073663294,\n",
       "                                       'Coagulase negative staphylococci': 0.051939346,\n",
       "                                       'Clinical nurse specialist': 0.24740708,\n",
       "                                       'coagulase negative staphylococcus': 0.045574717,\n",
       "                                       'coagulase-negative Staphylococcus': 0.05242399,\n",
       "                                       'central nerves system': 0.2068165,\n",
       "                                       'central-nervous-system': 0.19426312,\n",
       "                                       'congenital nephrotic syndrome': 0.073663294,\n",
       "                                       'central nervous system': 0.21235979,\n",
       "                                       'central nervous systems': 0.20499793,\n",
       "                                       'Crigler Najjar syndrome': 0.09956619,\n",
       "                                       'coagulase negative staph': 0.08048544,\n",
       "                                       'clinical nurse specialists': 0.26153192,\n",
       "                                       'Crigler-Najjar syndrome': 0.11076406,\n",
       "                                       'coagulase-negative staphylococci': 0.053313185,\n",
       "                                       'coagulase-negative staphylococcus': 0.05242399,\n",
       "                                       'central nervous': 0.23221487,\n",
       "                                       'clinical nurse specialist': 0.24740708,\n",
       "                                       'Canadian Neurological Scale': 0.34921497,\n",
       "                                       'coagulase-negative staphylococcal': 0.09281998,\n",
       "                                       'coagulase negative Staphylococcus': 0.045574717})}),\n",
       "             'the primary trial designates specific interventions to its patients depending on their hormone status, Cohort A is TNBC patients and cohort B is ER/PR +HER2- BC Patients, in contrast the secondary trial assigns interventions randomly.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'TNBC': defaultdict(float,\n",
       "                                      {'triple negative breast carcinoma': 0.17780638,\n",
       "                                       'triple-negative breast cancer': 0.21445757,\n",
       "                                       'triple negative breast cancer': 0.2130195}),\n",
       "                          'ER': defaultdict(float,\n",
       "                                      {'extinction-ratio': 0.07952173,\n",
       "                                       'equivalent rontgen': 0.09572125,\n",
       "                                       'endo-plasmic reticulum': 0.036033515,\n",
       "                                       'emergency room': 0.044623494,\n",
       "                                       'estrogen receptor-alpha': 0.3815449,\n",
       "                                       'environmental resistance': 0.041836265,\n",
       "                                       'erythrocyte receptor': 0.17808008,\n",
       "                                       'estradiol receptor': 0.2659546,\n",
       "                                       'extended-release': 0.17513691,\n",
       "                                       'energy restriction': 0.043380246,\n",
       "                                       'energy-restricted': 0.0023625912,\n",
       "                                       'estrogen-receptor': 0.3055571,\n",
       "                                       'energy retention': 0.014891566,\n",
       "                                       'electrorheological': 0.040225036,\n",
       "                                       'ejection rate': 0.05088604,\n",
       "                                       'external resistance': 0.036664296,\n",
       "                                       'Estrogen receptor alpha': 0.3483739,\n",
       "                                       'estrogen receptor': 0.32322028,\n",
       "                                       'early': 0.057985276,\n",
       "                                       'endoplasmatic reticulum': 0.047087006,\n",
       "                                       'Estradiol': 0.20610547,\n",
       "                                       'expiratory reserve': 0.0751065,\n",
       "                                       'endovascular repair': 0.06821124,\n",
       "                                       'Emergency Room': 0.044623494,\n",
       "                                       'early reticulocyte': 0.14908595,\n",
       "                                       'esophageal rupture': 0.010209361,\n",
       "                                       'Estrogen receptors': 0.30047098,\n",
       "                                       'evoked responses': 0.113326825,\n",
       "                                       'estrogen receptor protein': 0.27864727,\n",
       "                                       'erythromycin': 0.11027316,\n",
       "                                       'enhancement ratios': 0.17380343,\n",
       "                                       'equine rhinopneumonia': -0.0104058245,\n",
       "                                       'eye research': 0.1496085,\n",
       "                                       'extinction ratio': 0.085578725,\n",
       "                                       'equivalent roentgen': 0.13138324,\n",
       "                                       'emotion regulation': 0.11136408,\n",
       "                                       'enhancement ratio': 0.14314567,\n",
       "                                       'estrogen receptor status': 0.3325116,\n",
       "                                       'early repolarization': 0.16683744,\n",
       "                                       'early repolarisation': 0.17646267,\n",
       "                                       'electrical resistance': 0.049249217,\n",
       "                                       'evoked response': 0.107517,\n",
       "                                       'efficacy ratio': 0.28188187,\n",
       "                                       'estrogen': 0.18410586,\n",
       "                                       'endoplasmic reticular': 0.017958857,\n",
       "                                       'extraction ratio': 0.14035773,\n",
       "                                       'extended release': 0.15391167,\n",
       "                                       'external rotation': 0.016758906,\n",
       "                                       'epigastric region': 0.12939258,\n",
       "                                       'endoscopic resection': -0.028783333,\n",
       "                                       'ethoxyresorufin': 0.049569365,\n",
       "                                       'electro-resection': 0.038171455,\n",
       "                                       'early response': 0.20689878,\n",
       "                                       'endoplasmic reticulum': 0.057092432,\n",
       "                                       'enhanced reactivation': 0.15253359,\n",
       "                                       'electroresection': 0.020289445}),\n",
       "                          'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.20032161,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.20660135,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.1985677,\n",
       "                                       'human epidermal growth factor receptor 2': 0.19217655,\n",
       "                                       'human epidermal growth factor receptor-2': 0.20660135}),\n",
       "                          'BC': defaultdict(float,\n",
       "                                      {'breast cancer': 0.16660017,\n",
       "                                       'bactericidal concentration': 0.06970697,\n",
       "                                       'bulbocavernosus': -0.04111592,\n",
       "                                       'blood cultures': 0.12730928,\n",
       "                                       'buffy-coat': -0.07062838,\n",
       "                                       'bipolar cell': 0.092591666,\n",
       "                                       'biventer cervicis': 0.11114605,\n",
       "                                       'biochemical control': 0.12373678,\n",
       "                                       'biliary complications': 0.08327651,\n",
       "                                       'battle casualty': 0.0252337,\n",
       "                                       'blood count': 0.19391692,\n",
       "                                       'blue cross': 0.07516945,\n",
       "                                       'biotin carboxylase': 0.04538017,\n",
       "                                       'biliary colic': 0.08322295,\n",
       "                                       'blood glucose': 0.11860152,\n",
       "                                       'British Columbia': 0.016866887,\n",
       "                                       'buccocervical': 0.020161891,\n",
       "                                       'blood culture': 0.12453687,\n",
       "                                       'basal cell': 0.15302832,\n",
       "                                       'birth control': 0.22715381,\n",
       "                                       'brachio-cephalic': 0.009736682,\n",
       "                                       'benzalkonium chloride': 0.04552676,\n",
       "                                       'breast carcinoma': 0.13400146,\n",
       "                                       'birth-control': 0.24634254,\n",
       "                                       'basal-cell': 0.182107,\n",
       "                                       'bacterial cellulose': -0.07116465,\n",
       "                                       'body condition': -0.012128932,\n",
       "                                       'board certified': -0.03308829,\n",
       "                                       'board-certified': -0.007577352,\n",
       "                                       'brachium conjunctivum': -0.0017191702,\n",
       "                                       'bromocriptine': 0.09399045,\n",
       "                                       'back care': -0.02510893,\n",
       "                                       'bronchoconstriction': 0.037538804,\n",
       "                                       'blastic crisis': 0.10159102,\n",
       "                                       'bacitracin': 0.121780485,\n",
       "                                       'blood-count': 0.22592482,\n",
       "                                       'bladder capacity': 0.061093904,\n",
       "                                       'bronchial carcinoma': 0.050711717,\n",
       "                                       'bronchogenic carcinoma': 0.060786754,\n",
       "                                       'beta-carotene': 0.14221588,\n",
       "                                       'blast crisis': 0.08969616,\n",
       "                                       'body composition': 0.047589008,\n",
       "                                       'breast cancers': 0.21393043,\n",
       "                                       'black carbon': -0.04370763,\n",
       "                                       'buffy coat': -0.07000777,\n",
       "                                       'brachiocephalic': 0.011451916,\n",
       "                                       'bone conduction': 0.021950362,\n",
       "                                       'birthcontrol': 0.18024899,\n",
       "                                       'breastcancer': 0.14224465,\n",
       "                                       'blood-culture': 0.103428125,\n",
       "                                       'basket cell': -0.0076641086,\n",
       "                                       'bronchogenic cyst': 0.009400916,\n",
       "                                       'buccal cartilage': -0.02510598,\n",
       "                                       'backcross': -0.021601085,\n",
       "                                       'bicarbonate': 0.03797902,\n",
       "                                       'basaloid carcinoma': 0.06614956,\n",
       "                                       'Breast Cancer': 0.16660017,\n",
       "                                       'basic copy': 0.15039203,\n",
       "                                       'bone-conduction': 0.02244157,\n",
       "                                       'bile canaliculi': 0.025889765,\n",
       "                                       'Blue Cross': 0.07516945})}),\n",
       "             'Patients must present IHC 3+ or FISH amplified results to participate in the primary trial, meaning their cancer is Histologically-confirmed as being triple-positive.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IHC': defaultdict(float,\n",
       "                                      {'immunohisto-chemistry': 0.30610105,\n",
       "                                       'immuno histochemical': 0.3364384,\n",
       "                                       'intrahepatic cholestasis': 0.18765135,\n",
       "                                       'Idiopathic hypercalciuria': 0.1584594,\n",
       "                                       'immunohistochemical analysis': 0.30104858,\n",
       "                                       'immunohisto-chemical': 0.29659536,\n",
       "                                       'intra-hepatic cholestasis': 0.18127692,\n",
       "                                       'idiopathic haemochromatosis': 0.28547966,\n",
       "                                       'immuno-histochemistry': 0.32702643,\n",
       "                                       'immunohistochemistry': 0.3222758,\n",
       "                                       'induced hypertension chemotherapy': 0.20559028,\n",
       "                                       'idiopathic hemochromatosis': 0.28858572,\n",
       "                                       'immunohisto chemical': 0.29127333,\n",
       "                                       'Intermountain Health Care': 0.21855238,\n",
       "                                       'Immunohistochemical staining': 0.2804438,\n",
       "                                       'immuno-histochemical': 0.32931548,\n",
       "                                       'idiopathic hæmochromatosis': 0.25393474,\n",
       "                                       'immuno histochemistry': 0.3265925,\n",
       "                                       'immunohisto chemistry': 0.2850102,\n",
       "                                       'immunohistochemically': 0.24445617,\n",
       "                                       'idiopathic hypercalciuria': 0.1584594,\n",
       "                                       'inner-hair cell': 0.066285715,\n",
       "                                       'inner hair cells': 0.051829446,\n",
       "                                       'immunohistochemical': 0.27514327,\n",
       "                                       'inner hair cell': 0.046662632}),\n",
       "                          'FISH': defaultdict(float,\n",
       "                                      {'fluorescence in-situ hybridisation': 0.19995311,\n",
       "                                       'fluorescence-in-situ-hybridisation': 0.17939556,\n",
       "                                       'fluorescence in situ hybridisation': 0.19312531,\n",
       "                                       'fluorescent in situ hybridization': 0.2055251,\n",
       "                                       'fluorescence in situ hybridization technique': 0.21138372,\n",
       "                                       'fluorescence in situ hybridization': 0.20524871,\n",
       "                                       'fluorescent in situ hybridisation': 0.19463536,\n",
       "                                       'fluorescent in-situ hybridization': 0.21201897,\n",
       "                                       'fluorescence-in-situ-hybridization': 0.19948564,\n",
       "                                       'fluorescence in-situ hybridization': 0.21357483,\n",
       "                                       'fluorescent in-situ hybridisation': 0.20079729})}),\n",
       "             'the primary trial tests MRI scanning as a technique for guiding biopsies.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MRI': defaultdict(float,\n",
       "                                      {'magnetic-resonance imaging': 0.49997813,\n",
       "                                       'MR-imaging': 0.603183,\n",
       "                                       'magnetic resonance imaging': 0.5078371,\n",
       "                                       'magnetic resonance images': 0.45306498,\n",
       "                                       'magnetic resonance': 0.2785937,\n",
       "                                       'Magnetic resonance imagings': 0.5591279,\n",
       "                                       'magnet resonance imaging': 0.47708946,\n",
       "                                       'MR imaging': 0.62480235,\n",
       "                                       'magnetic-resonance-imaging': 0.46375895,\n",
       "                                       'magnetic resonance imagery': 0.3835525,\n",
       "                                       'Magnetic resonance imaging scan': 0.5866798,\n",
       "                                       'magnetic resonance tomography': 0.49265596,\n",
       "                                       'magnetic resonance image': 0.39452928,\n",
       "                                       'Magnetic resonance image': 0.39452928})}),\n",
       "             'Patients must have BUN < 20 mg/dL,  Platelet count: <90,000/mm3, Leukocyte count of 5,000/mm3 to 8,000/mm3 to be eligible for either the primary trial or the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'BUN': defaultdict(float,\n",
       "                                      {'Blood urea nitrogen concentration': 0.35040003,\n",
       "                                       'blood urea nitrogen': 0.29241738})}),\n",
       "             'Japanese participants with an ECOG of 2 are eligible for the secondary trial and the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.18107852,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.22471704,\n",
       "                                       'eastern cooperative oncology group': 0.22471704,\n",
       "                                       'Electrocochleography': 0.11439608,\n",
       "                                       'electrocochleogram': 0.13955177,\n",
       "                                       'electrocortical activity': 0.2009911,\n",
       "                                       'electrocorticograms': 0.19032258,\n",
       "                                       'electrocortical': 0.11114697})}),\n",
       "             'Patients with Scoliosis with a Cobb angle exceeding 20 degrees at the lumbar spine, or with a prior surgery at the lumbosacral spine are excluded from the primary trial, as these constitute contraindications to spine dual energy x-ray absorptiometry (DXA).': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DXA': defaultdict(float,\n",
       "                                      {'dual-energy X-ray absorptiometry': 0.46289468,\n",
       "                                       'dual x ray absorptiometry': 0.5565493,\n",
       "                                       'dual x-ray absorptiometry': 0.52732295,\n",
       "                                       'Dual energy X-ray absorptiometry': 0.47279114,\n",
       "                                       'dual Xray absorptiometry': 0.5050952,\n",
       "                                       'dual X ray absorptiometry': 0.5565493,\n",
       "                                       'dual-energy x-ray absorptiometry': 0.46289468,\n",
       "                                       'dual xray absorptiometry': 0.5050952,\n",
       "                                       'dual X-ray absorptiometry': 0.52732295,\n",
       "                                       'dual energy X-ray absorptiometry': 0.47279114,\n",
       "                                       'dual energy x-ray absorptiometry': 0.47279114})}),\n",
       "             'Patients with LVEF greater than or equal to 60% are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'LVEF': defaultdict(float,\n",
       "                                      {'left-ventricular ejection fraction': 0.29575196,\n",
       "                                       'Left ventricular ejection fractions': 0.28303868,\n",
       "                                       'left ventricular function': 0.24984293,\n",
       "                                       'left ventricular ejection fraction': 0.2906046,\n",
       "                                       'left ventricle ejection fraction': 0.30051652,\n",
       "                                       'left-ventricle ejection fraction': 0.29919714,\n",
       "                                       'LV ejection fraction': 0.31467837})}),\n",
       "             'Cohort 1 of the primary trial included 250 patients being treated with Sunitinib and Paclitaxel for a duration of 18 months or until death, and the mean PFS for this group was just under 7 and a half months.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.10677217,\n",
       "                                       'pyrogen-free saline': 0.120162405,\n",
       "                                       'pressure-flow study': -0.015324151,\n",
       "                                       'posterior fossa syndrome': 0.10865631,\n",
       "                                       'pressure flow study': -0.00037132576,\n",
       "                                       'primary fibromyalgia syndrome': 0.1513284,\n",
       "                                       'Piper Fatigue Scale': 0.09167682,\n",
       "                                       'patellofemoral syndrome': 0.10502185,\n",
       "                                       'Progression-free': 0.1140705,\n",
       "                                       'pulmonary function score': 0.18426195,\n",
       "                                       'pressure flow studies': -0.024368182,\n",
       "                                       'protein-free supernatant': 0.012907193,\n",
       "                                       'progression free survival': 0.34646872,\n",
       "                                       'protein free supernatant': 0.023820112,\n",
       "                                       'progression-free survival': 0.37186635,\n",
       "                                       'pressure/flow study': -0.0017342038})}),\n",
       "             'Women in cohort B of the primary trial with serum 25 (OH)D greater than or equal to 30 ng/ml did not receive weekly supplementation of cholecalciferol.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'OH': defaultdict(float,\n",
       "                                      {'on hand': 0.04847865,\n",
       "                                       'on-hand': 0.049282,\n",
       "                                       'ocular hypertension': 0.16735402,\n",
       "                                       'open heart': 0.028860476,\n",
       "                                       'omni hora': 0.042120766,\n",
       "                                       'outpatient hospital': 0.056836855,\n",
       "                                       'occupational history': 0.029327638,\n",
       "                                       'Ohio': 0.07691005,\n",
       "                                       'ocular hypertensive': 0.18478774,\n",
       "                                       'Orthostatic hypotension': 0.15206182,\n",
       "                                       'orthostatic hypotension': 0.15206182,\n",
       "                                       'out of hospital': 0.021116357,\n",
       "                                       'ovarian hyperstimulation': 0.25729412,\n",
       "                                       'occipital horn': 0.04213143,\n",
       "                                       'obstructive hypopnea': 0.11681164,\n",
       "                                       'occupational health': 0.15510161})}),\n",
       "             'One patient in the primary trial had abnormally low levels of AST, ALT and ANC.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'AST': defaultdict(float,\n",
       "                                      {'anti-streptolysin test': 0.34871823,\n",
       "                                       'atrial systolic tachycardia': 0.32169297,\n",
       "                                       'astrocyte': 0.17813598,\n",
       "                                       'arginine stimulation test': 0.41625547,\n",
       "                                       'astaxanthine': 0.35020298,\n",
       "                                       'aspartate amino-transferase': 0.2716263,\n",
       "                                       'anti-microbial susceptibility testing': 0.15632628,\n",
       "                                       'anterior spinothalamic tract': 0.31197822,\n",
       "                                       'arterial spin tagging': 0.14563291,\n",
       "                                       'Antimicrobial susceptibility testing': 0.14332098,\n",
       "                                       'aspartate-aminotransferase': 0.29650563,\n",
       "                                       'arginine-stimulation test': 0.41017434,\n",
       "                                       'antimicrobial susceptibility testing': 0.14332098,\n",
       "                                       'aspartate amino transferase': 0.24066977,\n",
       "                                       'average survival time': 0.05221404,\n",
       "                                       'aspartate transaminase': 0.25784308,\n",
       "                                       'acid suppressive therapy': 0.42237216,\n",
       "                                       'aspartate': 0.20636548,\n",
       "                                       'atrial overdrive stimulation rate': 0.2708398,\n",
       "                                       'arterial spin-tagging': 0.15856859,\n",
       "                                       'aspartate transferase': 0.24251647,\n",
       "                                       'aspartate aminotransferase': 0.29370725,\n",
       "                                       'antistreptolysin test': 0.38236913,\n",
       "                                       'androgen suppression therapy': 0.31480178,\n",
       "                                       'acute suppurative thyroiditis': 0.3261701,\n",
       "                                       'allatostatin': 0.36089855,\n",
       "                                       'anti-fungal susceptibility testing': 0.1967373,\n",
       "                                       'angiotensin sensitivity test': 0.3830662,\n",
       "                                       'acid-suppressive therapy': 0.4283334,\n",
       "                                       'antibiotic susceptibility testing': 0.1892705,\n",
       "                                       'Aryl sulfotransferase': 0.20372468,\n",
       "                                       'astigmatism': 0.2906697,\n",
       "                                       'androgen-suppression therapy': 0.3148116,\n",
       "                                       'aspartate-amino-transferase': 0.28911808,\n",
       "                                       'astaxanthin': 0.29083472,\n",
       "                                       'antifungal susceptibility testing': 0.14611419}),\n",
       "                          'ALT': defaultdict(float,\n",
       "                                      {'altitude': 0.13735683,\n",
       "                                       'alanine amino transferase': 0.25368738,\n",
       "                                       'avian laryngotracheitis': 0.11630636,\n",
       "                                       'alanine-aminotransferase': 0.30543286,\n",
       "                                       'alanine aminotransaminase': 0.30607313,\n",
       "                                       'alanine aminotransferase': 0.31683537,\n",
       "                                       'alanine transferase': 0.30107486,\n",
       "                                       'anterolateral thigh': 0.23805614,\n",
       "                                       'auxiliary liver transplantation': 0.28914064,\n",
       "                                       'alanine amino-transferase': 0.28315812,\n",
       "                                       'antero-lateral thigh': 0.22829293,\n",
       "                                       'alanine aminotransferases': 0.30176523,\n",
       "                                       'alanine-amino-transferase': 0.2835641,\n",
       "                                       'alternative lengthening of telomeres': 0.09798504,\n",
       "                                       'alanine aminotransferase activity': 0.34625316,\n",
       "                                       'autolymphocyte therapy': 0.32694146,\n",
       "                                       'alanine transaminase': 0.29553905,\n",
       "                                       'argon laser trabeculoplasty': 0.19700313}),\n",
       "                          'ANC': defaultdict(float,\n",
       "                                      {'acid neutralising capacity': 0.10723986,\n",
       "                                       'antigen-neutralising capacity': 0.20335789,\n",
       "                                       'antenatal care': 0.14682837,\n",
       "                                       'acid neutralization capacity': 0.07619583,\n",
       "                                       'ante-natal clinic': 0.26637405,\n",
       "                                       'antenatal clinics': 0.14617983,\n",
       "                                       'acid-neutralising capacity': 0.11111259,\n",
       "                                       'absolute neutrophil count': 0.23056982,\n",
       "                                       'Active noise control': -0.01527492,\n",
       "                                       'acid neutralizing capacity': 0.116480485,\n",
       "                                       'antigen-neutralizing capacity': 0.2079943,\n",
       "                                       'acid neutralisation capacity': 0.08647864,\n",
       "                                       'absolute neutrophil counts': 0.23128551,\n",
       "                                       'Army Nurse Corps': 0.14180806,\n",
       "                                       'antenatal clinic': 0.20451464,\n",
       "                                       'acid-neutralizing capacity': 0.1206309})}),\n",
       "             'Cohort 2 of the secondary trial and the primary trial are control groups, receiving a placebo tablet PO BID.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.20032287,\n",
       "                                       'parietal operculum': 0.17252626,\n",
       "                                       'post office': 0.10414999,\n",
       "                                       'percentage of observed value': 0.18478945,\n",
       "                                       'Phenol oxidase': 0.12925437,\n",
       "                                       'parapineal organ': 0.19142519,\n",
       "                                       'power output': 0.016208757,\n",
       "                                       'predominant organism': 0.11429801,\n",
       "                                       'pulse-oximetry': 0.19755219,\n",
       "                                       'perceptual organisation': 0.011110348,\n",
       "                                       'power outputs': -0.013199404,\n",
       "                                       'Personality Organization': 0.02591656,\n",
       "                                       'postoperative': 0.18835224,\n",
       "                                       'parieto occipital': 0.17579433,\n",
       "                                       'polyolefin': 0.09240678,\n",
       "                                       'parietooccipital': 0.15114246,\n",
       "                                       'poly-olefin': 0.10145744,\n",
       "                                       'peroral': 0.10961926,\n",
       "                                       'prostate only': 0.11068452,\n",
       "                                       'pressure overload': 0.06221158,\n",
       "                                       'peroxidase': 0.0346484,\n",
       "                                       'principal olive': 0.12411869,\n",
       "                                       'peri-operative': 0.17611979,\n",
       "                                       'posterior': 0.20275967,\n",
       "                                       'Perceptual Organization': 0.0006509014,\n",
       "                                       'period of onset': 0.13452901,\n",
       "                                       'posterior nuclear group': 0.11542416,\n",
       "                                       'phenol oxidase': 0.12925437,\n",
       "                                       'pressure': 0.07087057,\n",
       "                                       'per os (by mouth)': 0.22946484,\n",
       "                                       'parieto-occipital': 0.17222598,\n",
       "                                       'preoptic area': 0.053845163,\n",
       "                                       'perceptual organization': 0.0006509014,\n",
       "                                       'prophylactic oophorectomy': 0.10271707,\n",
       "                                       'phosphodiester': 0.15083432,\n",
       "                                       'pre-ovulatory': 0.18580626,\n",
       "                                       'palm oil': 0.07252175,\n",
       "                                       'preovulatory': 0.22080314,\n",
       "                                       'perioperative': 0.1862906,\n",
       "                                       'post operative': 0.18738726,\n",
       "                                       'post-operative': 0.18284416,\n",
       "                                       'phospho-diester': 0.09338907,\n",
       "                                       'protein oxidation': 0.040624004,\n",
       "                                       'palm-oil': 0.08173107,\n",
       "                                       'per os': 0.16386321,\n",
       "                                       'pericardial organ': 0.10200887,\n",
       "                                       'Pulse oximetry': 0.20032287,\n",
       "                                       'paraoxon': 0.23827921,\n",
       "                                       'propylene oxide': 0.22381341,\n",
       "                                       'phenoloxidase': 0.098233,\n",
       "                                       'peanut oil': 0.07389758}),\n",
       "                          'BID': defaultdict(float,\n",
       "                                      {'Bcl-2 interacting domain': -0.0014153756,\n",
       "                                       'Beta Interaction Domain': 0.08273641,\n",
       "                                       'body-image disturbance': 0.08389515,\n",
       "                                       'bis in die': 0.10127247,\n",
       "                                       'body image disturbance': 0.0690853,\n",
       "                                       'BCL-2 interacting domain': -0.0014153756,\n",
       "                                       'bipolar I disorder': 0.17506568,\n",
       "                                       'bis in die (twice a day)': 0.18607663,\n",
       "                                       'BH3-interacting-domain death agonist': 0.08403929,\n",
       "                                       'BH3 interacting domain death agonist': 0.07720244,\n",
       "                                       'beta-interaction domain': 0.06965737,\n",
       "                                       'body image dissatisfaction': 0.054601416,\n",
       "                                       'beta interaction domain': 0.08273641,\n",
       "                                       'body-image dissatisfaction': 0.07667498,\n",
       "                                       'bipolar-I disorder': 0.19881335,\n",
       "                                       'BH3-interacting domain death agonist': 0.075217225})}),\n",
       "             'Participants in cohort 1 of the primary trial weighing less than 45 kg receive 4 million units/m^2 less of IL-2, than participants over 45 kg, but all participants will be administered IL-2 3 times per week for 6 doses.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IL': defaultdict(float,\n",
       "                                      {'internal loop': 0.096941784,\n",
       "                                       'insertion loss': 0.048501343,\n",
       "                                       'Illinois': 0.05969493,\n",
       "                                       'interleukins': 0.34588453,\n",
       "                                       'interleukine': 0.3770604,\n",
       "                                       'intralipid': 0.19664195,\n",
       "                                       'intra-cellular loop': 0.12832154,\n",
       "                                       'ileum': 0.07511886,\n",
       "                                       'intra-ocular lens': 0.057972297,\n",
       "                                       'independent laboratory': 0.17704771,\n",
       "                                       'Intralipid': 0.19664195,\n",
       "                                       'Intravascular lymphomatosis': 0.13799848,\n",
       "                                       'ionic liquid': 0.00020664188,\n",
       "                                       'infralimbic': 0.03135682,\n",
       "                                       'Independent Living': 0.06479223,\n",
       "                                       'immature lung': 0.096138,\n",
       "                                       'Interleukin': 0.37609595,\n",
       "                                       'inguinal ligament': 0.12414948,\n",
       "                                       'interleukin': 0.37609595,\n",
       "                                       'immunoblastic lymphoma': 0.2092215,\n",
       "                                       'introgression line': 0.10642511,\n",
       "                                       'intraluminal': 0.12921591,\n",
       "                                       'intraocular lens': 0.05750799,\n",
       "                                       'intracellular loop': 0.11129193,\n",
       "                                       'intestinal lymphocyte': 0.20974061,\n",
       "                                       'Ionic liquid': 0.00020664188,\n",
       "                                       'intermediate lobe': 0.06670761})}),\n",
       "             'The Eribulin Mesylate group in the primary trial had a higher proportion of patients with complete response (CR) or partial response (PR) than the control group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.06988823,\n",
       "                                       'clot retraction': 0.09372178,\n",
       "                                       'conditioned response': 0.16479357,\n",
       "                                       'conditioned reflex': 0.08133525,\n",
       "                                       'charge recombination': 0.0589666,\n",
       "                                       'Czech Republic': -0.006963957,\n",
       "                                       'control region': 0.034634314,\n",
       "                                       'colonization rate': 0.041308835,\n",
       "                                       'complete remission rate': 0.4303064,\n",
       "                                       'Charles River': -0.024113324,\n",
       "                                       'Caloric restriction': 0.072815396,\n",
       "                                       'colonisation resistance': 0.07541358,\n",
       "                                       'complete regression': 0.11337887,\n",
       "                                       'conversion rate': 0.11561242,\n",
       "                                       'chest roentgenography': 0.13150461,\n",
       "                                       'chest radiograph': 0.11824611,\n",
       "                                       'colony reared': -0.02163772,\n",
       "                                       'cardiorespiratory': 0.08702726,\n",
       "                                       'circadian rhythm': 0.08311434,\n",
       "                                       'cardiac rupture': 0.14065059,\n",
       "                                       'carbonyl reductase': 0.14552703,\n",
       "                                       'calorie restriction': 0.047350004,\n",
       "                                       'cortical reaction': 0.1350489,\n",
       "                                       'complete remissions': 0.35507226,\n",
       "                                       'chest radiography': 0.101338275,\n",
       "                                       'computerised record': 0.021520533,\n",
       "                                       'charge-recombination': 0.07631506,\n",
       "                                       'Cardiac Rehabilitation': 0.14171854,\n",
       "                                       'calcium-binding protein calretinin': 0.17840464,\n",
       "                                       'chronic rejection': 0.1541959,\n",
       "                                       'colony-reared': -0.002559645,\n",
       "                                       'cognitive reserve': 0.09056745,\n",
       "                                       'critical ratio': 0.13456112,\n",
       "                                       'cortico-resistant': 0.30444482,\n",
       "                                       'caloric restriction': 0.072815396,\n",
       "                                       'corticoresistant': 0.16454488,\n",
       "                                       'corticosteroid-resistant': 0.28865266,\n",
       "                                       'Congo red': 0.030497892,\n",
       "                                       'complete responses': 0.22894104,\n",
       "                                       'chest and right arm': 0.02092158,\n",
       "                                       'conditioned reinforcement': 0.068362355,\n",
       "                                       'constant routine': 0.026354216,\n",
       "                                       'cardio-respiratory': 0.14013648,\n",
       "                                       'complete response rate': 0.34572595,\n",
       "                                       'cockroach': -0.020405669,\n",
       "                                       'chief resident': -0.057505295,\n",
       "                                       'calorie-restricted': 0.06861521,\n",
       "                                       'complete responders': 0.2675894,\n",
       "                                       'cysteine-rich': 0.15404569,\n",
       "                                       'controlled-release': 0.13973364,\n",
       "                                       'chemoradiation': 0.103661045,\n",
       "                                       'crown-rump': -0.03386645,\n",
       "                                       'crown-rump length': -0.0027802235,\n",
       "                                       'creatinine': 0.2816548,\n",
       "                                       'capture-recapture': 0.06739651,\n",
       "                                       'Congo-red': 0.054108582,\n",
       "                                       'coefficient of repeatability': 0.15817466,\n",
       "                                       'computed radiography': 0.08140362,\n",
       "                                       'controlled respiration': 0.12273263,\n",
       "                                       'conditioned reward': 0.095922545,\n",
       "                                       'complement receptors': 0.32386348,\n",
       "                                       'concentration-response': 0.18122911,\n",
       "                                       'complete': 0.07550979,\n",
       "                                       'chest roentgenogram': 0.15145211,\n",
       "                                       'complement receptor': 0.33565238,\n",
       "                                       'Cajal-Retzius': 0.016132617,\n",
       "                                       'cremasteric reflex': 0.16746743,\n",
       "                                       'clot-retraction': 0.070760526,\n",
       "                                       'conserved regions': -0.03620381,\n",
       "                                       'child-resistant': -0.01397694,\n",
       "                                       'control rats': 0.08233058,\n",
       "                                       'caries-resistant': 0.018286942,\n",
       "                                       'coronary revascularization': 0.19590259,\n",
       "                                       'colon resection': 0.085777804,\n",
       "                                       'contrast ratio': 0.07366645,\n",
       "                                       'concentration ratio': 0.1538953,\n",
       "                                       'Calreticulin': 0.2715526,\n",
       "                                       'composite resin': 0.012642664,\n",
       "                                       'completely': 0.09308639,\n",
       "                                       'colorectal': 0.11821547,\n",
       "                                       'complete response': 0.20411235,\n",
       "                                       'coronary risk': 0.16877422,\n",
       "                                       'conventional radiology': 0.16754344,\n",
       "                                       'Complete response': 0.20411235,\n",
       "                                       'cathode ray': -0.008820973,\n",
       "                                       'complete responder': 0.24904752,\n",
       "                                       'controlled release': 0.08895616,\n",
       "                                       'conditioned reflexes': 0.09217025,\n",
       "                                       'chemo-radiation': 0.32423657,\n",
       "                                       'complete remission': 0.29443973,\n",
       "                                       'conserved region': -0.036780182,\n",
       "                                       'coronary resistance': 0.21984279,\n",
       "                                       'cardiac resuscitation': 0.09443979,\n",
       "                                       'computed radiographic': 0.11483398,\n",
       "                                       'cooling rate': -0.012352183,\n",
       "                                       'clinical research': 0.3085309,\n",
       "                                       'colonization resistance': 0.041142855,\n",
       "                                       'compression ratio': -0.010516306,\n",
       "                                       'computerized record': 0.019346133,\n",
       "                                       'chromium': 0.07051206,\n",
       "                                       'colo-rectal': 0.08869074,\n",
       "                                       'contractile reserve': 0.10549155,\n",
       "                                       'clinical record': 0.25206146,\n",
       "                                       'concentration ratios': 0.16949257,\n",
       "                                       'clinical remission': 0.37148014,\n",
       "                                       'centric relation': 0.0030496682,\n",
       "                                       'cardiac rhythm': 0.080601834,\n",
       "                                       'capillary refill': 0.0969239,\n",
       "                                       'colonisation rate': 0.054708097,\n",
       "                                       'conventional radiography': 0.10235789,\n",
       "                                       'cellular receptor': 0.1913349}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.27097628,\n",
       "                                       'plaque reduction': -0.0031968802,\n",
       "                                       'partial response': 0.31040633,\n",
       "                                       'photoreactivation': 0.08169788,\n",
       "                                       'pentoxyresorufin': 0.12920122,\n",
       "                                       'panoramic radiography': 0.023313526,\n",
       "                                       'proliferative retinopathy': 0.17456777,\n",
       "                                       'partial responses': 0.30539262,\n",
       "                                       'protein': 0.06436197,\n",
       "                                       'prorennin': 0.20808628,\n",
       "                                       'prevalence rate': 0.17519622,\n",
       "                                       'prealbumin': 0.2164923,\n",
       "                                       'pregnancy rates': 0.06553808,\n",
       "                                       'pain relief': 0.081360705,\n",
       "                                       'partial remissions': 0.45149955,\n",
       "                                       'pattern recognition': -0.07460817,\n",
       "                                       'photo-reactivation': 0.09217701,\n",
       "                                       'protein restriction': 0.15591277,\n",
       "                                       'progesterone receptor': 0.20875372,\n",
       "                                       'placental restriction': 0.15549342,\n",
       "                                       'pneumatic retinopexy': 0.2221764,\n",
       "                                       'prorenin': 0.2590235,\n",
       "                                       'perirhinal cortex': 0.077887565,\n",
       "                                       'prothrombin ratio': 0.2872941,\n",
       "                                       'pars recta': 0.065085925,\n",
       "                                       'pattern reversal': -0.0006244635,\n",
       "                                       'pr interval (ekg)': 0.21525466,\n",
       "                                       'pityriasis rosea': 0.017555654,\n",
       "                                       'prevalence ratio': 0.21525133,\n",
       "                                       'Projection reconstruction': -0.0454355,\n",
       "                                       'pregnancy rate': 0.07746605,\n",
       "                                       'phenol red': 0.111888595,\n",
       "                                       'photoreceptor': 0.034418616,\n",
       "                                       'prednisolon': 0.25348148,\n",
       "                                       'partial responders': 0.32132792,\n",
       "                                       'proline-rich': 0.094659925,\n",
       "                                       'pseudorabies': 0.12755369,\n",
       "                                       'pulmonary regurgitation': 0.13648094,\n",
       "                                       'projection reconstruction': -0.0454355,\n",
       "                                       'photo-receptor': 0.119237095,\n",
       "                                       'protease': 0.16995624,\n",
       "                                       'progestine': 0.16052306,\n",
       "                                       'pentoxy-resorufin': 0.14946245,\n",
       "                                       'partial remission': 0.3913117,\n",
       "                                       'progestin receptor': 0.21184114,\n",
       "                                       'per rectum': 0.14673331,\n",
       "                                       'Plain radiography': 0.079296395,\n",
       "                                       'production rate': 0.08412916,\n",
       "                                       'pulmonary rehabilitation': 0.14802405,\n",
       "                                       'pentoxy resorufin': 0.15286316,\n",
       "                                       'proteinase': 0.09037964,\n",
       "                                       'Paeoniae radix': 0.14509238,\n",
       "                                       'Puerto Rico': 0.063161105,\n",
       "                                       'Prevalence ratios': 0.20978962,\n",
       "                                       'perirenal': 0.09423043,\n",
       "                                       'passive recovery': 0.08550197,\n",
       "                                       'propranolol': 0.23361692,\n",
       "                                       'primary response': 0.29070196,\n",
       "                                       'pregnant': 0.026833788,\n",
       "                                       'partial regression': 0.14649104,\n",
       "                                       'Photoreactivation': 0.08169788,\n",
       "                                       'peripheral resistance': 0.14216268,\n",
       "                                       'polymorphic reticulosis': 0.16690104,\n",
       "                                       'progressive ratio': 0.13870193,\n",
       "                                       'partial responder': 0.2863429,\n",
       "                                       'projection-reconstruction': -0.01512241,\n",
       "                                       'pro-renin': 0.25791365,\n",
       "                                       'phenol-red': 0.12119241,\n",
       "                                       'progestin': 0.17595944,\n",
       "                                       'pro-rennin': 0.20402291})}),\n",
       "             'More patients in cohort 2 of the primary trial had At Least 1 Adverse Event (AE) During the Treatment Period than in cohort 1.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'AE': defaultdict(float,\n",
       "                                      {'adverse events': 0.56840587,\n",
       "                                       'acute exacerbation': 0.34662268,\n",
       "                                       'atherosclerotic encephalopathy': 0.16956848,\n",
       "                                       'assimilation efficiency': -0.02108174,\n",
       "                                       'adverse-event': 0.5304129,\n",
       "                                       'atopic eczema': 0.17363374,\n",
       "                                       'apoenzyme': 0.09407685,\n",
       "                                       'apo-enzyme': 0.13442473,\n",
       "                                       'allylestrenol': 0.12872957,\n",
       "                                       'acrodermatitis enteropathica': 0.082381085,\n",
       "                                       'air entry': -0.046738766,\n",
       "                                       'anion exchange': 0.043756228,\n",
       "                                       'acoustic emission': -0.060808454,\n",
       "                                       'attaching and effacing': 0.015639909,\n",
       "                                       'aerobic exercise': 0.036245774,\n",
       "                                       'activation energy': -0.009992987,\n",
       "                                       'adverse effects': 0.36775887,\n",
       "                                       'air-entry': -0.048230447,\n",
       "                                       'adverse experience': 0.45131928,\n",
       "                                       'avian encephalomyelitis': 0.08238187,\n",
       "                                       'anion exchanger': 0.032635618,\n",
       "                                       'aqueous extract': 0.033507295,\n",
       "                                       'adverse event': 0.5125549,\n",
       "                                       'alcoholic embryopathy': 0.14606896,\n",
       "                                       'Absolute Error': 0.07927318,\n",
       "                                       'androstenedione': 0.08292582,\n",
       "                                       'anoxic encephalopathy': 0.10445936,\n",
       "                                       'alveolar echinococcosis': 0.13763782,\n",
       "                                       'agarose electrophoresis': 0.041040666,\n",
       "                                       'agricultural engineer': -0.009118382,\n",
       "                                       'Acoustic emission': -0.060808454,\n",
       "                                       'air embolism': 0.16492878,\n",
       "                                       'aeronautical engineer': 0.02143639,\n",
       "                                       'aldrin epoxidase': 0.14856145,\n",
       "                                       'absence epilepsy': 0.17772955,\n",
       "                                       'acridinium ester': 0.1398796})}),\n",
       "             'paclitaxel is the only drug in the primary trial given by IV.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.1501297,\n",
       "                                       'intravenous injection': 0.45009187,\n",
       "                                       'iridovirus': 0.25316292,\n",
       "                                       'intra-venous': 0.3512889,\n",
       "                                       'invitro': 0.22805774,\n",
       "                                       'intra ventricular': 0.23892571,\n",
       "                                       'intra vascular': 0.3360084,\n",
       "                                       'in vivo': 0.27356657,\n",
       "                                       'intravascular': 0.35508338,\n",
       "                                       'in-vivo': 0.31627902,\n",
       "                                       'inter-vertebral': 0.18595487,\n",
       "                                       'ichthyosis vulgaris': 0.07657103,\n",
       "                                       'intravenous': 0.4451492,\n",
       "                                       'intravaginal': 0.3009643,\n",
       "                                       'invasive': 0.118786246,\n",
       "                                       'iridescent virus': 0.18598872,\n",
       "                                       'isometric virus': 0.19029711,\n",
       "                                       'intravenous feeding device': 0.33749774,\n",
       "                                       'invivo': 0.22530073,\n",
       "                                       'instrumental variable': 0.17255022,\n",
       "                                       'intraventricular': 0.21722639,\n",
       "                                       'intra-vaginal': 0.28602695,\n",
       "                                       'intravertebral': 0.23250349,\n",
       "                                       'in vitro': 0.1734664,\n",
       "                                       'interventricular': 0.20266229,\n",
       "                                       'in-vitro': 0.23494427,\n",
       "                                       'intra venous': 0.3490548,\n",
       "                                       'iodine value': 0.04995314,\n",
       "                                       'ichnovirus': 0.17142579,\n",
       "                                       'inter-ventricular': 0.21457995,\n",
       "                                       'intra-vertebral': 0.23180512,\n",
       "                                       'intravenous injection device': 0.401839,\n",
       "                                       'intervertebral': 0.22723432,\n",
       "                                       'initial visit': 0.07714264,\n",
       "                                       'intravenous feeding': 0.35402152,\n",
       "                                       'intra-vascular': 0.3392536,\n",
       "                                       'intra-ventricular': 0.24002686})}),\n",
       "             'Abraxane + Tigatuzumab group of the primary trial has 10% more patients with either Complete Response (CR) disappearance of all target lesions; Partial Response (PR) at least a 30% decrease in the sum of the longest diameter of target lesions than the Abraxane Alone group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.13682006,\n",
       "                                       'clot retraction': 0.16758487,\n",
       "                                       'conditioned response': 0.108483955,\n",
       "                                       'conditioned reflex': 0.004118939,\n",
       "                                       'charge recombination': 0.08758196,\n",
       "                                       'Czech Republic': -0.017372666,\n",
       "                                       'control region': 0.11759208,\n",
       "                                       'colonization rate': 0.07204832,\n",
       "                                       'complete remission rate': 0.5057301,\n",
       "                                       'Charles River': -0.025025561,\n",
       "                                       'Caloric restriction': 0.013471483,\n",
       "                                       'colonisation resistance': 0.039122306,\n",
       "                                       'complete regression': 0.08155265,\n",
       "                                       'conversion rate': 0.10693599,\n",
       "                                       'chest roentgenography': 0.1685355,\n",
       "                                       'chest radiograph': 0.15170978,\n",
       "                                       'colony reared': -0.08808475,\n",
       "                                       'cardiorespiratory': -0.010558595,\n",
       "                                       'circadian rhythm': 0.02845114,\n",
       "                                       'cardiac rupture': 0.06354004,\n",
       "                                       'carbonyl reductase': 0.087088116,\n",
       "                                       'calorie restriction': 0.010690474,\n",
       "                                       'cortical reaction': 0.113852054,\n",
       "                                       'complete remissions': 0.43339178,\n",
       "                                       'chest radiography': 0.1673884,\n",
       "                                       'computerised record': -0.045444597,\n",
       "                                       'charge-recombination': 0.07655121,\n",
       "                                       'Cardiac Rehabilitation': 0.07644642,\n",
       "                                       'calcium-binding protein calretinin': 0.12756781,\n",
       "                                       'chronic rejection': 0.11911882,\n",
       "                                       'colony-reared': -0.073803626,\n",
       "                                       'cognitive reserve': -0.014661393,\n",
       "                                       'critical ratio': 0.15639839,\n",
       "                                       'cortico-resistant': 0.17907539,\n",
       "                                       'caloric restriction': 0.013471483,\n",
       "                                       'corticoresistant': 0.07148299,\n",
       "                                       'corticosteroid-resistant': 0.22455315,\n",
       "                                       'Congo red': 0.01936399,\n",
       "                                       'complete responses': 0.19285837,\n",
       "                                       'chest and right arm': 0.1487213,\n",
       "                                       'conditioned reinforcement': 0.014427579,\n",
       "                                       'constant routine': 0.026721226,\n",
       "                                       'cardio-respiratory': 0.06927269,\n",
       "                                       'complete response rate': 0.3457469,\n",
       "                                       'cockroach': -0.055416968,\n",
       "                                       'chief resident': -0.04422332,\n",
       "                                       'calorie-restricted': -0.0069989874,\n",
       "                                       'complete responders': 0.22664426,\n",
       "                                       'cysteine-rich': 0.019322723,\n",
       "                                       'controlled-release': 0.09851153,\n",
       "                                       'chemoradiation': 0.12883039,\n",
       "                                       'crown-rump': -0.029121626,\n",
       "                                       'crown-rump length': 0.04605749,\n",
       "                                       'creatinine': 0.045637302,\n",
       "                                       'capture-recapture': 0.09991078,\n",
       "                                       'Congo-red': 0.023688676,\n",
       "                                       'coefficient of repeatability': 0.116862275,\n",
       "                                       'computed radiography': 0.13505292,\n",
       "                                       'controlled respiration': 0.03234134,\n",
       "                                       'conditioned reward': 0.061720762,\n",
       "                                       'complement receptors': 0.24872231,\n",
       "                                       'concentration-response': 0.13162173,\n",
       "                                       'complete': 0.07492853,\n",
       "                                       'chest roentgenogram': 0.14868808,\n",
       "                                       'complement receptor': 0.2565505,\n",
       "                                       'Cajal-Retzius': 0.061252102,\n",
       "                                       'cremasteric reflex': 0.08107245,\n",
       "                                       'clot-retraction': 0.14210406,\n",
       "                                       'conserved regions': 0.060903803,\n",
       "                                       'child-resistant': -0.048788015,\n",
       "                                       'control rats': 0.10351559,\n",
       "                                       'caries-resistant': 0.10224908,\n",
       "                                       'coronary revascularization': 0.1950662,\n",
       "                                       'colon resection': 0.13812585,\n",
       "                                       'contrast ratio': 0.12890989,\n",
       "                                       'concentration ratio': 0.106365494,\n",
       "                                       'Calreticulin': 0.12770058,\n",
       "                                       'composite resin': -0.0040653762,\n",
       "                                       'completely': 0.116499,\n",
       "                                       'colorectal': 0.07045762,\n",
       "                                       'complete response': 0.20595953,\n",
       "                                       'coronary risk': 0.10372679,\n",
       "                                       'conventional radiology': 0.24276768,\n",
       "                                       'Complete response': 0.20595953,\n",
       "                                       'cathode ray': 0.04316124,\n",
       "                                       'complete responder': 0.20652136,\n",
       "                                       'controlled release': 0.067670934,\n",
       "                                       'conditioned reflexes': 0.018456372,\n",
       "                                       'chemo-radiation': 0.4192215,\n",
       "                                       'complete remission': 0.37041408,\n",
       "                                       'conserved region': 0.044667352,\n",
       "                                       'coronary resistance': 0.16846816,\n",
       "                                       'cardiac resuscitation': 0.027986418,\n",
       "                                       'computed radiographic': 0.13838248,\n",
       "                                       'cooling rate': 0.04971145,\n",
       "                                       'clinical research': 0.21505554,\n",
       "                                       'colonization resistance': 0.035850134,\n",
       "                                       'compression ratio': 0.005156023,\n",
       "                                       'computerized record': -0.045114636,\n",
       "                                       'chromium': 0.0680658,\n",
       "                                       'colo-rectal': 0.095066376,\n",
       "                                       'contractile reserve': 0.042039964,\n",
       "                                       'clinical record': 0.12036849,\n",
       "                                       'concentration ratios': 0.12788795,\n",
       "                                       'clinical remission': 0.38451847,\n",
       "                                       'centric relation': 0.001713291,\n",
       "                                       'cardiac rhythm': 0.030137679,\n",
       "                                       'capillary refill': 0.051151473,\n",
       "                                       'colonisation rate': 0.06540209,\n",
       "                                       'conventional radiography': 0.15269692,\n",
       "                                       'cellular receptor': 0.18257107}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.21272923,\n",
       "                                       'plaque reduction': 0.1637799,\n",
       "                                       'partial response': 0.29158798,\n",
       "                                       'photoreactivation': 0.111325085,\n",
       "                                       'pentoxyresorufin': 0.08006147,\n",
       "                                       'panoramic radiography': 0.109451614,\n",
       "                                       'proliferative retinopathy': 0.21919446,\n",
       "                                       'partial responses': 0.27163193,\n",
       "                                       'protein': -0.050316997,\n",
       "                                       'prorennin': 0.08284814,\n",
       "                                       'prevalence rate': 0.18607609,\n",
       "                                       'prealbumin': 0.07772493,\n",
       "                                       'pregnancy rates': 0.054941498,\n",
       "                                       'pain relief': 0.114570044,\n",
       "                                       'partial remissions': 0.52211976,\n",
       "                                       'pattern recognition': 0.021473862,\n",
       "                                       'photo-reactivation': 0.12120837,\n",
       "                                       'protein restriction': 0.0374963,\n",
       "                                       'progesterone receptor': 0.10144939,\n",
       "                                       'placental restriction': 0.06186221,\n",
       "                                       'pneumatic retinopexy': 0.23261839,\n",
       "                                       'prorenin': 0.10102948,\n",
       "                                       'perirhinal cortex': 0.113375984,\n",
       "                                       'prothrombin ratio': 0.1186903,\n",
       "                                       'pars recta': 0.04714876,\n",
       "                                       'pattern reversal': 0.0655415,\n",
       "                                       'pr interval (ekg)': 0.12500787,\n",
       "                                       'pityriasis rosea': 0.021169996,\n",
       "                                       'prevalence ratio': 0.20707841,\n",
       "                                       'Projection reconstruction': -0.021765921,\n",
       "                                       'pregnancy rate': 0.07169875,\n",
       "                                       'phenol red': 0.083604746,\n",
       "                                       'photoreceptor': 0.01906419,\n",
       "                                       'prednisolon': 0.20453474,\n",
       "                                       'partial responders': 0.28833032,\n",
       "                                       'proline-rich': -0.013246479,\n",
       "                                       'pseudorabies': 0.115184136,\n",
       "                                       'pulmonary regurgitation': 0.069898404,\n",
       "                                       'projection reconstruction': -0.021765921,\n",
       "                                       'photo-receptor': 0.13506374,\n",
       "                                       'protease': 0.07019593,\n",
       "                                       'progestine': 0.04219806,\n",
       "                                       'pentoxy-resorufin': 0.12518312,\n",
       "                                       'partial remission': 0.45283568,\n",
       "                                       'progestin receptor': 0.107262686,\n",
       "                                       'per rectum': 0.08727387,\n",
       "                                       'Plain radiography': 0.10850484,\n",
       "                                       'production rate': 0.08403788,\n",
       "                                       'pulmonary rehabilitation': 0.046235908,\n",
       "                                       'pentoxy resorufin': 0.1316118,\n",
       "                                       'proteinase': 0.051490583,\n",
       "                                       'Paeoniae radix': 0.055367894,\n",
       "                                       'Puerto Rico': 0.029393155,\n",
       "                                       'Prevalence ratios': 0.2098818,\n",
       "                                       'perirenal': 0.01482627,\n",
       "                                       'passive recovery': 0.1532146,\n",
       "                                       'propranolol': 0.1947728,\n",
       "                                       'primary response': 0.27721766,\n",
       "                                       'pregnant': -0.01671157,\n",
       "                                       'partial regression': 0.12538202,\n",
       "                                       'Photoreactivation': 0.111325085,\n",
       "                                       'peripheral resistance': 0.20489268,\n",
       "                                       'polymorphic reticulosis': 0.14695695,\n",
       "                                       'progressive ratio': 0.21078277,\n",
       "                                       'partial responder': 0.2644103,\n",
       "                                       'projection-reconstruction': 0.013334627,\n",
       "                                       'pro-renin': 0.13095245,\n",
       "                                       'phenol-red': 0.10342752,\n",
       "                                       'progestin': 0.06215105,\n",
       "                                       'pro-rennin': 0.10820281})}),\n",
       "             'the primary trial participants must take 6 tablets of Lapatinib Monotherapy (1500g) PO once daily.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.11759211,\n",
       "                                       'parietal operculum': 0.116695546,\n",
       "                                       'post office': 0.062275786,\n",
       "                                       'percentage of observed value': 0.1395616,\n",
       "                                       'Phenol oxidase': 0.08966468,\n",
       "                                       'parapineal organ': 0.10734969,\n",
       "                                       'power output': 0.04954738,\n",
       "                                       'predominant organism': 0.07347182,\n",
       "                                       'pulse-oximetry': 0.11811601,\n",
       "                                       'perceptual organisation': -0.025216797,\n",
       "                                       'power outputs': -0.011402703,\n",
       "                                       'Personality Organization': -0.04073708,\n",
       "                                       'postoperative': 0.14385417,\n",
       "                                       'parieto occipital': 0.12238722,\n",
       "                                       'polyolefin': 0.15230174,\n",
       "                                       'parietooccipital': 0.080524996,\n",
       "                                       'poly-olefin': 0.11689816,\n",
       "                                       'peroral': 0.14148428,\n",
       "                                       'prostate only': 0.12680738,\n",
       "                                       'pressure overload': 0.046230476,\n",
       "                                       'peroxidase': 0.09210787,\n",
       "                                       'principal olive': 0.105899036,\n",
       "                                       'peri-operative': 0.089326255,\n",
       "                                       'posterior': 0.061888736,\n",
       "                                       'Perceptual Organization': -0.025700003,\n",
       "                                       'period of onset': 0.11985551,\n",
       "                                       'posterior nuclear group': 0.04212049,\n",
       "                                       'phenol oxidase': 0.08966468,\n",
       "                                       'pressure': -0.0016390384,\n",
       "                                       'per os (by mouth)': 0.20433284,\n",
       "                                       'parieto-occipital': 0.106908016,\n",
       "                                       'preoptic area': 0.025631664,\n",
       "                                       'perceptual organization': -0.025700003,\n",
       "                                       'prophylactic oophorectomy': 0.12601508,\n",
       "                                       'phosphodiester': 0.1098964,\n",
       "                                       'pre-ovulatory': 0.110049784,\n",
       "                                       'palm oil': 0.091563664,\n",
       "                                       'preovulatory': 0.18684182,\n",
       "                                       'perioperative': 0.16204214,\n",
       "                                       'post operative': 0.12174984,\n",
       "                                       'post-operative': 0.1319425,\n",
       "                                       'phospho-diester': 0.0107698785,\n",
       "                                       'protein oxidation': 0.07424969,\n",
       "                                       'palm-oil': 0.039216135,\n",
       "                                       'per os': 0.12133654,\n",
       "                                       'pericardial organ': 0.079203464,\n",
       "                                       'Pulse oximetry': 0.11759211,\n",
       "                                       'paraoxon': 0.24029209,\n",
       "                                       'propylene oxide': 0.16963972,\n",
       "                                       'phenoloxidase': 0.11084564,\n",
       "                                       'peanut oil': 0.11682384})}),\n",
       "             'Participants with T2 N1 M0 breast carcinoma are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'T2': defaultdict(float,\n",
       "                                      {'time 2': 0.14392443,\n",
       "                                       'type 2': 0.21264383,\n",
       "                                       't2 (thoracic vertebra 2)': 0.25174424,\n",
       "                                       't2dm': 0.17253375,\n",
       "                                       'transverse relaxation': 0.0524533,\n",
       "                                       'twins two': 0.10248163,\n",
       "                                       'therapy': 0.0992896,\n",
       "                                       'Time 2': 0.14392443,\n",
       "                                       'thoracic vertebra 2': 0.112592235,\n",
       "                                       'T-2 toxin': 0.25777766}),\n",
       "                          'N1': defaultdict(float,\n",
       "                                      {'negativity': -0.01027764,\n",
       "                                       'negative wave': -0.039316107,\n",
       "                                       'negative peak': 0.02568557,\n",
       "                                       'negative': 0.059153248,\n",
       "                                       'negative component': -0.03081409}),\n",
       "                          'M0': defaultdict(float,\n",
       "                                      {'metastasis': 0.2671945})}),\n",
       "             'the primary trial results show that Zoledronic Acid Upfront is a better treatment than Zoledronic Acid Delayed-start for increasing Lumbar Spine (L1-L4) Bone Mineral Density (BMD).': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'L1': defaultdict(float,\n",
       "                                      {'l1 (first lumbar vertebra)': 0.40567958,\n",
       "                                       'long interspersed nucleotide element 1': 0.0885608,\n",
       "                                       'long interspersed nucleotide element-1': 0.09337807,\n",
       "                                       'LINE-1': 0.044554394,\n",
       "                                       'Long Interspersed Sequence One': 0.060953777,\n",
       "                                       'lipoxygenase-1': 0.15300259,\n",
       "                                       'long interspersed nuclear element 1': 0.026612636,\n",
       "                                       'long interspersed element 1': 0.026670353,\n",
       "                                       'lipoxygenase 1': 0.13486011,\n",
       "                                       'lumbar 1': 0.3999723,\n",
       "                                       'long interspersed nuclear element-1': 0.03804831,\n",
       "                                       'lymphatic vessel invasion stage 1': 0.13042107,\n",
       "                                       'long interspersed element-1': 0.029718874,\n",
       "                                       'lumbar vertebra 1': 0.40414137}),\n",
       "                          'BMD': defaultdict(float,\n",
       "                                      {'Becker muscular dystrophy': 0.095969714,\n",
       "                                       'bacitracin methylenedisalicylate': 0.1477503,\n",
       "                                       'Best macular dystrophy': 0.22699644,\n",
       "                                       'bone-mineral density': 0.42278567,\n",
       "                                       'bone mineral densities': 0.361771,\n",
       "                                       \"Best's macular dystrophy\": 0.19186892,\n",
       "                                       'benchmark dose': 0.27535167,\n",
       "                                       'broth microdilution': 0.118537575,\n",
       "                                       'bacitracin methylene disalicylate': 0.15503202,\n",
       "                                       'Bone mineral density': 0.43046787,\n",
       "                                       \"Becker's muscular dystrophy\": 0.1113716,\n",
       "                                       'bone mass density': 0.3450368,\n",
       "                                       'bone mineral density': 0.43046787,\n",
       "                                       'bone mineral densitometry': 0.35571054})}),\n",
       "             'the primary trial Patients receiving Neratinib Plus Capecitabine had a PFS  much longer than the study time frame of 38 months.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.14927536,\n",
       "                                       'pyrogen-free saline': 0.15741469,\n",
       "                                       'pressure-flow study': -0.048977427,\n",
       "                                       'posterior fossa syndrome': 0.15196945,\n",
       "                                       'pressure flow study': -0.04284789,\n",
       "                                       'primary fibromyalgia syndrome': 0.1992562,\n",
       "                                       'Piper Fatigue Scale': 0.08717077,\n",
       "                                       'patellofemoral syndrome': 0.17052534,\n",
       "                                       'Progression-free': 0.12347471,\n",
       "                                       'pulmonary function score': 0.225961,\n",
       "                                       'pressure flow studies': -0.04386922,\n",
       "                                       'protein-free supernatant': 0.068855435,\n",
       "                                       'progression free survival': 0.3416536,\n",
       "                                       'protein free supernatant': 0.0908508,\n",
       "                                       'progression-free survival': 0.36500546,\n",
       "                                       'pressure/flow study': -0.03324163})}),\n",
       "             'less than 60 participants in the TCH + P group of the primary trial achieved Total Pathological Complete Response (tpCR) Assessed Based on Tumor Samples.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'TCH': defaultdict(float,\n",
       "                                      {'turn, cough, hyperventilate': 0.005471373,\n",
       "                                       'tanned cell haemagglutination': 0.14184397,\n",
       "                                       \"Texas Children's Hospital\": 0.15207541,\n",
       "                                       'thiocarbohydrazide': 0.17780592,\n",
       "                                       'total circulating haemoglobin': 0.19504444,\n",
       "                                       'tetracycline hydrochloride': 0.15638284,\n",
       "                                       'tanned cell hemagglutination': 0.1679607,\n",
       "                                       'total cholesterol': 0.14308925,\n",
       "                                       'thunderclap headache': 0.017850505,\n",
       "                                       'total circulating hemoglobin': 0.19122586})}),\n",
       "             'Most the primary trial subjects experienced a complete response (CR), partial response (PR), or stable disease (SD) for at least 24 weeks.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.06553202,\n",
       "                                       'clot retraction': 0.14613925,\n",
       "                                       'conditioned response': 0.2668245,\n",
       "                                       'conditioned reflex': 0.16602145,\n",
       "                                       'charge recombination': 0.00090249255,\n",
       "                                       'Czech Republic': -0.0034807557,\n",
       "                                       'control region': 0.038601246,\n",
       "                                       'colonization rate': 0.098434016,\n",
       "                                       'complete remission rate': 0.568823,\n",
       "                                       'Charles River': -0.008214683,\n",
       "                                       'Caloric restriction': 0.11040648,\n",
       "                                       'colonisation resistance': 0.0764771,\n",
       "                                       'complete regression': 0.18810835,\n",
       "                                       'conversion rate': 0.1242994,\n",
       "                                       'chest roentgenography': 0.15798129,\n",
       "                                       'chest radiograph': 0.13301851,\n",
       "                                       'colony reared': 0.019312933,\n",
       "                                       'cardiorespiratory': 0.13536048,\n",
       "                                       'circadian rhythm': 0.13826157,\n",
       "                                       'cardiac rupture': 0.12728964,\n",
       "                                       'carbonyl reductase': 0.067943655,\n",
       "                                       'calorie restriction': 0.079060525,\n",
       "                                       'cortical reaction': 0.17440087,\n",
       "                                       'complete remissions': 0.4897384,\n",
       "                                       'chest radiography': 0.1259335,\n",
       "                                       'computerised record': 0.039334454,\n",
       "                                       'charge-recombination': 0.013934182,\n",
       "                                       'Cardiac Rehabilitation': 0.31166434,\n",
       "                                       'calcium-binding protein calretinin': 0.15505289,\n",
       "                                       'chronic rejection': 0.12692612,\n",
       "                                       'colony-reared': 0.03702885,\n",
       "                                       'cognitive reserve': 0.10816037,\n",
       "                                       'critical ratio': 0.12289466,\n",
       "                                       'cortico-resistant': 0.32862127,\n",
       "                                       'caloric restriction': 0.11040648,\n",
       "                                       'corticoresistant': 0.14096105,\n",
       "                                       'corticosteroid-resistant': 0.32405353,\n",
       "                                       'Congo red': -0.02871753,\n",
       "                                       'complete responses': 0.2562466,\n",
       "                                       'chest and right arm': 0.07631926,\n",
       "                                       'conditioned reinforcement': 0.14990525,\n",
       "                                       'constant routine': 0.17036334,\n",
       "                                       'cardio-respiratory': 0.20872332,\n",
       "                                       'complete response rate': 0.42521152,\n",
       "                                       'cockroach': -0.04363423,\n",
       "                                       'chief resident': -0.00011498667,\n",
       "                                       'calorie-restricted': 0.11557767,\n",
       "                                       'complete responders': 0.26185763,\n",
       "                                       'cysteine-rich': 0.09950536,\n",
       "                                       'controlled-release': 0.23349829,\n",
       "                                       'chemoradiation': 0.120052576,\n",
       "                                       'crown-rump': -0.029757833,\n",
       "                                       'crown-rump length': 0.08241195,\n",
       "                                       'creatinine': 0.16935486,\n",
       "                                       'capture-recapture': 0.046023283,\n",
       "                                       'Congo-red': -0.011400174,\n",
       "                                       'coefficient of repeatability': 0.23612101,\n",
       "                                       'computed radiography': 0.10122123,\n",
       "                                       'controlled respiration': 0.19404958,\n",
       "                                       'conditioned reward': 0.15548596,\n",
       "                                       'complement receptors': 0.22395651,\n",
       "                                       'concentration-response': 0.21860355,\n",
       "                                       'complete': 0.09237316,\n",
       "                                       'chest roentgenogram': 0.17513062,\n",
       "                                       'complement receptor': 0.23327044,\n",
       "                                       'Cajal-Retzius': 0.04954445,\n",
       "                                       'cremasteric reflex': 0.23511183,\n",
       "                                       'clot-retraction': 0.126068,\n",
       "                                       'conserved regions': -0.040598717,\n",
       "                                       'child-resistant': 0.019181354,\n",
       "                                       'control rats': 0.100755855,\n",
       "                                       'caries-resistant': 0.12482392,\n",
       "                                       'coronary revascularization': 0.26064354,\n",
       "                                       'colon resection': 0.12809406,\n",
       "                                       'contrast ratio': 0.04168435,\n",
       "                                       'concentration ratio': 0.1457221,\n",
       "                                       'Calreticulin': 0.14692555,\n",
       "                                       'composite resin': 0.027475832,\n",
       "                                       'completely': 0.14819014,\n",
       "                                       'colorectal': 0.10935585,\n",
       "                                       'complete response': 0.24302171,\n",
       "                                       'coronary risk': 0.1620685,\n",
       "                                       'conventional radiology': 0.19023246,\n",
       "                                       'Complete response': 0.24302171,\n",
       "                                       'cathode ray': 0.009613205,\n",
       "                                       'complete responder': 0.25771385,\n",
       "                                       'controlled release': 0.18478322,\n",
       "                                       'conditioned reflexes': 0.1793613,\n",
       "                                       'chemo-radiation': 0.29275316,\n",
       "                                       'complete remission': 0.422952,\n",
       "                                       'conserved region': -0.028485615,\n",
       "                                       'coronary resistance': 0.31572524,\n",
       "                                       'cardiac resuscitation': 0.19647232,\n",
       "                                       'computed radiographic': 0.113919124,\n",
       "                                       'cooling rate': 0.1079718,\n",
       "                                       'clinical research': 0.36579618,\n",
       "                                       'colonization resistance': 0.05784588,\n",
       "                                       'compression ratio': -0.009181172,\n",
       "                                       'computerized record': 0.03858074,\n",
       "                                       'chromium': 0.061216258,\n",
       "                                       'colo-rectal': 0.11138701,\n",
       "                                       'contractile reserve': 0.12408035,\n",
       "                                       'clinical record': 0.29573095,\n",
       "                                       'concentration ratios': 0.12662986,\n",
       "                                       'clinical remission': 0.50709105,\n",
       "                                       'centric relation': -0.0435007,\n",
       "                                       'cardiac rhythm': 0.13708502,\n",
       "                                       'capillary refill': 0.05434662,\n",
       "                                       'colonisation rate': 0.05820356,\n",
       "                                       'conventional radiography': 0.1284915,\n",
       "                                       'cellular receptor': 0.14318427}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.2245745,\n",
       "                                       'plaque reduction': 0.15928653,\n",
       "                                       'partial response': 0.345928,\n",
       "                                       'photoreactivation': 0.11495541,\n",
       "                                       'pentoxyresorufin': 0.08572944,\n",
       "                                       'panoramic radiography': 0.10829152,\n",
       "                                       'proliferative retinopathy': 0.15428492,\n",
       "                                       'partial responses': 0.32248968,\n",
       "                                       'protein': 0.05315767,\n",
       "                                       'prorennin': 0.13125062,\n",
       "                                       'prevalence rate': 0.17012444,\n",
       "                                       'prealbumin': 0.099027306,\n",
       "                                       'pregnancy rates': 0.023572497,\n",
       "                                       'pain relief': 0.10208109,\n",
       "                                       'partial remissions': 0.5329531,\n",
       "                                       'pattern recognition': -0.03892075,\n",
       "                                       'photo-reactivation': 0.1889288,\n",
       "                                       'protein restriction': 0.08003699,\n",
       "                                       'progesterone receptor': 0.13019022,\n",
       "                                       'placental restriction': 0.10338284,\n",
       "                                       'pneumatic retinopexy': 0.23332381,\n",
       "                                       'prorenin': 0.19444692,\n",
       "                                       'perirhinal cortex': 0.09324413,\n",
       "                                       'prothrombin ratio': 0.1578128,\n",
       "                                       'pars recta': 0.06850066,\n",
       "                                       'pattern reversal': 0.014616112,\n",
       "                                       'pr interval (ekg)': 0.25946456,\n",
       "                                       'pityriasis rosea': 0.06593939,\n",
       "                                       'prevalence ratio': 0.17282276,\n",
       "                                       'Projection reconstruction': -0.02639665,\n",
       "                                       'pregnancy rate': 0.044059023,\n",
       "                                       'phenol red': 0.072365716,\n",
       "                                       'photoreceptor': -0.0039932006,\n",
       "                                       'prednisolon': 0.21784031,\n",
       "                                       'partial responders': 0.30792117,\n",
       "                                       'proline-rich': 0.02098623,\n",
       "                                       'pseudorabies': 0.090194725,\n",
       "                                       'pulmonary regurgitation': 0.16714884,\n",
       "                                       'projection reconstruction': -0.02639665,\n",
       "                                       'photo-receptor': 0.043976363,\n",
       "                                       'protease': 0.13846967,\n",
       "                                       'progestine': 0.10285097,\n",
       "                                       'pentoxy-resorufin': 0.15235686,\n",
       "                                       'partial remission': 0.49943143,\n",
       "                                       'progestin receptor': 0.09237374,\n",
       "                                       'per rectum': 0.12603751,\n",
       "                                       'Plain radiography': 0.089020684,\n",
       "                                       'production rate': 0.14339119,\n",
       "                                       'pulmonary rehabilitation': 0.30318218,\n",
       "                                       'pentoxy resorufin': 0.16795366,\n",
       "                                       'proteinase': 0.08290473,\n",
       "                                       'Paeoniae radix': 0.07534997,\n",
       "                                       'Puerto Rico': -0.01092897,\n",
       "                                       'Prevalence ratios': 0.15277912,\n",
       "                                       'perirenal': 0.04090302,\n",
       "                                       'passive recovery': 0.18252578,\n",
       "                                       'propranolol': 0.15515901,\n",
       "                                       'primary response': 0.346289,\n",
       "                                       'pregnant': -0.00076747406,\n",
       "                                       'partial regression': 0.17206705,\n",
       "                                       'Photoreactivation': 0.11495541,\n",
       "                                       'peripheral resistance': 0.2107446,\n",
       "                                       'polymorphic reticulosis': 0.13475472,\n",
       "                                       'progressive ratio': 0.2539877,\n",
       "                                       'partial responder': 0.28537917,\n",
       "                                       'projection-reconstruction': 0.021153813,\n",
       "                                       'pro-renin': 0.17304283,\n",
       "                                       'phenol-red': 0.08507432,\n",
       "                                       'progestin': 0.072064154,\n",
       "                                       'pro-rennin': 0.13041538}),\n",
       "                          'SD': defaultdict(float,\n",
       "                                      {'superoxide-dismutase': 0.13860156,\n",
       "                                       'segregation distortion': -0.06350115,\n",
       "                                       'seborrheic dermatitis': 0.10702645,\n",
       "                                       'solvent/detergent': -0.022812547,\n",
       "                                       'standard-dose': 0.3072562,\n",
       "                                       'splice donor': 0.089608796,\n",
       "                                       'superoxyde dismutase': 0.13655692,\n",
       "                                       \"Sjogren's disease\": 0.2218263,\n",
       "                                       'Sprague Dawley': -0.029980937,\n",
       "                                       'Shine-Dalgarno sequence': 0.055639476,\n",
       "                                       'spasmodic dysphonia': 0.120965704,\n",
       "                                       'substance dependence': 0.113889374,\n",
       "                                       'shoulder dislocation': 0.08076525,\n",
       "                                       'short days': 0.14137463,\n",
       "                                       'sorbitol dehydrogenase': 0.10053664,\n",
       "                                       'systolic dysfunction': 0.13623385,\n",
       "                                       'sorbital dehydrogenase': 0.11363657,\n",
       "                                       'shoulder disarticulation': 0.13433558,\n",
       "                                       'sudden death': 0.086827986,\n",
       "                                       'serologically detected': 0.1374411,\n",
       "                                       'solvent-detergent': -0.024817044,\n",
       "                                       'somadendritic': -0.0752303,\n",
       "                                       'swine dysentery': 0.15143396,\n",
       "                                       'sleep-deprivation': 0.1107413,\n",
       "                                       'scalloped': -0.07911732,\n",
       "                                       \"Sjögren's disease\": 0.2218263,\n",
       "                                       'sagittal depth': 0.069798864,\n",
       "                                       'Scotch douche': -0.06913168,\n",
       "                                       'single-dose': 0.30909765,\n",
       "                                       'skin destruction': 0.016902804,\n",
       "                                       'Spatial disorientation': 0.022711758,\n",
       "                                       'selective decontamination': 0.18622726,\n",
       "                                       'short photoperiod': 0.12432554,\n",
       "                                       'short-day': 0.18664514,\n",
       "                                       'sexual dysfunction': 0.12433983,\n",
       "                                       'spermidine': 0.050733116,\n",
       "                                       'strength duration': 0.31841528,\n",
       "                                       'superoxide dismutase': 0.124163754,\n",
       "                                       \"Stensen's duct\": 0.07653459,\n",
       "                                       'somatization disorder': 0.17782444,\n",
       "                                       'sphincter dilatation': 0.10650234,\n",
       "                                       'sleep deprivation': 0.12956475,\n",
       "                                       'solid dispersion': -0.024400126,\n",
       "                                       'senile dementia': 0.09406192,\n",
       "                                       'soma-dendritic': 0.23176141,\n",
       "                                       'Sprague Dawley rat': 0.18512681,\n",
       "                                       'Sprague-Dawley': 0.20834085,\n",
       "                                       'stone disintegration': 0.006244788,\n",
       "                                       'serologically defined': 0.046887983,\n",
       "                                       'succinate-dehydrogenase': 0.12335297,\n",
       "                                       'seborrhoeic dermatitis': 0.09825203,\n",
       "                                       'standard-deviation': 0.06912585,\n",
       "                                       'stroke distance': 0.08964101,\n",
       "                                       'somatisation disorder': 0.15277961,\n",
       "                                       'spectral domain': -0.03449138,\n",
       "                                       'self-directedness': 0.044445094,\n",
       "                                       'steroid-dependant': 0.2163974,\n",
       "                                       \"Still's disease\": 0.14165853,\n",
       "                                       'Scotch-douche': -0.06129267,\n",
       "                                       'standard diet': 0.22474024,\n",
       "                                       'spontaneous delivery': 0.068418875,\n",
       "                                       'specially denatured': -0.0066821203,\n",
       "                                       'solvent and detergent': -0.018256752,\n",
       "                                       'serum defect': 0.1910081,\n",
       "                                       'sleep disorders': 0.11206782,\n",
       "                                       'segregation distorter': -0.04917934,\n",
       "                                       'stable disease': 0.40245196,\n",
       "                                       'stimulus drive': 0.19581528,\n",
       "                                       'Salla disease': 0.17353669,\n",
       "                                       'serologically determined': 0.15032765,\n",
       "                                       'striated duct': -0.0059212707,\n",
       "                                       'streptodornase': 0.11764036,\n",
       "                                       'Sprague-Dawley rat': 0.31571275,\n",
       "                                       'single dose': 0.25296468,\n",
       "                                       'social desirability': -0.032019082,\n",
       "                                       'sulfadiazine': 0.16256775,\n",
       "                                       'sporadic depression': 0.21187405,\n",
       "                                       'spreading depression': 0.035157047,\n",
       "                                       'septal defect': 0.0864334,\n",
       "                                       'systolic discharge': 0.23594487,\n",
       "                                       'steroid-dependent': 0.26931763,\n",
       "                                       'semantic differential': 0.002286725,\n",
       "                                       'succinatedehydrogenase': 0.21427952,\n",
       "                                       'Sprague-Dawley rats': 0.3154114,\n",
       "                                       'spatial disorientation': 0.022711758,\n",
       "                                       'severe disability': 0.1446447,\n",
       "                                       'super oxyde dismutase': 0.13666391,\n",
       "                                       'skin dose': 0.14277667,\n",
       "                                       'sleep disorder': 0.103486404,\n",
       "                                       'somatoform disorder': 0.10353843,\n",
       "                                       'standard deviations': 0.062791385,\n",
       "                                       'super-oxide dismutase': 0.05311013,\n",
       "                                       'semantic dementia': 0.07055615,\n",
       "                                       'sudden deafness': 0.053177547,\n",
       "                                       'standard dose': 0.29607657,\n",
       "                                       'Sprague--Dawley': 0.047787894,\n",
       "                                       'short day': 0.108238444,\n",
       "                                       'Shine-Dalgarno': 0.0015338473,\n",
       "                                       'succinate dehydrogenase': 0.1091647,\n",
       "                                       'standard deviation': 0.0520204,\n",
       "                                       'steroid dependant': 0.21742386,\n",
       "                                       'super oxide dismutase': 0.06992457,\n",
       "                                       'stable': 0.07304977,\n",
       "                                       'serologically detectable': 0.1777589,\n",
       "                                       \"Sandhoff's disease\": 0.1553116,\n",
       "                                       'steroid dependent': 0.23202592})}),\n",
       "             'The placebo group in the primary trial had a much lower Median PFS than the MM-121 cohort.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.12942739,\n",
       "                                       'pyrogen-free saline': 0.18430425,\n",
       "                                       'pressure-flow study': 0.0006413684,\n",
       "                                       'posterior fossa syndrome': 0.19258,\n",
       "                                       'pressure flow study': 0.0079701925,\n",
       "                                       'primary fibromyalgia syndrome': 0.2742141,\n",
       "                                       'Piper Fatigue Scale': 0.1306595,\n",
       "                                       'patellofemoral syndrome': 0.16299358,\n",
       "                                       'Progression-free': 0.05320359,\n",
       "                                       'pulmonary function score': 0.22083586,\n",
       "                                       'pressure flow studies': 0.013400552,\n",
       "                                       'protein-free supernatant': 0.07235884,\n",
       "                                       'progression free survival': 0.17590113,\n",
       "                                       'protein free supernatant': 0.08407532,\n",
       "                                       'progression-free survival': 0.22704671,\n",
       "                                       'pressure/flow study': 0.018392032}),\n",
       "                          'MM': defaultdict(float,\n",
       "                                      {'mixed micelles': 0.062216867,\n",
       "                                       'mathematical morphology': -0.09182375,\n",
       "                                       'Michaelis-Menten': 0.038985576,\n",
       "                                       'Mycoplasma meleagridis': 0.0064666723,\n",
       "                                       'malignant melanomas': 0.1114941,\n",
       "                                       'mismatch': 0.14041106,\n",
       "                                       'Malignant mesothelioma': 0.11368943,\n",
       "                                       'myelomeningocoele': 0.087852515,\n",
       "                                       'malignant mesothelioma': 0.11368943,\n",
       "                                       'megamitochondria': 0.027567467,\n",
       "                                       'meningococcal meningitis': 0.082364455,\n",
       "                                       'Miyoshi myopathy': 0.14274739,\n",
       "                                       'middle meningeal': 0.16459994,\n",
       "                                       'Michaelis Menten': 0.045358244,\n",
       "                                       'myelo-meningocoele': 0.111557916,\n",
       "                                       'muscularis mucosae': 0.023178047,\n",
       "                                       'mycophenolate mofetil': 0.24706063,\n",
       "                                       'methylmercury': 0.079490915,\n",
       "                                       'Menstrual Migraine': 0.0842624,\n",
       "                                       'macro-molecule': -0.02908893,\n",
       "                                       'molecular mechanics': -0.11214971,\n",
       "                                       'methadone maintenance': 0.07241486,\n",
       "                                       'multiple myelomas': 0.14216864,\n",
       "                                       'myelomeningocele': 0.06816938,\n",
       "                                       'Mirror movements': -0.060597498,\n",
       "                                       'mucous membranes': 0.03305233,\n",
       "                                       'middle molecule': 0.07274268,\n",
       "                                       'myelo-meningocele': 0.09584006,\n",
       "                                       'molecular mass': -0.009697416,\n",
       "                                       'myeloid metaplasia': 0.106005944,\n",
       "                                       'malignant melanoma': 0.11183005,\n",
       "                                       'minimal medium': 0.11033238,\n",
       "                                       'metanephric mesenchyme': 0.15030704,\n",
       "                                       'malignant mesotheliomas': 0.12188501,\n",
       "                                       'middle molecules': 0.059695374,\n",
       "                                       'medial malleolus': 0.14607543,\n",
       "                                       'mucous membrane': 0.019217197,\n",
       "                                       'macromolecule': -0.011139837,\n",
       "                                       'multiple myeloma': 0.15170799,\n",
       "                                       'maternal mortality': 0.13006525,\n",
       "                                       'Muscle mass': 0.0011447073,\n",
       "                                       'masseter muscle': 0.051817287,\n",
       "                                       'Mitochondrial myopathy': 0.11450057,\n",
       "                                       'mismatches': 0.12668747,\n",
       "                                       'model': 0.0013541543,\n",
       "                                       'Molecular mechanics': -0.11214971,\n",
       "                                       'mesangial matrix': -0.10963442,\n",
       "                                       'metastatic melanoma': 0.13104753})}),\n",
       "             'the primary trial studies the effects of CTX/IMQ/RT and IMQ+RT on Systemic Tumor Response Rates 9 weeks after the start of treatment.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CTX': defaultdict(float,\n",
       "                                      {'cefotaxime': 0.080519184,\n",
       "                                       'Cytoxan': 0.3101431,\n",
       "                                       'Crosslaps': -0.06029662,\n",
       "                                       'chemotaxis': 0.18775676,\n",
       "                                       'chemotherapy': 0.39442632,\n",
       "                                       'ceftriaxon': 0.13277657,\n",
       "                                       'cerebrotendinous xanthomatosis': 0.11658306,\n",
       "                                       'Charybdotoxin': 0.17132924,\n",
       "                                       'canthaxanthin': 0.056000262,\n",
       "                                       'cholera toxin': -0.0025377646,\n",
       "                                       'cortical': -0.011947144,\n",
       "                                       'cerebral cortex': 0.019610979,\n",
       "                                       'costotendinous xanthomatosis': 0.09907159,\n",
       "                                       'C-telopeptides': 0.113761924,\n",
       "                                       'C-telopeptide': 0.14849193,\n",
       "                                       'cytotoxicity': 0.22157308,\n",
       "                                       'contractions': -0.049169946,\n",
       "                                       'ciguatoxin': 0.109512076,\n",
       "                                       'Contractions': -0.049169946,\n",
       "                                       'ceftriaxone': 0.22268641,\n",
       "                                       'Cefotaxime': 0.080519184,\n",
       "                                       'cyclophosphamide': 0.24584293,\n",
       "                                       'cardiotoxin': 0.17091018})}),\n",
       "             'All participants of the primary trial must have recently undergone either an echocardiography or a MUGA scan.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MUGA': defaultdict(float,\n",
       "                                      {'multi gated acquisition scan': 0.13237055,\n",
       "                                       'multigated acquisition': 0.114534296,\n",
       "                                       'multi-gated acquisition': 0.07694093,\n",
       "                                       'multigated radionuclide angiography': 0.39447722,\n",
       "                                       'multiple-gated acquisition scan': 0.13978891,\n",
       "                                       'Multiple gated acquisition': 0.07578649,\n",
       "                                       'multiple gated acquisition scan': 0.14408651,\n",
       "                                       'multi-gated radionuclide angiography': 0.3658811})}),\n",
       "             'the primary trial results indicate that the Recommended Phase II Dose for paclitaxel, as Assessed by NCI Common Terminology Criteria for Adverse Events, is 90 mg/m2 .': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'II': defaultdict(float,\n",
       "                                      {'image intensifier': 0.08565795,\n",
       "                                       'icterus index': 0.07235681}),\n",
       "                          'NCI': defaultdict(float,\n",
       "                                      {'National Cancer Institute': 0.22508053,\n",
       "                                       'negative chemical ionization': 0.05741771,\n",
       "                                       \"National Cancer Institute's\": 0.25561458,\n",
       "                                       'no cognitive impairment': -0.018156089,\n",
       "                                       'negative chemical ionisation': 0.07394266,\n",
       "                                       'neuronal cytoplasmic inclusion': 0.024404097,\n",
       "                                       'nuclear contour index': 0.08503293})}),\n",
       "             'the secondary trial and the primary trial use best Overall Response (OR) as their evaluation metrics, however they use significantly different time frames.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'OR': defaultdict(float,\n",
       "                                      {'overall response': 0.3108416,\n",
       "                                       'objective response': 0.21926782,\n",
       "                                       'odds ratio': 0.1958941,\n",
       "                                       'open repair': 0.06721999,\n",
       "                                       'ovulation rate': 0.116671585,\n",
       "                                       'odds ration': 0.14694054,\n",
       "                                       'operating room': 0.055776242,\n",
       "                                       'oxido-reductase': 0.05189289,\n",
       "                                       'obesity-resistant': 0.043934952,\n",
       "                                       'ouabain-resistant': 0.08367696,\n",
       "                                       'objective responses': 0.1796736,\n",
       "                                       'orienting reflex': 0.08662882,\n",
       "                                       'operations research': 0.17403574,\n",
       "                                       'opioid receptor': 0.05195563,\n",
       "                                       'odds-ratio': 0.20164883,\n",
       "                                       'orienting response': 0.15746713,\n",
       "                                       'odorant receptor': 0.043421842,\n",
       "                                       'operating rooms': 0.048074104,\n",
       "                                       'oxidoreductase': 0.049127586,\n",
       "                                       'oestrogen receptor': 0.1382641,\n",
       "                                       'optic radiation': -0.00897025,\n",
       "                                       'oxido reductase': 0.06330001,\n",
       "                                       'optical rotation': 0.030254394,\n",
       "                                       'orthopedic research': 0.21783882,\n",
       "                                       'odds ratios': 0.19466761,\n",
       "                                       'oral rehydration': 0.06929116,\n",
       "                                       'operating-room': 0.0828605,\n",
       "                                       'olfactory receptor': 0.060438756,\n",
       "                                       'outflow resistance': 0.030822333,\n",
       "                                       'Oregon': 0.026325535,\n",
       "                                       'oestrogen-receptor': 0.111416675})}),\n",
       "             'Patients with HER2 negative MBC are eligible for both the primary trial and the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.29688594,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.3094257,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.29978606,\n",
       "                                       'human epidermal growth factor receptor 2': 0.30405185,\n",
       "                                       'human epidermal growth factor receptor-2': 0.3094257}),\n",
       "                          'MBC': defaultdict(float,\n",
       "                                      {'methyl benzimidazol-2-yl carbamate': 0.117486544,\n",
       "                                       'mononuclear blood cells': 0.18530498,\n",
       "                                       'microcrystalline bovine collagen': 0.049159482,\n",
       "                                       'maximal breathing capacity': 0.03600711,\n",
       "                                       'male breast cancer': 0.21102805,\n",
       "                                       'metastatic breast carcinoma': 0.26326767,\n",
       "                                       'maximal binding capacity': 0.009784269,\n",
       "                                       'microbial biomass carbon': 0.018698866,\n",
       "                                       'mononuclear blood cell': 0.18940692,\n",
       "                                       'methylthymol blue complex': 0.21760939,\n",
       "                                       'minimum bactericidal concentration': 0.08203639,\n",
       "                                       'maximal bladder capacity': 0.021860631,\n",
       "                                       'minimal bactericidal concentration': 0.088854305,\n",
       "                                       'maximum binding capacity': -0.008660243,\n",
       "                                       'metastatic breast cancer': 0.29912868})}),\n",
       "             'The patient group with the highest percent of Event-free Survival in the primary trial was Stage IIIB patients, and the worst was Stage IV Disease patients.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.06579549,\n",
       "                                       'intravenous injection': 0.22669989,\n",
       "                                       'iridovirus': 0.1762652,\n",
       "                                       'intra-venous': 0.24295199,\n",
       "                                       'invitro': 0.059737027,\n",
       "                                       'intra ventricular': 0.19981061,\n",
       "                                       'intra vascular': 0.20395622,\n",
       "                                       'in vivo': 0.20642063,\n",
       "                                       'intravascular': 0.2274392,\n",
       "                                       'in-vivo': 0.23963207,\n",
       "                                       'inter-vertebral': 0.21618056,\n",
       "                                       'ichthyosis vulgaris': 0.12481791,\n",
       "                                       'intravenous': 0.2689107,\n",
       "                                       'intravaginal': 0.109511256,\n",
       "                                       'invasive': 0.062487245,\n",
       "                                       'iridescent virus': 0.11085073,\n",
       "                                       'isometric virus': 0.06552715,\n",
       "                                       'intravenous feeding device': 0.13953912,\n",
       "                                       'invivo': 0.08137548,\n",
       "                                       'instrumental variable': 0.013554357,\n",
       "                                       'intraventricular': 0.16193251,\n",
       "                                       'intra-vaginal': 0.14800294,\n",
       "                                       'intravertebral': 0.1382324,\n",
       "                                       'in vitro': 0.12983263,\n",
       "                                       'interventricular': 0.17726697,\n",
       "                                       'in-vitro': 0.16326839,\n",
       "                                       'intra venous': 0.18324244,\n",
       "                                       'iodine value': 0.036778968,\n",
       "                                       'ichnovirus': 0.12865587,\n",
       "                                       'inter-ventricular': 0.22818379,\n",
       "                                       'intra-vertebral': 0.23859283,\n",
       "                                       'intravenous injection device': 0.16472988,\n",
       "                                       'intervertebral': 0.12994875,\n",
       "                                       'initial visit': 0.090129614,\n",
       "                                       'intravenous feeding': 0.18728453,\n",
       "                                       'intra-vascular': 0.27883753,\n",
       "                                       'intra-ventricular': 0.23852807})}),\n",
       "             'Only patients with HER2 positive breast carcinoma are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.28245288,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.28735065,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.28633907,\n",
       "                                       'human epidermal growth factor receptor 2': 0.28805012,\n",
       "                                       'human epidermal growth factor receptor-2': 0.28735065})}),\n",
       "             'the secondary trial and the primary trial results indicate that the PFS of participants is partially linked to age, cancer grade and ethnicity.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.0916295,\n",
       "                                       'pyrogen-free saline': 0.06755127,\n",
       "                                       'pressure-flow study': -0.02051924,\n",
       "                                       'posterior fossa syndrome': 0.14513436,\n",
       "                                       'pressure flow study': -0.0051010125,\n",
       "                                       'primary fibromyalgia syndrome': 0.26929393,\n",
       "                                       'Piper Fatigue Scale': 0.20795456,\n",
       "                                       'patellofemoral syndrome': 0.11558162,\n",
       "                                       'Progression-free': 0.12541768,\n",
       "                                       'pulmonary function score': 0.3465172,\n",
       "                                       'pressure flow studies': -0.025337338,\n",
       "                                       'protein-free supernatant': 0.017065516,\n",
       "                                       'progression free survival': 0.3593172,\n",
       "                                       'protein free supernatant': 0.0477461,\n",
       "                                       'progression-free survival': 0.39904875,\n",
       "                                       'pressure/flow study': 0.026674148})}),\n",
       "             'All the primary trial subjects are required to take the intervention tablet PO daily.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.24277471,\n",
       "                                       'parietal operculum': 0.1710228,\n",
       "                                       'post office': 0.11160889,\n",
       "                                       'percentage of observed value': 0.07212358,\n",
       "                                       'Phenol oxidase': 0.22673057,\n",
       "                                       'parapineal organ': 0.13915439,\n",
       "                                       'power output': 0.011616024,\n",
       "                                       'predominant organism': 0.14462484,\n",
       "                                       'pulse-oximetry': 0.24353668,\n",
       "                                       'perceptual organisation': 0.025257843,\n",
       "                                       'power outputs': -0.03767543,\n",
       "                                       'Personality Organization': 0.058413047,\n",
       "                                       'postoperative': 0.12325135,\n",
       "                                       'parieto occipital': 0.14086528,\n",
       "                                       'polyolefin': 0.14706704,\n",
       "                                       'parietooccipital': 0.089739986,\n",
       "                                       'poly-olefin': 0.15228792,\n",
       "                                       'peroral': 0.16065966,\n",
       "                                       'prostate only': 0.20952795,\n",
       "                                       'pressure overload': 0.08290123,\n",
       "                                       'peroxidase': 0.15406625,\n",
       "                                       'principal olive': 0.17185584,\n",
       "                                       'peri-operative': 0.17141546,\n",
       "                                       'posterior': 0.11754562,\n",
       "                                       'Perceptual Organization': 0.026530731,\n",
       "                                       'period of onset': 0.17679076,\n",
       "                                       'posterior nuclear group': 0.07129291,\n",
       "                                       'phenol oxidase': 0.22673057,\n",
       "                                       'pressure': 0.06392263,\n",
       "                                       'per os (by mouth)': 0.2496097,\n",
       "                                       'parieto-occipital': 0.126901,\n",
       "                                       'preoptic area': 0.069944434,\n",
       "                                       'perceptual organization': 0.026530731,\n",
       "                                       'prophylactic oophorectomy': 0.15687111,\n",
       "                                       'phosphodiester': 0.21690176,\n",
       "                                       'pre-ovulatory': 0.22241013,\n",
       "                                       'palm oil': 0.13829874,\n",
       "                                       'preovulatory': 0.24772094,\n",
       "                                       'perioperative': 0.23551203,\n",
       "                                       'post operative': 0.12584805,\n",
       "                                       'post-operative': 0.11968934,\n",
       "                                       'phospho-diester': 0.13378568,\n",
       "                                       'protein oxidation': 0.10714028,\n",
       "                                       'palm-oil': 0.12315623,\n",
       "                                       'per os': 0.14543217,\n",
       "                                       'pericardial organ': 0.10409985,\n",
       "                                       'Pulse oximetry': 0.24277471,\n",
       "                                       'paraoxon': 0.2850863,\n",
       "                                       'propylene oxide': 0.2455112,\n",
       "                                       'phenoloxidase': 0.14228146,\n",
       "                                       'peanut oil': 0.19021608})}),\n",
       "             'Patients with severe malabsorption disorders are ineligible for the primary trial, even if they are able to receive intravenous (IV) alimentation.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.20117621,\n",
       "                                       'intravenous injection': 0.4338957,\n",
       "                                       'iridovirus': 0.08805191,\n",
       "                                       'intra-venous': 0.32196206,\n",
       "                                       'invitro': 0.09794347,\n",
       "                                       'intra ventricular': 0.21405251,\n",
       "                                       'intra vascular': 0.22521083,\n",
       "                                       'in vivo': 0.17602724,\n",
       "                                       'intravascular': 0.3002893,\n",
       "                                       'in-vivo': 0.21826616,\n",
       "                                       'inter-vertebral': 0.15541135,\n",
       "                                       'ichthyosis vulgaris': 0.16809161,\n",
       "                                       'intravenous': 0.4069173,\n",
       "                                       'intravaginal': 0.20992325,\n",
       "                                       'invasive': 0.06901647,\n",
       "                                       'iridescent virus': 0.070152484,\n",
       "                                       'isometric virus': 0.08220548,\n",
       "                                       'intravenous feeding device': 0.36058488,\n",
       "                                       'invivo': 0.04768716,\n",
       "                                       'instrumental variable': 0.03494924,\n",
       "                                       'intraventricular': 0.20620218,\n",
       "                                       'intra-vaginal': 0.22815646,\n",
       "                                       'intravertebral': 0.17534228,\n",
       "                                       'in vitro': 0.10145453,\n",
       "                                       'interventricular': 0.19843078,\n",
       "                                       'in-vitro': 0.16374336,\n",
       "                                       'intra venous': 0.28909937,\n",
       "                                       'iodine value': 0.12219775,\n",
       "                                       'ichnovirus': 0.12191213,\n",
       "                                       'inter-ventricular': 0.21992657,\n",
       "                                       'intra-vertebral': 0.18890531,\n",
       "                                       'intravenous injection device': 0.36693692,\n",
       "                                       'intervertebral': 0.13978349,\n",
       "                                       'initial visit': 0.07595415,\n",
       "                                       'intravenous feeding': 0.44419542,\n",
       "                                       'intra-vascular': 0.26785812,\n",
       "                                       'intra-ventricular': 0.24642612})}),\n",
       "             'Adequate renal, hepatic and blood work is required for entry to the primary trial, this includes the following criteria; hemoglobin  11.5 g/dL, aswell as ALT, AST, alkaline phosphatase and total bilirubin < 2.5xULN, and Serum creatinine should be less than 1.7x ULN. These conditions are not explicitly required for the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ALT': defaultdict(float,\n",
       "                                      {'altitude': 0.0934652,\n",
       "                                       'alanine amino transferase': 0.18554287,\n",
       "                                       'avian laryngotracheitis': -0.028158944,\n",
       "                                       'alanine-aminotransferase': 0.20937227,\n",
       "                                       'alanine aminotransaminase': 0.23428631,\n",
       "                                       'alanine aminotransferase': 0.2258484,\n",
       "                                       'alanine transferase': 0.22085169,\n",
       "                                       'anterolateral thigh': 0.108840615,\n",
       "                                       'auxiliary liver transplantation': 0.39331943,\n",
       "                                       'alanine amino-transferase': 0.18035857,\n",
       "                                       'antero-lateral thigh': 0.10592478,\n",
       "                                       'alanine aminotransferases': 0.19869617,\n",
       "                                       'alanine-amino-transferase': 0.1788164,\n",
       "                                       'alternative lengthening of telomeres': 0.078842945,\n",
       "                                       'alanine aminotransferase activity': 0.2619889,\n",
       "                                       'autolymphocyte therapy': 0.2553608,\n",
       "                                       'alanine transaminase': 0.23922938,\n",
       "                                       'argon laser trabeculoplasty': 0.13506944}),\n",
       "                          'AST': defaultdict(float,\n",
       "                                      {'anti-streptolysin test': 0.40144816,\n",
       "                                       'atrial systolic tachycardia': 0.08346657,\n",
       "                                       'astrocyte': 0.044255637,\n",
       "                                       'arginine stimulation test': 0.39724576,\n",
       "                                       'astaxanthine': 0.16453849,\n",
       "                                       'aspartate amino-transferase': 0.17918868,\n",
       "                                       'anti-microbial susceptibility testing': 0.28246596,\n",
       "                                       'anterior spinothalamic tract': 0.12546226,\n",
       "                                       'arterial spin tagging': 0.14214587,\n",
       "                                       'Antimicrobial susceptibility testing': 0.24951276,\n",
       "                                       'aspartate-aminotransferase': 0.21645547,\n",
       "                                       'arginine-stimulation test': 0.40932488,\n",
       "                                       'antimicrobial susceptibility testing': 0.24951276,\n",
       "                                       'aspartate amino transferase': 0.17659323,\n",
       "                                       'average survival time': 0.07090668,\n",
       "                                       'aspartate transaminase': 0.22232006,\n",
       "                                       'acid suppressive therapy': 0.18358436,\n",
       "                                       'aspartate': 0.07836894,\n",
       "                                       'atrial overdrive stimulation rate': 0.16225608,\n",
       "                                       'arterial spin-tagging': 0.1331545,\n",
       "                                       'aspartate transferase': 0.17178008,\n",
       "                                       'aspartate aminotransferase': 0.22134116,\n",
       "                                       'antistreptolysin test': 0.39170924,\n",
       "                                       'androgen suppression therapy': 0.21804695,\n",
       "                                       'acute suppurative thyroiditis': 0.2223062,\n",
       "                                       'allatostatin': 0.20932907,\n",
       "                                       'anti-fungal susceptibility testing': 0.26273805,\n",
       "                                       'angiotensin sensitivity test': 0.38148615,\n",
       "                                       'acid-suppressive therapy': 0.1852295,\n",
       "                                       'antibiotic susceptibility testing': 0.30676705,\n",
       "                                       'Aryl sulfotransferase': 0.15163058,\n",
       "                                       'astigmatism': 0.04600401,\n",
       "                                       'androgen-suppression therapy': 0.20414013,\n",
       "                                       'aspartate-amino-transferase': 0.18254292,\n",
       "                                       'astaxanthin': 0.10154035,\n",
       "                                       'antifungal susceptibility testing': 0.2822629}),\n",
       "                          'ULN': defaultdict(float,\n",
       "                                      {'upper limit of normal': 0.021650933})}),\n",
       "             'the primary trial Participants received niraparib 200 milligrams (mg) PO once daily for a 28 day cycle, for 2 cycles': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.17641214,\n",
       "                                       'parietal operculum': 0.16028932,\n",
       "                                       'post office': 0.052200124,\n",
       "                                       'percentage of observed value': 0.17440881,\n",
       "                                       'Phenol oxidase': 0.13608354,\n",
       "                                       'parapineal organ': 0.19084735,\n",
       "                                       'power output': 0.069488354,\n",
       "                                       'predominant organism': 0.045607265,\n",
       "                                       'pulse-oximetry': 0.17871356,\n",
       "                                       'perceptual organisation': -0.06545137,\n",
       "                                       'power outputs': 0.019292526,\n",
       "                                       'Personality Organization': -0.035000987,\n",
       "                                       'postoperative': 0.19236632,\n",
       "                                       'parieto occipital': 0.14469121,\n",
       "                                       'polyolefin': 0.08602492,\n",
       "                                       'parietooccipital': 0.095779896,\n",
       "                                       'poly-olefin': 0.07836551,\n",
       "                                       'peroral': 0.15724719,\n",
       "                                       'prostate only': 0.13644129,\n",
       "                                       'pressure overload': 0.046314865,\n",
       "                                       'peroxidase': 0.12129923,\n",
       "                                       'principal olive': 0.05234033,\n",
       "                                       'peri-operative': 0.1326518,\n",
       "                                       'posterior': 0.14078304,\n",
       "                                       'Perceptual Organization': -0.05740595,\n",
       "                                       'period of onset': 0.21260291,\n",
       "                                       'posterior nuclear group': 0.077376485,\n",
       "                                       'phenol oxidase': 0.13608354,\n",
       "                                       'pressure': 0.01849857,\n",
       "                                       'per os (by mouth)': 0.14486842,\n",
       "                                       'parieto-occipital': 0.14136468,\n",
       "                                       'preoptic area': 0.030901846,\n",
       "                                       'perceptual organization': -0.05740595,\n",
       "                                       'prophylactic oophorectomy': 0.106475964,\n",
       "                                       'phosphodiester': 0.17158398,\n",
       "                                       'pre-ovulatory': 0.24475467,\n",
       "                                       'palm oil': 0.033632327,\n",
       "                                       'preovulatory': 0.2032309,\n",
       "                                       'perioperative': 0.20100494,\n",
       "                                       'post operative': 0.16850506,\n",
       "                                       'post-operative': 0.20249063,\n",
       "                                       'phospho-diester': 0.07438124,\n",
       "                                       'protein oxidation': 0.114536494,\n",
       "                                       'palm-oil': -0.00033201,\n",
       "                                       'per os': 0.11716919,\n",
       "                                       'pericardial organ': 0.12539984,\n",
       "                                       'Pulse oximetry': 0.17641214,\n",
       "                                       'paraoxon': 0.2957899,\n",
       "                                       'propylene oxide': 0.14433564,\n",
       "                                       'phenoloxidase': 0.15190746,\n",
       "                                       'peanut oil': 0.093909375})}),\n",
       "             'Median (95% Confidence Interval) Progression-Free Survival (PFS) was over a month higher for patients in the Docetaxel + Sunitinib group of the primary trial than for the Docetaxel group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.11944378,\n",
       "                                       'pyrogen-free saline': 0.032728944,\n",
       "                                       'pressure-flow study': -0.08058565,\n",
       "                                       'posterior fossa syndrome': 0.008999079,\n",
       "                                       'pressure flow study': -0.06796435,\n",
       "                                       'primary fibromyalgia syndrome': 0.16922347,\n",
       "                                       'Piper Fatigue Scale': 0.06815771,\n",
       "                                       'patellofemoral syndrome': 0.10839084,\n",
       "                                       'Progression-free': 0.11108965,\n",
       "                                       'pulmonary function score': 0.1775955,\n",
       "                                       'pressure flow studies': -0.08016632,\n",
       "                                       'protein-free supernatant': -0.011402127,\n",
       "                                       'progression free survival': 0.39340714,\n",
       "                                       'protein free supernatant': -0.0014909741,\n",
       "                                       'progression-free survival': 0.4308065,\n",
       "                                       'pressure/flow study': -0.057192266})}),\n",
       "             'Adequate renal, hepatic and blood work is required for entry to the primary trial and the secondary trial, this includes the following criteria; hemoglobin  11.5 g/dL, aswell as ALT, AST, alkaline phosphatase and total bilirubin < 2.5xULN, and Serum creatinine should be less than 1.7x ULN.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ALT': defaultdict(float,\n",
       "                                      {'altitude': 0.10145401,\n",
       "                                       'alanine amino transferase': 0.18855566,\n",
       "                                       'avian laryngotracheitis': -0.031347204,\n",
       "                                       'alanine-aminotransferase': 0.21290398,\n",
       "                                       'alanine aminotransaminase': 0.23366207,\n",
       "                                       'alanine aminotransferase': 0.23027214,\n",
       "                                       'alanine transferase': 0.22034506,\n",
       "                                       'anterolateral thigh': 0.10030046,\n",
       "                                       'auxiliary liver transplantation': 0.36023992,\n",
       "                                       'alanine amino-transferase': 0.18258466,\n",
       "                                       'antero-lateral thigh': 0.09992106,\n",
       "                                       'alanine aminotransferases': 0.20399448,\n",
       "                                       'alanine-amino-transferase': 0.18075952,\n",
       "                                       'alternative lengthening of telomeres': 0.07156415,\n",
       "                                       'alanine aminotransferase activity': 0.26907787,\n",
       "                                       'autolymphocyte therapy': 0.23348668,\n",
       "                                       'alanine transaminase': 0.2370123,\n",
       "                                       'argon laser trabeculoplasty': 0.13247693}),\n",
       "                          'AST': defaultdict(float,\n",
       "                                      {'anti-streptolysin test': 0.40287605,\n",
       "                                       'atrial systolic tachycardia': 0.08117583,\n",
       "                                       'astrocyte': 0.04999509,\n",
       "                                       'arginine stimulation test': 0.40169993,\n",
       "                                       'astaxanthine': 0.16205199,\n",
       "                                       'aspartate amino-transferase': 0.16664958,\n",
       "                                       'anti-microbial susceptibility testing': 0.2894945,\n",
       "                                       'anterior spinothalamic tract': 0.11391011,\n",
       "                                       'arterial spin tagging': 0.14316477,\n",
       "                                       'Antimicrobial susceptibility testing': 0.2603552,\n",
       "                                       'aspartate-aminotransferase': 0.20476398,\n",
       "                                       'arginine-stimulation test': 0.41426522,\n",
       "                                       'antimicrobial susceptibility testing': 0.2603552,\n",
       "                                       'aspartate amino transferase': 0.16558473,\n",
       "                                       'average survival time': 0.081477955,\n",
       "                                       'aspartate transaminase': 0.20542713,\n",
       "                                       'acid suppressive therapy': 0.16625315,\n",
       "                                       'aspartate': 0.064105086,\n",
       "                                       'atrial overdrive stimulation rate': 0.16465783,\n",
       "                                       'arterial spin-tagging': 0.13271695,\n",
       "                                       'aspartate transferase': 0.15629439,\n",
       "                                       'aspartate aminotransferase': 0.21010178,\n",
       "                                       'antistreptolysin test': 0.391342,\n",
       "                                       'androgen suppression therapy': 0.20403174,\n",
       "                                       'acute suppurative thyroiditis': 0.21015266,\n",
       "                                       'allatostatin': 0.21744148,\n",
       "                                       'anti-fungal susceptibility testing': 0.26112393,\n",
       "                                       'angiotensin sensitivity test': 0.38459563,\n",
       "                                       'acid-suppressive therapy': 0.1659227,\n",
       "                                       'antibiotic susceptibility testing': 0.31860933,\n",
       "                                       'Aryl sulfotransferase': 0.14096187,\n",
       "                                       'astigmatism': 0.046082158,\n",
       "                                       'androgen-suppression therapy': 0.18722072,\n",
       "                                       'aspartate-amino-transferase': 0.17019361,\n",
       "                                       'astaxanthin': 0.09720081,\n",
       "                                       'antifungal susceptibility testing': 0.28692216}),\n",
       "                          'ULN': defaultdict(float,\n",
       "                                      {'upper limit of normal': 0.026459333})}),\n",
       "             'The Maximum Tolerated Dose (MTD) of of 1-methyl-d-tryptophan (indoximod) observed in the primary trial was 800 mg.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MTD': defaultdict(float,\n",
       "                                      {'maximum tolerated dose': 0.60803276,\n",
       "                                       'Monroe tidal drainage': -0.09767189,\n",
       "                                       \"Midwife Teacher's Diploma\": -0.05938875,\n",
       "                                       'mean total dose': 0.3804968,\n",
       "                                       'maximally-tolerated dose': 0.6280036,\n",
       "                                       'metastatic trophoblastic disease': 0.11547944,\n",
       "                                       'maximal tolerated dose': 0.6154446,\n",
       "                                       'maximal-tolerated dose': 0.6272114,\n",
       "                                       'maximum tolerable dose': 0.5918738,\n",
       "                                       'muscle tension dysphonia': 0.15517923,\n",
       "                                       'muscle-tension dysphonia': 0.15353785,\n",
       "                                       'maximum tolerated dosage': 0.618981,\n",
       "                                       'maximum tolerated doses': 0.58402574,\n",
       "                                       'maximum-tolerated dose': 0.6249441,\n",
       "                                       'multiple tic disorder': 0.19076751,\n",
       "                                       'mannitol dehydrogenase': 0.22376072,\n",
       "                                       'methadone': 0.27012917,\n",
       "                                       'maximally tolerated dose': 0.62596667})}),\n",
       "             'The Herceptin group in the primary trial had a higher number of Patients Achieving Pathological Complete Response than the CT-P6 group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CT': defaultdict(float,\n",
       "                                      {'condensed tannin': 0.009835699,\n",
       "                                       'crista terminalis': 0.13845672,\n",
       "                                       'chlamydia': 0.10491077,\n",
       "                                       'chronic tonsillitis': 0.08047935,\n",
       "                                       'computed-tomographic': 0.15871322,\n",
       "                                       'computed tomogram': 0.13632137,\n",
       "                                       'coal-tar': -0.0049597584,\n",
       "                                       'calf thymus': 0.11578787,\n",
       "                                       'curly tail': -0.01874888,\n",
       "                                       'condensed tannins': 0.019850956,\n",
       "                                       'computerised tomograph': 0.07309176,\n",
       "                                       'counter-transference': 0.063428216,\n",
       "                                       'cardiothoracic': 0.142716,\n",
       "                                       'choroidal thickness': 0.088871785,\n",
       "                                       'core temperature': -0.056998525,\n",
       "                                       'collecting tubule': 0.11061836,\n",
       "                                       'C-terminal': 0.0074888472,\n",
       "                                       'cytotrophoblast': 0.12826903,\n",
       "                                       'cytoplasmic domain': 0.02027031,\n",
       "                                       'chest tube': 0.10883462,\n",
       "                                       'computerised tomographic': 0.099296995,\n",
       "                                       'clotting time': 0.13281003,\n",
       "                                       'carbon tetra-chloride': 0.045327965,\n",
       "                                       'charge transport': -0.0033326447,\n",
       "                                       'chemo-therapy': 0.3687562,\n",
       "                                       'circadian times': 0.042669423,\n",
       "                                       'cytidylyl-transferase': 0.12812322,\n",
       "                                       'charge transfer': 0.007948975,\n",
       "                                       'cognitive therapy': 0.184306,\n",
       "                                       'computertomography': 0.0718006,\n",
       "                                       'celiac trunc': 0.107923105,\n",
       "                                       'computerised tomography': 0.13541868,\n",
       "                                       'chronic thyroiditis': 0.23160377,\n",
       "                                       'crico-thyroid': 0.21398944,\n",
       "                                       'carbon tetra chloride': 0.046354454,\n",
       "                                       'contraction time': 0.050822347,\n",
       "                                       'Cardiac transplantation': 0.14975439,\n",
       "                                       'clinical trial': 0.38469005,\n",
       "                                       'central tendon': 0.09994496,\n",
       "                                       'cortical thickness': 0.11130245,\n",
       "                                       'conventional tillage': -0.011551494,\n",
       "                                       'carboxylterminus': 0.04894952,\n",
       "                                       'catalase': 0.043839667,\n",
       "                                       'circadian time': 0.04446575,\n",
       "                                       'concentration': 0.066657946,\n",
       "                                       'conservative treatment': 0.20437078,\n",
       "                                       'CTP': 0.23904711,\n",
       "                                       'corneal thickness': -0.006542959,\n",
       "                                       'critical thinking': 0.033525616,\n",
       "                                       'celiac trunk': -0.001858756,\n",
       "                                       'charge-transfer': 0.015243745,\n",
       "                                       'cytoplasmic tail': 0.02854684,\n",
       "                                       'countertransference': 0.024637705,\n",
       "                                       'computed tomographies': 0.19792907,\n",
       "                                       'code treatment time': 0.20260626,\n",
       "                                       'cellulose-triacetate': -0.0048763813,\n",
       "                                       'conventional treatment': 0.2906587,\n",
       "                                       'corticothalamic': 0.18054383,\n",
       "                                       'carcinoid tumor': 0.2654227,\n",
       "                                       'coeliac trunk': 0.061417293,\n",
       "                                       'chloramine-T': 0.12555358,\n",
       "                                       'carbontetrachloride': 0.05322314,\n",
       "                                       'cricothyroid muscle': 0.12382014,\n",
       "                                       'cerebral toxoplasmosis': 0.15406443,\n",
       "                                       'computerized tomography': 0.12349167,\n",
       "                                       'cervicothoracic': 0.12942424,\n",
       "                                       'computed tomography scan': 0.28777957,\n",
       "                                       'carboxyl-terminus': 0.07452718,\n",
       "                                       'Computer-Tomography': 0.07295603,\n",
       "                                       'corticotectal': 0.11249007,\n",
       "                                       'computerised tomogram': 0.03532844,\n",
       "                                       'computerized tomographic': 0.09753425,\n",
       "                                       'chemotherapy': 0.32423797,\n",
       "                                       'Cholera enterotoxin': 0.09903121,\n",
       "                                       'Catalase': 0.043839667,\n",
       "                                       'carbon tetrachloride': 0.087506734,\n",
       "                                       'choleratoxin': 0.0780546,\n",
       "                                       'computed tomography': 0.21558215,\n",
       "                                       'cholera toxin': 0.12227088,\n",
       "                                       'chorda tympani': 0.018482158,\n",
       "                                       'carcinoid tumour': 0.25214154,\n",
       "                                       'conventional therapy': 0.2582265,\n",
       "                                       'cold test': 0.11887196,\n",
       "                                       'cortico-thalamic': 0.15043126,\n",
       "                                       'conditioning-test': 0.13804191,\n",
       "                                       'chorda tympani nerve': 0.19019033,\n",
       "                                       'computed tomographic scans': 0.24471425,\n",
       "                                       'cyto-toxic': 0.09897316,\n",
       "                                       'cardio-thoracic': 0.13036615,\n",
       "                                       'calcitonin': 0.24542098,\n",
       "                                       'chloramine T': 0.08208547,\n",
       "                                       'cycle threshold': 0.08208149,\n",
       "                                       'cytotoxic': 0.18650717,\n",
       "                                       'carboxyl terminal': 0.07954307,\n",
       "                                       'coeliac trunc': 0.15614653,\n",
       "                                       'closure time': 0.0031114463,\n",
       "                                       'cancer/testis': 0.20920008,\n",
       "                                       'connective tissue': 0.09169587,\n",
       "                                       'cellulose triacetate': -0.0025933161,\n",
       "                                       'Computed-tomography': 0.21582852,\n",
       "                                       'control': 0.034557723,\n",
       "                                       'computerized tomogram': 0.029119438,\n",
       "                                       'counseling and testing': 0.22237322,\n",
       "                                       'carboxyl-terminal': 0.078880176,\n",
       "                                       'cricothyroid': 0.17740652,\n",
       "                                       'Cerebral toxoplasmosis': 0.15406443,\n",
       "                                       'computed-tomography': 0.21582852,\n",
       "                                       'chest-tube': 0.12571739,\n",
       "                                       'carboxyl terminus': 0.081488304,\n",
       "                                       'counter-transport': 0.035492167,\n",
       "                                       'cancer-testis': 0.21838048,\n",
       "                                       'countertransport': 0.049792346,\n",
       "                                       'corticosterone': 0.17926344,\n",
       "                                       'compliance': 0.03167942,\n",
       "                                       'Computed tomographic scanning': 0.1962213,\n",
       "                                       'Connecticut': 0.022502596,\n",
       "                                       'computed tomography scans': 0.27090743,\n",
       "                                       'cardiac transplantation': 0.14975439,\n",
       "                                       'computed tomography scanning': 0.22679964,\n",
       "                                       'computed tomograpy': 0.25961506,\n",
       "                                       'computed tomograph': 0.14684187,\n",
       "                                       'coal tar': -9.468198e-05,\n",
       "                                       'chloramin-T': 0.14994775,\n",
       "                                       'Computed tomographic scan': 0.25658685,\n",
       "                                       'computerized tomograms': 0.023494434,\n",
       "                                       'control group': 0.17137194,\n",
       "                                       'chymotrypsin': 0.26420495,\n",
       "                                       'carboxylterminal': 0.08921722,\n",
       "                                       'congenital Toxoplasmosis': 0.051360868,\n",
       "                                       'cellulose-tri-acetate': -0.02540345,\n",
       "                                       'Computed tomograms': 0.1521953,\n",
       "                                       'conduction time': -0.015759513,\n",
       "                                       'computerized tomograph': 0.06866775,\n",
       "                                       'Chlamydia trachomatis': 0.11500705,\n",
       "                                       'congenital toxoplasmosis': 0.051360868,\n",
       "                                       'cytidylyltransferase': 0.08951059,\n",
       "                                       'cardiac tamponade': 0.08464178,\n",
       "                                       'Category Test': 0.12209616,\n",
       "                                       'chloramin T': 0.081018284,\n",
       "                                       'cortico-tectal': 0.14395908,\n",
       "                                       'cancer testis': 0.19579889,\n",
       "                                       'connective-tissue': 0.08506253,\n",
       "                                       'computed tomographic': 0.16321938,\n",
       "                                       'carbon-tetrachloride': 0.08751089})}),\n",
       "             'the primary trial participants must take 6 tablets of Lapatinib Monotherapy (250mg) PO once daily.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.11313151,\n",
       "                                       'parietal operculum': 0.11786001,\n",
       "                                       'post office': 0.04990448,\n",
       "                                       'percentage of observed value': 0.13140194,\n",
       "                                       'Phenol oxidase': 0.07782176,\n",
       "                                       'parapineal organ': 0.09179901,\n",
       "                                       'power output': 0.03688335,\n",
       "                                       'predominant organism': 0.06454588,\n",
       "                                       'pulse-oximetry': 0.11108649,\n",
       "                                       'perceptual organisation': -0.024146885,\n",
       "                                       'power outputs': -0.019675253,\n",
       "                                       'Personality Organization': -0.040499493,\n",
       "                                       'postoperative': 0.1271324,\n",
       "                                       'parieto occipital': 0.111863695,\n",
       "                                       'polyolefin': 0.140092,\n",
       "                                       'parietooccipital': 0.07212553,\n",
       "                                       'poly-olefin': 0.10463236,\n",
       "                                       'peroral': 0.13556811,\n",
       "                                       'prostate only': 0.115735516,\n",
       "                                       'pressure overload': 0.030243304,\n",
       "                                       'peroxidase': 0.077858806,\n",
       "                                       'principal olive': 0.1104449,\n",
       "                                       'peri-operative': 0.08039787,\n",
       "                                       'posterior': 0.05548083,\n",
       "                                       'Perceptual Organization': -0.022489885,\n",
       "                                       'period of onset': 0.118869625,\n",
       "                                       'posterior nuclear group': 0.044687025,\n",
       "                                       'phenol oxidase': 0.07782176,\n",
       "                                       'pressure': -0.02214073,\n",
       "                                       'per os (by mouth)': 0.20613685,\n",
       "                                       'parieto-occipital': 0.09816182,\n",
       "                                       'preoptic area': 0.02275852,\n",
       "                                       'perceptual organization': -0.022489885,\n",
       "                                       'prophylactic oophorectomy': 0.1327545,\n",
       "                                       'phosphodiester': 0.09984676,\n",
       "                                       'pre-ovulatory': 0.10043621,\n",
       "                                       'palm oil': 0.07933975,\n",
       "                                       'preovulatory': 0.17603657,\n",
       "                                       'perioperative': 0.14942773,\n",
       "                                       'post operative': 0.10552863,\n",
       "                                       'post-operative': 0.114694424,\n",
       "                                       'phospho-diester': 0.0019605346,\n",
       "                                       'protein oxidation': 0.056677043,\n",
       "                                       'palm-oil': 0.02623954,\n",
       "                                       'per os': 0.13146836,\n",
       "                                       'pericardial organ': 0.06321131,\n",
       "                                       'Pulse oximetry': 0.11313151,\n",
       "                                       'paraoxon': 0.23148501,\n",
       "                                       'propylene oxide': 0.15529403,\n",
       "                                       'phenoloxidase': 0.09517324,\n",
       "                                       'peanut oil': 0.09975365})}),\n",
       "             'the primary trial results show that Participants receiving lapatinib 1500 milligrams (mg) orally were more likely to achieve DFS at 5 years than placebo patients, however, there was less than a 30% difference in DFS rate between the two cohorts.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DFS': defaultdict(float,\n",
       "                                      {'Defensive Functioning Scale': 0.19386397,\n",
       "                                       'Disease free survival': 0.32959685,\n",
       "                                       'decayed and filled tooth surfaces': 0.053903192,\n",
       "                                       'dysplasia of the fibrous sheath': 0.22465542,\n",
       "                                       'diclofenac-sodium': 0.1929989,\n",
       "                                       'disease-free survivals': 0.31082538,\n",
       "                                       'diclofenac sodium': 0.18177804,\n",
       "                                       'deoxyfructoserotonin': 0.16272071,\n",
       "                                       'Disease-free': 0.20783825,\n",
       "                                       'dental fear survey': 0.07716072,\n",
       "                                       'disease-free survival': 0.3535904,\n",
       "                                       'deoxyfructo-serotonin': 0.24461697,\n",
       "                                       'Dental Fear Survey': 0.07716072,\n",
       "                                       'disease free survival': 0.32959685,\n",
       "                                       'dental fear scale': 0.11381621,\n",
       "                                       'decayed or filled surfaces': 0.015929151,\n",
       "                                       'diabetic foot syndrome': 0.20111892,\n",
       "                                       'desoxyfructosylserotonin': 0.1418864,\n",
       "                                       'desoxyfructo-serotonin': 0.24081284})}),\n",
       "             'Patients with E2 outside the premenopausal range are ineligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'E2': defaultdict(float,\n",
       "                                      {'estradiol-17beta': 0.28299838,\n",
       "                                       'estrogen': 0.18881133,\n",
       "                                       'envelope 2': 0.1381752,\n",
       "                                       'early region 2': 0.1991405,\n",
       "                                       'estradiol': 0.21930932,\n",
       "                                       'Estradiol benzoate': 0.218047,\n",
       "                                       'Estradiol': 0.21930932,\n",
       "                                       'estradiol-17 beta': 0.3447255,\n",
       "                                       'estradiol 17beta': 0.26452503,\n",
       "                                       'estradiol 17-beta': 0.3076223,\n",
       "                                       'estradiol-17-beta': 0.312588})}),\n",
       "             'One patient in the primary trial had a 0.98 cm3 increase in Total MRI Functional Tumor Volume (FTV) over 3 months, almost 1cm3 less than average.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MRI': defaultdict(float,\n",
       "                                      {'magnetic-resonance imaging': 0.33445317,\n",
       "                                       'MR-imaging': 0.46892172,\n",
       "                                       'magnetic resonance imaging': 0.35240147,\n",
       "                                       'magnetic resonance images': 0.3070618,\n",
       "                                       'magnetic resonance': 0.19718142,\n",
       "                                       'Magnetic resonance imagings': 0.37628222,\n",
       "                                       'magnet resonance imaging': 0.33663845,\n",
       "                                       'MR imaging': 0.49154943,\n",
       "                                       'magnetic-resonance-imaging': 0.32028088,\n",
       "                                       'magnetic resonance imagery': 0.26405087,\n",
       "                                       'Magnetic resonance imaging scan': 0.4169353,\n",
       "                                       'magnetic resonance tomography': 0.36760232,\n",
       "                                       'magnetic resonance image': 0.2891196,\n",
       "                                       'Magnetic resonance image': 0.2891196})}),\n",
       "             'The Change From Baseline in Mean Duration of the QTcF Interval for patients in the primary trial was at its highest on Day 1 of the third cycle, before T-DM1 intravenous (IV) infusion.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.03436214,\n",
       "                                       'intravenous injection': 0.357473,\n",
       "                                       'iridovirus': 0.07025239,\n",
       "                                       'intra-venous': 0.3082576,\n",
       "                                       'invitro': 0.084841214,\n",
       "                                       'intra ventricular': 0.26722643,\n",
       "                                       'intra vascular': 0.24161848,\n",
       "                                       'in vivo': 0.20558438,\n",
       "                                       'intravascular': 0.3035131,\n",
       "                                       'in-vivo': 0.25825116,\n",
       "                                       'inter-vertebral': 0.14911442,\n",
       "                                       'ichthyosis vulgaris': 0.018132908,\n",
       "                                       'intravenous': 0.34563243,\n",
       "                                       'intravaginal': 0.17315917,\n",
       "                                       'invasive': -0.043143228,\n",
       "                                       'iridescent virus': -0.008599941,\n",
       "                                       'isometric virus': 0.08073522,\n",
       "                                       'intravenous feeding device': 0.21061459,\n",
       "                                       'invivo': 0.09482311,\n",
       "                                       'instrumental variable': 0.06822309,\n",
       "                                       'intraventricular': 0.26338345,\n",
       "                                       'intra-vaginal': 0.19680306,\n",
       "                                       'intravertebral': 0.13135323,\n",
       "                                       'in vitro': 0.13441569,\n",
       "                                       'interventricular': 0.25210556,\n",
       "                                       'in-vitro': 0.18248323,\n",
       "                                       'intra venous': 0.2809593,\n",
       "                                       'iodine value': 0.12526865,\n",
       "                                       'ichnovirus': -0.0042270576,\n",
       "                                       'inter-ventricular': 0.2666513,\n",
       "                                       'intra-vertebral': 0.17298196,\n",
       "                                       'intravenous injection device': 0.29446933,\n",
       "                                       'intervertebral': 0.08736572,\n",
       "                                       'initial visit': 0.22247906,\n",
       "                                       'intravenous feeding': 0.28455445,\n",
       "                                       'intra-vascular': 0.2779745,\n",
       "                                       'intra-ventricular': 0.28503373})}),\n",
       "             'CO2 is utilised as part of the intervention in a single one of the study groups in the primary trial, and saline is used in both of the study groups in the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CO2': defaultdict(float,\n",
       "                                      {'carbon dioxide': 0.40271056,\n",
       "                                       'carbon-dioxide': 0.37880716})}),\n",
       "             'There were 23 participants in cohort 1 of the primary trial with a (CR) or (PR) based on the Response Assessment in Neuro-Oncology Brain Metastasis (RANO-BM) response criteria.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.03441632,\n",
       "                                       'clot retraction': 0.08859573,\n",
       "                                       'conditioned response': 0.10150236,\n",
       "                                       'conditioned reflex': 0.023454951,\n",
       "                                       'charge recombination': -0.034334686,\n",
       "                                       'Czech Republic': -0.0070818984,\n",
       "                                       'control region': 0.050502118,\n",
       "                                       'colonization rate': 0.07382438,\n",
       "                                       'complete remission rate': 0.4365855,\n",
       "                                       'Charles River': 0.011074618,\n",
       "                                       'Caloric restriction': 0.013259334,\n",
       "                                       'colonisation resistance': 0.060845014,\n",
       "                                       'complete regression': 0.055469077,\n",
       "                                       'conversion rate': 0.16120747,\n",
       "                                       'chest roentgenography': 0.15453146,\n",
       "                                       'chest radiograph': 0.12305613,\n",
       "                                       'colony reared': -0.037975416,\n",
       "                                       'cardiorespiratory': 0.048223432,\n",
       "                                       'circadian rhythm': 0.07329417,\n",
       "                                       'cardiac rupture': 0.09397945,\n",
       "                                       'carbonyl reductase': 0.02921465,\n",
       "                                       'calorie restriction': 0.00026550054,\n",
       "                                       'cortical reaction': 0.21943048,\n",
       "                                       'complete remissions': 0.33191195,\n",
       "                                       'chest radiography': 0.12684317,\n",
       "                                       'computerised record': 0.0091280835,\n",
       "                                       'charge-recombination': -0.03287926,\n",
       "                                       'Cardiac Rehabilitation': 0.12073325,\n",
       "                                       'calcium-binding protein calretinin': 0.09434226,\n",
       "                                       'chronic rejection': 0.07027378,\n",
       "                                       'colony-reared': -0.031546596,\n",
       "                                       'cognitive reserve': 0.1780594,\n",
       "                                       'critical ratio': 0.13937642,\n",
       "                                       'cortico-resistant': 0.23984906,\n",
       "                                       'caloric restriction': 0.013259334,\n",
       "                                       'corticoresistant': 0.17626946,\n",
       "                                       'corticosteroid-resistant': 0.17448698,\n",
       "                                       'Congo red': 0.020726882,\n",
       "                                       'complete responses': 0.21124628,\n",
       "                                       'chest and right arm': 0.075281516,\n",
       "                                       'conditioned reinforcement': 0.03860215,\n",
       "                                       'constant routine': -0.0034058078,\n",
       "                                       'cardio-respiratory': 0.10528651,\n",
       "                                       'complete response rate': 0.3089442,\n",
       "                                       'cockroach': -0.035746273,\n",
       "                                       'chief resident': 0.027865792,\n",
       "                                       'calorie-restricted': -0.007682985,\n",
       "                                       'complete responders': 0.22979142,\n",
       "                                       'cysteine-rich': 0.047628056,\n",
       "                                       'controlled-release': 0.051573098,\n",
       "                                       'chemoradiation': 0.11065505,\n",
       "                                       'crown-rump': -0.010187187,\n",
       "                                       'crown-rump length': 0.034892794,\n",
       "                                       'creatinine': 0.14899506,\n",
       "                                       'capture-recapture': 0.020974845,\n",
       "                                       'Congo-red': 0.031014634,\n",
       "                                       'coefficient of repeatability': 0.19302207,\n",
       "                                       'computed radiography': 0.108264536,\n",
       "                                       'controlled respiration': 0.07356017,\n",
       "                                       'conditioned reward': 0.058212172,\n",
       "                                       'complement receptors': 0.120540306,\n",
       "                                       'concentration-response': 0.14474292,\n",
       "                                       'complete': 0.093899116,\n",
       "                                       'chest roentgenogram': 0.16520147,\n",
       "                                       'complement receptor': 0.13579255,\n",
       "                                       'Cajal-Retzius': -0.0021760075,\n",
       "                                       'cremasteric reflex': 0.21534786,\n",
       "                                       'clot-retraction': 0.059831474,\n",
       "                                       'conserved regions': 0.019231277,\n",
       "                                       'child-resistant': 0.00014948846,\n",
       "                                       'control rats': 0.021610193,\n",
       "                                       'caries-resistant': -0.020434903,\n",
       "                                       'coronary revascularization': 0.1387063,\n",
       "                                       'colon resection': 0.101877704,\n",
       "                                       'contrast ratio': 0.14769301,\n",
       "                                       'concentration ratio': 0.12859437,\n",
       "                                       'Calreticulin': 0.05700257,\n",
       "                                       'composite resin': -0.009599625,\n",
       "                                       'completely': 0.08299426,\n",
       "                                       'colorectal': 0.06852423,\n",
       "                                       'complete response': 0.18702306,\n",
       "                                       'coronary risk': 0.060802333,\n",
       "                                       'conventional radiology': 0.17168273,\n",
       "                                       'Complete response': 0.18702306,\n",
       "                                       'cathode ray': 0.032089848,\n",
       "                                       'complete responder': 0.21637464,\n",
       "                                       'controlled release': 0.020138334,\n",
       "                                       'conditioned reflexes': 0.034827825,\n",
       "                                       'chemo-radiation': 0.3804883,\n",
       "                                       'complete remission': 0.32190552,\n",
       "                                       'conserved region': 0.004492543,\n",
       "                                       'coronary resistance': 0.12423475,\n",
       "                                       'cardiac resuscitation': 0.11121888,\n",
       "                                       'computed radiographic': 0.1441083,\n",
       "                                       'cooling rate': 0.032717604,\n",
       "                                       'clinical research': 0.29956502,\n",
       "                                       'colonization resistance': 0.029133145,\n",
       "                                       'compression ratio': 0.033497807,\n",
       "                                       'computerized record': 0.0011984372,\n",
       "                                       'chromium': 0.06175242,\n",
       "                                       'colo-rectal': 0.09111121,\n",
       "                                       'contractile reserve': 0.04013088,\n",
       "                                       'clinical record': 0.2720367,\n",
       "                                       'concentration ratios': 0.1162323,\n",
       "                                       'clinical remission': 0.38098192,\n",
       "                                       'centric relation': -0.037996646,\n",
       "                                       'cardiac rhythm': 0.03213904,\n",
       "                                       'capillary refill': 0.020515392,\n",
       "                                       'colonisation rate': 0.07265889,\n",
       "                                       'conventional radiography': 0.08877638,\n",
       "                                       'cellular receptor': 0.09666162}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.14716597,\n",
       "                                       'plaque reduction': -0.02540038,\n",
       "                                       'partial response': 0.2511355,\n",
       "                                       'photoreactivation': -0.04224276,\n",
       "                                       'pentoxyresorufin': 0.04720656,\n",
       "                                       'panoramic radiography': 0.09277565,\n",
       "                                       'proliferative retinopathy': 0.15109856,\n",
       "                                       'partial responses': 0.26497182,\n",
       "                                       'protein': 0.012055008,\n",
       "                                       'prorennin': 0.113553606,\n",
       "                                       'prevalence rate': 0.16965547,\n",
       "                                       'prealbumin': 0.107983656,\n",
       "                                       'pregnancy rates': -0.023877101,\n",
       "                                       'pain relief': 0.077553324,\n",
       "                                       'partial remissions': 0.39426848,\n",
       "                                       'pattern recognition': 0.0041769347,\n",
       "                                       'photo-reactivation': -0.009816592,\n",
       "                                       'protein restriction': 0.024324855,\n",
       "                                       'progesterone receptor': 0.12407637,\n",
       "                                       'placental restriction': -0.0025156515,\n",
       "                                       'pneumatic retinopexy': 0.053759787,\n",
       "                                       'prorenin': 0.10850269,\n",
       "                                       'perirhinal cortex': 0.21435264,\n",
       "                                       'prothrombin ratio': 0.1460778,\n",
       "                                       'pars recta': 0.13458206,\n",
       "                                       'pattern reversal': 0.00080750335,\n",
       "                                       'pr interval (ekg)': 0.18653134,\n",
       "                                       'pityriasis rosea': -0.004730292,\n",
       "                                       'prevalence ratio': 0.20594452,\n",
       "                                       'Projection reconstruction': -0.058389515,\n",
       "                                       'pregnancy rate': -0.0012845865,\n",
       "                                       'phenol red': 0.10531931,\n",
       "                                       'photoreceptor': -0.019758077,\n",
       "                                       'prednisolon': 0.15151282,\n",
       "                                       'partial responders': 0.2650222,\n",
       "                                       'proline-rich': 0.0049438667,\n",
       "                                       'pseudorabies': 0.07530559,\n",
       "                                       'pulmonary regurgitation': 0.09911403,\n",
       "                                       'projection reconstruction': -0.058389515,\n",
       "                                       'photo-receptor': 0.019087467,\n",
       "                                       'protease': 0.029001737,\n",
       "                                       'progestine': -0.02833898,\n",
       "                                       'pentoxy-resorufin': 0.067960195,\n",
       "                                       'partial remission': 0.37229463,\n",
       "                                       'progestin receptor': 0.07223439,\n",
       "                                       'per rectum': 0.116086714,\n",
       "                                       'Plain radiography': 0.08200677,\n",
       "                                       'production rate': 0.051804073,\n",
       "                                       'pulmonary rehabilitation': 0.1227677,\n",
       "                                       'pentoxy resorufin': 0.05180569,\n",
       "                                       'proteinase': 0.035848226,\n",
       "                                       'Paeoniae radix': 0.061756458,\n",
       "                                       'Puerto Rico': 0.04836451,\n",
       "                                       'Prevalence ratios': 0.18192172,\n",
       "                                       'perirenal': 0.027829474,\n",
       "                                       'passive recovery': 0.05016437,\n",
       "                                       'propranolol': 0.10961502,\n",
       "                                       'primary response': 0.2555001,\n",
       "                                       'pregnant': -0.0027233532,\n",
       "                                       'partial regression': 0.08718388,\n",
       "                                       'Photoreactivation': -0.04224276,\n",
       "                                       'peripheral resistance': 0.15200114,\n",
       "                                       'polymorphic reticulosis': 0.045072377,\n",
       "                                       'progressive ratio': 0.13885576,\n",
       "                                       'partial responder': 0.23240356,\n",
       "                                       'projection-reconstruction': -0.02068444,\n",
       "                                       'pro-renin': 0.12663011,\n",
       "                                       'phenol-red': 0.10039396,\n",
       "                                       'progestin': -0.009413875,\n",
       "                                       'pro-rennin': 0.14624162})}),\n",
       "             'the primary trial uses a 3 week cycle for SB-715992 administration, and the study lasts for 21 cycles.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'SB': defaultdict(float,\n",
       "                                      {'Specific binding': 0.033716604,\n",
       "                                       'single breath': 0.07631383,\n",
       "                                       'spontaneous breathing': 0.0006193929,\n",
       "                                       'sympathetic blockade': 0.18702365,\n",
       "                                       'Southern blotting': 0.20299907,\n",
       "                                       'sinus bradycardia': 0.15773217,\n",
       "                                       'Southern blot': 0.16711177,\n",
       "                                       'stereotyped behavior': -0.0036090037,\n",
       "                                       'Saccharomyces boulardii': 0.14436288,\n",
       "                                       'scleral buckling': 0.097477995,\n",
       "                                       'serum bilirubin': 0.16801256,\n",
       "                                       'secobarbital': 0.12495156,\n",
       "                                       'sodium bicarbonate': 0.11210362,\n",
       "                                       'sodium butyrate': 0.14046857,\n",
       "                                       'spina bifida': 0.062629424,\n",
       "                                       'spina-bifida': 0.05598135,\n",
       "                                       'single-breath': 0.064465776,\n",
       "                                       'small bowel': 0.053434126,\n",
       "                                       'sulforhodamine B': 0.22677833,\n",
       "                                       'Single Bond': 0.067946,\n",
       "                                       'strand breaks': -0.016183713,\n",
       "                                       'spontaneous blastogenesis': 0.02642287,\n",
       "                                       'small-bowel': 0.08448965,\n",
       "                                       'sulphorhodamine B': 0.2428515,\n",
       "                                       'stereotyped behaviour': -0.010142436,\n",
       "                                       'sulforhodamine-B': 0.25287908,\n",
       "                                       'side branch': 0.013997721,\n",
       "                                       'specific binding': 0.033716604,\n",
       "                                       'sulphorhodamine-B': 0.2579188,\n",
       "                                       'salbutamol': 0.15972553,\n",
       "                                       'Sleeping Beauty': -0.015793357,\n",
       "                                       'Schiff base': 0.15917416,\n",
       "                                       'sleep bruxism': 0.14558701})}),\n",
       "             'The Exemestane group in the primary trial had a better median Progression-Free Survival than the Abiraterone Acetate + Prednisone group, however the patient with the maximum PFS was in the Abiraterone Acetate + Prednisone group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.117970824,\n",
       "                                       'pyrogen-free saline': 0.16292405,\n",
       "                                       'pressure-flow study': -0.042815186,\n",
       "                                       'posterior fossa syndrome': 0.104554035,\n",
       "                                       'pressure flow study': -0.04510744,\n",
       "                                       'primary fibromyalgia syndrome': 0.26621205,\n",
       "                                       'Piper Fatigue Scale': 0.10684671,\n",
       "                                       'patellofemoral syndrome': 0.1172556,\n",
       "                                       'Progression-free': 0.12704997,\n",
       "                                       'pulmonary function score': 0.15617831,\n",
       "                                       'pressure flow studies': -0.03967926,\n",
       "                                       'protein-free supernatant': 0.13281533,\n",
       "                                       'progression free survival': 0.32985058,\n",
       "                                       'protein free supernatant': 0.13400374,\n",
       "                                       'progression-free survival': 0.3572955,\n",
       "                                       'pressure/flow study': -0.028908659})}),\n",
       "             'Patients with HER2 positive breast or colon carcinoma are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.32696122,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.33433425,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.32758313,\n",
       "                                       'human epidermal growth factor receptor 2': 0.32549173,\n",
       "                                       'human epidermal growth factor receptor-2': 0.33433425})}),\n",
       "             'the secondary trial is testing for the DLT of its interventions, whereas the primary trial is evaluating the dose limiting toxicity for SentiMag and SiennaXP. ': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DLT': defaultdict(float,\n",
       "                                      {'double-lung transplantation': 0.23226887,\n",
       "                                       'direct linear transformation': 0.10433445,\n",
       "                                       'double lumen tube': 0.19814566,\n",
       "                                       'double-lumen tube': 0.18743579,\n",
       "                                       'dose limiting toxicity': 0.5384497,\n",
       "                                       'dose-limiting toxicity': 0.54471034,\n",
       "                                       'donor leukocyte transfusion': 0.1294593,\n",
       "                                       'double-lumen endobronchial tube': 0.21645015,\n",
       "                                       'double lumen endotracheal tube': 0.2571781,\n",
       "                                       'double lung transplantation': 0.23222119,\n",
       "                                       'double-lumen endotracheal tube': 0.24692889})}),\n",
       "             'Patients must have LVEF < 50% to be eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'LVEF': defaultdict(float,\n",
       "                                      {'left-ventricular ejection fraction': 0.26002008,\n",
       "                                       'Left ventricular ejection fractions': 0.24740253,\n",
       "                                       'left ventricular function': 0.23465979,\n",
       "                                       'left ventricular ejection fraction': 0.25525963,\n",
       "                                       'left ventricle ejection fraction': 0.26638922,\n",
       "                                       'left-ventricle ejection fraction': 0.26570722,\n",
       "                                       'LV ejection fraction': 0.28046176})}),\n",
       "             'Participants in the primary trial receive different interventions depending on their cancer hormone status, so Triple-Negative patients are seperated from HER2+ patients for example, whereas all patients in the secondary trial took the same intervention.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.22260831,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.23375389,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.22304745,\n",
       "                                       'human epidermal growth factor receptor 2': 0.22091748,\n",
       "                                       'human epidermal growth factor receptor-2': 0.23375389})}),\n",
       "             'Patients with stage I, II, III or IV breast cancer may be eliglbe for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'II': defaultdict(float,\n",
       "                                      {'image intensifier': 0.020997003,\n",
       "                                       'icterus index': 0.12560894}),\n",
       "                          'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': -0.005621401,\n",
       "                                       'intravenous injection': 0.2084836,\n",
       "                                       'iridovirus': 0.04166929,\n",
       "                                       'intra-venous': 0.09014047,\n",
       "                                       'invitro': -0.008383748,\n",
       "                                       'intra ventricular': 0.03990556,\n",
       "                                       'intra vascular': 0.0631015,\n",
       "                                       'in vivo': 0.20019929,\n",
       "                                       'intravascular': 0.10907334,\n",
       "                                       'in-vivo': 0.23943043,\n",
       "                                       'inter-vertebral': 0.026313724,\n",
       "                                       'ichthyosis vulgaris': 0.06273247,\n",
       "                                       'intravenous': 0.18146124,\n",
       "                                       'intravaginal': 0.11769212,\n",
       "                                       'invasive': 0.1090064,\n",
       "                                       'iridescent virus': 0.00276694,\n",
       "                                       'isometric virus': -0.07051068,\n",
       "                                       'intravenous feeding device': 0.14240345,\n",
       "                                       'invivo': 0.04076511,\n",
       "                                       'instrumental variable': 0.08651271,\n",
       "                                       'intraventricular': 0.021557504,\n",
       "                                       'intra-vaginal': 0.113414526,\n",
       "                                       'intravertebral': 0.03875412,\n",
       "                                       'in vitro': 0.14393531,\n",
       "                                       'interventricular': 0.03137246,\n",
       "                                       'in-vitro': 0.19071871,\n",
       "                                       'intra venous': 0.06715506,\n",
       "                                       'iodine value': 0.0025351474,\n",
       "                                       'ichnovirus': -0.020851787,\n",
       "                                       'inter-ventricular': 0.040614437,\n",
       "                                       'intra-vertebral': 0.03719924,\n",
       "                                       'intravenous injection device': 0.16736357,\n",
       "                                       'intervertebral': 0.039508022,\n",
       "                                       'initial visit': 0.069266036,\n",
       "                                       'intravenous feeding': 0.15574478,\n",
       "                                       'intra-vascular': 0.1035622,\n",
       "                                       'intra-ventricular': 0.052465487})}),\n",
       "             'Cohort 2 of the primary trial reported one case of AML.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'AML': defaultdict(float,\n",
       "                                      {'acute myelogenous leukemias': 0.5472138,\n",
       "                                       'acute myelogenous': 0.41425055,\n",
       "                                       'acute myeloblastic leukaemia': 0.47052777,\n",
       "                                       'amlodipine': 0.3435672,\n",
       "                                       'acute myeloid leukaemic': 0.42033827,\n",
       "                                       'acute myelogenous leukaemia': 0.46801624,\n",
       "                                       'Amlodipine': 0.3435672,\n",
       "                                       'acute myelogenous leukemia': 0.5374489,\n",
       "                                       'acute myeloid leukemia': 0.55165386,\n",
       "                                       'acute myeloid leukemic': 0.4133204,\n",
       "                                       'acute mucosal lesion': 0.31817025,\n",
       "                                       'acute myeloid leukaemias': 0.48475885,\n",
       "                                       'acute myelocytic leukemia': 0.5282358,\n",
       "                                       'anterior mitral leaflet': 0.27508327,\n",
       "                                       'acute myeloid': 0.41617772,\n",
       "                                       'acute myelocytic leukaemia': 0.46564403,\n",
       "                                       'acute myeloid leukemias': 0.56183344,\n",
       "                                       'acute myeloid leukaemia': 0.47233504,\n",
       "                                       'acute myeloblastic leukemia': 0.5320427,\n",
       "                                       'anatomic medullary locking': 0.14356723,\n",
       "                                       'angiomyolipoma': 0.22245577,\n",
       "                                       'angio-myolipoma': 0.321187,\n",
       "                                       'acute myeloblastic': 0.41079545})}),\n",
       "             'Less than 20 the primary trial participants achieved partial response (PR).': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.17976394,\n",
       "                                       'plaque reduction': 0.10759781,\n",
       "                                       'partial response': 0.48416114,\n",
       "                                       'photoreactivation': 0.0861834,\n",
       "                                       'pentoxyresorufin': 0.13359377,\n",
       "                                       'panoramic radiography': 0.0967121,\n",
       "                                       'proliferative retinopathy': 0.115788735,\n",
       "                                       'partial responses': 0.47926316,\n",
       "                                       'protein': 0.016530873,\n",
       "                                       'prorennin': 0.14968863,\n",
       "                                       'prevalence rate': 0.22017252,\n",
       "                                       'prealbumin': 0.10318558,\n",
       "                                       'pregnancy rates': 0.12343617,\n",
       "                                       'pain relief': 0.1287282,\n",
       "                                       'partial remissions': 0.45241413,\n",
       "                                       'pattern recognition': 0.009663752,\n",
       "                                       'photo-reactivation': 0.10584573,\n",
       "                                       'protein restriction': 0.17732778,\n",
       "                                       'progesterone receptor': 0.16712669,\n",
       "                                       'placental restriction': 0.1914829,\n",
       "                                       'pneumatic retinopexy': 0.20801666,\n",
       "                                       'prorenin': 0.18697828,\n",
       "                                       'perirhinal cortex': 0.16470164,\n",
       "                                       'prothrombin ratio': 0.20909004,\n",
       "                                       'pars recta': 0.108819515,\n",
       "                                       'pattern reversal': 0.030406272,\n",
       "                                       'pr interval (ekg)': 0.3066455,\n",
       "                                       'pityriasis rosea': 0.09638324,\n",
       "                                       'prevalence ratio': 0.25539082,\n",
       "                                       'Projection reconstruction': 0.046551384,\n",
       "                                       'pregnancy rate': 0.123745084,\n",
       "                                       'phenol red': 0.132703,\n",
       "                                       'photoreceptor': 0.05071013,\n",
       "                                       'prednisolon': 0.17976506,\n",
       "                                       'partial responders': 0.5297525,\n",
       "                                       'proline-rich': 0.053074855,\n",
       "                                       'pseudorabies': 0.15364178,\n",
       "                                       'pulmonary regurgitation': 0.11402151,\n",
       "                                       'projection reconstruction': 0.046551384,\n",
       "                                       'photo-receptor': 0.07316792,\n",
       "                                       'protease': 0.07366708,\n",
       "                                       'progestine': 0.11279181,\n",
       "                                       'pentoxy-resorufin': 0.17984915,\n",
       "                                       'partial remission': 0.41426092,\n",
       "                                       'progestin receptor': 0.14860475,\n",
       "                                       'per rectum': 0.10808785,\n",
       "                                       'Plain radiography': 0.1147294,\n",
       "                                       'production rate': 0.13780853,\n",
       "                                       'pulmonary rehabilitation': 0.22429818,\n",
       "                                       'pentoxy resorufin': 0.19232625,\n",
       "                                       'proteinase': 0.033635292,\n",
       "                                       'Paeoniae radix': 0.15329535,\n",
       "                                       'Puerto Rico': 0.12053551,\n",
       "                                       'Prevalence ratios': 0.24165186,\n",
       "                                       'perirenal': 0.08146602,\n",
       "                                       'passive recovery': 0.19646762,\n",
       "                                       'propranolol': 0.16404906,\n",
       "                                       'primary response': 0.44408104,\n",
       "                                       'pregnant': 0.020392593,\n",
       "                                       'partial regression': 0.2940089,\n",
       "                                       'Photoreactivation': 0.0861834,\n",
       "                                       'peripheral resistance': 0.26043263,\n",
       "                                       'polymorphic reticulosis': 0.17090257,\n",
       "                                       'progressive ratio': 0.22687213,\n",
       "                                       'partial responder': 0.4718758,\n",
       "                                       'projection-reconstruction': 0.076004066,\n",
       "                                       'pro-renin': 0.18373016,\n",
       "                                       'phenol-red': 0.13603106,\n",
       "                                       'progestin': 0.10601562,\n",
       "                                       'pro-rennin': 0.15249449})}),\n",
       "             'All the primary trial subjects are required to take the intervention PO daily.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.2412369,\n",
       "                                       'parietal operculum': 0.15575184,\n",
       "                                       'post office': 0.09688979,\n",
       "                                       'percentage of observed value': 0.079360686,\n",
       "                                       'Phenol oxidase': 0.1856062,\n",
       "                                       'parapineal organ': 0.10889865,\n",
       "                                       'power output': 0.02612672,\n",
       "                                       'predominant organism': 0.14073116,\n",
       "                                       'pulse-oximetry': 0.2421871,\n",
       "                                       'perceptual organisation': 0.011946669,\n",
       "                                       'power outputs': -0.02233804,\n",
       "                                       'Personality Organization': 0.049339574,\n",
       "                                       'postoperative': 0.10784924,\n",
       "                                       'parieto occipital': 0.1154955,\n",
       "                                       'polyolefin': 0.097567625,\n",
       "                                       'parietooccipital': 0.07107796,\n",
       "                                       'poly-olefin': 0.09164102,\n",
       "                                       'peroral': 0.12078886,\n",
       "                                       'prostate only': 0.1926099,\n",
       "                                       'pressure overload': 0.089777015,\n",
       "                                       'peroxidase': 0.12946948,\n",
       "                                       'principal olive': 0.1251234,\n",
       "                                       'peri-operative': 0.16299792,\n",
       "                                       'posterior': 0.094330795,\n",
       "                                       'Perceptual Organization': 0.013122387,\n",
       "                                       'period of onset': 0.19202664,\n",
       "                                       'posterior nuclear group': 0.07981427,\n",
       "                                       'phenol oxidase': 0.1856062,\n",
       "                                       'pressure': 0.059326425,\n",
       "                                       'per os (by mouth)': 0.23795024,\n",
       "                                       'parieto-occipital': 0.10228133,\n",
       "                                       'preoptic area': 0.076451376,\n",
       "                                       'perceptual organization': 0.013122387,\n",
       "                                       'prophylactic oophorectomy': 0.117223024,\n",
       "                                       'phosphodiester': 0.18955325,\n",
       "                                       'pre-ovulatory': 0.190854,\n",
       "                                       'palm oil': 0.08409713,\n",
       "                                       'preovulatory': 0.19947788,\n",
       "                                       'perioperative': 0.2168823,\n",
       "                                       'post operative': 0.11176569,\n",
       "                                       'post-operative': 0.11315283,\n",
       "                                       'phospho-diester': 0.1160845,\n",
       "                                       'protein oxidation': 0.111294545,\n",
       "                                       'palm-oil': 0.076829836,\n",
       "                                       'per os': 0.11320419,\n",
       "                                       'pericardial organ': 0.09144661,\n",
       "                                       'Pulse oximetry': 0.2412369,\n",
       "                                       'paraoxon': 0.21927497,\n",
       "                                       'propylene oxide': 0.16258432,\n",
       "                                       'phenoloxidase': 0.09760713,\n",
       "                                       'peanut oil': 0.1357535})}),\n",
       "             'Patients with a positive FISH result are eligible for the secondary trial, but not for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'FISH': defaultdict(float,\n",
       "                                      {'fluorescence in-situ hybridisation': 0.1823685,\n",
       "                                       'fluorescence-in-situ-hybridisation': 0.1580522,\n",
       "                                       'fluorescence in situ hybridisation': 0.1749645,\n",
       "                                       'fluorescent in situ hybridization': 0.17013627,\n",
       "                                       'fluorescence in situ hybridization technique': 0.19003509,\n",
       "                                       'fluorescence in situ hybridization': 0.18022317,\n",
       "                                       'fluorescent in situ hybridisation': 0.16771428,\n",
       "                                       'fluorescent in-situ hybridization': 0.17795755,\n",
       "                                       'fluorescence-in-situ-hybridization': 0.1673474,\n",
       "                                       'fluorescence in-situ hybridization': 0.18582317,\n",
       "                                       'fluorescent in-situ hybridisation': 0.17693673})}),\n",
       "             'participants from both cohorts of the primary trial had a drastically lower CNS Objective Response Rate than those in the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CNS': defaultdict(float,\n",
       "                                      {'central nerve system': 0.3195037,\n",
       "                                       'Congenital nephrotic syndrome': 0.11501591,\n",
       "                                       'Coagulase negative staphylococci': 0.0389503,\n",
       "                                       'Clinical nurse specialist': 0.1283443,\n",
       "                                       'coagulase negative staphylococcus': 0.04403559,\n",
       "                                       'coagulase-negative Staphylococcus': 0.039828714,\n",
       "                                       'central nerves system': 0.2777086,\n",
       "                                       'central-nervous-system': 0.27481145,\n",
       "                                       'congenital nephrotic syndrome': 0.11501591,\n",
       "                                       'central nervous system': 0.2929723,\n",
       "                                       'central nervous systems': 0.2942805,\n",
       "                                       'Crigler Najjar syndrome': 0.18714082,\n",
       "                                       'coagulase negative staph': 0.030715737,\n",
       "                                       'clinical nurse specialists': 0.15031688,\n",
       "                                       'Crigler-Najjar syndrome': 0.1926738,\n",
       "                                       'coagulase-negative staphylococci': 0.02863502,\n",
       "                                       'coagulase-negative staphylococcus': 0.039828714,\n",
       "                                       'central nervous': 0.29901746,\n",
       "                                       'clinical nurse specialist': 0.1283443,\n",
       "                                       'Canadian Neurological Scale': 0.45367908,\n",
       "                                       'coagulase-negative staphylococcal': 0.0830077,\n",
       "                                       'coagulase negative Staphylococcus': 0.04403559})}),\n",
       "             'the primary trial results suggest that 40 mg/m2 administered as a 3-hour intravenous (IV) infusion on Day 1 of each cycle + Capecitabine, may increase OS, compared to Capecitabine alone.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.05536316,\n",
       "                                       'intravenous injection': 0.43316427,\n",
       "                                       'iridovirus': 0.07494556,\n",
       "                                       'intra-venous': 0.30615816,\n",
       "                                       'invitro': 0.1726068,\n",
       "                                       'intra ventricular': 0.21270438,\n",
       "                                       'intra vascular': 0.27885836,\n",
       "                                       'in vivo': 0.3112491,\n",
       "                                       'intravascular': 0.29199684,\n",
       "                                       'in-vivo': 0.35965088,\n",
       "                                       'inter-vertebral': 0.16432853,\n",
       "                                       'ichthyosis vulgaris': 0.021828206,\n",
       "                                       'intravenous': 0.41076452,\n",
       "                                       'intravaginal': 0.18031324,\n",
       "                                       'invasive': 0.0142596895,\n",
       "                                       'iridescent virus': 0.034643423,\n",
       "                                       'isometric virus': 0.08818833,\n",
       "                                       'intravenous feeding device': 0.23256783,\n",
       "                                       'invivo': 0.13740017,\n",
       "                                       'instrumental variable': 0.01914098,\n",
       "                                       'intraventricular': 0.20024975,\n",
       "                                       'intra-vaginal': 0.19164178,\n",
       "                                       'intravertebral': 0.16951843,\n",
       "                                       'in vitro': 0.23626092,\n",
       "                                       'interventricular': 0.17869325,\n",
       "                                       'in-vitro': 0.3057063,\n",
       "                                       'intra venous': 0.30096105,\n",
       "                                       'iodine value': 0.22185542,\n",
       "                                       'ichnovirus': 0.012703912,\n",
       "                                       'inter-ventricular': 0.18318658,\n",
       "                                       'intra-vertebral': 0.2071795,\n",
       "                                       'intravenous injection device': 0.36333898,\n",
       "                                       'intervertebral': 0.107868634,\n",
       "                                       'initial visit': 0.09875418,\n",
       "                                       'intravenous feeding': 0.32794222,\n",
       "                                       'intra-vascular': 0.279706,\n",
       "                                       'intra-ventricular': 0.22068149}),\n",
       "                          'OS': defaultdict(float,\n",
       "                                      {'oculus sinister': 0.094201125,\n",
       "                                       'opposite-sex': -0.0032969604,\n",
       "                                       'open surgery': 0.16088812,\n",
       "                                       'over-shoot': 0.15604728,\n",
       "                                       'oxi-dative stress': 0.09451583,\n",
       "                                       'oligosaccharides': 0.13319747,\n",
       "                                       'orthopedic surgery': 0.18235226,\n",
       "                                       'overshoot': 0.12350291,\n",
       "                                       'open splenectomy': 0.10921723,\n",
       "                                       'ovarian stimulation': 0.40591645,\n",
       "                                       'over shoot': 0.11521415,\n",
       "                                       'obese strain': 0.082787745,\n",
       "                                       'Opitz syndrome': 0.20123297,\n",
       "                                       'outer segments': 0.020500146,\n",
       "                                       'ouabain-sensitive': 0.18419328,\n",
       "                                       'osteosarcoma': 0.18933259,\n",
       "                                       'oxidative stress': 0.115512215,\n",
       "                                       'overall survival time': 0.1819592,\n",
       "                                       'osteosarcomas': 0.17097433,\n",
       "                                       'oculus sinister (left eye)': 0.1031783,\n",
       "                                       'overlap syndrome': 0.03564708,\n",
       "                                       'outer segment': 0.034291536,\n",
       "                                       'oligomycin-sensitive': 0.16444452,\n",
       "                                       'oxidative-stress': 0.15293054,\n",
       "                                       'oral secretion': 0.059393574,\n",
       "                                       'oligosaccharide': 0.1515234,\n",
       "                                       'overall survival rate': 0.1844457,\n",
       "                                       'Omenn syndrome': 0.10925592,\n",
       "                                       'osteogenic sarcoma': 0.16661073,\n",
       "                                       \"Omenn's syndrome\": 0.12715718,\n",
       "                                       'one-step': 0.057416677,\n",
       "                                       'oligo-saccharide': 0.119555116,\n",
       "                                       'Ocimum sanctum': 0.1327526,\n",
       "                                       'overall survival': 0.10105273,\n",
       "                                       'One-Step': 0.057416677,\n",
       "                                       'oxydative stress': 0.18782093})}),\n",
       "             'the primary trial results indicate that the Recommended Phase II Dose for Vorinostat, as Assessed by NCI Common Terminology Criteria for Adverse Events, is 300 mg.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'II': defaultdict(float,\n",
       "                                      {'image intensifier': 0.052962065,\n",
       "                                       'icterus index': 0.075854234}),\n",
       "                          'NCI': defaultdict(float,\n",
       "                                      {'National Cancer Institute': 0.19142386,\n",
       "                                       'negative chemical ionization': 0.09194625,\n",
       "                                       \"National Cancer Institute's\": 0.2014103,\n",
       "                                       'no cognitive impairment': -0.036581635,\n",
       "                                       'negative chemical ionisation': 0.114264384,\n",
       "                                       'neuronal cytoplasmic inclusion': -0.015753336,\n",
       "                                       'nuclear contour index': 0.0560725})}),\n",
       "             'On day 1 Cohort 1 of the primary trial receive doxorubicin hydrochloride IV, oral cyclophosphamide, dexamethasone IV or orally and ondansetron IV.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.14398311,\n",
       "                                       'intravenous injection': 0.35778695,\n",
       "                                       'iridovirus': 0.15846546,\n",
       "                                       'intra-venous': 0.21534482,\n",
       "                                       'invitro': 0.07485701,\n",
       "                                       'intra ventricular': 0.1216355,\n",
       "                                       'intra vascular': 0.16667426,\n",
       "                                       'in vivo': 0.18217906,\n",
       "                                       'intravascular': 0.19884144,\n",
       "                                       'in-vivo': 0.25387734,\n",
       "                                       'inter-vertebral': 0.13150671,\n",
       "                                       'ichthyosis vulgaris': 0.12887862,\n",
       "                                       'intravenous': 0.35193926,\n",
       "                                       'intravaginal': 0.13391441,\n",
       "                                       'invasive': 0.04166067,\n",
       "                                       'iridescent virus': 0.11225903,\n",
       "                                       'isometric virus': 0.12572156,\n",
       "                                       'intravenous feeding device': 0.19817314,\n",
       "                                       'invivo': 0.036117382,\n",
       "                                       'instrumental variable': 0.03059223,\n",
       "                                       'intraventricular': 0.11455026,\n",
       "                                       'intra-vaginal': 0.15894651,\n",
       "                                       'intravertebral': 0.11312899,\n",
       "                                       'in vitro': 0.118454725,\n",
       "                                       'interventricular': 0.09900924,\n",
       "                                       'in-vitro': 0.20538247,\n",
       "                                       'intra venous': 0.17363633,\n",
       "                                       'iodine value': 0.1016417,\n",
       "                                       'ichnovirus': 0.13863099,\n",
       "                                       'inter-ventricular': 0.10667545,\n",
       "                                       'intra-vertebral': 0.16954145,\n",
       "                                       'intravenous injection device': 0.27242896,\n",
       "                                       'intervertebral': 0.10810354,\n",
       "                                       'initial visit': 0.21419783,\n",
       "                                       'intravenous feeding': 0.25062358,\n",
       "                                       'intra-vascular': 0.2033419,\n",
       "                                       'intra-ventricular': 0.13875571})}),\n",
       "             'The Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) for Alisertib in Combination With Paclitaxel, supported by results from cohort 2 of the primary trial, is 40 mg/m^2 orally, twice daily (BID) on Days 1-3, 8-10 and 15-17': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MTD': defaultdict(float,\n",
       "                                      {'maximum tolerated dose': 0.5781033,\n",
       "                                       'Monroe tidal drainage': -0.036150943,\n",
       "                                       \"Midwife Teacher's Diploma\": -0.015067582,\n",
       "                                       'mean total dose': 0.4020822,\n",
       "                                       'maximally-tolerated dose': 0.57215095,\n",
       "                                       'metastatic trophoblastic disease': 0.16942044,\n",
       "                                       'maximal tolerated dose': 0.58623993,\n",
       "                                       'maximal-tolerated dose': 0.57763964,\n",
       "                                       'maximum tolerable dose': 0.5457961,\n",
       "                                       'muscle tension dysphonia': 0.021283735,\n",
       "                                       'muscle-tension dysphonia': 0.010808916,\n",
       "                                       'maximum tolerated dosage': 0.5709476,\n",
       "                                       'maximum tolerated doses': 0.56180006,\n",
       "                                       'maximum-tolerated dose': 0.57374454,\n",
       "                                       'multiple tic disorder': 0.1353099,\n",
       "                                       'mannitol dehydrogenase': 0.1196301,\n",
       "                                       'methadone': 0.121439636,\n",
       "                                       'maximally tolerated dose': 0.570705}),\n",
       "                          'BID': defaultdict(float,\n",
       "                                      {'Bcl-2 interacting domain': -0.012772291,\n",
       "                                       'Beta Interaction Domain': 0.047908865,\n",
       "                                       'body-image disturbance': -0.040730767,\n",
       "                                       'bis in die': 0.039797556,\n",
       "                                       'body image disturbance': -0.029098503,\n",
       "                                       'BCL-2 interacting domain': -0.012772291,\n",
       "                                       'bipolar I disorder': 0.14485967,\n",
       "                                       'bis in die (twice a day)': 0.173859,\n",
       "                                       'BH3-interacting-domain death agonist': 0.13765186,\n",
       "                                       'BH3 interacting domain death agonist': 0.115565725,\n",
       "                                       'beta-interaction domain': 0.036340855,\n",
       "                                       'body image dissatisfaction': -0.037788756,\n",
       "                                       'beta interaction domain': 0.047908865,\n",
       "                                       'body-image dissatisfaction': -0.027048137,\n",
       "                                       'bipolar-I disorder': 0.16496237,\n",
       "                                       'BH3-interacting domain death agonist': 0.12011548})}),\n",
       "             'Renal cancer Patients from the primary trial receiving Standard of Care had a median PFS of 2.5 months by Core radiology laboratory assessment.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.11790996,\n",
       "                                       'pyrogen-free saline': 0.18476306,\n",
       "                                       'pressure-flow study': -0.01595117,\n",
       "                                       'posterior fossa syndrome': 0.03502068,\n",
       "                                       'pressure flow study': -0.012840037,\n",
       "                                       'primary fibromyalgia syndrome': 0.11790971,\n",
       "                                       'Piper Fatigue Scale': 0.10324231,\n",
       "                                       'patellofemoral syndrome': 0.111477524,\n",
       "                                       'Progression-free': 0.09909028,\n",
       "                                       'pulmonary function score': 0.23856802,\n",
       "                                       'pressure flow studies': -0.01938306,\n",
       "                                       'protein-free supernatant': 0.022763563,\n",
       "                                       'progression free survival': 0.28789127,\n",
       "                                       'protein free supernatant': 0.034162205,\n",
       "                                       'progression-free survival': 0.30751145,\n",
       "                                       'pressure/flow study': -0.0052445414})}),\n",
       "             'Patients from the primary trial receiving Standard of Care had a median PFS of 2.7months by Core radiology laboratory assessment.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.25142175,\n",
       "                                       'pyrogen-free saline': 0.17438966,\n",
       "                                       'pressure-flow study': 0.04491426,\n",
       "                                       'posterior fossa syndrome': 0.25852945,\n",
       "                                       'pressure flow study': 0.046796992,\n",
       "                                       'primary fibromyalgia syndrome': 0.302437,\n",
       "                                       'Piper Fatigue Scale': 0.21322727,\n",
       "                                       'patellofemoral syndrome': 0.27413642,\n",
       "                                       'Progression-free': 0.14872344,\n",
       "                                       'pulmonary function score': 0.37044725,\n",
       "                                       'pressure flow studies': 0.044339467,\n",
       "                                       'protein-free supernatant': 0.07843415,\n",
       "                                       'progression free survival': 0.30167374,\n",
       "                                       'protein free supernatant': 0.11212683,\n",
       "                                       'progression-free survival': 0.3366127,\n",
       "                                       'pressure/flow study': 0.06950575})}),\n",
       "             'Any patients with histologically confirmed stage 4 adenocarcinoma HER2/neu immunohistochemistry 3+, ECOG performance status <2 and a Negative HCG pregnancy test are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.2420817,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.2604787,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.2412811,\n",
       "                                       'human epidermal growth factor receptor 2': 0.25248358,\n",
       "                                       'human epidermal growth factor receptor-2': 0.2604787}),\n",
       "                          'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.074572995,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.5047421,\n",
       "                                       'eastern cooperative oncology group': 0.5047421,\n",
       "                                       'Electrocochleography': 0.12349413,\n",
       "                                       'electrocochleogram': 0.11312987,\n",
       "                                       'electrocortical activity': 0.04905383,\n",
       "                                       'electrocorticograms': 0.08367472,\n",
       "                                       'electrocortical': 0.03028115}),\n",
       "                          'HCG': defaultdict(float,\n",
       "                                      {'human chorionic gonadotropins': 0.23955381,\n",
       "                                       'human chorionic gonadotropin': 0.25917575,\n",
       "                                       'human chorionic gonadotrophin': 0.24680267,\n",
       "                                       'human chorionic gonadotropin hormone': 0.22909114,\n",
       "                                       'Human choriogonadotropin': 0.081477225})}),\n",
       "             'The Triple-Negative Breast Cancer cohort of the primary trial had a much lower ORR than the cohort receiving 1.4 mg/m2 of Eribulin.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ORR': defaultdict(float,\n",
       "                                      {'oxygen-reduction reaction': 0.14242508,\n",
       "                                       'overall response rate': 0.20586453,\n",
       "                                       'objective response rate': 0.17745768,\n",
       "                                       'oxygen reduction reaction': 0.14639723})}),\n",
       "             'Patients must have an ECOG score below 3 to participate in the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.1594499,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.2707214,\n",
       "                                       'eastern cooperative oncology group': 0.2707214,\n",
       "                                       'Electrocochleography': 0.14076969,\n",
       "                                       'electrocochleogram': 0.14964616,\n",
       "                                       'electrocortical activity': 0.13925897,\n",
       "                                       'electrocorticograms': 0.17034693,\n",
       "                                       'electrocortical': 0.08175343})}),\n",
       "             'Black men with and ECOG <=2, with ANC >1.5 x 10^9/L,Bilirubin > 2.0 mg/dl, PLT >100 x 10^9/L and no prior history of blood clots are eligible for the primary trial but excluded from the secondary trial': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.13021715,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.29070374,\n",
       "                                       'eastern cooperative oncology group': 0.29070374,\n",
       "                                       'Electrocochleography': 0.13539124,\n",
       "                                       'electrocochleogram': 0.12855735,\n",
       "                                       'electrocortical activity': 0.070475414,\n",
       "                                       'electrocorticograms': 0.14328238,\n",
       "                                       'electrocortical': 0.056963265}),\n",
       "                          'ANC': defaultdict(float,\n",
       "                                      {'acid neutralising capacity': 0.110615216,\n",
       "                                       'antigen-neutralising capacity': 0.20705532,\n",
       "                                       'antenatal care': 0.16314624,\n",
       "                                       'acid neutralization capacity': 0.097511366,\n",
       "                                       'ante-natal clinic': 0.30238038,\n",
       "                                       'antenatal clinics': 0.20678228,\n",
       "                                       'acid-neutralising capacity': 0.1018525,\n",
       "                                       'absolute neutrophil count': 0.2582684,\n",
       "                                       'Active noise control': -0.020994239,\n",
       "                                       'acid neutralizing capacity': 0.117079794,\n",
       "                                       'antigen-neutralizing capacity': 0.20669459,\n",
       "                                       'acid neutralisation capacity': 0.10354459,\n",
       "                                       'absolute neutrophil counts': 0.267465,\n",
       "                                       'Army Nurse Corps': 0.15844235,\n",
       "                                       'antenatal clinic': 0.25236914,\n",
       "                                       'acid-neutralizing capacity': 0.11036065}),\n",
       "                          'PLT': defaultdict(float,\n",
       "                                      {'platelet': 0.39181066,\n",
       "                                       'platelet count': 0.40954643,\n",
       "                                       'Pancreolauryl Test': 0.31815448,\n",
       "                                       'preferential looking test': 0.3150458,\n",
       "                                       'preferential-looking test': 0.29305494,\n",
       "                                       'platelet counts': 0.41018102,\n",
       "                                       'primed lymphocyte test': 0.41730997,\n",
       "                                       'posterolateral thoracotomy': 0.12840658,\n",
       "                                       'postero-lateral thoracotomy': 0.13279839,\n",
       "                                       'pancreolauryl test': 0.31815448,\n",
       "                                       'primed lymphocyte testing': 0.39741507,\n",
       "                                       'plantaris': 0.023566509,\n",
       "                                       'platelets': 0.40081134,\n",
       "                                       'primed lymphocyte typing': 0.3526027,\n",
       "                                       'pyoluteorin': 0.1412201,\n",
       "                                       'primed-lymphocyte test': 0.42141977})}),\n",
       "             'At least 11 patients in both cohorts of the primary trial achieved either complete response (CR) or partial response (PR). ': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.08997626,\n",
       "                                       'clot retraction': 0.17411597,\n",
       "                                       'conditioned response': 0.18852764,\n",
       "                                       'conditioned reflex': 0.11390646,\n",
       "                                       'charge recombination': 0.039036456,\n",
       "                                       'Czech Republic': 0.054297995,\n",
       "                                       'control region': 0.09136147,\n",
       "                                       'colonization rate': 0.09843486,\n",
       "                                       'complete remission rate': 0.6139189,\n",
       "                                       'Charles River': 0.07255148,\n",
       "                                       'Caloric restriction': 0.10988381,\n",
       "                                       'colonisation resistance': 0.09093319,\n",
       "                                       'complete regression': 0.16592981,\n",
       "                                       'conversion rate': 0.15438165,\n",
       "                                       'chest roentgenography': 0.2013825,\n",
       "                                       'chest radiograph': 0.1950184,\n",
       "                                       'colony reared': 0.0017957065,\n",
       "                                       'cardiorespiratory': 0.1453483,\n",
       "                                       'circadian rhythm': 0.09444502,\n",
       "                                       'cardiac rupture': 0.14545463,\n",
       "                                       'carbonyl reductase': 0.10479352,\n",
       "                                       'calorie restriction': 0.087234646,\n",
       "                                       'cortical reaction': 0.18699606,\n",
       "                                       'complete remissions': 0.5463045,\n",
       "                                       'chest radiography': 0.18578985,\n",
       "                                       'computerised record': 0.07094051,\n",
       "                                       'charge-recombination': 0.0444245,\n",
       "                                       'Cardiac Rehabilitation': 0.250097,\n",
       "                                       'calcium-binding protein calretinin': 0.14904118,\n",
       "                                       'chronic rejection': 0.15929459,\n",
       "                                       'colony-reared': 0.022007031,\n",
       "                                       'cognitive reserve': 0.115084104,\n",
       "                                       'critical ratio': 0.17238979,\n",
       "                                       'cortico-resistant': 0.3187001,\n",
       "                                       'caloric restriction': 0.10988381,\n",
       "                                       'corticoresistant': 0.19707067,\n",
       "                                       'corticosteroid-resistant': 0.30838916,\n",
       "                                       'Congo red': 0.07398509,\n",
       "                                       'complete responses': 0.33847895,\n",
       "                                       'chest and right arm': 0.14205201,\n",
       "                                       'conditioned reinforcement': 0.09122156,\n",
       "                                       'constant routine': 0.07175165,\n",
       "                                       'cardio-respiratory': 0.2180458,\n",
       "                                       'complete response rate': 0.4721112,\n",
       "                                       'cockroach': -0.046717092,\n",
       "                                       'chief resident': 0.047682866,\n",
       "                                       'calorie-restricted': 0.11857275,\n",
       "                                       'complete responders': 0.38928655,\n",
       "                                       'cysteine-rich': 0.1250792,\n",
       "                                       'controlled-release': 0.19039333,\n",
       "                                       'chemoradiation': 0.112946704,\n",
       "                                       'crown-rump': 0.024265379,\n",
       "                                       'crown-rump length': 0.0646858,\n",
       "                                       'creatinine': 0.20304328,\n",
       "                                       'capture-recapture': 0.09953709,\n",
       "                                       'Congo-red': 0.0888497,\n",
       "                                       'coefficient of repeatability': 0.24265623,\n",
       "                                       'computed radiography': 0.18375963,\n",
       "                                       'controlled respiration': 0.15968288,\n",
       "                                       'conditioned reward': 0.13749601,\n",
       "                                       'complement receptors': 0.30111188,\n",
       "                                       'concentration-response': 0.1734563,\n",
       "                                       'complete': 0.17312312,\n",
       "                                       'chest roentgenogram': 0.2096911,\n",
       "                                       'complement receptor': 0.31343803,\n",
       "                                       'Cajal-Retzius': 0.07678898,\n",
       "                                       'cremasteric reflex': 0.25983524,\n",
       "                                       'clot-retraction': 0.155798,\n",
       "                                       'conserved regions': 0.032302607,\n",
       "                                       'child-resistant': 0.019254183,\n",
       "                                       'control rats': 0.035559658,\n",
       "                                       'caries-resistant': 0.114443414,\n",
       "                                       'coronary revascularization': 0.28662816,\n",
       "                                       'colon resection': 0.17411128,\n",
       "                                       'contrast ratio': 0.11483126,\n",
       "                                       'concentration ratio': 0.15098113,\n",
       "                                       'Calreticulin': 0.16772169,\n",
       "                                       'composite resin': 0.038981225,\n",
       "                                       'completely': 0.16517358,\n",
       "                                       'colorectal': 0.16685937,\n",
       "                                       'complete response': 0.3024556,\n",
       "                                       'coronary risk': 0.18244888,\n",
       "                                       'conventional radiology': 0.2142081,\n",
       "                                       'Complete response': 0.3024556,\n",
       "                                       'cathode ray': 0.012226706,\n",
       "                                       'complete responder': 0.3579043,\n",
       "                                       'controlled release': 0.14106955,\n",
       "                                       'conditioned reflexes': 0.12737931,\n",
       "                                       'chemo-radiation': 0.35452986,\n",
       "                                       'complete remission': 0.48549938,\n",
       "                                       'conserved region': 0.00869439,\n",
       "                                       'coronary resistance': 0.27663767,\n",
       "                                       'cardiac resuscitation': 0.19851105,\n",
       "                                       'computed radiographic': 0.20562926,\n",
       "                                       'cooling rate': 0.044175223,\n",
       "                                       'clinical research': 0.4260803,\n",
       "                                       'colonization resistance': 0.065967865,\n",
       "                                       'compression ratio': 0.047815558,\n",
       "                                       'computerized record': 0.06785485,\n",
       "                                       'chromium': 0.11919124,\n",
       "                                       'colo-rectal': 0.19462605,\n",
       "                                       'contractile reserve': 0.107446894,\n",
       "                                       'clinical record': 0.3731985,\n",
       "                                       'concentration ratios': 0.15313771,\n",
       "                                       'clinical remission': 0.5478476,\n",
       "                                       'centric relation': 0.0018228849,\n",
       "                                       'cardiac rhythm': 0.11292656,\n",
       "                                       'capillary refill': 0.12250225,\n",
       "                                       'colonisation rate': 0.093986504,\n",
       "                                       'conventional radiography': 0.13734631,\n",
       "                                       'cellular receptor': 0.1716241}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.2933807,\n",
       "                                       'plaque reduction': 0.14826442,\n",
       "                                       'partial response': 0.4592112,\n",
       "                                       'photoreactivation': 0.07223874,\n",
       "                                       'pentoxyresorufin': 0.17316355,\n",
       "                                       'panoramic radiography': 0.122651435,\n",
       "                                       'proliferative retinopathy': 0.21805121,\n",
       "                                       'partial responses': 0.4581089,\n",
       "                                       'protein': 0.030384228,\n",
       "                                       'prorennin': 0.19376154,\n",
       "                                       'prevalence rate': 0.25250134,\n",
       "                                       'prealbumin': 0.14917059,\n",
       "                                       'pregnancy rates': 0.104069546,\n",
       "                                       'pain relief': 0.17495926,\n",
       "                                       'partial remissions': 0.6631488,\n",
       "                                       'pattern recognition': 0.0014837908,\n",
       "                                       'photo-reactivation': 0.117636375,\n",
       "                                       'protein restriction': 0.11061849,\n",
       "                                       'progesterone receptor': 0.1944733,\n",
       "                                       'placental restriction': 0.17916404,\n",
       "                                       'pneumatic retinopexy': 0.28101385,\n",
       "                                       'prorenin': 0.2507486,\n",
       "                                       'perirhinal cortex': 0.14613278,\n",
       "                                       'prothrombin ratio': 0.209828,\n",
       "                                       'pars recta': 0.1224029,\n",
       "                                       'pattern reversal': 0.04556753,\n",
       "                                       'pr interval (ekg)': 0.27246204,\n",
       "                                       'pityriasis rosea': 0.11296901,\n",
       "                                       'prevalence ratio': 0.27295122,\n",
       "                                       'Projection reconstruction': 0.023993092,\n",
       "                                       'pregnancy rate': 0.10699665,\n",
       "                                       'phenol red': 0.1698025,\n",
       "                                       'photoreceptor': 0.03583811,\n",
       "                                       'prednisolon': 0.2934045,\n",
       "                                       'partial responders': 0.47189444,\n",
       "                                       'proline-rich': 0.075947665,\n",
       "                                       'pseudorabies': 0.17206375,\n",
       "                                       'pulmonary regurgitation': 0.20952839,\n",
       "                                       'projection reconstruction': 0.023993092,\n",
       "                                       'photo-receptor': 0.10073462,\n",
       "                                       'protease': 0.15074922,\n",
       "                                       'progestine': 0.13813592,\n",
       "                                       'pentoxy-resorufin': 0.21356815,\n",
       "                                       'partial remission': 0.6109814,\n",
       "                                       'progestin receptor': 0.18416825,\n",
       "                                       'per rectum': 0.16869414,\n",
       "                                       'Plain radiography': 0.12382897,\n",
       "                                       'production rate': 0.09662635,\n",
       "                                       'pulmonary rehabilitation': 0.2546688,\n",
       "                                       'pentoxy resorufin': 0.22393128,\n",
       "                                       'proteinase': 0.088496394,\n",
       "                                       'Paeoniae radix': 0.2036639,\n",
       "                                       'Puerto Rico': 0.11273022,\n",
       "                                       'Prevalence ratios': 0.2627801,\n",
       "                                       'perirenal': 0.08770333,\n",
       "                                       'passive recovery': 0.16448587,\n",
       "                                       'propranolol': 0.25483298,\n",
       "                                       'primary response': 0.4191519,\n",
       "                                       'pregnant': 0.061669465,\n",
       "                                       'partial regression': 0.21214499,\n",
       "                                       'Photoreactivation': 0.07223874,\n",
       "                                       'peripheral resistance': 0.20587593,\n",
       "                                       'polymorphic reticulosis': 0.20859055,\n",
       "                                       'progressive ratio': 0.257646,\n",
       "                                       'partial responder': 0.41409323,\n",
       "                                       'projection-reconstruction': 0.0639598,\n",
       "                                       'pro-renin': 0.267818,\n",
       "                                       'phenol-red': 0.17878099,\n",
       "                                       'progestin': 0.1385819,\n",
       "                                       'pro-rennin': 0.17973427})}),\n",
       "             'Patients with tumors that are HER2 +, PR and ER -, are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.33436897,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.3437719,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.3313739,\n",
       "                                       'human epidermal growth factor receptor 2': 0.33246937,\n",
       "                                       'human epidermal growth factor receptor-2': 0.3437719}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.17534597,\n",
       "                                       'plaque reduction': 0.009190704,\n",
       "                                       'partial response': 0.1282948,\n",
       "                                       'photoreactivation': 0.02443776,\n",
       "                                       'pentoxyresorufin': 0.060289357,\n",
       "                                       'panoramic radiography': 0.047657218,\n",
       "                                       'proliferative retinopathy': 0.22838365,\n",
       "                                       'partial responses': 0.10759241,\n",
       "                                       'protein': 0.008686553,\n",
       "                                       'prorennin': 0.15710887,\n",
       "                                       'prevalence rate': 0.12453804,\n",
       "                                       'prealbumin': 0.10794332,\n",
       "                                       'pregnancy rates': -0.030208519,\n",
       "                                       'pain relief': 0.048153438,\n",
       "                                       'partial remissions': 0.40813982,\n",
       "                                       'pattern recognition': -0.056715928,\n",
       "                                       'photo-reactivation': 0.039173875,\n",
       "                                       'protein restriction': 0.12598479,\n",
       "                                       'progesterone receptor': 0.19166882,\n",
       "                                       'placental restriction': 0.14043207,\n",
       "                                       'pneumatic retinopexy': 0.12519813,\n",
       "                                       'prorenin': 0.13658127,\n",
       "                                       'perirhinal cortex': 0.060128216,\n",
       "                                       'prothrombin ratio': 0.19195414,\n",
       "                                       'pars recta': 0.06051959,\n",
       "                                       'pattern reversal': -0.031145884,\n",
       "                                       'pr interval (ekg)': 0.20491049,\n",
       "                                       'pityriasis rosea': 0.0720953,\n",
       "                                       'prevalence ratio': 0.15517424,\n",
       "                                       'Projection reconstruction': -0.08596533,\n",
       "                                       'pregnancy rate': -0.010847046,\n",
       "                                       'phenol red': 0.1096657,\n",
       "                                       'photoreceptor': 0.085334904,\n",
       "                                       'prednisolon': 0.16907294,\n",
       "                                       'partial responders': 0.14279859,\n",
       "                                       'proline-rich': 0.07904583,\n",
       "                                       'pseudorabies': 0.120403714,\n",
       "                                       'pulmonary regurgitation': 0.07844605,\n",
       "                                       'projection reconstruction': -0.08596533,\n",
       "                                       'photo-receptor': 0.14278097,\n",
       "                                       'protease': 0.110510744,\n",
       "                                       'progestine': 0.049979556,\n",
       "                                       'pentoxy-resorufin': 0.062492177,\n",
       "                                       'partial remission': 0.35578528,\n",
       "                                       'progestin receptor': 0.17837293,\n",
       "                                       'per rectum': 0.07126168,\n",
       "                                       'Plain radiography': 0.11785224,\n",
       "                                       'production rate': 0.012863456,\n",
       "                                       'pulmonary rehabilitation': 0.07820087,\n",
       "                                       'pentoxy resorufin': 0.061936524,\n",
       "                                       'proteinase': 0.101035595,\n",
       "                                       'Paeoniae radix': 0.16059871,\n",
       "                                       'Puerto Rico': 0.091452025,\n",
       "                                       'Prevalence ratios': 0.1402254,\n",
       "                                       'perirenal': 0.028651359,\n",
       "                                       'passive recovery': 0.037999827,\n",
       "                                       'propranolol': 0.1030714,\n",
       "                                       'primary response': 0.24935533,\n",
       "                                       'pregnant': -0.0383399,\n",
       "                                       'partial regression': 0.03581308,\n",
       "                                       'Photoreactivation': 0.02443776,\n",
       "                                       'peripheral resistance': 0.11274782,\n",
       "                                       'polymorphic reticulosis': 0.10941142,\n",
       "                                       'progressive ratio': 0.124448426,\n",
       "                                       'partial responder': 0.13625912,\n",
       "                                       'projection-reconstruction': -0.054632206,\n",
       "                                       'pro-renin': 0.15759483,\n",
       "                                       'phenol-red': 0.115689784,\n",
       "                                       'progestin': 0.08483381,\n",
       "                                       'pro-rennin': 0.12131055}),\n",
       "                          'ER': defaultdict(float,\n",
       "                                      {'extinction-ratio': 0.055322606,\n",
       "                                       'equivalent rontgen': 0.069211565,\n",
       "                                       'endo-plasmic reticulum': 0.09806075,\n",
       "                                       'emergency room': 0.11407793,\n",
       "                                       'estrogen receptor-alpha': 0.30211923,\n",
       "                                       'environmental resistance': -0.0396464,\n",
       "                                       'erythrocyte receptor': 0.24280807,\n",
       "                                       'estradiol receptor': 0.21666445,\n",
       "                                       'extended-release': 0.10801501,\n",
       "                                       'energy restriction': 0.0540086,\n",
       "                                       'energy-restricted': 0.06300937,\n",
       "                                       'estrogen-receptor': 0.2488293,\n",
       "                                       'energy retention': -0.05306578,\n",
       "                                       'electrorheological': 0.046433225,\n",
       "                                       'ejection rate': 0.050388314,\n",
       "                                       'external resistance': 0.03760779,\n",
       "                                       'Estrogen receptor alpha': 0.2476252,\n",
       "                                       'estrogen receptor': 0.21667498,\n",
       "                                       'early': 0.0137015795,\n",
       "                                       'endoplasmatic reticulum': 0.10385267,\n",
       "                                       'Estradiol': 0.10995507,\n",
       "                                       'expiratory reserve': 0.09738094,\n",
       "                                       'endovascular repair': 0.10778639,\n",
       "                                       'Emergency Room': 0.11407793,\n",
       "                                       'early reticulocyte': 0.16074954,\n",
       "                                       'esophageal rupture': 0.09119097,\n",
       "                                       'Estrogen receptors': 0.18443696,\n",
       "                                       'evoked responses': 0.10637993,\n",
       "                                       'estrogen receptor protein': 0.26615268,\n",
       "                                       'erythromycin': 0.1854595,\n",
       "                                       'enhancement ratios': 0.14266853,\n",
       "                                       'equine rhinopneumonia': 0.0030635023,\n",
       "                                       'eye research': 0.11528252,\n",
       "                                       'extinction ratio': 0.06481943,\n",
       "                                       'equivalent roentgen': 0.08883906,\n",
       "                                       'emotion regulation': 0.014232589,\n",
       "                                       'enhancement ratio': 0.14751682,\n",
       "                                       'estrogen receptor status': 0.25988814,\n",
       "                                       'early repolarization': 0.11185107,\n",
       "                                       'early repolarisation': 0.10718664,\n",
       "                                       'electrical resistance': 0.028467996,\n",
       "                                       'evoked response': 0.13092361,\n",
       "                                       'efficacy ratio': 0.18030748,\n",
       "                                       'estrogen': 0.075624175,\n",
       "                                       'endoplasmic reticular': 0.1092367,\n",
       "                                       'extraction ratio': 0.09339194,\n",
       "                                       'extended release': 0.10247128,\n",
       "                                       'external rotation': 0.037872203,\n",
       "                                       'epigastric region': 0.17375892,\n",
       "                                       'endoscopic resection': 0.113877825,\n",
       "                                       'ethoxyresorufin': 0.11110773,\n",
       "                                       'electro-resection': 0.16423535,\n",
       "                                       'early response': 0.16170195,\n",
       "                                       'endoplasmic reticulum': 0.0985449,\n",
       "                                       'enhanced reactivation': 0.11012585,\n",
       "                                       'electroresection': 0.1054589})}),\n",
       "             'The patient with the shortest PFS was in the secondary trial and the longest recorded PFS was in the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.19947779,\n",
       "                                       'pyrogen-free saline': 0.17724605,\n",
       "                                       'pressure-flow study': 0.036378693,\n",
       "                                       'posterior fossa syndrome': 0.27622503,\n",
       "                                       'pressure flow study': 0.04273073,\n",
       "                                       'primary fibromyalgia syndrome': 0.31230378,\n",
       "                                       'Piper Fatigue Scale': 0.17780103,\n",
       "                                       'patellofemoral syndrome': 0.23355386,\n",
       "                                       'Progression-free': 0.212599,\n",
       "                                       'pulmonary function score': 0.25924376,\n",
       "                                       'pressure flow studies': 0.041629355,\n",
       "                                       'protein-free supernatant': 0.11150154,\n",
       "                                       'progression free survival': 0.3494082,\n",
       "                                       'protein free supernatant': 0.13988326,\n",
       "                                       'progression-free survival': 0.40314353,\n",
       "                                       'pressure/flow study': 0.059959665})}),\n",
       "             'Patients with Clinical stage II (T2 N2) invasive mammary carcinoma are not eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'II': defaultdict(float,\n",
       "                                      {'image intensifier': -0.0019129226,\n",
       "                                       'icterus index': 0.080649614}),\n",
       "                          'T2': defaultdict(float,\n",
       "                                      {'time 2': 0.0814023,\n",
       "                                       'type 2': 0.24429198,\n",
       "                                       't2 (thoracic vertebra 2)': 0.13268979,\n",
       "                                       't2dm': 0.15091635,\n",
       "                                       'transverse relaxation': -0.015514777,\n",
       "                                       'twins two': 0.03578922,\n",
       "                                       'therapy': 0.040889073,\n",
       "                                       'Time 2': 0.0814023,\n",
       "                                       'thoracic vertebra 2': 0.0074912934,\n",
       "                                       'T-2 toxin': 0.2275284}),\n",
       "                          'N2': defaultdict(float,\n",
       "                                      {'Notch-2': 0.06913441,\n",
       "                                       'nodal stage 2': 0.34959185,\n",
       "                                       'nitrogen': 0.0009880963,\n",
       "                                       'nitrogen gas': 0.022856623,\n",
       "                                       'Notch2': 0.05328273,\n",
       "                                       'negative': 0.01719335,\n",
       "                                       'NOTCH2': 0.05328273,\n",
       "                                       'negative component': -0.07525095})}),\n",
       "             'The Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) for Alisertib in Combination With Paclitaxel, supported by the primary trial results, is 40 mg orally, twice daily (BID) on Days 1-3, 8-10 and 15-17': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MTD': defaultdict(float,\n",
       "                                      {'maximum tolerated dose': 0.565565,\n",
       "                                       'Monroe tidal drainage': -0.030626878,\n",
       "                                       \"Midwife Teacher's Diploma\": -0.019973902,\n",
       "                                       'mean total dose': 0.3877823,\n",
       "                                       'maximally-tolerated dose': 0.55979264,\n",
       "                                       'metastatic trophoblastic disease': 0.15806814,\n",
       "                                       'maximal tolerated dose': 0.5718984,\n",
       "                                       'maximal-tolerated dose': 0.5646679,\n",
       "                                       'maximum tolerable dose': 0.53178674,\n",
       "                                       'muscle tension dysphonia': 0.02536266,\n",
       "                                       'muscle-tension dysphonia': 0.015027152,\n",
       "                                       'maximum tolerated dosage': 0.5661373,\n",
       "                                       'maximum tolerated doses': 0.54957056,\n",
       "                                       'maximum-tolerated dose': 0.5616702,\n",
       "                                       'multiple tic disorder': 0.1304523,\n",
       "                                       'mannitol dehydrogenase': 0.12356569,\n",
       "                                       'methadone': 0.118309505,\n",
       "                                       'maximally tolerated dose': 0.55779463}),\n",
       "                          'BID': defaultdict(float,\n",
       "                                      {'Bcl-2 interacting domain': 9.798443e-05,\n",
       "                                       'Beta Interaction Domain': 0.051816985,\n",
       "                                       'body-image disturbance': -0.04049486,\n",
       "                                       'bis in die': 0.028940134,\n",
       "                                       'body image disturbance': -0.027701054,\n",
       "                                       'BCL-2 interacting domain': 9.798443e-05,\n",
       "                                       'bipolar I disorder': 0.14420685,\n",
       "                                       'bis in die (twice a day)': 0.16942188,\n",
       "                                       'BH3-interacting-domain death agonist': 0.13169117,\n",
       "                                       'BH3 interacting domain death agonist': 0.11090583,\n",
       "                                       'beta-interaction domain': 0.04094922,\n",
       "                                       'body image dissatisfaction': -0.04334199,\n",
       "                                       'beta interaction domain': 0.051816985,\n",
       "                                       'body-image dissatisfaction': -0.03426352,\n",
       "                                       'bipolar-I disorder': 0.16602485,\n",
       "                                       'BH3-interacting domain death agonist': 0.114276156})}),\n",
       "             'Cohort 2 subjects of the primary trial receive 3.25 mg of vaginal DHEA gel QD more than cohort 1 subjects, of the two cohorts in the secondary trial only cohort 1 recieves Duloxetine 30 mg daily.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DHEA': defaultdict(float,\n",
       "                                      {'dehydroepiandrosterone': 0.3340502,\n",
       "                                       'dehydroepi-androsterone': 0.3067587,\n",
       "                                       'dihydroepiandrosterone': 0.33268443,\n",
       "                                       'dehydro-epiandrosterone': 0.3436664}),\n",
       "                          'QD': defaultdict(float,\n",
       "                                      {'quinidine': 0.36780488,\n",
       "                                       'quaque die (every day)': 0.19074959,\n",
       "                                       'quaque die': 0.19526777,\n",
       "                                       'quinupristin-dalfopristin': 0.3683776,\n",
       "                                       'quater die': 0.20431966,\n",
       "                                       'quantum dot': 0.10662474,\n",
       "                                       'questionable dementia': 0.15483433})}),\n",
       "             'No cases of Metastasis to the CNS were recorded in the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CNS': defaultdict(float,\n",
       "                                      {'central nerve system': 0.22084512,\n",
       "                                       'Congenital nephrotic syndrome': 0.17477307,\n",
       "                                       'Coagulase negative staphylococci': 0.17119712,\n",
       "                                       'Clinical nurse specialist': 0.08737054,\n",
       "                                       'coagulase negative staphylococcus': 0.15084772,\n",
       "                                       'coagulase-negative Staphylococcus': 0.17885548,\n",
       "                                       'central nerves system': 0.19830857,\n",
       "                                       'central-nervous-system': 0.17960232,\n",
       "                                       'congenital nephrotic syndrome': 0.17477307,\n",
       "                                       'central nervous system': 0.17204465,\n",
       "                                       'central nervous systems': 0.16436242,\n",
       "                                       'Crigler Najjar syndrome': 0.19305356,\n",
       "                                       'coagulase negative staph': 0.15160283,\n",
       "                                       'clinical nurse specialists': 0.09214705,\n",
       "                                       'Crigler-Najjar syndrome': 0.2057322,\n",
       "                                       'coagulase-negative staphylococci': 0.19185378,\n",
       "                                       'coagulase-negative staphylococcus': 0.17885548,\n",
       "                                       'central nervous': 0.2114028,\n",
       "                                       'clinical nurse specialist': 0.08737054,\n",
       "                                       'Canadian Neurological Scale': 0.21131018,\n",
       "                                       'coagulase-negative staphylococcal': 0.21241243,\n",
       "                                       'coagulase negative Staphylococcus': 0.15084772})}),\n",
       "             'the primary trial and the secondary trial measure the DLT of their respective interventions, using the same time frame and the same unit of measure.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DLT': defaultdict(float,\n",
       "                                      {'double-lung transplantation': 0.19122201,\n",
       "                                       'direct linear transformation': 0.09230959,\n",
       "                                       'double lumen tube': 0.15034483,\n",
       "                                       'double-lumen tube': 0.13950516,\n",
       "                                       'dose limiting toxicity': 0.18956074,\n",
       "                                       'dose-limiting toxicity': 0.19964883,\n",
       "                                       'donor leukocyte transfusion': 0.09998997,\n",
       "                                       'double-lumen endobronchial tube': 0.17369856,\n",
       "                                       'double lumen endotracheal tube': 0.19417511,\n",
       "                                       'double lung transplantation': 0.19113894,\n",
       "                                       'double-lumen endotracheal tube': 0.18801749})}),\n",
       "             'Neither cohorts of the primary trial receive any medication orally or by IV.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.105326496,\n",
       "                                       'intravenous injection': 0.26260915,\n",
       "                                       'iridovirus': 0.114751995,\n",
       "                                       'intra-venous': 0.21934278,\n",
       "                                       'invitro': 0.024430478,\n",
       "                                       'intra ventricular': 0.12185051,\n",
       "                                       'intra vascular': 0.19236761,\n",
       "                                       'in vivo': 0.0983505,\n",
       "                                       'intravascular': 0.20320044,\n",
       "                                       'in-vivo': 0.14564379,\n",
       "                                       'inter-vertebral': 0.12752311,\n",
       "                                       'ichthyosis vulgaris': 0.06433058,\n",
       "                                       'intravenous': 0.3109178,\n",
       "                                       'intravaginal': 0.14108407,\n",
       "                                       'invasive': -0.02395277,\n",
       "                                       'iridescent virus': 0.069484316,\n",
       "                                       'isometric virus': 0.11349401,\n",
       "                                       'intravenous feeding device': 0.19003405,\n",
       "                                       'invivo': 0.0074223154,\n",
       "                                       'instrumental variable': 0.00557402,\n",
       "                                       'intraventricular': 0.13077603,\n",
       "                                       'intra-vaginal': 0.15981086,\n",
       "                                       'intravertebral': 0.14381535,\n",
       "                                       'in vitro': 0.060052462,\n",
       "                                       'interventricular': 0.12277859,\n",
       "                                       'in-vitro': 0.11259759,\n",
       "                                       'intra venous': 0.19391146,\n",
       "                                       'iodine value': 0.023236686,\n",
       "                                       'ichnovirus': 0.047478545,\n",
       "                                       'inter-ventricular': 0.12706295,\n",
       "                                       'intra-vertebral': 0.14584139,\n",
       "                                       'intravenous injection device': 0.19855389,\n",
       "                                       'intervertebral': 0.14752184,\n",
       "                                       'initial visit': -0.005554548,\n",
       "                                       'intravenous feeding': 0.26533034,\n",
       "                                       'intra-vascular': 0.19954245,\n",
       "                                       'intra-ventricular': 0.13375789})}),\n",
       "             'Patients with a COPD diagnosis through spirometry are ineligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'COPD': defaultdict(float,\n",
       "                                      {'chronic obstructive pulmonary disease': 0.41248143,\n",
       "                                       'chronic obstructive pulmonary diseases': 0.43082184})}),\n",
       "             'Neither cohorts of the primary trial receive any medication orally, by IV or by radiation.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.11704363,\n",
       "                                       'intravenous injection': 0.30105737,\n",
       "                                       'iridovirus': 0.16085276,\n",
       "                                       'intra-venous': 0.24454261,\n",
       "                                       'invitro': 0.04691721,\n",
       "                                       'intra ventricular': 0.15534082,\n",
       "                                       'intra vascular': 0.21649013,\n",
       "                                       'in vivo': 0.1537112,\n",
       "                                       'intravascular': 0.2428602,\n",
       "                                       'in-vivo': 0.1932796,\n",
       "                                       'inter-vertebral': 0.16915175,\n",
       "                                       'ichthyosis vulgaris': 0.08220383,\n",
       "                                       'intravenous': 0.34529555,\n",
       "                                       'intravaginal': 0.15714657,\n",
       "                                       'invasive': 0.014459025,\n",
       "                                       'iridescent virus': 0.115965694,\n",
       "                                       'isometric virus': 0.13217556,\n",
       "                                       'intravenous feeding device': 0.20917031,\n",
       "                                       'invivo': 0.018299252,\n",
       "                                       'instrumental variable': 0.018477898,\n",
       "                                       'intraventricular': 0.14634046,\n",
       "                                       'intra-vaginal': 0.17543277,\n",
       "                                       'intravertebral': 0.16919827,\n",
       "                                       'in vitro': 0.089434676,\n",
       "                                       'interventricular': 0.1349746,\n",
       "                                       'in-vitro': 0.13936305,\n",
       "                                       'intra venous': 0.20990805,\n",
       "                                       'iodine value': 0.053753693,\n",
       "                                       'ichnovirus': 0.085655786,\n",
       "                                       'inter-ventricular': 0.16446073,\n",
       "                                       'intra-vertebral': 0.18826246,\n",
       "                                       'intravenous injection device': 0.22886063,\n",
       "                                       'intervertebral': 0.15858538,\n",
       "                                       'initial visit': -0.0017450565,\n",
       "                                       'intravenous feeding': 0.27959478,\n",
       "                                       'intra-vascular': 0.23323047,\n",
       "                                       'intra-ventricular': 0.17490883})}),\n",
       "             'Best Overall Response (BOR) was 10.3% higher in cohort 1 of the primary trial than in cohort 2.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'BOR': defaultdict(float,\n",
       "                                      {'branchiootorenal': 0.19571371,\n",
       "                                       'branchio-otorenal': 0.16366251,\n",
       "                                       'branchio-oto-renal': 0.21612689,\n",
       "                                       'Branchio-oto-renal syndrome': 0.15382026,\n",
       "                                       'boronate': 0.16416393,\n",
       "                                       'borage oil': 0.17905952,\n",
       "                                       'basal optic root': 0.09398546})}),\n",
       "             'Patients in the primary trial receive a lower dose of Zometa by IV than the secondary trial patients receive of PI3K inhibitor BYL719  by IV.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.072355844,\n",
       "                                       'intravenous injection': 0.25072142,\n",
       "                                       'iridovirus': 0.13612878,\n",
       "                                       'intra-venous': 0.14722951,\n",
       "                                       'invitro': 0.082653545,\n",
       "                                       'intra ventricular': 0.07627555,\n",
       "                                       'intra vascular': 0.15532547,\n",
       "                                       'in vivo': 0.17265321,\n",
       "                                       'intravascular': 0.16623479,\n",
       "                                       'in-vivo': 0.23368897,\n",
       "                                       'inter-vertebral': 0.09659154,\n",
       "                                       'ichthyosis vulgaris': 0.076551326,\n",
       "                                       'intravenous': 0.24475525,\n",
       "                                       'intravaginal': 0.16147733,\n",
       "                                       'invasive': 0.012690762,\n",
       "                                       'iridescent virus': 0.036951274,\n",
       "                                       'isometric virus': 0.04293766,\n",
       "                                       'intravenous feeding device': 0.13322748,\n",
       "                                       'invivo': 0.07339561,\n",
       "                                       'instrumental variable': 0.057240896,\n",
       "                                       'intraventricular': 0.06417252,\n",
       "                                       'intra-vaginal': 0.17284182,\n",
       "                                       'intravertebral': 0.069031976,\n",
       "                                       'in vitro': 0.12586538,\n",
       "                                       'interventricular': 0.07315279,\n",
       "                                       'in-vitro': 0.1961217,\n",
       "                                       'intra venous': 0.13140677,\n",
       "                                       'iodine value': 0.14696799,\n",
       "                                       'ichnovirus': 0.051719714,\n",
       "                                       'inter-ventricular': 0.07343658,\n",
       "                                       'intra-vertebral': 0.11158341,\n",
       "                                       'intravenous injection device': 0.18386081,\n",
       "                                       'intervertebral': 0.062344514,\n",
       "                                       'initial visit': 0.10890948,\n",
       "                                       'intravenous feeding': 0.1714361,\n",
       "                                       'intra-vascular': 0.17654526,\n",
       "                                       'intra-ventricular': 0.08475452}),\n",
       "                          'PI3K': defaultdict(float,\n",
       "                                      {'phosphoinositide 3 kinase': 0.23916923,\n",
       "                                       'phosphoinositide 3-kinase': 0.24514578,\n",
       "                                       \"phosphatidylinositol-3'-kinase\": 0.2784266,\n",
       "                                       'phosphatidylinositol 3-kinase': 0.2856603,\n",
       "                                       'phosphatidylinositol 3 kinase': 0.27698272,\n",
       "                                       'Phosphatidyl-inositol-3-kinase': 0.28231305,\n",
       "                                       'phosphatidylinositol-3-kinase': 0.29431912,\n",
       "                                       'phosphatidylinositol-3 kinase': 0.29368156,\n",
       "                                       'phosphoinositide 3-kinases': 0.21991,\n",
       "                                       'phosphoinositide-3-kinase': 0.2517522,\n",
       "                                       \"phosphatidylinositol 3'-kinase\": 0.25782818,\n",
       "                                       'phosphoinositide-3 kinase': 0.25415766})}),\n",
       "             'Patients in the primary trial receive at least 150mg of IMGN853 by IV every 3 weeks.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.1698117,\n",
       "                                       'intravenous injection': 0.4719491,\n",
       "                                       'iridovirus': 0.22307658,\n",
       "                                       'intra-venous': 0.2986237,\n",
       "                                       'invitro': 0.21325988,\n",
       "                                       'intra ventricular': 0.21133293,\n",
       "                                       'intra vascular': 0.31638283,\n",
       "                                       'in vivo': 0.31356877,\n",
       "                                       'intravascular': 0.34499705,\n",
       "                                       'in-vivo': 0.37731075,\n",
       "                                       'inter-vertebral': 0.21821311,\n",
       "                                       'ichthyosis vulgaris': 0.13610496,\n",
       "                                       'intravenous': 0.442093,\n",
       "                                       'intravaginal': 0.24321242,\n",
       "                                       'invasive': 0.08994388,\n",
       "                                       'iridescent virus': 0.12305732,\n",
       "                                       'isometric virus': 0.1422826,\n",
       "                                       'intravenous feeding device': 0.30094203,\n",
       "                                       'invivo': 0.17571011,\n",
       "                                       'instrumental variable': 0.08709183,\n",
       "                                       'intraventricular': 0.17803037,\n",
       "                                       'intra-vaginal': 0.26491785,\n",
       "                                       'intravertebral': 0.21132147,\n",
       "                                       'in vitro': 0.22036272,\n",
       "                                       'interventricular': 0.18242718,\n",
       "                                       'in-vitro': 0.3046107,\n",
       "                                       'intra venous': 0.2809239,\n",
       "                                       'iodine value': 0.27849478,\n",
       "                                       'ichnovirus': 0.18905152,\n",
       "                                       'inter-ventricular': 0.20501217,\n",
       "                                       'intra-vertebral': 0.2686571,\n",
       "                                       'intravenous injection device': 0.401602,\n",
       "                                       'intervertebral': 0.16747633,\n",
       "                                       'initial visit': 0.18663627,\n",
       "                                       'intravenous feeding': 0.38242003,\n",
       "                                       'intra-vascular': 0.3387393,\n",
       "                                       'intra-ventricular': 0.23111685})}),\n",
       "             'The median TTP in cohort one of the primary trial is just under 27 months.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'TTP': defaultdict(float,\n",
       "                                      {'tocopherol transfer protein': 0.11742311,\n",
       "                                       'time to positivity': 0.15930043,\n",
       "                                       'time to peak tension': 0.18423015,\n",
       "                                       'time to progression': 0.3154378,\n",
       "                                       'thrombotic thrombocytopenic purpura': 0.29752588,\n",
       "                                       'tristetraprolin': 0.27108198,\n",
       "                                       'time to pregnancy': 0.23026618,\n",
       "                                       'time to disease progression': 0.3989949,\n",
       "                                       'thiamine triphosphate': 0.17779055,\n",
       "                                       'thymidine triphosphate': 0.22753175,\n",
       "                                       'Time to progression': 0.3154378,\n",
       "                                       'time to peak contraction': 0.2604298,\n",
       "                                       'time to peak': 0.2701182,\n",
       "                                       'thiamin triphosphate': 0.17124735,\n",
       "                                       'tender to palpation': 0.11190887,\n",
       "                                       'time to tumor progression': 0.37097228,\n",
       "                                       'Tolpa Torf Preparation': 0.17235455,\n",
       "                                       'thrombotic-thrombocytopenic purpura': 0.28220004,\n",
       "                                       'time-to-peak': 0.33789155})}),\n",
       "             'the primary trial and the secondary trial only have test groups, so all patients are receiving novel (FDA approved) interventions.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'FDA': defaultdict(float,\n",
       "                                      {'Food and Drug Administration': 0.2086783,\n",
       "                                       'Frenchay Dysarthria Assessment': 0.12851183,\n",
       "                                       \"Food and Drug Administration's\": 0.24043357,\n",
       "                                       'fluorescein-dextran-amine': 0.084631994,\n",
       "                                       'fluorescein diacetate': 0.07540381,\n",
       "                                       'fronto-dextra anterior': 0.24605086,\n",
       "                                       'fluorescein dextran amine': 0.094088405,\n",
       "                                       'fluosol-DA': 0.19441357,\n",
       "                                       'Fisher discriminant analysis': 0.06650343,\n",
       "                                       'Fluosol-DA': 0.19441357,\n",
       "                                       'Fluosol-DA 20%': 0.24944359,\n",
       "                                       \"Fisher's discriminant analysis\": 0.09449108})}),\n",
       "             'the primary trial results show that the Recommended Dose Level for Phase II Testing (RPTD) (Phase I) is 3 mg/ks cixutumumab.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'II': defaultdict(float,\n",
       "                                      {'image intensifier': 0.054247178,\n",
       "                                       'icterus index': 0.18808798}),\n",
       "                          'RPTD': defaultdict(float,\n",
       "                                      {'recommended phase II dose': 0.7152039,\n",
       "                                       'recommended Phase II dose': 0.7152039})}),\n",
       "             'In the primary trial the FEC-75 Then Paclitaxel/Trastuzumab group had more Invasive Tumor Remaining in the Breast than the Paclitaxel/Trastuzumab Then Trastuzumab/FEC-75 group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'FEC': defaultdict(float,\n",
       "                                      {'faecal egg counts': -0.020299189,\n",
       "                                       'Friend erythroleukaemia cell': 0.19071361,\n",
       "                                       'free erythrocyte coproporphyrin': 0.10798067,\n",
       "                                       'faecal egg count': -0.013245279,\n",
       "                                       'Friend erythroleukemia cell': 0.18529099,\n",
       "                                       'Friend erythroleukæmia cell': 0.06791722,\n",
       "                                       'fecal egg count': 0.023554202,\n",
       "                                       'fæcal egg count': 0.0786419})}),\n",
       "             'All the primary trial subjects either had Progressive disease, Complete CNS objective response rate or partial response rate.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CNS': defaultdict(float,\n",
       "                                      {'central nerve system': 0.34924117,\n",
       "                                       'Congenital nephrotic syndrome': 0.12014138,\n",
       "                                       'Coagulase negative staphylococci': 0.07061157,\n",
       "                                       'Clinical nurse specialist': 0.15326029,\n",
       "                                       'coagulase negative staphylococcus': 0.07842739,\n",
       "                                       'coagulase-negative Staphylococcus': 0.095028475,\n",
       "                                       'central nerves system': 0.31935623,\n",
       "                                       'central-nervous-system': 0.31491458,\n",
       "                                       'congenital nephrotic syndrome': 0.12014138,\n",
       "                                       'central nervous system': 0.34658638,\n",
       "                                       'central nervous systems': 0.35253814,\n",
       "                                       'Crigler Najjar syndrome': 0.18064511,\n",
       "                                       'coagulase negative staph': 0.08173543,\n",
       "                                       'clinical nurse specialists': 0.15242086,\n",
       "                                       'Crigler-Najjar syndrome': 0.19605814,\n",
       "                                       'coagulase-negative staphylococci': 0.08249701,\n",
       "                                       'coagulase-negative staphylococcus': 0.095028475,\n",
       "                                       'central nervous': 0.3096968,\n",
       "                                       'clinical nurse specialist': 0.15326029,\n",
       "                                       'Canadian Neurological Scale': 0.4814121,\n",
       "                                       'coagulase-negative staphylococcal': 0.14052428,\n",
       "                                       'coagulase negative Staphylococcus': 0.07842739})}),\n",
       "             '20 patients treated with Dasatinib and Letrozole in the primary trial had a Disease Free Interval (DFI) Greater Than 2 Years.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DFI': defaultdict(float,\n",
       "                                      {'deoxyribonucleic acid fragmentation index': 0.132077,\n",
       "                                       'daily food intake': 0.035755016,\n",
       "                                       'DNA fragmentation index': 0.029955987,\n",
       "                                       'disease free interval': 0.49140602,\n",
       "                                       'disease-free interval': 0.4773009,\n",
       "                                       'daily feed intake': 0.052604165,\n",
       "                                       'Dougados Functional Index': -0.0110741295})}),\n",
       "             'the primary trial participants will not receive any Lapatinib post WBRT.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'WBRT': defaultdict(float,\n",
       "                                      {'whole brain radiotherapy': 0.12470952,\n",
       "                                       'whole-breast radiotherapy': 0.175831,\n",
       "                                       'whole-brain radiation therapy': 0.13808595,\n",
       "                                       'whole brain radiation therapy': 0.14518027,\n",
       "                                       'whole brain irradiation': 0.13564895,\n",
       "                                       'whole-brain radiotherapy treatment': 0.13808665,\n",
       "                                       'whole-brain radiotherapy': 0.1302909,\n",
       "                                       'whole breast radiotherapy': 0.17082843})}),\n",
       "             'the primary trial Participants received niraparib 200 milligrams (mg) PO once daily for a 28 day cycle, for 3 cycles, after which all participants undergo neoadjuvant chemotherapy.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.08950027,\n",
       "                                       'parietal operculum': 0.1251048,\n",
       "                                       'post office': 0.037961487,\n",
       "                                       'percentage of observed value': 0.12733953,\n",
       "                                       'Phenol oxidase': 0.12025061,\n",
       "                                       'parapineal organ': 0.10194469,\n",
       "                                       'power output': 0.021738183,\n",
       "                                       'predominant organism': 0.042452436,\n",
       "                                       'pulse-oximetry': 0.08694544,\n",
       "                                       'perceptual organisation': -0.0853841,\n",
       "                                       'power outputs': -0.010169034,\n",
       "                                       'Personality Organization': -0.068546005,\n",
       "                                       'postoperative': 0.17897119,\n",
       "                                       'parieto occipital': 0.108191825,\n",
       "                                       'polyolefin': 0.06254165,\n",
       "                                       'parietooccipital': 0.0454197,\n",
       "                                       'poly-olefin': 0.057017982,\n",
       "                                       'peroral': 0.13863687,\n",
       "                                       'prostate only': 0.072327234,\n",
       "                                       'pressure overload': -0.0012086761,\n",
       "                                       'peroxidase': 0.09296175,\n",
       "                                       'principal olive': 0.05201245,\n",
       "                                       'peri-operative': 0.101807386,\n",
       "                                       'posterior': 0.10219362,\n",
       "                                       'Perceptual Organization': -0.078585304,\n",
       "                                       'period of onset': 0.1636716,\n",
       "                                       'posterior nuclear group': 0.07115152,\n",
       "                                       'phenol oxidase': 0.12025061,\n",
       "                                       'pressure': -0.027612401,\n",
       "                                       'per os (by mouth)': 0.13299991,\n",
       "                                       'parieto-occipital': 0.10683027,\n",
       "                                       'preoptic area': 0.01900615,\n",
       "                                       'perceptual organization': -0.078585304,\n",
       "                                       'prophylactic oophorectomy': 0.11309901,\n",
       "                                       'phosphodiester': 0.11869825,\n",
       "                                       'pre-ovulatory': 0.14855374,\n",
       "                                       'palm oil': 0.009451688,\n",
       "                                       'preovulatory': 0.17271903,\n",
       "                                       'perioperative': 0.16950776,\n",
       "                                       'post operative': 0.16134283,\n",
       "                                       'post-operative': 0.17878768,\n",
       "                                       'phospho-diester': 0.05932909,\n",
       "                                       'protein oxidation': 0.099049576,\n",
       "                                       'palm-oil': -0.025957543,\n",
       "                                       'per os': 0.117380954,\n",
       "                                       'pericardial organ': 0.06375418,\n",
       "                                       'Pulse oximetry': 0.08950027,\n",
       "                                       'paraoxon': 0.23451258,\n",
       "                                       'propylene oxide': 0.112996586,\n",
       "                                       'phenoloxidase': 0.13248952,\n",
       "                                       'peanut oil': 0.059345067})}),\n",
       "             'There over 20% difference in the Percentage of Participants With Best Tumor Response of Partial Response (PR) or Complete Response (CR) between the 2 cohorts of the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.17207322,\n",
       "                                       'plaque reduction': 0.035425372,\n",
       "                                       'partial response': 0.44543034,\n",
       "                                       'photoreactivation': 0.0054822923,\n",
       "                                       'pentoxyresorufin': 0.0741271,\n",
       "                                       'panoramic radiography': 0.11926105,\n",
       "                                       'proliferative retinopathy': 0.16507182,\n",
       "                                       'partial responses': 0.42898577,\n",
       "                                       'protein': -0.0015241663,\n",
       "                                       'prorennin': 0.12998354,\n",
       "                                       'prevalence rate': 0.23419547,\n",
       "                                       'prealbumin': 0.06353573,\n",
       "                                       'pregnancy rates': 0.09122141,\n",
       "                                       'pain relief': 0.08153705,\n",
       "                                       'partial remissions': 0.5499182,\n",
       "                                       'pattern recognition': 0.016215356,\n",
       "                                       'photo-reactivation': 0.05149138,\n",
       "                                       'protein restriction': 0.07740811,\n",
       "                                       'progesterone receptor': 0.13974613,\n",
       "                                       'placental restriction': 0.08193484,\n",
       "                                       'pneumatic retinopexy': 0.1351727,\n",
       "                                       'prorenin': 0.14669093,\n",
       "                                       'perirhinal cortex': 0.10913566,\n",
       "                                       'prothrombin ratio': 0.22437972,\n",
       "                                       'pars recta': 0.07578753,\n",
       "                                       'pattern reversal': 0.043758094,\n",
       "                                       'pr interval (ekg)': 0.23560566,\n",
       "                                       'pityriasis rosea': 0.045968313,\n",
       "                                       'prevalence ratio': 0.2966987,\n",
       "                                       'Projection reconstruction': -0.0043181255,\n",
       "                                       'pregnancy rate': 0.1074954,\n",
       "                                       'phenol red': 0.10309242,\n",
       "                                       'photoreceptor': -0.013839352,\n",
       "                                       'prednisolon': 0.17219989,\n",
       "                                       'partial responders': 0.45072773,\n",
       "                                       'proline-rich': 0.013395674,\n",
       "                                       'pseudorabies': 0.09476418,\n",
       "                                       'pulmonary regurgitation': 0.08555719,\n",
       "                                       'projection reconstruction': -0.0043181255,\n",
       "                                       'photo-receptor': 0.059437007,\n",
       "                                       'protease': 0.09015709,\n",
       "                                       'progestine': 0.027876122,\n",
       "                                       'pentoxy-resorufin': 0.11032357,\n",
       "                                       'partial remission': 0.48157763,\n",
       "                                       'progestin receptor': 0.11665257,\n",
       "                                       'per rectum': 0.10863124,\n",
       "                                       'Plain radiography': 0.11501247,\n",
       "                                       'production rate': 0.14626202,\n",
       "                                       'pulmonary rehabilitation': 0.11415803,\n",
       "                                       'pentoxy resorufin': 0.10812142,\n",
       "                                       'proteinase': 0.038472496,\n",
       "                                       'Paeoniae radix': 0.14472519,\n",
       "                                       'Puerto Rico': 0.08215897,\n",
       "                                       'Prevalence ratios': 0.2961912,\n",
       "                                       'perirenal': 0.031495348,\n",
       "                                       'passive recovery': 0.10726407,\n",
       "                                       'propranolol': 0.12728356,\n",
       "                                       'primary response': 0.41551954,\n",
       "                                       'pregnant': 0.011687577,\n",
       "                                       'partial regression': 0.22876045,\n",
       "                                       'Photoreactivation': 0.0054822923,\n",
       "                                       'peripheral resistance': 0.17531474,\n",
       "                                       'polymorphic reticulosis': 0.127889,\n",
       "                                       'progressive ratio': 0.25874215,\n",
       "                                       'partial responder': 0.4034495,\n",
       "                                       'projection-reconstruction': 0.034866214,\n",
       "                                       'pro-renin': 0.1568929,\n",
       "                                       'phenol-red': 0.11145851,\n",
       "                                       'progestin': 0.042533346,\n",
       "                                       'pro-rennin': 0.1420112}),\n",
       "                          'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.05347008,\n",
       "                                       'clot retraction': 0.09258354,\n",
       "                                       'conditioned response': 0.15345572,\n",
       "                                       'conditioned reflex': 0.038441997,\n",
       "                                       'charge recombination': 0.019002143,\n",
       "                                       'Czech Republic': 0.044344876,\n",
       "                                       'control region': 0.07710145,\n",
       "                                       'colonization rate': 0.13564569,\n",
       "                                       'complete remission rate': 0.57961273,\n",
       "                                       'Charles River': 0.0018994138,\n",
       "                                       'Caloric restriction': 0.07529548,\n",
       "                                       'colonisation resistance': 0.076859206,\n",
       "                                       'complete regression': 0.15401001,\n",
       "                                       'conversion rate': 0.20489413,\n",
       "                                       'chest roentgenography': 0.1931635,\n",
       "                                       'chest radiograph': 0.15698506,\n",
       "                                       'colony reared': -0.020926502,\n",
       "                                       'cardiorespiratory': 0.05045317,\n",
       "                                       'circadian rhythm': 0.05329031,\n",
       "                                       'cardiac rupture': 0.09194857,\n",
       "                                       'carbonyl reductase': 0.06088682,\n",
       "                                       'calorie restriction': 0.048063766,\n",
       "                                       'cortical reaction': 0.11581513,\n",
       "                                       'complete remissions': 0.4216504,\n",
       "                                       'chest radiography': 0.18079025,\n",
       "                                       'computerised record': 0.022776393,\n",
       "                                       'charge-recombination': 0.022035029,\n",
       "                                       'Cardiac Rehabilitation': 0.11090639,\n",
       "                                       'calcium-binding protein calretinin': 0.11205163,\n",
       "                                       'chronic rejection': 0.10877082,\n",
       "                                       'colony-reared': -0.008385416,\n",
       "                                       'cognitive reserve': 0.12302072,\n",
       "                                       'critical ratio': 0.24148548,\n",
       "                                       'cortico-resistant': 0.2296104,\n",
       "                                       'caloric restriction': 0.07529548,\n",
       "                                       'corticoresistant': 0.100793645,\n",
       "                                       'corticosteroid-resistant': 0.21518187,\n",
       "                                       'Congo red': 0.037340008,\n",
       "                                       'complete responses': 0.30556425,\n",
       "                                       'chest and right arm': 0.08220206,\n",
       "                                       'conditioned reinforcement': 0.044942565,\n",
       "                                       'constant routine': -0.021645658,\n",
       "                                       'cardio-respiratory': 0.12026524,\n",
       "                                       'complete response rate': 0.47147673,\n",
       "                                       'cockroach': -0.051210895,\n",
       "                                       'chief resident': 0.015023475,\n",
       "                                       'calorie-restricted': 0.041039437,\n",
       "                                       'complete responders': 0.35341856,\n",
       "                                       'cysteine-rich': 0.09037692,\n",
       "                                       'controlled-release': 0.068439044,\n",
       "                                       'chemoradiation': 0.11304104,\n",
       "                                       'crown-rump': -0.0026018098,\n",
       "                                       'crown-rump length': 0.07994052,\n",
       "                                       'creatinine': 0.09636464,\n",
       "                                       'capture-recapture': 0.057567585,\n",
       "                                       'Congo-red': 0.049120095,\n",
       "                                       'coefficient of repeatability': 0.21649988,\n",
       "                                       'computed radiography': 0.1755502,\n",
       "                                       'controlled respiration': 0.060777504,\n",
       "                                       'conditioned reward': 0.085325465,\n",
       "                                       'complement receptors': 0.22711721,\n",
       "                                       'concentration-response': 0.22270489,\n",
       "                                       'complete': 0.08364865,\n",
       "                                       'chest roentgenogram': 0.1843646,\n",
       "                                       'complement receptor': 0.23260278,\n",
       "                                       'Cajal-Retzius': 0.029900588,\n",
       "                                       'cremasteric reflex': 0.16351666,\n",
       "                                       'clot-retraction': 0.06911314,\n",
       "                                       'conserved regions': 0.047825444,\n",
       "                                       'child-resistant': -0.026594415,\n",
       "                                       'control rats': 0.030852364,\n",
       "                                       'caries-resistant': 0.034540914,\n",
       "                                       'coronary revascularization': 0.21021879,\n",
       "                                       'colon resection': 0.16122936,\n",
       "                                       'contrast ratio': 0.19395918,\n",
       "                                       'concentration ratio': 0.20247781,\n",
       "                                       'Calreticulin': 0.1004259,\n",
       "                                       'composite resin': 0.009537132,\n",
       "                                       'completely': 0.14899324,\n",
       "                                       'colorectal': 0.12326134,\n",
       "                                       'complete response': 0.29757756,\n",
       "                                       'coronary risk': 0.1769764,\n",
       "                                       'conventional radiology': 0.223674,\n",
       "                                       'Complete response': 0.29757756,\n",
       "                                       'cathode ray': 0.012855767,\n",
       "                                       'complete responder': 0.3267668,\n",
       "                                       'controlled release': 0.036659244,\n",
       "                                       'conditioned reflexes': 0.044172976,\n",
       "                                       'chemo-radiation': 0.4459693,\n",
       "                                       'complete remission': 0.35961208,\n",
       "                                       'conserved region': 0.030740373,\n",
       "                                       'coronary resistance': 0.23740907,\n",
       "                                       'cardiac resuscitation': 0.08817263,\n",
       "                                       'computed radiographic': 0.199902,\n",
       "                                       'cooling rate': 0.032193348,\n",
       "                                       'clinical research': 0.35302845,\n",
       "                                       'colonization resistance': 0.055473905,\n",
       "                                       'compression ratio': 0.092171535,\n",
       "                                       'computerized record': 0.023184022,\n",
       "                                       'chromium': 0.089507625,\n",
       "                                       'colo-rectal': 0.09802816,\n",
       "                                       'contractile reserve': 0.07974181,\n",
       "                                       'clinical record': 0.2764483,\n",
       "                                       'concentration ratios': 0.2117467,\n",
       "                                       'clinical remission': 0.4234963,\n",
       "                                       'centric relation': 0.036220245,\n",
       "                                       'cardiac rhythm': 0.031859215,\n",
       "                                       'capillary refill': 0.052580014,\n",
       "                                       'colonisation rate': 0.13433717,\n",
       "                                       'conventional radiography': 0.14719172,\n",
       "                                       'cellular receptor': 0.16425598})}),\n",
       "             'A patient presenting Glomerular filtration rate of 63, a severe iodinated contrast allergy and with BI-RADS category c breast tissue would be eligilbe for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'BI': defaultdict(float,\n",
       "                                      {'bioimpedance': 0.12658885,\n",
       "                                       'Barthel index': 0.07658792,\n",
       "                                       'biological indicator': 0.1800083,\n",
       "                                       'brain injury': 0.14435914,\n",
       "                                       'burn index': 0.03685735,\n",
       "                                       'brief intervention': 0.16362976,\n",
       "                                       'balloon injury': 0.1679284,\n",
       "                                       'base-in': 0.14138228,\n",
       "                                       'bone injury': 0.12931463,\n",
       "                                       'bacteriological index': 0.16422163,\n",
       "                                       'Bayesian inference': 0.018035457,\n",
       "                                       'bovine insulin': 0.15302558,\n",
       "                                       'bioelectrical impedance': 0.12470874,\n",
       "                                       'Billroth I': 0.0820216,\n",
       "                                       'backward inhibition': 0.069658235,\n",
       "                                       'brain-injured': 0.10570309,\n",
       "                                       'Breteau index': 0.10507796,\n",
       "                                       'bio-electrical impedance': 0.1399272,\n",
       "                                       'bi-ischial': 0.35656017,\n",
       "                                       'body injury': 0.099232,\n",
       "                                       'behavioural inhibition': 0.0976823,\n",
       "                                       'bacterial index': 0.12014265,\n",
       "                                       'biischial': 0.14510678,\n",
       "                                       'background interval': 0.098094806,\n",
       "                                       'Brinkman Index': 0.09063224,\n",
       "                                       'Bilroth-I': 0.20935683,\n",
       "                                       'bowel impaction': 0.1522668,\n",
       "                                       'Brinkman index': 0.09063224,\n",
       "                                       'body image': 0.064767584,\n",
       "                                       'bleeding index': 0.24618734,\n",
       "                                       'behavioral inhibition': 0.07580797,\n",
       "                                       'Binaural interaction': 0.067838505,\n",
       "                                       'body-image': 0.10212292,\n",
       "                                       'basilar impression': 0.056439772,\n",
       "                                       'bodily injury': 0.115646124,\n",
       "                                       'Barthel Index': 0.07658792,\n",
       "                                       'brain infarction': 0.19584908,\n",
       "                                       'brain injured': 0.094929785})}),\n",
       "             'A 75 year old female patient, with an ECOG of 3 and an estimated life expectancy of more than a year would be eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.14210258,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.43839648,\n",
       "                                       'eastern cooperative oncology group': 0.43839648,\n",
       "                                       'Electrocochleography': 0.1390914,\n",
       "                                       'electrocochleogram': 0.14732392,\n",
       "                                       'electrocortical activity': 0.09966028,\n",
       "                                       'electrocorticograms': 0.15047397,\n",
       "                                       'electrocortical': 0.07261529})}),\n",
       "             'DLT occurence, used as the outcome measurement in the secondary trial and Clinical Benefit Rate, used in the primary trial are not synonymous, and represent entirely different patient characteristics. ': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DLT': defaultdict(float,\n",
       "                                      {'double-lung transplantation': 0.18443267,\n",
       "                                       'direct linear transformation': 0.079633884,\n",
       "                                       'double lumen tube': 0.1527535,\n",
       "                                       'double-lumen tube': 0.153775,\n",
       "                                       'dose limiting toxicity': 0.22202283,\n",
       "                                       'dose-limiting toxicity': 0.24214268,\n",
       "                                       'donor leukocyte transfusion': 0.14898103,\n",
       "                                       'double-lumen endobronchial tube': 0.22863314,\n",
       "                                       'double lumen endotracheal tube': 0.24294953,\n",
       "                                       'double lung transplantation': 0.17918952,\n",
       "                                       'double-lumen endotracheal tube': 0.23486847})}),\n",
       "             'the primary trial results suggest that 40 mg/m2 administered as a 3-hour intravenous (IV) infusion on Day 1 of each cycle + Capecitabine, triples patient OS, compared to Capecitabine alone.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.10382966,\n",
       "                                       'intravenous injection': 0.47055176,\n",
       "                                       'iridovirus': 0.10717281,\n",
       "                                       'intra-venous': 0.35160992,\n",
       "                                       'invitro': 0.18157743,\n",
       "                                       'intra ventricular': 0.23938961,\n",
       "                                       'intra vascular': 0.2821977,\n",
       "                                       'in vivo': 0.32418934,\n",
       "                                       'intravascular': 0.3198961,\n",
       "                                       'in-vivo': 0.37530586,\n",
       "                                       'inter-vertebral': 0.20083103,\n",
       "                                       'ichthyosis vulgaris': 0.04258029,\n",
       "                                       'intravenous': 0.45446828,\n",
       "                                       'intravaginal': 0.23453516,\n",
       "                                       'invasive': 0.027690941,\n",
       "                                       'iridescent virus': 0.0708124,\n",
       "                                       'isometric virus': 0.112504445,\n",
       "                                       'intravenous feeding device': 0.27240327,\n",
       "                                       'invivo': 0.1252364,\n",
       "                                       'instrumental variable': 0.016131403,\n",
       "                                       'intraventricular': 0.22823076,\n",
       "                                       'intra-vaginal': 0.25252756,\n",
       "                                       'intravertebral': 0.18266793,\n",
       "                                       'in vitro': 0.2453486,\n",
       "                                       'interventricular': 0.20106617,\n",
       "                                       'in-vitro': 0.31486735,\n",
       "                                       'intra venous': 0.3296556,\n",
       "                                       'iodine value': 0.22028126,\n",
       "                                       'ichnovirus': 0.06304042,\n",
       "                                       'inter-ventricular': 0.21332964,\n",
       "                                       'intra-vertebral': 0.23898257,\n",
       "                                       'intravenous injection device': 0.39428937,\n",
       "                                       'intervertebral': 0.13757028,\n",
       "                                       'initial visit': 0.16699158,\n",
       "                                       'intravenous feeding': 0.36466953,\n",
       "                                       'intra-vascular': 0.29485726,\n",
       "                                       'intra-ventricular': 0.24856563}),\n",
       "                          'OS': defaultdict(float,\n",
       "                                      {'oculus sinister': 0.043707762,\n",
       "                                       'opposite-sex': 0.022015644,\n",
       "                                       'open surgery': 0.18024082,\n",
       "                                       'over-shoot': 0.107009664,\n",
       "                                       'oxi-dative stress': 0.054071717,\n",
       "                                       'oligosaccharides': 0.13727869,\n",
       "                                       'orthopedic surgery': 0.17383851,\n",
       "                                       'overshoot': 0.10461458,\n",
       "                                       'open splenectomy': 0.13415618,\n",
       "                                       'ovarian stimulation': 0.33968553,\n",
       "                                       'over shoot': 0.103138946,\n",
       "                                       'obese strain': 0.04885537,\n",
       "                                       'Opitz syndrome': 0.16879426,\n",
       "                                       'outer segments': 0.015900912,\n",
       "                                       'ouabain-sensitive': 0.18846828,\n",
       "                                       'osteosarcoma': 0.18211296,\n",
       "                                       'oxidative stress': 0.08453209,\n",
       "                                       'overall survival time': 0.23298396,\n",
       "                                       'osteosarcomas': 0.17110683,\n",
       "                                       'oculus sinister (left eye)': 0.07795657,\n",
       "                                       'overlap syndrome': 0.07150043,\n",
       "                                       'outer segment': 0.028226258,\n",
       "                                       'oligomycin-sensitive': 0.20800829,\n",
       "                                       'oxidative-stress': 0.11944021,\n",
       "                                       'oral secretion': 0.061958868,\n",
       "                                       'oligosaccharide': 0.16025825,\n",
       "                                       'overall survival rate': 0.24193554,\n",
       "                                       'Omenn syndrome': 0.105525464,\n",
       "                                       'osteogenic sarcoma': 0.14989382,\n",
       "                                       \"Omenn's syndrome\": 0.12497404,\n",
       "                                       'one-step': 0.11227894,\n",
       "                                       'oligo-saccharide': 0.11274649,\n",
       "                                       'Ocimum sanctum': 0.117934056,\n",
       "                                       'overall survival': 0.114332244,\n",
       "                                       'One-Step': 0.11227894,\n",
       "                                       'oxydative stress': 0.13791889})}),\n",
       "             'Less than 1/10 the primary trial subjects experienced a complete response (CR), partial response (PR), or stable disease (SD) for at least 24 weeks.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.056224097,\n",
       "                                       'clot retraction': 0.14414121,\n",
       "                                       'conditioned response': 0.25947157,\n",
       "                                       'conditioned reflex': 0.15391044,\n",
       "                                       'charge recombination': 0.0012477785,\n",
       "                                       'Czech Republic': 0.008719503,\n",
       "                                       'control region': 0.03413104,\n",
       "                                       'colonization rate': 0.12652223,\n",
       "                                       'complete remission rate': 0.5895555,\n",
       "                                       'Charles River': -0.002267518,\n",
       "                                       'Caloric restriction': 0.16960467,\n",
       "                                       'colonisation resistance': 0.07144382,\n",
       "                                       'complete regression': 0.18096703,\n",
       "                                       'conversion rate': 0.19516112,\n",
       "                                       'chest roentgenography': 0.15777643,\n",
       "                                       'chest radiograph': 0.1451495,\n",
       "                                       'colony reared': -0.002782924,\n",
       "                                       'cardiorespiratory': 0.117884375,\n",
       "                                       'circadian rhythm': 0.14267278,\n",
       "                                       'cardiac rupture': 0.14079852,\n",
       "                                       'carbonyl reductase': 0.05811804,\n",
       "                                       'calorie restriction': 0.13295883,\n",
       "                                       'cortical reaction': 0.17271698,\n",
       "                                       'complete remissions': 0.46711794,\n",
       "                                       'chest radiography': 0.1376096,\n",
       "                                       'computerised record': 0.036474705,\n",
       "                                       'charge-recombination': 0.016069625,\n",
       "                                       'Cardiac Rehabilitation': 0.29953352,\n",
       "                                       'calcium-binding protein calretinin': 0.14464228,\n",
       "                                       'chronic rejection': 0.16740513,\n",
       "                                       'colony-reared': 0.020016626,\n",
       "                                       'cognitive reserve': 0.13606676,\n",
       "                                       'critical ratio': 0.21109128,\n",
       "                                       'cortico-resistant': 0.34347016,\n",
       "                                       'caloric restriction': 0.16960467,\n",
       "                                       'corticoresistant': 0.16024342,\n",
       "                                       'corticosteroid-resistant': 0.33721435,\n",
       "                                       'Congo red': -0.0147750415,\n",
       "                                       'complete responses': 0.26585364,\n",
       "                                       'chest and right arm': 0.08064293,\n",
       "                                       'conditioned reinforcement': 0.13878585,\n",
       "                                       'constant routine': 0.17739396,\n",
       "                                       'cardio-respiratory': 0.20107809,\n",
       "                                       'complete response rate': 0.4754715,\n",
       "                                       'cockroach': -0.03259232,\n",
       "                                       'chief resident': 0.02018282,\n",
       "                                       'calorie-restricted': 0.16446781,\n",
       "                                       'complete responders': 0.2849769,\n",
       "                                       'cysteine-rich': 0.11697974,\n",
       "                                       'controlled-release': 0.21941201,\n",
       "                                       'chemoradiation': 0.10765635,\n",
       "                                       'crown-rump': -0.033662643,\n",
       "                                       'crown-rump length': 0.090560935,\n",
       "                                       'creatinine': 0.18842646,\n",
       "                                       'capture-recapture': 0.03959364,\n",
       "                                       'Congo-red': 0.003498558,\n",
       "                                       'coefficient of repeatability': 0.29162222,\n",
       "                                       'computed radiography': 0.11389798,\n",
       "                                       'controlled respiration': 0.17095463,\n",
       "                                       'conditioned reward': 0.15426673,\n",
       "                                       'complement receptors': 0.21218468,\n",
       "                                       'concentration-response': 0.22848457,\n",
       "                                       'complete': 0.067271575,\n",
       "                                       'chest roentgenogram': 0.17133935,\n",
       "                                       'complement receptor': 0.22115314,\n",
       "                                       'Cajal-Retzius': 0.051552743,\n",
       "                                       'cremasteric reflex': 0.24562502,\n",
       "                                       'clot-retraction': 0.1243491,\n",
       "                                       'conserved regions': -0.060324922,\n",
       "                                       'child-resistant': 0.03563367,\n",
       "                                       'control rats': 0.094038315,\n",
       "                                       'caries-resistant': 0.12983088,\n",
       "                                       'coronary revascularization': 0.26996836,\n",
       "                                       'colon resection': 0.13304932,\n",
       "                                       'contrast ratio': 0.101558365,\n",
       "                                       'concentration ratio': 0.20989144,\n",
       "                                       'Calreticulin': 0.15532613,\n",
       "                                       'composite resin': 0.019578623,\n",
       "                                       'completely': 0.1393441,\n",
       "                                       'colorectal': 0.13177028,\n",
       "                                       'complete response': 0.25218314,\n",
       "                                       'coronary risk': 0.23804206,\n",
       "                                       'conventional radiology': 0.1995268,\n",
       "                                       'Complete response': 0.25218314,\n",
       "                                       'cathode ray': 0.0021080123,\n",
       "                                       'complete responder': 0.27518415,\n",
       "                                       'controlled release': 0.16939588,\n",
       "                                       'conditioned reflexes': 0.16086185,\n",
       "                                       'chemo-radiation': 0.27593172,\n",
       "                                       'complete remission': 0.40027216,\n",
       "                                       'conserved region': -0.036080264,\n",
       "                                       'coronary resistance': 0.33312103,\n",
       "                                       'cardiac resuscitation': 0.17945582,\n",
       "                                       'computed radiographic': 0.1336147,\n",
       "                                       'cooling rate': 0.115496844,\n",
       "                                       'clinical research': 0.37720105,\n",
       "                                       'colonization resistance': 0.050610226,\n",
       "                                       'compression ratio': 0.05394604,\n",
       "                                       'computerized record': 0.035375398,\n",
       "                                       'chromium': 0.07538313,\n",
       "                                       'colo-rectal': 0.13198632,\n",
       "                                       'contractile reserve': 0.13901299,\n",
       "                                       'clinical record': 0.3063549,\n",
       "                                       'concentration ratios': 0.19056177,\n",
       "                                       'clinical remission': 0.48480475,\n",
       "                                       'centric relation': -0.03035452,\n",
       "                                       'cardiac rhythm': 0.12943707,\n",
       "                                       'capillary refill': 0.07700878,\n",
       "                                       'colonisation rate': 0.09709251,\n",
       "                                       'conventional radiography': 0.13655633,\n",
       "                                       'cellular receptor': 0.10448074}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.23701437,\n",
       "                                       'plaque reduction': 0.16251618,\n",
       "                                       'partial response': 0.3630668,\n",
       "                                       'photoreactivation': 0.10533373,\n",
       "                                       'pentoxyresorufin': 0.10489685,\n",
       "                                       'panoramic radiography': 0.115223944,\n",
       "                                       'proliferative retinopathy': 0.1516737,\n",
       "                                       'partial responses': 0.34624922,\n",
       "                                       'protein': 0.050550196,\n",
       "                                       'prorennin': 0.14205933,\n",
       "                                       'prevalence rate': 0.24510497,\n",
       "                                       'prealbumin': 0.10727787,\n",
       "                                       'pregnancy rates': 0.10133385,\n",
       "                                       'pain relief': 0.10687901,\n",
       "                                       'partial remissions': 0.5306571,\n",
       "                                       'pattern recognition': -0.06913089,\n",
       "                                       'photo-reactivation': 0.17151262,\n",
       "                                       'protein restriction': 0.12350965,\n",
       "                                       'progesterone receptor': 0.122468755,\n",
       "                                       'placental restriction': 0.12410844,\n",
       "                                       'pneumatic retinopexy': 0.23969156,\n",
       "                                       'prorenin': 0.19838086,\n",
       "                                       'perirhinal cortex': 0.10570478,\n",
       "                                       'prothrombin ratio': 0.23030475,\n",
       "                                       'pars recta': 0.07966087,\n",
       "                                       'pattern reversal': 0.011394179,\n",
       "                                       'pr interval (ekg)': 0.30204412,\n",
       "                                       'pityriasis rosea': 0.072675236,\n",
       "                                       'prevalence ratio': 0.2649925,\n",
       "                                       'Projection reconstruction': -0.033757932,\n",
       "                                       'pregnancy rate': 0.12094806,\n",
       "                                       'phenol red': 0.08778928,\n",
       "                                       'photoreceptor': -0.01961512,\n",
       "                                       'prednisolon': 0.22877887,\n",
       "                                       'partial responders': 0.35167015,\n",
       "                                       'proline-rich': 0.05114514,\n",
       "                                       'pseudorabies': 0.10264919,\n",
       "                                       'pulmonary regurgitation': 0.16691653,\n",
       "                                       'projection reconstruction': -0.033757932,\n",
       "                                       'photo-receptor': 0.037589446,\n",
       "                                       'protease': 0.1170184,\n",
       "                                       'progestine': 0.11829105,\n",
       "                                       'pentoxy-resorufin': 0.15355772,\n",
       "                                       'partial remission': 0.49022362,\n",
       "                                       'progestin receptor': 0.09270897,\n",
       "                                       'per rectum': 0.14115936,\n",
       "                                       'Plain radiography': 0.11287037,\n",
       "                                       'production rate': 0.17246863,\n",
       "                                       'pulmonary rehabilitation': 0.28651315,\n",
       "                                       'pentoxy resorufin': 0.17150946,\n",
       "                                       'proteinase': 0.052543126,\n",
       "                                       'Paeoniae radix': 0.09181421,\n",
       "                                       'Puerto Rico': 0.013978656,\n",
       "                                       'Prevalence ratios': 0.24660318,\n",
       "                                       'perirenal': 0.05755351,\n",
       "                                       'passive recovery': 0.17015326,\n",
       "                                       'propranolol': 0.16732761,\n",
       "                                       'primary response': 0.37061292,\n",
       "                                       'pregnant': 0.015727788,\n",
       "                                       'partial regression': 0.1749282,\n",
       "                                       'Photoreactivation': 0.10533373,\n",
       "                                       'peripheral resistance': 0.22553398,\n",
       "                                       'polymorphic reticulosis': 0.14273857,\n",
       "                                       'progressive ratio': 0.28241792,\n",
       "                                       'partial responder': 0.30769184,\n",
       "                                       'projection-reconstruction': 0.012241095,\n",
       "                                       'pro-renin': 0.1990431,\n",
       "                                       'phenol-red': 0.09912672,\n",
       "                                       'progestin': 0.09699568,\n",
       "                                       'pro-rennin': 0.15555042}),\n",
       "                          'SD': defaultdict(float,\n",
       "                                      {'superoxide-dismutase': 0.12911114,\n",
       "                                       'segregation distortion': -0.03406534,\n",
       "                                       'seborrheic dermatitis': 0.12026246,\n",
       "                                       'solvent/detergent': -0.0043699797,\n",
       "                                       'standard-dose': 0.35593688,\n",
       "                                       'splice donor': 0.08159947,\n",
       "                                       'superoxyde dismutase': 0.12881944,\n",
       "                                       \"Sjogren's disease\": 0.22637492,\n",
       "                                       'Sprague Dawley': -0.020902093,\n",
       "                                       'Shine-Dalgarno sequence': 0.038834207,\n",
       "                                       'spasmodic dysphonia': 0.1481528,\n",
       "                                       'substance dependence': 0.13205947,\n",
       "                                       'shoulder dislocation': 0.095535025,\n",
       "                                       'short days': 0.16084448,\n",
       "                                       'sorbitol dehydrogenase': 0.083867185,\n",
       "                                       'systolic dysfunction': 0.17191884,\n",
       "                                       'sorbital dehydrogenase': 0.09775264,\n",
       "                                       'shoulder disarticulation': 0.13787735,\n",
       "                                       'sudden death': 0.09578033,\n",
       "                                       'serologically detected': 0.14406638,\n",
       "                                       'solvent-detergent': -0.003130441,\n",
       "                                       'somadendritic': -0.072700985,\n",
       "                                       'swine dysentery': 0.15997654,\n",
       "                                       'sleep-deprivation': 0.12975599,\n",
       "                                       'scalloped': -0.064350486,\n",
       "                                       \"Sjögren's disease\": 0.22637492,\n",
       "                                       'sagittal depth': 0.09087726,\n",
       "                                       'Scotch douche': -0.052482538,\n",
       "                                       'single-dose': 0.33409688,\n",
       "                                       'skin destruction': 0.0036189854,\n",
       "                                       'Spatial disorientation': 0.04816594,\n",
       "                                       'selective decontamination': 0.1920428,\n",
       "                                       'short photoperiod': 0.15054533,\n",
       "                                       'short-day': 0.21309687,\n",
       "                                       'sexual dysfunction': 0.16242461,\n",
       "                                       'spermidine': 0.062877364,\n",
       "                                       'strength duration': 0.30926877,\n",
       "                                       'superoxide dismutase': 0.11931257,\n",
       "                                       \"Stensen's duct\": 0.07621768,\n",
       "                                       'somatization disorder': 0.18813512,\n",
       "                                       'sphincter dilatation': 0.12511328,\n",
       "                                       'sleep deprivation': 0.14532092,\n",
       "                                       'solid dispersion': -0.0043058004,\n",
       "                                       'senile dementia': 0.10914742,\n",
       "                                       'soma-dendritic': 0.20297305,\n",
       "                                       'Sprague Dawley rat': 0.18005003,\n",
       "                                       'Sprague-Dawley': 0.24598756,\n",
       "                                       'stone disintegration': -0.006064348,\n",
       "                                       'serologically defined': 0.047058072,\n",
       "                                       'succinate-dehydrogenase': 0.112426266,\n",
       "                                       'seborrhoeic dermatitis': 0.11332953,\n",
       "                                       'standard-deviation': 0.12948272,\n",
       "                                       'stroke distance': 0.10797675,\n",
       "                                       'somatisation disorder': 0.16194898,\n",
       "                                       'spectral domain': -0.040103547,\n",
       "                                       'self-directedness': 0.038792785,\n",
       "                                       'steroid-dependant': 0.23618051,\n",
       "                                       \"Still's disease\": 0.1526818,\n",
       "                                       'Scotch-douche': -0.05074158,\n",
       "                                       'standard diet': 0.25440973,\n",
       "                                       'spontaneous delivery': 0.077324666,\n",
       "                                       'specially denatured': -0.012254229,\n",
       "                                       'solvent and detergent': 0.0015169327,\n",
       "                                       'serum defect': 0.22358723,\n",
       "                                       'sleep disorders': 0.13613448,\n",
       "                                       'segregation distorter': -0.030283732,\n",
       "                                       'stable disease': 0.4053772,\n",
       "                                       'stimulus drive': 0.19662155,\n",
       "                                       'Salla disease': 0.17985491,\n",
       "                                       'serologically determined': 0.13198708,\n",
       "                                       'striated duct': -0.0057361815,\n",
       "                                       'streptodornase': 0.122873306,\n",
       "                                       'Sprague-Dawley rat': 0.31444225,\n",
       "                                       'single dose': 0.28651816,\n",
       "                                       'social desirability': 0.00015822891,\n",
       "                                       'sulfadiazine': 0.16904311,\n",
       "                                       'sporadic depression': 0.23500931,\n",
       "                                       'spreading depression': 0.047045927,\n",
       "                                       'septal defect': 0.10860723,\n",
       "                                       'systolic discharge': 0.24762942,\n",
       "                                       'steroid-dependent': 0.28052863,\n",
       "                                       'semantic differential': 0.0048872293,\n",
       "                                       'succinatedehydrogenase': 0.2014851,\n",
       "                                       'Sprague-Dawley rats': 0.31394383,\n",
       "                                       'spatial disorientation': 0.04816594,\n",
       "                                       'severe disability': 0.17304127,\n",
       "                                       'super oxyde dismutase': 0.12822296,\n",
       "                                       'skin dose': 0.17685595,\n",
       "                                       'sleep disorder': 0.12369301,\n",
       "                                       'somatoform disorder': 0.120326005,\n",
       "                                       'standard deviations': 0.123809405,\n",
       "                                       'super-oxide dismutase': 0.048040632,\n",
       "                                       'semantic dementia': 0.09929189,\n",
       "                                       'sudden deafness': 0.07105398,\n",
       "                                       'standard dose': 0.35073385,\n",
       "                                       'Sprague--Dawley': 0.06946204,\n",
       "                                       'short day': 0.13923675,\n",
       "                                       'Shine-Dalgarno': -0.00554394,\n",
       "                                       'succinate dehydrogenase': 0.10542118,\n",
       "                                       'standard deviation': 0.12369564,\n",
       "                                       'steroid dependant': 0.23399127,\n",
       "                                       'super oxide dismutase': 0.067786515,\n",
       "                                       'stable': 0.07920408,\n",
       "                                       'serologically detectable': 0.17766547,\n",
       "                                       \"Sandhoff's disease\": 0.16000359,\n",
       "                                       'steroid dependent': 0.24588665})}),\n",
       "             'WOCBP that refuse to use contraception are excluded from the primary trial, but may be eligible for the secondary trial if they are a UK resident.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'UK': defaultdict(float,\n",
       "                                      {'University of Kentucky': 0.021091685,\n",
       "                                       'Urokinase': 0.028184487,\n",
       "                                       'United Kingdom': 0.130741,\n",
       "                                       'urokinase': 0.028184487})}),\n",
       "             'The majority of patients in the primary trial had an EGFR Expression level of 0, and 0 patients had an EGFR of 3 or above.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'EGFR': defaultdict(float,\n",
       "                                      {'EGF receptors': 0.54530424,\n",
       "                                       'epidermal growth-factor receptor': 0.5140483,\n",
       "                                       'epidermal growth factor receptor': 0.5055547,\n",
       "                                       'epidermal growth factor': 0.45569435,\n",
       "                                       'estimated glomerular filtration rate': 0.3006345,\n",
       "                                       'Epidermal growth factor-receptor': 0.51350397,\n",
       "                                       'EGF-receptor': 0.5968764,\n",
       "                                       'epithelial growth factor receptor': 0.51832235,\n",
       "                                       'epidermal growth factor receptors': 0.47618592,\n",
       "                                       'epidermal growth factor-receptor': 0.51350397,\n",
       "                                       'epidermal-growth-factor receptor': 0.5158905,\n",
       "                                       'epidermal growth factor receptor gene': 0.50351477})}),\n",
       "             'In the primary trial there was no recorded difference in the Number/percentage of Participants With Dose Limiting Toxicities taking 100 mg vs 125 mg of oral PD-0332991, meaning 0% of patients in the primary trial suffered grade 4 or above thrombocytopenia.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PD': defaultdict(float,\n",
       "                                      {'personality disorders': 0.059752516,\n",
       "                                       'pyridostigmine': 0.27106404,\n",
       "                                       'protein': 0.03783973,\n",
       "                                       'protein deposition': 0.077673286,\n",
       "                                       \"Parkinsons's disease\": 0.19929294,\n",
       "                                       \"Parkinson's disease with dementia\": 0.25547355,\n",
       "                                       'posterior descending': 0.105273314,\n",
       "                                       'pancreatoduodenectomy': 0.13440931,\n",
       "                                       'percutaneous drainage': 0.1323391,\n",
       "                                       'proximal-distal': 0.174434,\n",
       "                                       'postural drainage': 0.11360404,\n",
       "                                       'periodontal disease': 0.15295005,\n",
       "                                       'peritoneal dialysate': 0.23413616,\n",
       "                                       'psychological distress': 0.037874315,\n",
       "                                       'pyloric dilator': 0.14895138,\n",
       "                                       'plasmodesma': 0.11266897,\n",
       "                                       'pharmacokinetic (PK)-pharmacodynamic': 0.42001808,\n",
       "                                       'provocation dose': 0.26196635,\n",
       "                                       'Perfusion defect': 0.24435696,\n",
       "                                       'prism diopter': 0.017670741,\n",
       "                                       'pharmacodynamic': 0.26905403,\n",
       "                                       'Preterm Delivery': 0.098305054,\n",
       "                                       'protein D': 0.17471327,\n",
       "                                       'Peyronies disease': 0.13374405,\n",
       "                                       'Pagets disease': 0.22902606,\n",
       "                                       'probing pocket depth': 0.017107045,\n",
       "                                       'pupillary diameter': 0.102440774,\n",
       "                                       'pancreatic duct': 0.050778814,\n",
       "                                       'pneumatic dilation': 0.10050537,\n",
       "                                       'Postnatal Day': 0.001942102,\n",
       "                                       'pupil diameter': 0.03610802,\n",
       "                                       'prednisolone': 0.2984923,\n",
       "                                       'pharmaco-dynamic': 0.31689432,\n",
       "                                       'parkinsonism-dementia': 0.22245258,\n",
       "                                       'persistent diarrhea': 0.13679942,\n",
       "                                       'persistent diarrhoea': 0.13764329,\n",
       "                                       'Phosducin': 0.2480847,\n",
       "                                       'parkinsonian': 0.15021026,\n",
       "                                       \"prisoner's dilemma\": 0.057948545,\n",
       "                                       'pharmaco-dynamics': 0.23676872,\n",
       "                                       'progressed': 0.0785428,\n",
       "                                       'Parkinsonism-dementia': 0.22245258,\n",
       "                                       'pancreatico-duodenectomy': 0.0629982,\n",
       "                                       'prism diopters': 0.010087438,\n",
       "                                       'postnatal days': -0.0004922915,\n",
       "                                       'potential difference across the cell membrane': 0.0069512543,\n",
       "                                       'peritoneal drainage': 0.13230227,\n",
       "                                       'Pancreas divisum': 0.19208752,\n",
       "                                       'pancreas disease': 0.126002,\n",
       "                                       'personality disorder': 0.07572219,\n",
       "                                       'pulse duration': 0.09147945,\n",
       "                                       'paired domain': -0.05459252,\n",
       "                                       'population doubling': 0.02170794,\n",
       "                                       'Picks disease': 0.10142089,\n",
       "                                       'peripheral dose': 0.4698226,\n",
       "                                       \"Peyronie's disease\": 0.16865693,\n",
       "                                       'pancreato-duodenectomy': 0.11803706,\n",
       "                                       'plasmodesmata': -0.0021370912,\n",
       "                                       'platelet deposition': 0.26926997,\n",
       "                                       \"Parkinson's disease\": 0.20985384,\n",
       "                                       'power density': 0.062768236,\n",
       "                                       'potential differences': 0.097739115,\n",
       "                                       \"Pierce's disease\": 0.11692654,\n",
       "                                       'progestin-dependent': 0.19868343,\n",
       "                                       'protein degradation': 0.080982774,\n",
       "                                       'parkinsonism dementia': 0.21452731,\n",
       "                                       'plasma desorption': 0.057119288,\n",
       "                                       'purging disorder': 0.15618193,\n",
       "                                       'Parkinsonism dementia': 0.21452731,\n",
       "                                       \"Parkinson's diseases\": 0.20625177,\n",
       "                                       'power Doppler': -6.225054e-05,\n",
       "                                       'prism dioptres': 0.017035432,\n",
       "                                       'pneumatic dilatation': 0.11610142,\n",
       "                                       'platycodin D': 0.21928957,\n",
       "                                       'pharmacodynamics': 0.26352572,\n",
       "                                       'phosphate depletion': 0.17423275,\n",
       "                                       'probing depth': 0.024475584,\n",
       "                                       'program director': 0.09822969,\n",
       "                                       'progressive disease': 0.19512278,\n",
       "                                       \"Paget's disease\": 0.247514,\n",
       "                                       'poorly differentiated': 0.11633483,\n",
       "                                       'prenatal diagnosis': 0.057038374,\n",
       "                                       'Prenatal diagnosis': 0.057038374,\n",
       "                                       \"parkinson's disease\": 0.20985384,\n",
       "                                       'pressure-diameter': 0.0065449867,\n",
       "                                       'pars distalis': 0.10346413,\n",
       "                                       'pancreaticoduodenectomy': 0.06993028,\n",
       "                                       \"Prisoner's Dilemma\": 0.057948545,\n",
       "                                       'panic disorder': 0.034548443,\n",
       "                                       'Parkinsons disease': 0.19745328,\n",
       "                                       \"Parkinsons' disease\": 0.20285614,\n",
       "                                       'P-wave dispersion': 0.04710983,\n",
       "                                       'P wave dispersion': 0.06441923,\n",
       "                                       'parkinsons disease': 0.19745328,\n",
       "                                       'pulsed Doppler': 0.018287433,\n",
       "                                       'Psychopathic deviate': 0.03445929,\n",
       "                                       'pancreas divisum': 0.19208752,\n",
       "                                       'postnatal day': 0.001942102,\n",
       "                                       'Prolidase deficiency': 0.23797731,\n",
       "                                       'pocket depth': 0.030616589,\n",
       "                                       'proton density': 0.09335969,\n",
       "                                       'pirfenidone': 0.18710756,\n",
       "                                       'probing depths': -0.010263857,\n",
       "                                       'Parkinson disease': 0.23394714,\n",
       "                                       'potential difference': 0.039837915,\n",
       "                                       \"Pick's disease\": 0.11844188,\n",
       "                                       'peritoneal dialysis': 0.21190788,\n",
       "                                       'power of discrimination': 0.100323334,\n",
       "                                       'pseudo-deficiency': 0.21053773,\n",
       "                                       'patients': 0.22817191,\n",
       "                                       'population doublings': 0.03272376,\n",
       "                                       'psychiatric disorder': 0.057116434,\n",
       "                                       \"prisoners' dilemma\": 0.078200914,\n",
       "                                       'preferred direction': 0.096776955,\n",
       "                                       'Parkinsonism': 0.19094135,\n",
       "                                       'pseudodeficiency': 0.20179145})}),\n",
       "             'Patients with an ECOG score between 3-5 are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.18859193,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.31646648,\n",
       "                                       'eastern cooperative oncology group': 0.31646648,\n",
       "                                       'Electrocochleography': 0.16567092,\n",
       "                                       'electrocochleogram': 0.16704436,\n",
       "                                       'electrocortical activity': 0.19124734,\n",
       "                                       'electrocorticograms': 0.21454008,\n",
       "                                       'electrocortical': 0.120441936})}),\n",
       "             'Patients with histologically confirmed, newly diagnosed stage 0 breast cancer cannot take part in the primary trial, or the secondary trial, unless they present LVEF below 50% ': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'LVEF': defaultdict(float,\n",
       "                                      {'left-ventricular ejection fraction': 0.18840405,\n",
       "                                       'Left ventricular ejection fractions': 0.18104467,\n",
       "                                       'left ventricular function': 0.1592959,\n",
       "                                       'left ventricular ejection fraction': 0.18843849,\n",
       "                                       'left ventricle ejection fraction': 0.18827298,\n",
       "                                       'left-ventricle ejection fraction': 0.18385099,\n",
       "                                       'LV ejection fraction': 0.1779488})}),\n",
       "             'Cohort 2 in the primary trial and the secondary trial but receive daily placebo doses PO.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.19311509,\n",
       "                                       'parietal operculum': 0.12055091,\n",
       "                                       'post office': 0.054759566,\n",
       "                                       'percentage of observed value': 0.114198595,\n",
       "                                       'Phenol oxidase': 0.11544126,\n",
       "                                       'parapineal organ': 0.12527408,\n",
       "                                       'power output': -0.010559635,\n",
       "                                       'predominant organism': 0.07118111,\n",
       "                                       'pulse-oximetry': 0.18102215,\n",
       "                                       'perceptual organisation': -0.04688279,\n",
       "                                       'power outputs': -0.037238833,\n",
       "                                       'Personality Organization': -0.019755607,\n",
       "                                       'postoperative': 0.17189516,\n",
       "                                       'parieto occipital': 0.12904848,\n",
       "                                       'polyolefin': 0.020128356,\n",
       "                                       'parietooccipital': 0.09742397,\n",
       "                                       'poly-olefin': 0.04088316,\n",
       "                                       'peroral': 0.07673455,\n",
       "                                       'prostate only': 0.10520003,\n",
       "                                       'pressure overload': 0.010231256,\n",
       "                                       'peroxidase': 0.027640557,\n",
       "                                       'principal olive': 0.092172995,\n",
       "                                       'peri-operative': 0.13950504,\n",
       "                                       'posterior': 0.12883343,\n",
       "                                       'Perceptual Organization': -0.054804903,\n",
       "                                       'period of onset': 0.1753456,\n",
       "                                       'posterior nuclear group': 0.09337979,\n",
       "                                       'phenol oxidase': 0.11544126,\n",
       "                                       'pressure': -0.017220637,\n",
       "                                       'per os (by mouth)': 0.22904466,\n",
       "                                       'parieto-occipital': 0.12126096,\n",
       "                                       'preoptic area': 0.043359242,\n",
       "                                       'perceptual organization': -0.054804903,\n",
       "                                       'prophylactic oophorectomy': 0.14576446,\n",
       "                                       'phosphodiester': 0.113013946,\n",
       "                                       'pre-ovulatory': 0.1907791,\n",
       "                                       'palm oil': 0.03838444,\n",
       "                                       'preovulatory': 0.17817707,\n",
       "                                       'perioperative': 0.16523688,\n",
       "                                       'post operative': 0.1508031,\n",
       "                                       'post-operative': 0.16267607,\n",
       "                                       'phospho-diester': 0.09336637,\n",
       "                                       'protein oxidation': 0.050054196,\n",
       "                                       'palm-oil': 0.029472033,\n",
       "                                       'per os': 0.1383935,\n",
       "                                       'pericardial organ': 0.06535856,\n",
       "                                       'Pulse oximetry': 0.19311509,\n",
       "                                       'paraoxon': 0.22047177,\n",
       "                                       'propylene oxide': 0.1586058,\n",
       "                                       'phenoloxidase': 0.07164982,\n",
       "                                       'peanut oil': 0.057360254})}),\n",
       "             'Patients with HER2 positive tumors are ineligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.3029178,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.30630141,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.2984185,\n",
       "                                       'human epidermal growth factor receptor 2': 0.29267228,\n",
       "                                       'human epidermal growth factor receptor-2': 0.30630141})}),\n",
       "             'Patients with LVEF equal to 53.5% are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'LVEF': defaultdict(float,\n",
       "                                      {'left-ventricular ejection fraction': 0.30213553,\n",
       "                                       'Left ventricular ejection fractions': 0.28927433,\n",
       "                                       'left ventricular function': 0.2306583,\n",
       "                                       'left ventricular ejection fraction': 0.29450685,\n",
       "                                       'left ventricle ejection fraction': 0.30287582,\n",
       "                                       'left-ventricle ejection fraction': 0.30363646,\n",
       "                                       'LV ejection fraction': 0.30966926})}),\n",
       "             'Participants with HER2- primary liver tumors, confirmed by fluorescence in-situ hybridization are eligible for the secondary trial and the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.2485184,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.25839084,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.25006816,\n",
       "                                       'human epidermal growth factor receptor 2': 0.2508796,\n",
       "                                       'human epidermal growth factor receptor-2': 0.25839084})}),\n",
       "             'Less than 40% of the primary trial participants achieved either complete response (CR) or partial response (PR).': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.05454774,\n",
       "                                       'clot retraction': 0.11942209,\n",
       "                                       'conditioned response': 0.21261784,\n",
       "                                       'conditioned reflex': 0.13072719,\n",
       "                                       'charge recombination': 0.03164123,\n",
       "                                       'Czech Republic': 0.039954316,\n",
       "                                       'control region': 0.08119388,\n",
       "                                       'colonization rate': 0.09828846,\n",
       "                                       'complete remission rate': 0.47118115,\n",
       "                                       'Charles River': 0.056678258,\n",
       "                                       'Caloric restriction': 0.17588629,\n",
       "                                       'colonisation resistance': 0.10684606,\n",
       "                                       'complete regression': 0.19314255,\n",
       "                                       'conversion rate': 0.20648013,\n",
       "                                       'chest roentgenography': 0.16103446,\n",
       "                                       'chest radiograph': 0.16091795,\n",
       "                                       'colony reared': -0.004720716,\n",
       "                                       'cardiorespiratory': 0.1218374,\n",
       "                                       'circadian rhythm': 0.11616736,\n",
       "                                       'cardiac rupture': 0.1353223,\n",
       "                                       'carbonyl reductase': 0.06466538,\n",
       "                                       'calorie restriction': 0.13413961,\n",
       "                                       'cortical reaction': 0.18568563,\n",
       "                                       'complete remissions': 0.36102796,\n",
       "                                       'chest radiography': 0.15712467,\n",
       "                                       'computerised record': 0.05060933,\n",
       "                                       'charge-recombination': 0.03706396,\n",
       "                                       'Cardiac Rehabilitation': 0.24581757,\n",
       "                                       'calcium-binding protein calretinin': 0.1087462,\n",
       "                                       'chronic rejection': 0.23775904,\n",
       "                                       'colony-reared': 0.021044428,\n",
       "                                       'cognitive reserve': 0.183383,\n",
       "                                       'critical ratio': 0.23061481,\n",
       "                                       'cortico-resistant': 0.27037302,\n",
       "                                       'caloric restriction': 0.17588629,\n",
       "                                       'corticoresistant': 0.16687666,\n",
       "                                       'corticosteroid-resistant': 0.23789468,\n",
       "                                       'Congo red': 0.050736878,\n",
       "                                       'complete responses': 0.30704138,\n",
       "                                       'chest and right arm': 0.11745894,\n",
       "                                       'conditioned reinforcement': 0.10384313,\n",
       "                                       'constant routine': 0.08354995,\n",
       "                                       'cardio-respiratory': 0.19736664,\n",
       "                                       'complete response rate': 0.51071143,\n",
       "                                       'cockroach': -0.030938813,\n",
       "                                       'chief resident': 0.02550116,\n",
       "                                       'calorie-restricted': 0.14928026,\n",
       "                                       'complete responders': 0.36540806,\n",
       "                                       'cysteine-rich': 0.100986466,\n",
       "                                       'controlled-release': 0.15640087,\n",
       "                                       'chemoradiation': 0.071168885,\n",
       "                                       'crown-rump': 0.010589322,\n",
       "                                       'crown-rump length': 0.07937295,\n",
       "                                       'creatinine': 0.18863212,\n",
       "                                       'capture-recapture': 0.07379339,\n",
       "                                       'Congo-red': 0.065827176,\n",
       "                                       'coefficient of repeatability': 0.2634532,\n",
       "                                       'computed radiography': 0.15620357,\n",
       "                                       'controlled respiration': 0.13599697,\n",
       "                                       'conditioned reward': 0.11106916,\n",
       "                                       'complement receptors': 0.25305408,\n",
       "                                       'concentration-response': 0.23852327,\n",
       "                                       'complete': 0.08165956,\n",
       "                                       'chest roentgenogram': 0.17694794,\n",
       "                                       'complement receptor': 0.25733733,\n",
       "                                       'Cajal-Retzius': 0.0427447,\n",
       "                                       'cremasteric reflex': 0.254426,\n",
       "                                       'clot-retraction': 0.11191877,\n",
       "                                       'conserved regions': -0.034739774,\n",
       "                                       'child-resistant': 0.037214655,\n",
       "                                       'control rats': 0.061419748,\n",
       "                                       'caries-resistant': 0.06312276,\n",
       "                                       'coronary revascularization': 0.22226435,\n",
       "                                       'colon resection': 0.09756485,\n",
       "                                       'contrast ratio': 0.17839481,\n",
       "                                       'concentration ratio': 0.2221941,\n",
       "                                       'Calreticulin': 0.110549495,\n",
       "                                       'composite resin': 0.032078777,\n",
       "                                       'completely': 0.12975074,\n",
       "                                       'colorectal': 0.16098385,\n",
       "                                       'complete response': 0.28686792,\n",
       "                                       'coronary risk': 0.20502262,\n",
       "                                       'conventional radiology': 0.19305015,\n",
       "                                       'Complete response': 0.28686792,\n",
       "                                       'cathode ray': -0.01108649,\n",
       "                                       'complete responder': 0.34437928,\n",
       "                                       'controlled release': 0.11711446,\n",
       "                                       'conditioned reflexes': 0.15045628,\n",
       "                                       'chemo-radiation': 0.21919274,\n",
       "                                       'complete remission': 0.31862387,\n",
       "                                       'conserved region': -0.041142065,\n",
       "                                       'coronary resistance': 0.2614945,\n",
       "                                       'cardiac resuscitation': 0.15060155,\n",
       "                                       'computed radiographic': 0.17148207,\n",
       "                                       'cooling rate': 0.03402693,\n",
       "                                       'clinical research': 0.41803917,\n",
       "                                       'colonization resistance': 0.054093905,\n",
       "                                       'compression ratio': 0.10152124,\n",
       "                                       'computerized record': 0.049037937,\n",
       "                                       'chromium': 0.14336799,\n",
       "                                       'colo-rectal': 0.17936495,\n",
       "                                       'contractile reserve': 0.12558189,\n",
       "                                       'clinical record': 0.26565337,\n",
       "                                       'concentration ratios': 0.21421358,\n",
       "                                       'clinical remission': 0.38930923,\n",
       "                                       'centric relation': 0.015084206,\n",
       "                                       'cardiac rhythm': 0.09823478,\n",
       "                                       'capillary refill': 0.09427624,\n",
       "                                       'colonisation rate': 0.10877577,\n",
       "                                       'conventional radiography': 0.14933154,\n",
       "                                       'cellular receptor': 0.09931281}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.20152447,\n",
       "                                       'plaque reduction': 0.103181094,\n",
       "                                       'partial response': 0.44179952,\n",
       "                                       'photoreactivation': 0.07526731,\n",
       "                                       'pentoxyresorufin': 0.15698978,\n",
       "                                       'panoramic radiography': 0.12451123,\n",
       "                                       'proliferative retinopathy': 0.13046804,\n",
       "                                       'partial responses': 0.43326533,\n",
       "                                       'protein': 0.04048716,\n",
       "                                       'prorennin': 0.16557962,\n",
       "                                       'prevalence rate': 0.26366055,\n",
       "                                       'prealbumin': 0.1033324,\n",
       "                                       'pregnancy rates': 0.13593094,\n",
       "                                       'pain relief': 0.12598068,\n",
       "                                       'partial remissions': 0.47245944,\n",
       "                                       'pattern recognition': -0.0021416715,\n",
       "                                       'photo-reactivation': 0.09497797,\n",
       "                                       'protein restriction': 0.18063577,\n",
       "                                       'progesterone receptor': 0.17019597,\n",
       "                                       'placental restriction': 0.19577858,\n",
       "                                       'pneumatic retinopexy': 0.22754782,\n",
       "                                       'prorenin': 0.21507402,\n",
       "                                       'perirhinal cortex': 0.18328357,\n",
       "                                       'prothrombin ratio': 0.23902714,\n",
       "                                       'pars recta': 0.101743355,\n",
       "                                       'pattern reversal': 0.050225284,\n",
       "                                       'pr interval (ekg)': 0.27099705,\n",
       "                                       'pityriasis rosea': 0.088611506,\n",
       "                                       'prevalence ratio': 0.30333602,\n",
       "                                       'Projection reconstruction': 0.046027098,\n",
       "                                       'pregnancy rate': 0.13901992,\n",
       "                                       'phenol red': 0.14002591,\n",
       "                                       'photoreceptor': 0.021730596,\n",
       "                                       'prednisolon': 0.19850594,\n",
       "                                       'partial responders': 0.47800332,\n",
       "                                       'proline-rich': 0.07965027,\n",
       "                                       'pseudorabies': 0.15098415,\n",
       "                                       'pulmonary regurgitation': 0.16410936,\n",
       "                                       'projection reconstruction': 0.046027098,\n",
       "                                       'photo-receptor': 0.049088042,\n",
       "                                       'protease': 0.077832066,\n",
       "                                       'progestine': 0.13347727,\n",
       "                                       'pentoxy-resorufin': 0.18405733,\n",
       "                                       'partial remission': 0.4353816,\n",
       "                                       'progestin receptor': 0.14502424,\n",
       "                                       'per rectum': 0.12853017,\n",
       "                                       'Plain radiography': 0.15326247,\n",
       "                                       'production rate': 0.12900549,\n",
       "                                       'pulmonary rehabilitation': 0.23639265,\n",
       "                                       'pentoxy resorufin': 0.19595228,\n",
       "                                       'proteinase': 0.033204544,\n",
       "                                       'Paeoniae radix': 0.14528431,\n",
       "                                       'Puerto Rico': 0.09202689,\n",
       "                                       'Prevalence ratios': 0.29083747,\n",
       "                                       'perirenal': 0.07989939,\n",
       "                                       'passive recovery': 0.17373443,\n",
       "                                       'propranolol': 0.15254271,\n",
       "                                       'primary response': 0.4397929,\n",
       "                                       'pregnant': 0.04671208,\n",
       "                                       'partial regression': 0.23282732,\n",
       "                                       'Photoreactivation': 0.07526731,\n",
       "                                       'peripheral resistance': 0.23046152,\n",
       "                                       'polymorphic reticulosis': 0.19030407,\n",
       "                                       'progressive ratio': 0.20102145,\n",
       "                                       'partial responder': 0.41221133,\n",
       "                                       'projection-reconstruction': 0.08535306,\n",
       "                                       'pro-renin': 0.2193169,\n",
       "                                       'phenol-red': 0.13889,\n",
       "                                       'progestin': 0.121836245,\n",
       "                                       'pro-rennin': 0.1624775})}),\n",
       "             'None of the patients in either cohort of the primary trial experienced DLT.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DLT': defaultdict(float,\n",
       "                                      {'double-lung transplantation': 0.07980373,\n",
       "                                       'direct linear transformation': 0.0867873,\n",
       "                                       'double lumen tube': 0.11520945,\n",
       "                                       'double-lumen tube': 0.11160994,\n",
       "                                       'dose limiting toxicity': 0.113337174,\n",
       "                                       'dose-limiting toxicity': 0.11466569,\n",
       "                                       'donor leukocyte transfusion': 0.08306466,\n",
       "                                       'double-lumen endobronchial tube': 0.18833008,\n",
       "                                       'double lumen endotracheal tube': 0.18647778,\n",
       "                                       'double lung transplantation': 0.07162148,\n",
       "                                       'double-lumen endotracheal tube': 0.18067092})}),\n",
       "             'Elizabeth has HER2 positive breast cancer, she is eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.20070082,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.20885456,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.20416738,\n",
       "                                       'human epidermal growth factor receptor 2': 0.20584503,\n",
       "                                       'human epidermal growth factor receptor-2': 0.20885456})}),\n",
       "             'The least common Chevalier grades for patients in the primary trial treated with Taxotere/Docetaxel were 1, 3D and 3C.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'3D': defaultdict(float,\n",
       "                                      {'3 dimensional': 0.074081495,\n",
       "                                       '3-dimensional': 0.06324274})}),\n",
       "             'the cyclophosphamide dose in the secondary trial is 150mg once every 4 weeks and the Placebo dose in the primary trial is 12mg QD.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'QD': defaultdict(float,\n",
       "                                      {'quinidine': 0.34952843,\n",
       "                                       'quaque die (every day)': 0.104409635,\n",
       "                                       'quaque die': 0.103442766,\n",
       "                                       'quinupristin-dalfopristin': 0.37676507,\n",
       "                                       'quater die': 0.13794737,\n",
       "                                       'quantum dot': 0.010111189,\n",
       "                                       'questionable dementia': 0.041251563})}),\n",
       "             'Patients with metastatic HER-2 positive adenocarcinoma of the breast can never be eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER': defaultdict(float,\n",
       "                                      {'heroin': 0.0067233993,\n",
       "                                       'human epidermal receptor': 0.08751376,\n",
       "                                       'hydrogen evolution reaction': 0.0119326925,\n",
       "                                       'human epidermal growth factor receptor': 0.13534185,\n",
       "                                       'human EGF receptor': 0.14066814,\n",
       "                                       'human estrogen receptor': 0.18257008})}),\n",
       "             'over 100 participants in the TCH + P group of the primary trial achieved Total Pathological Complete Response (tpCR) Assessed Based on Tumor Samples.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'TCH': defaultdict(float,\n",
       "                                      {'turn, cough, hyperventilate': 0.012107541,\n",
       "                                       'tanned cell haemagglutination': 0.14925492,\n",
       "                                       \"Texas Children's Hospital\": 0.15905975,\n",
       "                                       'thiocarbohydrazide': 0.17665645,\n",
       "                                       'total circulating haemoglobin': 0.1855507,\n",
       "                                       'tetracycline hydrochloride': 0.15343289,\n",
       "                                       'tanned cell hemagglutination': 0.17148823,\n",
       "                                       'total cholesterol': 0.14816873,\n",
       "                                       'thunderclap headache': 0.014858426,\n",
       "                                       'total circulating hemoglobin': 0.18303593})}),\n",
       "             '27.6% of Patients Who Have Fatty Acid Synthase (FASN) Expression in the primary trial treated with High Dose Omeprazole did not have Pathological Complete Response.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'FASN': defaultdict(float,\n",
       "                                      {'fatty-acid synthase': 0.55987084,\n",
       "                                       'fatty acid synthase': 0.5489507})}),\n",
       "             'the primary trial uses a set dosage of 1000 mg PO daily of Lapatinib, whereas the dose of Capecitabine changes with patients body weight.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.1361009,\n",
       "                                       'parietal operculum': 0.056459233,\n",
       "                                       'post office': -0.012739318,\n",
       "                                       'percentage of observed value': 0.1878829,\n",
       "                                       'Phenol oxidase': 0.025726963,\n",
       "                                       'parapineal organ': 0.10010311,\n",
       "                                       'power output': 0.034536924,\n",
       "                                       'predominant organism': 0.068948194,\n",
       "                                       'pulse-oximetry': 0.13250919,\n",
       "                                       'perceptual organisation': -0.018016087,\n",
       "                                       'power outputs': -0.034204375,\n",
       "                                       'Personality Organization': -0.0664487,\n",
       "                                       'postoperative': 0.11605107,\n",
       "                                       'parieto occipital': 0.05087872,\n",
       "                                       'polyolefin': 0.1051433,\n",
       "                                       'parietooccipital': 0.037320204,\n",
       "                                       'poly-olefin': 0.07271556,\n",
       "                                       'peroral': 0.062196176,\n",
       "                                       'prostate only': 0.059038542,\n",
       "                                       'pressure overload': 0.034476228,\n",
       "                                       'peroxidase': 0.05441272,\n",
       "                                       'principal olive': 0.0674323,\n",
       "                                       'peri-operative': 0.09647844,\n",
       "                                       'posterior': 0.0895997,\n",
       "                                       'Perceptual Organization': -0.026020477,\n",
       "                                       'period of onset': 0.14123516,\n",
       "                                       'posterior nuclear group': 0.016090352,\n",
       "                                       'phenol oxidase': 0.025726963,\n",
       "                                       'pressure': -0.02716799,\n",
       "                                       'per os (by mouth)': 0.18707013,\n",
       "                                       'parieto-occipital': 0.041423615,\n",
       "                                       'preoptic area': 0.058586415,\n",
       "                                       'perceptual organization': -0.026020477,\n",
       "                                       'prophylactic oophorectomy': 0.061296914,\n",
       "                                       'phosphodiester': 0.054890543,\n",
       "                                       'pre-ovulatory': 0.09121666,\n",
       "                                       'palm oil': 0.04876044,\n",
       "                                       'preovulatory': 0.17180797,\n",
       "                                       'perioperative': 0.1528502,\n",
       "                                       'post operative': 0.07646553,\n",
       "                                       'post-operative': 0.10880045,\n",
       "                                       'phospho-diester': 0.006800877,\n",
       "                                       'protein oxidation': 0.013811059,\n",
       "                                       'palm-oil': 0.01760868,\n",
       "                                       'per os': 0.16279733,\n",
       "                                       'pericardial organ': 0.08050312,\n",
       "                                       'Pulse oximetry': 0.1361009,\n",
       "                                       'paraoxon': 0.1694659,\n",
       "                                       'propylene oxide': 0.10312419,\n",
       "                                       'phenoloxidase': 0.07445471,\n",
       "                                       'peanut oil': 0.041037727})}),\n",
       "             'Neither the primary trial or the secondary trial are measuring Percentage of Participants With Overall Response Rate (ORR) Following Administration of Ispinesib.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ORR': defaultdict(float,\n",
       "                                      {'oxygen-reduction reaction': 0.10483667,\n",
       "                                       'overall response rate': 0.31359893,\n",
       "                                       'objective response rate': 0.2716201,\n",
       "                                       'oxygen reduction reaction': 0.102565534})}),\n",
       "             'Patients with ER-positive tumours are eligible for the primary trial but not for the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ER': defaultdict(float,\n",
       "                                      {'extinction-ratio': 0.061567627,\n",
       "                                       'equivalent rontgen': 0.090966046,\n",
       "                                       'endo-plasmic reticulum': 0.062498324,\n",
       "                                       'emergency room': 0.13532192,\n",
       "                                       'estrogen receptor-alpha': 0.25866318,\n",
       "                                       'environmental resistance': 0.018401174,\n",
       "                                       'erythrocyte receptor': 0.24257164,\n",
       "                                       'estradiol receptor': 0.14390828,\n",
       "                                       'extended-release': 0.11908878,\n",
       "                                       'energy restriction': 0.084176354,\n",
       "                                       'energy-restricted': 0.10267146,\n",
       "                                       'estrogen-receptor': 0.18502511,\n",
       "                                       'energy retention': -0.050678447,\n",
       "                                       'electrorheological': 0.09495964,\n",
       "                                       'ejection rate': 0.10431517,\n",
       "                                       'external resistance': 0.08452832,\n",
       "                                       'Estrogen receptor alpha': 0.21079336,\n",
       "                                       'estrogen receptor': 0.16491511,\n",
       "                                       'early': 0.05419577,\n",
       "                                       'endoplasmatic reticulum': 0.07156506,\n",
       "                                       'Estradiol': 0.053843763,\n",
       "                                       'expiratory reserve': 0.12648934,\n",
       "                                       'endovascular repair': 0.12277989,\n",
       "                                       'Emergency Room': 0.13532192,\n",
       "                                       'early reticulocyte': 0.15685616,\n",
       "                                       'esophageal rupture': 0.14229749,\n",
       "                                       'Estrogen receptors': 0.12594688,\n",
       "                                       'evoked responses': 0.13209197,\n",
       "                                       'estrogen receptor protein': 0.17054573,\n",
       "                                       'erythromycin': 0.23831283,\n",
       "                                       'enhancement ratios': 0.10942719,\n",
       "                                       'equine rhinopneumonia': 0.062453885,\n",
       "                                       'eye research': 0.10962951,\n",
       "                                       'extinction ratio': 0.06475301,\n",
       "                                       'equivalent roentgen': 0.12883681,\n",
       "                                       'emotion regulation': 0.036548793,\n",
       "                                       'enhancement ratio': 0.11052555,\n",
       "                                       'estrogen receptor status': 0.26774082,\n",
       "                                       'early repolarization': 0.102640025,\n",
       "                                       'early repolarisation': 0.113181576,\n",
       "                                       'electrical resistance': 0.11947246,\n",
       "                                       'evoked response': 0.16855747,\n",
       "                                       'efficacy ratio': 0.20854609,\n",
       "                                       'estrogen': 0.055676877,\n",
       "                                       'endoplasmic reticular': 0.103483535,\n",
       "                                       'extraction ratio': 0.07832804,\n",
       "                                       'extended release': 0.10134547,\n",
       "                                       'external rotation': 0.019720262,\n",
       "                                       'epigastric region': 0.20626846,\n",
       "                                       'endoscopic resection': 0.17724845,\n",
       "                                       'ethoxyresorufin': 0.13476944,\n",
       "                                       'electro-resection': 0.25020614,\n",
       "                                       'early response': 0.17741099,\n",
       "                                       'endoplasmic reticulum': 0.061604735,\n",
       "                                       'enhanced reactivation': 0.12629673,\n",
       "                                       'electroresection': 0.20609167})}),\n",
       "             'A patient presenting Glomerular filtration rate of 63 and with BI-RADS category c breast tissue would be eligilbe for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'BI': defaultdict(float,\n",
       "                                      {'bioimpedance': 0.10474304,\n",
       "                                       'Barthel index': 0.061516214,\n",
       "                                       'biological indicator': 0.15412389,\n",
       "                                       'brain injury': 0.13347572,\n",
       "                                       'burn index': -0.0016702693,\n",
       "                                       'brief intervention': 0.12170456,\n",
       "                                       'balloon injury': 0.17426579,\n",
       "                                       'base-in': 0.10430718,\n",
       "                                       'bone injury': 0.116396606,\n",
       "                                       'bacteriological index': 0.09731854,\n",
       "                                       'Bayesian inference': 0.032905247,\n",
       "                                       'bovine insulin': 0.13553807,\n",
       "                                       'bioelectrical impedance': 0.14530295,\n",
       "                                       'Billroth I': 0.041328136,\n",
       "                                       'backward inhibition': 0.023462184,\n",
       "                                       'brain-injured': 0.08321745,\n",
       "                                       'Breteau index': 0.122005224,\n",
       "                                       'bio-electrical impedance': 0.1292824,\n",
       "                                       'bi-ischial': 0.29606283,\n",
       "                                       'body injury': 0.0826931,\n",
       "                                       'behavioural inhibition': 0.04904448,\n",
       "                                       'bacterial index': 0.07646252,\n",
       "                                       'biischial': 0.118774,\n",
       "                                       'background interval': 0.068993226,\n",
       "                                       'Brinkman Index': 0.060870633,\n",
       "                                       'Bilroth-I': 0.1517068,\n",
       "                                       'bowel impaction': 0.119461164,\n",
       "                                       'Brinkman index': 0.060870633,\n",
       "                                       'body image': 0.09843466,\n",
       "                                       'bleeding index': 0.22841768,\n",
       "                                       'behavioral inhibition': 0.021699967,\n",
       "                                       'Binaural interaction': 0.054362576,\n",
       "                                       'body-image': 0.13365853,\n",
       "                                       'basilar impression': 0.00630996,\n",
       "                                       'bodily injury': 0.08853074,\n",
       "                                       'Barthel Index': 0.061516214,\n",
       "                                       'brain infarction': 0.15424833,\n",
       "                                       'brain injured': 0.075977206})}),\n",
       "             'All patients in the primary trial must have a bilateral breast MRI prior to study entry.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MRI': defaultdict(float,\n",
       "                                      {'magnetic-resonance imaging': 0.3085036,\n",
       "                                       'MR-imaging': 0.38106674,\n",
       "                                       'magnetic resonance imaging': 0.3494007,\n",
       "                                       'magnetic resonance images': 0.33142978,\n",
       "                                       'magnetic resonance': 0.20788766,\n",
       "                                       'Magnetic resonance imagings': 0.3544381,\n",
       "                                       'magnet resonance imaging': 0.36188686,\n",
       "                                       'MR imaging': 0.4103074,\n",
       "                                       'magnetic-resonance-imaging': 0.2966604,\n",
       "                                       'magnetic resonance imagery': 0.30361813,\n",
       "                                       'Magnetic resonance imaging scan': 0.40312815,\n",
       "                                       'magnetic resonance tomography': 0.33756056,\n",
       "                                       'magnetic resonance image': 0.31220543,\n",
       "                                       'Magnetic resonance image': 0.31220543})}),\n",
       "             'Patients with tumors that are HER2 negative, PR and ER positive are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.33144504,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.34374064,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.3285828,\n",
       "                                       'human epidermal growth factor receptor 2': 0.33291486,\n",
       "                                       'human epidermal growth factor receptor-2': 0.34374064}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.17211029,\n",
       "                                       'plaque reduction': 0.0008273646,\n",
       "                                       'partial response': 0.13704571,\n",
       "                                       'photoreactivation': 0.03010413,\n",
       "                                       'pentoxyresorufin': 0.058735743,\n",
       "                                       'panoramic radiography': 0.04917305,\n",
       "                                       'proliferative retinopathy': 0.23219478,\n",
       "                                       'partial responses': 0.118982784,\n",
       "                                       'protein': -0.0099460455,\n",
       "                                       'prorennin': 0.14954603,\n",
       "                                       'prevalence rate': 0.12918809,\n",
       "                                       'prealbumin': 0.09031728,\n",
       "                                       'pregnancy rates': -0.031053642,\n",
       "                                       'pain relief': 0.03377322,\n",
       "                                       'partial remissions': 0.42270505,\n",
       "                                       'pattern recognition': -0.07012432,\n",
       "                                       'photo-reactivation': 0.04307142,\n",
       "                                       'protein restriction': 0.13260455,\n",
       "                                       'progesterone receptor': 0.19403404,\n",
       "                                       'placental restriction': 0.16399126,\n",
       "                                       'pneumatic retinopexy': 0.1433515,\n",
       "                                       'prorenin': 0.13607347,\n",
       "                                       'perirhinal cortex': 0.07350813,\n",
       "                                       'prothrombin ratio': 0.2050744,\n",
       "                                       'pars recta': 0.04675892,\n",
       "                                       'pattern reversal': -0.027618531,\n",
       "                                       'pr interval (ekg)': 0.2110222,\n",
       "                                       'pityriasis rosea': 0.0742307,\n",
       "                                       'prevalence ratio': 0.16118659,\n",
       "                                       'Projection reconstruction': -0.08511898,\n",
       "                                       'pregnancy rate': -0.008350776,\n",
       "                                       'phenol red': 0.10243983,\n",
       "                                       'photoreceptor': 0.08589199,\n",
       "                                       'prednisolon': 0.16306491,\n",
       "                                       'partial responders': 0.1575189,\n",
       "                                       'proline-rich': 0.0746173,\n",
       "                                       'pseudorabies': 0.1346096,\n",
       "                                       'pulmonary regurgitation': 0.07380559,\n",
       "                                       'projection reconstruction': -0.08511898,\n",
       "                                       'photo-receptor': 0.1519636,\n",
       "                                       'protease': 0.11427915,\n",
       "                                       'progestine': 0.03898485,\n",
       "                                       'pentoxy-resorufin': 0.06073486,\n",
       "                                       'partial remission': 0.36471847,\n",
       "                                       'progestin receptor': 0.18093683,\n",
       "                                       'per rectum': 0.07653657,\n",
       "                                       'Plain radiography': 0.113681324,\n",
       "                                       'production rate': 0.013886604,\n",
       "                                       'pulmonary rehabilitation': 0.07401871,\n",
       "                                       'pentoxy resorufin': 0.06325426,\n",
       "                                       'proteinase': 0.08989893,\n",
       "                                       'Paeoniae radix': 0.15696914,\n",
       "                                       'Puerto Rico': 0.08346369,\n",
       "                                       'Prevalence ratios': 0.14600967,\n",
       "                                       'perirenal': 0.043658815,\n",
       "                                       'passive recovery': 0.046367157,\n",
       "                                       'propranolol': 0.094878554,\n",
       "                                       'primary response': 0.25858825,\n",
       "                                       'pregnant': -0.041834295,\n",
       "                                       'partial regression': 0.034755576,\n",
       "                                       'Photoreactivation': 0.03010413,\n",
       "                                       'peripheral resistance': 0.15317765,\n",
       "                                       'polymorphic reticulosis': 0.124025285,\n",
       "                                       'progressive ratio': 0.10350835,\n",
       "                                       'partial responder': 0.1495388,\n",
       "                                       'projection-reconstruction': -0.059451606,\n",
       "                                       'pro-renin': 0.15368894,\n",
       "                                       'phenol-red': 0.11010949,\n",
       "                                       'progestin': 0.06859594,\n",
       "                                       'pro-rennin': 0.11757395}),\n",
       "                          'ER': defaultdict(float,\n",
       "                                      {'extinction-ratio': 0.059261356,\n",
       "                                       'equivalent rontgen': 0.06877027,\n",
       "                                       'endo-plasmic reticulum': 0.124668434,\n",
       "                                       'emergency room': 0.10523226,\n",
       "                                       'estrogen receptor-alpha': 0.30128115,\n",
       "                                       'environmental resistance': -0.03002328,\n",
       "                                       'erythrocyte receptor': 0.27112645,\n",
       "                                       'estradiol receptor': 0.21487983,\n",
       "                                       'extended-release': 0.09352019,\n",
       "                                       'energy restriction': 0.058335572,\n",
       "                                       'energy-restricted': 0.07522945,\n",
       "                                       'estrogen-receptor': 0.247153,\n",
       "                                       'energy retention': -0.06258508,\n",
       "                                       'electrorheological': 0.059344485,\n",
       "                                       'ejection rate': 0.049726132,\n",
       "                                       'external resistance': 0.05892741,\n",
       "                                       'Estrogen receptor alpha': 0.24443863,\n",
       "                                       'estrogen receptor': 0.21132928,\n",
       "                                       'early': 0.011272658,\n",
       "                                       'endoplasmatic reticulum': 0.12141127,\n",
       "                                       'Estradiol': 0.08567153,\n",
       "                                       'expiratory reserve': 0.0980924,\n",
       "                                       'endovascular repair': 0.103246674,\n",
       "                                       'Emergency Room': 0.10523226,\n",
       "                                       'early reticulocyte': 0.18581884,\n",
       "                                       'esophageal rupture': 0.071693055,\n",
       "                                       'Estrogen receptors': 0.1795125,\n",
       "                                       'evoked responses': 0.127374,\n",
       "                                       'estrogen receptor protein': 0.25830862,\n",
       "                                       'erythromycin': 0.19866695,\n",
       "                                       'enhancement ratios': 0.1282064,\n",
       "                                       'equine rhinopneumonia': 0.0006487361,\n",
       "                                       'eye research': 0.1276082,\n",
       "                                       'extinction ratio': 0.067995384,\n",
       "                                       'equivalent roentgen': 0.08881704,\n",
       "                                       'emotion regulation': 0.0049189283,\n",
       "                                       'enhancement ratio': 0.13515288,\n",
       "                                       'estrogen receptor status': 0.27252534,\n",
       "                                       'early repolarization': 0.12617889,\n",
       "                                       'early repolarisation': 0.1208204,\n",
       "                                       'electrical resistance': 0.038256083,\n",
       "                                       'evoked response': 0.15235859,\n",
       "                                       'efficacy ratio': 0.18929723,\n",
       "                                       'estrogen': 0.05633185,\n",
       "                                       'endoplasmic reticular': 0.12894858,\n",
       "                                       'extraction ratio': 0.0781849,\n",
       "                                       'extended release': 0.08283877,\n",
       "                                       'external rotation': 0.048892688,\n",
       "                                       'epigastric region': 0.17916581,\n",
       "                                       'endoscopic resection': 0.11306286,\n",
       "                                       'ethoxyresorufin': 0.0975623,\n",
       "                                       'electro-resection': 0.17526561,\n",
       "                                       'early response': 0.1675322,\n",
       "                                       'endoplasmic reticulum': 0.111909695,\n",
       "                                       'enhanced reactivation': 0.13287371,\n",
       "                                       'electroresection': 0.11548761})}),\n",
       "             'Potential participants will be considered regardless of the hormone receptivity of their breast cancer, except if they are overexpressing ERBB2.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ERBB2': defaultdict(float,\n",
       "                                      {'erythroblastic leukemia viral oncogene homologue 2': 0.29037687,\n",
       "                                       'erythroblastic leukemia viral oncogene homolog 2': 0.2856348,\n",
       "                                       'erythroblastic leukaemia viral oncogene homolog 2': 0.28115043,\n",
       "                                       'erythroblastic leukaemia viral oncogene homologue 2': 0.28784055})}),\n",
       "             'Anna is a 57 year old female with an ECOG of 0, diagnosed with a HER2-positive invasive adenocarcinoma of the breast, with ipsilateral nodes pN2. She is eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.11381731,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.5044843,\n",
       "                                       'eastern cooperative oncology group': 0.5044843,\n",
       "                                       'Electrocochleography': 0.1264425,\n",
       "                                       'electrocochleogram': 0.12948921,\n",
       "                                       'electrocortical activity': 0.06792737,\n",
       "                                       'electrocorticograms': 0.11225512,\n",
       "                                       'electrocortical': 0.107284866}),\n",
       "                          'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.3112876,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.32340363,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.31436628,\n",
       "                                       'human epidermal growth factor receptor 2': 0.3216026,\n",
       "                                       'human epidermal growth factor receptor-2': 0.32340363})}),\n",
       "             'the primary trial and the secondary trial monitor the DFS of their patient cohorts, however the secondary trial reports the % of patients with DFS >= 5 years whereas the primary trial reports % of participants with DFS >= 2 years.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DFS': defaultdict(float,\n",
       "                                      {'Defensive Functioning Scale': 0.28443557,\n",
       "                                       'Disease free survival': 0.26625353,\n",
       "                                       'decayed and filled tooth surfaces': 0.0016902016,\n",
       "                                       'dysplasia of the fibrous sheath': 0.15228438,\n",
       "                                       'diclofenac-sodium': 0.10449958,\n",
       "                                       'disease-free survivals': 0.31122762,\n",
       "                                       'diclofenac sodium': 0.09313847,\n",
       "                                       'deoxyfructoserotonin': 0.106991835,\n",
       "                                       'Disease-free': 0.069969386,\n",
       "                                       'dental fear survey': 0.08773929,\n",
       "                                       'disease-free survival': 0.2875645,\n",
       "                                       'deoxyfructo-serotonin': 0.15720513,\n",
       "                                       'Dental Fear Survey': 0.08773929,\n",
       "                                       'disease free survival': 0.26625353,\n",
       "                                       'dental fear scale': 0.13970603,\n",
       "                                       'decayed or filled surfaces': -0.019932028,\n",
       "                                       'diabetic foot syndrome': 0.16611724,\n",
       "                                       'desoxyfructosylserotonin': 0.05664316,\n",
       "                                       'desoxyfructo-serotonin': 0.15297653})}),\n",
       "             'Patients with pure ductal carcinoma in situ (DCIS) are eligible for both the secondary trial and the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DCIS': defaultdict(float,\n",
       "                                      {'ductal carcinoma in-situ': 0.56464213,\n",
       "                                       'ductal carcinoma in situ': 0.5409978,\n",
       "                                       'ductal carcinoma-in-situ': 0.56328696,\n",
       "                                       'ductal carcinoma of breast': 0.4307217,\n",
       "                                       'ductal carcinoma in situ of the breast': 0.464021})}),\n",
       "             'Mark has HER2 positive breast cancer, he is eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.19960961,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.21083719,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.1977738,\n",
       "                                       'human epidermal growth factor receptor 2': 0.20239553,\n",
       "                                       'human epidermal growth factor receptor-2': 0.21083719})}),\n",
       "             'Adult Patients with Histologically proven Unifocal HER2- infiltrating breast cancer that have not had Previous lumpectomy or same side mammary reduction and have no Contra-indication to surgery are excluded from the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.24325389,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.23939477,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.24360876,\n",
       "                                       'human epidermal growth factor receptor 2': 0.23732348,\n",
       "                                       'human epidermal growth factor receptor-2': 0.23939477})}),\n",
       "             'Results from the primary trial and the secondary trial indicate Abraxane + Tigatuzumab produce better ORR than Caelyx, Docetaxe and Trastuzumab.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ORR': defaultdict(float,\n",
       "                                      {'oxygen-reduction reaction': 0.21519138,\n",
       "                                       'overall response rate': 0.2516203,\n",
       "                                       'objective response rate': 0.22491224,\n",
       "                                       'oxygen reduction reaction': 0.21255593})}),\n",
       "             'Patients with No QT prolongation are excluded from the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'QT': defaultdict(float,\n",
       "                                      {'qt interval (ecg)': 0.3585994})}),\n",
       "             'On days 1-7 Cohort 1 of the primary trial receive doxorubicin hydrochloride IV, oral cyclophosphamide, dexamethasone IV or orally and ondansetron IV.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.16165414,\n",
       "                                       'intravenous injection': 0.37015513,\n",
       "                                       'iridovirus': 0.1605429,\n",
       "                                       'intra-venous': 0.23218566,\n",
       "                                       'invitro': 0.07376468,\n",
       "                                       'intra ventricular': 0.12602666,\n",
       "                                       'intra vascular': 0.17517668,\n",
       "                                       'in vivo': 0.18553185,\n",
       "                                       'intravascular': 0.21081746,\n",
       "                                       'in-vivo': 0.2516812,\n",
       "                                       'inter-vertebral': 0.13773361,\n",
       "                                       'ichthyosis vulgaris': 0.14819795,\n",
       "                                       'intravenous': 0.3681398,\n",
       "                                       'intravaginal': 0.14356777,\n",
       "                                       'invasive': 0.046931602,\n",
       "                                       'iridescent virus': 0.117535375,\n",
       "                                       'isometric virus': 0.1253356,\n",
       "                                       'intravenous feeding device': 0.21091864,\n",
       "                                       'invivo': 0.029339269,\n",
       "                                       'instrumental variable': 0.01626255,\n",
       "                                       'intraventricular': 0.11971317,\n",
       "                                       'intra-vaginal': 0.17461503,\n",
       "                                       'intravertebral': 0.12114005,\n",
       "                                       'in vitro': 0.12079652,\n",
       "                                       'interventricular': 0.10378713,\n",
       "                                       'in-vitro': 0.20447657,\n",
       "                                       'intra venous': 0.18701908,\n",
       "                                       'iodine value': 0.10734721,\n",
       "                                       'ichnovirus': 0.14951038,\n",
       "                                       'inter-ventricular': 0.11209763,\n",
       "                                       'intra-vertebral': 0.17873073,\n",
       "                                       'intravenous injection device': 0.278623,\n",
       "                                       'intervertebral': 0.11122868,\n",
       "                                       'initial visit': 0.1852115,\n",
       "                                       'intravenous feeding': 0.26405635,\n",
       "                                       'intra-vascular': 0.21540903,\n",
       "                                       'intra-ventricular': 0.14581369})}),\n",
       "             'cohort 1 of the secondary trial had a much longer median PFS than cohort 1 of the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.13004646,\n",
       "                                       'pyrogen-free saline': 0.081346996,\n",
       "                                       'pressure-flow study': -0.017405309,\n",
       "                                       'posterior fossa syndrome': 0.21584833,\n",
       "                                       'pressure flow study': -0.009146813,\n",
       "                                       'primary fibromyalgia syndrome': 0.29294845,\n",
       "                                       'Piper Fatigue Scale': 0.113266975,\n",
       "                                       'patellofemoral syndrome': 0.16350968,\n",
       "                                       'Progression-free': 0.07445604,\n",
       "                                       'pulmonary function score': 0.21154302,\n",
       "                                       'pressure flow studies': -0.011341441,\n",
       "                                       'protein-free supernatant': 0.0112963645,\n",
       "                                       'progression free survival': 0.24261406,\n",
       "                                       'protein free supernatant': 0.03472627,\n",
       "                                       'progression-free survival': 0.295323,\n",
       "                                       'pressure/flow study': 0.0028658176})}),\n",
       "             'The Exemestane group in the primary trial had a better median Tumor Response than the Abiraterone Acetate + Prednisone group, however the patient with the maximum TR was in the Abiraterone Acetate + Prednisone group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'TR': defaultdict(float,\n",
       "                                      {'trapezius': 0.018647006,\n",
       "                                       'terminal repeat': 0.006720619,\n",
       "                                       'tandem repeat': 0.016509382,\n",
       "                                       'tuberculin R': 0.14906366,\n",
       "                                       'trenimon': -0.0026195666,\n",
       "                                       'therapeutic radiology': 0.2604136,\n",
       "                                       'transferrin': 0.18400793,\n",
       "                                       'training': -0.03024896,\n",
       "                                       'trained': -0.051604114,\n",
       "                                       'Texas-red': 0.02936415,\n",
       "                                       'Texas red': 0.04752957,\n",
       "                                       'trypsine': 0.13596533,\n",
       "                                       'tremor': 0.03188899,\n",
       "                                       'tricuspid regurgitation': 0.030766372,\n",
       "                                       'transferrin receptor': 0.1500426,\n",
       "                                       'tandem repeats': 0.045848776,\n",
       "                                       'treadmill-running': -0.00029149096,\n",
       "                                       'trypsin': 0.12610513,\n",
       "                                       'trypanothione reductase': 0.14790167,\n",
       "                                       'thyroid hormone receptor': 0.18324873,\n",
       "                                       'taste reactivity': 0.057197493,\n",
       "                                       'Texas Red': 0.04752957,\n",
       "                                       'tiazofurin': 0.25127664,\n",
       "                                       'trough': -0.065240264,\n",
       "                                       'treadmill running': -0.02034395,\n",
       "                                       'trp repressor': 0.06746802,\n",
       "                                       'temperature-resistant': -0.0029928861,\n",
       "                                       'Thyroid hormone receptors': 0.1879463,\n",
       "                                       'Tiazofurin': 0.25127664,\n",
       "                                       'trachea': 0.08315157,\n",
       "                                       'transformed': 0.008527635,\n",
       "                                       'Turnover rates': 0.059576258,\n",
       "                                       'turbidity-reducing': 0.12233765,\n",
       "                                       'thyroid hormone': 0.1272351,\n",
       "                                       'trach': 0.06469635,\n",
       "                                       'thursday': -0.019687064,\n",
       "                                       'Thioredoxin reductase': 0.14936945,\n",
       "                                       'thioredoxin reductase': 0.14936945,\n",
       "                                       'Texas-Red': 0.02936415,\n",
       "                                       'Thiazin red': 0.0004797914,\n",
       "                                       'time-resolved': 0.038411222,\n",
       "                                       'transitional region': 0.01258852,\n",
       "                                       'thrombin receptor': 0.15234214,\n",
       "                                       'temperature resistant': -0.00076375494,\n",
       "                                       'total response': 0.12666492,\n",
       "                                       'terminal repeats': 0.008113185,\n",
       "                                       'total resistance': 0.040195834,\n",
       "                                       'tetrazolium reduction': 0.08257868,\n",
       "                                       'time release': 0.017990516,\n",
       "                                       'triamcinolone': 0.2951044,\n",
       "                                       'T regulatory': 0.1418977,\n",
       "                                       'transport rate': 0.100776054})}),\n",
       "             'Patients with HER2 negative BC are eligible for both the primary trial and the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.2869446,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.30220705,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.29123765,\n",
       "                                       'human epidermal growth factor receptor 2': 0.29652786,\n",
       "                                       'human epidermal growth factor receptor-2': 0.30220705}),\n",
       "                          'BC': defaultdict(float,\n",
       "                                      {'breast cancer': 0.21023047,\n",
       "                                       'bactericidal concentration': 0.08255504,\n",
       "                                       'bulbocavernosus': -0.019552033,\n",
       "                                       'blood cultures': 0.16415973,\n",
       "                                       'buffy-coat': -0.036484245,\n",
       "                                       'bipolar cell': 0.20089406,\n",
       "                                       'biventer cervicis': 0.15049976,\n",
       "                                       'biochemical control': 0.07653246,\n",
       "                                       'biliary complications': 0.16403675,\n",
       "                                       'battle casualty': 0.04699286,\n",
       "                                       'blood count': 0.24656655,\n",
       "                                       'blue cross': 0.17767811,\n",
       "                                       'biotin carboxylase': 0.1328593,\n",
       "                                       'biliary colic': 0.1372185,\n",
       "                                       'blood glucose': 0.13887891,\n",
       "                                       'British Columbia': 0.11286183,\n",
       "                                       'buccocervical': 0.09379777,\n",
       "                                       'blood culture': 0.14997913,\n",
       "                                       'basal cell': 0.24039328,\n",
       "                                       'birth control': 0.1420761,\n",
       "                                       'brachio-cephalic': 0.11606665,\n",
       "                                       'benzalkonium chloride': 0.045228545,\n",
       "                                       'breast carcinoma': 0.20607029,\n",
       "                                       'birth-control': 0.16964088,\n",
       "                                       'basal-cell': 0.25122723,\n",
       "                                       'bacterial cellulose': -0.024329256,\n",
       "                                       'body condition': 0.058293294,\n",
       "                                       'board certified': 0.078384064,\n",
       "                                       'board-certified': 0.09944313,\n",
       "                                       'brachium conjunctivum': 0.15963095,\n",
       "                                       'bromocriptine': 0.106951825,\n",
       "                                       'back care': 0.059682664,\n",
       "                                       'bronchoconstriction': 0.0582352,\n",
       "                                       'blastic crisis': 0.113366075,\n",
       "                                       'bacitracin': 0.20389575,\n",
       "                                       'blood-count': 0.2528719,\n",
       "                                       'bladder capacity': 0.027896686,\n",
       "                                       'bronchial carcinoma': 0.09081124,\n",
       "                                       'bronchogenic carcinoma': 0.09036985,\n",
       "                                       'beta-carotene': 0.18862033,\n",
       "                                       'blast crisis': 0.04087168,\n",
       "                                       'body composition': 0.032409895,\n",
       "                                       'breast cancers': 0.24057731,\n",
       "                                       'black carbon': 0.045991622,\n",
       "                                       'buffy coat': -0.045398794,\n",
       "                                       'brachiocephalic': 0.12490528,\n",
       "                                       'bone conduction': 0.020984113,\n",
       "                                       'birthcontrol': 0.18238822,\n",
       "                                       'breastcancer': 0.18351829,\n",
       "                                       'blood-culture': 0.11737986,\n",
       "                                       'basket cell': 0.044768427,\n",
       "                                       'bronchogenic cyst': 0.054840367,\n",
       "                                       'buccal cartilage': 0.062685356,\n",
       "                                       'backcross': 0.10513839,\n",
       "                                       'bicarbonate': 0.112950005,\n",
       "                                       'basaloid carcinoma': 0.14080903,\n",
       "                                       'Breast Cancer': 0.21023047,\n",
       "                                       'basic copy': 0.08164884,\n",
       "                                       'bone-conduction': 0.02359431,\n",
       "                                       'bile canaliculi': 0.07417396,\n",
       "                                       'Blue Cross': 0.17767811})}),\n",
       "             'In the primary trial There was less than 3 months difference between the maximum and minimum recorded TTP of the Exemestane group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'TTP': defaultdict(float,\n",
       "                                      {'tocopherol transfer protein': 0.1220001,\n",
       "                                       'time to positivity': 0.16412058,\n",
       "                                       'time to peak tension': 0.16983725,\n",
       "                                       'time to progression': 0.26956946,\n",
       "                                       'thrombotic thrombocytopenic purpura': 0.20739943,\n",
       "                                       'tristetraprolin': 0.31103697,\n",
       "                                       'time to pregnancy': 0.18124597,\n",
       "                                       'time to disease progression': 0.3098237,\n",
       "                                       'thiamine triphosphate': 0.20101008,\n",
       "                                       'thymidine triphosphate': 0.2710673,\n",
       "                                       'Time to progression': 0.26956946,\n",
       "                                       'time to peak contraction': 0.3229372,\n",
       "                                       'time to peak': 0.2550562,\n",
       "                                       'thiamin triphosphate': 0.17867692,\n",
       "                                       'tender to palpation': 0.04026068,\n",
       "                                       'time to tumor progression': 0.2799401,\n",
       "                                       'Tolpa Torf Preparation': 0.17056549,\n",
       "                                       'thrombotic-thrombocytopenic purpura': 0.21322434,\n",
       "                                       'time-to-peak': 0.3555849})}),\n",
       "             'In the primary trial, Dasatinib, 70 mg, Twice Daily results in a better median PFS than Dasatinib, 100 mg, Daily.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.021388344,\n",
       "                                       'pyrogen-free saline': 0.12964444,\n",
       "                                       'pressure-flow study': 0.0017013578,\n",
       "                                       'posterior fossa syndrome': 0.099367134,\n",
       "                                       'pressure flow study': 0.0017747888,\n",
       "                                       'primary fibromyalgia syndrome': 0.19592497,\n",
       "                                       'Piper Fatigue Scale': 0.16749898,\n",
       "                                       'patellofemoral syndrome': 0.0336619,\n",
       "                                       'Progression-free': 0.080549836,\n",
       "                                       'pulmonary function score': 0.17481242,\n",
       "                                       'pressure flow studies': 0.011399224,\n",
       "                                       'protein-free supernatant': 0.0961516,\n",
       "                                       'progression free survival': 0.21465616,\n",
       "                                       'protein free supernatant': 0.107307084,\n",
       "                                       'progression-free survival': 0.23308453,\n",
       "                                       'pressure/flow study': 0.012118832})}),\n",
       "             'ECOG > 1 and a life expectancy over 12 weeks are necessary to participate in the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.15947849,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.38119438,\n",
       "                                       'eastern cooperative oncology group': 0.38119438,\n",
       "                                       'Electrocochleography': 0.13006644,\n",
       "                                       'electrocochleogram': 0.13411461,\n",
       "                                       'electrocortical activity': 0.17526327,\n",
       "                                       'electrocorticograms': 0.17934483,\n",
       "                                       'electrocortical': 0.098929815})}),\n",
       "             'the secondary trial uses Clinical Benefit (CBR) as outcome measurement, which is different from Proportion of Participants With a Pathologic Complete Response Rate which is used for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CBR': defaultdict(float,\n",
       "                                      {'clinical benefit response': 0.58793205,\n",
       "                                       'cannabinoid receptor': 0.19773503,\n",
       "                                       'case-based reasoning': 0.07911027,\n",
       "                                       'central benzodiazepine receptor': 0.15187791,\n",
       "                                       'clinical benefit rate': 0.53515345,\n",
       "                                       'Case-Based Reasoning': 0.07911027,\n",
       "                                       'critical body residue': 0.16245855,\n",
       "                                       'central-type benzodiazepine receptor': 0.13540396,\n",
       "                                       'central benzodiazepine receptors': 0.12997018,\n",
       "                                       'community-based rehabilitation': 0.22735533,\n",
       "                                       'carotid baroreflex': 0.1466872,\n",
       "                                       'community based rehabilitation': 0.2565333,\n",
       "                                       'carbonyl reductase': 0.10326071,\n",
       "                                       'case based reasoning': 0.08960083,\n",
       "                                       'crude birth rate': 0.08291423,\n",
       "                                       'Clinical benefit response': 0.58793205})}),\n",
       "             'Japanese participants with an ECOG <=1 are eligible for the secondary trial and the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.16100462,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.21384302,\n",
       "                                       'eastern cooperative oncology group': 0.21384302,\n",
       "                                       'Electrocochleography': 0.10866061,\n",
       "                                       'electrocochleogram': 0.120114,\n",
       "                                       'electrocortical activity': 0.1871999,\n",
       "                                       'electrocorticograms': 0.1763922,\n",
       "                                       'electrocortical': 0.10159503})}),\n",
       "             'Abnormal LVEF, Pregnancy or lactating automatically eliminates patients from participating in the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'LVEF': defaultdict(float,\n",
       "                                      {'left-ventricular ejection fraction': 0.2628966,\n",
       "                                       'Left ventricular ejection fractions': 0.27346957,\n",
       "                                       'left ventricular function': 0.22200365,\n",
       "                                       'left ventricular ejection fraction': 0.2558043,\n",
       "                                       'left ventricle ejection fraction': 0.26392138,\n",
       "                                       'left-ventricle ejection fraction': 0.26457298,\n",
       "                                       'LV ejection fraction': 0.25957507})}),\n",
       "             'Participants of the primary trial must be older than 18, have histologically confirmed stage 3 or above breast cancer, ECOG<2 and a life expectancy exceeding 6 months.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.051334724,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.51014376,\n",
       "                                       'eastern cooperative oncology group': 0.51014376,\n",
       "                                       'Electrocochleography': 0.051124915,\n",
       "                                       'electrocochleogram': 0.038180325,\n",
       "                                       'electrocortical activity': 0.043266043,\n",
       "                                       'electrocorticograms': 0.07141506,\n",
       "                                       'electrocortical': 0.022677688})}),\n",
       "             'Patients with BUN < 20 mg/dL,  Platelet count: <90,000/mm3, Leukocyte count of 5,000/mm3 to 8,000/mm3 may be eligible for both the primary trial and the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'BUN': defaultdict(float,\n",
       "                                      {'Blood urea nitrogen concentration': 0.35604763,\n",
       "                                       'blood urea nitrogen': 0.29791647})}),\n",
       "             'A 75 year old female patient, with an ECOG of 1 and an estimated life expectancy of more than a year would be eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.13472168,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.4297206,\n",
       "                                       'eastern cooperative oncology group': 0.4297206,\n",
       "                                       'Electrocochleography': 0.13671367,\n",
       "                                       'electrocochleogram': 0.14175092,\n",
       "                                       'electrocortical activity': 0.097618856,\n",
       "                                       'electrocorticograms': 0.14249066,\n",
       "                                       'electrocortical': 0.06690308})}),\n",
       "             'In the primary trial The Percentage of Participants With Objective Response (OR) for the Afatinib Monotherapy was 13% lower than the Afatinib and Paclitaxel or Vinorelbine Combination Therapy group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'OR': defaultdict(float,\n",
       "                                      {'overall response': 0.30888608,\n",
       "                                       'objective response': 0.3539822,\n",
       "                                       'odds ratio': 0.3197995,\n",
       "                                       'open repair': 0.09160957,\n",
       "                                       'ovulation rate': 0.18463857,\n",
       "                                       'odds ration': 0.24799381,\n",
       "                                       'operating room': 0.06311358,\n",
       "                                       'oxido-reductase': 0.1645068,\n",
       "                                       'obesity-resistant': 0.06992151,\n",
       "                                       'ouabain-resistant': 0.22933836,\n",
       "                                       'objective responses': 0.29946998,\n",
       "                                       'orienting reflex': 0.07057523,\n",
       "                                       'operations research': 0.12503497,\n",
       "                                       'opioid receptor': 0.13981496,\n",
       "                                       'odds-ratio': 0.32161608,\n",
       "                                       'orienting response': 0.17316097,\n",
       "                                       'odorant receptor': 0.0549761,\n",
       "                                       'operating rooms': 0.056897722,\n",
       "                                       'oxidoreductase': 0.13435139,\n",
       "                                       'oestrogen receptor': 0.17311017,\n",
       "                                       'optic radiation': 0.06215138,\n",
       "                                       'oxido reductase': 0.16400602,\n",
       "                                       'optical rotation': 0.04707997,\n",
       "                                       'orthopedic research': 0.12291633,\n",
       "                                       'odds ratios': 0.3138466,\n",
       "                                       'oral rehydration': 0.062161546,\n",
       "                                       'operating-room': 0.08872368,\n",
       "                                       'olfactory receptor': 0.07307497,\n",
       "                                       'outflow resistance': 0.09690587,\n",
       "                                       'Oregon': 0.07269978,\n",
       "                                       'oestrogen-receptor': 0.16322932})}),\n",
       "             'INR equal to or above 1.5 is mandatory for participation in the primary trial, it is not necessary for the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'INR': defaultdict(float,\n",
       "                                      {'international normalised ratio': 0.2730904,\n",
       "                                       'insulin receptor': 0.1088647,\n",
       "                                       'initiator': 0.22043386,\n",
       "                                       'international normalized ratio': 0.25944695,\n",
       "                                       'international normalized ratios': 0.2594143,\n",
       "                                       'initiator element': 0.21473163,\n",
       "                                       'International Normalised Ratios': 0.27796093})}),\n",
       "             'IV is used as route of administration by the interventions in the primary trial and the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.14161427,\n",
       "                                       'intravenous injection': 0.54165494,\n",
       "                                       'iridovirus': 0.24987085,\n",
       "                                       'intra-venous': 0.45538256,\n",
       "                                       'invitro': 0.22447532,\n",
       "                                       'intra ventricular': 0.33361387,\n",
       "                                       'intra vascular': 0.42205343,\n",
       "                                       'in vivo': 0.33254302,\n",
       "                                       'intravascular': 0.41636074,\n",
       "                                       'in-vivo': 0.3995766,\n",
       "                                       'inter-vertebral': 0.28582567,\n",
       "                                       'ichthyosis vulgaris': 0.08760713,\n",
       "                                       'intravenous': 0.5163425,\n",
       "                                       'intravaginal': 0.34718415,\n",
       "                                       'invasive': 0.1104428,\n",
       "                                       'iridescent virus': 0.14904904,\n",
       "                                       'isometric virus': 0.16620494,\n",
       "                                       'intravenous feeding device': 0.41420397,\n",
       "                                       'invivo': 0.23919646,\n",
       "                                       'instrumental variable': 0.33965477,\n",
       "                                       'intraventricular': 0.27695477,\n",
       "                                       'intra-vaginal': 0.35630143,\n",
       "                                       'intravertebral': 0.2899326,\n",
       "                                       'in vitro': 0.27999204,\n",
       "                                       'interventricular': 0.27972814,\n",
       "                                       'in-vitro': 0.3509046,\n",
       "                                       'intra venous': 0.43383548,\n",
       "                                       'iodine value': 0.23255485,\n",
       "                                       'ichnovirus': 0.17816266,\n",
       "                                       'inter-ventricular': 0.3530064,\n",
       "                                       'intra-vertebral': 0.30723915,\n",
       "                                       'intravenous injection device': 0.5196288,\n",
       "                                       'intervertebral': 0.26463804,\n",
       "                                       'initial visit': 0.23539394,\n",
       "                                       'intravenous feeding': 0.41171992,\n",
       "                                       'intra-vascular': 0.45402747,\n",
       "                                       'intra-ventricular': 0.35667074})}),\n",
       "             'In order to be eligible for both the secondary trial and the primary trial, patients must be female, over the age of 18, ECOG <2 and have Histologically confirmed HER2 negative breast cancer.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.057425514,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.41146252,\n",
       "                                       'eastern cooperative oncology group': 0.41146252,\n",
       "                                       'Electrocochleography': 0.059435252,\n",
       "                                       'electrocochleogram': 0.062759705,\n",
       "                                       'electrocortical activity': 0.050279833,\n",
       "                                       'electrocorticograms': 0.07032157,\n",
       "                                       'electrocortical': 0.021921033}),\n",
       "                          'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.26289794,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.26992917,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.2702336,\n",
       "                                       'human epidermal growth factor receptor 2': 0.27332965,\n",
       "                                       'human epidermal growth factor receptor-2': 0.26992917})}),\n",
       "             'Patients with left-sided breast cancer and an ECOG of 3 are excluded from the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.10545243,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.39924076,\n",
       "                                       'eastern cooperative oncology group': 0.39924076,\n",
       "                                       'Electrocochleography': 0.14428622,\n",
       "                                       'electrocochleogram': 0.14079146,\n",
       "                                       'electrocortical activity': 0.054973826,\n",
       "                                       'electrocorticograms': 0.11559008,\n",
       "                                       'electrocortical': 0.086292826})}),\n",
       "             'Patients with radiologically confirmed metatases in the CNS are excluded from both the secondary trial and the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CNS': defaultdict(float,\n",
       "                                      {'central nerve system': 0.24371952,\n",
       "                                       'Congenital nephrotic syndrome': 0.1807575,\n",
       "                                       'Coagulase negative staphylococci': 0.10347224,\n",
       "                                       'Clinical nurse specialist': 0.10876352,\n",
       "                                       'coagulase negative staphylococcus': 0.098206155,\n",
       "                                       'coagulase-negative Staphylococcus': 0.110402584,\n",
       "                                       'central nerves system': 0.20789109,\n",
       "                                       'central-nervous-system': 0.22471358,\n",
       "                                       'congenital nephrotic syndrome': 0.1807575,\n",
       "                                       'central nervous system': 0.23649454,\n",
       "                                       'central nervous systems': 0.24293017,\n",
       "                                       'Crigler Najjar syndrome': 0.22375584,\n",
       "                                       'coagulase negative staph': 0.11177942,\n",
       "                                       'clinical nurse specialists': 0.13532797,\n",
       "                                       'Crigler-Najjar syndrome': 0.2534561,\n",
       "                                       'coagulase-negative staphylococci': 0.1103974,\n",
       "                                       'coagulase-negative staphylococcus': 0.110402584,\n",
       "                                       'central nervous': 0.23694533,\n",
       "                                       'clinical nurse specialist': 0.10876352,\n",
       "                                       'Canadian Neurological Scale': 0.33620784,\n",
       "                                       'coagulase-negative staphylococcal': 0.15004817,\n",
       "                                       'coagulase negative Staphylococcus': 0.098206155})}),\n",
       "             'Anna is a 57 year old female with an ECOG of 0, diagnosed with an invasive adenocarcinoma of the breast, IHC results were 1+. She is eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.07424667,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.5275402,\n",
       "                                       'eastern cooperative oncology group': 0.5275402,\n",
       "                                       'Electrocochleography': 0.15010732,\n",
       "                                       'electrocochleogram': 0.14531481,\n",
       "                                       'electrocortical activity': 0.025109863,\n",
       "                                       'electrocorticograms': 0.07589375,\n",
       "                                       'electrocortical': 0.047505524}),\n",
       "                          'IHC': defaultdict(float,\n",
       "                                      {'immunohisto-chemistry': 0.2658752,\n",
       "                                       'immuno histochemical': 0.25499174,\n",
       "                                       'intrahepatic cholestasis': 0.20253801,\n",
       "                                       'Idiopathic hypercalciuria': 0.17206451,\n",
       "                                       'immunohistochemical analysis': 0.27533722,\n",
       "                                       'immunohisto-chemical': 0.2586852,\n",
       "                                       'intra-hepatic cholestasis': 0.19263898,\n",
       "                                       'idiopathic haemochromatosis': 0.2929279,\n",
       "                                       'immuno-histochemistry': 0.2299701,\n",
       "                                       'immunohistochemistry': 0.27292517,\n",
       "                                       'induced hypertension chemotherapy': 0.25213262,\n",
       "                                       'idiopathic hemochromatosis': 0.284651,\n",
       "                                       'immunohisto chemical': 0.2635816,\n",
       "                                       'Intermountain Health Care': 0.32441974,\n",
       "                                       'Immunohistochemical staining': 0.24003887,\n",
       "                                       'immuno-histochemical': 0.24495316,\n",
       "                                       'idiopathic hæmochromatosis': 0.2728195,\n",
       "                                       'immuno histochemistry': 0.22370067,\n",
       "                                       'immunohisto chemistry': 0.2458867,\n",
       "                                       'immunohistochemically': 0.17351946,\n",
       "                                       'idiopathic hypercalciuria': 0.17206451,\n",
       "                                       'inner-hair cell': 0.09983051,\n",
       "                                       'inner hair cells': 0.082923,\n",
       "                                       'immunohistochemical': 0.22811793,\n",
       "                                       'inner hair cell': 0.08359757})}),\n",
       "             'In order to meet the inclusion criteria for the primary trial patients must have had ineffective aromatase inhibitor (AI) therapy before study entry, ': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'AI': defaultdict(float,\n",
       "                                      {'avidity index': 0.15641572,\n",
       "                                       'anaphylatoxin inactivator': 0.26834726,\n",
       "                                       'Apnoea Index': 0.23822524,\n",
       "                                       'anaphylatoxin inhibitor': 0.26867884,\n",
       "                                       'Axonal injury': 0.06942033,\n",
       "                                       'anal incontinence': 0.18233287,\n",
       "                                       'adrenal incidentalomas': 0.24524713,\n",
       "                                       'auto-immune': 0.11699744,\n",
       "                                       'accidental injury': 0.028821047,\n",
       "                                       'allergy and immunology': 0.24833848,\n",
       "                                       'apnoea index': 0.23822524,\n",
       "                                       'artificial insemination': 0.24252515,\n",
       "                                       'aluminum': 0.052745696,\n",
       "                                       'American Indian': 0.08467552,\n",
       "                                       'Apoptosis': 0.10260499,\n",
       "                                       'angiotensine-I': 0.23732652,\n",
       "                                       'American Indians': 0.07298713,\n",
       "                                       'after infection': 0.08169933,\n",
       "                                       'atrial insufficiency': 0.23894687,\n",
       "                                       'angiotensin-I': 0.21990849,\n",
       "                                       'angiogenesis inhibitor': 0.24365933,\n",
       "                                       'autoimmunity': 0.21526234,\n",
       "                                       'activity index': 0.0710375,\n",
       "                                       'asymmetry index': 0.07685347,\n",
       "                                       'androgen independent': 0.29979154,\n",
       "                                       'Astragalus Injection': 0.17284556,\n",
       "                                       'atherogenic index': 0.15737095,\n",
       "                                       'apoptosis index': 0.19348943,\n",
       "                                       'avian influenza': 0.037866052,\n",
       "                                       'anxiety index': 0.21230665,\n",
       "                                       'apnea index': 0.21598975,\n",
       "                                       'axioincisal': 0.08553109,\n",
       "                                       'autoimmune': 0.21919829,\n",
       "                                       'Artificial intelligence': 0.047599502,\n",
       "                                       'adiposity index': 0.18754685,\n",
       "                                       'association-induction': 0.1024976,\n",
       "                                       'angiotensine I': 0.22918749,\n",
       "                                       'Amelogenesis imperfecta': 0.22610371,\n",
       "                                       'artificial inseminations': 0.25696436,\n",
       "                                       'aromatase inhibitor': 0.6557546,\n",
       "                                       'acetabular index': 0.15233245,\n",
       "                                       'apoptotic index': 0.27559316,\n",
       "                                       'adrenal insufficiency': 0.31106806,\n",
       "                                       'apical impulse': 0.03984603,\n",
       "                                       'allelic imbalances': 0.2674952,\n",
       "                                       'aortic insufficiency': 0.23946016,\n",
       "                                       'auto-immunity': 0.11465794,\n",
       "                                       'artificially inseminated': 0.2670887,\n",
       "                                       'axio-incisal': 0.15524805,\n",
       "                                       'Apoptotic': 0.12433629,\n",
       "                                       'adequate intake': 0.17376128,\n",
       "                                       'anterior insula': 0.13701713,\n",
       "                                       'artificial intelligence': 0.047599502,\n",
       "                                       'anti-inflammatory': 0.23565249,\n",
       "                                       'aortic incompetence': 0.18698917,\n",
       "                                       'articulation index': 0.11790731,\n",
       "                                       'angiotensin I': 0.21181904,\n",
       "                                       'aromatase inhibitors': 0.63851726,\n",
       "                                       'angiotensine 1': 0.22290185,\n",
       "                                       'angiotensin-1': 0.19810104,\n",
       "                                       'angiotensine-1': 0.21642134,\n",
       "                                       'activity': -0.0353431,\n",
       "                                       'Adequate Intake': 0.17376128,\n",
       "                                       'anchorage-independent': 0.07817029,\n",
       "                                       'acute ileus': 0.073599555,\n",
       "                                       'apoptotic indices': 0.23103514,\n",
       "                                       'allelic imbalance': 0.28206667,\n",
       "                                       'Apnea Index': 0.21598975,\n",
       "                                       'active ingredient': 0.20351246,\n",
       "                                       'androgen-independent': 0.32505536,\n",
       "                                       'angiotensin 1': 0.19193117,\n",
       "                                       'aggregation index': 0.10086822})}),\n",
       "             'Patients must have Human epidermal growth factor receptor 2 (HER2) overexpressive tumors to participate in the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.57585853,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.5744714,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.5749281,\n",
       "                                       'human epidermal growth factor receptor 2': 0.56926465,\n",
       "                                       'human epidermal growth factor receptor-2': 0.5744714})}),\n",
       "             'Patients with stage I, II, III or IV triple negative breast cancer are not eliglbe for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'II': defaultdict(float,\n",
       "                                      {'image intensifier': -0.022255547,\n",
       "                                       'icterus index': 0.09300652}),\n",
       "                          'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': -0.01012018,\n",
       "                                       'intravenous injection': 0.12143685,\n",
       "                                       'iridovirus': 0.028350934,\n",
       "                                       'intra-venous': 0.06821232,\n",
       "                                       'invitro': -0.052921697,\n",
       "                                       'intra ventricular': 0.056674078,\n",
       "                                       'intra vascular': 0.04867388,\n",
       "                                       'in vivo': 0.12954804,\n",
       "                                       'intravascular': 0.08041639,\n",
       "                                       'in-vivo': 0.16332848,\n",
       "                                       'inter-vertebral': 0.004280376,\n",
       "                                       'ichthyosis vulgaris': 0.05812917,\n",
       "                                       'intravenous': 0.12933525,\n",
       "                                       'intravaginal': 0.07272623,\n",
       "                                       'invasive': 0.064841606,\n",
       "                                       'iridescent virus': 0.0002549235,\n",
       "                                       'isometric virus': -0.049726296,\n",
       "                                       'intravenous feeding device': 0.06849841,\n",
       "                                       'invivo': -0.013072093,\n",
       "                                       'instrumental variable': 0.06525976,\n",
       "                                       'intraventricular': 0.035296593,\n",
       "                                       'intra-vaginal': 0.0704563,\n",
       "                                       'intravertebral': 0.046016824,\n",
       "                                       'in vitro': 0.06499306,\n",
       "                                       'interventricular': 0.042455867,\n",
       "                                       'in-vitro': 0.0978522,\n",
       "                                       'intra venous': 0.051222265,\n",
       "                                       'iodine value': -0.013260611,\n",
       "                                       'ichnovirus': -0.029356401,\n",
       "                                       'inter-ventricular': 0.049143776,\n",
       "                                       'intra-vertebral': 0.008098763,\n",
       "                                       'intravenous injection device': 0.07598783,\n",
       "                                       'intervertebral': 0.05449442,\n",
       "                                       'initial visit': 0.055739444,\n",
       "                                       'intravenous feeding': 0.099541634,\n",
       "                                       'intra-vascular': 0.07728596,\n",
       "                                       'intra-ventricular': 0.058449544})}),\n",
       "             'ECOG < 2 and a life expectancy over 12 weeks are necessary to participate in the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.14473583,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.3729152,\n",
       "                                       'eastern cooperative oncology group': 0.3729152,\n",
       "                                       'Electrocochleography': 0.11440739,\n",
       "                                       'electrocochleogram': 0.11791042,\n",
       "                                       'electrocortical activity': 0.16162844,\n",
       "                                       'electrocorticograms': 0.16508296,\n",
       "                                       'electrocortical': 0.084695965})}),\n",
       "             'Adult Patients with histologic confirmation of invasive bilateral breast carcinoma (T3 N1 M0) are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'T3': defaultdict(float,\n",
       "                                      {'tri-iodothyronine': 0.123364136,\n",
       "                                       'triiodothyronine': 0.0966738,\n",
       "                                       'type 3': 0.15353599,\n",
       "                                       'tumor size 3': 0.39557606,\n",
       "                                       'triidothyronine': 0.07164337,\n",
       "                                       'triiodothyroxine': 0.08991205,\n",
       "                                       'triodothyronine': 0.1263522,\n",
       "                                       \"thyroid hormone 3,3',5-triiodo-L-thyronine\": 0.10086156,\n",
       "                                       'treatment': 0.07266687,\n",
       "                                       'triiodo-thyronine': 0.080847256,\n",
       "                                       'total T3': 0.18878303,\n",
       "                                       'thoracic 3': 0.17649053,\n",
       "                                       'tri-iodothyronin': 0.1273205,\n",
       "                                       'tylenol #3': 0.000755109,\n",
       "                                       'Thyroid hormone': 0.028859459,\n",
       "                                       'thoracic vertebra 3': 0.17624828,\n",
       "                                       'total 3 children': 0.072960876,\n",
       "                                       'Type 3': 0.15353599,\n",
       "                                       'triiodothyronin': 0.09822223,\n",
       "                                       'third thoracic vertebra': 0.16838379}),\n",
       "                          'N1': defaultdict(float,\n",
       "                                      {'negativity': -0.048643142,\n",
       "                                       'negative wave': -0.03853046,\n",
       "                                       'negative peak': 0.047394246,\n",
       "                                       'negative': 0.045279264,\n",
       "                                       'negative component': -0.03625657}),\n",
       "                          'M0': defaultdict(float,\n",
       "                                      {'metastasis': 0.23713182})}),\n",
       "             'Patients with Scoliosis with a Cobb angle exceeding 20 degrees at the lumbar spine, or with a prior surgery at the lumbosacral spine are excluded from the primary trial, as these would interfere with the necessary CT and MRI scans for the study.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CT': defaultdict(float,\n",
       "                                      {'condensed tannin': -0.06858526,\n",
       "                                       'crista terminalis': 0.22104993,\n",
       "                                       'chlamydia': 0.06673297,\n",
       "                                       'chronic tonsillitis': 0.11149052,\n",
       "                                       'computed-tomographic': 0.18275689,\n",
       "                                       'computed tomogram': 0.18919276,\n",
       "                                       'coal-tar': 0.057089362,\n",
       "                                       'calf thymus': 0.06474542,\n",
       "                                       'curly tail': 0.043170393,\n",
       "                                       'condensed tannins': -0.05448762,\n",
       "                                       'computerised tomograph': 0.15448755,\n",
       "                                       'counter-transference': 0.041905317,\n",
       "                                       'cardiothoracic': 0.17146052,\n",
       "                                       'choroidal thickness': 0.17135833,\n",
       "                                       'core temperature': 0.055060953,\n",
       "                                       'collecting tubule': 0.05659477,\n",
       "                                       'C-terminal': 0.0013219063,\n",
       "                                       'cytotrophoblast': 0.06341149,\n",
       "                                       'cytoplasmic domain': -0.012699369,\n",
       "                                       'chest tube': 0.103619725,\n",
       "                                       'computerised tomographic': 0.16922238,\n",
       "                                       'clotting time': 0.0037580486,\n",
       "                                       'carbon tetra-chloride': 0.017937701,\n",
       "                                       'charge transport': -0.09352578,\n",
       "                                       'chemo-therapy': 0.108525954,\n",
       "                                       'circadian times': 0.0036572758,\n",
       "                                       'cytidylyl-transferase': 0.033831395,\n",
       "                                       'charge transfer': -0.06659238,\n",
       "                                       'cognitive therapy': 0.077342354,\n",
       "                                       'computertomography': 0.16102333,\n",
       "                                       'celiac trunc': 0.21051529,\n",
       "                                       'computerised tomography': 0.19554296,\n",
       "                                       'chronic thyroiditis': 0.09885731,\n",
       "                                       'crico-thyroid': 0.20423557,\n",
       "                                       'carbon tetra chloride': 0.018340884,\n",
       "                                       'contraction time': 0.08233613,\n",
       "                                       'Cardiac transplantation': 0.11883904,\n",
       "                                       'clinical trial': 0.30231425,\n",
       "                                       'central tendon': 0.22168444,\n",
       "                                       'cortical thickness': 0.17193982,\n",
       "                                       'conventional tillage': 0.03780841,\n",
       "                                       'carboxylterminus': 0.03946635,\n",
       "                                       'catalase': -0.0020357613,\n",
       "                                       'circadian time': 0.009165734,\n",
       "                                       'concentration': -0.005878577,\n",
       "                                       'conservative treatment': 0.18148385,\n",
       "                                       'CTP': 0.08974329,\n",
       "                                       'corneal thickness': 0.081538744,\n",
       "                                       'critical thinking': 0.022241473,\n",
       "                                       'celiac trunk': 0.2898207,\n",
       "                                       'charge-transfer': -0.06622108,\n",
       "                                       'cytoplasmic tail': 0.030683775,\n",
       "                                       'countertransference': 0.0898931,\n",
       "                                       'computed tomographies': 0.25638244,\n",
       "                                       'code treatment time': 0.1113953,\n",
       "                                       'cellulose-triacetate': 0.057306956,\n",
       "                                       'conventional treatment': 0.15665862,\n",
       "                                       'corticothalamic': 0.16091214,\n",
       "                                       'carcinoid tumor': 0.10588414,\n",
       "                                       'coeliac trunk': 0.29433393,\n",
       "                                       'chloramine-T': 0.09743437,\n",
       "                                       'carbontetrachloride': 0.088063076,\n",
       "                                       'cricothyroid muscle': 0.20118985,\n",
       "                                       'cerebral toxoplasmosis': 0.07687713,\n",
       "                                       'computerized tomography': 0.17500922,\n",
       "                                       'cervicothoracic': 0.31147894,\n",
       "                                       'computed tomography scan': 0.27252224,\n",
       "                                       'carboxyl-terminus': 0.04902413,\n",
       "                                       'Computer-Tomography': 0.14425938,\n",
       "                                       'corticotectal': 0.14986573,\n",
       "                                       'computerised tomogram': 0.112133704,\n",
       "                                       'computerized tomographic': 0.15603676,\n",
       "                                       'chemotherapy': 0.11249327,\n",
       "                                       'Cholera enterotoxin': 0.014128095,\n",
       "                                       'Catalase': -0.0020357613,\n",
       "                                       'carbon tetrachloride': 0.07132025,\n",
       "                                       'choleratoxin': 0.046759028,\n",
       "                                       'computed tomography': 0.24155189,\n",
       "                                       'cholera toxin': 0.054933827,\n",
       "                                       'chorda tympani': 0.059186608,\n",
       "                                       'carcinoid tumour': 0.064873055,\n",
       "                                       'conventional therapy': 0.13336757,\n",
       "                                       'cold test': 0.10771927,\n",
       "                                       'cortico-thalamic': 0.10509202,\n",
       "                                       'conditioning-test': 0.083283335,\n",
       "                                       'chorda tympani nerve': 0.17269872,\n",
       "                                       'computed tomographic scans': 0.3006092,\n",
       "                                       'cyto-toxic': 0.0797214,\n",
       "                                       'cardio-thoracic': 0.27373293,\n",
       "                                       'calcitonin': 0.098955944,\n",
       "                                       'chloramine T': 0.09239443,\n",
       "                                       'cycle threshold': 0.060440272,\n",
       "                                       'cytotoxic': 0.11426573,\n",
       "                                       'carboxyl terminal': 0.04249134,\n",
       "                                       'coeliac trunc': 0.20284611,\n",
       "                                       'closure time': -0.0051914593,\n",
       "                                       'cancer/testis': 0.108810864,\n",
       "                                       'connective tissue': 0.17328618,\n",
       "                                       'cellulose triacetate': 0.06915441,\n",
       "                                       'Computed-tomography': 0.2177939,\n",
       "                                       'control': -0.07868355,\n",
       "                                       'computerized tomogram': 0.098381236,\n",
       "                                       'counseling and testing': 0.18975578,\n",
       "                                       'carboxyl-terminal': 0.04588366,\n",
       "                                       'cricothyroid': 0.1957522,\n",
       "                                       'Cerebral toxoplasmosis': 0.07687713,\n",
       "                                       'computed-tomography': 0.2177939,\n",
       "                                       'chest-tube': 0.13863192,\n",
       "                                       'carboxyl terminus': 0.042438213,\n",
       "                                       'counter-transport': 0.0654177,\n",
       "                                       'cancer-testis': 0.086965986,\n",
       "                                       'countertransport': 0.04653003,\n",
       "                                       'corticosterone': 0.13978109,\n",
       "                                       'compliance': 0.02456699,\n",
       "                                       'Computed tomographic scanning': 0.22106197,\n",
       "                                       'Connecticut': 0.03410632,\n",
       "                                       'computed tomography scans': 0.30414823,\n",
       "                                       'cardiac transplantation': 0.11883904,\n",
       "                                       'computed tomography scanning': 0.24314885,\n",
       "                                       'computed tomograpy': 0.29093122,\n",
       "                                       'computed tomograph': 0.19084707,\n",
       "                                       'coal tar': 0.046846326,\n",
       "                                       'chloramin-T': 0.11264156,\n",
       "                                       'Computed tomographic scan': 0.2688942,\n",
       "                                       'computerized tomograms': 0.109401375,\n",
       "                                       'control group': 0.07748369,\n",
       "                                       'chymotrypsin': 0.019607252,\n",
       "                                       'carboxylterminal': 0.08348111,\n",
       "                                       'congenital Toxoplasmosis': 0.08991351,\n",
       "                                       'cellulose-tri-acetate': 0.074461594,\n",
       "                                       'Computed tomograms': 0.21936879,\n",
       "                                       'conduction time': -0.06854949,\n",
       "                                       'computerized tomograph': 0.13866493,\n",
       "                                       'Chlamydia trachomatis': 0.039368447,\n",
       "                                       'congenital toxoplasmosis': 0.08991351,\n",
       "                                       'cytidylyltransferase': 0.09386014,\n",
       "                                       'cardiac tamponade': 0.034578234,\n",
       "                                       'Category Test': 0.1019269,\n",
       "                                       'chloramin T': 0.092303045,\n",
       "                                       'cortico-tectal': 0.1164821,\n",
       "                                       'cancer testis': 0.066951744,\n",
       "                                       'connective-tissue': 0.15544996,\n",
       "                                       'computed tomographic': 0.20725957,\n",
       "                                       'carbon-tetrachloride': 0.057091095}),\n",
       "                          'MRI': defaultdict(float,\n",
       "                                      {'magnetic-resonance imaging': 0.18001807,\n",
       "                                       'MR-imaging': 0.22390835,\n",
       "                                       'magnetic resonance imaging': 0.19790451,\n",
       "                                       'magnetic resonance images': 0.15917993,\n",
       "                                       'magnetic resonance': 0.043109845,\n",
       "                                       'Magnetic resonance imagings': 0.23365337,\n",
       "                                       'magnet resonance imaging': 0.17195907,\n",
       "                                       'MR imaging': 0.24156678,\n",
       "                                       'magnetic-resonance-imaging': 0.15084678,\n",
       "                                       'magnetic resonance imagery': 0.08815324,\n",
       "                                       'Magnetic resonance imaging scan': 0.24455985,\n",
       "                                       'magnetic resonance tomography': 0.18793535,\n",
       "                                       'magnetic resonance image': 0.09838783,\n",
       "                                       'Magnetic resonance image': 0.09838783})}),\n",
       "             'Patients with T1N1M0, T2N1M0, T3N1M0 and TxN1M0 tumors are eliglbe for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'T1N1M0': defaultdict(float,\n",
       "                                      {'tumor-1, node-1, metastasis-0': 0.4813976}),\n",
       "                          'T2N1M0': defaultdict(float,\n",
       "                                      {'tumor-2, node-1, metastasis-0': 0.4876341}),\n",
       "                          'T3N1M0': defaultdict(float,\n",
       "                                      {'tumor 3, node 1, metastasis 0': 0.51821065})}),\n",
       "             'T4 N3 M0 adenocarcinoma of the breast are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'T4': defaultdict(float,\n",
       "                                      {'tetraiodothyronine': 0.15570825,\n",
       "                                       'thyroxin': 0.11816006,\n",
       "                                       'thyroxine': 0.13266717,\n",
       "                                       'thyroid hormone': 0.06617887,\n",
       "                                       't4 (fourth thoracic vertebra)': 0.3075435,\n",
       "                                       'T helper cells': 0.20410684,\n",
       "                                       'thyroxine level': 0.14275423,\n",
       "                                       'tripchlorolide': 0.05509717,\n",
       "                                       'tumor': 0.37592036,\n",
       "                                       'thoracic vertebra 4': 0.20113245,\n",
       "                                       'time 4': 0.12489123,\n",
       "                                       'T helper': 0.16286302}),\n",
       "                          'M0': defaultdict(float,\n",
       "                                      {'metastasis': 0.31153962})}),\n",
       "             'The Single IV Infusion of ZA 4 mg group of the primary trial had a smaller Percentage Change From Baseline in Urinary N-telopeptide of Type I Collagen than the Odanacatib 5 mg group': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.118339285,\n",
       "                                       'intravenous injection': 0.2871313,\n",
       "                                       'iridovirus': 0.07246038,\n",
       "                                       'intra-venous': 0.20530578,\n",
       "                                       'invitro': 0.043333296,\n",
       "                                       'intra ventricular': 0.038257897,\n",
       "                                       'intra vascular': 0.19603282,\n",
       "                                       'in vivo': 0.22038795,\n",
       "                                       'intravascular': 0.22244,\n",
       "                                       'in-vivo': 0.2603231,\n",
       "                                       'inter-vertebral': 0.18370767,\n",
       "                                       'ichthyosis vulgaris': 0.11310315,\n",
       "                                       'intravenous': 0.2387254,\n",
       "                                       'intravaginal': 0.09074424,\n",
       "                                       'invasive': 0.03053337,\n",
       "                                       'iridescent virus': 0.005287962,\n",
       "                                       'isometric virus': 0.010302722,\n",
       "                                       'intravenous feeding device': 0.14280592,\n",
       "                                       'invivo': -0.009766024,\n",
       "                                       'instrumental variable': -0.019888528,\n",
       "                                       'intraventricular': 0.027531732,\n",
       "                                       'intra-vaginal': 0.10542038,\n",
       "                                       'intravertebral': 0.08321656,\n",
       "                                       'in vitro': 0.14352657,\n",
       "                                       'interventricular': -0.0037507548,\n",
       "                                       'in-vitro': 0.21026587,\n",
       "                                       'intra venous': 0.18869749,\n",
       "                                       'iodine value': 0.2165979,\n",
       "                                       'ichnovirus': 0.055828027,\n",
       "                                       'inter-ventricular': 0.032654993,\n",
       "                                       'intra-vertebral': 0.21102107,\n",
       "                                       'intravenous injection device': 0.24235855,\n",
       "                                       'intervertebral': 0.07782395,\n",
       "                                       'initial visit': 0.07119593,\n",
       "                                       'intravenous feeding': 0.1619468,\n",
       "                                       'intra-vascular': 0.21108782,\n",
       "                                       'intra-ventricular': 0.067756005}),\n",
       "                          'ZA': defaultdict(float,\n",
       "                                      {'zeolite A': 0.18322638,\n",
       "                                       'zonula adhaerens': 0.07179788,\n",
       "                                       'zygapophyseal': 0.14084785,\n",
       "                                       'zonula adherens': 0.28070456,\n",
       "                                       'zinc adequate': 0.22521141,\n",
       "                                       'zinc acetate': 0.29758346,\n",
       "                                       'zinc-adequate': 0.22101411,\n",
       "                                       'zoledronic acid': 0.36451566,\n",
       "                                       'zygapophysial': 0.17204425})}),\n",
       "             'the secondary trial uses Overall Survival (OS) as outcome measurement, which is different from Proportion of Participants With a Pathologic Complete Response Rate which is used for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'OS': defaultdict(float,\n",
       "                                      {'oculus sinister': 0.05790533,\n",
       "                                       'opposite-sex': 0.0252656,\n",
       "                                       'open surgery': 0.107943445,\n",
       "                                       'over-shoot': 0.0080710435,\n",
       "                                       'oxi-dative stress': 0.079516776,\n",
       "                                       'oligosaccharides': 0.06063727,\n",
       "                                       'orthopedic surgery': 0.15546462,\n",
       "                                       'overshoot': 0.041634116,\n",
       "                                       'open splenectomy': 0.1524459,\n",
       "                                       'ovarian stimulation': 0.14278564,\n",
       "                                       'over shoot': 0.03972051,\n",
       "                                       'obese strain': 0.034846,\n",
       "                                       'Opitz syndrome': 0.23249114,\n",
       "                                       'outer segments': 0.07812088,\n",
       "                                       'ouabain-sensitive': 0.110822566,\n",
       "                                       'osteosarcoma': 0.26740342,\n",
       "                                       'oxidative stress': 0.1225847,\n",
       "                                       'overall survival time': 0.37198806,\n",
       "                                       'osteosarcomas': 0.2536096,\n",
       "                                       'oculus sinister (left eye)': 0.06963658,\n",
       "                                       'overlap syndrome': 0.1279585,\n",
       "                                       'outer segment': 0.0794951,\n",
       "                                       'oligomycin-sensitive': 0.1272778,\n",
       "                                       'oxidative-stress': 0.1521811,\n",
       "                                       'oral secretion': -0.00859298,\n",
       "                                       'oligosaccharide': 0.06544731,\n",
       "                                       'overall survival rate': 0.5153341,\n",
       "                                       'Omenn syndrome': 0.12622446,\n",
       "                                       'osteogenic sarcoma': 0.24208003,\n",
       "                                       \"Omenn's syndrome\": 0.14262238,\n",
       "                                       'one-step': -0.013045592,\n",
       "                                       'oligo-saccharide': 0.06687052,\n",
       "                                       'Ocimum sanctum': 0.09592923,\n",
       "                                       'overall survival': 0.3736712,\n",
       "                                       'One-Step': -0.013045592,\n",
       "                                       'oxydative stress': 0.14983128})}),\n",
       "             'the primary trial uses a set dosage of 1000 mg PO daily of Lapatinib, whereas the dose of Capecitabine changes with Body surface area.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.14327279,\n",
       "                                       'parietal operculum': 0.07553725,\n",
       "                                       'post office': -0.029779512,\n",
       "                                       'percentage of observed value': 0.18352766,\n",
       "                                       'Phenol oxidase': 0.021014275,\n",
       "                                       'parapineal organ': 0.11190101,\n",
       "                                       'power output': 0.032405153,\n",
       "                                       'predominant organism': 0.06519862,\n",
       "                                       'pulse-oximetry': 0.13875303,\n",
       "                                       'perceptual organisation': -0.004270168,\n",
       "                                       'power outputs': -0.034334343,\n",
       "                                       'Personality Organization': -0.059395365,\n",
       "                                       'postoperative': 0.10524053,\n",
       "                                       'parieto occipital': 0.06650887,\n",
       "                                       'polyolefin': 0.105655745,\n",
       "                                       'parietooccipital': 0.057176616,\n",
       "                                       'poly-olefin': 0.067146525,\n",
       "                                       'peroral': 0.06960208,\n",
       "                                       'prostate only': 0.07756752,\n",
       "                                       'pressure overload': 0.0048532225,\n",
       "                                       'peroxidase': 0.04745678,\n",
       "                                       'principal olive': 0.067157194,\n",
       "                                       'peri-operative': 0.098328084,\n",
       "                                       'posterior': 0.09563051,\n",
       "                                       'Perceptual Organization': -0.011529003,\n",
       "                                       'period of onset': 0.14898641,\n",
       "                                       'posterior nuclear group': 0.018699802,\n",
       "                                       'phenol oxidase': 0.021014275,\n",
       "                                       'pressure': -0.05218745,\n",
       "                                       'per os (by mouth)': 0.19396351,\n",
       "                                       'parieto-occipital': 0.062423643,\n",
       "                                       'preoptic area': 0.10008594,\n",
       "                                       'perceptual organization': -0.011529003,\n",
       "                                       'prophylactic oophorectomy': 0.071272075,\n",
       "                                       'phosphodiester': 0.060167372,\n",
       "                                       'pre-ovulatory': 0.10060021,\n",
       "                                       'palm oil': 0.0383481,\n",
       "                                       'preovulatory': 0.17681293,\n",
       "                                       'perioperative': 0.14577308,\n",
       "                                       'post operative': 0.068329744,\n",
       "                                       'post-operative': 0.103411116,\n",
       "                                       'phospho-diester': 0.0010783467,\n",
       "                                       'protein oxidation': -0.0049818372,\n",
       "                                       'palm-oil': 0.0051648677,\n",
       "                                       'per os': 0.1659307,\n",
       "                                       'pericardial organ': 0.08449821,\n",
       "                                       'Pulse oximetry': 0.14327279,\n",
       "                                       'paraoxon': 0.1762859,\n",
       "                                       'propylene oxide': 0.101704,\n",
       "                                       'phenoloxidase': 0.0749299,\n",
       "                                       'peanut oil': 0.034436014})}),\n",
       "             'the percentage of participants achieving complete response (CR) or partial response (PR) was much lower in the HER2-positive group in the primary trial,than in the ER+ and/or PR+ group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.08109743,\n",
       "                                       'clot retraction': 0.103964336,\n",
       "                                       'conditioned response': 0.2262459,\n",
       "                                       'conditioned reflex': 0.13780154,\n",
       "                                       'charge recombination': 0.057083413,\n",
       "                                       'Czech Republic': -0.014163038,\n",
       "                                       'control region': 0.059331805,\n",
       "                                       'colonization rate': 0.08435854,\n",
       "                                       'complete remission rate': 0.4594465,\n",
       "                                       'Charles River': -0.050314642,\n",
       "                                       'Caloric restriction': 0.040088717,\n",
       "                                       'colonisation resistance': 0.08437426,\n",
       "                                       'complete regression': 0.12550734,\n",
       "                                       'conversion rate': 0.1332767,\n",
       "                                       'chest roentgenography': 0.14387815,\n",
       "                                       'chest radiograph': 0.12645915,\n",
       "                                       'colony reared': -0.010346108,\n",
       "                                       'cardiorespiratory': 0.1256174,\n",
       "                                       'circadian rhythm': 0.09428813,\n",
       "                                       'cardiac rupture': 0.10839092,\n",
       "                                       'carbonyl reductase': 0.105010554,\n",
       "                                       'calorie restriction': -0.008953045,\n",
       "                                       'cortical reaction': 0.19423181,\n",
       "                                       'complete remissions': 0.36572856,\n",
       "                                       'chest radiography': 0.099747896,\n",
       "                                       'computerised record': 0.008954476,\n",
       "                                       'charge-recombination': 0.0663928,\n",
       "                                       'Cardiac Rehabilitation': 0.17253204,\n",
       "                                       'calcium-binding protein calretinin': 0.1392441,\n",
       "                                       'chronic rejection': 0.16631271,\n",
       "                                       'colony-reared': 0.0011777895,\n",
       "                                       'cognitive reserve': 0.17857908,\n",
       "                                       'critical ratio': 0.17963801,\n",
       "                                       'cortico-resistant': 0.28086087,\n",
       "                                       'caloric restriction': 0.040088717,\n",
       "                                       'corticoresistant': 0.08880803,\n",
       "                                       'corticosteroid-resistant': 0.24221739,\n",
       "                                       'Congo red': -0.004065193,\n",
       "                                       'complete responses': 0.28607565,\n",
       "                                       'chest and right arm': 0.11670983,\n",
       "                                       'conditioned reinforcement': 0.06252906,\n",
       "                                       'constant routine': 0.004697234,\n",
       "                                       'cardio-respiratory': 0.18050496,\n",
       "                                       'complete response rate': 0.43240184,\n",
       "                                       'cockroach': -0.06478868,\n",
       "                                       'chief resident': -0.037964087,\n",
       "                                       'calorie-restricted': 0.0014134113,\n",
       "                                       'complete responders': 0.3060487,\n",
       "                                       'cysteine-rich': 0.10022107,\n",
       "                                       'controlled-release': 0.053437732,\n",
       "                                       'chemoradiation': 0.03641853,\n",
       "                                       'crown-rump': -0.056346234,\n",
       "                                       'crown-rump length': 0.016167255,\n",
       "                                       'creatinine': 0.1685316,\n",
       "                                       'capture-recapture': 0.06497066,\n",
       "                                       'Congo-red': 0.013694018,\n",
       "                                       'coefficient of repeatability': 0.20010298,\n",
       "                                       'computed radiography': 0.066773005,\n",
       "                                       'controlled respiration': 0.110903114,\n",
       "                                       'conditioned reward': 0.09387294,\n",
       "                                       'complement receptors': 0.33649373,\n",
       "                                       'concentration-response': 0.2097272,\n",
       "                                       'complete': 0.06274653,\n",
       "                                       'chest roentgenogram': 0.15782183,\n",
       "                                       'complement receptor': 0.33066618,\n",
       "                                       'Cajal-Retzius': 0.020070476,\n",
       "                                       'cremasteric reflex': 0.25223494,\n",
       "                                       'clot-retraction': 0.087190405,\n",
       "                                       'conserved regions': 0.019191818,\n",
       "                                       'child-resistant': -0.030889763,\n",
       "                                       'control rats': 0.027053226,\n",
       "                                       'caries-resistant': 0.036475234,\n",
       "                                       'coronary revascularization': 0.21489117,\n",
       "                                       'colon resection': 0.052534565,\n",
       "                                       'contrast ratio': 0.13746715,\n",
       "                                       'concentration ratio': 0.16096897,\n",
       "                                       'Calreticulin': 0.0839295,\n",
       "                                       'composite resin': -0.02748786,\n",
       "                                       'completely': 0.118684575,\n",
       "                                       'colorectal': 0.09599097,\n",
       "                                       'complete response': 0.27054918,\n",
       "                                       'coronary risk': 0.18381527,\n",
       "                                       'conventional radiology': 0.14701377,\n",
       "                                       'Complete response': 0.27054918,\n",
       "                                       'cathode ray': -0.027208628,\n",
       "                                       'complete responder': 0.29308775,\n",
       "                                       'controlled release': 0.016887205,\n",
       "                                       'conditioned reflexes': 0.17425412,\n",
       "                                       'chemo-radiation': 0.27216884,\n",
       "                                       'complete remission': 0.30614483,\n",
       "                                       'conserved region': 0.0025271697,\n",
       "                                       'coronary resistance': 0.24521726,\n",
       "                                       'cardiac resuscitation': 0.094464555,\n",
       "                                       'computed radiographic': 0.091451384,\n",
       "                                       'cooling rate': -0.017374905,\n",
       "                                       'clinical research': 0.33369446,\n",
       "                                       'colonization resistance': 0.054548167,\n",
       "                                       'compression ratio': 0.056454908,\n",
       "                                       'computerized record': 0.006319456,\n",
       "                                       'chromium': 0.0306668,\n",
       "                                       'colo-rectal': 0.08056692,\n",
       "                                       'contractile reserve': 0.051704872,\n",
       "                                       'clinical record': 0.2027039,\n",
       "                                       'concentration ratios': 0.1644041,\n",
       "                                       'clinical remission': 0.39515162,\n",
       "                                       'centric relation': 0.0066436385,\n",
       "                                       'cardiac rhythm': 0.10579541,\n",
       "                                       'capillary refill': 0.017824983,\n",
       "                                       'colonisation rate': 0.085216485,\n",
       "                                       'conventional radiography': 0.082868464,\n",
       "                                       'cellular receptor': 0.18297109}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.16060497,\n",
       "                                       'plaque reduction': 0.039544333,\n",
       "                                       'partial response': 0.39766967,\n",
       "                                       'photoreactivation': 0.062989384,\n",
       "                                       'pentoxyresorufin': 0.039615437,\n",
       "                                       'panoramic radiography': 0.03725561,\n",
       "                                       'proliferative retinopathy': 0.16705383,\n",
       "                                       'partial responses': 0.39834613,\n",
       "                                       'protein': 0.04019707,\n",
       "                                       'prorennin': 0.11588786,\n",
       "                                       'prevalence rate': 0.23069602,\n",
       "                                       'prealbumin': 0.028586045,\n",
       "                                       'pregnancy rates': 0.09091244,\n",
       "                                       'pain relief': 0.044320945,\n",
       "                                       'partial remissions': 0.47294584,\n",
       "                                       'pattern recognition': -0.05973815,\n",
       "                                       'photo-reactivation': 0.08030922,\n",
       "                                       'protein restriction': 0.1406085,\n",
       "                                       'progesterone receptor': 0.23409428,\n",
       "                                       'placental restriction': 0.1692064,\n",
       "                                       'pneumatic retinopexy': 0.1470118,\n",
       "                                       'prorenin': 0.17446992,\n",
       "                                       'perirhinal cortex': 0.15135537,\n",
       "                                       'prothrombin ratio': 0.27595276,\n",
       "                                       'pars recta': 0.0641888,\n",
       "                                       'pattern reversal': 0.04698979,\n",
       "                                       'pr interval (ekg)': 0.2462443,\n",
       "                                       'pityriasis rosea': 0.038015902,\n",
       "                                       'prevalence ratio': 0.2748321,\n",
       "                                       'Projection reconstruction': -0.054591265,\n",
       "                                       'pregnancy rate': 0.10872075,\n",
       "                                       'phenol red': 0.06913788,\n",
       "                                       'photoreceptor': 0.031283565,\n",
       "                                       'prednisolon': 0.15779229,\n",
       "                                       'partial responders': 0.39160544,\n",
       "                                       'proline-rich': 0.02880755,\n",
       "                                       'pseudorabies': 0.097972944,\n",
       "                                       'pulmonary regurgitation': 0.14095022,\n",
       "                                       'projection reconstruction': -0.054591265,\n",
       "                                       'photo-receptor': 0.1204207,\n",
       "                                       'protease': 0.15079871,\n",
       "                                       'progestine': 0.102815986,\n",
       "                                       'pentoxy-resorufin': 0.061397884,\n",
       "                                       'partial remission': 0.41560772,\n",
       "                                       'progestin receptor': 0.19927259,\n",
       "                                       'per rectum': 0.07406628,\n",
       "                                       'Plain radiography': 0.06524676,\n",
       "                                       'production rate': 0.08986492,\n",
       "                                       'pulmonary rehabilitation': 0.17928807,\n",
       "                                       'pentoxy resorufin': 0.07626,\n",
       "                                       'proteinase': 0.09892106,\n",
       "                                       'Paeoniae radix': 0.12910177,\n",
       "                                       'Puerto Rico': 0.045196142,\n",
       "                                       'Prevalence ratios': 0.28211853,\n",
       "                                       'perirenal': 0.0073921187,\n",
       "                                       'passive recovery': 0.12674896,\n",
       "                                       'propranolol': 0.060238272,\n",
       "                                       'primary response': 0.3551384,\n",
       "                                       'pregnant': 0.013219895,\n",
       "                                       'partial regression': 0.18032151,\n",
       "                                       'Photoreactivation': 0.062989384,\n",
       "                                       'peripheral resistance': 0.2259322,\n",
       "                                       'polymorphic reticulosis': 0.16557805,\n",
       "                                       'progressive ratio': 0.15497747,\n",
       "                                       'partial responder': 0.3476016,\n",
       "                                       'projection-reconstruction': 0.001006577,\n",
       "                                       'pro-renin': 0.15796804,\n",
       "                                       'phenol-red': 0.08932488,\n",
       "                                       'progestin': 0.11033861,\n",
       "                                       'pro-rennin': 0.12311356}),\n",
       "                          'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.31849292,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.33035845,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.32247573,\n",
       "                                       'human epidermal growth factor receptor 2': 0.32141668,\n",
       "                                       'human epidermal growth factor receptor-2': 0.33035845}),\n",
       "                          'ER': defaultdict(float,\n",
       "                                      {'extinction-ratio': 0.17534143,\n",
       "                                       'equivalent rontgen': 0.13410261,\n",
       "                                       'endo-plasmic reticulum': 0.111764476,\n",
       "                                       'emergency room': 0.030416973,\n",
       "                                       'estrogen receptor-alpha': 0.31671783,\n",
       "                                       'environmental resistance': 0.056220777,\n",
       "                                       'erythrocyte receptor': 0.34148252,\n",
       "                                       'estradiol receptor': 0.24258384,\n",
       "                                       'extended-release': 0.10751309,\n",
       "                                       'energy restriction': 0.03922823,\n",
       "                                       'energy-restricted': 0.03288767,\n",
       "                                       'estrogen-receptor': 0.26456138,\n",
       "                                       'energy retention': 0.08374955,\n",
       "                                       'electrorheological': 0.0910889,\n",
       "                                       'ejection rate': 0.17016846,\n",
       "                                       'external resistance': 0.069598034,\n",
       "                                       'Estrogen receptor alpha': 0.26519907,\n",
       "                                       'estrogen receptor': 0.2520889,\n",
       "                                       'early': 0.022902334,\n",
       "                                       'endoplasmatic reticulum': 0.1878006,\n",
       "                                       'Estradiol': 0.10965514,\n",
       "                                       'expiratory reserve': 0.15052013,\n",
       "                                       'endovascular repair': 0.07651728,\n",
       "                                       'Emergency Room': 0.030416973,\n",
       "                                       'early reticulocyte': 0.22261493,\n",
       "                                       'esophageal rupture': 0.06341673,\n",
       "                                       'Estrogen receptors': 0.23499687,\n",
       "                                       'evoked responses': 0.30828124,\n",
       "                                       'estrogen receptor protein': 0.26515427,\n",
       "                                       'erythromycin': 0.1746482,\n",
       "                                       'enhancement ratios': 0.19983222,\n",
       "                                       'equine rhinopneumonia': 0.044934466,\n",
       "                                       'eye research': 0.112104535,\n",
       "                                       'extinction ratio': 0.18432246,\n",
       "                                       'equivalent roentgen': 0.13666712,\n",
       "                                       'emotion regulation': 0.12434053,\n",
       "                                       'enhancement ratio': 0.19316591,\n",
       "                                       'estrogen receptor status': 0.36004815,\n",
       "                                       'early repolarization': 0.18363978,\n",
       "                                       'early repolarisation': 0.18063964,\n",
       "                                       'electrical resistance': 0.06762324,\n",
       "                                       'evoked response': 0.31490442,\n",
       "                                       'efficacy ratio': 0.31343976,\n",
       "                                       'estrogen': 0.09823398,\n",
       "                                       'endoplasmic reticular': 0.16076387,\n",
       "                                       'extraction ratio': 0.17120573,\n",
       "                                       'extended release': 0.10125629,\n",
       "                                       'external rotation': 0.053740248,\n",
       "                                       'epigastric region': 0.15698816,\n",
       "                                       'endoscopic resection': 0.033527356,\n",
       "                                       'ethoxyresorufin': 0.052288674,\n",
       "                                       'electro-resection': 0.12482084,\n",
       "                                       'early response': 0.31091246,\n",
       "                                       'endoplasmic reticulum': 0.20290639,\n",
       "                                       'enhanced reactivation': 0.2047759,\n",
       "                                       'electroresection': 0.09690913})}),\n",
       "             'There were no participants in cohort 1 of the primary trial with a (CR) or (PR) based on the Response Assessment in Neuro-Oncology Brain Metastasis (RANO-BM) response criteria.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.036001585,\n",
       "                                       'clot retraction': 0.09848514,\n",
       "                                       'conditioned response': 0.081259675,\n",
       "                                       'conditioned reflex': 0.001764699,\n",
       "                                       'charge recombination': -0.034982488,\n",
       "                                       'Czech Republic': 0.009869677,\n",
       "                                       'control region': 0.03855196,\n",
       "                                       'colonization rate': 0.036838464,\n",
       "                                       'complete remission rate': 0.4051861,\n",
       "                                       'Charles River': 0.0110108545,\n",
       "                                       'Caloric restriction': 0.043399177,\n",
       "                                       'colonisation resistance': 0.047473047,\n",
       "                                       'complete regression': 0.06305243,\n",
       "                                       'conversion rate': 0.11305266,\n",
       "                                       'chest roentgenography': 0.18216696,\n",
       "                                       'chest radiograph': 0.14619128,\n",
       "                                       'colony reared': -0.043400966,\n",
       "                                       'cardiorespiratory': 0.06876679,\n",
       "                                       'circadian rhythm': 0.06682368,\n",
       "                                       'cardiac rupture': 0.121732086,\n",
       "                                       'carbonyl reductase': 0.056291576,\n",
       "                                       'calorie restriction': 0.0225172,\n",
       "                                       'cortical reaction': 0.21956652,\n",
       "                                       'complete remissions': 0.30342856,\n",
       "                                       'chest radiography': 0.14763027,\n",
       "                                       'computerised record': -0.0089098355,\n",
       "                                       'charge-recombination': -0.030997237,\n",
       "                                       'Cardiac Rehabilitation': 0.12155294,\n",
       "                                       'calcium-binding protein calretinin': 0.09612076,\n",
       "                                       'chronic rejection': 0.07874238,\n",
       "                                       'colony-reared': -0.029811226,\n",
       "                                       'cognitive reserve': 0.15873152,\n",
       "                                       'critical ratio': 0.12456468,\n",
       "                                       'cortico-resistant': 0.25161138,\n",
       "                                       'caloric restriction': 0.043399177,\n",
       "                                       'corticoresistant': 0.18584566,\n",
       "                                       'corticosteroid-resistant': 0.20002583,\n",
       "                                       'Congo red': 0.042967774,\n",
       "                                       'complete responses': 0.18125372,\n",
       "                                       'chest and right arm': 0.08741766,\n",
       "                                       'conditioned reinforcement': -0.005087283,\n",
       "                                       'constant routine': -0.0032878853,\n",
       "                                       'cardio-respiratory': 0.11270077,\n",
       "                                       'complete response rate': 0.28319418,\n",
       "                                       'cockroach': -0.019562148,\n",
       "                                       'chief resident': 0.035577793,\n",
       "                                       'calorie-restricted': 0.021679088,\n",
       "                                       'complete responders': 0.19613576,\n",
       "                                       'cysteine-rich': 0.06363664,\n",
       "                                       'controlled-release': 0.031560924,\n",
       "                                       'chemoradiation': 0.09764088,\n",
       "                                       'crown-rump': -0.0058311187,\n",
       "                                       'crown-rump length': 0.016363813,\n",
       "                                       'creatinine': 0.16677369,\n",
       "                                       'capture-recapture': -0.0033254514,\n",
       "                                       'Congo-red': 0.05625039,\n",
       "                                       'coefficient of repeatability': 0.15449418,\n",
       "                                       'computed radiography': 0.11605927,\n",
       "                                       'controlled respiration': 0.08135274,\n",
       "                                       'conditioned reward': 0.012565484,\n",
       "                                       'complement receptors': 0.13608065,\n",
       "                                       'concentration-response': 0.1073254,\n",
       "                                       'complete': 0.055279903,\n",
       "                                       'chest roentgenogram': 0.18887866,\n",
       "                                       'complement receptor': 0.15707852,\n",
       "                                       'Cajal-Retzius': 0.01940572,\n",
       "                                       'cremasteric reflex': 0.2174049,\n",
       "                                       'clot-retraction': 0.067984916,\n",
       "                                       'conserved regions': 0.027513979,\n",
       "                                       'child-resistant': -0.01262248,\n",
       "                                       'control rats': 0.0028230122,\n",
       "                                       'caries-resistant': -0.03845367,\n",
       "                                       'coronary revascularization': 0.15195504,\n",
       "                                       'colon resection': 0.08974941,\n",
       "                                       'contrast ratio': 0.121533126,\n",
       "                                       'concentration ratio': 0.088772014,\n",
       "                                       'Calreticulin': 0.072855935,\n",
       "                                       'composite resin': -0.035525333,\n",
       "                                       'completely': 0.06563221,\n",
       "                                       'colorectal': 0.08894962,\n",
       "                                       'complete response': 0.19980754,\n",
       "                                       'coronary risk': 0.06808088,\n",
       "                                       'conventional radiology': 0.18378896,\n",
       "                                       'Complete response': 0.19980754,\n",
       "                                       'cathode ray': 0.043716066,\n",
       "                                       'complete responder': 0.20813197,\n",
       "                                       'controlled release': -0.0062311734,\n",
       "                                       'conditioned reflexes': 0.011273013,\n",
       "                                       'chemo-radiation': 0.3665409,\n",
       "                                       'complete remission': 0.2845197,\n",
       "                                       'conserved region': 0.011139391,\n",
       "                                       'coronary resistance': 0.13750459,\n",
       "                                       'cardiac resuscitation': 0.12426974,\n",
       "                                       'computed radiographic': 0.15174443,\n",
       "                                       'cooling rate': 0.0087891,\n",
       "                                       'clinical research': 0.26554522,\n",
       "                                       'colonization resistance': 0.006466411,\n",
       "                                       'compression ratio': 0.013032147,\n",
       "                                       'computerized record': -0.016227491,\n",
       "                                       'chromium': 0.06514932,\n",
       "                                       'colo-rectal': 0.10503565,\n",
       "                                       'contractile reserve': 0.050918125,\n",
       "                                       'clinical record': 0.2680171,\n",
       "                                       'concentration ratios': 0.06392488,\n",
       "                                       'clinical remission': 0.35887134,\n",
       "                                       'centric relation': -0.04314072,\n",
       "                                       'cardiac rhythm': 0.04643836,\n",
       "                                       'capillary refill': 0.016827937,\n",
       "                                       'colonisation rate': 0.043909572,\n",
       "                                       'conventional radiography': 0.104549855,\n",
       "                                       'cellular receptor': 0.100204945}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.1505473,\n",
       "                                       'plaque reduction': -0.022045791,\n",
       "                                       'partial response': 0.24076629,\n",
       "                                       'photoreactivation': -0.038107794,\n",
       "                                       'pentoxyresorufin': 0.057895552,\n",
       "                                       'panoramic radiography': 0.094635546,\n",
       "                                       'proliferative retinopathy': 0.17067361,\n",
       "                                       'partial responses': 0.241073,\n",
       "                                       'protein': -0.013064741,\n",
       "                                       'prorennin': 0.12528852,\n",
       "                                       'prevalence rate': 0.14774723,\n",
       "                                       'prealbumin': 0.096429706,\n",
       "                                       'pregnancy rates': -0.038623672,\n",
       "                                       'pain relief': 0.03902612,\n",
       "                                       'partial remissions': 0.38064268,\n",
       "                                       'pattern recognition': -0.02955356,\n",
       "                                       'photo-reactivation': -0.013400189,\n",
       "                                       'protein restriction': 0.04750887,\n",
       "                                       'progesterone receptor': 0.12023565,\n",
       "                                       'placental restriction': 0.05024109,\n",
       "                                       'pneumatic retinopexy': 0.08083832,\n",
       "                                       'prorenin': 0.12343994,\n",
       "                                       'perirhinal cortex': 0.21627943,\n",
       "                                       'prothrombin ratio': 0.14838572,\n",
       "                                       'pars recta': 0.10976001,\n",
       "                                       'pattern reversal': 0.0031731783,\n",
       "                                       'pr interval (ekg)': 0.18463555,\n",
       "                                       'pityriasis rosea': 0.019190995,\n",
       "                                       'prevalence ratio': 0.17753376,\n",
       "                                       'Projection reconstruction': -0.05832855,\n",
       "                                       'pregnancy rate': -0.00943173,\n",
       "                                       'phenol red': 0.11326485,\n",
       "                                       'photoreceptor': -0.028978592,\n",
       "                                       'prednisolon': 0.14994842,\n",
       "                                       'partial responders': 0.2628498,\n",
       "                                       'proline-rich': 0.020567818,\n",
       "                                       'pseudorabies': 0.10944152,\n",
       "                                       'pulmonary regurgitation': 0.115015395,\n",
       "                                       'projection reconstruction': -0.05832855,\n",
       "                                       'photo-receptor': 0.020106185,\n",
       "                                       'protease': 0.03009534,\n",
       "                                       'progestine': -0.01817485,\n",
       "                                       'pentoxy-resorufin': 0.06416909,\n",
       "                                       'partial remission': 0.34878975,\n",
       "                                       'progestin receptor': 0.07596579,\n",
       "                                       'per rectum': 0.11485734,\n",
       "                                       'Plain radiography': 0.11003322,\n",
       "                                       'production rate': 0.026887279,\n",
       "                                       'pulmonary rehabilitation': 0.11988907,\n",
       "                                       'pentoxy resorufin': 0.048766326,\n",
       "                                       'proteinase': 0.023766719,\n",
       "                                       'Paeoniae radix': 0.06784592,\n",
       "                                       'Puerto Rico': 0.06232496,\n",
       "                                       'Prevalence ratios': 0.1490043,\n",
       "                                       'perirenal': 0.04775189,\n",
       "                                       'passive recovery': 0.04500021,\n",
       "                                       'propranolol': 0.11385867,\n",
       "                                       'primary response': 0.25058588,\n",
       "                                       'pregnant': -0.0066779256,\n",
       "                                       'partial regression': 0.068477854,\n",
       "                                       'Photoreactivation': -0.038107794,\n",
       "                                       'peripheral resistance': 0.15513827,\n",
       "                                       'polymorphic reticulosis': 0.07840753,\n",
       "                                       'progressive ratio': 0.09080423,\n",
       "                                       'partial responder': 0.23691897,\n",
       "                                       'projection-reconstruction': -0.025587577,\n",
       "                                       'pro-renin': 0.1348922,\n",
       "                                       'phenol-red': 0.11161072,\n",
       "                                       'progestin': -0.0027025985,\n",
       "                                       'pro-rennin': 0.14845303})}),\n",
       "             'the primary trial is a phase II trial in which all participants will recieve topical fluocinonide 0.05% face cream twice daily for two weeks.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'II': defaultdict(float,\n",
       "                                      {'image intensifier': 0.10660299,\n",
       "                                       'icterus index': 0.13406664})}),\n",
       "             'The patient with the shortest PFS was in the secondary trial, at only 5 days, and the longest recorded PFS was in the primary trial at 78 months.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.13525476,\n",
       "                                       'pyrogen-free saline': 0.1880859,\n",
       "                                       'pressure-flow study': 0.007035626,\n",
       "                                       'posterior fossa syndrome': 0.20464219,\n",
       "                                       'pressure flow study': 0.007249059,\n",
       "                                       'primary fibromyalgia syndrome': 0.24422112,\n",
       "                                       'Piper Fatigue Scale': 0.16628678,\n",
       "                                       'patellofemoral syndrome': 0.1593047,\n",
       "                                       'Progression-free': 0.21529995,\n",
       "                                       'pulmonary function score': 0.24439579,\n",
       "                                       'pressure flow studies': 0.008526027,\n",
       "                                       'protein-free supernatant': 0.107106075,\n",
       "                                       'progression free survival': 0.36396965,\n",
       "                                       'protein free supernatant': 0.12829287,\n",
       "                                       'progression-free survival': 0.407244,\n",
       "                                       'pressure/flow study': 0.027903574})}),\n",
       "             'In the primary trial the FEC-75 Then Paclitaxel/Trastuzumab group produced better Pathological complete response (pCR) rates than the Paclitaxel/Trastuzumab Then Trastuzumab/FEC-75 group.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'FEC': defaultdict(float,\n",
       "                                      {'faecal egg counts': 0.006402653,\n",
       "                                       'Friend erythroleukaemia cell': 0.24548112,\n",
       "                                       'free erythrocyte coproporphyrin': 0.20383199,\n",
       "                                       'faecal egg count': 0.00846294,\n",
       "                                       'Friend erythroleukemia cell': 0.24595088,\n",
       "                                       'Friend erythroleukæmia cell': 0.12448653,\n",
       "                                       'fecal egg count': 0.039453316,\n",
       "                                       'fæcal egg count': 0.05242616})}),\n",
       "             'the primary trial is testing a novel radiotracer called PET/CT to evaluate its use for visualization of HER2+ lesions.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PET': defaultdict(float,\n",
       "                                      {'paraffin-embedded tissue': 0.20298609,\n",
       "                                       'polyethylene terephtalate': 0.062372237,\n",
       "                                       'peritoneal equilibration test': 0.22732815,\n",
       "                                       'polyester': -0.045237623,\n",
       "                                       'poly (ethylene terephthalate)': 0.054319903,\n",
       "                                       'peritoneal equilibration tests': 0.2081641,\n",
       "                                       'pancreatic endocrine tumors': 0.16317773,\n",
       "                                       'Positron emission tomography': 0.3405341,\n",
       "                                       'positron emission computed tomography': 0.41171426,\n",
       "                                       'polyethylene terephthalate': 0.040830944,\n",
       "                                       'patulous eustachian tube': 0.19069949,\n",
       "                                       'pre-eclamptic toxemia': 0.01959217,\n",
       "                                       'poly(ethylene terephthalate)': 0.054319903,\n",
       "                                       'poly-(ethylene terephthalate)': 0.07587298,\n",
       "                                       'pre-eclamptic toxaemia': 0.02570035,\n",
       "                                       'peritonaeal equilibration test': 0.22473131,\n",
       "                                       'positron-emission tomography': 0.34619838,\n",
       "                                       'positron-emission-tomography': 0.3390031,\n",
       "                                       'positron emission tomography': 0.3405341,\n",
       "                                       'photoinduced electron transfer': 0.12051765,\n",
       "                                       'positron emission tomograph': 0.2912649,\n",
       "                                       'preeclamptic toxaemia': -0.006478281,\n",
       "                                       'partial exchange transfusion': 0.1475237,\n",
       "                                       'pressure equalization tubes': 0.10993424,\n",
       "                                       'polyethylene-terephthalate': 0.046696298,\n",
       "                                       'pancreatic endocrine tumour': 0.1574029,\n",
       "                                       'positron emission-computed tomography': 0.39908218,\n",
       "                                       'polyethyleneterephthalate': 0.024959667,\n",
       "                                       'poly-ethylene terephthalate': 0.07605864,\n",
       "                                       'preeclamptic toxemia': -0.016407315,\n",
       "                                       'Polyethyleneterephthalate': 0.024959667,\n",
       "                                       'poly(ethyleneterephthalate)': 0.05868206,\n",
       "                                       'pancreatic endocrine tumor': 0.15279192,\n",
       "                                       'Peritoneal Equilibration Test': 0.22732815,\n",
       "                                       'positron emission tomographic': 0.31787917,\n",
       "                                       'phosphatidylethanol': 0.02508757,\n",
       "                                       'paraffin embedded tissue': 0.199999}),\n",
       "                          'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.28631455,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.29051062,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.28390333,\n",
       "                                       'human epidermal growth factor receptor 2': 0.27683166,\n",
       "                                       'human epidermal growth factor receptor-2': 0.29051062})}),\n",
       "             'the primary trial and the secondary trial monitor the %  of their patient cohorts with DFS < 6years.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DFS': defaultdict(float,\n",
       "                                      {'Defensive Functioning Scale': 0.33015826,\n",
       "                                       'Disease free survival': 0.36662307,\n",
       "                                       'decayed and filled tooth surfaces': 0.0093799895,\n",
       "                                       'dysplasia of the fibrous sheath': 0.22409858,\n",
       "                                       'diclofenac-sodium': 0.09862006,\n",
       "                                       'disease-free survivals': 0.38298875,\n",
       "                                       'diclofenac sodium': 0.10185239,\n",
       "                                       'deoxyfructoserotonin': 0.15656044,\n",
       "                                       'Disease-free': 0.18852428,\n",
       "                                       'dental fear survey': 0.1230352,\n",
       "                                       'disease-free survival': 0.39151123,\n",
       "                                       'deoxyfructo-serotonin': 0.19671719,\n",
       "                                       'Dental Fear Survey': 0.1230352,\n",
       "                                       'disease free survival': 0.36662307,\n",
       "                                       'dental fear scale': 0.20617753,\n",
       "                                       'decayed or filled surfaces': -0.035797466,\n",
       "                                       'diabetic foot syndrome': 0.21798389,\n",
       "                                       'desoxyfructosylserotonin': 0.099711545,\n",
       "                                       'desoxyfructo-serotonin': 0.1858113})}),\n",
       "             'the primary trial and the secondary trial are not studying patient PFS, ORR or DLTs.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.12580894,\n",
       "                                       'pyrogen-free saline': 0.16289856,\n",
       "                                       'pressure-flow study': -0.015736654,\n",
       "                                       'posterior fossa syndrome': 0.11626577,\n",
       "                                       'pressure flow study': -0.023551833,\n",
       "                                       'primary fibromyalgia syndrome': 0.168698,\n",
       "                                       'Piper Fatigue Scale': 0.11277045,\n",
       "                                       'patellofemoral syndrome': 0.12814748,\n",
       "                                       'Progression-free': 0.05319831,\n",
       "                                       'pulmonary function score': 0.13642794,\n",
       "                                       'pressure flow studies': -0.0029501412,\n",
       "                                       'protein-free supernatant': 0.16145872,\n",
       "                                       'progression free survival': 0.15559195,\n",
       "                                       'protein free supernatant': 0.14104153,\n",
       "                                       'progression-free survival': 0.18405014,\n",
       "                                       'pressure/flow study': -0.002380632}),\n",
       "                          'ORR': defaultdict(float,\n",
       "                                      {'oxygen-reduction reaction': 0.050977353,\n",
       "                                       'overall response rate': 0.05457924,\n",
       "                                       'objective response rate': 0.047213532,\n",
       "                                       'oxygen reduction reaction': 0.079821})}),\n",
       "             'the secondary trial and the primary trial both measure PFS of their patient cohorts.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.12713787,\n",
       "                                       'pyrogen-free saline': 0.09759487,\n",
       "                                       'pressure-flow study': 0.06204089,\n",
       "                                       'posterior fossa syndrome': 0.20644607,\n",
       "                                       'pressure flow study': 0.07516202,\n",
       "                                       'primary fibromyalgia syndrome': 0.30659738,\n",
       "                                       'Piper Fatigue Scale': 0.20250446,\n",
       "                                       'patellofemoral syndrome': 0.15587133,\n",
       "                                       'Progression-free': 0.11464859,\n",
       "                                       'pulmonary function score': 0.3392594,\n",
       "                                       'pressure flow studies': 0.076025575,\n",
       "                                       'protein-free supernatant': 0.03802168,\n",
       "                                       'progression free survival': 0.35088405,\n",
       "                                       'protein free supernatant': 0.07434573,\n",
       "                                       'progression-free survival': 0.398482,\n",
       "                                       'pressure/flow study': 0.10398207})}),\n",
       "             'Patients must have AST, ALP and ALT < 1.5 ULN to participate in the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'AST': defaultdict(float,\n",
       "                                      {'anti-streptolysin test': 0.34590748,\n",
       "                                       'atrial systolic tachycardia': 0.17576064,\n",
       "                                       'astrocyte': 0.14161488,\n",
       "                                       'arginine stimulation test': 0.3712775,\n",
       "                                       'astaxanthine': 0.3071127,\n",
       "                                       'aspartate amino-transferase': 0.23437126,\n",
       "                                       'anti-microbial susceptibility testing': 0.24793753,\n",
       "                                       'anterior spinothalamic tract': 0.21570186,\n",
       "                                       'arterial spin tagging': 0.18951623,\n",
       "                                       'Antimicrobial susceptibility testing': 0.22718033,\n",
       "                                       'aspartate-aminotransferase': 0.24593961,\n",
       "                                       'arginine-stimulation test': 0.36259234,\n",
       "                                       'antimicrobial susceptibility testing': 0.22718033,\n",
       "                                       'aspartate amino transferase': 0.22899494,\n",
       "                                       'average survival time': 0.0883708,\n",
       "                                       'aspartate transaminase': 0.2545151,\n",
       "                                       'acid suppressive therapy': 0.31369665,\n",
       "                                       'aspartate': 0.19005097,\n",
       "                                       'atrial overdrive stimulation rate': 0.22953513,\n",
       "                                       'arterial spin-tagging': 0.1858336,\n",
       "                                       'aspartate transferase': 0.21852598,\n",
       "                                       'aspartate aminotransferase': 0.2534633,\n",
       "                                       'antistreptolysin test': 0.37259388,\n",
       "                                       'androgen suppression therapy': 0.31418827,\n",
       "                                       'acute suppurative thyroiditis': 0.25335732,\n",
       "                                       'allatostatin': 0.3109007,\n",
       "                                       'anti-fungal susceptibility testing': 0.2137788,\n",
       "                                       'angiotensin sensitivity test': 0.3493076,\n",
       "                                       'acid-suppressive therapy': 0.30041495,\n",
       "                                       'antibiotic susceptibility testing': 0.26313028,\n",
       "                                       'Aryl sulfotransferase': 0.17666318,\n",
       "                                       'astigmatism': 0.2057387,\n",
       "                                       'androgen-suppression therapy': 0.29841802,\n",
       "                                       'aspartate-amino-transferase': 0.24029139,\n",
       "                                       'astaxanthin': 0.24786256,\n",
       "                                       'antifungal susceptibility testing': 0.22334692}),\n",
       "                          'ALP': defaultdict(float,\n",
       "                                      {'antileukoprotease': 0.34568116,\n",
       "                                       'acute leucemia protocol': 0.37494263,\n",
       "                                       'alkaline': 0.14501996,\n",
       "                                       'alkyl-lysophospholipid': 0.22936736,\n",
       "                                       'acute lupus pericarditis': 0.20605391,\n",
       "                                       'antilymphocytic plasma': 0.3164487,\n",
       "                                       'anti-leukoproteinase': 0.34377244,\n",
       "                                       'alkaline protease': 0.19818498,\n",
       "                                       'alkaline-phosphatase': 0.22303206,\n",
       "                                       'anterior lobe of pituitary': 0.15968423,\n",
       "                                       'anti-leucoproteinase': 0.3159996,\n",
       "                                       'alprazolam': 0.17907359,\n",
       "                                       'alkalinephosphatase': 0.26004097,\n",
       "                                       'acute leukemia protocol': 0.44148275,\n",
       "                                       'alkaline phosphate': 0.21821885,\n",
       "                                       'acute leukaemia protocol': 0.40082774,\n",
       "                                       'aluminium phosphide': 0.15470292,\n",
       "                                       'antileukoproteinase': 0.31334618,\n",
       "                                       'argon laser photocoagulation': 0.20465314,\n",
       "                                       'atherogenic lipoprotein phenotype': 0.22631508,\n",
       "                                       'antileucoproteinase': 0.28739327,\n",
       "                                       'alveolar proteinosis': 0.17313237,\n",
       "                                       'alkaline phosphatase': 0.23200662,\n",
       "                                       'acute leucaemia protocol': 0.438346,\n",
       "                                       'Alkyl-lysophospholipids': 0.15576878,\n",
       "                                       'alkaline phosphatase activity': 0.20837429,\n",
       "                                       'alkaline phosphatases': 0.16471422}),\n",
       "                          'ALT': defaultdict(float,\n",
       "                                      {'altitude': 0.111470014,\n",
       "                                       'alanine amino transferase': 0.24068911,\n",
       "                                       'avian laryngotracheitis': 0.046319664,\n",
       "                                       'alanine-aminotransferase': 0.24798042,\n",
       "                                       'alanine aminotransaminase': 0.26627564,\n",
       "                                       'alanine aminotransferase': 0.2648416,\n",
       "                                       'alanine transferase': 0.25740513,\n",
       "                                       'anterolateral thigh': 0.2019415,\n",
       "                                       'auxiliary liver transplantation': 0.3363246,\n",
       "                                       'alanine amino-transferase': 0.2422946,\n",
       "                                       'antero-lateral thigh': 0.18519504,\n",
       "                                       'alanine aminotransferases': 0.23033984,\n",
       "                                       'alanine-amino-transferase': 0.24037345,\n",
       "                                       'alternative lengthening of telomeres': 0.12664874,\n",
       "                                       'alanine aminotransferase activity': 0.25531763,\n",
       "                                       'autolymphocyte therapy': 0.319364,\n",
       "                                       'alanine transaminase': 0.26210308,\n",
       "                                       'argon laser trabeculoplasty': 0.24445485}),\n",
       "                          'ULN': defaultdict(float,\n",
       "                                      {'upper limit of normal': 0.0753195})}),\n",
       "             'Lidoderm products are used in a intervention arm 1 of the secondary trial, and an FFDM product is used in arm 1 of the primary trial': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'FFDM': defaultdict(float,\n",
       "                                      {'full-field digital mammography': 0.08974738,\n",
       "                                       'full field digital mammography': 0.084050134,\n",
       "                                       'full field digital mammogram': 0.10806424,\n",
       "                                       'freedom from distant metastasis': 0.1397083,\n",
       "                                       'freedom from distant metastases': 0.13736019,\n",
       "                                       'full-field digital mammogram': 0.0988351})}),\n",
       "             'the secondary trial records several gastrointestinal adverse events, whereas the primary trial doesn‚Äö√Ñ√¥t record any GI adverse events.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'GI': defaultdict(float,\n",
       "                                      {'gyrification index': 0.10975463,\n",
       "                                       'Glucagon immunoreactivity': 0.18325704,\n",
       "                                       'Gingival inflammation': 0.12013516,\n",
       "                                       'growth index': -0.0031620264,\n",
       "                                       'growth inhibition': 0.13781992,\n",
       "                                       'guided imagery': -0.041602977,\n",
       "                                       'gastrointestinal tract': 0.24581367,\n",
       "                                       'genomic island': 0.0940412,\n",
       "                                       'gastrointestinal': 0.23281313,\n",
       "                                       'glass ionomer cement': -0.02686367,\n",
       "                                       'gastrointestinal illness': 0.24923721,\n",
       "                                       'germination index': 0.06628122,\n",
       "                                       'global ischaemia': 0.16398363,\n",
       "                                       'global ischemia': 0.16085005,\n",
       "                                       'galvanic isolation': 0.07280494,\n",
       "                                       'gait-initiation': 0.09824729,\n",
       "                                       'gastro-intestinal illness': 0.2650597,\n",
       "                                       'gastroenterology': 0.27645087,\n",
       "                                       'gastro-intestinal': 0.2767864,\n",
       "                                       'glycaemic indices': 0.19785267,\n",
       "                                       'glossopharyngeal insufflation': 0.09698981,\n",
       "                                       'gingival indices': 0.12680572,\n",
       "                                       'gingival index': 0.111121036,\n",
       "                                       'gastro intestinal': 0.22459981,\n",
       "                                       'glucose intolerance': 0.17733636,\n",
       "                                       'gastroenterologist': 0.20576009,\n",
       "                                       'glucose-inhibited': 0.22539298,\n",
       "                                       'GIGANTEA': 0.033365607,\n",
       "                                       'gigantocellular reticular nucleus': 0.07066505,\n",
       "                                       'gait initiation': 0.071346804,\n",
       "                                       'glycemic index': 0.14473036,\n",
       "                                       'glass ionomer': 0.008364537,\n",
       "                                       'genogroup I': 0.123688556,\n",
       "                                       'genogroup 1': 0.12930594,\n",
       "                                       'gingival inflammation': 0.12013516,\n",
       "                                       'Great Island': 0.0074427947,\n",
       "                                       'gastro-enterology': 0.2462156,\n",
       "                                       'Group I': 0.116827704,\n",
       "                                       'Glass ionomer': 0.008364537,\n",
       "                                       'glycaemic index': 0.17088199,\n",
       "                                       'giant interneuron': -0.011528119,\n",
       "                                       'glass-ionomer': 0.015258424,\n",
       "                                       'genomic instability': 0.07253894})}),\n",
       "             'the secondary trial and the primary trial both used MRI for their interventions.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MRI': defaultdict(float,\n",
       "                                      {'magnetic-resonance imaging': 0.43448985,\n",
       "                                       'MR-imaging': 0.47566316,\n",
       "                                       'magnetic resonance imaging': 0.4537483,\n",
       "                                       'magnetic resonance images': 0.42089146,\n",
       "                                       'magnetic resonance': 0.32331142,\n",
       "                                       'Magnetic resonance imagings': 0.48962194,\n",
       "                                       'magnet resonance imaging': 0.4410576,\n",
       "                                       'MR imaging': 0.4636033,\n",
       "                                       'magnetic-resonance-imaging': 0.41522682,\n",
       "                                       'magnetic resonance imagery': 0.36455464,\n",
       "                                       'Magnetic resonance imaging scan': 0.48761252,\n",
       "                                       'magnetic resonance tomography': 0.42095935,\n",
       "                                       'magnetic resonance image': 0.35943672,\n",
       "                                       'Magnetic resonance image': 0.35943672})}),\n",
       "             'Patients with a QT interval longer than half a second are excluded from the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'QT': defaultdict(float,\n",
       "                                      {'qt interval (ecg)': 0.5558932})}),\n",
       "             'All participants in the primary trial are administered with Lapatinib 1500 mg PO QD and Pazopanib 800 mg.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.19683048,\n",
       "                                       'parietal operculum': 0.17719312,\n",
       "                                       'post office': 0.039458968,\n",
       "                                       'percentage of observed value': 0.14579402,\n",
       "                                       'Phenol oxidase': 0.12180996,\n",
       "                                       'parapineal organ': 0.2041948,\n",
       "                                       'power output': 0.028636096,\n",
       "                                       'predominant organism': 0.109023385,\n",
       "                                       'pulse-oximetry': 0.19896176,\n",
       "                                       'perceptual organisation': -0.0028508261,\n",
       "                                       'power outputs': 0.0037386138,\n",
       "                                       'Personality Organization': -0.005846767,\n",
       "                                       'postoperative': 0.17399795,\n",
       "                                       'parieto occipital': 0.17602028,\n",
       "                                       'polyolefin': 0.1463169,\n",
       "                                       'parietooccipital': 0.16272163,\n",
       "                                       'poly-olefin': 0.12015225,\n",
       "                                       'peroral': 0.18046749,\n",
       "                                       'prostate only': 0.1640416,\n",
       "                                       'pressure overload': 0.026546286,\n",
       "                                       'peroxidase': 0.109260015,\n",
       "                                       'principal olive': 0.13877746,\n",
       "                                       'peri-operative': 0.16812672,\n",
       "                                       'posterior': 0.11967943,\n",
       "                                       'Perceptual Organization': -0.00028218518,\n",
       "                                       'period of onset': 0.14514302,\n",
       "                                       'posterior nuclear group': 0.101715855,\n",
       "                                       'phenol oxidase': 0.12180996,\n",
       "                                       'pressure': 0.016574169,\n",
       "                                       'per os (by mouth)': 0.22256006,\n",
       "                                       'parieto-occipital': 0.16394037,\n",
       "                                       'preoptic area': 0.044994395,\n",
       "                                       'perceptual organization': -0.00028218518,\n",
       "                                       'prophylactic oophorectomy': 0.14928173,\n",
       "                                       'phosphodiester': 0.21691261,\n",
       "                                       'pre-ovulatory': 0.16821294,\n",
       "                                       'palm oil': 0.10738788,\n",
       "                                       'preovulatory': 0.2721027,\n",
       "                                       'perioperative': 0.21138981,\n",
       "                                       'post operative': 0.14371926,\n",
       "                                       'post-operative': 0.15764007,\n",
       "                                       'phospho-diester': 0.08913673,\n",
       "                                       'protein oxidation': 0.04782784,\n",
       "                                       'palm-oil': 0.07729761,\n",
       "                                       'per os': 0.21117975,\n",
       "                                       'pericardial organ': 0.1521716,\n",
       "                                       'Pulse oximetry': 0.19683048,\n",
       "                                       'paraoxon': 0.30747506,\n",
       "                                       'propylene oxide': 0.18398525,\n",
       "                                       'phenoloxidase': 0.17474172,\n",
       "                                       'peanut oil': 0.15983227}),\n",
       "                          'QD': defaultdict(float,\n",
       "                                      {'quinidine': 0.36690694,\n",
       "                                       'quaque die (every day)': 0.13607244,\n",
       "                                       'quaque die': 0.13733919,\n",
       "                                       'quinupristin-dalfopristin': 0.463951,\n",
       "                                       'quater die': 0.12774628,\n",
       "                                       'quantum dot': 0.057816394,\n",
       "                                       'questionable dementia': 0.10362404})}),\n",
       "             'the primary trial did not use PFS to evaluate the performance of its interventions.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.07241143,\n",
       "                                       'pyrogen-free saline': 0.16396934,\n",
       "                                       'pressure-flow study': 0.01121844,\n",
       "                                       'posterior fossa syndrome': 0.10840192,\n",
       "                                       'pressure flow study': 0.008283025,\n",
       "                                       'primary fibromyalgia syndrome': 0.18157858,\n",
       "                                       'Piper Fatigue Scale': 0.1448197,\n",
       "                                       'patellofemoral syndrome': 0.08765382,\n",
       "                                       'Progression-free': 0.012299464,\n",
       "                                       'pulmonary function score': 0.17619766,\n",
       "                                       'pressure flow studies': 0.019976828,\n",
       "                                       'protein-free supernatant': 0.15020986,\n",
       "                                       'progression free survival': 0.11807863,\n",
       "                                       'protein free supernatant': 0.14294036,\n",
       "                                       'progression-free survival': 0.15693158,\n",
       "                                       'pressure/flow study': 0.031108465})}),\n",
       "             'The Change From Baseline in Mean Duration of the QTcF Interval for patients in the primary trial was at its highest on Day 1 of the third cycle, post T-DM1 intravenous (IV) infusion.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IV': defaultdict(float,\n",
       "                                      {'icthyosis vulgaris': 0.034043804,\n",
       "                                       'intravenous injection': 0.37270463,\n",
       "                                       'iridovirus': 0.0787801,\n",
       "                                       'intra-venous': 0.31714988,\n",
       "                                       'invitro': 0.09561565,\n",
       "                                       'intra ventricular': 0.2724417,\n",
       "                                       'intra vascular': 0.25348446,\n",
       "                                       'in vivo': 0.21548359,\n",
       "                                       'intravascular': 0.31611213,\n",
       "                                       'in-vivo': 0.26783597,\n",
       "                                       'inter-vertebral': 0.15860508,\n",
       "                                       'ichthyosis vulgaris': 0.019012103,\n",
       "                                       'intravenous': 0.35665268,\n",
       "                                       'intravaginal': 0.17597125,\n",
       "                                       'invasive': -0.033010136,\n",
       "                                       'iridescent virus': -0.0030658806,\n",
       "                                       'isometric virus': 0.080941774,\n",
       "                                       'intravenous feeding device': 0.22142301,\n",
       "                                       'invivo': 0.10688598,\n",
       "                                       'instrumental variable': 0.06965083,\n",
       "                                       'intraventricular': 0.2672965,\n",
       "                                       'intra-vaginal': 0.19951554,\n",
       "                                       'intravertebral': 0.13819681,\n",
       "                                       'in vitro': 0.13647296,\n",
       "                                       'interventricular': 0.25734288,\n",
       "                                       'in-vitro': 0.18615791,\n",
       "                                       'intra venous': 0.28997055,\n",
       "                                       'iodine value': 0.13123983,\n",
       "                                       'ichnovirus': 0.0040358906,\n",
       "                                       'inter-ventricular': 0.27226013,\n",
       "                                       'intra-vertebral': 0.18202563,\n",
       "                                       'intravenous injection device': 0.30843806,\n",
       "                                       'intervertebral': 0.094021134,\n",
       "                                       'initial visit': 0.21448904,\n",
       "                                       'intravenous feeding': 0.29456902,\n",
       "                                       'intra-vascular': 0.28942853,\n",
       "                                       'intra-ventricular': 0.28955796})}),\n",
       "             'The shortest PFS in the Talazoparib group of the primary trial was over a month longer than the study duration.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.104987934,\n",
       "                                       'pyrogen-free saline': 0.17617184,\n",
       "                                       'pressure-flow study': -0.06046206,\n",
       "                                       'posterior fossa syndrome': 0.14004402,\n",
       "                                       'pressure flow study': -0.045584984,\n",
       "                                       'primary fibromyalgia syndrome': 0.24102543,\n",
       "                                       'Piper Fatigue Scale': 0.13441542,\n",
       "                                       'patellofemoral syndrome': 0.14077182,\n",
       "                                       'Progression-free': 0.14893512,\n",
       "                                       'pulmonary function score': 0.13322379,\n",
       "                                       'pressure flow studies': -0.048413884,\n",
       "                                       'protein-free supernatant': 0.07160554,\n",
       "                                       'progression free survival': 0.2743026,\n",
       "                                       'protein free supernatant': 0.08232208,\n",
       "                                       'progression-free survival': 0.315758,\n",
       "                                       'pressure/flow study': -0.041046154})}),\n",
       "             'Patients with HER2 + breast cancer stage 1-4  are eligible for both the primary trial and the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.25802928,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.26459205,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.26768854,\n",
       "                                       'human epidermal growth factor receptor 2': 0.27019843,\n",
       "                                       'human epidermal growth factor receptor-2': 0.26459205})}),\n",
       "             'Patients with clinically significant grade 3 PVD are eligible for the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PVD': defaultdict(float,\n",
       "                                      {'pulmonary-vascular disease': 0.34988153,\n",
       "                                       'postvagotomy diarrhoea': 0.14164278,\n",
       "                                       'physical vapor deposition': 0.101507545,\n",
       "                                       'post vagotomy diarrhoea': 0.16514699,\n",
       "                                       'postural vertical dimension': 0.16639198,\n",
       "                                       'portal vein diameter': 0.19360897,\n",
       "                                       'pulmonary valve disease': 0.29202497,\n",
       "                                       'post vagotomy diarrhea': 0.17015433,\n",
       "                                       'pulmonary vascular disease': 0.35569155,\n",
       "                                       'portal vein dilation': 0.22337972,\n",
       "                                       'post-vagotomy diarrhoea': 0.17501947,\n",
       "                                       'physical-vapor deposition': 0.09924611,\n",
       "                                       'physical vapour deposition': 0.11817841,\n",
       "                                       'premature ventricular depolarisation': 0.2834314,\n",
       "                                       'posterior vitreous detachment': 0.22099076,\n",
       "                                       'postvagotomy diarrhea': 0.14798327,\n",
       "                                       'physical-vapour deposition': 0.113014184,\n",
       "                                       'peripheral vascular disease': 0.3704498,\n",
       "                                       'premature ventricular depolarization': 0.289862,\n",
       "                                       'post-vagotomy diarrhea': 0.17336136})}),\n",
       "             ' Patients must have histologically or cytologically confirmed ERBB2+ invasive breast cancer, with Primary tumor > 2 cm in diameter to participate in the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ERBB2': defaultdict(float,\n",
       "                                      {'erythroblastic leukemia viral oncogene homologue 2': 0.2110642,\n",
       "                                       'erythroblastic leukemia viral oncogene homolog 2': 0.20091172,\n",
       "                                       'erythroblastic leukaemia viral oncogene homolog 2': 0.20144336,\n",
       "                                       'erythroblastic leukaemia viral oncogene homologue 2': 0.21452934})}),\n",
       "             'The Maximum Tolerated Dose (MTD) of of 1-Pemetrexed-d-tryptophan (indoximod) observed in the primary trial was 800 mg.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MTD': defaultdict(float,\n",
       "                                      {'maximum tolerated dose': 0.592956,\n",
       "                                       'Monroe tidal drainage': -0.119518965,\n",
       "                                       \"Midwife Teacher's Diploma\": -0.055981766,\n",
       "                                       'mean total dose': 0.36257535,\n",
       "                                       'maximally-tolerated dose': 0.6166634,\n",
       "                                       'metastatic trophoblastic disease': 0.13256335,\n",
       "                                       'maximal tolerated dose': 0.60217035,\n",
       "                                       'maximal-tolerated dose': 0.61614627,\n",
       "                                       'maximum tolerable dose': 0.56973886,\n",
       "                                       'muscle tension dysphonia': 0.1367135,\n",
       "                                       'muscle-tension dysphonia': 0.13810816,\n",
       "                                       'maximum tolerated dosage': 0.6074325,\n",
       "                                       'maximum tolerated doses': 0.57053304,\n",
       "                                       'maximum-tolerated dose': 0.6124641,\n",
       "                                       'multiple tic disorder': 0.17272815,\n",
       "                                       'mannitol dehydrogenase': 0.22970182,\n",
       "                                       'methadone': 0.2622762,\n",
       "                                       'maximally tolerated dose': 0.6112869})}),\n",
       "             'Lower doses of MM-121 are utilised in cohort1 of the primary trial than in cohort 2, Paclitaxel doses are the same for both cohorts.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MM': defaultdict(float,\n",
       "                                      {'mixed micelles': 0.16320077,\n",
       "                                       'mathematical morphology': -0.041997775,\n",
       "                                       'Michaelis-Menten': 0.12446034,\n",
       "                                       'Mycoplasma meleagridis': 0.14251214,\n",
       "                                       'malignant melanomas': 0.15222067,\n",
       "                                       'mismatch': 0.17799906,\n",
       "                                       'Malignant mesothelioma': 0.17882237,\n",
       "                                       'myelomeningocoele': 0.16806899,\n",
       "                                       'malignant mesothelioma': 0.17882237,\n",
       "                                       'megamitochondria': 0.06925086,\n",
       "                                       'meningococcal meningitis': 0.14418821,\n",
       "                                       'Miyoshi myopathy': 0.12345173,\n",
       "                                       'middle meningeal': 0.16242127,\n",
       "                                       'Michaelis Menten': 0.118324235,\n",
       "                                       'myelo-meningocoele': 0.220978,\n",
       "                                       'muscularis mucosae': 0.050251376,\n",
       "                                       'mycophenolate mofetil': 0.25692213,\n",
       "                                       'methylmercury': 0.16552018,\n",
       "                                       'Menstrual Migraine': 0.09018691,\n",
       "                                       'macro-molecule': 0.043311693,\n",
       "                                       'molecular mechanics': -0.03758317,\n",
       "                                       'methadone maintenance': 0.17078938,\n",
       "                                       'multiple myelomas': 0.28222868,\n",
       "                                       'myelomeningocele': 0.14986978,\n",
       "                                       'Mirror movements': -0.072322085,\n",
       "                                       'mucous membranes': 0.059416942,\n",
       "                                       'middle molecule': 0.1536947,\n",
       "                                       'myelo-meningocele': 0.2193828,\n",
       "                                       'molecular mass': 0.15080765,\n",
       "                                       'myeloid metaplasia': 0.23840135,\n",
       "                                       'malignant melanoma': 0.16608553,\n",
       "                                       'minimal medium': 0.17293791,\n",
       "                                       'metanephric mesenchyme': 0.15285826,\n",
       "                                       'malignant mesotheliomas': 0.1808435,\n",
       "                                       'middle molecules': 0.13657723,\n",
       "                                       'medial malleolus': 0.14496164,\n",
       "                                       'mucous membrane': 0.06885167,\n",
       "                                       'macromolecule': 0.06751648,\n",
       "                                       'multiple myeloma': 0.28917807,\n",
       "                                       'maternal mortality': 0.14152457,\n",
       "                                       'Muscle mass': 0.010522684,\n",
       "                                       'masseter muscle': 0.09541941,\n",
       "                                       'Mitochondrial myopathy': 0.1126948,\n",
       "                                       'mismatches': 0.1329335,\n",
       "                                       'model': 0.011739501,\n",
       "                                       'Molecular mechanics': -0.03758317,\n",
       "                                       'mesangial matrix': 0.0028955368,\n",
       "                                       'metastatic melanoma': 0.1962865})}),\n",
       "             'Patients must present IHC 3+ or FISH amplified results to participate in the primary trial, meaning their cancer is Histologically-confirmed as being HER2-positive.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'IHC': defaultdict(float,\n",
       "                                      {'immunohisto-chemistry': 0.29131845,\n",
       "                                       'immuno histochemical': 0.3909542,\n",
       "                                       'intrahepatic cholestasis': 0.16380046,\n",
       "                                       'Idiopathic hypercalciuria': 0.10275555,\n",
       "                                       'immunohistochemical analysis': 0.30728957,\n",
       "                                       'immunohisto-chemical': 0.2813726,\n",
       "                                       'intra-hepatic cholestasis': 0.1654551,\n",
       "                                       'idiopathic haemochromatosis': 0.24245499,\n",
       "                                       'immuno-histochemistry': 0.39610055,\n",
       "                                       'immunohistochemistry': 0.31931546,\n",
       "                                       'induced hypertension chemotherapy': 0.19718398,\n",
       "                                       'idiopathic hemochromatosis': 0.2462974,\n",
       "                                       'immunohisto chemical': 0.276607,\n",
       "                                       'Intermountain Health Care': 0.16578732,\n",
       "                                       'Immunohistochemical staining': 0.28190422,\n",
       "                                       'immuno-histochemical': 0.38138485,\n",
       "                                       'idiopathic hæmochromatosis': 0.22026911,\n",
       "                                       'immuno histochemistry': 0.39782527,\n",
       "                                       'immunohisto chemistry': 0.27167293,\n",
       "                                       'immunohistochemically': 0.24460259,\n",
       "                                       'idiopathic hypercalciuria': 0.10275555,\n",
       "                                       'inner-hair cell': 0.094483756,\n",
       "                                       'inner hair cells': 0.082163624,\n",
       "                                       'immunohistochemical': 0.2686901,\n",
       "                                       'inner hair cell': 0.07399316}),\n",
       "                          'FISH': defaultdict(float,\n",
       "                                      {'fluorescence in-situ hybridisation': 0.18873043,\n",
       "                                       'fluorescence-in-situ-hybridisation': 0.1697758,\n",
       "                                       'fluorescence in situ hybridisation': 0.18193856,\n",
       "                                       'fluorescent in situ hybridization': 0.20025358,\n",
       "                                       'fluorescence in situ hybridization technique': 0.19656822,\n",
       "                                       'fluorescence in situ hybridization': 0.19419858,\n",
       "                                       'fluorescent in situ hybridisation': 0.18848369,\n",
       "                                       'fluorescent in-situ hybridization': 0.20594953,\n",
       "                                       'fluorescence-in-situ-hybridization': 0.19033454,\n",
       "                                       'fluorescence in-situ hybridization': 0.20327617,\n",
       "                                       'fluorescent in-situ hybridisation': 0.19361915}),\n",
       "                          'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.2770351,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.29465145,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.2796311,\n",
       "                                       'human epidermal growth factor receptor 2': 0.28986895,\n",
       "                                       'human epidermal growth factor receptor-2': 0.29465145})}),\n",
       "             'the primary trial only records GI adverse events.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'GI': defaultdict(float,\n",
       "                                      {'gyrification index': 0.08367374,\n",
       "                                       'Glucagon immunoreactivity': 0.16560519,\n",
       "                                       'Gingival inflammation': 0.06642549,\n",
       "                                       'growth index': -0.056460485,\n",
       "                                       'growth inhibition': 0.0982877,\n",
       "                                       'guided imagery': -0.008637472,\n",
       "                                       'gastrointestinal tract': 0.1655863,\n",
       "                                       'genomic island': 0.081990495,\n",
       "                                       'gastrointestinal': 0.1651732,\n",
       "                                       'glass ionomer cement': 0.036130548,\n",
       "                                       'gastrointestinal illness': 0.18044798,\n",
       "                                       'germination index': 0.024275484,\n",
       "                                       'global ischaemia': 0.17674926,\n",
       "                                       'global ischemia': 0.16449808,\n",
       "                                       'galvanic isolation': 0.12398533,\n",
       "                                       'gait-initiation': 0.04761406,\n",
       "                                       'gastro-intestinal illness': 0.19285533,\n",
       "                                       'gastroenterology': 0.18438008,\n",
       "                                       'gastro-intestinal': 0.18331908,\n",
       "                                       'glycaemic indices': 0.1639162,\n",
       "                                       'glossopharyngeal insufflation': 0.05662373,\n",
       "                                       'gingival indices': 0.07737603,\n",
       "                                       'gingival index': 0.063655086,\n",
       "                                       'gastro intestinal': 0.17178501,\n",
       "                                       'glucose intolerance': 0.19532423,\n",
       "                                       'gastroenterologist': 0.17603648,\n",
       "                                       'glucose-inhibited': 0.2047397,\n",
       "                                       'GIGANTEA': 0.03387337,\n",
       "                                       'gigantocellular reticular nucleus': 0.070220925,\n",
       "                                       'gait initiation': 0.035542425,\n",
       "                                       'glycemic index': 0.13174091,\n",
       "                                       'glass ionomer': 0.076514415,\n",
       "                                       'genogroup I': 0.091662325,\n",
       "                                       'genogroup 1': 0.123050705,\n",
       "                                       'gingival inflammation': 0.06642549,\n",
       "                                       'Great Island': 0.043946605,\n",
       "                                       'gastro-enterology': 0.15232335,\n",
       "                                       'Group I': 0.017780613,\n",
       "                                       'Glass ionomer': 0.076514415,\n",
       "                                       'glycaemic index': 0.15590626,\n",
       "                                       'giant interneuron': 0.010591273,\n",
       "                                       'glass-ionomer': 0.051630426,\n",
       "                                       'genomic instability': 0.014172814})}),\n",
       "             'Female Patients with LVEF > 50%,  who have previously undergone treatment with trastuzumab emtansine or lapatinib are still eligible for the secondary trial but are excluded from the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'LVEF': defaultdict(float,\n",
       "                                      {'left-ventricular ejection fraction': 0.22083832,\n",
       "                                       'Left ventricular ejection fractions': 0.22407883,\n",
       "                                       'left ventricular function': 0.19267139,\n",
       "                                       'left ventricular ejection fraction': 0.23069482,\n",
       "                                       'left ventricle ejection fraction': 0.23407227,\n",
       "                                       'left-ventricle ejection fraction': 0.21797885,\n",
       "                                       'LV ejection fraction': 0.2365621})}),\n",
       "             'At least 8 participants in the primary trial had a Central Nervous System (CNS) Progression Free Survival (PFS) >= 3 months.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CNS': defaultdict(float,\n",
       "                                      {'central nerve system': 0.37024483,\n",
       "                                       'Congenital nephrotic syndrome': 0.09186612,\n",
       "                                       'Coagulase negative staphylococci': 0.036627643,\n",
       "                                       'Clinical nurse specialist': 0.1849722,\n",
       "                                       'coagulase negative staphylococcus': 0.045683507,\n",
       "                                       'coagulase-negative Staphylococcus': 0.064093925,\n",
       "                                       'central nerves system': 0.33867463,\n",
       "                                       'central-nervous-system': 0.34499687,\n",
       "                                       'congenital nephrotic syndrome': 0.09186612,\n",
       "                                       'central nervous system': 0.3676455,\n",
       "                                       'central nervous systems': 0.35860798,\n",
       "                                       'Crigler Najjar syndrome': 0.1471477,\n",
       "                                       'coagulase negative staph': 0.0515068,\n",
       "                                       'clinical nurse specialists': 0.19933692,\n",
       "                                       'Crigler-Najjar syndrome': 0.15187906,\n",
       "                                       'coagulase-negative staphylococci': 0.048427097,\n",
       "                                       'coagulase-negative staphylococcus': 0.064093925,\n",
       "                                       'central nervous': 0.34446532,\n",
       "                                       'clinical nurse specialist': 0.1849722,\n",
       "                                       'Canadian Neurological Scale': 0.39667213,\n",
       "                                       'coagulase-negative staphylococcal': 0.10072544,\n",
       "                                       'coagulase negative Staphylococcus': 0.045683507}),\n",
       "                          'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.05521196,\n",
       "                                       'pyrogen-free saline': 0.13484026,\n",
       "                                       'pressure-flow study': -0.04524268,\n",
       "                                       'posterior fossa syndrome': 0.15041703,\n",
       "                                       'pressure flow study': -0.027541785,\n",
       "                                       'primary fibromyalgia syndrome': 0.21068233,\n",
       "                                       'Piper Fatigue Scale': 0.17487359,\n",
       "                                       'patellofemoral syndrome': 0.08051071,\n",
       "                                       'Progression-free': 0.3000299,\n",
       "                                       'pulmonary function score': 0.22373703,\n",
       "                                       'pressure flow studies': -0.04845987,\n",
       "                                       'protein-free supernatant': 0.115749344,\n",
       "                                       'progression free survival': 0.58009785,\n",
       "                                       'protein free supernatant': 0.12501521,\n",
       "                                       'progression-free survival': 0.60734254,\n",
       "                                       'pressure/flow study': -0.006595263})}),\n",
       "             'Patients with HER2 positive breast tumors are eligible for the primary trial and the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.32769683,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.33262312,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.32985517,\n",
       "                                       'human epidermal growth factor receptor 2': 0.32638475,\n",
       "                                       'human epidermal growth factor receptor-2': 0.33262312})}),\n",
       "             'Most patients treated with Dasatinib and Letrozole in the primary trial had a Disease Free Interval (DFI) Greater Than 2 Years.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'DFI': defaultdict(float,\n",
       "                                      {'deoxyribonucleic acid fragmentation index': 0.14166087,\n",
       "                                       'daily food intake': 0.054769307,\n",
       "                                       'DNA fragmentation index': 0.038809933,\n",
       "                                       'disease free interval': 0.56023234,\n",
       "                                       'disease-free interval': 0.5470591,\n",
       "                                       'daily feed intake': 0.08079441,\n",
       "                                       'Dougados Functional Index': 0.016198428})}),\n",
       "             'There were no patients in either cohort of the primary trial with a PFS exceeding 6 months.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.12884256,\n",
       "                                       'pyrogen-free saline': 0.1969881,\n",
       "                                       'pressure-flow study': 0.03282602,\n",
       "                                       'posterior fossa syndrome': 0.15208085,\n",
       "                                       'pressure flow study': 0.029565107,\n",
       "                                       'primary fibromyalgia syndrome': 0.17716046,\n",
       "                                       'Piper Fatigue Scale': 0.09366697,\n",
       "                                       'patellofemoral syndrome': 0.13397087,\n",
       "                                       'Progression-free': 0.13307628,\n",
       "                                       'pulmonary function score': 0.16233549,\n",
       "                                       'pressure flow studies': 0.024617244,\n",
       "                                       'protein-free supernatant': 0.17095838,\n",
       "                                       'progression free survival': 0.20836544,\n",
       "                                       'protein free supernatant': 0.16063538,\n",
       "                                       'progression-free survival': 0.2378198,\n",
       "                                       'pressure/flow study': 0.03220121})}),\n",
       "             'the primary trial participants are given saracatinib PO for a maximum of 28 days.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.17173675,\n",
       "                                       'parietal operculum': 0.11154464,\n",
       "                                       'post office': 0.057576396,\n",
       "                                       'percentage of observed value': 0.11323662,\n",
       "                                       'Phenol oxidase': 0.16396645,\n",
       "                                       'parapineal organ': 0.18482639,\n",
       "                                       'power output': 0.021252336,\n",
       "                                       'predominant organism': 0.045024272,\n",
       "                                       'pulse-oximetry': 0.17133325,\n",
       "                                       'perceptual organisation': -0.05053284,\n",
       "                                       'power outputs': -0.03860717,\n",
       "                                       'Personality Organization': 0.008617531,\n",
       "                                       'postoperative': 0.1922841,\n",
       "                                       'parieto occipital': 0.13468209,\n",
       "                                       'polyolefin': 0.11762283,\n",
       "                                       'parietooccipital': 0.09474353,\n",
       "                                       'poly-olefin': 0.1449654,\n",
       "                                       'peroral': 0.14591597,\n",
       "                                       'prostate only': 0.12136888,\n",
       "                                       'pressure overload': -0.0022468027,\n",
       "                                       'peroxidase': 0.135809,\n",
       "                                       'principal olive': 0.1236936,\n",
       "                                       'peri-operative': 0.13248579,\n",
       "                                       'posterior': 0.13666046,\n",
       "                                       'Perceptual Organization': -0.038791895,\n",
       "                                       'period of onset': 0.2642191,\n",
       "                                       'posterior nuclear group': 0.09507025,\n",
       "                                       'phenol oxidase': 0.16396645,\n",
       "                                       'pressure': -0.022092009,\n",
       "                                       'per os (by mouth)': 0.19496347,\n",
       "                                       'parieto-occipital': 0.121622294,\n",
       "                                       'preoptic area': 0.11815766,\n",
       "                                       'perceptual organization': -0.038791895,\n",
       "                                       'prophylactic oophorectomy': 0.17562139,\n",
       "                                       'phosphodiester': 0.18087408,\n",
       "                                       'pre-ovulatory': 0.23495291,\n",
       "                                       'palm oil': 0.1253354,\n",
       "                                       'preovulatory': 0.27223462,\n",
       "                                       'perioperative': 0.1965949,\n",
       "                                       'post operative': 0.14965431,\n",
       "                                       'post-operative': 0.17700225,\n",
       "                                       'phospho-diester': 0.06002793,\n",
       "                                       'protein oxidation': 0.10389853,\n",
       "                                       'palm-oil': 0.10258544,\n",
       "                                       'per os': 0.12259647,\n",
       "                                       'pericardial organ': 0.07412358,\n",
       "                                       'Pulse oximetry': 0.17173675,\n",
       "                                       'paraoxon': 0.30999464,\n",
       "                                       'propylene oxide': 0.13511486,\n",
       "                                       'phenoloxidase': 0.17596552,\n",
       "                                       'peanut oil': 0.12893547})}),\n",
       "             'Patients must have LVEF < 50% to be eligible for the primary trial and the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'LVEF': defaultdict(float,\n",
       "                                      {'left-ventricular ejection fraction': 0.26214635,\n",
       "                                       'Left ventricular ejection fractions': 0.2503462,\n",
       "                                       'left ventricular function': 0.23492195,\n",
       "                                       'left ventricular ejection fraction': 0.2556826,\n",
       "                                       'left ventricle ejection fraction': 0.26541254,\n",
       "                                       'left-ventricle ejection fraction': 0.26705047,\n",
       "                                       'LV ejection fraction': 0.28605726})}),\n",
       "             'Patients must have eceptorsestrogen receptor (ER) -, progesterone receptor (PR) - and human epidermal growth factor receptor 2 (HER2) - breast cancer, aswell as not having Dysphagia.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ER': defaultdict(float,\n",
       "                                      {'extinction-ratio': 0.012077771,\n",
       "                                       'equivalent rontgen': 0.065727726,\n",
       "                                       'endo-plasmic reticulum': 0.06971847,\n",
       "                                       'emergency room': 0.10819087,\n",
       "                                       'estrogen receptor-alpha': 0.49805802,\n",
       "                                       'environmental resistance': -0.055126548,\n",
       "                                       'erythrocyte receptor': 0.27635112,\n",
       "                                       'estradiol receptor': 0.45645094,\n",
       "                                       'extended-release': 0.11746374,\n",
       "                                       'energy restriction': 0.09176984,\n",
       "                                       'energy-restricted': 0.12152699,\n",
       "                                       'estrogen-receptor': 0.49174455,\n",
       "                                       'energy retention': -0.046761155,\n",
       "                                       'electrorheological': 0.0916063,\n",
       "                                       'ejection rate': 0.09555646,\n",
       "                                       'external resistance': 0.0076887864,\n",
       "                                       'Estrogen receptor alpha': 0.46335697,\n",
       "                                       'estrogen receptor': 0.48163414,\n",
       "                                       'early': -0.020975493,\n",
       "                                       'endoplasmatic reticulum': 0.100997366,\n",
       "                                       'Estradiol': 0.33683968,\n",
       "                                       'expiratory reserve': 0.1943206,\n",
       "                                       'endovascular repair': 0.15024564,\n",
       "                                       'Emergency Room': 0.10819087,\n",
       "                                       'early reticulocyte': 0.10864172,\n",
       "                                       'esophageal rupture': 0.14042099,\n",
       "                                       'Estrogen receptors': 0.45604062,\n",
       "                                       'evoked responses': 0.16289884,\n",
       "                                       'estrogen receptor protein': 0.4354024,\n",
       "                                       'erythromycin': 0.23118709,\n",
       "                                       'enhancement ratios': 0.1016831,\n",
       "                                       'equine rhinopneumonia': 0.11067804,\n",
       "                                       'eye research': 0.1302713,\n",
       "                                       'extinction ratio': 0.016168106,\n",
       "                                       'equivalent roentgen': 0.10854329,\n",
       "                                       'emotion regulation': 0.07288991,\n",
       "                                       'enhancement ratio': 0.10135787,\n",
       "                                       'estrogen receptor status': 0.5307937,\n",
       "                                       'early repolarization': 0.1771103,\n",
       "                                       'early repolarisation': 0.16971949,\n",
       "                                       'electrical resistance': -0.008666565,\n",
       "                                       'evoked response': 0.16176523,\n",
       "                                       'efficacy ratio': 0.16683096,\n",
       "                                       'estrogen': 0.29675677,\n",
       "                                       'endoplasmic reticular': 0.1336604,\n",
       "                                       'extraction ratio': 0.11668045,\n",
       "                                       'extended release': 0.09407956,\n",
       "                                       'external rotation': -0.0010081168,\n",
       "                                       'epigastric region': 0.25815296,\n",
       "                                       'endoscopic resection': 0.20989354,\n",
       "                                       'ethoxyresorufin': 0.20074444,\n",
       "                                       'electro-resection': 0.20702636,\n",
       "                                       'early response': 0.16102906,\n",
       "                                       'endoplasmic reticulum': 0.09541447,\n",
       "                                       'enhanced reactivation': 0.10497233,\n",
       "                                       'electroresection': 0.15064543}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.2826679,\n",
       "                                       'plaque reduction': 0.0763066,\n",
       "                                       'partial response': 0.16268253,\n",
       "                                       'photoreactivation': -0.020962914,\n",
       "                                       'pentoxyresorufin': 0.13513568,\n",
       "                                       'panoramic radiography': 0.13852,\n",
       "                                       'proliferative retinopathy': 0.1254058,\n",
       "                                       'partial responses': 0.17110038,\n",
       "                                       'protein': 0.020927353,\n",
       "                                       'prorennin': 0.13043204,\n",
       "                                       'prevalence rate': 0.2212648,\n",
       "                                       'prealbumin': 0.14175105,\n",
       "                                       'pregnancy rates': 0.015726559,\n",
       "                                       'pain relief': 0.18848011,\n",
       "                                       'partial remissions': 0.42543453,\n",
       "                                       'pattern recognition': -0.07085187,\n",
       "                                       'photo-reactivation': -0.0149032995,\n",
       "                                       'protein restriction': 0.15546143,\n",
       "                                       'progesterone receptor': 0.41316497,\n",
       "                                       'placental restriction': 0.24738672,\n",
       "                                       'pneumatic retinopexy': 0.23956677,\n",
       "                                       'prorenin': 0.21225187,\n",
       "                                       'perirhinal cortex': 0.089725725,\n",
       "                                       'prothrombin ratio': 0.13308102,\n",
       "                                       'pars recta': 0.06528703,\n",
       "                                       'pattern reversal': -0.010394074,\n",
       "                                       'pr interval (ekg)': 0.15977278,\n",
       "                                       'pityriasis rosea': 0.07976798,\n",
       "                                       'prevalence ratio': 0.24610348,\n",
       "                                       'Projection reconstruction': -0.023362242,\n",
       "                                       'pregnancy rate': 0.017908188,\n",
       "                                       'phenol red': 0.15929917,\n",
       "                                       'photoreceptor': 0.011732488,\n",
       "                                       'prednisolon': 0.27342686,\n",
       "                                       'partial responders': 0.20111345,\n",
       "                                       'proline-rich': 0.112559184,\n",
       "                                       'pseudorabies': 0.11534177,\n",
       "                                       'pulmonary regurgitation': 0.22019412,\n",
       "                                       'projection reconstruction': -0.023362242,\n",
       "                                       'photo-receptor': 0.13395047,\n",
       "                                       'protease': 0.07634154,\n",
       "                                       'progestine': 0.27342966,\n",
       "                                       'pentoxy-resorufin': 0.14090452,\n",
       "                                       'partial remission': 0.3754644,\n",
       "                                       'progestin receptor': 0.38289976,\n",
       "                                       'per rectum': 0.1131397,\n",
       "                                       'Plain radiography': 0.17913204,\n",
       "                                       'production rate': -0.042036667,\n",
       "                                       'pulmonary rehabilitation': 0.16150507,\n",
       "                                       'pentoxy resorufin': 0.15088128,\n",
       "                                       'proteinase': 0.04424731,\n",
       "                                       'Paeoniae radix': 0.12753946,\n",
       "                                       'Puerto Rico': -0.01681572,\n",
       "                                       'Prevalence ratios': 0.23236662,\n",
       "                                       'perirenal': 0.06490651,\n",
       "                                       'passive recovery': 0.020844746,\n",
       "                                       'propranolol': 0.24205256,\n",
       "                                       'primary response': 0.1383742,\n",
       "                                       'pregnant': 0.024250533,\n",
       "                                       'partial regression': 0.04471175,\n",
       "                                       'Photoreactivation': -0.020962914,\n",
       "                                       'peripheral resistance': 0.11605217,\n",
       "                                       'polymorphic reticulosis': 0.13884404,\n",
       "                                       'progressive ratio': 0.059333052,\n",
       "                                       'partial responder': 0.17242087,\n",
       "                                       'projection-reconstruction': -0.016457956,\n",
       "                                       'pro-renin': 0.14592929,\n",
       "                                       'phenol-red': 0.1748805,\n",
       "                                       'progestin': 0.26903415,\n",
       "                                       'pro-rennin': 0.07540201}),\n",
       "                          'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.36963266,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.3704813,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.36742565,\n",
       "                                       'human epidermal growth factor receptor 2': 0.36276823,\n",
       "                                       'human epidermal growth factor receptor-2': 0.3704813})}),\n",
       "             'Patients with ER positive, PR positive or HER2 positive tumors may be eligible for the secondary trial or the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ER': defaultdict(float,\n",
       "                                      {'extinction-ratio': 0.08171213,\n",
       "                                       'equivalent rontgen': 0.09321166,\n",
       "                                       'endo-plasmic reticulum': 0.13501434,\n",
       "                                       'emergency room': 0.11274028,\n",
       "                                       'estrogen receptor-alpha': 0.30562538,\n",
       "                                       'environmental resistance': 0.008828381,\n",
       "                                       'erythrocyte receptor': 0.27129734,\n",
       "                                       'estradiol receptor': 0.21024518,\n",
       "                                       'extended-release': 0.16465157,\n",
       "                                       'energy restriction': 0.09301223,\n",
       "                                       'energy-restricted': 0.11000009,\n",
       "                                       'estrogen-receptor': 0.23966505,\n",
       "                                       'energy retention': -0.032398596,\n",
       "                                       'electrorheological': 0.10774624,\n",
       "                                       'ejection rate': 0.090420075,\n",
       "                                       'external resistance': 0.095081955,\n",
       "                                       'Estrogen receptor alpha': 0.25849804,\n",
       "                                       'estrogen receptor': 0.21760109,\n",
       "                                       'early': 0.03388651,\n",
       "                                       'endoplasmatic reticulum': 0.12614839,\n",
       "                                       'Estradiol': 0.058142267,\n",
       "                                       'expiratory reserve': 0.14269055,\n",
       "                                       'endovascular repair': 0.13839966,\n",
       "                                       'Emergency Room': 0.11274028,\n",
       "                                       'early reticulocyte': 0.2096603,\n",
       "                                       'esophageal rupture': 0.10665311,\n",
       "                                       'Estrogen receptors': 0.17643534,\n",
       "                                       'evoked responses': 0.18070768,\n",
       "                                       'estrogen receptor protein': 0.24699393,\n",
       "                                       'erythromycin': 0.19017965,\n",
       "                                       'enhancement ratios': 0.17799155,\n",
       "                                       'equine rhinopneumonia': 0.020056937,\n",
       "                                       'eye research': 0.15129213,\n",
       "                                       'extinction ratio': 0.08299478,\n",
       "                                       'equivalent roentgen': 0.14578421,\n",
       "                                       'emotion regulation': 0.02570761,\n",
       "                                       'enhancement ratio': 0.17556576,\n",
       "                                       'estrogen receptor status': 0.29125467,\n",
       "                                       'early repolarization': 0.17732999,\n",
       "                                       'early repolarisation': 0.17723112,\n",
       "                                       'electrical resistance': 0.08198261,\n",
       "                                       'evoked response': 0.19819833,\n",
       "                                       'efficacy ratio': 0.21950397,\n",
       "                                       'estrogen': 0.046784926,\n",
       "                                       'endoplasmic reticular': 0.15171923,\n",
       "                                       'extraction ratio': 0.124704,\n",
       "                                       'extended release': 0.14842406,\n",
       "                                       'external rotation': 0.067765355,\n",
       "                                       'epigastric region': 0.25195402,\n",
       "                                       'endoscopic resection': 0.12908539,\n",
       "                                       'ethoxyresorufin': 0.10957961,\n",
       "                                       'electro-resection': 0.23400968,\n",
       "                                       'early response': 0.19156902,\n",
       "                                       'endoplasmic reticulum': 0.109910265,\n",
       "                                       'enhanced reactivation': 0.18113868,\n",
       "                                       'electroresection': 0.1698675}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.15161358,\n",
       "                                       'plaque reduction': 0.022309657,\n",
       "                                       'partial response': 0.17930476,\n",
       "                                       'photoreactivation': 0.04730676,\n",
       "                                       'pentoxyresorufin': 0.06763923,\n",
       "                                       'panoramic radiography': 0.080229156,\n",
       "                                       'proliferative retinopathy': 0.23112762,\n",
       "                                       'partial responses': 0.16835788,\n",
       "                                       'protein': -0.024738561,\n",
       "                                       'prorennin': 0.13441096,\n",
       "                                       'prevalence rate': 0.13319992,\n",
       "                                       'prealbumin': 0.0954054,\n",
       "                                       'pregnancy rates': -0.010526967,\n",
       "                                       'pain relief': 0.015579494,\n",
       "                                       'partial remissions': 0.4814729,\n",
       "                                       'pattern recognition': -0.03284764,\n",
       "                                       'photo-reactivation': 0.07366095,\n",
       "                                       'protein restriction': 0.12580961,\n",
       "                                       'progesterone receptor': 0.19991021,\n",
       "                                       'placental restriction': 0.19062364,\n",
       "                                       'pneumatic retinopexy': 0.1789134,\n",
       "                                       'prorenin': 0.12437051,\n",
       "                                       'perirhinal cortex': 0.11211568,\n",
       "                                       'prothrombin ratio': 0.20538393,\n",
       "                                       'pars recta': 0.07119356,\n",
       "                                       'pattern reversal': 0.004969337,\n",
       "                                       'pr interval (ekg)': 0.24420522,\n",
       "                                       'pityriasis rosea': 0.061139945,\n",
       "                                       'prevalence ratio': 0.17593941,\n",
       "                                       'Projection reconstruction': -0.04889732,\n",
       "                                       'pregnancy rate': 0.0053513735,\n",
       "                                       'phenol red': 0.119671576,\n",
       "                                       'photoreceptor': 0.089857265,\n",
       "                                       'prednisolon': 0.14098822,\n",
       "                                       'partial responders': 0.20765772,\n",
       "                                       'proline-rich': 0.053328082,\n",
       "                                       'pseudorabies': 0.14991525,\n",
       "                                       'pulmonary regurgitation': 0.11733095,\n",
       "                                       'projection reconstruction': -0.04889732,\n",
       "                                       'photo-receptor': 0.13185978,\n",
       "                                       'protease': 0.086072765,\n",
       "                                       'progestine': 0.029540082,\n",
       "                                       'pentoxy-resorufin': 0.09541335,\n",
       "                                       'partial remission': 0.42168513,\n",
       "                                       'progestin receptor': 0.17821792,\n",
       "                                       'per rectum': 0.10406762,\n",
       "                                       'Plain radiography': 0.1391276,\n",
       "                                       'production rate': 0.0381135,\n",
       "                                       'pulmonary rehabilitation': 0.11517954,\n",
       "                                       'pentoxy resorufin': 0.10096204,\n",
       "                                       'proteinase': 0.07317432,\n",
       "                                       'Paeoniae radix': 0.16941546,\n",
       "                                       'Puerto Rico': 0.07653904,\n",
       "                                       'Prevalence ratios': 0.16617523,\n",
       "                                       'perirenal': 0.08369889,\n",
       "                                       'passive recovery': 0.10978201,\n",
       "                                       'propranolol': 0.070508376,\n",
       "                                       'primary response': 0.30502635,\n",
       "                                       'pregnant': -0.024056252,\n",
       "                                       'partial regression': 0.08028767,\n",
       "                                       'Photoreactivation': 0.04730676,\n",
       "                                       'peripheral resistance': 0.20787284,\n",
       "                                       'polymorphic reticulosis': 0.18009415,\n",
       "                                       'progressive ratio': 0.15173966,\n",
       "                                       'partial responder': 0.19924305,\n",
       "                                       'projection-reconstruction': -0.022689719,\n",
       "                                       'pro-renin': 0.14335768,\n",
       "                                       'phenol-red': 0.12841582,\n",
       "                                       'progestin': 0.049503066,\n",
       "                                       'pro-rennin': 0.12359035}),\n",
       "                          'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.32523644,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.3411962,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.32371432,\n",
       "                                       'human epidermal growth factor receptor 2': 0.3304789,\n",
       "                                       'human epidermal growth factor receptor-2': 0.3411962})}),\n",
       "             'All participants in the primary trial are administered with Lapatinib 1500 mg PO QD.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PO': defaultdict(float,\n",
       "                                      {'pulse oximetry': 0.14685637,\n",
       "                                       'parietal operculum': 0.17236751,\n",
       "                                       'post office': 0.04838401,\n",
       "                                       'percentage of observed value': 0.18178332,\n",
       "                                       'Phenol oxidase': 0.11968574,\n",
       "                                       'parapineal organ': 0.175784,\n",
       "                                       'power output': 0.00010507181,\n",
       "                                       'predominant organism': 0.13553628,\n",
       "                                       'pulse-oximetry': 0.14947423,\n",
       "                                       'perceptual organisation': -0.01755444,\n",
       "                                       'power outputs': -0.04205399,\n",
       "                                       'Personality Organization': -0.028395874,\n",
       "                                       'postoperative': 0.18403728,\n",
       "                                       'parieto occipital': 0.1690837,\n",
       "                                       'polyolefin': 0.1871749,\n",
       "                                       'parietooccipital': 0.15549593,\n",
       "                                       'poly-olefin': 0.15121941,\n",
       "                                       'peroral': 0.18190123,\n",
       "                                       'prostate only': 0.176158,\n",
       "                                       'pressure overload': 0.047651406,\n",
       "                                       'peroxidase': 0.1233164,\n",
       "                                       'principal olive': 0.14065284,\n",
       "                                       'peri-operative': 0.20715398,\n",
       "                                       'posterior': 0.14394268,\n",
       "                                       'Perceptual Organization': -0.022320203,\n",
       "                                       'period of onset': 0.14617246,\n",
       "                                       'posterior nuclear group': 0.096637204,\n",
       "                                       'phenol oxidase': 0.11968574,\n",
       "                                       'pressure': 0.023038758,\n",
       "                                       'per os (by mouth)': 0.21051522,\n",
       "                                       'parieto-occipital': 0.15279391,\n",
       "                                       'preoptic area': 0.019982032,\n",
       "                                       'perceptual organization': -0.022320203,\n",
       "                                       'prophylactic oophorectomy': 0.14451581,\n",
       "                                       'phosphodiester': 0.2060329,\n",
       "                                       'pre-ovulatory': 0.17603923,\n",
       "                                       'palm oil': 0.10566172,\n",
       "                                       'preovulatory': 0.2782445,\n",
       "                                       'perioperative': 0.25366676,\n",
       "                                       'post operative': 0.17034777,\n",
       "                                       'post-operative': 0.17588942,\n",
       "                                       'phospho-diester': 0.07798907,\n",
       "                                       'protein oxidation': 0.047159553,\n",
       "                                       'palm-oil': 0.07231449,\n",
       "                                       'per os': 0.19283083,\n",
       "                                       'pericardial organ': 0.15003832,\n",
       "                                       'Pulse oximetry': 0.14685637,\n",
       "                                       'paraoxon': 0.2947977,\n",
       "                                       'propylene oxide': 0.18402374,\n",
       "                                       'phenoloxidase': 0.19548686,\n",
       "                                       'peanut oil': 0.14051224}),\n",
       "                          'QD': defaultdict(float,\n",
       "                                      {'quinidine': 0.40948427,\n",
       "                                       'quaque die (every day)': 0.20479792,\n",
       "                                       'quaque die': 0.21700947,\n",
       "                                       'quinupristin-dalfopristin': 0.47079334,\n",
       "                                       'quater die': 0.20081228,\n",
       "                                       'quantum dot': 0.10961276,\n",
       "                                       'questionable dementia': 0.09811478})}),\n",
       "             'In order to meet the inclusion criteria for the primary trial patients must have had aromatase inhibitor (AI) therapy before study entry, resulting in complete tumor response.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'AI': defaultdict(float,\n",
       "                                      {'avidity index': 0.12388939,\n",
       "                                       'anaphylatoxin inactivator': 0.21629243,\n",
       "                                       'Apnoea Index': 0.20458707,\n",
       "                                       'anaphylatoxin inhibitor': 0.22432487,\n",
       "                                       'Axonal injury': 0.050216574,\n",
       "                                       'anal incontinence': 0.0891516,\n",
       "                                       'adrenal incidentalomas': 0.24277434,\n",
       "                                       'auto-immune': 0.11823518,\n",
       "                                       'accidental injury': -0.020008046,\n",
       "                                       'allergy and immunology': 0.19584928,\n",
       "                                       'apnoea index': 0.20458707,\n",
       "                                       'artificial insemination': 0.15622635,\n",
       "                                       'aluminum': 0.021778112,\n",
       "                                       'American Indian': 0.05473225,\n",
       "                                       'Apoptosis': 0.109925166,\n",
       "                                       'angiotensine-I': 0.20652534,\n",
       "                                       'American Indians': 0.042121343,\n",
       "                                       'after infection': 0.06026324,\n",
       "                                       'atrial insufficiency': 0.16652326,\n",
       "                                       'angiotensin-I': 0.2077864,\n",
       "                                       'angiogenesis inhibitor': 0.2858291,\n",
       "                                       'autoimmunity': 0.18468222,\n",
       "                                       'activity index': 0.07743449,\n",
       "                                       'asymmetry index': 0.041188534,\n",
       "                                       'androgen independent': 0.28430256,\n",
       "                                       'Astragalus Injection': 0.12594758,\n",
       "                                       'atherogenic index': 0.13813926,\n",
       "                                       'apoptosis index': 0.23580793,\n",
       "                                       'avian influenza': -0.018461252,\n",
       "                                       'anxiety index': 0.14788261,\n",
       "                                       'apnea index': 0.17344767,\n",
       "                                       'axioincisal': 0.060790293,\n",
       "                                       'autoimmune': 0.17344613,\n",
       "                                       'Artificial intelligence': 0.04058042,\n",
       "                                       'adiposity index': 0.13779114,\n",
       "                                       'association-induction': 0.065876946,\n",
       "                                       'angiotensine I': 0.19240047,\n",
       "                                       'Amelogenesis imperfecta': 0.21365356,\n",
       "                                       'artificial inseminations': 0.16737877,\n",
       "                                       'aromatase inhibitor': 0.59033996,\n",
       "                                       'acetabular index': 0.13632943,\n",
       "                                       'apoptotic index': 0.2739756,\n",
       "                                       'adrenal insufficiency': 0.22123346,\n",
       "                                       'apical impulse': 0.012776591,\n",
       "                                       'allelic imbalances': 0.26593336,\n",
       "                                       'aortic insufficiency': 0.18059027,\n",
       "                                       'auto-immunity': 0.12782618,\n",
       "                                       'artificially inseminated': 0.18406107,\n",
       "                                       'axio-incisal': 0.12711854,\n",
       "                                       'Apoptotic': 0.10117272,\n",
       "                                       'adequate intake': 0.1383998,\n",
       "                                       'anterior insula': 0.10504496,\n",
       "                                       'artificial intelligence': 0.04058042,\n",
       "                                       'anti-inflammatory': 0.17665045,\n",
       "                                       'aortic incompetence': 0.13380407,\n",
       "                                       'articulation index': 0.06896695,\n",
       "                                       'angiotensin I': 0.19251905,\n",
       "                                       'aromatase inhibitors': 0.5657012,\n",
       "                                       'angiotensine 1': 0.19258596,\n",
       "                                       'angiotensin-1': 0.20048273,\n",
       "                                       'angiotensine-1': 0.19923013,\n",
       "                                       'activity': -0.05997906,\n",
       "                                       'Adequate Intake': 0.1383998,\n",
       "                                       'anchorage-independent': 0.10458555,\n",
       "                                       'acute ileus': 0.00031715355,\n",
       "                                       'apoptotic indices': 0.23434189,\n",
       "                                       'allelic imbalance': 0.2696063,\n",
       "                                       'Apnea Index': 0.17344767,\n",
       "                                       'active ingredient': 0.1568706,\n",
       "                                       'androgen-independent': 0.31886983,\n",
       "                                       'angiotensin 1': 0.18102361,\n",
       "                                       'aggregation index': 0.10151726})}),\n",
       "             'In order to be eligible for both the secondary trial and the primary trial, patients must be female, over the age of 18, ECOG <2 and have Histologically confirmed HER2 + breast cancer.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ECOG': defaultdict(float,\n",
       "                                      {'electrocorticogram': 0.060810897,\n",
       "                                       'Eastern Cooperative Oncology Group': 0.42168617,\n",
       "                                       'eastern cooperative oncology group': 0.42168617,\n",
       "                                       'Electrocochleography': 0.060853038,\n",
       "                                       'electrocochleogram': 0.066144295,\n",
       "                                       'electrocortical activity': 0.05385437,\n",
       "                                       'electrocorticograms': 0.072922565,\n",
       "                                       'electrocortical': 0.02130437}),\n",
       "                          'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.27263,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.2798768,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.27962735,\n",
       "                                       'human epidermal growth factor receptor 2': 0.28230533,\n",
       "                                       'human epidermal growth factor receptor-2': 0.2798768})}),\n",
       "             'Participants of the primary trial must undergo at least one MRI during the intervention and a strict chemotherapy regiment, whereas in the secondary trial patients must use a fitbit.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MRI': defaultdict(float,\n",
       "                                      {'magnetic-resonance imaging': 0.2610424,\n",
       "                                       'MR-imaging': 0.34769106,\n",
       "                                       'magnetic resonance imaging': 0.27765867,\n",
       "                                       'magnetic resonance images': 0.24673419,\n",
       "                                       'magnetic resonance': 0.19658144,\n",
       "                                       'Magnetic resonance imagings': 0.30757648,\n",
       "                                       'magnet resonance imaging': 0.2713554,\n",
       "                                       'MR imaging': 0.34179085,\n",
       "                                       'magnetic-resonance-imaging': 0.25190592,\n",
       "                                       'magnetic resonance imagery': 0.2249118,\n",
       "                                       'Magnetic resonance imaging scan': 0.3284723,\n",
       "                                       'magnetic resonance tomography': 0.2524025,\n",
       "                                       'magnetic resonance image': 0.22523287,\n",
       "                                       'Magnetic resonance image': 0.22523287})}),\n",
       "             'There was one GU and three GI adverse events recorded in the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'GU': defaultdict(float,\n",
       "                                      {'Goldblatt unit': 0.1480988,\n",
       "                                       'glycogenic unit': 0.34770924,\n",
       "                                       'glucose utilization': 0.2877403,\n",
       "                                       'genito urinary': 0.28801304,\n",
       "                                       'gastric ulcer': 0.37335056,\n",
       "                                       'gastric': 0.32510632,\n",
       "                                       'glucose uptake': 0.24645329,\n",
       "                                       'gravitational ulcer': 0.3894316,\n",
       "                                       'gonococcal urethritis': 0.21355416,\n",
       "                                       'gastric ulcers': 0.3818111,\n",
       "                                       'Glucose uptake': 0.24645329,\n",
       "                                       'genito-urinary': 0.2811332,\n",
       "                                       'genitourinary': 0.24188149}),\n",
       "                          'GI': defaultdict(float,\n",
       "                                      {'gyrification index': 0.22959255,\n",
       "                                       'Glucagon immunoreactivity': 0.368071,\n",
       "                                       'Gingival inflammation': 0.19105473,\n",
       "                                       'growth index': 0.06706121,\n",
       "                                       'growth inhibition': 0.18547726,\n",
       "                                       'guided imagery': 0.010884317,\n",
       "                                       'gastrointestinal tract': 0.30685622,\n",
       "                                       'genomic island': 0.17461589,\n",
       "                                       'gastrointestinal': 0.31086916,\n",
       "                                       'glass ionomer cement': 0.062217604,\n",
       "                                       'gastrointestinal illness': 0.35814244,\n",
       "                                       'germination index': 0.16378498,\n",
       "                                       'global ischaemia': 0.29297736,\n",
       "                                       'global ischemia': 0.26890236,\n",
       "                                       'galvanic isolation': 0.09061907,\n",
       "                                       'gait-initiation': 0.13819745,\n",
       "                                       'gastro-intestinal illness': 0.36520994,\n",
       "                                       'gastroenterology': 0.34318483,\n",
       "                                       'gastro-intestinal': 0.30442235,\n",
       "                                       'glycaemic indices': 0.37667635,\n",
       "                                       'glossopharyngeal insufflation': 0.2144148,\n",
       "                                       'gingival indices': 0.22598703,\n",
       "                                       'gingival index': 0.21340856,\n",
       "                                       'gastro intestinal': 0.301678,\n",
       "                                       'glucose intolerance': 0.37226924,\n",
       "                                       'gastroenterologist': 0.2928434,\n",
       "                                       'glucose-inhibited': 0.37819418,\n",
       "                                       'GIGANTEA': 0.18906277,\n",
       "                                       'gigantocellular reticular nucleus': 0.09632068,\n",
       "                                       'gait initiation': 0.11518825,\n",
       "                                       'glycemic index': 0.3530108,\n",
       "                                       'glass ionomer': 0.096574835,\n",
       "                                       'genogroup I': 0.22212468,\n",
       "                                       'genogroup 1': 0.26738757,\n",
       "                                       'gingival inflammation': 0.19105473,\n",
       "                                       'Great Island': 0.11351353,\n",
       "                                       'gastro-enterology': 0.29948103,\n",
       "                                       'Group I': 0.171177,\n",
       "                                       'Glass ionomer': 0.096574835,\n",
       "                                       'glycaemic index': 0.3734531,\n",
       "                                       'giant interneuron': 0.017567845,\n",
       "                                       'glass-ionomer': 0.094325036,\n",
       "                                       'genomic instability': 0.16123468})}),\n",
       "             'The majority of the primary trial participants achieved CR or PR.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'CR': defaultdict(float,\n",
       "                                      {'cross-reactive': 0.011279777,\n",
       "                                       'clot retraction': 0.11823461,\n",
       "                                       'conditioned response': 0.1391217,\n",
       "                                       'conditioned reflex': 0.112174675,\n",
       "                                       'charge recombination': 0.0497836,\n",
       "                                       'Czech Republic': 0.05272752,\n",
       "                                       'control region': 0.0784625,\n",
       "                                       'colonization rate': 0.16431439,\n",
       "                                       'complete remission rate': 0.4450574,\n",
       "                                       'Charles River': 0.07085493,\n",
       "                                       'Caloric restriction': 0.12949577,\n",
       "                                       'colonisation resistance': 0.09313868,\n",
       "                                       'complete regression': 0.15010178,\n",
       "                                       'conversion rate': 0.26189104,\n",
       "                                       'chest roentgenography': 0.1731673,\n",
       "                                       'chest radiograph': 0.16722402,\n",
       "                                       'colony reared': 0.06516133,\n",
       "                                       'cardiorespiratory': 0.13037103,\n",
       "                                       'circadian rhythm': 0.085384,\n",
       "                                       'cardiac rupture': 0.118131414,\n",
       "                                       'carbonyl reductase': 0.09037185,\n",
       "                                       'calorie restriction': 0.1093151,\n",
       "                                       'cortical reaction': 0.14447537,\n",
       "                                       'complete remissions': 0.3200456,\n",
       "                                       'chest radiography': 0.1514244,\n",
       "                                       'computerised record': 0.109252356,\n",
       "                                       'charge-recombination': 0.044512335,\n",
       "                                       'Cardiac Rehabilitation': 0.24143752,\n",
       "                                       'calcium-binding protein calretinin': 0.1309564,\n",
       "                                       'chronic rejection': 0.10750361,\n",
       "                                       'colony-reared': 0.08840726,\n",
       "                                       'cognitive reserve': 0.21413341,\n",
       "                                       'critical ratio': 0.22753057,\n",
       "                                       'cortico-resistant': 0.2885659,\n",
       "                                       'caloric restriction': 0.12949577,\n",
       "                                       'corticoresistant': 0.14799654,\n",
       "                                       'corticosteroid-resistant': 0.18364865,\n",
       "                                       'Congo red': 0.036706742,\n",
       "                                       'complete responses': 0.23435444,\n",
       "                                       'chest and right arm': 0.071832396,\n",
       "                                       'conditioned reinforcement': 0.13439277,\n",
       "                                       'constant routine': 0.108770646,\n",
       "                                       'cardio-respiratory': 0.18359579,\n",
       "                                       'complete response rate': 0.38246474,\n",
       "                                       'cockroach': -0.049349196,\n",
       "                                       'chief resident': 0.07782276,\n",
       "                                       'calorie-restricted': 0.11854656,\n",
       "                                       'complete responders': 0.30161697,\n",
       "                                       'cysteine-rich': 0.13295929,\n",
       "                                       'controlled-release': 0.151298,\n",
       "                                       'chemoradiation': 0.09153371,\n",
       "                                       'crown-rump': -0.004216493,\n",
       "                                       'crown-rump length': 0.05934717,\n",
       "                                       'creatinine': 0.22710344,\n",
       "                                       'capture-recapture': 0.07210512,\n",
       "                                       'Congo-red': 0.05055783,\n",
       "                                       'coefficient of repeatability': 0.33158305,\n",
       "                                       'computed radiography': 0.15761006,\n",
       "                                       'controlled respiration': 0.12830907,\n",
       "                                       'conditioned reward': 0.12692998,\n",
       "                                       'complement receptors': 0.23509033,\n",
       "                                       'concentration-response': 0.21937153,\n",
       "                                       'complete': 0.075624466,\n",
       "                                       'chest roentgenogram': 0.17515571,\n",
       "                                       'complement receptor': 0.2253452,\n",
       "                                       'Cajal-Retzius': 0.064617544,\n",
       "                                       'cremasteric reflex': 0.22515179,\n",
       "                                       'clot-retraction': 0.09525038,\n",
       "                                       'conserved regions': 0.05134843,\n",
       "                                       'child-resistant': 0.074803494,\n",
       "                                       'control rats': 0.07900902,\n",
       "                                       'caries-resistant': 0.078830004,\n",
       "                                       'coronary revascularization': 0.22694355,\n",
       "                                       'colon resection': 0.08122424,\n",
       "                                       'contrast ratio': 0.18778345,\n",
       "                                       'concentration ratio': 0.27189258,\n",
       "                                       'Calreticulin': 0.07619628,\n",
       "                                       'composite resin': -0.006942025,\n",
       "                                       'completely': 0.12772629,\n",
       "                                       'colorectal': 0.06597541,\n",
       "                                       'complete response': 0.15938367,\n",
       "                                       'coronary risk': 0.24258713,\n",
       "                                       'conventional radiology': 0.20158112,\n",
       "                                       'Complete response': 0.15938367,\n",
       "                                       'cathode ray': 0.029318318,\n",
       "                                       'complete responder': 0.22553849,\n",
       "                                       'controlled release': 0.11291045,\n",
       "                                       'conditioned reflexes': 0.14097048,\n",
       "                                       'chemo-radiation': 0.17476894,\n",
       "                                       'complete remission': 0.277599,\n",
       "                                       'conserved region': 0.021058097,\n",
       "                                       'coronary resistance': 0.2863925,\n",
       "                                       'cardiac resuscitation': 0.18420112,\n",
       "                                       'computed radiographic': 0.16357496,\n",
       "                                       'cooling rate': 0.014356557,\n",
       "                                       'clinical research': 0.47142255,\n",
       "                                       'colonization resistance': 0.08811272,\n",
       "                                       'compression ratio': 0.09722395,\n",
       "                                       'computerized record': 0.107764214,\n",
       "                                       'chromium': 0.09308238,\n",
       "                                       'colo-rectal': 0.08807945,\n",
       "                                       'contractile reserve': 0.12178862,\n",
       "                                       'clinical record': 0.33164838,\n",
       "                                       'concentration ratios': 0.2696433,\n",
       "                                       'clinical remission': 0.37280986,\n",
       "                                       'centric relation': 0.054179255,\n",
       "                                       'cardiac rhythm': 0.0952816,\n",
       "                                       'capillary refill': 0.095209554,\n",
       "                                       'colonisation rate': 0.15904473,\n",
       "                                       'conventional radiography': 0.1671144,\n",
       "                                       'cellular receptor': 0.1226432}),\n",
       "                          'PR': defaultdict(float,\n",
       "                                      {'prednisolone': 0.11440741,\n",
       "                                       'plaque reduction': 0.08490534,\n",
       "                                       'partial response': 0.23071639,\n",
       "                                       'photoreactivation': 0.059048716,\n",
       "                                       'pentoxyresorufin': 0.07652639,\n",
       "                                       'panoramic radiography': 0.12430598,\n",
       "                                       'proliferative retinopathy': 0.1538351,\n",
       "                                       'partial responses': 0.26851237,\n",
       "                                       'protein': 0.091473065,\n",
       "                                       'prorennin': 0.13974838,\n",
       "                                       'prevalence rate': 0.34181756,\n",
       "                                       'prealbumin': 0.07392131,\n",
       "                                       'pregnancy rates': 0.16247553,\n",
       "                                       'pain relief': 0.13027866,\n",
       "                                       'partial remissions': 0.37626362,\n",
       "                                       'pattern recognition': 0.043060046,\n",
       "                                       'photo-reactivation': 0.08573941,\n",
       "                                       'protein restriction': 0.14998989,\n",
       "                                       'progesterone receptor': 0.14116055,\n",
       "                                       'placental restriction': 0.12323947,\n",
       "                                       'pneumatic retinopexy': 0.18915746,\n",
       "                                       'prorenin': 0.18344751,\n",
       "                                       'perirhinal cortex': 0.15965113,\n",
       "                                       'prothrombin ratio': 0.28993487,\n",
       "                                       'pars recta': 0.09173128,\n",
       "                                       'pattern reversal': 0.06760391,\n",
       "                                       'pr interval (ekg)': 0.30680293,\n",
       "                                       'pityriasis rosea': 0.025786614,\n",
       "                                       'prevalence ratio': 0.38204956,\n",
       "                                       'Projection reconstruction': 0.04427726,\n",
       "                                       'pregnancy rate': 0.15525138,\n",
       "                                       'phenol red': 0.13182887,\n",
       "                                       'photoreceptor': 0.034201104,\n",
       "                                       'prednisolon': 0.12028786,\n",
       "                                       'partial responders': 0.2964623,\n",
       "                                       'proline-rich': 0.10383737,\n",
       "                                       'pseudorabies': 0.13701923,\n",
       "                                       'pulmonary regurgitation': 0.16264592,\n",
       "                                       'projection reconstruction': 0.04427726,\n",
       "                                       'photo-receptor': 0.06489192,\n",
       "                                       'protease': 0.08604426,\n",
       "                                       'progestine': 0.08597843,\n",
       "                                       'pentoxy-resorufin': 0.1161135,\n",
       "                                       'partial remission': 0.34779093,\n",
       "                                       'progestin receptor': 0.12755083,\n",
       "                                       'per rectum': 0.1116051,\n",
       "                                       'Plain radiography': 0.1347662,\n",
       "                                       'production rate': 0.17481716,\n",
       "                                       'pulmonary rehabilitation': 0.23392381,\n",
       "                                       'pentoxy resorufin': 0.13676253,\n",
       "                                       'proteinase': 0.08406429,\n",
       "                                       'Paeoniae radix': 0.1606223,\n",
       "                                       'Puerto Rico': 0.08782918,\n",
       "                                       'Prevalence ratios': 0.37543482,\n",
       "                                       'perirenal': 0.06973301,\n",
       "                                       'passive recovery': 0.115442365,\n",
       "                                       'propranolol': 0.112491995,\n",
       "                                       'primary response': 0.37355927,\n",
       "                                       'pregnant': -0.00033095665,\n",
       "                                       'partial regression': 0.18284118,\n",
       "                                       'Photoreactivation': 0.059048716,\n",
       "                                       'peripheral resistance': 0.20855507,\n",
       "                                       'polymorphic reticulosis': 0.19671768,\n",
       "                                       'progressive ratio': 0.27529106,\n",
       "                                       'partial responder': 0.2070603,\n",
       "                                       'projection-reconstruction': 0.066893905,\n",
       "                                       'pro-renin': 0.19965145,\n",
       "                                       'phenol-red': 0.14165312,\n",
       "                                       'progestin': 0.069522634,\n",
       "                                       'pro-rennin': 0.17113337})}),\n",
       "             'Best Overall Response (BOR) was less than 10% higher in cohort 1 of the primary trial than in cohort 2.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'BOR': defaultdict(float,\n",
       "                                      {'branchiootorenal': 0.20335668,\n",
       "                                       'branchio-otorenal': 0.17747088,\n",
       "                                       'branchio-oto-renal': 0.22331725,\n",
       "                                       'Branchio-oto-renal syndrome': 0.17221165,\n",
       "                                       'boronate': 0.1550339,\n",
       "                                       'borage oil': 0.17425711,\n",
       "                                       'basal optic root': 0.09566246})}),\n",
       "             'In the primary trial there was no recorded difference in the Number/percentage of Participants With Dose Limiting Toxicities taking 100 mg vs 125 mg of oral PD-0332991.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PD': defaultdict(float,\n",
       "                                      {'personality disorders': 0.02882311,\n",
       "                                       'pyridostigmine': 0.2670445,\n",
       "                                       'protein': -0.017260801,\n",
       "                                       'protein deposition': 0.058457483,\n",
       "                                       \"Parkinsons's disease\": 0.1889993,\n",
       "                                       \"Parkinson's disease with dementia\": 0.29263666,\n",
       "                                       'posterior descending': 0.07301162,\n",
       "                                       'pancreatoduodenectomy': 0.13077907,\n",
       "                                       'percutaneous drainage': 0.10558842,\n",
       "                                       'proximal-distal': 0.13744971,\n",
       "                                       'postural drainage': 0.08940751,\n",
       "                                       'periodontal disease': 0.10247304,\n",
       "                                       'peritoneal dialysate': 0.17704307,\n",
       "                                       'psychological distress': 0.0176803,\n",
       "                                       'pyloric dilator': 0.14009048,\n",
       "                                       'plasmodesma': 0.05529125,\n",
       "                                       'pharmacokinetic (PK)-pharmacodynamic': 0.43055576,\n",
       "                                       'provocation dose': 0.24147989,\n",
       "                                       'Perfusion defect': 0.1616645,\n",
       "                                       'prism diopter': 0.013041969,\n",
       "                                       'pharmacodynamic': 0.2916625,\n",
       "                                       'Preterm Delivery': 0.06109763,\n",
       "                                       'protein D': 0.13026768,\n",
       "                                       'Peyronies disease': 0.106064506,\n",
       "                                       'Pagets disease': 0.1350894,\n",
       "                                       'probing pocket depth': -0.036701962,\n",
       "                                       'pupillary diameter': 0.090223394,\n",
       "                                       'pancreatic duct': 0.07135311,\n",
       "                                       'pneumatic dilation': 0.0637643,\n",
       "                                       'Postnatal Day': -0.024423838,\n",
       "                                       'pupil diameter': 0.028845044,\n",
       "                                       'prednisolone': 0.2545652,\n",
       "                                       'pharmaco-dynamic': 0.33102292,\n",
       "                                       'parkinsonism-dementia': 0.24207437,\n",
       "                                       'persistent diarrhea': 0.095148,\n",
       "                                       'persistent diarrhoea': 0.0920704,\n",
       "                                       'Phosducin': 0.19514965,\n",
       "                                       'parkinsonian': 0.13845044,\n",
       "                                       \"prisoner's dilemma\": 0.039931253,\n",
       "                                       'pharmaco-dynamics': 0.27809677,\n",
       "                                       'progressed': 0.0686966,\n",
       "                                       'Parkinsonism-dementia': 0.24207437,\n",
       "                                       'pancreatico-duodenectomy': 0.05993676,\n",
       "                                       'prism diopters': 0.0053621517,\n",
       "                                       'postnatal days': -0.02382727,\n",
       "                                       'potential difference across the cell membrane': 0.0567528,\n",
       "                                       'peritoneal drainage': 0.09710462,\n",
       "                                       'Pancreas divisum': 0.18021528,\n",
       "                                       'pancreas disease': 0.09697322,\n",
       "                                       'personality disorder': 0.044313867,\n",
       "                                       'pulse duration': 0.07957601,\n",
       "                                       'paired domain': -0.058138542,\n",
       "                                       'population doubling': -0.0048653125,\n",
       "                                       'Picks disease': 0.054021083,\n",
       "                                       'peripheral dose': 0.45637286,\n",
       "                                       \"Peyronie's disease\": 0.14541389,\n",
       "                                       'pancreato-duodenectomy': 0.096552886,\n",
       "                                       'plasmodesmata': -0.0464065,\n",
       "                                       'platelet deposition': 0.1415824,\n",
       "                                       \"Parkinson's disease\": 0.19154161,\n",
       "                                       'power density': 0.043589327,\n",
       "                                       'potential differences': 0.1699075,\n",
       "                                       \"Pierce's disease\": 0.07526764,\n",
       "                                       'progestin-dependent': 0.20069307,\n",
       "                                       'protein degradation': 0.030018,\n",
       "                                       'parkinsonism dementia': 0.20491573,\n",
       "                                       'plasma desorption': 0.004849155,\n",
       "                                       'purging disorder': 0.1190931,\n",
       "                                       'Parkinsonism dementia': 0.20491573,\n",
       "                                       \"Parkinson's diseases\": 0.20213754,\n",
       "                                       'power Doppler': -0.024223048,\n",
       "                                       'prism dioptres': 0.0044180234,\n",
       "                                       'pneumatic dilatation': 0.080446914,\n",
       "                                       'platycodin D': 0.15321803,\n",
       "                                       'pharmacodynamics': 0.29753125,\n",
       "                                       'phosphate depletion': 0.13059394,\n",
       "                                       'probing depth': -0.013104619,\n",
       "                                       'program director': 0.08364154,\n",
       "                                       'progressive disease': 0.16901895,\n",
       "                                       \"Paget's disease\": 0.16188782,\n",
       "                                       'poorly differentiated': 0.14754169,\n",
       "                                       'prenatal diagnosis': 0.0480251,\n",
       "                                       'Prenatal diagnosis': 0.0480251,\n",
       "                                       \"parkinson's disease\": 0.19154161,\n",
       "                                       'pressure-diameter': -0.017628321,\n",
       "                                       'pars distalis': 0.054028846,\n",
       "                                       'pancreaticoduodenectomy': 0.08251003,\n",
       "                                       \"Prisoner's Dilemma\": 0.039931253,\n",
       "                                       'panic disorder': 0.00054660445,\n",
       "                                       'Parkinsons disease': 0.17079103,\n",
       "                                       \"Parkinsons' disease\": 0.18229336,\n",
       "                                       'P-wave dispersion': 0.049591493,\n",
       "                                       'P wave dispersion': 0.0649705,\n",
       "                                       'parkinsons disease': 0.17079103,\n",
       "                                       'pulsed Doppler': -0.0060058334,\n",
       "                                       'Psychopathic deviate': 0.036841046,\n",
       "                                       'pancreas divisum': 0.18021528,\n",
       "                                       'postnatal day': -0.024423838,\n",
       "                                       'Prolidase deficiency': 0.24093367,\n",
       "                                       'pocket depth': -0.029107437,\n",
       "                                       'proton density': 0.08303796,\n",
       "                                       'pirfenidone': 0.18319447,\n",
       "                                       'probing depths': -0.04760215,\n",
       "                                       'Parkinson disease': 0.19804327,\n",
       "                                       'potential difference': 0.11246974,\n",
       "                                       \"Pick's disease\": 0.05318674,\n",
       "                                       'peritoneal dialysis': 0.12391744,\n",
       "                                       'power of discrimination': 0.10917089,\n",
       "                                       'pseudo-deficiency': 0.20885132,\n",
       "                                       'patients': 0.20744964,\n",
       "                                       'population doublings': 0.011020581,\n",
       "                                       'psychiatric disorder': 0.01928754,\n",
       "                                       \"prisoners' dilemma\": 0.07094947,\n",
       "                                       'preferred direction': 0.07476073,\n",
       "                                       'Parkinsonism': 0.16823678,\n",
       "                                       'pseudodeficiency': 0.19456871})}),\n",
       "             'postmenopausal women with T1-4N1-3M1 Early invasive breast cancer are eligible for the primary trial, and Premenopausal women with T4-4N1-3M1 Early invasive breast cancerare eligible for the secondary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'T1': defaultdict(float,\n",
       "                                      {'thoracic 1': 0.115335956,\n",
       "                                       'term births': 0.051845264,\n",
       "                                       'tricuspid first sound': 0.07283568,\n",
       "                                       'type 1': 0.19063357,\n",
       "                                       'twitch height': -0.051484164,\n",
       "                                       'Time 1': 0.14708874,\n",
       "                                       'thoracic vertebra 1': 0.04403348,\n",
       "                                       't1 (size, tumor staging)': 0.43410933,\n",
       "                                       'time 1': 0.14708874,\n",
       "                                       'therapy': -0.009954429,\n",
       "                                       't1 (first thoracic vertebra)': 0.18258253,\n",
       "                                       'treatment 1': 0.21280031}),\n",
       "                          'T4': defaultdict(float,\n",
       "                                      {'tetraiodothyronine': 0.09663603,\n",
       "                                       'thyroxin': 0.08501157,\n",
       "                                       'thyroxine': 0.102629125,\n",
       "                                       'thyroid hormone': 0.07737439,\n",
       "                                       't4 (fourth thoracic vertebra)': 0.23793162,\n",
       "                                       'T helper cells': 0.1753775,\n",
       "                                       'thyroxine level': 0.17696851,\n",
       "                                       'tripchlorolide': 0.034841243,\n",
       "                                       'tumor': 0.20254551,\n",
       "                                       'thoracic vertebra 4': 0.1144596,\n",
       "                                       'time 4': 0.097849905,\n",
       "                                       'T helper': 0.08329126})}),\n",
       "             'Fluorouracil, testosterone, and cyclophosphamide (FEC) are used in both cohorts of the secondary trial, but not in cohort 1 of the primary trial.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'FEC': defaultdict(float,\n",
       "                                      {'faecal egg counts': 0.090778284,\n",
       "                                       'Friend erythroleukaemia cell': 0.19894616,\n",
       "                                       'free erythrocyte coproporphyrin': 0.24703337,\n",
       "                                       'faecal egg count': 0.09602969,\n",
       "                                       'Friend erythroleukemia cell': 0.1970609,\n",
       "                                       'Friend erythroleukæmia cell': 0.17705275,\n",
       "                                       'fecal egg count': 0.10806743,\n",
       "                                       'fæcal egg count': 0.20136806})}),\n",
       "             'Patients will have to undergo an MRI scan of the spine for before entry for both the secondary trial and the primary trial, for the primary trial patients will also need to have a brain MR and PET imaging, after study entry.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'MRI': defaultdict(float,\n",
       "                                      {'magnetic-resonance imaging': 0.3542712,\n",
       "                                       'MR-imaging': 0.44311538,\n",
       "                                       'magnetic resonance imaging': 0.39294174,\n",
       "                                       'magnetic resonance images': 0.36771235,\n",
       "                                       'magnetic resonance': 0.22296661,\n",
       "                                       'Magnetic resonance imagings': 0.43081558,\n",
       "                                       'magnet resonance imaging': 0.38179728,\n",
       "                                       'MR imaging': 0.45258117,\n",
       "                                       'magnetic-resonance-imaging': 0.33455983,\n",
       "                                       'magnetic resonance imagery': 0.31298992,\n",
       "                                       'Magnetic resonance imaging scan': 0.45929852,\n",
       "                                       'magnetic resonance tomography': 0.37160504,\n",
       "                                       'magnetic resonance image': 0.31590396,\n",
       "                                       'Magnetic resonance image': 0.31590396}),\n",
       "                          'MR': defaultdict(float,\n",
       "                                      {'molecular remission': 0.14187746,\n",
       "                                       'measles and rubella': 0.14504117,\n",
       "                                       'muscle relaxant': 0.06285078,\n",
       "                                       'Maillard reaction': -0.057466675,\n",
       "                                       'mitochondria-rich': 0.034087088,\n",
       "                                       'mitotic rate': 0.002927149,\n",
       "                                       'Maudsley reactive': -0.047838528,\n",
       "                                       'mitral regurgitation': 0.15105282,\n",
       "                                       'methyl-red': 0.03630757,\n",
       "                                       'mentally-retarded': 0.027756412,\n",
       "                                       'multiresistant': 0.047127243,\n",
       "                                       'mannose receptor': 0.07919494,\n",
       "                                       'magnetoresistance': 0.038985856,\n",
       "                                       'median raphe nucleus': 0.16862032,\n",
       "                                       'mister': -0.031557437,\n",
       "                                       'methemoglobin reductase': 0.08087661,\n",
       "                                       'mannose-resistant': 0.030447764,\n",
       "                                       'muscle-relaxant': 0.09335162,\n",
       "                                       'macrophage mannose receptor': 0.053448785,\n",
       "                                       'mandelate racemase': -0.033796318,\n",
       "                                       'medical record': 0.32857537,\n",
       "                                       'mandibular reflex': 0.07672689,\n",
       "                                       'mentally retarded': 0.044256847,\n",
       "                                       'milk replacer': -0.05905109,\n",
       "                                       'medial raphe': 0.23423435,\n",
       "                                       'magnetic resistance': 0.07418466,\n",
       "                                       'molecular replacement': 0.0016175603,\n",
       "                                       'modulation rate': 0.061129186,\n",
       "                                       'magnetic resonance': 0.22296661,\n",
       "                                       'mitral reflux': 0.15363802,\n",
       "                                       'mortality ratio': 0.05361923,\n",
       "                                       'minor response': 0.05563063,\n",
       "                                       'metabolic rate': 0.05825976,\n",
       "                                       'methyl red': 0.014789655,\n",
       "                                       'medical representative': 0.25886753,\n",
       "                                       'mortality-rate': 0.04354911,\n",
       "                                       'metabolic rates': 0.05285083,\n",
       "                                       'mineralocorticoid receptor': 0.07729513,\n",
       "                                       'mannose resistant': 0.02351763,\n",
       "                                       'metabolic ratio': 0.079451114,\n",
       "                                       'methicillin-resistant': 0.06615765,\n",
       "                                       'morbid risk': 0.20669308,\n",
       "                                       'multicentric reticulohistiocytosis': 0.07706388,\n",
       "                                       'muscle receptor': 0.07953765,\n",
       "                                       'modified release': 0.1301646,\n",
       "                                       'megaroentgen': 0.02126451,\n",
       "                                       'metabolic ratios': 0.07499003,\n",
       "                                       'mortality rate': 0.023783563,\n",
       "                                       'multi-receptive': 0.09501517,\n",
       "                                       'magnetic-resonance': 0.19272247,\n",
       "                                       'Maddox rod': 0.07071582,\n",
       "                                       'modified-release': 0.10726738,\n",
       "                                       'myocardial revascularization': 0.1665388,\n",
       "                                       'mother reared': -0.047658782,\n",
       "                                       'minor responses': 0.06498591,\n",
       "                                       'mitral valve regurgitation': 0.084114395,\n",
       "                                       'Multicentric reticulohistiocytosis': 0.07706388,\n",
       "                                       'medication reconciliation': 0.23644239,\n",
       "                                       'mental retardation': 0.10774854,\n",
       "                                       'morphinone reductase': 0.090408295,\n",
       "                                       'mineralocorticoid receptors': 0.051456675,\n",
       "                                       'Maudsley Reactive': -0.047838528,\n",
       "                                       'mannose-receptor': 0.061176486,\n",
       "                                       'Menstrual regulation': 0.007318337,\n",
       "                                       'medial rectus': 0.2443475,\n",
       "                                       'multireceptive': 0.068392046,\n",
       "                                       'mother-reared': -0.04048941,\n",
       "                                       'multi-resistant': 0.030197706,\n",
       "                                       'Mental Rotation': 0.15987411,\n",
       "                                       'median raphe': 0.06746801}),\n",
       "                          'PET': defaultdict(float,\n",
       "                                      {'paraffin-embedded tissue': 0.12757866,\n",
       "                                       'polyethylene terephtalate': -0.010714616,\n",
       "                                       'peritoneal equilibration test': 0.2388986,\n",
       "                                       'polyester': -0.07665069,\n",
       "                                       'poly (ethylene terephthalate)': -0.030339567,\n",
       "                                       'peritoneal equilibration tests': 0.21343054,\n",
       "                                       'pancreatic endocrine tumors': -0.03821334,\n",
       "                                       'Positron emission tomography': 0.25530383,\n",
       "                                       'positron emission computed tomography': 0.30088252,\n",
       "                                       'polyethylene terephthalate': -0.017053617,\n",
       "                                       'patulous eustachian tube': 0.1157225,\n",
       "                                       'pre-eclamptic toxemia': 0.015941761,\n",
       "                                       'poly(ethylene terephthalate)': -0.030339567,\n",
       "                                       'poly-(ethylene terephthalate)': -0.022047035,\n",
       "                                       'pre-eclamptic toxaemia': 0.0070393225,\n",
       "                                       'peritonaeal equilibration test': 0.24664888,\n",
       "                                       'positron-emission tomography': 0.2519107,\n",
       "                                       'positron-emission-tomography': 0.24787869,\n",
       "                                       'positron emission tomography': 0.25530383,\n",
       "                                       'photoinduced electron transfer': 0.021615189,\n",
       "                                       'positron emission tomograph': 0.23359726,\n",
       "                                       'preeclamptic toxaemia': 0.0057178787,\n",
       "                                       'partial exchange transfusion': 0.20044644,\n",
       "                                       'pressure equalization tubes': 0.09325851,\n",
       "                                       'polyethylene-terephthalate': -0.011785229,\n",
       "                                       'pancreatic endocrine tumour': -0.04780334,\n",
       "                                       'positron emission-computed tomography': 0.2927749,\n",
       "                                       'polyethyleneterephthalate': -0.032756723,\n",
       "                                       'poly-ethylene terephthalate': -0.008935827,\n",
       "                                       'preeclamptic toxemia': 0.017201168,\n",
       "                                       'Polyethyleneterephthalate': -0.032756723,\n",
       "                                       'poly(ethyleneterephthalate)': -0.024141863,\n",
       "                                       'pancreatic endocrine tumor': -0.043053627,\n",
       "                                       'Peritoneal Equilibration Test': 0.2388986,\n",
       "                                       'positron emission tomographic': 0.24272859,\n",
       "                                       'phosphatidylethanol': -0.016780362,\n",
       "                                       'paraffin embedded tissue': 0.12560253})}),\n",
       "             '3/49 the primary trial Participants With HER2-expressing Metastatic and/or Unresectable Breast Cancer had a Maximum change from baseline in QTcF of over 30 ms.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'HER2': defaultdict(float,\n",
       "                                      {'human epidermal-growth-factor receptor-2': 0.28908247,\n",
       "                                       'Human epidermal growth factor receptor-2': 0.28748238,\n",
       "                                       'human epidermal-growth-factor receptor 2': 0.29296288,\n",
       "                                       'human epidermal growth factor receptor 2': 0.2863137,\n",
       "                                       'human epidermal growth factor receptor-2': 0.28748238})}),\n",
       "             'In order to be eligible for the primary trial, patients must not have prior radiation, anthracycline or systemic anticancer therapy , and must have T1-3, N0 and M0 breast cancer.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'T1': defaultdict(float,\n",
       "                                      {'thoracic 1': 0.17892444,\n",
       "                                       'term births': 0.0060539343,\n",
       "                                       'tricuspid first sound': 0.07581708,\n",
       "                                       'type 1': 0.20646192,\n",
       "                                       'twitch height': -0.024005184,\n",
       "                                       'Time 1': 0.110920094,\n",
       "                                       'thoracic vertebra 1': 0.08119817,\n",
       "                                       't1 (size, tumor staging)': 0.42493352,\n",
       "                                       'time 1': 0.110920094,\n",
       "                                       'therapy': 0.11910547,\n",
       "                                       't1 (first thoracic vertebra)': 0.18328038,\n",
       "                                       'treatment 1': 0.33018237}),\n",
       "                          'N0': defaultdict(float,\n",
       "                                      {'node 0': 0.11283986,\n",
       "                                       'node negative': 0.035750926,\n",
       "                                       'node-negative': 0.05156892}),\n",
       "                          'M0': defaultdict(float,\n",
       "                                      {'metastasis': 0.24832278})}),\n",
       "             'the secondary trial records only gastrointestinal adverse events, whereas the primary trial doesn‚Äö√Ñ√¥t record any GI adverse events.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'GI': defaultdict(float,\n",
       "                                      {'gyrification index': 0.100235805,\n",
       "                                       'Glucagon immunoreactivity': 0.1747533,\n",
       "                                       'Gingival inflammation': 0.11076514,\n",
       "                                       'growth index': -0.01179573,\n",
       "                                       'growth inhibition': 0.12264831,\n",
       "                                       'guided imagery': -0.050509688,\n",
       "                                       'gastrointestinal tract': 0.2221804,\n",
       "                                       'genomic island': 0.08804571,\n",
       "                                       'gastrointestinal': 0.20185007,\n",
       "                                       'glass ionomer cement': -0.03525609,\n",
       "                                       'gastrointestinal illness': 0.2304429,\n",
       "                                       'germination index': 0.050810862,\n",
       "                                       'global ischaemia': 0.1591499,\n",
       "                                       'global ischemia': 0.16081516,\n",
       "                                       'galvanic isolation': 0.0711915,\n",
       "                                       'gait-initiation': 0.07602268,\n",
       "                                       'gastro-intestinal illness': 0.24952307,\n",
       "                                       'gastroenterology': 0.25403613,\n",
       "                                       'gastro-intestinal': 0.2489472,\n",
       "                                       'glycaemic indices': 0.1939006,\n",
       "                                       'glossopharyngeal insufflation': 0.088194706,\n",
       "                                       'gingival indices': 0.11057581,\n",
       "                                       'gingival index': 0.09496484,\n",
       "                                       'gastro intestinal': 0.19915171,\n",
       "                                       'glucose intolerance': 0.16936894,\n",
       "                                       'gastroenterologist': 0.18988521,\n",
       "                                       'glucose-inhibited': 0.20642796,\n",
       "                                       'GIGANTEA': 0.022110071,\n",
       "                                       'gigantocellular reticular nucleus': 0.05578004,\n",
       "                                       'gait initiation': 0.051099073,\n",
       "                                       'glycemic index': 0.13770838,\n",
       "                                       'glass ionomer': -0.0012769058,\n",
       "                                       'genogroup I': 0.11134036,\n",
       "                                       'genogroup 1': 0.117547154,\n",
       "                                       'gingival inflammation': 0.11076514,\n",
       "                                       'Great Island': 0.003843154,\n",
       "                                       'gastro-enterology': 0.22153534,\n",
       "                                       'Group I': 0.10382234,\n",
       "                                       'Glass ionomer': -0.0012769058,\n",
       "                                       'glycaemic index': 0.16879009,\n",
       "                                       'giant interneuron': -0.026628263,\n",
       "                                       'glass-ionomer': 0.0036947082,\n",
       "                                       'genomic instability': 0.066132225})}),\n",
       "             'One patient in the primary trial had a WBC count far below normal.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'WBC': defaultdict(float,\n",
       "                                      {'white blood cell count': 0.4969359,\n",
       "                                       'white blood cell': 0.44574216,\n",
       "                                       'white-blood count': 0.5217778,\n",
       "                                       'whole-body counter': 0.12760563,\n",
       "                                       'white blood cells': 0.42968827,\n",
       "                                       'white-blood cell': 0.4467616,\n",
       "                                       'white-blood-cell count': 0.5441723,\n",
       "                                       'white blood-cell count': 0.51702553,\n",
       "                                       'white blood count': 0.48157832,\n",
       "                                       'white blood cell counts': 0.50269306})}),\n",
       "             'the secondary trial and the primary trial study the Progression Free Survival (PFS) of their participants, however they use different Units of Measure.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.06297188,\n",
       "                                       'pyrogen-free saline': 0.06916929,\n",
       "                                       'pressure-flow study': 0.07011413,\n",
       "                                       'posterior fossa syndrome': 0.055228755,\n",
       "                                       'pressure flow study': 0.067818366,\n",
       "                                       'primary fibromyalgia syndrome': 0.26943582,\n",
       "                                       'Piper Fatigue Scale': 0.16885252,\n",
       "                                       'patellofemoral syndrome': 0.07170595,\n",
       "                                       'Progression-free': 0.06262712,\n",
       "                                       'pulmonary function score': 0.22390173,\n",
       "                                       'pressure flow studies': 0.06518107,\n",
       "                                       'protein-free supernatant': 0.022836259,\n",
       "                                       'progression free survival': 0.340447,\n",
       "                                       'protein free supernatant': 0.04358165,\n",
       "                                       'progression-free survival': 0.37717524,\n",
       "                                       'pressure/flow study': 0.107667506})}),\n",
       "             'the primary trial and the secondary trial both report Objective Response Rate (ORR) of their patients.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'ORR': defaultdict(float,\n",
       "                                      {'oxygen-reduction reaction': 0.19455385,\n",
       "                                       'overall response rate': 0.5089485,\n",
       "                                       'objective response rate': 0.4749329,\n",
       "                                       'oxygen reduction reaction': 0.19080506})}),\n",
       "             'The Ridaforolimus + Dalotuzumab + Exemestane group of the primary trial had a median PFS of over 38.43 months.': defaultdict(<function __main__.<lambda>.<locals>.<lambda>()>,\n",
       "                         {'PFS': defaultdict(float,\n",
       "                                      {'patello-femoral syndrome': 0.13051663,\n",
       "                                       'pyrogen-free saline': 0.18120909,\n",
       "                                       'pressure-flow study': -0.05124701,\n",
       "                                       'posterior fossa syndrome': 0.22834587,\n",
       "                                       'pressure flow study': -0.045973897,\n",
       "                                       'primary fibromyalgia syndrome': 0.29112092,\n",
       "                                       'Piper Fatigue Scale': 0.16132516,\n",
       "                                       'patellofemoral syndrome': 0.1503028,\n",
       "                                       'Progression-free': 0.17805931,\n",
       "                                       'pulmonary function score': 0.2835369,\n",
       "                                       'pressure flow studies': -0.06047426,\n",
       "                                       'protein-free supernatant': 0.042692356,\n",
       "                                       'progression free survival': 0.35802227,\n",
       "                                       'protein free supernatant': 0.07200269,\n",
       "                                       'progression-free survival': 0.3849594,\n",
       "                                       'pressure/flow study': -0.026061572})})})"
      ]
     },
     "execution_count": 425,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "hyp2sf2lf"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 428,
   "id": "f9d19b43",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "# Flatten the nested dictionary\n",
    "rows = []\n",
    "\n",
    "for outer_key, inner_dict in hyp2sf2lf.items():\n",
    "    for inner_key, inner_dict_2 in inner_dict.items():\n",
    "        for inner_key_2, value in inner_dict_2.items():\n",
    "            rows.append({\n",
    "                'hypothesis': outer_key,\n",
    "                'short_form': inner_key,\n",
    "                'long_form': inner_key_2,\n",
    "                'similarity': value,\n",
    "            })\n",
    "\n",
    "# Create a DataFrame from the flattened dictionary\n",
    "df = pd.DataFrame(rows)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 429,
   "id": "4d30013e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>hypothesis</th>\n",
       "      <th>short_form</th>\n",
       "      <th>long_form</th>\n",
       "      <th>similarity</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>IV</td>\n",
       "      <td>icthyosis vulgaris</td>\n",
       "      <td>0.129565</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>IV</td>\n",
       "      <td>intravenous injection</td>\n",
       "      <td>0.296456</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>IV</td>\n",
       "      <td>iridovirus</td>\n",
       "      <td>0.160161</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>IV</td>\n",
       "      <td>intra-venous</td>\n",
       "      <td>0.221235</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "      <td>IV</td>\n",
       "      <td>invitro</td>\n",
       "      <td>0.109974</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13743</th>\n",
       "      <td>The Ridaforolimus + Dalotuzumab + Exemestane g...</td>\n",
       "      <td>PFS</td>\n",
       "      <td>progression free survival</td>\n",
       "      <td>0.358022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13744</th>\n",
       "      <td>The Ridaforolimus + Dalotuzumab + Exemestane g...</td>\n",
       "      <td>PFS</td>\n",
       "      <td>protein free supernatant</td>\n",
       "      <td>0.072003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13745</th>\n",
       "      <td>The Ridaforolimus + Dalotuzumab + Exemestane g...</td>\n",
       "      <td>PFS</td>\n",
       "      <td>progression-free survival</td>\n",
       "      <td>0.384959</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13746</th>\n",
       "      <td>The Ridaforolimus + Dalotuzumab + Exemestane g...</td>\n",
       "      <td>PFS</td>\n",
       "      <td>pressure/flow study</td>\n",
       "      <td>-0.026062</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13747</th>\n",
       "      <td>The Ridaforolimus + Dalotuzumab + Exemestane g...</td>\n",
       "      <td>PFS</td>\n",
       "      <td>value</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>13748 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              hypothesis short_form  \\\n",
       "0      All the primary trial participants do not rece...         IV   \n",
       "1      All the primary trial participants do not rece...         IV   \n",
       "2      All the primary trial participants do not rece...         IV   \n",
       "3      All the primary trial participants do not rece...         IV   \n",
       "4      All the primary trial participants do not rece...         IV   \n",
       "...                                                  ...        ...   \n",
       "13743  The Ridaforolimus + Dalotuzumab + Exemestane g...        PFS   \n",
       "13744  The Ridaforolimus + Dalotuzumab + Exemestane g...        PFS   \n",
       "13745  The Ridaforolimus + Dalotuzumab + Exemestane g...        PFS   \n",
       "13746  The Ridaforolimus + Dalotuzumab + Exemestane g...        PFS   \n",
       "13747  The Ridaforolimus + Dalotuzumab + Exemestane g...        PFS   \n",
       "\n",
       "                       long_form  similarity  \n",
       "0             icthyosis vulgaris    0.129565  \n",
       "1          intravenous injection    0.296456  \n",
       "2                     iridovirus    0.160161  \n",
       "3                   intra-venous    0.221235  \n",
       "4                        invitro    0.109974  \n",
       "...                          ...         ...  \n",
       "13743  progression free survival    0.358022  \n",
       "13744   protein free supernatant    0.072003  \n",
       "13745  progression-free survival    0.384959  \n",
       "13746        pressure/flow study   -0.026062  \n",
       "13747                      value    0.000000  \n",
       "\n",
       "[13748 rows x 4 columns]"
      ]
     },
     "execution_count": 429,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 435,
   "id": "650bb1a9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<pandas.core.groupby.generic.DataFrameGroupBy object at 0x384760bb0>"
      ]
     },
     "execution_count": 435,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.groupby(['hypothesis', 'short_form'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 436,
   "id": "5cb259f2",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "max_indices = df.groupby(['hypothesis', 'short_form'])['similarity'].idxmax()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 438,
   "id": "943dfa71",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "max_rows = df.loc[max_indices]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 444,
   "id": "1e4022d7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['ERBB2', 'PR', 'TO', 'ULN', 'HER2', 'CTCAE', 'DVT', 'DFI', 'FASN',\n",
       "       'ECOG', 'BI', 'LVEF', 'CR', 'MTD', 'ER', 'II', 'IV', 'ALT', 'AST',\n",
       "       'M1', 'N1', 'T1', 'M0', 'T3', 'CHF', 'PO', 'QD', 'CNS', 'PFS',\n",
       "       'MUGA', 'MRI', 'IHC', 'HCG', 'BOR', 'ANC', 'PLT', 'NSCLC', 'CO2',\n",
       "       'LA', 'AML', 'BID', 'DHEA', 'DLT', 'FEC', 'ORR', 'NKTR', 'HIV',\n",
       "       'INR', 'N0', 'AI', 'OR', 'TTP', 'PD', 'SD', 'FFDM', 'MM', 'AE',\n",
       "       'GI', 'WBC', 'IL', 'T2', 'T4', 'USA', 'PI3K', 'ALP', 'BUN', 'FISH',\n",
       "       'MR', 'PET', 'AIDS', 'BCC', 'N2', 'E2', 'BC', 'MBC', 'QT', 'DXA',\n",
       "       'CT', 'T1N1M0', 'T2N1M0', 'T3N1M0', 'T1N2M0', 'T3N1M1', 'COPD',\n",
       "       'FEV1', 'PVD', 'HER', 'DCIS', 'TR', 'ZA', 'TNBC', 'HR', 'OS', '3D',\n",
       "       'EGFR', 'MRSA', 'GU', 'UK', 'OH', 'TCH', 'PBR', 'DFS', 'FDA',\n",
       "       'WBRT', 'PTR', 'NCI', 'BMD', 'L1', 'RPTD', 'CTX', 'SB', 'CBR'],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 444,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "max_rows['short_form'].unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 446,
   "id": "a32758e8",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>hypothesis</th>\n",
       "      <th>short_form</th>\n",
       "      <th>long_form</th>\n",
       "      <th>similarity</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>12376</th>\n",
       "      <td>Patients must have histologically or cytologi...</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>erythroblastic leukaemia viral oncogene homolo...</td>\n",
       "      <td>0.214529</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>977</th>\n",
       "      <td>Patients must have histologically or cytologi...</td>\n",
       "      <td>PR</td>\n",
       "      <td>partial remissions</td>\n",
       "      <td>0.384406</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1043</th>\n",
       "      <td>Patients must have histologically or cytologi...</td>\n",
       "      <td>TO</td>\n",
       "      <td>tracheobronchopathia osteochondroplastica</td>\n",
       "      <td>0.116574</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2174</th>\n",
       "      <td>To be eligible for both the secondary trial a...</td>\n",
       "      <td>ULN</td>\n",
       "      <td>upper limit of normal</td>\n",
       "      <td>0.036212</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3164</th>\n",
       "      <td>To be eligible for both the secondary trial a...</td>\n",
       "      <td>ULN</td>\n",
       "      <td>upper limit of normal</td>\n",
       "      <td>0.039008</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>480</th>\n",
       "      <td>the secondary trial is testing for the DLT of ...</td>\n",
       "      <td>DLT</td>\n",
       "      <td>double-lumen endobronchial tube</td>\n",
       "      <td>0.309175</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13671</th>\n",
       "      <td>the secondary trial records only gastrointesti...</td>\n",
       "      <td>GI</td>\n",
       "      <td>gastroenterology</td>\n",
       "      <td>0.254036</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12171</th>\n",
       "      <td>the secondary trial records several gastrointe...</td>\n",
       "      <td>GI</td>\n",
       "      <td>gastro-intestinal</td>\n",
       "      <td>0.276786</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10808</th>\n",
       "      <td>the secondary trial uses Clinical Benefit (CBR...</td>\n",
       "      <td>CBR</td>\n",
       "      <td>clinical benefit response</td>\n",
       "      <td>0.587932</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11436</th>\n",
       "      <td>the secondary trial uses Overall Survival (OS)...</td>\n",
       "      <td>OS</td>\n",
       "      <td>overall survival rate</td>\n",
       "      <td>0.515334</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>498 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              hypothesis short_form  \\\n",
       "12376   Patients must have histologically or cytologi...      ERBB2   \n",
       "977     Patients must have histologically or cytologi...         PR   \n",
       "1043    Patients must have histologically or cytologi...         TO   \n",
       "2174    To be eligible for both the secondary trial a...        ULN   \n",
       "3164    To be eligible for both the secondary trial a...        ULN   \n",
       "...                                                  ...        ...   \n",
       "480    the secondary trial is testing for the DLT of ...        DLT   \n",
       "13671  the secondary trial records only gastrointesti...         GI   \n",
       "12171  the secondary trial records several gastrointe...         GI   \n",
       "10808  the secondary trial uses Clinical Benefit (CBR...        CBR   \n",
       "11436  the secondary trial uses Overall Survival (OS)...         OS   \n",
       "\n",
       "                                               long_form  similarity  \n",
       "12376  erythroblastic leukaemia viral oncogene homolo...    0.214529  \n",
       "977                                   partial remissions    0.384406  \n",
       "1043           tracheobronchopathia osteochondroplastica    0.116574  \n",
       "2174                               upper limit of normal    0.036212  \n",
       "3164                               upper limit of normal    0.039008  \n",
       "...                                                  ...         ...  \n",
       "480                      double-lumen endobronchial tube    0.309175  \n",
       "13671                                   gastroenterology    0.254036  \n",
       "12171                                  gastro-intestinal    0.276786  \n",
       "10808                          clinical benefit response    0.587932  \n",
       "11436                              overall survival rate    0.515334  \n",
       "\n",
       "[498 rows x 4 columns]"
      ]
     },
     "execution_count": 446,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "max_rows"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 774,
   "id": "4405c27a",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Patients with Scoliosis with a Cobb angle exceeding 20 degrees at the lumbar spine, or with a prior surgery at the lumbosacral spine are excluded from the primary trial, as these would interfere with the necessary CT and MRI scans for the study.',\n",
       " 'The Herceptin group in the primary trial had a higher number of Patients Achieving Pathological Complete Response than the CT-P6 group.',\n",
       " 'The Herceptin group in the primary trial had a higher percentage of Patients Achieving partial Pathological Response than the CT-P6 and ZA group.',\n",
       " 'the primary trial and the secondary trial interventions involve a variety of scans, such as CT, PET and dosimetry ',\n",
       " 'the primary trial and the secondary trial interventions involve a variety of scans, such as CT, PET, MRI and dosimetry ']"
      ]
     },
     "execution_count": 774,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(max_rows[max_rows['short_form'] == 'CT']['hypothesis'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 773,
   "id": "df175646",
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['cervicothoracic',\n",
       " 'clinical trial',\n",
       " 'clinical trial',\n",
       " 'clinical trial',\n",
       " 'clinical trial']"
      ]
     },
     "execution_count": 773,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(max_rows[max_rows['short_form'] == 'CT']['long_form'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 732,
   "id": "bc6a4ff8",
   "metadata": {},
   "outputs": [],
   "source": [
    "multiple = ['PR','CT', 'OS', 'CR', 'MTD', 'ER', 'PFS']\n",
    "single = ['ERBB2','ULN', 'HER2', 'CTCAE', 'DVT', 'DFI','FASN', 'ECOG', 'LVEF', 'ALT', 'CHF', \n",
    "         'IV', 'PO', 'QD', 'CNS', 'MUGA', 'IHC', 'HCG', 'ANC', 'PLT', 'NSCLC','AML','BID',\n",
    "         'DHEA','DLT', 'ORR', 'HIV', 'INR', 'TTP', 'FFDM', 'GI','WBC', 'PI3K', 'ALP', 'BUN', 'FISH', 'MR', 'PET',\n",
    "         'AIDS','BCC', 'BC', 'MBC', 'QT', 'T1N1M0', 'T2N1M0' ,'T3N1M0', 'T1N2M0', 'T3N1M1', 'COPD', 'FEV1',\n",
    "         'PVD', 'HER', 'ZA', 'TNBC', 'DFS', 'FDA', 'WBRT', 'HR', 'EGFR', 'MRSA', 'GU','NCI', 'MRI' ]\n",
    "remove = ['TO','BI', 'II','M1', 'N1', 'T1', 'M0', 'T3', 'BOR', 'LA','FEC', 'NKTR', 'N0', 'M0', 'AI', 'OR', 'PD',\n",
    "         'SD', 'MM','AE', 'IL', 'T2', 'T4', 'USA','N2', 'E2', 'DXA', 'DCIS', 'TR','PBR', 'PTR', '3D', 'UK', 'OH',\n",
    "         'TCH', 'BMD', 'L1', 'RPTD', 'CTS','SB', 'CBR','CO2']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1061,
   "id": "d50ac3e2",
   "metadata": {},
   "outputs": [],
   "source": [
    "to_avoid = [\n",
    "    'the percentage of participants achieving complete response (CR) or partial response (PR) was 6x higher in the HER2-positive group in the primary trial, than in the ER+ and/or PR+ group.',\n",
    " 'the percentage of participants achieving complete response (CR) or partial response (PR) was much lower in the HER2-positive group in the primary trial,than in the ER+ and/or PR+ group.',\n",
    " 'the percentage of participants achieving complete response (CR) or partial response (PR) was 6x higher in the HER2-positive group in the primary trial, than in the ER+ and/or PR+ group.',\n",
    " 'the percentage of participants achieving complete response (CR) or partial response (PR) was much lower in the HER2-positive group in the primary trial,than in the ER+ and/or PR+ group.',\n",
    " ' Patients must have histologically or cytologically confirmed PR+ invasive breast cancer, with Primary tumor > 2 cm in diameter TO PARTICIPATE in the primary trial.',\n",
    " 'A patient with stage 2B , pathologically confirmed PR positive breast cancer is elgible for both the primary trial and the secondary trial.',\n",
    " 'Patients with ER positive, PR positive or HER2 positive stage 4 tumors may be eligible for the secondary trial or the primary trial.',\n",
    " 'Patients with ER positive, PR positive or HER2 positive tumors may be eligible for the secondary trial or the primary trial.',\n",
    " 'Patients with tumors that are HER2 +, PR and ER -, are eligible for the primary trial.',\n",
    " 'Patients with tumors that are HER2 negative, PR and ER positive are eligible for the primary trial.',\n",
    "    'Patients must have eceptorsestrogen receptor (ER) -, progesterone receptor (PR) - and human epidermal growth factor receptor 2 (HER2) - breast cancer, aswell as not having Dysphagia.',\n",
    "'Patients must have eceptorsestrogen receptor (ER) -, progesterone receptor (PR) - and human epidermal growth factor receptor 2 (HER2) - non metastatic breast cancer, aswell as not having Dysphagia.',\n",
    " 'The Herceptin group in the primary trial had a higher number of Patients Achieving Pathological Complete Response than the CT-P6 group.',\n",
    " 'The Herceptin group in the primary trial had a higher percentage of Patients Achieving partial Pathological Response than the CT-P6 and ZA group.',\n",
    "    'Patients with Scoliosis with a Cobb angle exceeding 20 degrees at the lumbar spine, or with a prior surgery at the lumbosacral spine are excluded from the primary trial, as these would interfere with the necessary CT and MRI scans for the study.',\n",
    " 'the primary trial and the secondary trial interventions involve a variety of scans, such as CT, PET and dosimetry ',\n",
    " 'the primary trial and the secondary trial interventions involve a variety of scans, such as CT, PET, MRI and dosimetry '\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 766,
   "id": "95937ff6",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 1062,
   "id": "749d88e4",
   "metadata": {},
   "outputs": [],
   "source": [
    "progesterone_receptor_1 = ['the percentage of participants achieving complete response (CR) or partial response (PR) was 6x higher in the HER2-positive group in the primary trial, than in the ER+ and/or PR+ group.',\n",
    " 'the percentage of participants achieving complete response (CR) or partial response (PR) was much lower in the HER2-positive group in the primary trial,than in the ER+ and/or PR+ group.',\n",
    " ]\n",
    "progesterone_receptor_2 = [' Patients must have histologically or cytologically confirmed PR+ invasive breast cancer, with Primary tumor > 2 cm in diameter TO PARTICIPATE in the primary trial.',\n",
    " 'A patient with stage 2B , pathologically confirmed PR positive breast cancer is elgible for both the primary trial and the secondary trial.',\n",
    " 'Patients with ER positive, PR positive or HER2 positive stage 4 tumors may be eligible for the secondary trial or the primary trial.',\n",
    " 'Patients with ER positive, PR positive or HER2 positive tumors may be eligible for the secondary trial or the primary trial.',\n",
    " 'Patients with tumors that are HER2 +, PR and ER -, are eligible for the primary trial.',\n",
    " 'Patients with tumors that are HER2 negative, PR and ER positive are eligible for the primary trial.',]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 991,
   "id": "6dd1e224",
   "metadata": {},
   "outputs": [],
   "source": [
    "NOT_CHANGED = [\n",
    "'Patients must have eceptorsestrogen receptor (ER) -, progesterone receptor (PR) - and human epidermal growth factor receptor 2 (HER2) - breast cancer, aswell as not having Dysphagia.',\n",
    "'Patients must have eceptorsestrogen receptor (ER) -, progesterone receptor (PR) - and human epidermal growth factor receptor 2 (HER2) - non metastatic breast cancer, aswell as not having Dysphagia.',\n",
    " 'The Herceptin group in the primary trial had a higher number of Patients Achieving Pathological Complete Response than the CT-P6 group.',\n",
    " 'The Herceptin group in the primary trial had a higher percentage of Patients Achieving partial Pathological Response than the CT-P6 and ZA group.',\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1063,
   "id": "80a2371b",
   "metadata": {},
   "outputs": [],
   "source": [
    "mapping = {'ER+': 'eceptorsestrogen receptor', 'PR+': 'progesterone receptor', 'HER2': 'Human epidermal growth factor receptor-2',}\n",
    "\n",
    "more_hypotheses = dd(list)\n",
    "for h in progesterone_receptor_1:\n",
    "    h_new = h\n",
    "    #more_hypotheses[h].append(h)\n",
    "    for sf, lf in mapping.items():\n",
    "        h_new = h_new.replace(sf, f'{sf} ({lf})')\n",
    "        \n",
    "        #more_hypotheses[h].append(h.replace(sf, f'{sf} ({lf})'))\n",
    "        #more_hypotheses[h].append(h.replace(sf, f'{lf} ({sf})'))\n",
    "        #more_hypotheses[h].append(h.replace(sf, f'{lf}'))\n",
    "    if h_new not in more_hypotheses:\n",
    "        more_hypotheses[h].append(h_new)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1064,
   "id": "f5356e0f",
   "metadata": {},
   "outputs": [],
   "source": [
    "mapping = {'ER': 'eceptorsestrogen receptor', 'PR': 'progesterone receptor', 'ER+': 'eceptorsestrogen receptor', 'PR+': 'progesterone receptor' }\n",
    "for h in progesterone_receptor_2:\n",
    "    if 'HER2' in h:\n",
    "        h=h.replace('HER2', 'Human epidermal growth factor receptor-2')\n",
    "    h_new = h\n",
    "    #more_hypotheses[h].append(h)\n",
    "    for sf, lf in mapping.items():\n",
    "        if lf in h:\n",
    "            continue\n",
    "        h_new = h_new.replace(sf, f'{sf} ({lf})')\n",
    "        \n",
    "        #more_hypotheses[h].append(h.replace(sf, f'{sf} ({lf})'))\n",
    "        #more_hypotheses[h].append(h.replace(sf, f'{lf} ({sf})'))\n",
    "        #more_hypotheses[h].append(h.replace(sf, f'{lf}'))\n",
    "    if h_new not in more_hypotheses:\n",
    "        more_hypotheses[h].append(h_new)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1065,
   "id": "2f6c006c",
   "metadata": {},
   "outputs": [],
   "source": [
    "computed_tomography = ['Patients with Scoliosis with a Cobb angle exceeding 20 degrees at the lumbar spine, or with a prior surgery at the lumbosacral spine are excluded from the primary trial, as these would interfere with the necessary CT and MRI scans for the study.',\n",
    " 'the primary trial and the secondary trial interventions involve a variety of scans, such as CT, PET and dosimetry ',\n",
    " 'the primary trial and the secondary trial interventions involve a variety of scans, such as CT, PET, MRI and dosimetry ']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1066,
   "id": "899e31a5",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "for h, sfs in hypothesis2sf.items():\n",
    "    if h not in computed_tomography:\n",
    "        continue\n",
    "    h_new = h # all short form resolved or original\n",
    "    #more_hypotheses[h].append(h)\n",
    "    for sf in list(set(sfs)):\n",
    "        if sf in sf2replace:\n",
    "            lf = sf2replace[sf]\n",
    "            if lf in h:\n",
    "                continue\n",
    "            h_new = h_new.replace(sf, f'{sf} ({lf})')\n",
    "        \n",
    "            #more_hypotheses[h].append(h.replace(sf, f'{sf} ({lf})'))\n",
    "            #more_hypotheses[h].append(h.replace(sf, f'{lf} ({sf})'))\n",
    "            #more_hypotheses[h].append(h.replace(sf, f'{lf}'))\n",
    "    if h_new not in new_hypotheses:\n",
    "        more_hypotheses[h].append(h_new)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 996,
   "id": "435670dc",
   "metadata": {},
   "outputs": [],
   "source": [
    "sf2replace = {\n",
    "    'CT': 'computed tomography',\n",
    "    'PR': 'partial response',\n",
    "    'OS': 'Overall Survival',\n",
    "    'PFS': 'progression-free survival',\n",
    "    'ER': 'eceptorsestrogen receptor',\n",
    "    'CR': 'Complete Response',\n",
    "    'MTD': 'Maximum Tolerated Dose',\n",
    "    'MRI': 'magnetic resonance imaging',\n",
    "    'NSCLC': 'non small cell lung cancer',\n",
    "    'PLT': 'platelet count',\n",
    "    'ANC': 'absolute neutrophil counts',\n",
    "    'HCG': 'human chorionic gonadotropin',\n",
    "    'IHC': 'immuno histochemistry',\n",
    "    'ERBB2': 'erythroblastic leukemia viral oncogene homologue 2',\n",
    "    'ULN': 'upper limit of normal',\n",
    "    'HER2': 'Human epidermal growth factor receptor-2',\n",
    "    'CTCAE': 'Common Terminology Criteria for Adverse Events',\n",
    "    'DVT': 'deep vein thrombosis',\n",
    "    'DFI': 'disease-free interval',\n",
    "    'FASN': 'fatty-acid synthase',\n",
    "    'ECOG': 'Eastern Cooperative Oncology Group',\n",
    "    'LVEF': 'left ventricular ejection fraction',\n",
    "    'CHF': 'congestive heart failure',\n",
    "    'NCI': 'National Cancer Institute',\n",
    "    'GU': 'genito urinary',\n",
    "    'MRSA': 'meticillin-resistant Staphylococcus aureus',\n",
    "    'EGFR': 'epidermal growth factor receptor',\n",
    "    'HR': 'hormone receptor',\n",
    "    'WBRT': 'whole-breast radiotherapy',\n",
    "    'FDA': 'Food and Drug Administration',\n",
    "    'DFS': 'disease-free survival',\n",
    "    'ZA': 'zoledronic acid',\n",
    "    'TNBC': 'triple-negative breast cancer',\n",
    "    'HER': 'human estrogen receptor',\n",
    "    'PVD': 'peripheral vascular disease',\n",
    "    'FEV1': 'forced expiratory volume in 1s',\n",
    "    'ALT': 'alanine amino transferase',\n",
    "    'AST': 'aspartate amino transferase',\n",
    "    'IV': 'intravenous',\n",
    "    'PO': 'per os',\n",
    "    'QD': 'quater die',\n",
    "    'CNS': 'central nerve system',\n",
    "    'MUGA': 'multi-gated acquisition',\n",
    "    'AML': 'acute myeloid leukemias',\n",
    "    'BID': 'bis in die',\n",
    "    'DHEA': 'dehydro-epiandrosterone',\n",
    "    'DLT': 'dose-limiting toxicity',\n",
    "    'ORR': 'overall response rate',\n",
    "    'HIV': 'human Immunodeficiency virus',\n",
    "    'INR': 'international normalized ratio',\n",
    "    'TTP': 'time to progression',\n",
    "    'FFDM': 'full field digital mammography',\n",
    "    'GI': 'gastro-intestinal',\n",
    "    'WBC': 'white-blood-cell count',\n",
    "    'PI3K': 'phosphatidylinositol-3-kinase',\n",
    "    'ALP': 'alkaline phosphatase',\n",
    "    'BUN': 'blood urea nitrogen',\n",
    "    'FISH': 'fluorescent in-situ hybridization',\n",
    "    'MR': 'magnetic resonance',\n",
    "    'PET': 'positron emission tomography',\n",
    "    'AIDS': 'acquired immunodeficiency syndromes',\n",
    "    'BCC': 'basal cell carcinoma',\n",
    "    'BC': 'breast cancer',\n",
    "    'MBC': 'metastatic breast cancer',\n",
    "    'QT': 'qt interval (ecg)',\n",
    "    'T1N1M0': 'tumor-1, node-1, metastasis-0',\n",
    "    'T2N1M0': 'tumor-2, node-1, metastasis-0',\n",
    "    'T3N1M0': 'tumor 3, node 1, metastasis 0',\n",
    "    'T1N2M0': 'tumor-1, node-2, metastasis-0',\n",
    "    'T3N1M1': 'tumor stage 3, lymph node stage 1, distant metastasis',\n",
    "    'COPD': 'chronic obstructive pulmonary diseases'\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 997,
   "id": "373309c2",
   "metadata": {},
   "outputs": [],
   "source": [
    "new_hypotheses= dd(list)\n",
    "\n",
    "for h, sfs in hypothesis2sf.items():\n",
    "    if h in to_avoid:\n",
    "        continue\n",
    "    h_new = h # all short form resolved or original\n",
    "    #new_hypotheses[h].append(h)\n",
    "    for sf in list(set(sfs)):\n",
    "        if sf in sf2replace:\n",
    "            lf = sf2replace[sf]\n",
    "            if lf in h:\n",
    "                continue\n",
    "            h_new = h_new.replace(sf, f'{sf} ({lf})')\n",
    "            \n",
    "            #new_hypotheses[h].append(h.replace(sf, f'{sf} ({lf})'))\n",
    "            #new_hypotheses[h].append(h.replace(sf, f'{lf} ({sf})'))\n",
    "            #new_hypotheses[h].append(h.replace(sf, f'{lf}'))\n",
    "    if h_new not in new_hypotheses:\n",
    "        new_hypotheses[h].append(h_new)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 998,
   "id": "dbaf9de9",
   "metadata": {},
   "outputs": [],
   "source": [
    "new_hypotheses.update(more_hypotheses)\n",
    "new_hypotheses = {h:list(set(hl)) for h, hl in new_hypotheses.items()}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 999,
   "id": "320b5c34",
   "metadata": {},
   "outputs": [],
   "source": [
    "pos_h = []\n",
    "for h, hl in new_hypotheses.items():\n",
    "    pos_h.extend(hl)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1000,
   "id": "fa5db9cf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "354"
      ]
     },
     "execution_count": 1000,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(pos_h)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "41e1609e",
   "metadata": {},
   "source": [
    "### Negative Hypotheses"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 842,
   "id": "5d389c15",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|███████████████████████████████████████████████████████████████████████████████████████████| 71/71 [00:58<00:00,  1.20it/s]\n"
     ]
    }
   ],
   "source": [
    "model = SentenceTransformer('sentence-transformers/all-mpnet-base-v2')\n",
    "model.to(\"mps\")\n",
    "\n",
    "sf2lfsim = dd(lambda: dd(lambda:dd(float)))\n",
    "for sf, lf in tqdm(sf2replace.items()):\n",
    "    h_v = model.encode(lf)\n",
    "    for lf_1 in list(sf2lf[sf]):\n",
    "        lf_v = model.encode(lf_1)\n",
    "        cos_sim = dot(h_v, lf_v)/(norm(h_v)*norm(lf_v))\n",
    "        sf2lfsim[sf][lf][lf_1] = cos_sim"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 963,
   "id": "0e6de988",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Flatten the nested dictionary\n",
    "rows = []\n",
    "\n",
    "for outer_key, inner_dict in sf2lfsim.items():\n",
    "    for inner_key, inner_dict_2 in inner_dict.items():\n",
    "        for inner_key_2, value in inner_dict_2.items():\n",
    "            rows.append({\n",
    "                'short_form': outer_key,\n",
    "                'long_form_original': inner_key,\n",
    "                'long_form_compare': inner_key_2,\n",
    "                'similarity': value,\n",
    "            })\n",
    "\n",
    "# Create a DataFrame from the flattened dictionary\n",
    "df = pd.DataFrame(rows)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 964,
   "id": "7b5301de",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>short_form</th>\n",
       "      <th>long_form_original</th>\n",
       "      <th>long_form_compare</th>\n",
       "      <th>similarity</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>CT</td>\n",
       "      <td>computed tomography</td>\n",
       "      <td>condensed tannin</td>\n",
       "      <td>0.120465</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>CT</td>\n",
       "      <td>computed tomography</td>\n",
       "      <td>crista terminalis</td>\n",
       "      <td>0.196065</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>CT</td>\n",
       "      <td>computed tomography</td>\n",
       "      <td>chlamydia</td>\n",
       "      <td>0.152755</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>CT</td>\n",
       "      <td>computed tomography</td>\n",
       "      <td>chronic tonsillitis</td>\n",
       "      <td>0.191517</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>CT</td>\n",
       "      <td>computed tomography</td>\n",
       "      <td>computed-tomographic</td>\n",
       "      <td>0.918712</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1367</th>\n",
       "      <td>T3N1M0</td>\n",
       "      <td>tumor 3, node 1, metastasis 0</td>\n",
       "      <td>tumor 3, node 1, metastasis 0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1368</th>\n",
       "      <td>T1N2M0</td>\n",
       "      <td>tumor-1, node-2, metastasis-0</td>\n",
       "      <td>tumor-1, node-2, metastasis-0</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1369</th>\n",
       "      <td>T3N1M1</td>\n",
       "      <td>tumor stage 3, lymph node stage 1, distant met...</td>\n",
       "      <td>tumor stage 3, lymph node stage 1, distant met...</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1370</th>\n",
       "      <td>COPD</td>\n",
       "      <td>chronic obstructive pulmonary diseases</td>\n",
       "      <td>chronic obstructive pulmonary disease</td>\n",
       "      <td>0.983393</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1371</th>\n",
       "      <td>COPD</td>\n",
       "      <td>chronic obstructive pulmonary diseases</td>\n",
       "      <td>chronic obstructive pulmonary diseases</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1372 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     short_form                                 long_form_original  \\\n",
       "0            CT                                computed tomography   \n",
       "1            CT                                computed tomography   \n",
       "2            CT                                computed tomography   \n",
       "3            CT                                computed tomography   \n",
       "4            CT                                computed tomography   \n",
       "...         ...                                                ...   \n",
       "1367     T3N1M0                      tumor 3, node 1, metastasis 0   \n",
       "1368     T1N2M0                      tumor-1, node-2, metastasis-0   \n",
       "1369     T3N1M1  tumor stage 3, lymph node stage 1, distant met...   \n",
       "1370       COPD             chronic obstructive pulmonary diseases   \n",
       "1371       COPD             chronic obstructive pulmonary diseases   \n",
       "\n",
       "                                      long_form_compare  similarity  \n",
       "0                                      condensed tannin    0.120465  \n",
       "1                                     crista terminalis    0.196065  \n",
       "2                                             chlamydia    0.152755  \n",
       "3                                   chronic tonsillitis    0.191517  \n",
       "4                                  computed-tomographic    0.918712  \n",
       "...                                                 ...         ...  \n",
       "1367                      tumor 3, node 1, metastasis 0    1.000000  \n",
       "1368                      tumor-1, node-2, metastasis-0    1.000000  \n",
       "1369  tumor stage 3, lymph node stage 1, distant met...    1.000000  \n",
       "1370              chronic obstructive pulmonary disease    0.983393  \n",
       "1371             chronic obstructive pulmonary diseases    1.000000  \n",
       "\n",
       "[1372 rows x 4 columns]"
      ]
     },
     "execution_count": 964,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 965,
   "id": "a4cff564",
   "metadata": {},
   "outputs": [],
   "source": [
    "min_indices = df[df['similarity'] < 0.2].groupby(['short_form', 'long_form_original'])['similarity'].idxmin()\n",
    "min_rows = df.loc[min_indices]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 966,
   "id": "cada9182",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>short_form</th>\n",
       "      <th>long_form_original</th>\n",
       "      <th>long_form_compare</th>\n",
       "      <th>similarity</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1120</th>\n",
       "      <td>ALP</td>\n",
       "      <td>alkaline phosphatase</td>\n",
       "      <td>acute lupus pericarditis</td>\n",
       "      <td>0.135870</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>779</th>\n",
       "      <td>ALT</td>\n",
       "      <td>alanine amino transferase</td>\n",
       "      <td>alternative lengthening of telomeres</td>\n",
       "      <td>0.092067</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>964</th>\n",
       "      <td>AML</td>\n",
       "      <td>acute myeloid leukemias</td>\n",
       "      <td>anatomic medullary locking</td>\n",
       "      <td>0.114904</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>504</th>\n",
       "      <td>ANC</td>\n",
       "      <td>absolute neutrophil counts</td>\n",
       "      <td>Active noise control</td>\n",
       "      <td>-0.019969</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>798</th>\n",
       "      <td>AST</td>\n",
       "      <td>aspartate amino transferase</td>\n",
       "      <td>average survival time</td>\n",
       "      <td>0.025281</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1345</th>\n",
       "      <td>BC</td>\n",
       "      <td>breast cancer</td>\n",
       "      <td>basic copy</td>\n",
       "      <td>-0.028135</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1274</th>\n",
       "      <td>BCC</td>\n",
       "      <td>basal cell carcinoma</td>\n",
       "      <td>bacterial community composition</td>\n",
       "      <td>-0.047191</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>972</th>\n",
       "      <td>BID</td>\n",
       "      <td>bis in die</td>\n",
       "      <td>body image disturbance</td>\n",
       "      <td>0.010780</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>588</th>\n",
       "      <td>CHF</td>\n",
       "      <td>congestive heart failure</td>\n",
       "      <td>chick embryo fibroblast</td>\n",
       "      <td>0.088474</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>920</th>\n",
       "      <td>CNS</td>\n",
       "      <td>central nerve system</td>\n",
       "      <td>coagulase-negative Staphylococcus</td>\n",
       "      <td>-0.011514</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>343</th>\n",
       "      <td>CR</td>\n",
       "      <td>Complete Response</td>\n",
       "      <td>calorie restriction</td>\n",
       "      <td>-0.064121</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>CT</td>\n",
       "      <td>computed tomography</td>\n",
       "      <td>charge transfer</td>\n",
       "      <td>0.055660</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>564</th>\n",
       "      <td>DFI</td>\n",
       "      <td>disease-free interval</td>\n",
       "      <td>DNA fragmentation index</td>\n",
       "      <td>0.023320</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>720</th>\n",
       "      <td>DFS</td>\n",
       "      <td>disease-free survival</td>\n",
       "      <td>desoxyfructosylserotonin</td>\n",
       "      <td>0.085806</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>989</th>\n",
       "      <td>DLT</td>\n",
       "      <td>dose-limiting toxicity</td>\n",
       "      <td>direct linear transformation</td>\n",
       "      <td>0.072969</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>576</th>\n",
       "      <td>ECOG</td>\n",
       "      <td>Eastern Cooperative Oncology Group</td>\n",
       "      <td>electrocortical activity</td>\n",
       "      <td>0.067301</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>630</th>\n",
       "      <td>EGFR</td>\n",
       "      <td>epidermal growth factor receptor</td>\n",
       "      <td>estimated glomerular filtration rate</td>\n",
       "      <td>0.129256</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>284</th>\n",
       "      <td>ER</td>\n",
       "      <td>eceptorsestrogen receptor</td>\n",
       "      <td>early</td>\n",
       "      <td>0.049846</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>699</th>\n",
       "      <td>FDA</td>\n",
       "      <td>Food and Drug Administration</td>\n",
       "      <td>Fisher discriminant analysis</td>\n",
       "      <td>0.084328</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1048</th>\n",
       "      <td>FFDM</td>\n",
       "      <td>full field digital mammography</td>\n",
       "      <td>freedom from distant metastasis</td>\n",
       "      <td>0.167814</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1093</th>\n",
       "      <td>GI</td>\n",
       "      <td>gastro-intestinal</td>\n",
       "      <td>genomic instability</td>\n",
       "      <td>0.046009</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>604</th>\n",
       "      <td>GU</td>\n",
       "      <td>genito urinary</td>\n",
       "      <td>glucose utilization</td>\n",
       "      <td>0.104981</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>734</th>\n",
       "      <td>HER</td>\n",
       "      <td>human estrogen receptor</td>\n",
       "      <td>heroin</td>\n",
       "      <td>0.080635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>652</th>\n",
       "      <td>HR</td>\n",
       "      <td>hormone receptor</td>\n",
       "      <td>hepatic resection</td>\n",
       "      <td>0.060492</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>530</th>\n",
       "      <td>IHC</td>\n",
       "      <td>immuno histochemistry</td>\n",
       "      <td>Intermountain Health Care</td>\n",
       "      <td>0.030019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1024</th>\n",
       "      <td>INR</td>\n",
       "      <td>international normalized ratio</td>\n",
       "      <td>initiator element</td>\n",
       "      <td>-0.027268</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>836</th>\n",
       "      <td>IV</td>\n",
       "      <td>intravenous</td>\n",
       "      <td>isometric virus</td>\n",
       "      <td>0.145714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1362</th>\n",
       "      <td>MBC</td>\n",
       "      <td>metastatic breast cancer</td>\n",
       "      <td>maximum binding capacity</td>\n",
       "      <td>0.032716</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1175</th>\n",
       "      <td>MR</td>\n",
       "      <td>magnetic resonance</td>\n",
       "      <td>mandelate racemase</td>\n",
       "      <td>-0.033912</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>434</th>\n",
       "      <td>MTD</td>\n",
       "      <td>Maximum Tolerated Dose</td>\n",
       "      <td>Monroe tidal drainage</td>\n",
       "      <td>-0.056194</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>596</th>\n",
       "      <td>NCI</td>\n",
       "      <td>National Cancer Institute</td>\n",
       "      <td>negative chemical ionization</td>\n",
       "      <td>0.100642</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1002</th>\n",
       "      <td>ORR</td>\n",
       "      <td>overall response rate</td>\n",
       "      <td>oxygen reduction reaction</td>\n",
       "      <td>0.098132</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>236</th>\n",
       "      <td>OS</td>\n",
       "      <td>Overall Survival</td>\n",
       "      <td>oligomycin-sensitive</td>\n",
       "      <td>-0.005303</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1251</th>\n",
       "      <td>PET</td>\n",
       "      <td>positron emission tomography</td>\n",
       "      <td>pancreatic endocrine tumour</td>\n",
       "      <td>-0.004321</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>253</th>\n",
       "      <td>PFS</td>\n",
       "      <td>progression-free survival</td>\n",
       "      <td>posterior fossa syndrome</td>\n",
       "      <td>-0.007043</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>488</th>\n",
       "      <td>PLT</td>\n",
       "      <td>platelet count</td>\n",
       "      <td>postero-lateral thoracotomy</td>\n",
       "      <td>-0.020743</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>876</th>\n",
       "      <td>PO</td>\n",
       "      <td>per os</td>\n",
       "      <td>pressure overload</td>\n",
       "      <td>-0.047745</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>PR</td>\n",
       "      <td>partial response</td>\n",
       "      <td>proliferative retinopathy</td>\n",
       "      <td>-0.001620</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>751</th>\n",
       "      <td>PVD</td>\n",
       "      <td>peripheral vascular disease</td>\n",
       "      <td>physical-vapor deposition</td>\n",
       "      <td>0.019018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1043</th>\n",
       "      <td>TTP</td>\n",
       "      <td>time to progression</td>\n",
       "      <td>thrombotic-thrombocytopenic purpura</td>\n",
       "      <td>0.029090</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     short_form                  long_form_original  \\\n",
       "1120        ALP                alkaline phosphatase   \n",
       "779         ALT           alanine amino transferase   \n",
       "964         AML             acute myeloid leukemias   \n",
       "504         ANC          absolute neutrophil counts   \n",
       "798         AST         aspartate amino transferase   \n",
       "1345         BC                       breast cancer   \n",
       "1274        BCC                basal cell carcinoma   \n",
       "972         BID                          bis in die   \n",
       "588         CHF            congestive heart failure   \n",
       "920         CNS                central nerve system   \n",
       "343          CR                   Complete Response   \n",
       "27           CT                 computed tomography   \n",
       "564         DFI               disease-free interval   \n",
       "720         DFS               disease-free survival   \n",
       "989         DLT              dose-limiting toxicity   \n",
       "576        ECOG  Eastern Cooperative Oncology Group   \n",
       "630        EGFR    epidermal growth factor receptor   \n",
       "284          ER           eceptorsestrogen receptor   \n",
       "699         FDA        Food and Drug Administration   \n",
       "1048       FFDM      full field digital mammography   \n",
       "1093         GI                   gastro-intestinal   \n",
       "604          GU                      genito urinary   \n",
       "734         HER             human estrogen receptor   \n",
       "652          HR                    hormone receptor   \n",
       "530         IHC               immuno histochemistry   \n",
       "1024        INR      international normalized ratio   \n",
       "836          IV                         intravenous   \n",
       "1362        MBC            metastatic breast cancer   \n",
       "1175         MR                  magnetic resonance   \n",
       "434         MTD              Maximum Tolerated Dose   \n",
       "596         NCI           National Cancer Institute   \n",
       "1002        ORR               overall response rate   \n",
       "236          OS                    Overall Survival   \n",
       "1251        PET        positron emission tomography   \n",
       "253         PFS           progression-free survival   \n",
       "488         PLT                      platelet count   \n",
       "876          PO                              per os   \n",
       "150          PR                    partial response   \n",
       "751         PVD         peripheral vascular disease   \n",
       "1043        TTP                 time to progression   \n",
       "\n",
       "                         long_form_compare  similarity  \n",
       "1120              acute lupus pericarditis    0.135870  \n",
       "779   alternative lengthening of telomeres    0.092067  \n",
       "964             anatomic medullary locking    0.114904  \n",
       "504                   Active noise control   -0.019969  \n",
       "798                  average survival time    0.025281  \n",
       "1345                            basic copy   -0.028135  \n",
       "1274       bacterial community composition   -0.047191  \n",
       "972                 body image disturbance    0.010780  \n",
       "588                chick embryo fibroblast    0.088474  \n",
       "920      coagulase-negative Staphylococcus   -0.011514  \n",
       "343                    calorie restriction   -0.064121  \n",
       "27                         charge transfer    0.055660  \n",
       "564                DNA fragmentation index    0.023320  \n",
       "720               desoxyfructosylserotonin    0.085806  \n",
       "989           direct linear transformation    0.072969  \n",
       "576               electrocortical activity    0.067301  \n",
       "630   estimated glomerular filtration rate    0.129256  \n",
       "284                                  early    0.049846  \n",
       "699           Fisher discriminant analysis    0.084328  \n",
       "1048       freedom from distant metastasis    0.167814  \n",
       "1093                   genomic instability    0.046009  \n",
       "604                    glucose utilization    0.104981  \n",
       "734                                 heroin    0.080635  \n",
       "652                      hepatic resection    0.060492  \n",
       "530              Intermountain Health Care    0.030019  \n",
       "1024                     initiator element   -0.027268  \n",
       "836                        isometric virus    0.145714  \n",
       "1362              maximum binding capacity    0.032716  \n",
       "1175                    mandelate racemase   -0.033912  \n",
       "434                  Monroe tidal drainage   -0.056194  \n",
       "596           negative chemical ionization    0.100642  \n",
       "1002             oxygen reduction reaction    0.098132  \n",
       "236                   oligomycin-sensitive   -0.005303  \n",
       "1251           pancreatic endocrine tumour   -0.004321  \n",
       "253               posterior fossa syndrome   -0.007043  \n",
       "488            postero-lateral thoracotomy   -0.020743  \n",
       "876                      pressure overload   -0.047745  \n",
       "150              proliferative retinopathy   -0.001620  \n",
       "751              physical-vapor deposition    0.019018  \n",
       "1043   thrombotic-thrombocytopenic purpura    0.029090  "
      ]
     },
     "execution_count": 966,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "min_rows"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 967,
   "id": "cc67e356",
   "metadata": {},
   "outputs": [],
   "source": [
    "neg_sf2replace = dict(zip(min_rows['short_form'], min_rows['long_form_compare']))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 986,
   "id": "189e1c24",
   "metadata": {},
   "outputs": [],
   "source": [
    "neg_hypotheses= dd(list)\n",
    "\n",
    "for h, sfs in hypothesis2sf.items():\n",
    "    if h in to_avoid:\n",
    "        continue\n",
    "    h_new = h # all short form resolved or original\n",
    "    for sf in list(set(sfs)):\n",
    "        if sf in neg_sf2replace:\n",
    "            lf = neg_sf2replace[sf]\n",
    "            if sf2replace[sf].lower() not in h.lower():\n",
    "                h_new = h_new.replace(sf, f'{sf} ({lf})')\n",
    "                #neg_hypotheses[h].append(h.replace(sf, f'{sf} ({lf})'))\n",
    "                #neg_hypotheses[h].append(h.replace(sf, f'{lf} ({sf})'))\n",
    "                #neg_hypotheses[h].append(h.replace(sf, f'{lf}'))\n",
    "    if h_new not in new_hypotheses and h!=h_new:\n",
    "        neg_hypotheses[h].append(h_new)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 987,
   "id": "4bb01cdc",
   "metadata": {},
   "outputs": [],
   "source": [
    "neg_h = []\n",
    "for h, hl in neg_hypotheses.items():\n",
    "    neg_h.extend(hl)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 988,
   "id": "d8a3e578",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "180"
      ]
     },
     "execution_count": 988,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(neg_h)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 989,
   "id": "6b46f501",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "defaultdict(list,\n",
       "            {'All the primary trial participants do not receive any oral capecitabine, oral lapatinib ditosylate or cixutumumab IV, in conrast all the secondary trial subjects receive these.': ['All the primary trial participants do not receive any oral capecitabine, oral lapatinib ditosylate or cixutumumab IV (isometric virus), in conrast all the secondary trial subjects receive these.'],\n",
       "             'Patients with Platelet count over 100,000/mm¬¨‚â•, ANC <  1,700/mm¬¨‚â• and Hemoglobin between 4 to 5 grams per deciliter are eligible for the primary trial.': ['Patients with Platelet count over 100,000/mm¬¨‚â•, ANC (Active noise control) <  1,700/mm¬¨‚â• and Hemoglobin between 4 to 5 grams per deciliter are eligible for the primary trial.'],\n",
       "             'Adele is an 85 year old woman with Stage II histologically confirmed ER+ breast cancer with an ECOG of 0, she is eligible for the primary trial': ['Adele is an 85 year old woman with Stage II histologically confirmed ER (early)+ breast cancer with an ECOG (electrocortical activity) of 0, she is eligible for the primary trial'],\n",
       "             'Most of the cases of CHF in the primary trial, were in cohort 1.': ['Most of the cases of CHF (chick embryo fibroblast) in the primary trial, were in cohort 1.'],\n",
       "             'The shortest PFS in the Talazoparib group of the primary trial was over a month shorter than the Median PFS for that group.': ['The shortest PFS (posterior fossa syndrome) (posterior fossa syndrome) in the Talazoparib group of the primary trial was over a month shorter than the Median PFS (posterior fossa syndrome) (posterior fossa syndrome) for that group.'],\n",
       "             'the secondary trial is testing for the DLT of its interventions, whereas the primary trial is evaluating the efficacy of lymph node detection through the use of SentiMag and SiennaXP. ': ['the secondary trial is testing for the DLT (direct linear transformation) of its interventions, whereas the primary trial is evaluating the efficacy of lymph node detection through the use of SentiMag and SiennaXP. '],\n",
       "             'Participants of the primary trial must be older than 18, have histologically confirmed stage 4 breast cancer, ECOG<2 and a life expectancy exceeding 6 months.': ['Participants of the primary trial must be older than 18, have histologically confirmed stage 4 breast cancer, ECOG (electrocortical activity)<2 and a life expectancy exceeding 6 months.'],\n",
       "             'There was 38% more patients with DLT in cohort 2 of the primary trial than in cohort 1.': ['There was 38% more patients with DLT (direct linear transformation) in cohort 2 of the primary trial than in cohort 1.'],\n",
       "             'the primary trial and the secondary trial are not studying PFS, PBR or DLTs.': ['the primary trial and the secondary trial are not studying PFS (posterior fossa syndrome), PBR or DLTs.'],\n",
       "             'participants of cohort 1 in the primary trial and all participants of the secondary trial take 1 milligram of anastrozole and 40 milligrams of simvastatin PO QD.': ['participants of cohort 1 in the primary trial and all participants of the secondary trial take 1 milligram of anastrozole and 40 milligrams of simvastatin PO (pressure overload) QD.'],\n",
       "             \"the primary trial and the secondary trial use ECOG to evaluate potential candidates' performance status.\": [\"the primary trial and the secondary trial use ECOG (electrocortical activity) to evaluate potential candidates' performance status.\"],\n",
       "             'Every patient in the primary trial is given tipifarnib PO, along with paclitaxel, doxorubicin hydrochloride and acyclophosphamide IV, but only a subset of participants undergo axillary lymph node dissection.': ['Every patient in the primary trial is given tipifarnib PO (pressure overload), along with paclitaxel, doxorubicin hydrochloride and acyclophosphamide IV (isometric virus), but only a subset of participants undergo axillary lymph node dissection.'],\n",
       "             'In the primary trial, Dasatinib, 70 mg, Twice Daily results in a better median PFS than Dasatinib, 100 mg, Daily. The opposite was true in the secondary trial.': ['In the primary trial, Dasatinib, 70 mg, Twice Daily results in a better median PFS (posterior fossa syndrome) than Dasatinib, 100 mg, Daily. The opposite was true in the secondary trial.'],\n",
       "             'At least one participant in the primary trial receiving an oral treatment of film-coated Afatinib tablet at a starting dose of 40 milligram (mg) once daily and weekly 10 minutes intravenous infusions of Vinorelbine 25 mg/meter^2 (meter=m) had a PFS over 9 months.': ['At least one participant in the primary trial receiving an oral treatment of film-coated Afatinib tablet at a starting dose of 40 milligram (mg) once daily and weekly 10 minutes intravenous infusions of Vinorelbine 25 mg/meter^2 (meter=m) had a PFS (posterior fossa syndrome) over 9 months.'],\n",
       "             'Patients will have to undergo an MRI scan for before entry for both the secondary trial and the primary trial, for the primary trial patients will also need to have a brain MR and PET imaging, after study entry.': ['Patients will have to undergo an MR (mandelate racemase)I scan for before entry for both the secondary trial and the primary trial, for the primary trial patients will also need to have a brain MR (mandelate racemase) and PET (pancreatic endocrine tumour) imaging, after study entry.'],\n",
       "             'At least 400 participants in the primary trial receiving an oral treatment of film-coated Afatinib tablet at a starting dose of 40 milligram (mg) once daily and weekly 10 minutes intravenous infusions of Vinorelbine 25 mg/meter^2 (meter=m) had a PFS over 9 months.': ['At least 400 participants in the primary trial receiving an oral treatment of film-coated Afatinib tablet at a starting dose of 40 milligram (mg) once daily and weekly 10 minutes intravenous infusions of Vinorelbine 25 mg/meter^2 (meter=m) had a PFS (posterior fossa syndrome) over 9 months.'],\n",
       "             'INR of 1.35 is enough for participation in the primary trial and the secondary trial.': ['INR (initiator element) of 1.35 is enough for participation in the primary trial and the secondary trial.'],\n",
       "             'the primary trial studies the effects of CTX/IMQ/RT and Epothilone on Central Nervous System (CNS) Progression-free Survival(PFS), 9 weeks after the start of treatment.': ['the primary trial studies the effects of CTX/IMQ/RT and Epothilone on Central Nervous System (CNS (coagulase-negative Staphylococcus)) Progression-free Survival(PFS), 9 weeks after the start of treatment.'],\n",
       "             'the primary trial has a topical intervention, whereas the secondary trial has both oral and IV interventions.': ['the primary trial has a topical intervention, whereas the secondary trial has both oral and IV (isometric virus) interventions.'],\n",
       "             'The median TTP for patients in cohort one of the primary trial is NA.': ['The median TTP (thrombotic-thrombocytopenic purpura) for patients in cohort one of the primary trial is NA.'],\n",
       "             'The patient group with the highest percent of PFS at 5 months in the primary trial was Stage IIIB patients, and the worst was Stage IV Disease patients.': ['The patient group with the highest percent of PFS (posterior fossa syndrome) at 5 months in the primary trial was Stage IIIB patients, and the worst was Stage IV (isometric virus) Disease patients.'],\n",
       "             'Black men with and ECOG <=2, with ANC >1.5 x 10^9/L, PLT >100 x 10^9/L and no prior history of blood clots are eligible for the primary trial but excluded from the secondary trial': ['Black men with and ECOG (electrocortical activity) <=2, with ANC (Active noise control) >1.5 x 10^9/L, PLT (postero-lateral thoracotomy) >100 x 10^9/L and no prior history of blood clots are eligible for the primary trial but excluded from the secondary trial'],\n",
       "             'the primary trial and the secondary trial both evaluate response rates, however the primary trial studies CNS response, whereas the secondary trial studies tumor response, additionally, they test different treatments.': ['the primary trial and the secondary trial both evaluate response rates, however the primary trial studies CNS (coagulase-negative Staphylococcus) response, whereas the secondary trial studies tumor response, additionally, they test different treatments.'],\n",
       "             'Patients in the primary trial receive at most 200mg of IMGN853 by IV every 3 weeks.': ['Patients in the primary trial receive at most 200mg of IMGN853 by IV (isometric virus) every 3 weeks.'],\n",
       "             'Patients with tumors overexpressing HER-2 are eligible for the secondary trial, but not for the primary trial.': ['Patients with tumors overexpressing HER (heroin)-2 are eligible for the secondary trial, but not for the primary trial.'],\n",
       "             'The the primary trial placebo group had a better mean retention than the donepezil hydrochloride PO QD group.': ['The the primary trial placebo group had a better mean retention than the donepezil hydrochloride PO (pressure overload) QD group.'],\n",
       "             'Patients in cohort 1 of the primary trial may receive gradually increasing doses of Afatinib monotherapy from 40mg PO to 50mg PO.': ['Patients in cohort 1 of the primary trial may receive gradually increasing doses of Afatinib monotherapy from 40mg PO (pressure overload) (pressure overload) to 50mg PO (pressure overload) (pressure overload).'],\n",
       "             'The Ridaforolimus + Dalotuzumab + Exemestane group of the primary trial had a median PFS of over 5 months.': ['The Ridaforolimus + Dalotuzumab + Exemestane group of the primary trial had a median PFS (posterior fossa syndrome) of over 5 months.'],\n",
       "             'Patients must have either AST or ALT < 1.5 ULN to participate in the primary trial.': ['Patients must have either AST (average survival time) or ALT (alternative lengthening of telomeres) < 1.5 ULN to participate in the primary trial.'],\n",
       "             'All the primary trial participants and cohort 1 participants in the secondary trial do not receive any oral capecitabine, oral lapatinib ditosylate or cixutumumab IV, however cohort 2 of the secondary trial receive all of these.': ['All the primary trial participants and cohort 1 participants in the secondary trial do not receive any oral capecitabine, oral lapatinib ditosylate or cixutumumab IV (isometric virus), however cohort 2 of the secondary trial receive all of these.'],\n",
       "             'Group 1 of the secondary trial has a higher ORR than both the Everolimus + Letrozole cohort of the primary trial and the trastuzumab cohort.': ['Group 1 of the secondary trial has a higher ORR (oxygen reduction reaction) than both the Everolimus + Letrozole cohort of the primary trial and the trastuzumab cohort.'],\n",
       "             'the primary trial participants are given saracatinib PO every single day of the study duration.': ['the primary trial participants are given saracatinib PO (pressure overload) every single day of the study duration.'],\n",
       "             'No participants of the primary trial had a Progression Free Survival over 1 year, but several patients had a PFS of less than 1 month.': ['No participants of the primary trial had a Progression Free Survival over 1 year, but several patients had a PFS (posterior fossa syndrome) of less than 1 month.'],\n",
       "             'According to the results of the primary trial the MTD of paclitaxel is approximately is 120 mg.': ['According to the results of the primary trial the MTD (Monroe tidal drainage) of paclitaxel is approximately is 120 mg.'],\n",
       "             'Less than 5% of the primary trial participants achieved CR or PR.': ['Less than 5% of the primary trial participants achieved CR (calorie restriction) or PR (proliferative retinopathy).'],\n",
       "             'The the primary trial placebo group performed much better than the test group, as a lower PFS is ideal.': ['The the primary trial placebo group performed much better than the test group, as a lower PFS (posterior fossa syndrome) is ideal.'],\n",
       "             'Patients in the primary trial receive a lower dose of Zometa by IV than the secondary trial patients receive of ado-trastuzumab emtansine.': ['Patients in the primary trial receive a lower dose of Zometa by IV (isometric virus) than the secondary trial patients receive of ado-trastuzumab emtansine.'],\n",
       "             'According to the results of the primary trial the MTD of dasatinib in combination with weekly paclitaxel is approximately is 120 mg.': ['According to the results of the primary trial the MTD (Monroe tidal drainage) of dasatinib in combination with weekly paclitaxel is approximately is 120 mg.'],\n",
       "             'All 4 of the CHF cases in the primary trial, were in cohort 1.': ['All 4 of the CHF (chick embryo fibroblast) cases in the primary trial, were in cohort 1.'],\n",
       "             'the secondary trial and the primary trial both accept patients with HER-2/neu-overexpressing adenocarcinoma of the breast.': ['the secondary trial and the primary trial both accept patients with HER (heroin)-2/neu-overexpressing adenocarcinoma of the breast.'],\n",
       "             'The the primary trial placebo group had a over 10% higher mean retention than the donepezil hydrochloride PO QD group.': ['The the primary trial placebo group had a over 10% higher mean retention than the donepezil hydrochloride PO (pressure overload) QD group.'],\n",
       "             'Patients with left-sided breast cancer and an ECOG between 1-2 are excluded from the primary trial.': ['Patients with left-sided breast cancer and an ECOG (electrocortical activity) between 1-2 are excluded from the primary trial.'],\n",
       "             'Every patient in the primary trial is given tipifarnib PO, along with paclitaxel, doxorubicin hydrochloride and acyclophosphamide IV.': ['Every patient in the primary trial is given tipifarnib PO (pressure overload), along with paclitaxel, doxorubicin hydrochloride and acyclophosphamide IV (isometric virus).'],\n",
       "             'Patients with Platelet count over 100,000/mm¬¨‚â•, ANC <  1,700/mm¬¨‚â• and Hemoglobin between 11 to 18 grams per deciliter are eligible for the primary trial.': ['Patients with Platelet count over 100,000/mm¬¨‚â•, ANC (Active noise control) <  1,700/mm¬¨‚â• and Hemoglobin between 11 to 18 grams per deciliter are eligible for the primary trial.'],\n",
       "             'participants of cohort 1 in the primary trial and all participants of the secondary trial take 1 milligram of anastrozole PO QD.': ['participants of cohort 1 in the primary trial and all participants of the secondary trial take 1 milligram of anastrozole PO (pressure overload) QD.'],\n",
       "             'the primary trial and the secondary trial measure the DLT of their respective interventions, using the same time frame.': ['the primary trial and the secondary trial measure the DLT (direct linear transformation) of their respective interventions, using the same time frame.'],\n",
       "             'Cohort 1 of the primary trial had a longer PFS than cohort 2. However the patient with the longest PFS was in cohort 2.': ['Cohort 1 of the primary trial had a longer PFS (posterior fossa syndrome) (posterior fossa syndrome) than cohort 2. However the patient with the longest PFS (posterior fossa syndrome) (posterior fossa syndrome) was in cohort 2.'],\n",
       "             'Adele is an 85 year old woman with Stage IV histologically confirmed ER+ breast cancer with an ECOG of 0, she has a life expectancy below 6 months and a history of thrombotic events. She is eligible for the primary trial': ['Adele is an 85 year old woman with Stage IV (isometric virus) histologically confirmed ER (early)+ breast cancer with an ECOG (electrocortical activity) of 0, she has a life expectancy below 6 months and a history of thrombotic events. She is eligible for the primary trial'],\n",
       "             'The majority of the primary trial subjects either had Progressive disease or undetermined CNS objective response rate.': ['The majority of the primary trial subjects either had Progressive disease or undetermined CNS (coagulase-negative Staphylococcus) objective response rate.'],\n",
       "             'the primary trial and the secondary trial both administer treatments to their patients through IV.': ['the primary trial and the secondary trial both administer treatments to their patients through IV (isometric virus).'],\n",
       "             'There were no patients in either cohort of the primary trial with a PFS exceeding one year.': ['There were no patients in either cohort of the primary trial with a PFS (posterior fossa syndrome) exceeding one year.'],\n",
       "             'the primary trial and the secondary trial both administer Zometa to their patients through IV, although in different doses.': ['the primary trial and the secondary trial both administer Zometa to their patients through IV (isometric virus), although in different doses.'],\n",
       "             'Cohort 1 of the primary trial reported one case of AML.': ['Cohort 1 of the primary trial reported one case of AML (anatomic medullary locking).'],\n",
       "             'the primary trial patients receive Trametinib, Akt Inhibitor GSK2141795 PO QD on days 1-28, up to a maximum of 8 cycles.': ['the primary trial patients receive Trametinib, Akt Inhibitor GSK2141795 PO (pressure overload) QD on days 1-28, up to a maximum of 8 cycles.'],\n",
       "             'None of the adverse events which occurred in the primary trial were not GI related.': ['None of the adverse events which occurred in the primary trial were not GI (genomic instability) related.'],\n",
       "             'The Triple-Negative Breast Cancer cohort of the primary trial had a much lower ORR than the HR+/HER2- cohort.': ['The Triple-Negative Breast Cancer cohort of the primary trial had a much lower ORR (oxygen reduction reaction) than the HR (hepatic resection)+/HER2- cohort.'],\n",
       "             'the primary trial results show that Participants receiving lapatinib 1500 milligrams (mg) orally were twice as likely to achieve DFS at 5 years than placebo patients.': ['the primary trial results show that Participants receiving lapatinib 1500 milligrams (mg) orally were twice as likely to achieve DFS (desoxyfructosylserotonin) at 5 years than placebo patients.'],\n",
       "             'There were twice as many patients with DLT in cohort 2 of the primary trial than in cohort 1.': ['There were twice as many patients with DLT (direct linear transformation) in cohort 2 of the primary trial than in cohort 1.'],\n",
       "             'the primary trial results indicate that CoQ10 reduces the PFS of breast cancer patients compared to a placebo by about 8%': ['the primary trial results indicate that CoQ10 reduces the PFS (posterior fossa syndrome) of breast cancer patients compared to a placebo by about 8%'],\n",
       "             'All participants in the primary trial had a Central Nervous System (CNS) Progression Free Survival (PFS) >= 16 weeks.': ['All participants in the primary trial had a Central Nervous System (CNS (coagulase-negative Staphylococcus)) Progression Free Survival (PFS (posterior fossa syndrome)) >= 16 weeks.'],\n",
       "             'the primary trial do not receive any intervention by IV, orally or by surgery during the study.': ['the primary trial do not receive any intervention by IV (isometric virus), orally or by surgery during the study.'],\n",
       "             'Both cohorts in the primary trial outperformed cohort 1 of the secondary trial in median PFS.': ['Both cohorts in the primary trial outperformed cohort 1 of the secondary trial in median PFS (posterior fossa syndrome).'],\n",
       "             'Cohort 1 of the primary trial included over 200 patients being treated with Sunitinib and Paclitaxel for a duration of 18 months or until death, and the median PFS for this group was just under 7 and a half months.': ['Cohort 1 of the primary trial included over 200 patients being treated with Sunitinib and Paclitaxel for a duration of 18 months or until death, and the median PFS (posterior fossa syndrome) for this group was just under 7 and a half months.'],\n",
       "             \"Female patients over the age of 60, with Histologically confirmed breast cancer and advanced Alzheimer's disease are ineligible for both the secondary trial and the primary trial, unless they have an ECOG>2.\": [\"Female patients over the age of 60, with Histologically confirmed breast cancer and advanced Alzheimer's disease are ineligible for both the secondary trial and the primary trial, unless they have an ECOG (electrocortical activity)>2.\"],\n",
       "             'Patients with BCC are excluded from the primary trial and the secondary trial.': ['Patients with BCC (bacterial community composition) are excluded from the primary trial and the secondary trial.'],\n",
       "             'Patients with metastatic HER-2-negative adenocarcinoma of the breast may be eligible for the primary trial.': ['Patients with metastatic HER (heroin)-2-negative adenocarcinoma of the breast may be eligible for the primary trial.'],\n",
       "             'In the primary trial There was less than 3 days difference between the maximum recorded TTP of the Exemestane group and the Anastrozole group.': ['In the primary trial There was less than 3 days difference between the maximum recorded TTP (thrombotic-thrombocytopenic purpura) of the Exemestane group and the Anastrozole group.'],\n",
       "             'Group 1 of the secondary trial has a higher ORR than both the NKTR-102 14 Day cohort of the primary trial and the NKTR-102 21 Days cohort.': ['Group 1 of the secondary trial has a higher ORR (oxygen reduction reaction) than both the NKTR-102 14 Day cohort of the primary trial and the NKTR-102 21 Days cohort.'],\n",
       "             'the secondary trial and the primary trial both measure PFS of their patient cohorts and use the same time frame.': ['the secondary trial and the primary trial both measure PFS (posterior fossa syndrome) of their patient cohorts and use the same time frame.'],\n",
       "             'Patients prescribed with bisoprolol or labetalol to treat CHF are eligible for the primary trial.': ['Patients prescribed with bisoprolol or labetalol to treat CHF (chick embryo fibroblast) are eligible for the primary trial.'],\n",
       "             'Patients with Cancer that has spread from a breast tumor to their CNS are able to take part in the primary trial.': ['Patients with Cancer that has spread from a breast tumor to their CNS (coagulase-negative Staphylococcus) are able to take part in the primary trial.'],\n",
       "             'the primary trial designates specific interventions to its patients depending on their hormone status, Cohort A is TNBC patients and cohort B is ER/PR +HER2- BC Patients, in contrast the secondary trial assigns interventions randomly.': ['the primary trial designates specific interventions to its patients depending on their hormone status, Cohort A is TNBC (basic copy) patients and cohort B is ER (early)/PR +HER (early)2- BC (basic copy) Patients, in contrast the secondary trial assigns interventions randomly.'],\n",
       "             'Patients must present IHC 3+ or FISH amplified results to participate in the primary trial, meaning their cancer is Histologically-confirmed as being triple-positive.': ['Patients must present IHC (Intermountain Health Care) 3+ or FISH amplified results to participate in the primary trial, meaning their cancer is Histologically-confirmed as being triple-positive.'],\n",
       "             'Japanese participants with an ECOG of 2 are eligible for the secondary trial and the primary trial.': ['Japanese participants with an ECOG (electrocortical activity) of 2 are eligible for the secondary trial and the primary trial.'],\n",
       "             'Cohort 1 of the primary trial included 250 patients being treated with Sunitinib and Paclitaxel for a duration of 18 months or until death, and the mean PFS for this group was just under 7 and a half months.': ['Cohort 1 of the primary trial included 250 patients being treated with Sunitinib and Paclitaxel for a duration of 18 months or until death, and the mean PFS (posterior fossa syndrome) for this group was just under 7 and a half months.'],\n",
       "             'One patient in the primary trial had abnormally low levels of AST, ALT and ANC.': ['One patient in the primary trial had abnormally low levels of AST (average survival time), ALT (alternative lengthening of telomeres) and ANC (Active noise control).'],\n",
       "             'Cohort 2 of the secondary trial and the primary trial are control groups, receiving a placebo tablet PO BID.': ['Cohort 2 of the secondary trial and the primary trial are control groups, receiving a placebo tablet PO (pressure overload) BID (body image disturbance).'],\n",
       "             'paclitaxel is the only drug in the primary trial given by IV.': ['paclitaxel is the only drug in the primary trial given by IV (isometric virus).'],\n",
       "             'the primary trial participants must take 6 tablets of Lapatinib Monotherapy (1500g) PO once daily.': ['the primary trial participants must take 6 tablets of Lapatinib Monotherapy (1500g) PO (pressure overload) once daily.'],\n",
       "             'the primary trial Patients receiving Neratinib Plus Capecitabine had a PFS  much longer than the study time frame of 38 months.': ['the primary trial Patients receiving Neratinib Plus Capecitabine had a PFS (posterior fossa syndrome)  much longer than the study time frame of 38 months.'],\n",
       "             'The placebo group in the primary trial had a much lower Median PFS than the MM-121 cohort.': ['The placebo group in the primary trial had a much lower Median PFS (posterior fossa syndrome) (posterior fossa syndrome) than the MM-121 cohort.'],\n",
       "             'the primary trial results indicate that the Recommended Phase II Dose for paclitaxel, as Assessed by NCI Common Terminology Criteria for Adverse Events, is 90 mg/m2 .': ['the primary trial results indicate that the Recommended Phase II Dose for paclitaxel, as Assessed by NCI (negative chemical ionization) Common Terminology Criteria for Adverse Events, is 90 mg/m2 .'],\n",
       "             'Patients with HER2 negative MBC are eligible for both the primary trial and the secondary trial.': ['Patients with HER2 negative MBC (maximum binding capacity) are eligible for both the primary trial and the secondary trial.'],\n",
       "             'The patient group with the highest percent of Event-free Survival in the primary trial was Stage IIIB patients, and the worst was Stage IV Disease patients.': ['The patient group with the highest percent of Event-free Survival in the primary trial was Stage IIIB patients, and the worst was Stage IV (isometric virus) Disease patients.'],\n",
       "             'the secondary trial and the primary trial results indicate that the PFS of participants is partially linked to age, cancer grade and ethnicity.': ['the secondary trial and the primary trial results indicate that the PFS (posterior fossa syndrome) of participants is partially linked to age, cancer grade and ethnicity.'],\n",
       "             'All the primary trial subjects are required to take the intervention tablet PO daily.': ['All the primary trial subjects are required to take the intervention tablet PO (pressure overload) daily.'],\n",
       "             'Adequate renal, hepatic and blood work is required for entry to the primary trial, this includes the following criteria; hemoglobin  11.5 g/dL, aswell as ALT, AST, alkaline phosphatase and total bilirubin < 2.5xULN, and Serum creatinine should be less than 1.7x ULN. These conditions are not explicitly required for the secondary trial.': ['Adequate renal, hepatic and blood work is required for entry to the primary trial, this includes the following criteria; hemoglobin  11.5 g/dL, aswell as ALT (alternative lengthening of telomeres), AST (average survival time), alkaline phosphatase and total bilirubin < 2.5xULN, and Serum creatinine should be less than 1.7x ULN. These conditions are not explicitly required for the secondary trial.'],\n",
       "             'the primary trial Participants received niraparib 200 milligrams (mg) PO once daily for a 28 day cycle, for 2 cycles': ['the primary trial Participants received niraparib 200 milligrams (mg) PO (pressure overload) once daily for a 28 day cycle, for 2 cycles'],\n",
       "             'Adequate renal, hepatic and blood work is required for entry to the primary trial and the secondary trial, this includes the following criteria; hemoglobin  11.5 g/dL, aswell as ALT, AST, alkaline phosphatase and total bilirubin < 2.5xULN, and Serum creatinine should be less than 1.7x ULN.': ['Adequate renal, hepatic and blood work is required for entry to the primary trial and the secondary trial, this includes the following criteria; hemoglobin  11.5 g/dL, aswell as ALT (alternative lengthening of telomeres), AST (average survival time), alkaline phosphatase and total bilirubin < 2.5xULN, and Serum creatinine should be less than 1.7x ULN.'],\n",
       "             'the primary trial participants must take 6 tablets of Lapatinib Monotherapy (250mg) PO once daily.': ['the primary trial participants must take 6 tablets of Lapatinib Monotherapy (250mg) PO (pressure overload) once daily.'],\n",
       "             'the primary trial results show that Participants receiving lapatinib 1500 milligrams (mg) orally were more likely to achieve DFS at 5 years than placebo patients, however, there was less than a 30% difference in DFS rate between the two cohorts.': ['the primary trial results show that Participants receiving lapatinib 1500 milligrams (mg) orally were more likely to achieve DFS (desoxyfructosylserotonin) (desoxyfructosylserotonin) at 5 years than placebo patients, however, there was less than a 30% difference in DFS (desoxyfructosylserotonin) (desoxyfructosylserotonin) rate between the two cohorts.'],\n",
       "             'There were 23 participants in cohort 1 of the primary trial with a (CR) or (PR) based on the Response Assessment in Neuro-Oncology Brain Metastasis (RANO-BM) response criteria.': ['There were 23 participants in cohort 1 of the primary trial with a (CR (calorie restriction)) or (PR (proliferative retinopathy)) based on the Response Assessment in Neuro-Oncology Brain Metastasis (RANO-BM) response criteria.'],\n",
       "             'the secondary trial is testing for the DLT of its interventions, whereas the primary trial is evaluating the dose limiting toxicity for SentiMag and SiennaXP. ': ['the secondary trial is testing for the DLT (direct linear transformation) of its interventions, whereas the primary trial is evaluating the dose limiting toxicity for SentiMag and SiennaXP. '],\n",
       "             'Patients with stage I, II, III or IV breast cancer may be eliglbe for the primary trial.': ['Patients with stage I, II, III or IV (isometric virus) breast cancer may be eliglbe for the primary trial.'],\n",
       "             'Cohort 2 of the primary trial reported one case of AML.': ['Cohort 2 of the primary trial reported one case of AML (anatomic medullary locking).'],\n",
       "             'All the primary trial subjects are required to take the intervention PO daily.': ['All the primary trial subjects are required to take the intervention PO (pressure overload) daily.'],\n",
       "             'participants from both cohorts of the primary trial had a drastically lower CNS Objective Response Rate than those in the secondary trial.': ['participants from both cohorts of the primary trial had a drastically lower CNS (coagulase-negative Staphylococcus) Objective Response Rate than those in the secondary trial.'],\n",
       "             'the primary trial results suggest that 40 mg/m2 administered as a 3-hour intravenous (IV) infusion on Day 1 of each cycle + Capecitabine, may increase OS, compared to Capecitabine alone.': ['the primary trial results suggest that 40 mg/m2 administered as a 3-hour intravenous (IV) infusion on Day 1 of each cycle + Capecitabine, may increase OS (oligomycin-sensitive), compared to Capecitabine alone.'],\n",
       "             'the primary trial results indicate that the Recommended Phase II Dose for Vorinostat, as Assessed by NCI Common Terminology Criteria for Adverse Events, is 300 mg.': ['the primary trial results indicate that the Recommended Phase II Dose for Vorinostat, as Assessed by NCI (negative chemical ionization) Common Terminology Criteria for Adverse Events, is 300 mg.'],\n",
       "             'On day 1 Cohort 1 of the primary trial receive doxorubicin hydrochloride IV, oral cyclophosphamide, dexamethasone IV or orally and ondansetron IV.': ['On day 1 Cohort 1 of the primary trial receive doxorubicin hydrochloride IV (isometric virus) (isometric virus) (isometric virus), oral cyclophosphamide, dexamethasone IV (isometric virus) (isometric virus) (isometric virus) or orally and ondansetron IV (isometric virus) (isometric virus) (isometric virus).'],\n",
       "             'The Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) for Alisertib in Combination With Paclitaxel, supported by results from cohort 2 of the primary trial, is 40 mg/m^2 orally, twice daily (BID) on Days 1-3, 8-10 and 15-17': ['The Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) for Alisertib in Combination With Paclitaxel, supported by results from cohort 2 of the primary trial, is 40 mg/m^2 orally, twice daily (BID (body image disturbance)) on Days 1-3, 8-10 and 15-17'],\n",
       "             'Renal cancer Patients from the primary trial receiving Standard of Care had a median PFS of 2.5 months by Core radiology laboratory assessment.': ['Renal cancer Patients from the primary trial receiving Standard of Care had a median PFS (posterior fossa syndrome) of 2.5 months by Core radiology laboratory assessment.'],\n",
       "             'Patients from the primary trial receiving Standard of Care had a median PFS of 2.7months by Core radiology laboratory assessment.': ['Patients from the primary trial receiving Standard of Care had a median PFS (posterior fossa syndrome) of 2.7months by Core radiology laboratory assessment.'],\n",
       "             'Any patients with histologically confirmed stage 4 adenocarcinoma HER2/neu immunohistochemistry 3+, ECOG performance status <2 and a Negative HCG pregnancy test are eligible for the primary trial.': ['Any patients with histologically confirmed stage 4 adenocarcinoma HER2/neu immunohistochemistry 3+, ECOG (electrocortical activity) performance status <2 and a Negative HCG pregnancy test are eligible for the primary trial.'],\n",
       "             'The Triple-Negative Breast Cancer cohort of the primary trial had a much lower ORR than the cohort receiving 1.4 mg/m2 of Eribulin.': ['The Triple-Negative Breast Cancer cohort of the primary trial had a much lower ORR (oxygen reduction reaction) than the cohort receiving 1.4 mg/m2 of Eribulin.'],\n",
       "             'Patients must have an ECOG score below 3 to participate in the primary trial.': ['Patients must have an ECOG (electrocortical activity) score below 3 to participate in the primary trial.'],\n",
       "             'Black men with and ECOG <=2, with ANC >1.5 x 10^9/L,Bilirubin > 2.0 mg/dl, PLT >100 x 10^9/L and no prior history of blood clots are eligible for the primary trial but excluded from the secondary trial': ['Black men with and ECOG (electrocortical activity) <=2, with ANC (Active noise control) >1.5 x 10^9/L,Bilirubin > 2.0 mg/dl, PLT (postero-lateral thoracotomy) >100 x 10^9/L and no prior history of blood clots are eligible for the primary trial but excluded from the secondary trial'],\n",
       "             'The patient with the shortest PFS was in the secondary trial and the longest recorded PFS was in the primary trial.': ['The patient with the shortest PFS (posterior fossa syndrome) (posterior fossa syndrome) was in the secondary trial and the longest recorded PFS (posterior fossa syndrome) (posterior fossa syndrome) was in the primary trial.'],\n",
       "             'The Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) for Alisertib in Combination With Paclitaxel, supported by the primary trial results, is 40 mg orally, twice daily (BID) on Days 1-3, 8-10 and 15-17': ['The Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) for Alisertib in Combination With Paclitaxel, supported by the primary trial results, is 40 mg orally, twice daily (BID (body image disturbance)) on Days 1-3, 8-10 and 15-17'],\n",
       "             'No cases of Metastasis to the CNS were recorded in the primary trial.': ['No cases of Metastasis to the CNS (coagulase-negative Staphylococcus) were recorded in the primary trial.'],\n",
       "             'the primary trial and the secondary trial measure the DLT of their respective interventions, using the same time frame and the same unit of measure.': ['the primary trial and the secondary trial measure the DLT (direct linear transformation) of their respective interventions, using the same time frame and the same unit of measure.'],\n",
       "             'Neither cohorts of the primary trial receive any medication orally or by IV.': ['Neither cohorts of the primary trial receive any medication orally or by IV (isometric virus).'],\n",
       "             'Neither cohorts of the primary trial receive any medication orally, by IV or by radiation.': ['Neither cohorts of the primary trial receive any medication orally, by IV (isometric virus) or by radiation.'],\n",
       "             'Patients in the primary trial receive a lower dose of Zometa by IV than the secondary trial patients receive of PI3K inhibitor BYL719  by IV.': ['Patients in the primary trial receive a lower dose of Zometa by IV (isometric virus) (isometric virus) than the secondary trial patients receive of PI3K inhibitor BYL719  by IV (isometric virus) (isometric virus).'],\n",
       "             'Patients in the primary trial receive at least 150mg of IMGN853 by IV every 3 weeks.': ['Patients in the primary trial receive at least 150mg of IMGN853 by IV (isometric virus) every 3 weeks.'],\n",
       "             'The median TTP in cohort one of the primary trial is just under 27 months.': ['The median TTP (thrombotic-thrombocytopenic purpura) in cohort one of the primary trial is just under 27 months.'],\n",
       "             'the primary trial and the secondary trial only have test groups, so all patients are receiving novel (FDA approved) interventions.': ['the primary trial and the secondary trial only have test groups, so all patients are receiving novel (FDA (Fisher discriminant analysis) approved) interventions.'],\n",
       "             'All the primary trial subjects either had Progressive disease, Complete CNS objective response rate or partial response rate.': ['All the primary trial subjects either had Progressive disease, Complete CNS (coagulase-negative Staphylococcus) objective response rate or partial response rate.'],\n",
       "             '20 patients treated with Dasatinib and Letrozole in the primary trial had a Disease Free Interval (DFI) Greater Than 2 Years.': ['20 patients treated with Dasatinib and Letrozole in the primary trial had a Disease Free Interval (DFI (DNA fragmentation index)) Greater Than 2 Years.'],\n",
       "             'the primary trial Participants received niraparib 200 milligrams (mg) PO once daily for a 28 day cycle, for 3 cycles, after which all participants undergo neoadjuvant chemotherapy.': ['the primary trial Participants received niraparib 200 milligrams (mg) PO (pressure overload) once daily for a 28 day cycle, for 3 cycles, after which all participants undergo neoadjuvant chemotherapy.'],\n",
       "             'A 75 year old female patient, with an ECOG of 3 and an estimated life expectancy of more than a year would be eligible for the primary trial.': ['A 75 year old female patient, with an ECOG (electrocortical activity) of 3 and an estimated life expectancy of more than a year would be eligible for the primary trial.'],\n",
       "             'DLT occurence, used as the outcome measurement in the secondary trial and Clinical Benefit Rate, used in the primary trial are not synonymous, and represent entirely different patient characteristics. ': ['DLT (direct linear transformation) occurence, used as the outcome measurement in the secondary trial and Clinical Benefit Rate, used in the primary trial are not synonymous, and represent entirely different patient characteristics. '],\n",
       "             'the primary trial results suggest that 40 mg/m2 administered as a 3-hour intravenous (IV) infusion on Day 1 of each cycle + Capecitabine, triples patient OS, compared to Capecitabine alone.': ['the primary trial results suggest that 40 mg/m2 administered as a 3-hour intravenous (IV) infusion on Day 1 of each cycle + Capecitabine, triples patient OS (oligomycin-sensitive), compared to Capecitabine alone.'],\n",
       "             'The majority of patients in the primary trial had an EGFR Expression level of 0, and 0 patients had an EGFR of 3 or above.': ['The majority of patients in the primary trial had an EGFR (estimated glomerular filtration rate) (estimated glomerular filtration rate) Expression level of 0, and 0 patients had an EGFR (estimated glomerular filtration rate) (estimated glomerular filtration rate) of 3 or above.'],\n",
       "             'Patients with an ECOG score between 3-5 are eligible for the primary trial.': ['Patients with an ECOG (electrocortical activity) score between 3-5 are eligible for the primary trial.'],\n",
       "             'Cohort 2 in the primary trial and the secondary trial but receive daily placebo doses PO.': ['Cohort 2 in the primary trial and the secondary trial but receive daily placebo doses PO (pressure overload).'],\n",
       "             'None of the patients in either cohort of the primary trial experienced DLT.': ['None of the patients in either cohort of the primary trial experienced DLT (direct linear transformation).'],\n",
       "             'Patients with metastatic HER-2 positive adenocarcinoma of the breast can never be eligible for the primary trial.': ['Patients with metastatic HER (heroin)-2 positive adenocarcinoma of the breast can never be eligible for the primary trial.'],\n",
       "             'the primary trial uses a set dosage of 1000 mg PO daily of Lapatinib, whereas the dose of Capecitabine changes with patients body weight.': ['the primary trial uses a set dosage of 1000 mg PO (pressure overload) daily of Lapatinib, whereas the dose of Capecitabine changes with patients body weight.'],\n",
       "             'Patients with ER-positive tumours are eligible for the primary trial but not for the secondary trial.': ['Patients with ER (early)-positive tumours are eligible for the primary trial but not for the secondary trial.'],\n",
       "             'Anna is a 57 year old female with an ECOG of 0, diagnosed with a HER2-positive invasive adenocarcinoma of the breast, with ipsilateral nodes pN2. She is eligible for the primary trial.': ['Anna is a 57 year old female with an ECOG (electrocortical activity) of 0, diagnosed with a HER2-positive invasive adenocarcinoma of the breast, with ipsilateral nodes pN2. She is eligible for the primary trial.'],\n",
       "             'the primary trial and the secondary trial monitor the DFS of their patient cohorts, however the secondary trial reports the % of patients with DFS >= 5 years whereas the primary trial reports % of participants with DFS >= 2 years.': ['the primary trial and the secondary trial monitor the DFS (desoxyfructosylserotonin) (desoxyfructosylserotonin) (desoxyfructosylserotonin) of their patient cohorts, however the secondary trial reports the % of patients with DFS (desoxyfructosylserotonin) (desoxyfructosylserotonin) (desoxyfructosylserotonin) >= 5 years whereas the primary trial reports % of participants with DFS (desoxyfructosylserotonin) (desoxyfructosylserotonin) (desoxyfructosylserotonin) >= 2 years.'],\n",
       "             'Results from the primary trial and the secondary trial indicate Abraxane + Tigatuzumab produce better ORR than Caelyx, Docetaxe and Trastuzumab.': ['Results from the primary trial and the secondary trial indicate Abraxane + Tigatuzumab produce better ORR (oxygen reduction reaction) than Caelyx, Docetaxe and Trastuzumab.'],\n",
       "             'On days 1-7 Cohort 1 of the primary trial receive doxorubicin hydrochloride IV, oral cyclophosphamide, dexamethasone IV or orally and ondansetron IV.': ['On days 1-7 Cohort 1 of the primary trial receive doxorubicin hydrochloride IV (isometric virus) (isometric virus) (isometric virus), oral cyclophosphamide, dexamethasone IV (isometric virus) (isometric virus) (isometric virus) or orally and ondansetron IV (isometric virus) (isometric virus) (isometric virus).'],\n",
       "             'cohort 1 of the secondary trial had a much longer median PFS than cohort 1 of the primary trial.': ['cohort 1 of the secondary trial had a much longer median PFS (posterior fossa syndrome) than cohort 1 of the primary trial.'],\n",
       "             'Patients with HER2 negative BC are eligible for both the primary trial and the secondary trial.': ['Patients with HER2 negative BC (basic copy) are eligible for both the primary trial and the secondary trial.'],\n",
       "             'In the primary trial There was less than 3 months difference between the maximum and minimum recorded TTP of the Exemestane group.': ['In the primary trial There was less than 3 months difference between the maximum and minimum recorded TTP (thrombotic-thrombocytopenic purpura) of the Exemestane group.'],\n",
       "             'In the primary trial, Dasatinib, 70 mg, Twice Daily results in a better median PFS than Dasatinib, 100 mg, Daily.': ['In the primary trial, Dasatinib, 70 mg, Twice Daily results in a better median PFS (posterior fossa syndrome) than Dasatinib, 100 mg, Daily.'],\n",
       "             'ECOG > 1 and a life expectancy over 12 weeks are necessary to participate in the primary trial.': ['ECOG (electrocortical activity) > 1 and a life expectancy over 12 weeks are necessary to participate in the primary trial.'],\n",
       "             'Japanese participants with an ECOG <=1 are eligible for the secondary trial and the primary trial.': ['Japanese participants with an ECOG (electrocortical activity) <=1 are eligible for the secondary trial and the primary trial.'],\n",
       "             'Participants of the primary trial must be older than 18, have histologically confirmed stage 3 or above breast cancer, ECOG<2 and a life expectancy exceeding 6 months.': ['Participants of the primary trial must be older than 18, have histologically confirmed stage 3 or above breast cancer, ECOG (electrocortical activity)<2 and a life expectancy exceeding 6 months.'],\n",
       "             'A 75 year old female patient, with an ECOG of 1 and an estimated life expectancy of more than a year would be eligible for the primary trial.': ['A 75 year old female patient, with an ECOG (electrocortical activity) of 1 and an estimated life expectancy of more than a year would be eligible for the primary trial.'],\n",
       "             'INR equal to or above 1.5 is mandatory for participation in the primary trial, it is not necessary for the secondary trial.': ['INR (initiator element) equal to or above 1.5 is mandatory for participation in the primary trial, it is not necessary for the secondary trial.'],\n",
       "             'IV is used as route of administration by the interventions in the primary trial and the secondary trial.': ['IV (isometric virus) is used as route of administration by the interventions in the primary trial and the secondary trial.'],\n",
       "             'In order to be eligible for both the secondary trial and the primary trial, patients must be female, over the age of 18, ECOG <2 and have Histologically confirmed HER2 negative breast cancer.': ['In order to be eligible for both the secondary trial and the primary trial, patients must be female, over the age of 18, ECOG (electrocortical activity) <2 and have Histologically confirmed HER2 negative breast cancer.'],\n",
       "             'Patients with left-sided breast cancer and an ECOG of 3 are excluded from the primary trial.': ['Patients with left-sided breast cancer and an ECOG (electrocortical activity) of 3 are excluded from the primary trial.'],\n",
       "             'Patients with radiologically confirmed metatases in the CNS are excluded from both the secondary trial and the primary trial.': ['Patients with radiologically confirmed metatases in the CNS (coagulase-negative Staphylococcus) are excluded from both the secondary trial and the primary trial.'],\n",
       "             'Anna is a 57 year old female with an ECOG of 0, diagnosed with an invasive adenocarcinoma of the breast, IHC results were 1+. She is eligible for the primary trial.': ['Anna is a 57 year old female with an ECOG (electrocortical activity) of 0, diagnosed with an invasive adenocarcinoma of the breast, IHC (Intermountain Health Care) results were 1+. She is eligible for the primary trial.'],\n",
       "             'Patients with stage I, II, III or IV triple negative breast cancer are not eliglbe for the primary trial.': ['Patients with stage I, II, III or IV (isometric virus) triple negative breast cancer are not eliglbe for the primary trial.'],\n",
       "             'ECOG < 2 and a life expectancy over 12 weeks are necessary to participate in the primary trial.': ['ECOG (electrocortical activity) < 2 and a life expectancy over 12 weeks are necessary to participate in the primary trial.'],\n",
       "             'The Single IV Infusion of ZA 4 mg group of the primary trial had a smaller Percentage Change From Baseline in Urinary N-telopeptide of Type I Collagen than the Odanacatib 5 mg group': ['The Single IV (isometric virus) Infusion of ZA 4 mg group of the primary trial had a smaller Percentage Change From Baseline in Urinary N-telopeptide of Type I Collagen than the Odanacatib 5 mg group'],\n",
       "             'the primary trial uses a set dosage of 1000 mg PO daily of Lapatinib, whereas the dose of Capecitabine changes with Body surface area.': ['the primary trial uses a set dosage of 1000 mg PO (pressure overload) daily of Lapatinib, whereas the dose of Capecitabine changes with Body surface area.'],\n",
       "             'There were no participants in cohort 1 of the primary trial with a (CR) or (PR) based on the Response Assessment in Neuro-Oncology Brain Metastasis (RANO-BM) response criteria.': ['There were no participants in cohort 1 of the primary trial with a (CR (calorie restriction)) or (PR (proliferative retinopathy)) based on the Response Assessment in Neuro-Oncology Brain Metastasis (RANO-BM) response criteria.'],\n",
       "             'The patient with the shortest PFS was in the secondary trial, at only 5 days, and the longest recorded PFS was in the primary trial at 78 months.': ['The patient with the shortest PFS (posterior fossa syndrome) (posterior fossa syndrome) was in the secondary trial, at only 5 days, and the longest recorded PFS (posterior fossa syndrome) (posterior fossa syndrome) was in the primary trial at 78 months.'],\n",
       "             'the primary trial is testing a novel radiotracer called PET/CT to evaluate its use for visualization of HER2+ lesions.': ['the primary trial is testing a novel radiotracer called PET (pancreatic endocrine tumour)/CT to evaluate its use for visualization of HER2+ lesions.'],\n",
       "             'the primary trial and the secondary trial monitor the %  of their patient cohorts with DFS < 6years.': ['the primary trial and the secondary trial monitor the %  of their patient cohorts with DFS (desoxyfructosylserotonin) < 6years.'],\n",
       "             'the primary trial and the secondary trial are not studying patient PFS, ORR or DLTs.': ['the primary trial and the secondary trial are not studying patient PFS (posterior fossa syndrome), ORR (oxygen reduction reaction) or DLTs.'],\n",
       "             'the secondary trial and the primary trial both measure PFS of their patient cohorts.': ['the secondary trial and the primary trial both measure PFS (posterior fossa syndrome) of their patient cohorts.'],\n",
       "             'Patients must have AST, ALP and ALT < 1.5 ULN to participate in the primary trial.': ['Patients must have AST (average survival time), ALP (acute lupus pericarditis) and ALT (alternative lengthening of telomeres) < 1.5 ULN to participate in the primary trial.'],\n",
       "             'Lidoderm products are used in a intervention arm 1 of the secondary trial, and an FFDM product is used in arm 1 of the primary trial': ['Lidoderm products are used in a intervention arm 1 of the secondary trial, and an FFDM (freedom from distant metastasis) product is used in arm 1 of the primary trial'],\n",
       "             'the secondary trial records several gastrointestinal adverse events, whereas the primary trial doesn‚Äö√Ñ√¥t record any GI adverse events.': ['the secondary trial records several gastrointestinal adverse events, whereas the primary trial doesn‚Äö√Ñ√¥t record any GI (genomic instability) adverse events.'],\n",
       "             'All participants in the primary trial are administered with Lapatinib 1500 mg PO QD and Pazopanib 800 mg.': ['All participants in the primary trial are administered with Lapatinib 1500 mg PO (pressure overload) QD and Pazopanib 800 mg.'],\n",
       "             'the primary trial did not use PFS to evaluate the performance of its interventions.': ['the primary trial did not use PFS (posterior fossa syndrome) to evaluate the performance of its interventions.'],\n",
       "             'The shortest PFS in the Talazoparib group of the primary trial was over a month longer than the study duration.': ['The shortest PFS (posterior fossa syndrome) in the Talazoparib group of the primary trial was over a month longer than the study duration.'],\n",
       "             'Patients with clinically significant grade 3 PVD are eligible for the primary trial.': ['Patients with clinically significant grade 3 PVD (physical-vapor deposition) are eligible for the primary trial.'],\n",
       "             'Patients must present IHC 3+ or FISH amplified results to participate in the primary trial, meaning their cancer is Histologically-confirmed as being HER2-positive.': ['Patients must present IHC (Intermountain Health Care) 3+ or FISH amplified results to participate in the primary trial, meaning their cancer is Histologically-confirmed as being HER2-positive.'],\n",
       "             'the primary trial only records GI adverse events.': ['the primary trial only records GI (genomic instability) adverse events.'],\n",
       "             'At least 8 participants in the primary trial had a Central Nervous System (CNS) Progression Free Survival (PFS) >= 3 months.': ['At least 8 participants in the primary trial had a Central Nervous System (CNS (coagulase-negative Staphylococcus)) Progression Free Survival (PFS (posterior fossa syndrome)) >= 3 months.'],\n",
       "             'Most patients treated with Dasatinib and Letrozole in the primary trial had a Disease Free Interval (DFI) Greater Than 2 Years.': ['Most patients treated with Dasatinib and Letrozole in the primary trial had a Disease Free Interval (DFI (DNA fragmentation index)) Greater Than 2 Years.'],\n",
       "             'There were no patients in either cohort of the primary trial with a PFS exceeding 6 months.': ['There were no patients in either cohort of the primary trial with a PFS (posterior fossa syndrome) exceeding 6 months.'],\n",
       "             'the primary trial participants are given saracatinib PO for a maximum of 28 days.': ['the primary trial participants are given saracatinib PO (pressure overload) for a maximum of 28 days.'],\n",
       "             'All participants in the primary trial are administered with Lapatinib 1500 mg PO QD.': ['All participants in the primary trial are administered with Lapatinib 1500 mg PO (pressure overload) QD.'],\n",
       "             'In order to be eligible for both the secondary trial and the primary trial, patients must be female, over the age of 18, ECOG <2 and have Histologically confirmed HER2 + breast cancer.': ['In order to be eligible for both the secondary trial and the primary trial, patients must be female, over the age of 18, ECOG (electrocortical activity) <2 and have Histologically confirmed HER2 + breast cancer.'],\n",
       "             'There was one GU and three GI adverse events recorded in the primary trial.': ['There was one GU (glucose utilization) and three GI (genomic instability) adverse events recorded in the primary trial.'],\n",
       "             'The majority of the primary trial participants achieved CR or PR.': ['The majority of the primary trial participants achieved CR (calorie restriction) or PR (proliferative retinopathy).'],\n",
       "             'Patients will have to undergo an MRI scan of the spine for before entry for both the secondary trial and the primary trial, for the primary trial patients will also need to have a brain MR and PET imaging, after study entry.': ['Patients will have to undergo an MR (mandelate racemase)I scan of the spine for before entry for both the secondary trial and the primary trial, for the primary trial patients will also need to have a brain MR (mandelate racemase) and PET (pancreatic endocrine tumour) imaging, after study entry.'],\n",
       "             'the secondary trial records only gastrointestinal adverse events, whereas the primary trial doesn‚Äö√Ñ√¥t record any GI adverse events.': ['the secondary trial records only gastrointestinal adverse events, whereas the primary trial doesn‚Äö√Ñ√¥t record any GI (genomic instability) adverse events.'],\n",
       "             'the secondary trial and the primary trial study the Progression Free Survival (PFS) of their participants, however they use different Units of Measure.': ['the secondary trial and the primary trial study the Progression Free Survival (PFS (posterior fossa syndrome)) of their participants, however they use different Units of Measure.'],\n",
       "             'the primary trial and the secondary trial both report Objective Response Rate (ORR) of their patients.': ['the primary trial and the secondary trial both report Objective Response Rate (ORR (oxygen reduction reaction)) of their patients.'],\n",
       "             'The Ridaforolimus + Dalotuzumab + Exemestane group of the primary trial had a median PFS of over 38.43 months.': ['The Ridaforolimus + Dalotuzumab + Exemestane group of the primary trial had a median PFS (posterior fossa syndrome) of over 38.43 months.']})"
      ]
     },
     "execution_count": 989,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "neg_hypotheses"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1c3f9537",
   "metadata": {},
   "source": [
    "### Creating New Dataset "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 970,
   "id": "604acdea",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1692"
      ]
     },
     "execution_count": 970,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(data_dict)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1001,
   "id": "0a0c8e5b",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "new_data = []\n",
    "for h, h_data in data_dict.items():\n",
    "    h, label = h.split('_____')\n",
    "    if h not in new_hypotheses:\n",
    "        new_rw = dd()\n",
    "        new_rw.update(h_data)\n",
    "        new_rw['Statement'] = h\n",
    "        new_data.append(new_rw)\n",
    "        continue\n",
    "    for h_new in new_hypotheses[h]:\n",
    "        new_rw = dd()\n",
    "        new_rw.update(h_data)\n",
    "        new_rw['Statement'] = h_new\n",
    "        new_data.append(new_rw)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1002,
   "id": "903529af",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Type</th>\n",
       "      <th>Section_id</th>\n",
       "      <th>Primary_id</th>\n",
       "      <th>Secondary_id</th>\n",
       "      <th>Label</th>\n",
       "      <th>Statement</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT01928186</td>\n",
       "      <td>NCT00684983</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00662129</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>Patients with Platelet count over 100,000/mm¬¨...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Adverse Events</td>\n",
       "      <td>NCT00093145</td>\n",
       "      <td>NCT00703326</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Heart-related adverse events were recorded in ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT01097642</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>Adult Patients with histologic confirmation of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT00852930</td>\n",
       "      <td>NCT02308020</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>Laser Therapy is in each cohort of the primary...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1695</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00213980</td>\n",
       "      <td>NCT02536339</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Adequate blood, kidney, and hepatic function a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1696</th>\n",
       "      <td>Single</td>\n",
       "      <td>Results</td>\n",
       "      <td>NCT01605396</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>The Ridaforolimus + Dalotuzumab + Exemestane g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1697</th>\n",
       "      <td>Single</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT00181363</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>The only difference between the interventions ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1698</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00834678</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Patients must have a white blood cell count ab...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1699</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Results</td>\n",
       "      <td>NCT01004172</td>\n",
       "      <td>NCT00802945</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>the primary trial and the secondary trial both...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1700 rows × 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            Type      Section_id   Primary_id Secondary_id          Label  \\\n",
       "0     Comparison    Intervention  NCT01928186  NCT00684983  Contradiction   \n",
       "1         Single     Eligibility  NCT00662129          NaN  Contradiction   \n",
       "2     Comparison  Adverse Events  NCT00093145  NCT00703326     Entailment   \n",
       "3         Single     Eligibility  NCT01097642          NaN  Contradiction   \n",
       "4     Comparison    Intervention  NCT00852930  NCT02308020  Contradiction   \n",
       "...          ...             ...          ...          ...            ...   \n",
       "1695  Comparison     Eligibility  NCT00213980  NCT02536339     Entailment   \n",
       "1696      Single         Results  NCT01605396          NaN  Contradiction   \n",
       "1697      Single    Intervention  NCT00181363          NaN     Entailment   \n",
       "1698      Single     Eligibility  NCT00834678          NaN     Entailment   \n",
       "1699  Comparison         Results  NCT01004172  NCT00802945  Contradiction   \n",
       "\n",
       "                                              Statement  \n",
       "0     All the primary trial participants do not rece...  \n",
       "1     Patients with Platelet count over 100,000/mm¬¨...  \n",
       "2     Heart-related adverse events were recorded in ...  \n",
       "3     Adult Patients with histologic confirmation of...  \n",
       "4     Laser Therapy is in each cohort of the primary...  \n",
       "...                                                 ...  \n",
       "1695  Adequate blood, kidney, and hepatic function a...  \n",
       "1696  The Ridaforolimus + Dalotuzumab + Exemestane g...  \n",
       "1697  The only difference between the interventions ...  \n",
       "1698  Patients must have a white blood cell count ab...  \n",
       "1699  the primary trial and the secondary trial both...  \n",
       "\n",
       "[1700 rows x 6 columns]"
      ]
     },
     "execution_count": 1002,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.DataFrame(new_data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1005,
   "id": "2618c5ca",
   "metadata": {},
   "outputs": [],
   "source": [
    "new_data = []\n",
    "for h, h_data in data_dict.items():\n",
    "    h, label = h.split('_____')\n",
    "    if h not in neg_hypotheses:\n",
    "        new_rw = dd()\n",
    "        new_rw.update(h_data)\n",
    "        new_rw['Statement'] = h\n",
    "        new_data.append(new_rw)\n",
    "        continue\n",
    "    for h_new in neg_hypotheses[h]:\n",
    "        new_rw = dd()\n",
    "        new_rw.update(h_data)\n",
    "        new_rw['Statement'] = h_new\n",
    "        if h_data['Label'] == 'Contradiction':\n",
    "            new_rw['Label'] = 'Entailment'\n",
    "        if h_data['Label'] == 'Entailment':\n",
    "            new_rw['Label'] = 'Contradiction'\n",
    "            \n",
    "        new_data.append(new_rw)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1006,
   "id": "d2c89247",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Type</th>\n",
       "      <th>Section_id</th>\n",
       "      <th>Primary_id</th>\n",
       "      <th>Secondary_id</th>\n",
       "      <th>Label</th>\n",
       "      <th>Statement</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT01928186</td>\n",
       "      <td>NCT00684983</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00662129</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Patients with Platelet count over 100,000/mm¬¨...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Adverse Events</td>\n",
       "      <td>NCT00093145</td>\n",
       "      <td>NCT00703326</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Heart-related adverse events were recorded in ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT01097642</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>Adult Patients with histologic confirmation of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT00852930</td>\n",
       "      <td>NCT02308020</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>Laser Therapy is in each cohort of the primary...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1695</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00213980</td>\n",
       "      <td>NCT02536339</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Adequate blood, kidney, and hepatic function a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1696</th>\n",
       "      <td>Single</td>\n",
       "      <td>Results</td>\n",
       "      <td>NCT01605396</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>The Ridaforolimus + Dalotuzumab + Exemestane g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1697</th>\n",
       "      <td>Single</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT00181363</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>The only difference between the interventions ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1698</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00834678</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Patients must have a white blood cell count ab...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1699</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Results</td>\n",
       "      <td>NCT01004172</td>\n",
       "      <td>NCT00802945</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>the primary trial and the secondary trial both...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1700 rows × 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            Type      Section_id   Primary_id Secondary_id          Label  \\\n",
       "0     Comparison    Intervention  NCT01928186  NCT00684983     Entailment   \n",
       "1         Single     Eligibility  NCT00662129          NaN     Entailment   \n",
       "2     Comparison  Adverse Events  NCT00093145  NCT00703326     Entailment   \n",
       "3         Single     Eligibility  NCT01097642          NaN  Contradiction   \n",
       "4     Comparison    Intervention  NCT00852930  NCT02308020  Contradiction   \n",
       "...          ...             ...          ...          ...            ...   \n",
       "1695  Comparison     Eligibility  NCT00213980  NCT02536339     Entailment   \n",
       "1696      Single         Results  NCT01605396          NaN     Entailment   \n",
       "1697      Single    Intervention  NCT00181363          NaN     Entailment   \n",
       "1698      Single     Eligibility  NCT00834678          NaN     Entailment   \n",
       "1699  Comparison         Results  NCT01004172  NCT00802945  Contradiction   \n",
       "\n",
       "                                              Statement  \n",
       "0     All the primary trial participants do not rece...  \n",
       "1     Patients with Platelet count over 100,000/mm¬¨...  \n",
       "2     Heart-related adverse events were recorded in ...  \n",
       "3     Adult Patients with histologic confirmation of...  \n",
       "4     Laser Therapy is in each cohort of the primary...  \n",
       "...                                                 ...  \n",
       "1695  Adequate blood, kidney, and hepatic function a...  \n",
       "1696  The Ridaforolimus + Dalotuzumab + Exemestane g...  \n",
       "1697  The only difference between the interventions ...  \n",
       "1698  Patients must have a white blood cell count ab...  \n",
       "1699  the primary trial and the secondary trial both...  \n",
       "\n",
       "[1700 rows x 6 columns]"
      ]
     },
     "execution_count": 1006,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.DataFrame(new_data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1008,
   "id": "7f8bf533",
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.DataFrame(new_data).drop_duplicates().to_json('dataset_2.json', orient='index')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1007,
   "id": "0dd624ed",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Type</th>\n",
       "      <th>Section_id</th>\n",
       "      <th>Primary_id</th>\n",
       "      <th>Secondary_id</th>\n",
       "      <th>Label</th>\n",
       "      <th>Statement</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT01928186</td>\n",
       "      <td>NCT00684983</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00662129</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Patients with Platelet count over 100,000/mm¬¨...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Adverse Events</td>\n",
       "      <td>NCT00093145</td>\n",
       "      <td>NCT00703326</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Heart-related adverse events were recorded in ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT01097642</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>Adult Patients with histologic confirmation of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT00852930</td>\n",
       "      <td>NCT02308020</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>Laser Therapy is in each cohort of the primary...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1695</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00213980</td>\n",
       "      <td>NCT02536339</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Adequate blood, kidney, and hepatic function a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1696</th>\n",
       "      <td>Single</td>\n",
       "      <td>Results</td>\n",
       "      <td>NCT01605396</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>The Ridaforolimus + Dalotuzumab + Exemestane g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1697</th>\n",
       "      <td>Single</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT00181363</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>The only difference between the interventions ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1698</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00834678</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Patients must have a white blood cell count ab...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1699</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Results</td>\n",
       "      <td>NCT01004172</td>\n",
       "      <td>NCT00802945</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>the primary trial and the secondary trial both...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1700 rows × 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            Type      Section_id   Primary_id Secondary_id          Label  \\\n",
       "0     Comparison    Intervention  NCT01928186  NCT00684983     Entailment   \n",
       "1         Single     Eligibility  NCT00662129          NaN     Entailment   \n",
       "2     Comparison  Adverse Events  NCT00093145  NCT00703326     Entailment   \n",
       "3         Single     Eligibility  NCT01097642          NaN  Contradiction   \n",
       "4     Comparison    Intervention  NCT00852930  NCT02308020  Contradiction   \n",
       "...          ...             ...          ...          ...            ...   \n",
       "1695  Comparison     Eligibility  NCT00213980  NCT02536339     Entailment   \n",
       "1696      Single         Results  NCT01605396          NaN     Entailment   \n",
       "1697      Single    Intervention  NCT00181363          NaN     Entailment   \n",
       "1698      Single     Eligibility  NCT00834678          NaN     Entailment   \n",
       "1699  Comparison         Results  NCT01004172  NCT00802945  Contradiction   \n",
       "\n",
       "                                              Statement  \n",
       "0     All the primary trial participants do not rece...  \n",
       "1     Patients with Platelet count over 100,000/mm¬¨...  \n",
       "2     Heart-related adverse events were recorded in ...  \n",
       "3     Adult Patients with histologic confirmation of...  \n",
       "4     Laser Therapy is in each cohort of the primary...  \n",
       "...                                                 ...  \n",
       "1695  Adequate blood, kidney, and hepatic function a...  \n",
       "1696  The Ridaforolimus + Dalotuzumab + Exemestane g...  \n",
       "1697  The only difference between the interventions ...  \n",
       "1698  Patients must have a white blood cell count ab...  \n",
       "1699  the primary trial and the secondary trial both...  \n",
       "\n",
       "[1700 rows x 6 columns]"
      ]
     },
     "execution_count": 1007,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.DataFrame(new_data).drop_duplicates()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "db8e1338",
   "metadata": {},
   "source": [
    "## Long Form to Short Form"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1179,
   "id": "3b92a18b",
   "metadata": {},
   "outputs": [],
   "source": [
    "available_lfs = list(set([lf.lower() for lf in list(lf2sf.keys()) if len(lf.split()) > 1]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1180,
   "id": "c2f5d47f",
   "metadata": {},
   "outputs": [],
   "source": [
    "llf2ulf = { lf.lower():lf for lf in list(inventory['LF']) if len(lf.split()) > 1}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1181,
   "id": "e1f30e2f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "124029"
      ]
     },
     "execution_count": 1181,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(available_lfs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1182,
   "id": "8f8b0656",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|███████████████████████████████████████████████████████████████████████████████████████| 1700/1700 [00:57<00:00, 29.66it/s]\n"
     ]
    }
   ],
   "source": [
    "lfinh = dd(list)\n",
    "for h in tqdm(hypotheses):\n",
    "    for lf in available_lfs:\n",
    "        if f' {lf} ' in h.lower() and f' {lf} (' not in h.lower() and f' {lf}(' not in h.lower():\n",
    "            lfinh[h].append(lf)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1183,
   "id": "398bd387",
   "metadata": {},
   "outputs": [],
   "source": [
    "h2lfs = dd(list)\n",
    "for h, lfs in lfinh.items():\n",
    "    sorted_lfs = sorted(lfs, key=len, reverse=True)\n",
    "    longest_containing_all = []\n",
    "    for lf in sorted_lfs:\n",
    "        is_contained = any(lf in lf_o for lf_o in sorted_lfs if lf_o != lf)\n",
    "        if not is_contained:\n",
    "            longest_containing_all.append(lf)\n",
    "    h2lfs[h] = longest_containing_all"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1184,
   "id": "df582bc8",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████████████████████████████████████████████| 606/606 [00:00<00:00, 170427.00it/s]\n"
     ]
    }
   ],
   "source": [
    "new_hypotheses_lfs = dd(list)\n",
    "\n",
    "for h, lfs in tqdm(h2lfs.items()):\n",
    "    h_new = h\n",
    "    for lf in lfs:\n",
    "        ulf = llf2ulf[lf]\n",
    "        if ulf in lf2sf:\n",
    "            h_new = h_new.replace(lf, list(lf2sf[ulf])[0])\n",
    "    new_hypotheses_lfs[h].append(h_new)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1185,
   "id": "6fc90e76",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "606"
      ]
     },
     "execution_count": 1185,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(new_hypotheses_lfs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1186,
   "id": "ba5df1bc",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████████████████████████████████████████████| 606/606 [00:00<00:00, 350296.06it/s]\n"
     ]
    }
   ],
   "source": [
    "new_hypotheses_lfs_2 = dd(list)\n",
    "\n",
    "for h, lfs in tqdm(h2lfs.items()):\n",
    "    h_new = h\n",
    "    for lf in lfs:\n",
    "        ulf = llf2ulf[lf]\n",
    "        if ulf in lf2sf:\n",
    "            sf = list(lf2sf[ulf])[0]\n",
    "            h_new = h_new.replace(lf, f'{lf} ({sf})')\n",
    "    new_hypotheses_lfs_2[h].append(h_new)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1187,
   "id": "bee77e0d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "606"
      ]
     },
     "execution_count": 1187,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(new_hypotheses_lfs_2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1188,
   "id": "1a00a8f8",
   "metadata": {},
   "outputs": [],
   "source": [
    "i=1\n",
    "new_data = []\n",
    "for h, h_data in data_dict.items():\n",
    "    h, label = h.split('_____')\n",
    "    if h not in new_hypotheses_lfs:\n",
    "        new_rw = dd()\n",
    "        new_rw.update(h_data)\n",
    "        new_rw['Statement'] = h\n",
    "        new_data.append(new_rw)\n",
    "        continue\n",
    "    for h_new in new_hypotheses_lfs[h]:\n",
    "        new_rw = dd()\n",
    "        new_rw.update(h_data)\n",
    "        new_rw['Statement'] = h_new\n",
    "        new_data.append(new_rw)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1190,
   "id": "3e825a63",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Type</th>\n",
       "      <th>Section_id</th>\n",
       "      <th>Primary_id</th>\n",
       "      <th>Secondary_id</th>\n",
       "      <th>Label</th>\n",
       "      <th>Statement</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT01928186</td>\n",
       "      <td>NCT00684983</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00662129</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>Patients with Platelet count over 100,000/mm¬¨...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Adverse Events</td>\n",
       "      <td>NCT00093145</td>\n",
       "      <td>NCT00703326</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Heart-related AES were recorded in both the pr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT01097642</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>Adult Patients with histologic confirmation of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT00852930</td>\n",
       "      <td>NCT02308020</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>Laser Therapy is in each cohort of the primary...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1695</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00213980</td>\n",
       "      <td>NCT02536339</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Adequate blood, kidney, and hepatic function a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1696</th>\n",
       "      <td>Single</td>\n",
       "      <td>Results</td>\n",
       "      <td>NCT01605396</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>The Ridaforolimus + Dalotuzumab + Exemestane g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1697</th>\n",
       "      <td>Single</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT00181363</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>The only difference between the interventions ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1698</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00834678</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Patients must have a WBCCNT above 1,500/mm¬¨‚â...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1699</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Results</td>\n",
       "      <td>NCT01004172</td>\n",
       "      <td>NCT00802945</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>the primary trial and the secondary trial both...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1700 rows × 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            Type      Section_id   Primary_id Secondary_id          Label  \\\n",
       "0     Comparison    Intervention  NCT01928186  NCT00684983  Contradiction   \n",
       "1         Single     Eligibility  NCT00662129          NaN  Contradiction   \n",
       "2     Comparison  Adverse Events  NCT00093145  NCT00703326     Entailment   \n",
       "3         Single     Eligibility  NCT01097642          NaN  Contradiction   \n",
       "4     Comparison    Intervention  NCT00852930  NCT02308020  Contradiction   \n",
       "...          ...             ...          ...          ...            ...   \n",
       "1695  Comparison     Eligibility  NCT00213980  NCT02536339     Entailment   \n",
       "1696      Single         Results  NCT01605396          NaN  Contradiction   \n",
       "1697      Single    Intervention  NCT00181363          NaN     Entailment   \n",
       "1698      Single     Eligibility  NCT00834678          NaN     Entailment   \n",
       "1699  Comparison         Results  NCT01004172  NCT00802945  Contradiction   \n",
       "\n",
       "                                              Statement  \n",
       "0     All the primary trial participants do not rece...  \n",
       "1     Patients with Platelet count over 100,000/mm¬¨...  \n",
       "2     Heart-related AES were recorded in both the pr...  \n",
       "3     Adult Patients with histologic confirmation of...  \n",
       "4     Laser Therapy is in each cohort of the primary...  \n",
       "...                                                 ...  \n",
       "1695  Adequate blood, kidney, and hepatic function a...  \n",
       "1696  The Ridaforolimus + Dalotuzumab + Exemestane g...  \n",
       "1697  The only difference between the interventions ...  \n",
       "1698  Patients must have a WBCCNT above 1,500/mm¬¨‚â...  \n",
       "1699  the primary trial and the secondary trial both...  \n",
       "\n",
       "[1700 rows x 6 columns]"
      ]
     },
     "execution_count": 1190,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.DataFrame(new_data).drop_duplicates()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1191,
   "id": "eb984dfc",
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.DataFrame(new_data).drop_duplicates().to_json('dataset_3.json', orient='index')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1192,
   "id": "fffb265a",
   "metadata": {},
   "outputs": [],
   "source": [
    "i=1\n",
    "new_data = []\n",
    "for h, h_data in data_dict.items():\n",
    "    h, label = h.split('_____')\n",
    "    if h not in new_hypotheses_lfs_2:\n",
    "        new_rw = dd()\n",
    "        new_rw.update(h_data)\n",
    "        new_rw['Statement'] = h\n",
    "        new_data.append(new_rw)\n",
    "        continue\n",
    "    for h_new in new_hypotheses_lfs_2[h]:\n",
    "        new_rw = dd()\n",
    "        new_rw.update(h_data)\n",
    "        new_rw['Statement'] = h_new\n",
    "        new_data.append(new_rw)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1193,
   "id": "77f63e90",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Type</th>\n",
       "      <th>Section_id</th>\n",
       "      <th>Primary_id</th>\n",
       "      <th>Secondary_id</th>\n",
       "      <th>Label</th>\n",
       "      <th>Statement</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT01928186</td>\n",
       "      <td>NCT00684983</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>All the primary trial participants do not rece...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00662129</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>Patients with Platelet count over 100,000/mm¬¨...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Adverse Events</td>\n",
       "      <td>NCT00093145</td>\n",
       "      <td>NCT00703326</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Heart-related adverse events (AES) were record...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT01097642</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>Adult Patients with histologic confirmation of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT00852930</td>\n",
       "      <td>NCT02308020</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>Laser Therapy is in each cohort of the primary...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1695</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00213980</td>\n",
       "      <td>NCT02536339</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Adequate blood, kidney, and hepatic function a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1696</th>\n",
       "      <td>Single</td>\n",
       "      <td>Results</td>\n",
       "      <td>NCT01605396</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>The Ridaforolimus + Dalotuzumab + Exemestane g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1697</th>\n",
       "      <td>Single</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>NCT00181363</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>The only difference between the interventions ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1698</th>\n",
       "      <td>Single</td>\n",
       "      <td>Eligibility</td>\n",
       "      <td>NCT00834678</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Entailment</td>\n",
       "      <td>Patients must have a white blood cell count (W...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1699</th>\n",
       "      <td>Comparison</td>\n",
       "      <td>Results</td>\n",
       "      <td>NCT01004172</td>\n",
       "      <td>NCT00802945</td>\n",
       "      <td>Contradiction</td>\n",
       "      <td>the primary trial and the secondary trial both...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1700 rows × 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            Type      Section_id   Primary_id Secondary_id          Label  \\\n",
       "0     Comparison    Intervention  NCT01928186  NCT00684983  Contradiction   \n",
       "1         Single     Eligibility  NCT00662129          NaN  Contradiction   \n",
       "2     Comparison  Adverse Events  NCT00093145  NCT00703326     Entailment   \n",
       "3         Single     Eligibility  NCT01097642          NaN  Contradiction   \n",
       "4     Comparison    Intervention  NCT00852930  NCT02308020  Contradiction   \n",
       "...          ...             ...          ...          ...            ...   \n",
       "1695  Comparison     Eligibility  NCT00213980  NCT02536339     Entailment   \n",
       "1696      Single         Results  NCT01605396          NaN  Contradiction   \n",
       "1697      Single    Intervention  NCT00181363          NaN     Entailment   \n",
       "1698      Single     Eligibility  NCT00834678          NaN     Entailment   \n",
       "1699  Comparison         Results  NCT01004172  NCT00802945  Contradiction   \n",
       "\n",
       "                                              Statement  \n",
       "0     All the primary trial participants do not rece...  \n",
       "1     Patients with Platelet count over 100,000/mm¬¨...  \n",
       "2     Heart-related adverse events (AES) were record...  \n",
       "3     Adult Patients with histologic confirmation of...  \n",
       "4     Laser Therapy is in each cohort of the primary...  \n",
       "...                                                 ...  \n",
       "1695  Adequate blood, kidney, and hepatic function a...  \n",
       "1696  The Ridaforolimus + Dalotuzumab + Exemestane g...  \n",
       "1697  The only difference between the interventions ...  \n",
       "1698  Patients must have a white blood cell count (W...  \n",
       "1699  the primary trial and the secondary trial both...  \n",
       "\n",
       "[1700 rows x 6 columns]"
      ]
     },
     "execution_count": 1193,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.DataFrame(new_data).drop_duplicates()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1194,
   "id": "d085938a",
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.DataFrame(new_data).drop_duplicates().to_json('dataset_4.json', orient='index')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f1994410",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python [conda env:nlct]",
   "language": "python",
   "name": "conda-env-nlct-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.18"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
